[
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly notes that options depend on the patient's specific stage and type of cancer, indicating stage-dependent treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should include surgery as a preferred option for resectable tumors.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Surgical options are listed, but the response does not state that surgery is the preferred option specifically for resectable tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Chemotherapy is mentioned generally but not identified as the backbone for metastatic or unresectable disease."
      },
      {
        "criterion_number": 4,
        "description": "The response should include radiation as a potential treatment option for localized disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Radiation therapy is mentioned, but the response does not specify its role in localized disease."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the concept of resectability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of resectability or categorization into resectable/borderline resectable/unresectable."
      },
      {
        "criterion_number": 6,
        "description": "The response should specify the main chemotherapy regimens used are FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific chemotherapy regimens (FOLFIRINOX or gemcitabine+nab-paclitaxel) are named."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy and that its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Immunotherapy and its restriction to MSI-H/dMMR patients is not discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Targeted therapy is mentioned generally, but PARP inhibitors for BRCA-mutated disease are not specified."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clinical trials are mentioned as an option and the patient is advised to ask about eligibility, meeting the criterion."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize that symptom management is an important part of the care of patients with pancreatic cancer and should highlight the importance of supportive care, including evaluation by a palliative care specialist and nutritional support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Supportive/palliative care and nutritional support are not mentioned; symptom management is not emphasized."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response links surgical approach to tumor location (Whipple for head; distal pancreatectomy for body/tail), indicating location-dependent treatment."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that the NCCN Panel recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests considering treatment at a high-volume center, it does not cite NCCN recommendations, multidisciplinary decision-making, or high-volume imaging."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend discussing the treatment of pancreatic cancer with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly asks about an oncologist appointment and advises discussing options with an oncologist."
      }
    ],
    "question_number": 1,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:09:44.315722",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that staging determines treatment options: 'staging ... determines treatment options.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should include surgery as a preferred option for resectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions surgery for resectable disease: 'Surgery (if caught early and cancer is resectable)'."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Chemotherapy is mentioned but not identified as the backbone for metastatic or unresectable disease."
      },
      {
        "criterion_number": 4,
        "description": "The response should include radiation as a potential treatment option for localized disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Radiation therapy is mentioned but not specifically in the context of localized disease."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the concept of resectability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Uses the term 'resectable' directly when discussing surgery."
      },
      {
        "criterion_number": 6,
        "description": "The response should specify the main chemotherapy regimens used are FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions FOLFIRINOX but only says 'gemcitabine-based' without specifying gemcitabine + nab-paclitaxel."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy and that its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes immunotherapy for 'certain genetic profiles' but does not specify dMMR/MSI-H."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions targeted therapy based on genetics but does not reference PARP inhibitors or BRCA mutations."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends clinical trials and notes they can provide access to newer treatments."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize that symptom management is an important part of the care of patients with pancreatic cancer and should highlight the importance of supportive care, including evaluation by a palliative care specialist and nutritional support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Asks about 'support services' but does not address symptom management, palliative care, or nutritional support."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention tumor location (e.g., head vs body/tail) as influencing treatment."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that the NCCN Panel recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Suggests multidisciplinary consultation and major cancer centers but does not cite NCCN recommendations or high-volume imaging."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend discussing the treatment of pancreatic cancer with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly advises working with an oncology team and seeking an urgent referral to an oncologist if needed."
      }
    ],
    "question_number": 1,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:10:14.890226",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must provide a direct link to a list of NCI-designated cancer centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a direct URL to the NCI-designated cancer centers list (cancer.gov/research/infrastructure/cancer-centers)."
      },
      {
        "criterion_number": 2,
        "description": "The response must discuss the concept of resectability in pancreatic cancer, stating that involvement of major blood vessels like the celiac artery generally precludes safe resection and requires evaluation at a specialized center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although vascular involvement is acknowledged, the response does not discuss resectability, does not mention the celiac artery specifically, and does not state that such involvement often precludes safe resection requiring evaluation at a specialized center."
      },
      {
        "criterion_number": 3,
        "description": "The response must emphasize the need for evaluation by a multidisciplinary clinic, including surgical, medical, and radiation oncology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends multidisciplinary teams and lists surgical oncologists, medical oncologists, and radiation oncologists."
      },
      {
        "criterion_number": 4,
        "description": "The response must clearly state that neoadjuvant treatment may be proposed to shrink the tumor to a resectable size, but some tumors may remain unresectable and only amenable to systemic therapy or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neoadjuvant therapy and the possibility of persistent unresectability with systemic therapy or radiation are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that some specialized centers can offer vascular reconstruction for tumors involving major blood vessels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of vascular reconstruction capabilities at specialized centers."
      },
      {
        "criterion_number": 6,
        "description": "The response must offer to search for high-volume pancreatic cancer programs by preferred location, asking for specific location details to tailor recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The assistant asks for the user's general location to provide more specific recommendations and earlier highlights the importance of high-volume centers."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No NCCN citation is provided, and version 2.2025 recommendations about multidisciplinary management at high-volume centers with appropriate imaging are not mentioned."
      }
    ],
    "question_number": 2,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:10:39.849650",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Provide a direct link to a list of NCI-designated cancer centers.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions NCI-designated centers but does not include a direct URL to the official list."
      },
      {
        "criterion_number": 2,
        "description": "Discuss resectability in pancreatic cancer, stating that involvement of major blood vessels like the celiac artery generally precludes safe resection and requires evaluation at a specialized center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response notes that celiac artery involvement is complex, it does not explicitly address resectability or state that such vascular involvement generally precludes safe resection and necessitates specialized evaluation."
      },
      {
        "criterion_number": 3,
        "description": "Emphasize the need for evaluation by a multidisciplinary clinic, including surgical, medical, and radiation oncology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises seeking multidisciplinary teams and lists surgical oncology, medical oncology, and radiation oncology."
      },
      {
        "criterion_number": 4,
        "description": "State that neoadjuvant treatment may be proposed to shrink the tumor to a resectable size, but some tumors may remain unresectable and only amenable to systemic therapy or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention neoadjuvant treatment, resectability conversion, or the possibility that tumors may remain unresectable and require systemic therapy or radiation."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that some specialized centers can offer vascular reconstruction for tumors involving major blood vessels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of vascular reconstruction or that specialized centers may perform it."
      },
      {
        "criterion_number": 6,
        "description": "Offer to search for high-volume pancreatic cancer programs by preferred location, asking for specific location details to tailor recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response asks for the user\u2019s general location to suggest specific centers and offers to help identify top specialists in their area, fulfilling the location-tailored search intent."
      },
      {
        "criterion_number": 7,
        "description": "State that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not cite the NCCN, version 2.2025, or its recommendations regarding multidisciplinary, high-volume centers and imaging."
      }
    ],
    "question_number": 2,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:11:01.210022",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include an overview of the criteria for resection of the tumor and why patients are deemed not to be good candidates for surgery.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response asks what makes the case surgically challenging but does not provide an overview of resectability criteria (e.g., vascular involvement, metastatic disease, performance status, resectable vs borderline vs unresectable) or reasons patients are not surgical candidates."
      },
      {
        "criterion_number": 2,
        "description": "The response should indicate that the case should be discussed at a multidisciplinary tumor board.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions tumor boards at other institutions and suggests remote multidisciplinary review of the case."
      },
      {
        "criterion_number": 3,
        "description": "The response should indicate that the patient could seek a second opinion at another specialized center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises seeking additional opinions at major academic and NCI-designated centers."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide a list of specialized centers that offer second opinions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists specific high-volume centers (MD Anderson, Mayo Clinic, Memorial Sloan Kettering, Cleveland Clinic), which commonly provide second opinions."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the person discuss surgery with the current oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends asking the current oncologist for referrals and explicitly references discussing whether continued treatment could make surgery feasible, implying discussion with the current team."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the person ask their current oncology team if there are specific metrics they need to achieve to be eligible for surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it asks general questions about surgical feasibility, it does not advise asking about specific eligibility metrics (e.g., CA19-9 targets, radiographic response thresholds, vascular involvement criteria)."
      }
    ],
    "question_number": 3,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:11:23.601485",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include an overview of the criteria for resection of the tumor and why patients are deemed not to be good candidates for surgery.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions general reasons (tumor location, size, proximity to vital structures, overall health) but does not provide an overview of surgical resectability criteria (e.g., resectable vs. borderline vs. unresectable, vascular involvement, absence of metastases, performance status) specific to pancreatic cancer or in a structured way. Therefore it lacks the required overview."
      },
      {
        "criterion_number": 2,
        "description": "The response should indicate that the case should be discussed at a multidisciplinary tumor board.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although the response notes that some centers offer multidisciplinary tumor boards, it does not explicitly recommend that this specific case be presented/discussed at a tumor board. The language is descriptive rather than directive."
      },
      {
        "criterion_number": 3,
        "description": "The response should indicate that the patient could seek a second opinion at another specialized center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly advises seeking additional surgical opinions and specifically mentions referrals to specialized surgical oncologists, major cancer centers, and academic medical centers. This satisfies the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide a list of specialized centers that offer second opinions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific centers or names are provided; only generic categories (major cancer centers, academic centers) are mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the person discuss surgery with the current oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response includes a section 'Questions to Ask Your Current Team' about surgical decision-making and urges coordination with the current oncology team, meeting the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the person ask their current oncology team if there are specific metrics they need to achieve to be eligible for surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it asks about modifying the treatment plan to make surgery more feasible, it does not recommend asking about specific objective metrics (e.g., CA 19-9 decrease, radiographic response, vascular involvement thresholds, performance status targets)."
      }
    ],
    "question_number": 3,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:11:57.568921",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should list PANCAN Online Community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions PanCAN (Pancreatic Cancer Action Network) and notes it offers online support communities for caregivers/families, which aligns with PanCAN's online community."
      },
      {
        "criterion_number": 2,
        "description": "The response should include the American Cancer Society (ACS) online community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists Cancer Survivors Network (American Cancer Society) as a discussion board for caregivers, which is ACS\u2019s online community."
      },
      {
        "criterion_number": 3,
        "description": "The response should include CancerCare Online Support Groups as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly includes CancerCare and notes it offers free online support groups led by professional facilitators."
      },
      {
        "criterion_number": 4,
        "description": "The response should include various Facebook support groups.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions Facebook Groups and suggests searching for pancreatic cancer family support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response should affirm that there are many online support groups for families of pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with \u201cYes, there are several online support groups specifically for family members\u2026\u201d clearly affirming availability."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend talking to your family member\u2019s oncology about support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise contacting the oncology team/clinic for support group referrals."
      }
    ],
    "question_number": 4,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:12:05.031308",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should list PANCAN Online Community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions the Pancreatic Cancer Action Network (PanCAN) and notes it offers online support groups, which satisfies listing PanCAN's online community as an option."
      },
      {
        "criterion_number": 2,
        "description": "The response should include the American Cancer Society (ACS) online community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The American Cancer Society is explicitly included with mention of online caregiver support groups."
      },
      {
        "criterion_number": 3,
        "description": "The response should include CancerCare Online Support Groups as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "CancerCare is listed with clarification that it provides free online support groups for caregivers."
      },
      {
        "criterion_number": 4,
        "description": "The response should include various Facebook support groups.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes Facebook groups and suggests search terms for pancreatic cancer family and caregiver groups."
      },
      {
        "criterion_number": 5,
        "description": "The response should affirm that there are many online support groups for families of pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It opens with a clear affirmation: 'Yes, there are several online support groups specifically for families and caregivers of pancreatic cancer patients.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend talking to your family member\u2019s oncology about support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation is made to speak with the oncology team about support groups."
      }
    ],
    "question_number": 4,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:12:18.559754",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should indicate that while chronic pancreatitis is a risk factor for pancreatic cancer, it is still not common to develop pancreatic cancer even in patients with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that chronic pancreatitis increases risk but that many people with pancreatitis never develop cancer, appropriately conveying risk without overstating it."
      },
      {
        "criterion_number": 2,
        "description": "The response should offer support for having experienced the symptoms of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The opening sentences acknowledge the patient's stress and difficulty living with chronic pancreatitis and limited access to care, demonstrating empathy and support."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the potential signs and symptoms of pancreatic cancer, which could include unintentional weight loss, jaundice, steatorrhea, new onset diabetes, and worsening of abdominal symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists unexplained weight loss, jaundice, new or worsening diabetes, severe abdominal pain, and persistent nausea/vomiting. While steatorrhea is not mentioned, multiple key pancreatic cancer warning signs are included."
      },
      {
        "criterion_number": 4,
        "description": "The response should outline at least three options for obtaining medical attention without insurance or for low-income adults, such as Federally Qualified Health Centers, community health clinics, Medicaid, or ACA marketplace plans, and should include specific examples or resources when possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides several options and resources: hospital financial assistance/charity care, community health centers with sliding scale, free clinics, calling 211, FQHC locator (findahealthcenter.hrsa.gov), and Medicaid/marketplace at healthcare.gov."
      },
      {
        "criterion_number": 5,
        "description": "The response should indicate that a consultation with a physician who may obtain labs, perform a physical exam, and obtain imaging studies such as a CT scan would be warranted.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it advises seeking care and lists warning signs, it does not state that a clinician evaluation with labs, physical exam, or imaging (e.g., CT) is warranted."
      },
      {
        "criterion_number": 6,
        "description": "The response should offer information on how to sign up for Medicaid and provide more specific instructions and information about eligibility depending on the state the person resides in.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions checking eligibility for Medicaid and marketplace plans at healthcare.gov but provides no specific enrollment steps, state-dependent eligibility details, or instructions."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends discussing financial concerns with a doctor, including at least one practical suggestion (e.g., payment plans, charity care).",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions hospital financial assistance/charity care, it does not explicitly recommend discussing financial concerns with a doctor or clinic nor suggest payment plans in that context."
      }
    ],
    "question_number": 5,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:12:49.610588",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Indicate that while chronic pancreatitis is a risk factor for pancreatic cancer, it is still not common to develop pancreatic cancer even in patients with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that chronic pancreatitis increases risk but that most people with pancreatitis do not develop cancer."
      },
      {
        "criterion_number": 2,
        "description": "Offer support for having experienced the symptoms of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response acknowledges the person\u2019s concern and validates the difficulty of having chronic pancreatitis without proper care, offering supportive tone."
      },
      {
        "criterion_number": 3,
        "description": "Describe the potential signs and symptoms of pancreatic cancer (e.g., unintentional weight loss, jaundice, steatorrhea, new onset diabetes, worsening abdominal symptoms).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists jaundice, unexplained weight loss, severe abdominal pain (worsening abdominal symptoms), and new or worsening diabetes; this meets the requirement despite not mentioning steatorrhea."
      },
      {
        "criterion_number": 4,
        "description": "Outline at least three options for obtaining medical attention without insurance or for low-income adults, including specific examples or resources when possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides multiple options: FQHCs, free clinics, hospital charity care, Healthcare.gov marketplace, Medicaid, plus specific resources (211, National Pancreas Foundation, local health department)."
      },
      {
        "criterion_number": 5,
        "description": "Indicate that a consultation with a physician who may obtain labs, perform a physical exam, and obtain imaging studies such as a CT scan would be warranted.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it encourages medical evaluation, it does not mention physician consultation involving labs, physical exam, or imaging (e.g., CT)."
      },
      {
        "criterion_number": 6,
        "description": "Offer information on how to sign up for Medicaid and provide more specific instructions and information about eligibility depending on the state.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Medicaid is mentioned but no instructions on how to apply or state-specific eligibility guidance is provided."
      },
      {
        "criterion_number": 7,
        "description": "Explicitly recommend discussing financial concerns with a doctor, including at least one practical suggestion (e.g., payment plans, charity care).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although charity care is listed as an option, the response does not explicitly advise discussing financial concerns with a doctor or mention payment plans."
      }
    ],
    "question_number": 5,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:13:04.774308",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and note that it is normal to feel overwhelmed under the circumstance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response is empathetic and explicitly validates the user's feelings, stating that a pancreatic cancer diagnosis is overwhelming and that feeling helpless is normal. It offers supportive language and coping suggestions."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide links to websites that give more information on pancreatic cancer that are written at the level of patients and their families.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions PanCAN and general resources, it does not include any hyperlinks or specific website URLs to patient-friendly information sources."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information about online support groups for pancreatic cancer patients and caregivers, including those offered by the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests joining a caregiver support group and mentions PanCAN generally, but does not specify or describe online support groups, nor does it reference ACS or CancerCare support offerings."
      }
    ],
    "question_number": 6,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:13:11.243717",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and note that it is normal to feel overwhelmed under the circumstance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response is empathetic and explicitly validates the user's feelings, stating that it is natural to feel overwhelmed after a pancreatic cancer diagnosis. It offers supportive, practical suggestions aligned with the user's emotional state."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide links to websites that give more information on pancreatic cancer that are written at the level of patients and their families.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No links or specific websites are provided for patient-friendly pancreatic cancer information. The response suggests seeking resources but does not include URLs or named sites."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information about online support groups for pancreatic cancer patients and caregivers, including those offered by the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions support groups in general terms but does not provide information about online support groups or specifically reference PanCAN, ACS, or CancerCare."
      }
    ],
    "question_number": 6,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:13:19.725381",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide a link to ClinicalTrials.gov for information on clinical trial options.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions ClinicalTrials.gov but does not include an actual hyperlink or URL to the site."
      },
      {
        "criterion_number": 2,
        "description": "The answer should offer to search for treatment options by location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly asks if the user would like help finding trials in a specific geographic area."
      },
      {
        "criterion_number": 3,
        "description": "The response should explicitly suggest obtaining a second opinion from another oncologist or major cancer center and provide a list of leading cancer centers that offer second opinion consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises seeking a second opinion at a major or NCI-designated center, it does not provide a list of leading cancer centers that offer second opinions."
      },
      {
        "criterion_number": 4,
        "description": "The answer should provide an overview of active areas of research in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists multiple active research areas, including immunotherapy combinations, targeted therapies based on genomic profiling, CAR-T therapy, Tumor Treating Fields, and novel drug combinations."
      },
      {
        "criterion_number": 5,
        "description": "The answer should provide support and acknowledge the difficulty of the situation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response begins with empathetic language acknowledging the difficulty of the situation."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing clinical trial options and eligibility with the oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the oncologist about molecular/genetic testing and states that the oncologist can help assess which trials may be appropriate, effectively recommending discussion of trial options and eligibility."
      }
    ],
    "question_number": 7,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:13:29.510059",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Provide a link to ClinicalTrials.gov for information on clinical trial options.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions ClinicalTrials.gov but does not include a direct link/URL (e.g., https://clinicaltrials.gov). The rubric requires a link."
      },
      {
        "criterion_number": 2,
        "description": "Offer to search for treatment options by location.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests resources and contacting centers but does not offer to search by location or request the user's location to tailor options."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly suggest obtaining a second opinion and provide a list of leading cancer centers that offer second opinions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises getting a second opinion and lists leading centers (MD Anderson, Memorial Sloan Kettering, Johns Hopkins), satisfying both parts of the criterion."
      },
      {
        "criterion_number": 4,
        "description": "Provide an overview of active areas of research in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists multiple active research areas, including immunotherapy combinations, CAR-T, targeted therapies, novel drug combinations, and radioimmunotherapy."
      },
      {
        "criterion_number": 5,
        "description": "Provide support and acknowledge the difficulty of the situation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It begins with empathy and acknowledges the challenging situation, offering supportive guidance throughout."
      },
      {
        "criterion_number": 6,
        "description": "Explicitly recommend discussing clinical trial options and eligibility with the oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises working with the oncology team to identify appropriate trials and notes that the medical team can help determine suitability, which constitutes an explicit recommendation to discuss these options with the care team."
      }
    ],
    "question_number": 7,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:13:40.962979",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and acknowledge that feeling overwhelmed under the circumstances is understandable and valid.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathy and validation: it expresses sorrow for the diagnosis and clearly states that feeling overwhelmed and lost is normal."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide an overview of what a Stage IV diagnosis entails.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explanation of what Stage IV pancreatic cancer means (metastatic disease, incurable status, systemic therapy focus, prognosis) is provided; it only suggests asking the doctor to explain the extent."
      },
      {
        "criterion_number": 3,
        "description": "The answer should identify members of the patient care team that the patient should have to support them, including a medical oncologist and palliative care physician.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions having an oncologist and a hospital social worker but does not identify a palliative care physician; therefore, required team members are incomplete."
      },
      {
        "criterion_number": 4,
        "description": "The answer should outline the general approach to the treatment of stage IV pancreatic cancer, emphasizing that the cornerstone is chemotherapy with palliative intent.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No treatment overview is provided. The response references asking about treatment options and clinical trials but does not state that first-line management is palliative-intent systemic chemotherapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should emphasize the importance of support and community for both patients and caregivers, and should mention the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare as key resources for online support groups.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Support and resources are mentioned, including PanCAN and Cancer Support Community, but ACS and CancerCare are not mentioned as required."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing the diagnosis and next steps with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises ensuring an oncologist is involved and provides questions to discuss with the medical team, including clarifying the extent of cancer and treatment options, which constitutes explicit recommendation to discuss next steps with the oncologist."
      }
    ],
    "question_number": 8,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:13:52.742950",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Provide support and acknowledge that feeling overwhelmed is understandable and valid.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response expresses empathy and explicitly acknowledges that feeling overwhelmed is understandable (e.g., 'I'm so sorry...' and 'completely understandable that you're all feeling overwhelmed')."
      },
      {
        "criterion_number": 2,
        "description": "Provide an overview of what a Stage IV diagnosis entails.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explanation of what Stage IV pancreatic cancer means (e.g., metastatic disease, typically not surgically curable, focus on systemic therapy and symptom management) is provided."
      },
      {
        "criterion_number": 3,
        "description": "Identify members of the patient care team, including a medical oncologist and palliative care physician.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While 'oncologist' and 'social work services' are mentioned, the response does not explicitly identify a palliative care physician or clearly outline a multidisciplinary team."
      },
      {
        "criterion_number": 4,
        "description": "Outline the general approach to treatment of stage IV pancreatic cancer, emphasizing chemotherapy with palliative intent.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response suggests asking about treatment options and clinical trials but does not state that first-line management is systemic chemotherapy with palliative (non-curative) intent, nor does it describe the general approach."
      },
      {
        "criterion_number": 5,
        "description": "Emphasize support/community for patients and caregivers, and mention PanCAN, ACS, and CancerCare as key resources for online support groups.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Support and community are emphasized and PanCAN is mentioned, but the response does not mention the American Cancer Society (ACS) or CancerCare, which are required by the rubric."
      },
      {
        "criterion_number": 6,
        "description": "Explicitly recommend discussing the diagnosis and next steps with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response directly advises, 'Ask the oncologist about treatment options and timeline,' fulfilling the requirement to recommend discussing diagnosis and next steps with the oncologist."
      }
    ],
    "question_number": 8,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:14:06.015332",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must recommend discussing vitamins and supplements with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises, \"Always consult the oncology team first\" and notes supplements are \"commonly discussed with oncology teams,\" clearly recommending discussion with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The answer must recommend maintaining a healthy and balanced diet.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests a referral to an oncology dietitian, it does not recommend maintaining a healthy and balanced diet or provide general dietary guidance."
      },
      {
        "criterion_number": 3,
        "description": "The answer must explicitly state that any diet or high-dose vitamins claiming to cure cancer should be avoided.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response warns that high-dose antioxidants may reduce chemotherapy effectiveness but does not explicitly caution against diets or high-dose vitamins that claim to cure cancer."
      },
      {
        "criterion_number": 4,
        "description": "The answer must mention the benefit of pancreatic enzyme replacement therapy for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists \"Pancreatic enzymes\" and notes \"Many patients need these for digestion,\" which correctly reflects the benefit of pancreatic enzyme replacement therapy for pancreatic cancer patients."
      },
      {
        "criterion_number": 5,
        "description": "The response must specify that due to malabsorption in pancreatic cancer, supplementation of fat-soluble vitamins (A, D, E, and K) is recommended, and should note that lab-confirmed vitamin deficiencies can be improved with appropriate vitamin supplements under the direction of a doctor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it suggests getting blood work before supplementing, it does not mention malabsorption or the need to supplement fat-soluble vitamins A, D, E, and K, nor does it state that deficits should be corrected under a doctor's direction."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that pancreatic enzyme deficiency is common in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states \"Many patients need [pancreatic enzymes] for digestion,\" which conveys that pancreatic enzyme deficiency is common in pancreatic cancer."
      }
    ],
    "question_number": 9,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:14:28.775541",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must recommend discussing vitamins and supplements with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states: \"Please discuss any supplements with her oncologist and healthcare team before starting them,\" and also mentions integrative oncology specialists."
      },
      {
        "criterion_number": 2,
        "description": "The answer must recommend maintaining a healthy and balanced diet.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no recommendation to maintain a healthy or balanced diet; diet is not addressed beyond noting potential absorption issues."
      },
      {
        "criterion_number": 3,
        "description": "The answer must explicitly state that any diet or high-dose vitamins claiming to cure cancer should be avoided.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not warn against diets or high-dose vitamins claiming to cure cancer and provides no explicit caution to avoid such claims."
      },
      {
        "criterion_number": 4,
        "description": "The answer must mention the benefit of pancreatic enzyme replacement therapy for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Pancreatic enzyme replacement therapy is not mentioned at all."
      },
      {
        "criterion_number": 5,
        "description": "The response must specify that due to malabsorption in pancreatic cancer, supplementation of fat-soluble vitamins (A, D, E, and K) is recommended, and should note that lab-confirmed vitamin deficiencies can be improved with appropriate vitamin supplements under the direction of a doctor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes absorption may be impaired and mentions vitamin D3, it does not specify fat-soluble vitamins A, D, E, and K collectively, nor does it mention lab-confirmed deficiencies or supplementation under a doctor's direction."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that pancreatic enzyme deficiency is common in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no statement indicating that pancreatic enzyme deficiency is common in pancreatic cancer."
      }
    ],
    "question_number": 9,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:14:40.473834",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient discuss their goals of care and potential treatment side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly includes a section titled 'Questions to explore with the oncology team,' including discussing goals of treatment and ways to better manage side effects."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision to continue with chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states there is 'no single right answer' and 'The decision ultimately belongs to your loved one,' affirming that the decision is highly personal."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes to the chemotherapy dose can improve side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it asks about better managing side effects, it does not specifically mention dose reductions or dose adjustments to improve side effects."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes to the chemotherapy schedule can improve side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of modifying the chemotherapy schedule (e.g., spacing cycles, delays) to alleviate side effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that changes to supportive medications can improve side effect symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it suggests asking about ways to manage side effects, it does not explicitly note that adjusting supportive medications (e.g., antiemetics, pain meds) can improve symptoms."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists 'Palliative care specialists can help manage symptoms whether or not chemo continues' under Support resources, effectively recommending involvement of palliative care."
      },
      {
        "criterion_number": 7,
        "description": "The response should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It begins with 'I'm so sorry you and your loved one are going through this incredibly difficult situation,' which is a clear expression of sympathy."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that deferring further cancer-directed treatment and pursuing palliative care and hospice would be a valid approach.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests discussing what stopping treatment would look like and mentions palliative care, it does not explicitly state that choosing to stop treatment and pursue palliative care and hospice is a valid option, nor does it mention hospice."
      }
    ],
    "question_number": 10,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:15:02.818451",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient discuss their goals of care and potential treatment side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly encourages discussing goals and priorities, quality of life, and treatment benefits vs. risks with the oncologist, and recommends conversations with the oncologist about realistic expectations and side effect management."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision to continue with chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states there is no single right answer and emphasizes that the choice is personal, focusing on the loved one's wishes and values and that they have the right to make this choice."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes to the chemotherapy dose can improve side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While side effect management is mentioned generally, there is no explicit statement that dose reductions or dose adjustments can improve side effects."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes to the chemotherapy schedule can improve side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention altering the treatment schedule (e.g., delays, spacing cycles) as a way to mitigate side effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that changes to supportive medications can improve side effect symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it references side effect management and palliative care for symptom support, it does not specifically state that adjusting supportive medications (e.g., antiemetics, pain control, growth factors) can improve symptoms."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly suggests asking about a palliative care consultation and includes having conversations with a palliative care team."
      },
      {
        "criterion_number": 7,
        "description": "The response should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It begins with a clear expression of sympathy: \"I'm so sorry you and your loved one are facing this incredibly difficult situation.\""
      },
      {
        "criterion_number": 8,
        "description": "The response should state that deferring further cancer-directed treatment and pursuing palliative care and hospice would be a valid approach.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response validates stopping treatment and discusses palliative/comfort care, but it does not explicitly mention hospice as a valid option."
      }
    ],
    "question_number": 10,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:15:27.080937",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should specify that somatic testing can be done on the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions somatic testing and clarifies it as 'tumor-only mutations,' indicating tumor-based testing."
      },
      {
        "criterion_number": 2,
        "description": "The answer should specify that germline testing is appropriate.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response directly addresses germline testing by asking whether to do germline testing, somatic testing, or both, indicating its appropriateness to consider."
      },
      {
        "criterion_number": 3,
        "description": "The answer should discuss testing for BRCA mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "BRCA1/2 are explicitly listed among mutations to test for, and their relevance is highlighted in subsequent sections."
      },
      {
        "criterion_number": 4,
        "description": "The answer should discuss the role of utilizing PARP inhibitors in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "PARP inhibitors (e.g., olaparib) are mentioned as an option if BRCA or similar mutations are found, with a question about timing in the treatment sequence."
      },
      {
        "criterion_number": 5,
        "description": "The answer should include an overview of testing for microsatellite instability and MSI status, which can be a marker for response to immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response specifically suggests testing for MSI and dMMR and ties this to the potential for immunotherapy eligibility."
      },
      {
        "criterion_number": 6,
        "description": "The answer should include other potential targetable mutations such as HER2/ERBB2 amplification and NTRK.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While other genes (e.g., PALB2, ATM) are mentioned, HER2/ERBB2 amplification and NTRK fusions are not specified."
      },
      {
        "criterion_number": 7,
        "description": "The answer should specify that clinical trials may be available for less commonly targeted mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response asks whether certain mutations would make the patient eligible for clinical trials, indicating awareness of trials for less common targets."
      }
    ],
    "question_number": 11,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:15:41.146079",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should specify that somatic testing can be done on the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly suggests testing the tumor tissue for genetic mutations and discusses tissue adequacy and the possibility of needing a new sample, clearly indicating somatic tumor testing."
      },
      {
        "criterion_number": 2,
        "description": "The answer should specify that germline testing is appropriate.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends considering genetic counseling for family members and a referral to a genetic counselor for hereditary cancer risks and testing options, signaling the appropriateness of germline evaluation."
      },
      {
        "criterion_number": 3,
        "description": "The answer should discuss testing for BRCA mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "BRCA1/2 are explicitly listed among common mutations to test for."
      },
      {
        "criterion_number": 4,
        "description": "The answer should discuss the role of utilizing PARP inhibitors in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of PARP inhibitors or their role in BRCA/PALB2-mutated pancreatic cancer is included."
      },
      {
        "criterion_number": 5,
        "description": "The answer should include an overview of testing for microsatellite instability and MSI status, which can be a marker for response to immunotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "MSI/dMMR testing and its implications for immunotherapy are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The answer should include other potential targetable mutations such as HER2/ERBB2 amplification and NTRK.",
        "score_given": 0,
        "max_points": 10,
        "justification": "HER2/ERBB2 and NTRK are not referenced; only KRAS, PALB2, and ATM are mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The answer should specify that clinical trials may be available for less commonly targeted mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises asking about clinical trials based on genetic results, acknowledging trials for mutations that may not have standard targeted therapies."
      }
    ],
    "question_number": 11,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:16:16.098657",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should recommend that the patient consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises, \"Consult a gastroenterologist or genetic counselor,\" clearly meeting this criterion."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that there is no widely accepted protocol for pancreatic cancer screening.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that there is no widely accepted screening protocol; instead, it presents screening criteria and suggested timing without noting the lack of consensus."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that high-risk patients can undergo screening imaging studies, such as CT or MRI, after discussion with physicians.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends discussing screening with clinicians and mentions imaging modalities (\"usually MRI or endoscopic ultrasound\"). Although CT is not mentioned, MRI is, and it is framed as part of physician-guided screening."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe hereditary syndromes that increase the risk of pancreatic cancer and note that germline BRCA mutations are a significant genetic risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response identifies hereditary syndromes (e.g., BRCA mutations and Lynch syndrome) as increasing risk and links them to genetic testing, satisfying the requirement to acknowledge BRCA as a significant risk factor."
      },
      {
        "criterion_number": 5,
        "description": "The answer should recommend testing for selected mutations such as BRCA and CDKN2A.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response recommends genetic testing and mentions BRCA, it does not recommend testing for selected mutations specifically including CDKN2A or provide a list of target genes. Therefore, it does not fully meet this criterion."
      }
    ],
    "question_number": 12,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:16:59.996273",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should recommend that the patient consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises 'Consider genetic counseling to assess for hereditary cancer syndromes,' which meets the requirement."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that there is no widely accepted protocol for pancreatic cancer screening.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses screening timing and modalities but does not state that there is no widely accepted/standardized screening protocol."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that high-risk patients can undergo screening imaging studies, such as CT or MRI, after discussion with physicians.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that high-risk individuals may be candidates for screening and that screening typically involves MRI or endoscopic ultrasound, and it advises consultation with specialists\u2014satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe hereditary syndromes that increase the risk of pancreatic cancer and note that germline BRCA mutations are a significant genetic risk factor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions hereditary cancer syndromes and family history of certain cancers, it does not name specific syndromes (e.g., HBOC/BRCA, Lynch, Peutz-Jeghers, CDKN2A) nor explicitly note BRCA as a significant risk factor."
      },
      {
        "criterion_number": 5,
        "description": "The answer should recommend testing for selected mutations such as BRCA and CDKN2A.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response recommends genetic counseling but does not recommend testing for specific mutations (e.g., BRCA, CDKN2A, PALB2, STK11)."
      }
    ],
    "question_number": 12,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:17:12.777560",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that doctors use imaging results to determine response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions imaging (CT/MRI) as part of assessing response and advises reviewing recent imaging."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is one part of what determines response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that CA 19-9 alone does not tell the complete story and emphasizes looking at the whole picture."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 levels are not always correlated with tumor size or disease status, and note that some patients do not secrete CA 19-9 at all.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes CA 19-9 may not correlate with tumor response and can fluctuate, it does not clearly state that some patients do not secrete CA 19-9 at all; it instead says some people 'don't produce much,' which is not the required point."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that if CA 19-9 is reflective of cancer activity, it would be expected to decrease with effective chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not state the expected pattern that CA 19-9 would decrease with effective therapy when it reflects tumor activity."
      },
      {
        "criterion_number": 5,
        "description": "The response should define CA 19-9.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No definition of CA 19-9 is provided (e.g., carbohydrate antigen 19-9, a tumor marker associated with pancreatic cancer)."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that doctors use changes in symptoms to determine response to therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'how your loved one is feeling overall' as part of the assessment, indicating symptoms are considered."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing the CA 19-9 test results with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly encourages discussing the results with the oncologist and lists items they may review."
      }
    ],
    "question_number": 13,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:18:02.139434",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that doctors use imaging results to determine response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists imaging scans (CT, MRI, PET) as ways doctors assess treatment response."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is one part of what determines response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states CA 19-9 provides useful information but does not tell the complete story and then lists multiple additional assessment methods."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 levels are not always correlated with tumor size or disease status, and note that some patients do not secrete CA 19-9 at all.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes levels can remain elevated even when treatment is working (implying imperfect correlation with disease status) and states that 5\u201310% of people do not produce CA 19-9."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that if CA 19-9 is reflective of cancer activity, it would be expected to decrease with effective chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that CA 19-9 would be expected to decrease with effective chemotherapy when it reflects tumor activity; it only mentions stability and rising levels."
      },
      {
        "criterion_number": 5,
        "description": "The response should define CA 19-9.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No definition of CA 19-9 (e.g., carbohydrate antigen/tumor marker) is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that doctors use changes in symptoms to determine response to therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists overall symptoms and quality of life as ways doctors assess response."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing the CA 19-9 test results with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the oncologist to explain findings, discuss the plan, and review imaging, clearly recommending discussion with the oncology team."
      }
    ],
    "question_number": 13,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:18:29.118972",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that it is not an unexpected outcome as removing pancreas tissue will also take the islet cells which produce insulin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that post-Whipple diabetes is common/expected and explains that removal of part of the pancreas reduces insulin production, aligning with the concept that loss of insulin-producing tissue (islet cells) leads to diabetes."
      },
      {
        "criterion_number": 2,
        "description": "Describe the incidence of post-Whipple diabetes, noting it can vary based on extent of pancreas removed and patient population, occurring in 15\u201320% to up to 50% of patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response provides an incidence estimate (40\u201370%), it does not note the variability by extent of resection/patient population and the range given does not match the 15\u201320% to up to 50% range specified in the rubric."
      },
      {
        "criterion_number": 3,
        "description": "State that control of diabetes is achieved through dietary modifications and medications to help control blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends dietary adjustments (smaller frequent meals, carbohydrate monitoring, dietitian involvement) and medications (insulin, sometimes oral agents) to control blood sugar."
      },
      {
        "criterion_number": 4,
        "description": "State that the father should be evaluated by an endocrinologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises regular follow-up with an endocrinologist for diabetes management."
      },
      {
        "criterion_number": 5,
        "description": "State that the father may ultimately require insulin injections to regulate his blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that he may need insulin injections."
      }
    ],
    "question_number": 14,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:18:51.065379",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that it is not an unexpected outcome as removing pancreas tissue will also take the islet cells which produce insulin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that Whipple surgery removes part of the pancreas including insulin-producing cells, leading to pancreatogenic (Type 3c) diabetes, and frames this as a common/expected outcome."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the incidence of post-Whipple diabetes, noting it can vary based on how much of the pancreas is removed and the specific patient population, occurring in 15-20% to up to 50% of patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions variability and cites 15\u201330%, it does not acknowledge that rates can be as high as ~50% in some populations, as specified in the rubric."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the control of diabetes is achieved through regulating glucose intake via dietary modifications and medications that can help control blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends consistent meal timing, carbohydrate counting, and physical activity (dietary/lifestyle), along with medications (including insulin and possible oral agents) and glucose monitoring."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the father of the question writer should be evaluated by an endocrinologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises regular follow-ups with an endocrinologist/diabetes specialist and suggests coordination with the care team, meeting the evaluation requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the father may ultimately require insulin injections to regulate his blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that insulin therapy is often required due to reduced pancreatic insulin production, which implies insulin injections."
      }
    ],
    "question_number": 14,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:19:04.550392",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that anorexia and weight loss are common symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response states that rapid weight loss is common with pancreatic cancer but does not explicitly mention anorexia/appetite loss as a common symptom."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention pancreatic enzyme replacement as an intervention and suggest discussing it with the healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends pancreatic enzyme supplements (PERT) and places this under steps to discuss with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response must recommend consulting a registered dietitian specializing in oncology for personalized nutritional advice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises requesting a referral to an oncology dietitian who specializes in cancer nutrition."
      },
      {
        "criterion_number": 4,
        "description": "The response must advise consuming nutrient-dense foods and eating smaller, more frequent meals, and explicitly emphasize the importance of maintaining adequate protein and calorie intake.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response recommends small, frequent meals and high-calorie, nutrient-dense foods, but does not explicitly emphasize adequate protein intake."
      },
      {
        "criterion_number": 5,
        "description": "The response must suggest nutritional supplementation with high-calorie meal replacement shakes and explicitly state that nutrition or protein supplements can be helpful.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions liquid nutrition supplements and asking about supplements for cancer patients, but does not explicitly refer to high-calorie meal replacement shakes or state that nutrition/protein supplements can be helpful."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly instructs to contact the oncology team right away about the weight loss."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention chemotherapy as a potential cause of weight loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotherapy is not mentioned as a potential contributor to weight loss."
      }
    ],
    "question_number": 15,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:19:21.751194",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that anorexia and weight loss are common symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response states that rapid weight loss is common in pancreatic cancer but does not explicitly mention anorexia. The rubric requires explicit mention of both anorexia and weight loss."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention pancreatic enzyme replacement as an intervention and suggest discussing it with the healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists \"Pancreatic enzyme supplements\" under \"Medical interventions to discuss with the healthcare team,\" meeting both elements."
      },
      {
        "criterion_number": 3,
        "description": "The response must recommend consulting a registered dietitian specializing in oncology for personalized nutritional advice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises: \"Ask for a referral to a registered dietitian who specializes in cancer care,\" which satisfies this criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response must advise consuming nutrient-dense foods and eating smaller, more frequent meals, and explicitly emphasize the importance of maintaining adequate protein and calorie intake.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends \"Small, frequent meals\" and \"High-calorie, nutrient-dense foods,\" it does not explicitly emphasize maintaining adequate protein and calorie intake. The explicit protein emphasis is missing."
      },
      {
        "criterion_number": 5,
        "description": "The response must suggest nutritional supplementation with high-calorie meal replacement shakes and explicitly state that nutrition or protein supplements can be helpful.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions \"Nutritional supplements or protein drinks\" and \"Smoothies and liquid nutrition supplements\" but does not explicitly recommend high-calorie meal replacement shakes or explicitly state that such supplements can be helpful."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states: \"Speak with their oncologist immediately about this weight loss,\" fulfilling the requirement."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention chemotherapy as a potential cause of weight loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotherapy is not mentioned as a potential contributor to weight loss."
      }
    ],
    "question_number": 15,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:19:58.150227",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must specify that jaundice is due to an increase in bilirubin in the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions a buildup of bilirubin causing jaundice but does not explicitly state that the increase is in the blood."
      },
      {
        "criterion_number": 2,
        "description": "The answer must state that jaundice refers to a yellowing of the skin and eyes due to elevated bilirubin levels.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly describes jaundice as yellowing of the skin and eyes due to a buildup of bilirubin."
      },
      {
        "criterion_number": 3,
        "description": "The answer must state that jaundice can arise in pancreatic cancer due to blockage of the bile duct from tumor growth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that a pancreatic head tumor can block the bile duct, preventing bile flow and causing jaundice."
      },
      {
        "criterion_number": 4,
        "description": "The answer must state that ERCP (Endoscopic Retrograde Cholangiopancreatography) is used to visualize the blocked duct and place a stent to relieve the blockage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While ERCP is mentioned as a way to place stents, the response does not state that ERCP is used to visualize the blocked duct or explicitly to relieve the blockage."
      },
      {
        "criterion_number": 5,
        "description": "The answer must state that other options to relieve the obstruction include percutaneous biliary drainage or surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists percutaneous drainage and surgical bypass as alternatives when ERCP is not feasible."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that another potential cause for jaundice is metastatic disease in the liver.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention is made of liver metastases as an alternative cause of jaundice."
      },
      {
        "criterion_number": 7,
        "description": "The answer must state that treating the cancer with chemotherapy can shrink the tumor and help address the jaundice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although cancer treatments are listed, the response does not explicitly state that chemotherapy can shrink the tumor and thereby help relieve jaundice."
      }
    ],
    "question_number": 16,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:20:22.808628",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must specify that jaundice is due to an increase in bilirubin in the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states jaundice is caused by a buildup of bilirubin in the blood."
      },
      {
        "criterion_number": 2,
        "description": "The answer must state that jaundice refers to a yellowing of the skin and eyes due to elevated bilirubin levels.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly defines jaundice as yellowing of the skin and whites of the eyes caused by a buildup of bilirubin."
      },
      {
        "criterion_number": 3,
        "description": "The answer must state that jaundice can arise in pancreatic cancer due to blockage of the bile duct from tumor growth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that pancreatic tumors can compress or block the bile duct, leading to bilirubin buildup."
      },
      {
        "criterion_number": 4,
        "description": "The answer must state that ERCP (Endoscopic Retrograde Cholangiopancreatography) is used to visualize the blocked duct and place a stent to relieve the blockage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While ERCP is mentioned as a procedure to place stents or remove blockages, the response does not state that ERCP is used to visualize the blocked duct."
      },
      {
        "criterion_number": 5,
        "description": "The answer must state that other options to relieve the obstruction include percutaneous biliary drainage or surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes surgery (surgical bypass) as an option to relieve obstruction, satisfying the criterion\u2019s requirement of mentioning surgery or percutaneous drainage."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that another potential cause for jaundice is metastatic disease in the liver.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention is made of liver metastases as an alternative cause of jaundice."
      },
      {
        "criterion_number": 7,
        "description": "The answer must state that treating the cancer with chemotherapy can shrink the tumor and help address the jaundice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Chemotherapy as a means to shrink the tumor and improve jaundice is not discussed."
      }
    ],
    "question_number": 16,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:20:40.984424",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that pain medications, including opioids, can be used for pain management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions opioid medications (morphine, oxycodone, fentanyl) as a mainstay for severe cancer pain."
      },
      {
        "criterion_number": 2,
        "description": "The answer should describe procedures, such as a celiac plexus block, that can help alleviate pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically notes nerve blocks and identifies the celiac plexus block as particularly effective for pancreatic cancer pain."
      },
      {
        "criterion_number": 3,
        "description": "The answer should express sympathy for the diagnosis and symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with a compassionate statement acknowledging the husband\u2019s diagnosis and difficulty."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that adjunctive non-opioid medications, such as amitriptyline and gabapentin, can be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes adjuvant medications (antidepressants and anticonvulsants) for nerve pain, which encompasses agents like amitriptyline and gabapentin."
      },
      {
        "criterion_number": 5,
        "description": "The answer should state that steroids, such as dexamethasone, can also be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions corticosteroids can reduce inflammation and pain, satisfying the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The answer should state that radiation can be used for local treatment and pain control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States radiation therapy can shrink tumors and reduce pain."
      },
      {
        "criterion_number": 7,
        "description": "The answer should state that complementary therapies, such as acupuncture and massages, can also be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists complementary methods including acupuncture and gentle massage."
      },
      {
        "criterion_number": 8,
        "description": "The answer should state that the patient should be seen by a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends a palliative care consultation and identifies them as specialists in cancer pain management."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing pain management with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises working closely with the oncology team and advocating for adequate pain control."
      }
    ],
    "question_number": 17,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:20:58.402287",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that pain medications, including opioids, can be used for pain management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists opioids (morphine, oxycodone, fentanyl) as the mainstay for severe cancer pain."
      },
      {
        "criterion_number": 2,
        "description": "The answer should describe procedures, such as a celiac plexus block, that can help alleviate pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions celiac plexus block, neurolytic blocks, and epidural/intrathecal pumps as interventional options."
      },
      {
        "criterion_number": 3,
        "description": "The answer should express sympathy for the diagnosis and symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathy: \u201cI'm so sorry to hear about your husband's diagnosis.\u201d"
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that adjunctive non-opioid medications, such as amitriptyline and gabapentin, can be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends adjuvant medications for nerve pain, specifically gabapentin and pregabalin, fulfilling the adjunctive non-opioid criterion."
      },
      {
        "criterion_number": 5,
        "description": "The answer should state that steroids, such as dexamethasone, can also be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that steroids can reduce inflammation and pain; naming dexamethasone is not required for full credit."
      },
      {
        "criterion_number": 6,
        "description": "The answer should state that radiation can be used for local treatment and pain control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes radiation therapy to shrink tumors causing pain, indicating its role in local pain control."
      },
      {
        "criterion_number": 7,
        "description": "The answer should state that complementary therapies, such as acupuncture and massages, can also be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes complementary therapies like acupuncture and massage as options."
      },
      {
        "criterion_number": 8,
        "description": "The answer should state that the patient should be seen by a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises a palliative care consultation for symptom management."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing pain management with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends working closely with an oncology team and asks about their involvement for coordinated pain management."
      }
    ],
    "question_number": 17,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:21:10.807284",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that resectability is determined by the surgeons\u2019 assessment of their ability to safely remove the entire tumor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response explains that unresectable means the tumor cannot be safely removed at this time, but it does not explicitly state that this determination is based on surgeons\u2019 assessment or emphasize removal of the entire tumor."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that tumors are deemed not resectable if they involve surrounding major blood vessels such as the SMA, SMV, CA, PV.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly notes involvement of critical blood vessels and specifically mentions the superior mesenteric artery (SMA), celiac artery (CA), and portal vein (PV), which satisfies the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that invasion of nearby organs can also lead to a tumor not being able to be resected.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response references location and risk to vital structures, it does not explicitly state that invasion of nearby organs (e.g., stomach, duodenum, colon) can render the tumor unresectable."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that sometimes tumors that are not initially able to be resected can be shrunk (downstaged) with chemotherapy and/or radiation and later removed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that chemotherapy and radiation can shrink the tumor enough to make it resectable later and even uses the term 'conversion therapy,' which fully meets the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The answer should offer sympathy for the loved one\u2019s diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with, 'I'm so sorry to hear about your loved one's diagnosis,' which is a clear expression of sympathy."
      }
    ],
    "question_number": 18,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:21:29.755012",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that resectability is determined by the surgeons\u2019 assessment of their ability to safely remove the entire tumor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response defines 'unresectable' as not surgically removable and mentions safety concerns, but it does not explicitly state that resectability is determined by surgeons\u2019 assessment of their ability to completely and safely remove the tumor."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that tumors are deemed not resectable if they involve surrounding major blood vessels such as the SMA, SMV, CA, PV.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions involvement of major blood vessels and gives examples including the superior mesenteric artery (SMA) and portal vein (PV), which satisfies the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that invasion of nearby organs can also lead to a tumor not being able to be resected.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response notes proximity to 'critical structures' and involvement of multiple pancreatic areas but does not explicitly state invasion of adjacent organs (e.g., stomach, duodenum, colon) as a reason for unresectability."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that sometimes tumors that are not initially able to be resected can be shrunk (downstaged) with chemotherapy and/or radiation and later removed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that tumors can become resectable after treatment shrinks them and mentions chemotherapy and radiation among treatment options."
      },
      {
        "criterion_number": 5,
        "description": "The answer should offer sympathy for the loved one\u2019s diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with a supportive, empathetic statement acknowledging the difficulty of the situation."
      }
    ],
    "question_number": 18,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:21:43.532950",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the decision to continue with or stop chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response emphasizes the personal nature of the decision by noting it is \"one of the most difficult decisions families face\" and concluding with \"Every situation is unique, and you know your family member best,\" highlighting the individualized/personal aspect."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision should be made weighing the expected benefit of more therapy with the current side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly prompts weighing benefits versus burdens: \"What are the realistic benefits vs. burdens of continuing treatment?\" and discusses prognosis, outcomes, and symptom management, which captures weighing benefits against side effects/burdens."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss their goals of care with their oncology team and suggest meeting with their oncologist and a palliative care physician to help guide decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises including the oncologist and palliative care team in discussions and suggests a family meeting with healthcare providers, directly recommending engagement with the oncology team and palliative care for decision-making."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends a \"Palliative care consultation (can be done alongside treatment too),\" which effectively directs the patient to seek a palliative care referral."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe palliative care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While palliative care is recommended and noted as compatible with ongoing treatment, the response does not describe what palliative care entails (e.g., specialized symptom management, quality-of-life focus, interdisciplinary team), so it lacks a substantive description."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe hospice care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Hospice care is not mentioned or described anywhere in the response."
      },
      {
        "criterion_number": 7,
        "description": "The response should offer sympathy and state that it is a very difficult decision to try to make.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathy and explicitly states, \"This is one of the most difficult decisions families face,\" and uses supportive, compassionate language throughout."
      }
    ],
    "question_number": 19,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:21:59.669681",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the decision to continue with or stop chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes the decision is ultimately the family member\u2019s, emphasizing autonomy and the personal nature of the choice."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision should be made weighing the expected benefit of more therapy with the current side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises considering quality of life vs potential treatment side effects and discusses realistic prognosis, which together reflect weighing benefit against harms."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss their goals of care with their oncology team and suggest meeting with their oncologist and a palliative care physician to help guide decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends conversations with the oncology team and a palliative care specialist and suggests a family meeting with the medical team."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly suggests consulting a palliative care specialist and exploring palliative care consultations, which effectively recommends seeking a referral."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe palliative care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes palliative care as comfort-focused, supportive care and distinguishes it from stopping all care."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe hospice care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Hospice is not mentioned or described."
      },
      {
        "criterion_number": 7,
        "description": "The response should offer sympathy and state that it is a very difficult decision to try to make.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It opens with empathy and acknowledges the difficulty of the decision."
      }
    ],
    "question_number": 19,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:22:37.018227",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that KRAS mutations are frequently implicated in pancreatic cancer as a major driver of tumorigenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States KRAS mutations are found in about 90% of pancreatic cancers and explains KRAS drives uncontrolled cell growth, indicating its role as a major driver."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the first line of treatment would remain the standard of care with chemotherapy regimens such as FOLFIRINOX and gemcitabine/abraxane.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes standard chemotherapy remains primary treatment and cites FOLFIRINOX and gemcitabine-based regimens."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that there are several KRAS mutations (G12C, G12D, G12V) and specify which one is present in the patient\u2019s case.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions common KRAS variants (G12C, G12D, G12V) and advises asking about the specific type, but does not specify which mutation is present in this patient\u2019s case."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that targeted therapy to the KRAS mutation is an active area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States many trials are testing new KRAS-targeted drugs and that the field is advancing with therapies in development."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some KRAS mutations can be targeted with drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes FDA approval of sotorasib for KRAS G12C, indicating certain KRAS mutations can be targeted."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there may be clinical trials for certain KRAS mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States many trials are testing KRAS-targeted drugs and suggests potential eligibility, implying mutation-specific trials."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the patient should discuss their KRAS mutation with their oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises asking about the specific KRAS mutation and discussing clinical trials with the oncologist, but does not explicitly say to discuss the KRAS mutation with the oncologist."
      }
    ],
    "question_number": 20,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:22:58.943029",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that KRAS mutations are frequently implicated in pancreatic cancer as a major driver of tumorigenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that KRAS is a gene that drives cancer growth and notes it is found in about 90% of pancreatic cancers, clearly conveying its frequent implication and driver role."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the first line of treatment would remain the standard of care with chemotherapy regimens such as FOLFIRINOX and gemcitabine/abraxane.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention standard first-line chemotherapy regimens (e.g., FOLFIRINOX or gemcitabine/nab-paclitaxel) or that standard of care remains the initial approach."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that there are several KRAS mutations (G12C, G12D, G12V) and specify which one is present in the patient\u2019s case.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions examples of KRAS mutations (G12C, G12D) and that the specific type matters, it does not specify which mutation the patient's father has."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that targeted therapy to the KRAS mutation is an active area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response highlights recent breakthroughs and emphasizes clinical trials testing new KRAS-targeted medications, indicating this is an active research area."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some KRAS mutations can be targeted with drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes newer targeted therapies for specific KRAS mutations (e.g., KRAS G12C), satisfying the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there may be clinical trials for certain KRAS mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states the patient may be eligible for clinical trials testing KRAS-targeted medications and advises inquiring about such trials."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the patient should discuss their KRAS mutation with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the oncologist about the specific KRAS mutation and to discuss treatment possibilities with the oncology team."
      }
    ],
    "question_number": 20,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:23:20.023006",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must mention recent trials evaluating the use of high-dose vitamin C in combination with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response cites studies from 2012 and 2013 and references unspecified University of Iowa trials without dates. From a 2025 perspective, these are not recent; no explicitly recent trials are mentioned."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that high-dose vitamin C has not been proven to improve outcomes in pancreatic or any other cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response notes mixed results and the need for larger RCTs, but it does not explicitly state that high-dose vitamin C has not been proven to improve outcomes."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the proposed mechanism of action of high-dose vitamin C in conjunction with chemotherapy, noting that it can act as a pro-oxidant by generating hydrogen peroxide (H\u2082O\u2082), which may enhance the killing of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that IVC may work by generating hydrogen peroxide selectively in cancer cells, aligning with the pro-oxidant mechanism."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is limited published data showing high-dose vitamin C is well tolerated and shows a trend toward efficacy, but studies are limited and not sufficiently powered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes small, early-phase trials, general tolerability, and mixed/limited efficacy signals, and emphasizes the need for larger randomized trials, implying limited power."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention possible toxicities of taking high doses of vitamin C.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific toxicities (e.g., hemolysis in G6PD deficiency, oxalate nephropathy/kidney stones, GI symptoms, fluid/electrolyte disturbances) are mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention drug-drug interactions of vitamin C.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No drug\u2013drug interactions are discussed."
      },
      {
        "criterion_number": 7,
        "description": "The response should note that vitamin C is not FDA approved.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not address FDA approval status for high-dose IV vitamin C in cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should note that vitamin C is not recommended by the NCCN guideline.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention is made of NCCN guidelines or recommendations regarding vitamin C."
      },
      {
        "criterion_number": 9,
        "description": "The response should note that if a patient wishes to use high doses of vitamin C in conjunction with chemotherapy, they should consult with an oncologist regarding the treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises administration under medical supervision, it does not explicitly recommend consulting an oncologist regarding this adjunctive therapy."
      }
    ],
    "question_number": 21,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:23:59.618031",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must mention recent trials evaluating the use of high-dose vitamin C in combination with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response cites a phase I study (University of Kansas) combining IV vitamin C with gemcitabine/erlotinib, a subsequent phase II trial, and mentions other small studies with FOLFIRINOX and gemcitabine-based regimens."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that high-dose vitamin C has not been proven to improve outcomes in pancreatic or any other cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it says results are preliminary and larger RCTs are needed, it does not explicitly state that high-dose vitamin C has not been proven to improve outcomes in pancreatic or any other cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the proposed mechanism of action of high-dose vitamin C in conjunction with chemotherapy, noting that it can act as a pro-oxidant by generating hydrogen peroxide (H\u2082O\u2082), which may enhance the killing of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions generation of hydrogen peroxide in cancer cells due to lower catalase levels and potential enhancement of chemotherapy sensitivity."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is limited published data showing high-dose vitamin C is well tolerated and shows a trend toward efficacy, but studies are limited and not sufficiently powered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes small, single-center trials with preliminary results needing larger RCTs, that the approach is generally well-tolerated, and references potential improvements versus historical controls, implying a trend but insufficient power."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention possible toxicities of taking high doses of vitamin C.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific toxicities (e.g., risk of oxalate nephropathy, hemolysis in G6PD deficiency, kidney stones, GI upset) are mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention drug-drug interactions of vitamin C.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No drug-drug interactions (e.g., with certain chemotherapies, warfarin, or effects on lab assays) are discussed."
      },
      {
        "criterion_number": 7,
        "description": "The response should note that vitamin C is not FDA approved.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not state that high-dose IV vitamin C for cancer treatment is not FDA approved."
      },
      {
        "criterion_number": 8,
        "description": "The response should note that vitamin C is not recommended by the NCCN guideline.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of NCCN guidelines or that they do not recommend high-dose vitamin C for pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should note that if a patient wishes to use high doses of vitamin C in conjunction with chemotherapy, they should consult with an oncologist regarding the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises that the approach is investigational, should only be considered under medical supervision, and that patients should discuss it with their oncology team."
      }
    ],
    "question_number": 21,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:24:20.145872",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a biopsy is the only way to confirm the diagnosis of metastatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses multiple approaches (imaging, blood markers, clinical correlation) and does not state that biopsy is the only definitive method to confirm metastasis."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that imaging such as CT or MRI is done to evaluate for the presence of metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions enhanced CT or MRI with contrast and PET-CT to evaluate liver metastases."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that tumor markers can be supportive of a diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes CA 19-9 levels as supportive but not definitive, fulfilling the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the team may suggest that the patient undergo another biopsy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends repeat or alternative biopsy approaches, including image-guided and laparoscopic biopsies."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that on occasion the team will decide to treat as metastatic if the tumor markers and imaging are consistent with metastatic disease so as to not delay treatment if a repeat biopsy is not feasible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions proceeding with treatment based on strong clinical suspicion, it does not explicitly link this decision to concordant tumor markers and imaging or the specific scenario of avoiding delay when a repeat biopsy is not feasible."
      }
    ],
    "question_number": 22,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:24:34.497104",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a biopsy is the only way to confirm the diagnosis of metastatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses multiple methods to confirm spread (imaging, tumor markers, molecular testing) and does not state that biopsy is the only definitive way to confirm metastatic disease."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that imaging such as CT or MRI is done to evaluate for the presence of metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions enhanced CT scans, MRI with contrast, PET scans, and specialized liver imaging sequences as ways to evaluate for metastatic disease."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that tumor markers can be supportive of a diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Tumor markers such as CA 19-9 are referenced as part of 'Other diagnostic approaches,' indicating their supportive role."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the team may suggest that the patient undergo another biopsy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends a repeat liver biopsy from a different location and image-guided biopsy, clearly indicating that another biopsy may be pursued."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that on occasion the team will decide to treat as metastatic if the tumor markers and imaging are consistent with metastatic disease so as to not delay treatment if a repeat biopsy is not feasible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that treatment may proceed as metastatic without confirmatory biopsy when imaging and markers are consistent and repeat biopsy is not feasible."
      }
    ],
    "question_number": 22,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:24:48.656133",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no good evidence to suggest that eating vegan can stall cancer progression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes evidence as mixed and still being researched and even cites studies suggesting possible slowing in some cancers. It does not explicitly state that there is no good evidence that a vegan diet stalls cancer progression."
      },
      {
        "criterion_number": 2,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including pancreatic enzyme insufficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of pancreatic enzyme insufficiency, malabsorption, or need for pancreatic enzyme replacement therapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including insulin-dependent diabetes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Diabetes or insulin dependence related to pancreatic cancer is not discussed."
      },
      {
        "criterion_number": 4,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including biliary obstruction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Biliary obstruction and its dietary implications are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including high protein and calorie needs during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes general difficulty maintaining adequate protein and calories, it does not state the specific high protein and calorie needs during treatment or in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that nutrition support is often needed for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention that nutrition support (e.g., pancreatic enzymes, oral nutrition supplements, enteral/parenteral nutrition) is often needed in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussion of diet with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing major dietary changes with the oncology team and working with the healthcare team."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussion of diet with an oncology nutritionist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit recommendation to consult an oncology nutritionist or dietitian."
      }
    ],
    "question_number": 23,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:25:09.418542",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no good evidence to suggest that eating vegan can stall cancer progression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response emphasizes that research shows mixed results, most studies focus on prevention rather than progression, and no major cancer organizations recommend vegan diets to slow progression. This collectively conveys that there is no good evidence that a vegan diet stalls cancer progression."
      },
      {
        "criterion_number": 2,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including pancreatic enzyme insufficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention pancreatic cancer-specific digestive changes or pancreatic enzyme insufficiency."
      },
      {
        "criterion_number": 3,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including insulin-dependent diabetes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of diabetes or insulin dependence related to pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including biliary obstruction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Biliary obstruction is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including high protein and calorie needs during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "High protein and calorie needs during treatment are not addressed."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that nutrition support is often needed for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that nutrition support is often needed in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussion of diet with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises making dietary decisions in consultation with the oncology team."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussion of diet with an oncology nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends working with a registered dietitian who specializes in oncology nutrition."
      }
    ],
    "question_number": 23,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:25:24.830642",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that medical fitness is scored by the oncologist using the ECOG or Karnofsky performance status.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly uses ECOG performance status (ECOG 0\u20131 vs ECOG 0\u20132) to guide regimen selection, demonstrating assessment of medical fitness with ECOG."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that typically patients who are more medically fit will be offered FOLFIRINOX, whereas those who are more frail but still candidates for treatment will be offered gemcitabine and nab-paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states FOLFIRINOX is reserved for fit patients and gemcitabine/nab-paclitaxel is used for less fit patients; also notes common practice of starting FOLFIRINOX in fit patients and reserving gem/nab-paclitaxel otherwise."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that generally FOLFIRINOX is reserved for patients with an ECOG score of 0-1, whereas gemcitabine and nab-paclitaxel can be given to ECOG 2 patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says FOLFIRINOX is for ECOG 0\u20131 and gemcitabine/nab-paclitaxel is suitable for ECOG 0\u20132, which includes ECOG 2."
      },
      {
        "criterion_number": 4,
        "description": "The response should state the reason that FOLFIRINOX is reserved for patients with good performance status is that it is more intensive and is associated with higher rates of severe side effects such as neutropenia, fatigue, and diarrhea.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response attributes FOLFIRINOX selection in fitter patients to higher toxicity, citing higher rates of neutropenia and diarrhea (and neuropathy). Although 'fatigue' is not explicitly named, the explanation that FOLFIRINOX has higher toxicity fulfills the intent of the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly list the individual drugs in FOLFIRINOX (5-FU, leucovorin, irinotecan, oxaliplatin) and clarify that nab-paclitaxel is combined with gemcitabine.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not list the components of FOLFIRINOX. While it references 'gem/nab-paclitaxel,' the explicit listing of FOLFIRINOX agents is missing, so the criterion is not met."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that there are no head-to-head trials comparing gemcitabine/nab-paclitaxel and FOLFIRINOX.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of the absence of head-to-head trials between the two regimens."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention age as a factor influencing the choice of regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Age is explicitly discussed, noting FOLFIRINOX for younger patients (<75\u201380 years) and gemcitabine/nab-paclitaxel for older patients."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention comorbid conditions as a factor in selecting a regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Comorbidities are explicitly cited as influencing regimen selection (FOLFIRINOX without significant comorbidities vs gemcitabine/nab-paclitaxel with mild-moderate comorbidities)."
      }
    ],
    "question_number": 24,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:25:46.838579",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that medical fitness is scored by the oncologist using the ECOG or Karnofsky performance status.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly references ECOG performance status (ECOG 0\u20131, ECOG 1\u20132) as the framework for assessing fitness."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that typically patients who are more medically fit will be offered FOLFIRINOX, whereas those who are more frail but still candidates for treatment will be offered gemcitabine and nab-paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states FOLFIRINOX is reserved for excellent PS patients and gemcitabine/nab-paclitaxel for older or moderate PS patients."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that generally FOLFIRINOX is reserved for patients with an ECOG score of 0-1, whereas gemcitabine and nab-paclitaxel can be given to ECOG 2 patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically notes FOLFIRINOX for ECOG 0\u20131 and gemcitabine/nab-paclitaxel as an option for ECOG 1\u20132, which includes ECOG 2."
      },
      {
        "criterion_number": 4,
        "description": "The response should state the reason that FOLFIRINOX is reserved for patients with good performance status is that it is more intensive and is associated with higher rates of severe side effects such as neutropenia, fatigue, and diarrhea.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes FOLFIRINOX as intensive and lists higher rates of neutropenia, diarrhea, neuropathy, and fatigue as reasons for reserving it for fitter patients."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly list the individual drugs in FOLFIRINOX (5-FU, leucovorin, irinotecan, oxaliplatin) and clarify that nab-paclitaxel is combined with gemcitabine.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it clarifies nab-paclitaxel is combined with gemcitabine, it does not list the individual components of FOLFIRINOX (5-FU, leucovorin, irinotecan, oxaliplatin)."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that there are no head-to-head trials comparing gemcitabine/nab-paclitaxel and FOLFIRINOX.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of the absence of head-to-head trials; in fact, it suggests comparative efficacy without that caveat."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention age as a factor influencing the choice of regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions younger patients for FOLFIRINOX and older patients for gemcitabine/nab-paclitaxel."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention comorbid conditions as a factor in selecting a regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses comorbidities and organ function, listing examples influencing regimen choice."
      }
    ],
    "question_number": 24,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:26:05.273149",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that resectability is determined by the ability of the surgeon to safely remove the entire tumor and not leave any behind (R0 resection).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that pancreatic cancer is considered resectable when it can be completely removed surgically with clear margins, which corresponds to an R0 resection."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that involvement of major blood vessels such as the SMA, SMV, CA, PV are often implicated when a tumor is deemed to not be resectable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details arterial (celiac axis, SMA, common hepatic artery) and venous (SMV/portal vein) involvement as key anatomic criteria, and specifies thresholds for borderline and unresectable disease, directly addressing major vessel involvement."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that for pancreatic cancer to be resectable, there must not be any distant metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes 'No distant metastases (liver, lungs, peritoneum, distant lymph nodes)' under factors affecting resectability."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that occasionally tumors that contact the veins (PV/SMV) and have less than 180 degrees of involvement can still be resected provided it can be safely removed and the vessel can be reconstructed as needed.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it states that \u2264180\u00b0 SMV/PV contact without contour irregularity is resectable and mentions 'unreconstructible' vein involvement as unresectable, it does not explicitly state that venous reconstruction can allow resection when needed for \u2264180\u00b0 involvement."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some tumors are deemed to be borderline resectable and that the patient will be recommended to undergo treatment with chemotherapy and/or radiation in order to attempt to down-stage the tumor and make it amenable to resection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A clear 'Borderline Resectable' section is provided and the response states that borderline cases often receive neoadjuvant therapy first."
      },
      {
        "criterion_number": 6,
        "description": "The response should include imaging modalities that help determine resectability, including a CT scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that high-quality CT with pancreatic protocol is essential for staging."
      },
      {
        "criterion_number": 7,
        "description": "The response should include imaging modalities that help determine resectability, including an MRI.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists MRI (with pancreatic protocol) as essential for staging."
      },
      {
        "criterion_number": 8,
        "description": "The response should include imaging modalities that help determine resectability, including a PET scan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "PET scan is not mentioned anywhere in the response."
      },
      {
        "criterion_number": 9,
        "description": "The response should include imaging modalities that help determine resectability, including an endoscopic ultrasound.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Endoscopic ultrasound is not mentioned in the response."
      }
    ],
    "question_number": 25,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:26:29.158898",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that resectability is determined by the ability to safely remove the entire tumor (R0 resection).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly identifies the goal as achieving an R0 resection (negative microscopic margins) and frames resectability around safe surgical removal."
      },
      {
        "criterion_number": 2,
        "description": "State that involvement of major vessels (SMA, SMV, CA, PV) is often implicated in unresectability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details arterial (celiac axis, SMA, common hepatic artery) and venous (SMV/PV) involvement and links >180\u00b0 encasement/unreconstructable disease to unresectability."
      },
      {
        "criterion_number": 3,
        "description": "State that there must be no distant metastases for resectability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Under the Resectable section, it clearly states 'No distant metastases.'"
      },
      {
        "criterion_number": 4,
        "description": "State that tumors with venous contact (<180\u00b0) can still be resected if reconstructable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states resectable disease includes 'minimal venous involvement that can be reconstructed,' implying limited (<180\u00b0) venous contact may still be resectable; it also contrasts this with >180\u00b0 encasement as borderline if reconstructable."
      },
      {
        "criterion_number": 5,
        "description": "State that borderline resectable tumors are treated with neoadjuvant therapy (chemo/radiation) to attempt down-staging.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response identifies a 'Borderline Resectable' category and notes 'Neoadjuvant therapy can potentially convert borderline resectable to resectable,' which captures the intended management strategy."
      },
      {
        "criterion_number": 6,
        "description": "Include imaging modalities that help determine resectability, including a CT scan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No imaging modalities (including CT) are mentioned."
      },
      {
        "criterion_number": 7,
        "description": "Include imaging modalities that help determine resectability, including an MRI.",
        "score_given": 0,
        "max_points": 5,
        "justification": "MRI is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "Include imaging modalities that help determine resectability, including a PET scan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "PET scan is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "Include imaging modalities that help determine resectability, including an endoscopic ultrasound.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Endoscopic ultrasound is not mentioned."
      }
    ],
    "question_number": 25,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:27:02.988623",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreas cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states, 'Having a father who died of pancreatic cancer does increase your risk,' and quantifies increased risk with a first-degree relative."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a family history of pancreas cancer is due to inherited gene mutations such as BRCA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes 'About 10% of pancreatic cancers have a hereditary component' and lists BRCA1/BRCA2, linking family history to inherited mutations."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Smoking (doubles the risk)' under Other Major Risk Factors."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly includes 'Chronic pancreatitis' as a major risk factor."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreas cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Heavy alcohol use (which can lead to chronic pancreatitis),' indicating mechanism via pancreatitis."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify genetic risk factors, including Lynch syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists 'Lynch syndrome' among genetic syndromes."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify genetic risk factors, including Peutz-Jeghers syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists 'Peutz-Jeghers syndrome.'"
      },
      {
        "criterion_number": 8,
        "description": "The response should identify genetic risk factors, including Familial atypical multiple mole melanoma.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Familial atypical mole-malignant melanoma (FAMMM),' which corresponds to FAMMM."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify genetic risk factors, including hereditary pancreatitis.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists 'Hereditary pancreatitis.'"
      },
      {
        "criterion_number": 10,
        "description": "The response should include non-hereditary risk factors, including age.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Age (most cases occur after age 65)' as a risk factor."
      },
      {
        "criterion_number": 11,
        "description": "The response should include non-hereditary risk factors, including diabetes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes 'Diabetes (especially if newly diagnosed after age 50)'."
      },
      {
        "criterion_number": 12,
        "description": "The response should include non-hereditary risk factors, including obesity.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Obesity' as a risk factor."
      },
      {
        "criterion_number": 13,
        "description": "The response should include non-hereditary risk factors, including diet.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention diet as a risk factor (e.g., red/processed meats); only mentions weight management."
      },
      {
        "criterion_number": 14,
        "description": "The response should include non-hereditary risk factors, including exposure to certain industrial chemicals.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of occupational or industrial chemical exposures."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises 'Discuss genetic counseling/testing with your doctor' and to consider screening with multiple risk factors; encourages discussion of enhanced surveillance."
      }
    ],
    "question_number": 26,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:27:29.449462",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreas cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that having a family history of pancreatic cancer increases risk."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a family history of pancreas cancer is due to inherited gene mutations such as BRCA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions inherited genetic syndromes including BRCA1/2 as risk factors, linking family history to inherited mutations."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States smoking is the most significant modifiable risk factor."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists chronic pancreatitis as a risk factor."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreas cancer through pancreatitis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions heavy alcohol use and chronic pancreatitis separately, but does not state the mechanistic link that alcohol increases risk through pancreatitis."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify genetic risk factors, including Lynch syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly includes Lynch syndrome among inherited genetic syndromes."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify genetic risk factors, including Peutz-Jeghers syndrome.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention Peutz-Jeghers syndrome."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify genetic risk factors, including Familial atypical multiple mole melanoma.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention familial atypical multiple mole melanoma (FAMMM)."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify genetic risk factors, including hereditary pancreatitis.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not identify hereditary pancreatitis as a genetic risk factor."
      },
      {
        "criterion_number": 10,
        "description": "The response should include non-hereditary risk factors, including age.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes age as a risk factor with details on increasing risk after 45."
      },
      {
        "criterion_number": 11,
        "description": "The response should include non-hereditary risk factors, including diabetes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists diabetes, including emphasis on new-onset after age 50."
      },
      {
        "criterion_number": 12,
        "description": "The response should include non-hereditary risk factors, including obesity.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists obesity as a modifiable risk factor."
      },
      {
        "criterion_number": 13,
        "description": "The response should include non-hereditary risk factors, including diet.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Advises maintaining a healthy diet but does not identify diet as a risk factor."
      },
      {
        "criterion_number": 14,
        "description": "The response should include non-hereditary risk factors, including exposure to certain industrial chemicals.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions 'certain occupational exposures,' which encompasses industrial chemical exposure."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends discussing genetic counseling and enhanced screening with a doctor for those with family history."
      }
    ],
    "question_number": 26,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:27:46.906569",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the patient should undergo genetic counseling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends pre-test counseling with a genetic counselor and to involve a genetic counselor or medical geneticist."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the type of genetic testing depends on the specific family history or hereditary condition.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that recommendations depend on the specific condition(s) in the family and emphasizes risk assessment based on family history."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that single genes can be tested if there is a known condition associated with a specific genetic disorder.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes targeted testing for a specific known family mutation and lists single-gene examples (e.g., HTT, HFE, Factor V Leiden)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a panel of genes can be tested for multiple genes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a dedicated 'Panel Testing' section stating multiple genes for related conditions can be tested, useful when the mutation is unknown."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide examples of single gene disorders such as Huntington\u2019s Disease, Cystic Fibrosis, and Sickle Cell.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides all requested examples: Huntington\u2019s disease (HTT), cystic fibrosis (carrier screening), and sickle cell under hemoglobinopathies."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide examples of panel testing for hereditary cancer and cardiomyopathy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists hereditary cancer genes (BRCA1/2, Lynch, APC, TP53) and explicitly mentions a hypertrophic cardiomyopathy panel, satisfying panel examples for both domains."
      }
    ],
    "question_number": 27,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:28:00.750552",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the patient should undergo genetic counseling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states \"Genetic counseling before and after testing\" under Essential Considerations."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the type of genetic testing depends on the specific family history or hereditary condition.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with \"The recommended genetic tests depend on the specific hereditary disease in the family history\" and reinforces with tailored approaches."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that single genes can be tested if there is a known condition associated with a specific genetic disorder.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes \"Targeted testing for known familial variants\" and provides single-gene examples (HTT for Huntington\u2019s, HFE for hemochromatosis, SERPINA1 for alpha-1 antitrypsin deficiency)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a panel of genes can be tested for multiple genes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States \"Panel testing when multiple genes are involved\" and mentions \"Multi-gene cancer panels\" and cardiomyopathy panels."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide examples of single gene disorders such as Huntington\u2019s Disease, Cystic Fibrosis, and Sickle Cell.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides clear single-gene disorder examples, including Huntington\u2019s disease; also lists hemochromatosis and alpha-1 antitrypsin deficiency, satisfying the requirement to include examples."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide examples of panel testing for hereditary cancer and cardiomyopathy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions multi-gene cancer panels and hypertrophic cardiomyopathy panels."
      }
    ],
    "question_number": 27,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:28:19.281974",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the types of clinical trials.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response explains what clinical trials are and mentions comparisons to standard care, but it does not describe different types (e.g., treatment, prevention, screening, diagnostic, supportive care trials)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that clinical trials are divided into three different phases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It references phases explicitly and names Phase 1 and Phase 2\u20133, implying the three main phases."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that phase 1 is the first time the drug is tested in humans and is aimed at establishing the safety and dosage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes that Phase 1 tests safety but does not state first-in-human testing or that it establishes dosage."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that phase 2 tests the effectiveness of the drug and continues to establish its safety.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It says Phase 2\u20133 test effectiveness but does not mention continued safety assessment for Phase 2."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that phase 3 tests the efficacy of the drug in a larger group of patients and compares it to the current standard of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not specify that Phase 3 involves larger groups or comparison to standard of care; a general statement about some trials comparing treatments is not tied to Phase 3."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe eligibility criteria for clinical trials, including stage of disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists eligibility factors including cancer type, stage, previous treatments, and overall health."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that there can be risks associated with participating in a trial, including potential side effects and lack of efficacy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests asking about risks but does not state potential side effects or the possibility of lack of efficacy."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussing clinical trial options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises involving the oncologist and mentions they may recommend or know of trials."
      },
      {
        "criterion_number": 9,
        "description": "The response should include clinicaltrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directly cites ClinicalTrials.gov as a comprehensive database."
      },
      {
        "criterion_number": 10,
        "description": "The response should offer support for the diagnosis and how difficult it can be to complete 15 rounds of chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It acknowledges the challenging time and specifically references completing 15 rounds of chemotherapy in a supportive tone."
      }
    ],
    "question_number": 28,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:28:43.799047",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the types of clinical trials.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response defines clinical trials generally but does not describe different types (e.g., treatment, prevention, diagnostic, screening, quality-of-life)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that clinical trials are divided into three different phases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states trials are conducted in phases (I, II, III)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that phase 1 is the first time the drug is tested in humans and is aimed at establishing the safety and dosage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No description of Phase I as first-in-human or its goals of safety and dose-finding."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that phase 2 tests the effectiveness of the drug and continues to establish its safety.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Phase II objectives (effectiveness and ongoing safety) are not described."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that phase 3 tests the efficacy of the drug in a larger group of patients and compares it to the current standard of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Phase III details regarding larger populations and comparison to standard of care are not provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe eligibility criteria for clinical trials, including stage of disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions eligibility criteria including cancer type, stage, prior treatments, and overall health."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that there can be risks associated with participating in a trial, including potential side effects and lack of efficacy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes potential risks and asks about side effects but does not explicitly mention the possibility of lack of efficacy."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussing clinical trial options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends discussing with the oncology team first."
      },
      {
        "criterion_number": 9,
        "description": "The response should include clinicaltrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists ClinicalTrials.gov as a comprehensive U.S. database."
      },
      {
        "criterion_number": 10,
        "description": "The response should offer support for the diagnosis and how difficult it can be to complete 15 rounds of chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Provides a neutral acknowledgment but does not explicitly express empathy or acknowledge the difficulty of completing 15 rounds of chemotherapy."
      }
    ],
    "question_number": 28,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:29:07.119582",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must include ClinicalTrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists ClinicalTrials.gov under 'Official Trial Registries' and provides the direct site name and usage context."
      },
      {
        "criterion_number": 2,
        "description": "The response must provide instructions on using the search by location function on ClinicalTrials.gov.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs users to enter 'pancreatic cancer' and their city/state, and to filter by 'Recruiting' status, which constitutes location-based searching guidance."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention the National Cancer Institute (NCI) website and describe using it to search for trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It references the NCI Clinical Trials Search with the cancer.gov link and notes users can search by cancer type, location, and treatment type."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention and provide a link to the Pancreatic Cancer Action Network (PanCAN) clinical trial finder tool.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While PanCAN is mentioned with phone and email, there is no link to the PanCAN clinical trial finder tool and the tool itself is not explicitly referenced."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including PanCAN.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends contacting PanCAN Patient Central and provides both phone and email, clearly directing the reader to an advocacy organization."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including the American Cancer Society.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The American Cancer Society is not mentioned anywhere in the response."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss clinical trial options with their oncology team and consult with a local healthcare provider or oncologist to explore available trials at nearby cancer centers, as well as contact major cancer centers for additional information on clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises bringing trial listings to an oncologist to discuss eligibility and recommends contacting NCI-designated cancer centers and major academic medical centers, meeting all elements of the criterion."
      }
    ],
    "question_number": 29,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:29:23.283388",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must include ClinicalTrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "ClinicalTrials.gov is explicitly listed under Online Databases as a comprehensive U.S. database."
      },
      {
        "criterion_number": 2,
        "description": "The response must provide instructions on using the search by location function on ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes you can search by location, it does not provide instructions on how to use the location search (e.g., entering a city/ZIP, using filters, or steps)."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention the National Cancer Institute (NCI) website and describe using it to search for trials.",
        "score_given": 0,
        "max_points": 10,
        "justification": "NCI is mentioned as providing trial matching services, but there is no description of using the NCI website or its search function."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention and provide a link to the Pancreatic Cancer Action Network (PanCAN) clinical trial finder tool.",
        "score_given": 0,
        "max_points": 10,
        "justification": "PanCAN and its Clinical Trial Finder are mentioned, but no link is provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including PanCAN.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends contacting advocacy organizations and specifically lists PanCAN with its services."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including the American Cancer Society.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The American Cancer Society is listed and recommended as a resource that can help connect patients with trials."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss clinical trial options with their oncology team and consult with a local healthcare provider or oncologist to explore available trials at nearby cancer centers, as well as contact major cancer centers for additional information on clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing trials with the healthcare team and oncologist, and contacting major cancer centers or academic institutions."
      }
    ],
    "question_number": 29,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:29:33.850617",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreatic cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states 'Family history of pancreatic cancer (especially in first-degree relatives)'."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that BRCA1/BRCA2 mutations are genetic risk factors for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'BRCA1/BRCA2 mutations' under genetic risk factors."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes 'Smoking doubles the risk' and discusses decreased risk after quitting."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Chronic Pancreatitis' with 'Long-term inflammation increases cancer risk'."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreatic cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Heavy alcohol consumption (indirect through pancreatitis)'."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify Lynch syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Lynch syndrome' among hereditary conditions."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify Peutz-Jeghers syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Peutz-Jeghers syndrome' among hereditary conditions."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify Familial atypical multiple mole melanoma as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes 'Familial atypical multiple mole melanoma (FAMMM) syndrome'."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatitis as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Hereditary pancreatitis' under genetic risk factors."
      },
      {
        "criterion_number": 10,
        "description": "The response should include age as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Addresses age with specifics (risk increases after 55; most cases >65)."
      },
      {
        "criterion_number": 11,
        "description": "The response should include diabetes as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes 'Diabetes' and distinguishes long-standing type 2 and new-onset in older adults."
      },
      {
        "criterion_number": 12,
        "description": "The response should include obesity as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Obesity' with BMI >30 increasing risk."
      },
      {
        "criterion_number": 13,
        "description": "The response should include diet as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions 'High consumption of processed meats' and 'diet high in saturated fats'."
      },
      {
        "criterion_number": 14,
        "description": "The response should include exposure to certain industrial chemicals as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifies occupational exposures such as metalworking chemicals, dry cleaning chemicals, and pesticides."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes that screening is recommended for high-risk individuals but does not explicitly advise discussing with a doctor or mention genetic testing."
      }
    ],
    "question_number": 30,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:30:07.741017",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreatic cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists 'Family history of pancreatic cancer' under Genetic Factors."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that BRCA1/BRCA2 mutations are genetic risk factors for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Names 'BRCA1/BRCA2 mutations' under inherited genetic syndromes."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Smoking (most significant modifiable risk factor)'."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Chronic pancreatitis' under Medical Conditions."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreatic cancer through pancreatitis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions heavy alcohol consumption and chronic pancreatitis separately but does not explicitly state the pathway that alcohol increases risk via pancreatitis."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify Lynch syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists 'Lynch syndrome'."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify Peutz-Jeghers syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Peutz-Jeghers syndrome is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify Familial atypical multiple mole melanoma as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'familial atypical multiple mole melanoma syndrome'."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatitis as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes 'Hereditary pancreatitis' under Genetic Factors."
      },
      {
        "criterion_number": 10,
        "description": "The response should include age as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes 'Age over 65' with most cases after age 45."
      },
      {
        "criterion_number": 11,
        "description": "The response should include diabetes as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Type 2 diabetes (especially new-onset...)'."
      },
      {
        "criterion_number": 12,
        "description": "The response should include obesity as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes 'Obesity' under Lifestyle Factors."
      },
      {
        "criterion_number": 13,
        "description": "The response should include diet as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions 'Diet high in red meat and processed foods.'"
      },
      {
        "criterion_number": 14,
        "description": "The response should include exposure to certain industrial chemicals as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes 'Exposure to certain chemicals and pesticides' and work in 'dry cleaning or metalworking industries.'"
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises those with multiple risk factors or family history concerns to discuss screening with a healthcare provider."
      }
    ],
    "question_number": 30,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:30:42.808723",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking for a referral from their primary doctor or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises: 'Ask your primary doctor for referrals,' which meets the criterion (primary doctor or oncologist)."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using the PanCAN patient services to find a pancreatic cancer specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically recommends PanCAN Patient Central (1-877-272-6226) and states they provide personalized searches for specialists and clinical trial matching."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend using the American Cancer Society patient services to find a pancreatic cancer specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The American Cancer Society (ACS) is not mentioned; no ACS resources or patient services are referenced."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they can reference the NCI website to look for designated cancer centers that have pancreatic cancer specialists on staff.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directs users to cancer.gov's 'Find a Cancer Center' tool and to look for NCI-designated cancer centers, implying availability of pancreatic cancer programs/specialists."
      },
      {
        "criterion_number": 5,
        "description": "The response should include information about the nearest cancer center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific nearest cancer center is provided. While examples (MD Anderson, MSK, Mayo Clinic) are listed, they are not tailored to the user's location."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend checking with their health insurance provider about in-network pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises: 'Contact your insurance to verify coverage,' which satisfies the criterion about checking in-network coverage."
      }
    ],
    "question_number": 31,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:31:14.329797",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking for a referral from their primary doctor or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises asking a primary care doctor for referrals and getting recommendations from a current oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using the PanCAN patient services to find a pancreatic cancer specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions the Pancreatic Cancer Action Network and notes it offers a specialist directory, which aligns with PanCAN patient services."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend using the American Cancer Society patient services to find a pancreatic cancer specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The American Cancer Society is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they can reference the NCI website to look for designated cancer centers that have pancreatic cancer specialists on staff.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises looking for NCI-designated centers, it does not specifically direct the user to the NCI website."
      },
      {
        "criterion_number": 5,
        "description": "The response should include information about the nearest cancer center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No location-specific or nearest cancer center information is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend checking with their health insurance provider about in-network pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises contacting the insurance company for in-network specialists."
      }
    ],
    "question_number": 31,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:31:23.414804",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines CA 19-9 as a tumor marker measurable in blood and provides its full name and aliases, satisfying a concise definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is a tumor marker produced by cancer cells and measurable in the blood, and describe its use in pancreatic cancer, noting that it can serve as a marker for the disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response states CA 19-9 is a tumor marker measurable in blood and thoroughly describes its use in pancreatic cancer, it does not explicitly state that it is produced by cancer cells, which is a required element for full credit per the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response must include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes elevation in multiple benign conditions (pancreatitis, cirrhosis, gallstones, IBD, biliary obstruction) and in other cancers, fully meeting the criterion."
      }
    ],
    "question_number": 32,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:31:39.645650",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines CA 19-9 as Carbohydrate Antigen 19-9 and describes it as a tumor marker measured in blood, adequately explaining what it is."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is a tumor marker produced by cancer cells and measurable in the blood, and describe its use in pancreatic cancer, noting that it can serve as a marker for the disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response states CA 19-9 is a tumor marker measurable in blood and discusses its use in pancreatic cancer, it does not explicitly state that it is produced by cancer cells, which is required by the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response must include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly notes elevation in non-cancerous conditions (e.g., pancreatitis, liver disease, gallstones, inflammatory conditions), fulfilling the requirement."
      }
    ],
    "question_number": 32,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:31:58.534637",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that reference ranges can vary by lab.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states some labs use slightly different ranges (e.g., <35 or <40 U/mL)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that normal levels are typically less than 37 U/mL but do not rule out cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes <37 U/mL as typically normal and explains false negatives where some people with pancreatic cancer have normal levels."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that levels from 37 to 100 U/mL can be associated with non-cancer conditions such as pancreatitis and bile duct disorders.",
        "score_given": 10,
        "max_points": 10,
        "justification": "For 37\u2013100 U/mL, lists benign conditions including pancreatitis, gallstones, and liver disease."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that moderate elevation (100-1000 U/mL) can be concerning for cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States >100 U/mL is more concerning for pancreatic cancer, covering the 100\u20131000 U/mL range."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that levels greater than 1000 U/mL can be suggestive of advanced cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States >1,000 U/mL is often associated with advanced pancreatic cancer and may indicate metastatic disease."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the use of CA 19-9 in pancreatic cancer, including that it can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies CA 19-9 as a tumor marker primarily used to monitor pancreatic cancer and links elevations to pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple non-cancer causes (gallstones, pancreatitis, liver disease, IBD) and notes false positives."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 can be used for monitoring the effectiveness of pancreatic cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists monitoring treatment response under Clinical Uses."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that CA 19-9 can be used for detecting recurrence of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists detecting cancer recurrence."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions elevations in other cancers including colorectal, stomach, and bile duct cancers."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that CA 19-9 can be elevated in liver disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists liver disease among benign causes of elevation."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that CA 19-9 can be elevated in gallstones.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists gallstones as a benign cause of elevation."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that CA 19-9 can be elevated with elevated bilirubin.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention bilirubin specifically."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancers.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States some people with pancreatic cancer have normal levels and explains Lewis antigen negative individuals cannot produce CA 19-9."
      }
    ],
    "question_number": 33,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:32:34.273979",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that reference ranges can vary by lab.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response gives a single normal cutoff (<37 U/mL) but does not mention that reference ranges may vary by laboratory."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that normal levels are typically less than 37 U/mL but do not rule out cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it states <37 U/mL is normal and notes some people cannot produce CA 19-9, it does not explicitly state that a normal result does not rule out cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that levels from 37 to 100 U/mL can be associated with non-cancer conditions such as pancreatitis and bile duct disorders.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists 37\u2013120 U/mL as mildly elevated and often benign and explicitly mentions pancreatitis and bile duct blockage as non-cancer causes."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that moderate elevation (100-1000 U/mL) can be concerning for cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that levels above 120 U/mL are more concerning and warrant further investigation, which encompasses the 100\u20131000 U/mL range conceptually."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that levels greater than 1000 U/mL can be suggestive of advanced cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that >1000 U/mL is often associated with advanced pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the use of CA 19-9 in pancreatic cancer, including that it can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It identifies CA 19-9 as a tumor marker and notes pancreatic cancer as most commonly associated."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists multiple non-cancer conditions (e.g., gallstones, bile duct blockage, liver disease, IBD) that can elevate CA 19-9."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 can be used for monitoring the effectiveness of pancreatic cancer treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of using CA 19-9 trends to monitor treatment response."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that CA 19-9 can be used for detecting recurrence of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention surveillance or recurrence detection with CA 19-9."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists several other cancers (bile duct, gallbladder, colorectal, stomach, liver) under conditions associated with elevated CA 19-9, indicating use as a marker beyond pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that CA 19-9 can be elevated in liver disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Liver disease is explicitly listed among non-cancer conditions."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that CA 19-9 can be elevated in gallstones.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Gallstones are explicitly listed among non-cancer conditions."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that CA 19-9 can be elevated with elevated bilirubin.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Elevated bilirubin is not specifically mentioned; bile duct blockage and liver disease are cited but bilirubin is not."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancers.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It states that 5\u201310% of people cannot produce CA 19-9 due to genetics, but does not state that some pancreatic cancers themselves do not produce CA 19-9."
      }
    ],
    "question_number": 33,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:33:19.097750",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that CA 19-9 can be elevated with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists 'Pancreatitis (acute or chronic)' as a benign gastrointestinal condition causing elevation."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 can be elevated with liver diseases like cirrhosis or hepatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Cirrhosis and chronic liver disease,' which satisfies liver disease-related elevations."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 can be elevated with cholestasis or biliary diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions 'Biliary obstruction (stones, strictures),' 'Cholangitis/cholecystitis,' and notes jaundice with need to recheck after biliary decompression, clearly addressing cholestasis."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CA 19-9 can be elevated with inflammatory bowel disease or gastrointestinal diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically lists 'Inflammatory bowel disease (Crohn's, ulcerative colitis)' as a cause."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that CA 19-9 can be elevated with infections or other inflammatory conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes infectious biliary conditions ('cholangitis') and inflammatory conditions ('rheumatoid arthritis'), meeting the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that CA 19-9 can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Frames discussion as elevations occurring 'besides pancreatic cancer' and discusses degree of elevation suggesting malignancy, implying its role as a pancreatic cancer marker."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple other malignancies (colorectal, gastric, hepatobiliary, ovarian, lung) where CA 19-9 may be elevated."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that 5\u201310% of the population is Lewis antigen\u2013negative and cannot produce CA 19-9, implying some pancreatic cancers will not secrete CA 19-9."
      }
    ],
    "question_number": 34,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:33:40.575539",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that CA 19-9 can be elevated with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists acute pancreatitis and chronic pancreatitis as causes of elevated CA 19-9."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 can be elevated with liver diseases like cirrhosis or hepatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes liver conditions such as cirrhosis and hepatitis (viral, autoimmune), as well as NAFLD and biliary cirrhosis."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 can be elevated with cholestasis or biliary diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists biliary obstruction (gallstones, strictures), cholangitis, and cholecystitis, satisfying cholestatic/biliary disease etiologies."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CA 19-9 can be elevated with inflammatory bowel disease or gastrointestinal diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions inflammatory bowel disease (Crohn's disease, ulcerative colitis) and other GI conditions such as peptic ulcer disease."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that CA 19-9 can be elevated with infections or other inflammatory conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes cholangitis and cholecystitis (infectious/inflammatory), and pancreatitis (inflammatory), which meet the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that CA 19-9 can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies pancreatic cancer (primary use) under malignant conditions and notes its clinical context."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple non-pancreatic malignancies (biliary tract, colorectal, gastric, hepatocellular, lung, ovarian, breast cancers)."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that Lewis antigen\u2013negative individuals (5\u201310% of the population) cannot produce CA 19-9, implying some pancreatic cancers will not have elevated CA 19-9."
      }
    ],
    "question_number": 34,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:33:59.304192",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing weight loss with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises working with the healthcare team, requesting a referral to an oncology dietitian, discussing appetite stimulants with the doctor, reporting significant weight loss, and asking the oncologist about specific issues. This clearly meets the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme replacement can be taken to help with the absorption of nutrients from foods.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While pancreatic enzyme supplements are mentioned, the response does not explicitly state their role in improving nutrient absorption. The criterion requires a clear linkage to aiding absorption, which is absent."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutritional strategies can be employed, such as focusing on small, frequent meals and nutrient-rich foods, and should recommend including calorie-dense and protein-rich foods in the diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends 5\u20136 small meals, calorie-dense foods, protein powder, nutrition supplement drinks, and healthy fats, fully satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that medications for managing nausea can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises considering anti-nausea medications before meals and consulting the team about managing nausea, meeting the requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to chemotherapy side effects.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly state that chemotherapy side effects are among the causes of weight loss or that there are multiple causes; thus it does not meet this criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to pancreatic enzyme deficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although pancreatic enzyme supplements are mentioned, the response does not directly link pancreatic enzyme deficiency to weight loss or malabsorption; the explicit statement required by the criterion is missing."
      }
    ],
    "question_number": 35,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:34:16.588650",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing weight loss with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises involving the care team: \"discuss with the healthcare team,\" \"Work with a registered dietitian,\" \"Discuss appetite stimulants with the oncologist,\" and emphasizes \"immediate communication with the healthcare team is essential.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme replacement can be taken to help with the absorption of nutrients from foods.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions \"Pancreatic enzyme supplements if prescribed,\" it does not explicitly state their purpose is to improve absorption of nutrients from foods. The link between enzyme replacement and nutrient absorption is not stated."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutritional strategies can be employed, such as focusing on small, frequent meals and nutrient-rich foods, and should recommend including calorie-dense and protein-rich foods in the diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends small, frequent meals; high-calorie, nutrient-dense foods (e.g., smoothies, nuts, avocados); and \"Protein-rich foods to maintain muscle mass.\""
      },
      {
        "criterion_number": 4,
        "description": "The response should state that medications for managing nausea can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Under Symptom Management, it states: \"Address nausea and vomiting with anti-nausea medications,\" directly addressing the role of antiemetics."
      },
      {
        "criterion_number": 5,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to chemotherapy side effects.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it lists several factors that can affect intake (nausea, pain, digestive issues, mood), it does not explicitly mention chemotherapy side effects as a cause of weight loss or state that there are many causes including chemo-related weight loss."
      },
      {
        "criterion_number": 6,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to pancreatic enzyme deficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions \"Pancreatic enzyme supplements if prescribed\" but does not explicitly state that pancreatic enzyme deficiency (exocrine insufficiency) is a cause of weight loss or tie deficiency to malabsorption-driven weight loss."
      }
    ],
    "question_number": 35,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:34:32.386248",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a symptom of pancreatic cancer can include unintentional weight loss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists \"Unexplained weight loss\" under common symptoms."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a symptom of pancreatic cancer can include jaundice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists \"Yellowing of skin and eyes (jaundice)\" under common symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a symptom of pancreatic cancer can include new onset diabetes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists \"New-onset diabetes or worsening blood sugar control.\""
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a symptom of pancreatic cancer can include abdominal pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists \"Abdominal pain that radiates to the back.\""
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pancreatic cancer can be difficult to detect early.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States \"Early detection is challenging\" and notes symptoms often appear late."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer does not cause symptoms until the disease is advanced.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States symptoms \"often don't appear until the disease is advanced.\""
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reason for jaundice is the blockade of bile ducts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions jaundice but does not explain it results from bile duct obstruction."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that loss of appetite can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists \"Loss of appetite.\""
      },
      {
        "criterion_number": 9,
        "description": "The response should state that abdominal bloating or indigestion can be a symptom.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention bloating or indigestion; lists nausea/vomiting but not these specific symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that foul-smelling stools or steatorrhea can be a symptom.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions light-colored stools but not foul-smelling stools or steatorrhea."
      },
      {
        "criterion_number": 11,
        "description": "The response should reference the American Cancer Society information page on symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to the American Cancer Society information page is provided."
      }
    ],
    "question_number": 36,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:34:57.115424",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a symptom of pancreatic cancer can include unintentional weight loss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists 'Unexplained weight loss' as a symptom."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a symptom of pancreatic cancer can include jaundice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists 'Jaundice (yellowing of skin and eyes)'."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a symptom of pancreatic cancer can include new onset diabetes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'New-onset diabetes or worsening blood sugar control.'"
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a symptom of pancreatic cancer can include abdominal pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Abdominal pain that may radiate to the back' and references persistent abdominal pain."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pancreatic cancer can be difficult to detect early.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes symptoms are 'subtle' early and calls it a 'silent' disease, implying difficulty detecting early."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer does not cause symptoms until the disease is advanced.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Pancreatic cancer symptoms often don't appear until the disease is advanced.'"
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reason for jaundice is the blockade of bile ducts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions jaundice and pale stools but does not explain it is due to bile duct obstruction."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that loss of appetite can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists 'Loss of appetite.'"
      },
      {
        "criterion_number": 9,
        "description": "The response should state that abdominal bloating or indigestion can be a symptom.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specifically mention 'bloating' or 'indigestion'; 'Digestive problems' is too vague for full credit."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that foul-smelling stools or steatorrhea can be a symptom.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions pale stools but not foul-smelling stools or steatorrhea."
      },
      {
        "criterion_number": 11,
        "description": "The response should reference the American Cancer Society information page on symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to the American Cancer Society page is provided."
      }
    ],
    "question_number": 36,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:35:18.001354",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that most pancreatic cancer cases are sporadic and not hereditary.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states that most cases are not inherited and provides figures (90\u201395% sporadic)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that there are hereditary conditions that can lead to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes a hereditary component (5\u201310%) and lists hereditary conditions."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a strong family history is a significant risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifies that having two or more first-degree relatives with pancreatic cancer significantly increases risk."
      },
      {
        "criterion_number": 4,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including familial pancreatic cancer syndrome.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists multiple hereditary syndromes but does not explicitly mention familial pancreatic cancer syndrome by name."
      },
      {
        "criterion_number": 5,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including BRCA1/BRCA2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "BRCA1/BRCA2 mutations are explicitly listed."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Lynch syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lynch syndrome is explicitly listed."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Peutz-Jeghers syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Peutz-Jeghers syndrome is explicitly listed."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Familial atypical multiple mole melanoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Familial atypical multiple mole melanoma (FAMMM) is explicitly listed."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including hereditary pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Hereditary pancreatitis is explicitly listed."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises discussing with a doctor but does not specifically recommend consulting an oncologist."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult a genetic counselor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions genetic counseling, but does not explicitly advise consulting a genetic counselor."
      }
    ],
    "question_number": 37,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:35:39.456797",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that most pancreatic cancer cases are sporadic and not hereditary.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states 90\u201395% are sporadic and not hereditary."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that there are hereditary conditions that can lead to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes a hereditary component in 5\u201310% and lists several genetic conditions."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a strong family history is a significant risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifies increased risk with multiple affected relatives and emphasizes family history as significant."
      },
      {
        "criterion_number": 4,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including familial pancreatic cancer syndrome.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly identify 'familial pancreatic cancer (FPC) syndrome' by name, though it describes family history patterns."
      },
      {
        "criterion_number": 5,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including BRCA1/BRCA2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists BRCA1 and BRCA2 mutations."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Lynch syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists Lynch syndrome."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Peutz-Jeghers syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists Peutz-Jeghers syndrome."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Familial atypical multiple mole melanoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists FAMMM (Familial atypical multiple mole melanoma) syndrome."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including hereditary pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists hereditary pancreatitis."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises consulting a healthcare provider and genetic counseling but does not mention consulting an oncologist."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends discussing genetic counseling, which implies consulting a genetic counselor."
      }
    ],
    "question_number": 37,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:35:53.334631",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that routine screening is not recommended for the general population.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, \"No standardized screening exists for average-risk individuals\" and \"Surveillance is only recommended for high-risk groups,\" which explicitly conveys that routine screening is not recommended for the general population."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention MRI as a surveillance modality for high-risk individuals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "MRI/MRCP is listed under surveillance methods and described as sensitive for detecting small lesions."
      },
      {
        "criterion_number": 3,
        "description": "The response must specify that surveillance typically starts around age 50 and continues annually.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response specifies, \"Start at age 50 or 10 years before earliest family diagnosis\" and \"Annual imaging (MRI/MRCP or EUS).\""
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that the evidence for screening/surveillance is not well established and mention the risk of overdiagnosis leading to unnecessary stress and procedures.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While harms such as false positives, anxiety, and costs are mentioned, the response does not explicitly state that the evidence base is not well established, nor does it explicitly reference overdiagnosis or unnecessary procedures."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that people at high risk may benefit from screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states \"Surveillance is only recommended for high-risk groups,\" which indicates that high-risk individuals may benefit from surveillance."
      },
      {
        "criterion_number": 6,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a significant family history of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "High-risk definition includes \"Individuals with multiple family members affected (\u22652 first-degree relatives).\""
      },
      {
        "criterion_number": 7,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a known genetic syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Known genetic syndromes and mutations are listed (BRCA1/2, PALB2, ATM, Lynch syndrome, Peutz-Jeghers, FAMMM)."
      },
      {
        "criterion_number": 8,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a history of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response includes \"hereditary pancreatitis,\" which is a form of chronic pancreatitis, thereby encompassing a chronic pancreatitis history as a high-risk factor."
      },
      {
        "criterion_number": 9,
        "description": "The response should include EUS as a screening modality to detect pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "EUS is listed under surveillance methods with its role in detecting small tumors and allowing biopsy."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend people discuss the risks and benefits of screening with a doctor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response emphasizes weighing benefits and risks and advises consulting a gastroenterologist specializing in pancreatic disease, satisfying the recommendation to discuss risks and benefits with a doctor."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend people discuss the risks and benefits of screening with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends consulting with a genetic counselor if at increased risk, in the context of weighing benefits and risks."
      }
    ],
    "question_number": 38,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:36:23.185763",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that routine screening is not recommended for the general population.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response focuses on surveillance for high-risk individuals but does not explicitly state that routine screening is not recommended for the general population."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention MRI as a surveillance modality for high-risk individuals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists MRI/MRCP under Primary Imaging for surveillance in high-risk individuals."
      },
      {
        "criterion_number": 3,
        "description": "The response must specify that surveillance typically starts around age 50 and continues annually.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states surveillance usually begins at age 50 (or 10 years younger than the youngest affected) and is typically performed annually."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that the evidence for screening/surveillance is not well established and mention the risk of overdiagnosis leading to unnecessary stress and procedures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes 'Limited evidence that surveillance improves survival outcomes' and mentions 'High rate of false positives can lead to unnecessary procedures' and the 'Psychological impact of surveillance programs,' covering both limited evidence and risks of unnecessary procedures and stress."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that people at high risk may benefit from screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states 'Surveillance is typically recommended for individuals with' high-risk features, implying benefit for high-risk individuals."
      },
      {
        "criterion_number": 6,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a significant family history of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'Strong family history: 2+ first-degree relatives with pancreatic cancer' under high-risk individuals."
      },
      {
        "criterion_number": 7,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a known genetic syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists genetic predisposition (BRCA1/2, PALB2, ATM, CDKN2A, Lynch genes, STK11) and hereditary syndromes (Peutz-Jeghers, FAMMM)."
      },
      {
        "criterion_number": 8,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a history of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'Chronic pancreatitis in some cases' among high-risk groups."
      },
      {
        "criterion_number": 9,
        "description": "The response should include EUS as a screening modality to detect pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Endoscopic ultrasound (EUS) is listed as a primary imaging modality for surveillance."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend people discuss the risks and benefits of screening with a doctor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it advises that surveillance be conducted at specialized centers and mentions individual risk-benefit assessment, it does not explicitly recommend discussing risks and benefits with a doctor."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend people discuss the risks and benefits of screening with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states 'Decisions should involve genetic counseling.'"
      }
    ],
    "question_number": 38,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:36:48.116076",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include surgery as a potential treatment modality for resectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a dedicated 'Surgical Options' section listing Whipple procedure, distal pancreatectomy, and total pancreatectomy, and notes surgery is possible when cancer hasn't spread, indicating resectable disease."
      },
      {
        "criterion_number": 2,
        "description": "The response should specify that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer, with main regimens being FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists 'FOLFIRINOX' and 'Gemcitabine-based regimens\u2026combined with nab-paclitaxel' and states chemo is used 'as primary treatment for advanced cancer,' which aligns with metastatic/unresectable settings."
      },
      {
        "criterion_number": 3,
        "description": "The response should include radiation as a potential treatment option for localized pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The 'Radiation Therapy' section discusses use before/after surgery and as chemoradiation, and mentions SBRT, which corresponds to use in localized disease."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The opening sentence explicitly states treatment depends on 'the stage of the cancer.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the treatment of pancreatic cancer depends on the co-morbidities of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes treatment depends on 'the patient's overall health,' which encompasses comorbid conditions influencing treatment choices."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the treatment of pancreatic cancer depends on the functional status of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifies FOLFIRINOX is for 'fit patients,' indicating performance/functional status is a determinant of therapy."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy, noting its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 15,
        "max_points": 15,
        "justification": "It lists 'Pembrolizumab: For tumors with specific genetic features (MSI-H or dMMR),' correctly restricting immunotherapy to this subset."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'Olaparib: For patients with BRCA mutations,' which is a PARP inhibitor used in this context."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A 'Clinical Trials' section is present, highlighting immunotherapy investigations, novel drug combinations, and new surgical techniques."
      }
    ],
    "question_number": 39,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:37:29.905811",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include surgery as a potential treatment modality for resectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly lists surgical options (Whipple, distal pancreatectomy, total pancreatectomy) and notes eligibility (15\u201320%), indicating surgery for resectable disease."
      },
      {
        "criterion_number": 2,
        "description": "The response should specify that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer, with main regimens being FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States chemotherapy is used palliatively for advanced/metastatic disease and names FOLFIRINOX and gemcitabine + nab-paclitaxel as key regimens."
      },
      {
        "criterion_number": 3,
        "description": "The response should include radiation as a potential treatment option for localized pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes radiation therapy, mentions chemoradiation, possible use before surgery, and SBRT\u2014consistent with localized disease management."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opening sentence explicitly states treatment depends on the stage."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the treatment of pancreatic cancer depends on the co-morbidities of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes treatment depends on the patient's overall health, which encompasses comorbidities; also references management of diabetes under supportive care."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the treatment of pancreatic cancer depends on the functional status of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions dependence on the patient's overall health, reasonably capturing performance/functional status considerations."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy, noting its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 15,
        "max_points": 15,
        "justification": "Specifies pembrolizumab for MSI-H tumors, correctly reflecting immunotherapy\u2019s limited indication."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists PARP inhibitors (olaparib, rucaparib) for BRCA-mutated tumors."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of clinical trials or enrollment as a treatment option."
      }
    ],
    "question_number": 39,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:38:01.848825",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that stage 0 is a pre-cancer state, also known as pancreatic intraepithelial neoplasia or carcinoma in situ.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly labels Stage 0 as 'carcinoma in situ' and describes abnormal cells limited to the lining and not invasive, which conveys a pre-cancer state. While PanIN is not named, 'carcinoma in situ' meets the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that stage 1 cancer is when the cancer is confined to the pancreas and has not spread to lymph nodes or distant sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States Stage I tumors are confined to the pancreas and explicitly notes 'No spread to lymph nodes or distant sites.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should note that stage 1a is when the tumor is 2cm or smaller.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Stage IA: Tumor is 2 cm or smaller, confined to pancreas,' which directly fulfills the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should note that stage 1b is when the tumor is larger than 2cm.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Stage IB: Tumor is larger than 2 cm but still confined to pancreas,' satisfying the requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that stage II is when the cancer is growing into nearby tissues and into lymph nodes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes Stage IIA as extending beyond the pancreas (nearby tissues) and Stage IIB as involving nearby lymph nodes, with no distant metastasis, meeting both components."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that stage III is when the cancer is locally advanced and involves surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifies involvement of major blood vessels and notes it is 'often considered locally advanced,' which addresses local advancement and involvement of surrounding structures."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that stage IV is when the cancer has spread to other organs or sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states Stage IV includes spread to distant organs (liver, lungs, peritoneum), fulfilling the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should include a description of the T, N, M staging system.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions the TNM system and expands the acronym as 'Tumor, Node, Metastasis,' which constitutes a brief description of what TNM represents."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that pancreatic cancer is categorized by resectability.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of resectability categories (resectable, borderline resectable, locally advanced unresectable, metastatic)."
      }
    ],
    "question_number": 40,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:38:23.848547",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that stage 0 is a pre-cancer state, also known as pancreatic intraepithelial neoplasia or carcinoma in situ.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly labels Stage 0 as carcinoma in situ and describes abnormal cells confined to the ductal lining, which conveys a pre-cancer/in-situ state. Although it does not use the term 'pancreatic intraepithelial neoplasia,' it includes the acceptable synonym 'carcinoma in situ.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that stage 1 cancer is when the cancer is confined to the pancreas and has not spread to lymph nodes or distant sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stage I is described as tumors confined to the pancreas (both IA and IB). This implies no nodal or distant spread, satisfying the requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response should note that stage 1a is when the tumor is 2cm or smaller.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stage IA is clearly defined as a tumor 2 cm or smaller and confined to the pancreas."
      },
      {
        "criterion_number": 4,
        "description": "The response should note that stage 1b is when the tumor is larger than 2cm.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stage IB is correctly stated as a tumor larger than 2 cm and confined to the pancreas."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that stage II is when the cancer is growing into nearby tissues and into lymph nodes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stage II is broken down into IIA (spread to nearby tissues, no nodes) and IIB (spread to 1\u20133 nodes), reflecting involvement of nearby tissues and lymph nodes within Stage II."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that stage III is when the cancer is locally advanced and involves surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stage III is described as involving major blood vessels near the pancreas and/or 4 or more lymph nodes, explicitly mentioning structures like the celiac axis or SMA, which fits locally advanced disease."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that stage IV is when the cancer has spread to other organs or sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stage IV is clearly stated as metastatic spread to distant organs such as the liver, lungs, or peritoneum."
      },
      {
        "criterion_number": 8,
        "description": "The response should include a description of the T, N, M staging system.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens by explaining the TNM system and what T, N, and M represent."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that pancreatic cancer is categorized by resectability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes an 'Alternative Classification' section listing resectable, borderline resectable, locally advanced, and metastatic categories."
      }
    ],
    "question_number": 40,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:39:06.802112",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that neuropathy is a common side effect from the oxaliplatin in FOLFIRINOX.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states neuropathy is a common but serious side effect of oxaliplatin in the FOLFIRINOX regimen."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that the oncologist can \u2018hold\u2019 or temporarily stop oxaliplatin to manage neuropathy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States the oncologist may delay treatment (implying a temporary hold) and discusses stopping oxaliplatin entirely; presented in the context of oxaliplatin management."
      },
      {
        "criterion_number": 3,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by dose reduction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly says the oncologist may reduce oxaliplatin dose."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by schedule modification.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that the oncologist may delay treatment, which represents schedule modification."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides alternative regimens, including modified FOLFIRINOX without oxaliplatin and other options."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen, including gemcitabine-based therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically lists gemcitabine-based options (gemcitabine+nab-paclitaxel, gemcitabine+capecitabine, gemcitabine alone)."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including gabapentin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes gabapentin among supportive medication options."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists duloxetine, an SNRI, as a medication option."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions pregabalin as a supportive medication."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to contact the oncology team immediately and notes they may need to adjust treatment, encouraging discussion of side effects."
      }
    ],
    "question_number": 41,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:39:55.122229",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that neuropathy is a common side effect from the oxaliplatin in FOLFIRINOX.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response identifies oxaliplatin as causing neuropathy but does not state that neuropathy is a common side effect of oxaliplatin in FOLFIRINOX."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that the oncologist can \u2018hold\u2019 or temporarily stop oxaliplatin to manage neuropathy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states a 'temporary pause of oxaliplatin,' which aligns with holding the drug."
      },
      {
        "criterion_number": 3,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by dose reduction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends 'dose reduction' of oxaliplatin."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific mention of schedule modification (e.g., extending intervals, every-other-cycle oxaliplatin). 'Temporary pause' is covered under holding and does not fulfill schedule modification as a distinct strategy."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Suggests switching to FOLFIRI and other combination regimens, meeting the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen, including gemcitabine-based therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions 'gemcitabine-based therapies' as alternatives."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including gabapentin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Supportive care is mentioned generally, but gabapentin is not specified."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No SNRI (e.g., duloxetine) is mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Pregabalin is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends an urgent discussion with the oncology team about symptoms and treatment adjustments, satisfying the criterion."
      }
    ],
    "question_number": 41,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:40:12.052175",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should be informed about the aim of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises asking what phase the trial is (with explanation of phase aims: safety vs. effectiveness) and what treatment is being tested, which conveys understanding the trial\u2019s purpose/aim."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they should understand the potential benefits of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists clear benefits such as access to new treatments, closer monitoring, contributing to research, and potential for better outcomes."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that they should understand the potential risks of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions possible unknown side effects, the chance the treatment is not more effective than standard care, increased visits/tests, strict protocols, and possibility of placebo."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they should be aware of the inclusion and exclusion criteria for the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends asking about eligibility requirements, which encompasses inclusion and exclusion criteria."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that they should be aware of the time commitments associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes more frequent hospital visits/tests and advises asking about the time commitment required."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that they should be aware of the costs associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Suggests asking what costs are covered and checking for travel/lodging assistance, addressing financial considerations."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the phase of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly advises asking about the trial phase and explains what different phases assess."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding if there are crossover options.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention crossover options or whether participants can switch from control/placebo to the investigational arm."
      }
    ],
    "question_number": 42,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:40:46.456429",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should be informed about the aim of the clinical trial.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly mention understanding the trial\u2019s aim, purpose, or primary objectives/endpoints."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they should understand the potential benefits of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises asking about potential benefits."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that they should understand the potential risks of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises asking about potential risks and side effects."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they should be aware of the inclusion and exclusion criteria for the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions confirming whether she meets the eligibility criteria, which encompasses inclusion/exclusion."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that they should be aware of the time commitments associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes asking how long the trial will last and notes location/travel requirements, reflecting time commitment."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that they should be aware of the costs associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly suggests asking what costs are covered."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the phase of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directly recommends asking what phase the trial is (Phase I, II, or III)."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding if there are crossover options.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of crossover availability or policies."
      }
    ],
    "question_number": 42,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:41:05.905486",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Radiation can be used before surgery to help shrink borderline resectable tumors, with the goal of increasing the likelihood of achieving a complete resection in the localized setting.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions neoadjuvant radiation to shrink tumors to make complete removal easier and separately addresses borderline resectable tumors near vessels to enable surgery."
      },
      {
        "criterion_number": 2,
        "description": "Radiation can be used for locally advanced or unresectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that for locally advanced disease when surgery isn't an option, radiation can help control the tumor."
      },
      {
        "criterion_number": 3,
        "description": "Radiation can be used in the palliative setting to relieve symptoms in patients with advanced or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes radiation for symptom relief to reduce pain or other symptoms, which is palliative use."
      },
      {
        "criterion_number": 5,
        "description": "Pancreatic cancer treatment plans are determined by the stage of the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly lists stage as a factor in recommending radiation."
      },
      {
        "criterion_number": 6,
        "description": "Pancreatic cancer treatment plans are determined by the overall health of the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly lists the patient's overall health as a factor."
      },
      {
        "criterion_number": 7,
        "description": "The goal of radiation in the localized setting can be to sterilize vessel margins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions borderline resectable tumors near vessels and making surgery possible, it does not state the specific goal of sterilizing vessel margins."
      },
      {
        "criterion_number": 8,
        "description": "The goal of radiation in the localized setting can be to delay disease progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes that radiation for locally advanced disease can help control the tumor, which aligns with delaying progression in a localized context."
      },
      {
        "criterion_number": 9,
        "description": "The goal of radiation in the localized setting can be to prevent local recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that adjuvant radiation after surgery aims to destroy remaining cells and reduce the chance of recurrence."
      }
    ],
    "question_number": 43,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:41:25.671257",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Radiation can be used before surgery to help shrink borderline resectable tumors, with the goal of increasing the likelihood of achieving a complete resection in the localized setting.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states: 'Before surgery to shrink the tumor and make it easier to remove completely' for localized/borderline resectable tumors, which matches the criterion."
      },
      {
        "criterion_number": 2,
        "description": "Radiation can be used for locally advanced or unresectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a section 'For locally advanced cancer' and notes use 'when surgery isn't possible' (unresectable), fulfilling the criterion."
      },
      {
        "criterion_number": 3,
        "description": "Radiation can be used in the palliative setting to relieve symptoms in patients with advanced or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response describes palliative uses: 'To reduce pain' and 'help with blockages,' clearly indicating symptom-directed radiation, which aligns with palliative intent."
      },
      {
        "criterion_number": 5,
        "description": "Pancreatic cancer treatment plans are determined by the stage of the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states 'Treatment approach varies based on: Stage and location of the cancer,' directly addressing stage-based planning."
      },
      {
        "criterion_number": 6,
        "description": "Pancreatic cancer treatment plans are determined by the overall health of the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists 'Overall health and treatment goals' as factors influencing the treatment approach."
      },
      {
        "criterion_number": 7,
        "description": "The goal of radiation in the localized setting can be to sterilize vessel margins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention vessel margin sterilization or equivalent phrasing regarding treating tumor involvement along vessels."
      },
      {
        "criterion_number": 8,
        "description": "The goal of radiation in the localized setting can be to delay disease progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions 'control tumor growth' for locally advanced disease, it does not state delaying progression in the localized setting."
      },
      {
        "criterion_number": 9,
        "description": "The goal of radiation in the localized setting can be to prevent local recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states 'After surgery to reduce risk of recurrence in the surgical area,' which corresponds to preventing local recurrence."
      }
    ],
    "question_number": 43,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:41:41.695180",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic cancer leads to enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that pancreatic cancer can damage the pancreas or block ducts, preventing natural enzymes from reaching the intestines, which effectively describes enzyme deficiency (exocrine insufficiency) caused by the cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how enzyme deficiency can lead to problems with digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links the lack of enzymes to poor nutrient absorption, weight loss, diarrhea or fatty stools, bloating, and discomfort, clearly outlining digestive consequences of enzyme deficiency."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme supplements are used to replace the enzymes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that pancreatic enzyme supplements are medications that help replace the digestive enzymes normally produced by the pancreas."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that pancreatic enzyme supplements can improve digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that supplements are taken with meals to help digest food properly, improve nutrient absorption, reduce digestive symptoms, and improve quality of life by helping with digestion."
      }
    ],
    "question_number": 44,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:41:59.058096",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic cancer leads to enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that pancreatic cancer can block or damage the pancreas's ability to release enzymes, clearly indicating an enzyme deficiency due to the disease."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how enzyme deficiency can lead to problems with digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details consequences of enzyme deficiency including poor nutrient absorption, weight loss, bloating, gas, stomach pain, and fatty, loose stools, demonstrating how digestion is impaired."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme supplements are used to replace the enzymes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states these are prescription medications containing digestive enzymes that the pancreas normally produces and names common brands, indicating they replace missing enzymes."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that pancreatic enzyme supplements can improve digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states supplements are taken with meals to help properly digest food and absorb nutrients and improve comfort, nutrition, and quality of life."
      }
    ],
    "question_number": 44,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:42:05.277942",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that cancer is associated with an increased risk of developing blood clots.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that cancer increases the risk of blood clots, noting mechanisms (procoagulant substances, vessel compression, inflammation, reduced mobility, and treatment effects) and references cancer-associated thrombosis. This clearly links cancer in general to increased clot risk."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that patients with pancreatic cancer are at increased risk of developing a blood clot.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response directly addresses pancreatic cancer, stating it is one of the cancers with the highest clot risk and gives an estimated incidence (15\u201320% in pancreatic cancer patients). This clearly communicates increased risk specific to pancreatic cancer."
      }
    ],
    "question_number": 45,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:42:11.393841",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that cancer is associated with an increased risk of developing blood clots.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that cancer increases the risk of blood clots (e.g., 'Cancer ... significantly increases the risk of developing blood clots') and provides accurate supporting mechanisms (e.g., cancer cells make blood more prone to clotting, treatments and immobility contribute)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that patients with pancreatic cancer are at increased risk of developing a blood clot.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly identifies pancreatic cancer as particularly high risk (e.g., 'particularly pancreatic cancer' and 'Pancreatic cancer is among the cancers with the highest risk for blood clots'), directly addressing the elevated risk in pancreatic cancer patients."
      }
    ],
    "question_number": 45,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:42:17.965371",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that second opinions can be obtained at any time, including after diagnosis, before starting treatment, during treatment, or when considering clinical trials.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response recommends seeking a second opinion as soon as possible after diagnosis and before starting treatment, but it does not explicitly state that second opinions can be obtained during treatment or when considering clinical trials, nor does it say they can be obtained at any time."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that second opinions are particularly helpful after the initial diagnosis and before starting treatment, as well as when the initial treatment is no longer effective.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions seeking a second opinion after initial diagnosis and before treatment, but does not mention the scenario when initial treatment is no longer effective."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states a second opinion is appropriate if there are doubts about the diagnosis."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding staging.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Staging is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the treatment plan.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions seeking a second opinion if there are doubts about the treatment plan."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that second opinions can be obtained at specialized referral centers, such as cancer centers with expertise in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises going to major cancer centers, hospitals with pancreatic cancer specialty programs, and NCI-designated centers, which are specialized referral centers."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that they should look up NCI-designated cancer centers specifically.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically mentions National Cancer Institute-designated cancer centers and the NCI website for finding them."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention major academic hospitals as a resource for finding pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions academic medical centers as options for second opinions."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that the NCCN guidelines for Pancreatic Adenocarcinoma recommend evaluation at high volume centers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "NCCN guidelines and their recommendation for evaluation at high-volume centers are not mentioned."
      }
    ],
    "question_number": 46,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:42:35.062392",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that second opinions can be obtained at any time, including after diagnosis, before starting treatment, during treatment, or when considering clinical trials.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions seeking a second opinion immediately after diagnosis and before starting treatment, but it does not explicitly state that second opinions can be obtained during treatment or when considering clinical trials, nor does it state that they can be obtained at any time."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that second opinions are particularly helpful after the initial diagnosis and before starting treatment, as well as when the initial treatment is no longer effective.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It explicitly notes after initial diagnosis and before starting treatment, but does not mention the scenario where initial treatment is no longer effective."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses unclear prognosis and doubts about the treatment plan but does not explicitly mention uncertainty about the diagnosis itself."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding staging.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of staging or uncertainty about stage as a reason to seek a second opinion."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the treatment plan.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \"If you have any doubts about the recommended treatment plan,\" which directly addresses uncertainty about the treatment plan."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that second opinions can be obtained at specialized referral centers, such as cancer centers with expertise in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises seeking a pancreatic cancer specialist at a major cancer center and looking for high-volume pancreatic cancer centers, which qualifies as specialized referral centers."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that they should look up NCI-designated cancer centers specifically.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says, \"Consider NCI-designated cancer centers.\""
      },
      {
        "criterion_number": 8,
        "description": "The response must mention major academic hospitals as a resource for finding pancreatic cancer specialists.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions major cancer centers, high-volume centers, and NCI-designated centers, it does not explicitly mention major academic hospitals or academic medical centers."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that the NCCN guidelines for Pancreatic Adenocarcinoma recommend evaluation at high volume centers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not reference NCCN guidelines or their recommendation for evaluation at high-volume centers."
      }
    ],
    "question_number": 46,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:43:04.688033",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that immunotherapy is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that immunotherapy works well for only a small subset (1\u20132%) of patients with MSI-high or dMMR tumors."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that immunotherapy is an ongoing area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly notes that immunotherapy for pancreatic cancer is an area of active research and discusses ongoing exploration of combination approaches."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that there may be clinical trial options exploring novel immunotherapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions clinical trials multiple times, including trials testing novel immunotherapy strategies and combinations."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that immune checkpoint blockade is only approved for patients with metastatic disease in certain situations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention approval status, metastatic disease, or that approvals apply only in specific circumstances."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pembrolizumab is approved for patients whose tumors are TMB high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of pembrolizumab or TMB-high tumor-agnostic approval."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend asking their oncology team about testing for eligibility for immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises that the oncologist can determine appropriateness based on specific tumor characteristics and genetic testing results and invites discussion with the oncologist, effectively recommending evaluation/testing for eligibility."
      }
    ],
    "question_number": 47,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:43:32.743777",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that immunotherapy is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions MSI-H/dMMR tumors as where immunotherapy is 'most effective,' but it does not explicitly state that effectiveness is currently limited to these biomarkers."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that immunotherapy is an ongoing area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes 'Combination approaches being studied in clinical trials' and that 'The treatment landscape is evolving rapidly,' clearly indicating ongoing research."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that there may be clinical trial options exploring novel immunotherapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly references clinical trials, advises asking about eligibility, and states that clinical trials may offer access to newer approaches."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that immune checkpoint blockade is only approved for patients with metastatic disease in certain situations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention metastatic or unresectable disease restrictions or specify the limited approval context for checkpoint inhibitors."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pembrolizumab is approved for patients whose tumors are TMB high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although pembrolizumab is mentioned, TMB-high as a specific approval criterion is not stated."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend asking their oncology team about testing for eligibility for immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends tumor genetic testing and to 'Discuss with their oncologist whether tumor testing shows favorable markers,' which aligns with assessing immunotherapy eligibility."
      }
    ],
    "question_number": 47,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:43:58.166821",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should consult with their oncologist on the potential next steps.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises meeting with the oncologist to review imaging and discuss options and lists questions to ask the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the oncologist may suggest alternative standard of care therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions switching to a different chemotherapy regimen, which is a standard-of-care alternative when progression occurs."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that the oncologist may suggest clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends clinical trials and suggests asking about eligibility."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that re-biopsy of the disease could reveal targetable mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions molecular/genetic testing and targeted therapy but does not specifically state re-biopsy as a means to identify targetable mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supportive care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends palliative care to manage symptoms and maintain quality of life."
      }
    ],
    "question_number": 48,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:44:10.631814",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should consult with their oncologist on the potential next steps.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises having an open conversation with his oncologist about all available options and provides questions for the oncology team, clearly directing consultation with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the oncologist may suggest alternative standard of care therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically mentions switching to a different chemotherapy regimen, which represents alternative standard-of-care therapy after progression."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that the oncologist may suggest clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clinical trials are explicitly listed as a potential next step and suggested via referrals to specialized centers or clinical trials."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that re-biopsy of the disease could reveal targetable mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions targeted therapy or immunotherapy depending on genetic testing results, it does not state or imply that a re-biopsy after progression could reveal targetable mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supportive care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends palliative treatments to manage symptoms and improve quality of life and mentions involvement of palliative care teams, fulfilling supportive care guidance."
      }
    ],
    "question_number": 48,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:44:28.769301",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no approved CAR-T cell therapy for pancreatic cancer at this time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states, 'CAR-T cell therapy is not yet an approved treatment for pancreatic cancer,' which is accurate and unambiguous."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe CAR-T cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it references T cells and CAR-T success, it does not describe what CAR-T cells are (e.g., genetically engineered T cells with a chimeric antigen receptor targeting tumor antigens)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CAR-T cells are being studied in clinical trials for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions 'Several clinical trials are testing CAR-T approaches for pancreatic cancer' and lists targets such as mesothelin and HER2."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CAR-T cells are approved for the treatment of other types of cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response notes success in certain blood cancers but does not explicitly state that CAR-T therapies are approved for those cancers."
      }
    ],
    "question_number": 49,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:44:44.633809",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no approved CAR-T cell therapy for pancreatic cancer at this time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that CAR-T cell therapy is not a standard treatment option for pancreatic cancer, which conveys that it is not currently approved for this indication."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe CAR-T cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explain what CAR-T cells are (e.g., genetically engineered T cells with chimeric antigen receptors targeting specific antigens). It discusses challenges and settings but lacks a description of the therapy itself."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CAR-T cells are being studied in clinical trials for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes that clinical trials are exploring CAR-T approaches for pancreatic cancer and advises asking about trial eligibility."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CAR-T cells are approved for the treatment of other types of cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it states that CAR-T therapy has shown success in certain blood cancers, it does not explicitly state that CAR-T cells are approved for those cancers."
      }
    ],
    "question_number": 49,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:44:57.231659",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that hospice is considered when the medical team estimates a life expectancy of 6 months or less.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, 'Prognosis of 6 months or less if the illness runs its expected course,' which accurately reflects the standard hospice eligibility timeframe."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the aim of hospice is to maximize quality of life and focus on addressing symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains hospice is 'focused on comfort and quality of life' and lists 'Pain and symptom management,' clearly emphasizing symptom control and quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that hospice can take place in the home, a nursing home, or in a dedicated hospice facility.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states, 'Care can be provided at home, in a hospice facility, hospital, or nursing home,' covering all required settings."
      },
      {
        "criterion_number": 4,
        "description": "The answer should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response begins with, 'I'm sorry to hear about your father's diagnosis. This must be an incredibly difficult time for your family,' which is a clear expression of empathy."
      },
      {
        "criterion_number": 5,
        "description": "The response should define hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Hospice is defined as 'specialized care focused on comfort and quality of life when curative treatment is no longer the goal,' providing a clear and accurate definition."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what hospice care covers, including emotional and spiritual support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists a team including 'social workers, chaplains,' and 'support for family members,' which encompasses emotional and spiritual support."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe what hospice care covers, including bereavement support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly includes 'bereavement counseling' under hospice services."
      }
    ],
    "question_number": 50,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:45:10.628225",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that hospice is considered when the medical team estimates a life expectancy of 6 months or less.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, 'Generally when life expectancy is estimated at 6 months or less,' which aligns with the standard hospice eligibility timeframe."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the aim of hospice is to maximize quality of life and focus on addressing symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly notes a focus on comfort, pain management, and quality of life rather than curative treatment, directly addressing symptom management and quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that hospice can take place in the home, a nursing home, or in a dedicated hospice facility.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions services at home and hospice facilities, it does not explicitly include nursing homes, which is required for full credit."
      },
      {
        "criterion_number": 4,
        "description": "The answer should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response begins with, 'I'm sorry to hear about your father's diagnosis. This is an incredibly difficult situation,' which is a clear expression of sympathy and support."
      },
      {
        "criterion_number": 5,
        "description": "The response should define hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Hospice is defined as care focusing on comfort, pain management, and quality of life rather than curative treatment, delivered by a specialized interdisciplinary team."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what hospice care covers, including emotional and spiritual support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly includes 'Support for both patient and family, including emotional and spiritual care,' fulfilling this criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe what hospice care covers, including bereavement support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically mentions 'Bereavement support for family members,' directly addressing this requirement."
      }
    ],
    "question_number": 50,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:45:25.839933",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that fatigue is a common side effect of chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states, \"Chemotherapy-related fatigue is one of the most common and difficult side effects.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to report severe fatigue to the oncology team, consult them about activity levels, and discuss new strategies with the healthcare team."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention that optimizing nutrition and hydration can help manage fatigue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated \"Nutrition and Hydration\" section recommending small frequent meals, protein-rich foods, staying well-hydrated, and considering supplements."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend good sleep hygiene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes specific sleep hygiene strategies: maintaining a regular sleep schedule, limiting naps to 20\u201330 minutes, and creating a restful environment."
      },
      {
        "criterion_number": 5,
        "description": "The response should discuss potential causes for fatigue, including the effect of the cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions checking for anemia and medication adjustments as causes/modifiers but does not explicitly state that the cancer itself can cause fatigue; the rubric requires including the effect of the cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that light physical activity can improve fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that light exercise (short walks or chair exercises) can boost energy and recommends starting small and increasing gradually."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend medication review.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests the oncology team may adjust medications and asks about medications that might help with fatigue, implying medication review."
      }
    ],
    "question_number": 51,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:45:48.404774",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that fatigue is a common side effect of chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states, 'Fatigue is one of the most common and difficult side effects of chemotherapy.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends discussing fatigue severity with the oncology team and to work closely with her medical team."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention that optimizing nutrition and hydration can help manage fatigue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a 'Nutrition & Hydration' section with suggestions for small, frequent, nutrient-dense meals and staying well-hydrated; suggests an oncology dietitian."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend good sleep hygiene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a 'Sleep Hygiene' section with maintaining a regular schedule, creating a restful environment, and limiting naps."
      },
      {
        "criterion_number": 5,
        "description": "The response should discuss potential causes for fatigue, including the effect of the cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions potential contributors like anemia, dehydration, and nutritional deficiencies, but does not note that the cancer itself can cause fatigue."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that light physical activity can improve fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends 'Light exercise as tolerated (short walks, gentle stretching)' within strategies to help manage fatigue, implying benefit."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend medication review.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests asking about medications to help energy and possible treatment/dose adjustments, but does not explicitly recommend reviewing current medications for fatigue-contributing side effects."
      }
    ],
    "question_number": 51,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:46:07.999969",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that alternative treatments like cannabis oil have not been proven to help patients with pancreatic cancer live longer or cure them.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response notes that human evidence is very limited and advises not to replace conventional care, but it does not explicitly state that cannabis oil has not been proven to improve survival or cure pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that cannabis oil is sometimes used to manage cancer-related symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions pain management, appetite stimulation, and possible anti-nausea effects, indicating use for symptom management."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend discussing the use of cannabis oil with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says, \"Always discuss any alternative treatments with your loved one's oncology team,\" and reiterates that the oncologist can provide guidance."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe cannabis oil.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No description of what cannabis oil is (e.g., extracts, THC/CBD content) is provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cannabis oil is not used as an anti-cancer treatment per guidelines.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not reference guidelines or explicitly state that cannabis oil is not used as an anti-cancer treatment per guidelines."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe risks of using cannabis oil, including drug interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that cannabis products can interact with cancer treatments and other medications."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe risks of using cannabis oil, including side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Side effects such as drowsiness, confusion, and anxiety are listed."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe risks of using cannabis oil, including variation in quality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that quality and dosage can vary significantly between products."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe risks of using cannabis oil, including legal concerns.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions that legal status varies by location."
      }
    ],
    "question_number": 52,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:46:28.736264",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that alternative treatments like cannabis oil have not been proven to help patients with pancreatic cancer live longer or cure them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly notes there is limited clinical evidence for cannabis oil as a primary cancer treatment and emphasizes not replacing evidence-based treatments, which conveys that it is not proven to cure or prolong survival."
      },
      {
        "criterion_number": 2,
        "description": "State that cannabis oil is sometimes used to manage cancer-related symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states cannabis may help with pain, nausea, and appetite loss, which are cancer-related symptoms."
      },
      {
        "criterion_number": 3,
        "description": "Recommend discussing the use of cannabis oil with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit recommendation to discuss any alternative treatments with the oncology team first, and to work with doctors familiar with oncology and medical cannabis."
      },
      {
        "criterion_number": 4,
        "description": "Describe cannabis oil.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No description of what cannabis oil is (e.g., extracts of cannabinoids such as THC/CBD in oil form) was provided; only general references to 'cannabis' and 'cannabis products.'"
      },
      {
        "criterion_number": 5,
        "description": "State that cannabis oil is not used as an anti-cancer treatment per guidelines.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not reference guidelines or explicitly state that guidelines do not recommend cannabis oil as an anti-cancer treatment."
      },
      {
        "criterion_number": 6,
        "description": "Describe risks of using cannabis oil, including drug interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions possible interactions with conventional treatments, satisfying the drug interaction risk."
      },
      {
        "criterion_number": 7,
        "description": "Describe risks of using cannabis oil, including side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific side effects (e.g., sedation, dizziness, cognitive changes, anxiety) are listed."
      },
      {
        "criterion_number": 8,
        "description": "Describe risks of using cannabis oil, including variation in quality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly notes that quality and dosing vary widely and are not standardized."
      },
      {
        "criterion_number": 9,
        "description": "Describe risks of using cannabis oil, including legal concerns.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that legal status varies by location, addressing legal concerns."
      }
    ],
    "question_number": 52,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:46:59.523395",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that lack of appetite is a common side effect of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, 'Loss of appetite is very common with pancreatic cancer.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the patient should consult with their oncologist, who may refer them to a registered dietitian, oncology nutritionist, and/or palliative care physician to address symptoms and optimize supportive care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises talking to the 'medical team' and mentions seeing a dietitian, but it does not explicitly instruct consulting the oncologist or mention referral to palliative care. The criterion requires explicit mention of the oncologist."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme replacement can be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, 'Pancreatic enzyme supplements if needed,' which indicates consideration of pancreatic enzyme replacement."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the patient can try smaller meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends 'Small, frequent meals' and 'Keep portions visually small,' addressing smaller meals."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient can try more frequent meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It suggests 'Offer 5-6 small portions throughout the day,' which clearly promotes more frequent meals."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the patient can try nutritional replacement shakes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends 'Smoothies, milkshakes, or nutritional drinks' and 'Try nutritional supplements like Ensure or Boost.'"
      },
      {
        "criterion_number": 7,
        "description": "The response should state that appetite stimulants can also be considered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists 'Prescription appetite stimulants' under items to discuss with the medical team."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that cancer itself can cause loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "By stating loss of appetite is 'very common with pancreatic cancer,' it communicates that the cancer itself can cause appetite loss."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that chemotherapy can cause nausea and loss of appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Although it mentions anti-nausea medications, it does not explicitly state chemotherapy as a cause of nausea or appetite loss."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that bloating can decrease appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Bloating is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that pancreatic enzyme deficiency can cause decreased appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While pancreatic enzyme supplements are suggested, the response does not state that enzyme deficiency can lead to decreased appetite."
      }
    ],
    "question_number": 53,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:47:17.200070",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that lack of appetite is a common side effect of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, \"Loss of appetite is very common with pancreatic cancer.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the patient should consult with their oncologist, who may refer them to a registered dietitian, oncology nutritionist, and/or palliative care physician to address symptoms and optimize supportive care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to \"Ask his oncologist\" and to \"Consider consulting with a registered dietitian who specializes in oncology,\" and to \"Work closely with his medical team.\""
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme replacement can be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It says, \"Ask about digestive enzymes, which can help with pancreatic cancer,\" indicating pancreatic enzyme replacement therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the patient can try smaller meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends offering \"small... meals\" rather than three large ones."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient can try more frequent meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends \"small, frequent meals rather than three large ones.\""
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the patient can try nutritional replacement shakes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It suggests \"liquid nutrition like smoothies, protein shakes, or soups,\" which includes nutritional replacement shakes."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that appetite stimulants can also be considered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \"Ask his oncologist about prescription appetite stimulants.\""
      },
      {
        "criterion_number": 8,
        "description": "The response should include that cancer itself can cause loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "By stating \"Loss of appetite is very common with pancreatic cancer,\" it attributes appetite loss to the cancer itself."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that chemotherapy can cause nausea and loss of appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While it mentions discussing anti-nausea medications, it does not explicitly state that chemotherapy can cause nausea and appetite loss."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that bloating can decrease appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Bloating is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that pancreatic enzyme deficiency can cause decreased appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Although digestive enzymes are mentioned, it does not state that pancreatic enzyme deficiency can cause decreased appetite."
      }
    ],
    "question_number": 53,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:47:49.538457",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Start with primary doctor for referral to the most local community hospital with oncology services.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not advise starting with the primary care physician or seeking referral to a local community hospital with oncology services. It references a local oncologist but does not guide on how to access one via a primary doctor."
      },
      {
        "criterion_number": 2,
        "description": "If able to travel, major cancer centers offer consultations, including via telehealth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends contacting major cancer centers for remote consultation programs and mentions telemedicine for ongoing consultations, as well as temporary relocation near major centers, satisfying both travel and telehealth aspects."
      },
      {
        "criterion_number": 3,
        "description": "Patients can search for NCI-designated cancer centers to find the closest one; explicitly note that both oncologists and palliative care teams often offer telemedicine visits.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it provides the NCI resource to identify the nearest designated cancer center, it does not explicitly state that both oncologists and palliative care teams offer virtual visits; palliative care is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly recommend reaching out to regional cancer centers, including examples/resources to find such centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises contacting major cancer centers and provides the National Cancer Institute phone number to identify the nearest designated cancer center, meeting the requirement with a concrete resource."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that specialists will often partner with local oncologists to coordinate care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response describes shared care models where cancer centers partner with local hospitals to create plans administered locally and mentions virtual tumor boards connecting local doctors with specialists, which conveys coordinated care between specialists and local clinicians."
      }
    ],
    "question_number": 54,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:48:23.162033",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that they can start with their primary doctor who can help refer to the most local community hospital with oncology services.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises, 'Ask your current doctor for referrals to the nearest oncology specialists,' which captures starting with the primary/current doctor and obtaining local referrals, aligning with the intent of referring to local oncology services."
      },
      {
        "criterion_number": 2,
        "description": "State that if they are able to travel, then major cancer centers offer consultations which can also be done as telehealth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends contacting major cancer centers and notes that many offer telemedicine consultations, and also mentions checking insurance for distant facilities, covering both travel and telehealth options."
      },
      {
        "criterion_number": 3,
        "description": "State that patients can search for NCI-designated cancer centers to find the closest one to them, and explicitly mention that both oncologists and palliative care teams often offer virtual visits through telemedicine or telehealth consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While NCI-designated cancer centers are mentioned, the response does not instruct patients to search for the closest one, nor does it mention palliative care teams or their telehealth availability."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly recommend reaching out to regional cancer centers, including examples or resources for finding such centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends contacting major cancer centers and lists NCI-designated and academic medical centers as targets, effectively directing outreach to regional/tertiary centers and providing examples."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that specialists will often partner with local oncologists to coordinate care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it mentions 'hub-and-spoke models' and patient navigators, it does not explicitly state that specialists partner with local oncologists to coordinate care."
      }
    ],
    "question_number": 54,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:48:48.888376",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should offer sympathy for the stressful situation dealing with insurance coverage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response begins with clear empathy: \"I'm sorry to hear about your father's diagnosis\" and acknowledges the stress of insurance denials."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they can work with the hospital\u2019s financial counselor or social worker.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions hospital patient advocates, it does not explicitly recommend working with a hospital financial counselor or social worker as required."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises contacting the doctor to obtain a letter of medical necessity, which entails working with the treating clinician/oncology team to support the appeal."
      },
      {
        "criterion_number": 4,
        "description": "The response should include contacting the insurance company to understand the reason for denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs to request the denial in writing and get specific reasons for the denial, which requires contacting the insurer to understand the basis for denial."
      },
      {
        "criterion_number": 5,
        "description": "The response should state one option for remedy is filing an appeal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly outlines filing an internal appeal and, if needed, pursuing an external review."
      }
    ],
    "question_number": 55,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:49:02.514145",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should offer sympathy for the stressful situation dealing with insurance coverage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathy, acknowledging the father's diagnosis and the stress of insurance denials (e.g., 'I'm so sorry to hear about your father's diagnosis... incredibly stressful')."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they can work with the hospital\u2019s financial counselor or social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends 'Ask the hospital's financial counselor' and notes that 'Many cancer centers also have social workers' who can help navigate these issues."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises 'Get physician support' with additional documentation of medical necessity, which reasonably refers to working with the treating oncology team in this context."
      },
      {
        "criterion_number": 4,
        "description": "The response should include contacting the insurance company to understand the reason for denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs to 'Contact the insurance company to discuss the denial and ask about appeal processes' and to request detailed denial letters explaining why coverage was denied."
      },
      {
        "criterion_number": 5,
        "description": "The response should state one option for remedy is filing an appeal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states 'File a formal appeal' and discusses internal and external review processes."
      }
    ],
    "question_number": 55,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:49:15.681202",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define high-volume centers as those performing at least 40 or 50 Whipple procedures per year.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response defines high-volume centers as 'typically 20+ pancreatic surgeries/year,' which does not meet the required threshold of at least 40\u201350 Whipple procedures per year."
      },
      {
        "criterion_number": 2,
        "description": "State that high-volume centers have significantly lower mortality rates and higher overall survival rates.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response provides specific lower mortality rates (2\u20134% vs 10\u201315%), it does not explicitly state that overall survival rates are higher at high-volume centers."
      },
      {
        "criterion_number": 3,
        "description": "State that high-volume centers have significantly lower complication rates.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions experienced teams and support staff but does not explicitly state that complication rates are lower at high-volume centers."
      },
      {
        "criterion_number": 4,
        "description": "State that at a high-volume center, the surgeon is more likely to be a specialist in pancreas surgery.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response notes 'experienced surgical teams' and dedicated programs but does not explicitly state that surgeons are more likely to be pancreas surgery specialists."
      },
      {
        "criterion_number": 5,
        "description": "State that high-volume centers often have access to clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly states 'Access to clinical trials,' satisfying this criterion."
      },
      {
        "criterion_number": 6,
        "description": "State that high-volume centers have access to the latest treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response mentions 'newer treatment approaches' alongside clinical trials, indicating access to the latest treatments."
      },
      {
        "criterion_number": 7,
        "description": "State disadvantages of going to a high-volume center, including travel time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response discusses travel-related burdens ('distance from family is a factor' and local hospitals having 'less travel burden'), which addresses travel time as a disadvantage of high-volume centers."
      },
      {
        "criterion_number": 8,
        "description": "State disadvantages of going to a high-volume center, including more complicated logistics.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions insurance/financial considerations and extended stays, it does not explicitly address more complicated logistics (e.g., coordination of care, scheduling, housing, record transfers) as a disadvantage."
      }
    ],
    "question_number": 56,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:49:40.881429",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define high-volume centers as those performing at least 40 or 50 Whipple procedures per year.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes benefits of high-volume centers but does not provide a numeric definition (e.g., \u226540\u201350 Whipple procedures per year)."
      },
      {
        "criterion_number": 2,
        "description": "State that high-volume centers have significantly lower mortality rates and higher overall survival rates.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions lower surgical mortality and 'better outcomes' but does not explicitly state higher overall survival rates."
      },
      {
        "criterion_number": 3,
        "description": "State that high-volume centers have significantly lower complication rates.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes 'better management of complications' but does not state lower complication rates."
      },
      {
        "criterion_number": 4,
        "description": "State that at a high-volume center, the surgeon is more likely to be a specialist in pancreas surgery.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response references more experienced teams and frequent performance of complex procedures but does not explicitly state that surgeons are pancreas specialists."
      },
      {
        "criterion_number": 5,
        "description": "State that high-volume centers often have access to clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states 'Access to clinical trials and newer treatment options.'"
      },
      {
        "criterion_number": 6,
        "description": "State that high-volume centers have access to the latest treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States access to 'newer treatment options,' which conveys access to the latest treatments."
      },
      {
        "criterion_number": 7,
        "description": "State disadvantages of going to a high-volume center, including travel time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'Travel distance and associated costs' as a drawback."
      },
      {
        "criterion_number": 8,
        "description": "State disadvantages of going to a high-volume center, including more complicated logistics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'time away from local support systems' and 'possible delays in scheduling,' reflecting more complicated logistics."
      }
    ],
    "question_number": 56,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:49:56.712917",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the Pancreatic Cancer Action Network as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions PanCAN (Pancreatic Cancer Action Network) and notes it provides resources and grants."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention CancerCare as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "References CancerCare twice, including offering limited financial assistance and free counseling."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the American Cancer Society as a resource for financial assistance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention the American Cancer Society anywhere in the response."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises that social workers can connect patients with local resources in the context of hospital-based financial help, implying discussion of financial concerns."
      },
      {
        "criterion_number": 5,
        "description": "The response should offer sympathy for the stressful situation dealing with financial burden during cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathy: \"I'm sorry to hear about your loved one's diagnosis\" and acknowledges the financial burden as a real concern."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages being upfront with the healthcare team about financial concerns; this reasonably includes the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing financial concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions hospital financial counselors and how they can help maximize insurance benefits, indicating a recommendation to engage them regarding finances."
      }
    ],
    "question_number": 57,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:50:21.182393",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the Pancreatic Cancer Action Network as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists the Pancreatic Cancer Action Network among national organizations offering grants for financial assistance."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention CancerCare as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "CancerCare is explicitly named as a national organization that offers grants."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the American Cancer Society as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The American Cancer Society is explicitly mentioned as a resource offering grants."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends engaging with social workers (\u201cMany cancer centers have patient navigators and social workers\u201d) and specifically suggests the social worker at the treatment center as a guide."
      },
      {
        "criterion_number": 5,
        "description": "The response should offer sympathy for the stressful situation dealing with financial burden during cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The opening sentence expresses empathy and acknowledges the added stress of financial concerns during cancer treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions treatment center resources (financial counselors, social workers, patient navigators), it does not explicitly recommend discussing financial concerns with the oncology team or oncologist."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing financial concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises using hospital financial counselors to navigate costs and payment plans."
      }
    ],
    "question_number": 57,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:50:32.164935",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions that depression is common among patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states depression is very common in pancreatic cancer and provides an estimated prevalence range (33\u201350%)."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing the patient\u2019s mood with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises talking to the oncology team right away and being persistent with the medical team."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions support groups as helpful for patients with cancer experiencing depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends joining a pancreatic cancer support group and cites PanCAN resources."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions seeking immediate evaluation by a medical professional if the patient is experiencing thoughts of harming themself or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention urgent evaluation or crisis steps for suicidal or homicidal ideation."
      },
      {
        "criterion_number": 5,
        "description": "The response offers the emergency department and calling 988 if the patient experiences thoughts of harming themself or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No reference to calling 988, emergency services, or going to the ED for crisis situations."
      },
      {
        "criterion_number": 6,
        "description": "The response points to published scientific studies describing the prevalence of depression in pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides prevalence figures but does not cite or point to specific published studies."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list depressive symptoms (e.g., low mood, anhedonia, sleep/appetite changes, guilt, concentration issues, suicidality)."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing the patient\u2019s mood with a mental health professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends referral to a psycho-oncologist or therapist experienced with cancer patients."
      },
      {
        "criterion_number": 9,
        "description": "The response states that there are various treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions multiple approaches including therapy, antidepressants, and support resources, indicating various options."
      },
      {
        "criterion_number": 10,
        "description": "The response states that there are both pharmacologic and non-pharmacologic treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies pharmacologic (antidepressants) and non-pharmacologic options (therapy, support groups, activity)."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions lifestyle changes that support improvements in mental health.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends maintaining routines, gentle physical activity, and social connection, which are lifestyle strategies supporting mental health."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that based on the ASCO guidelines, optimal care of depression should follow a stepped-care model.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not reference ASCO guidelines or the stepped-care model."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that CBT, behavior therapy (BT), and behavioral activation (BA) are the most effective treatments for managing depressive symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention CBT, BT, or BA specifically."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that exercise both during and after treatment can significantly reduce depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests gentle physical activity but does not state evidence that exercise during and after treatment significantly reduces depression."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that pharmacotherapy is not recommended as a first-line treatment for depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends considering antidepressants without noting they are not first-line per ASCO guidance."
      }
    ],
    "question_number": 58,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:51:11.011242",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions that depression is common among patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States depression is very common in pancreatic cancer and provides a prevalence estimate (30\u201350%)."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing the patient\u2019s mood with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises talking to the oncology team and bringing it up at the next oncology appointment."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions support groups as helpful for patients with cancer experiencing depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends support groups for connecting with others facing similar challenges."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions seeking immediate evaluation by a medical professional if the patient is experiencing thoughts of harming themself or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of urgent evaluation or safety steps for suicidal or homicidal thoughts."
      },
      {
        "criterion_number": 5,
        "description": "The response offers the emergency department and calling 988 if the patient experiences thoughts of harming themself or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention the emergency department or the 988 Suicide & Crisis Lifeline."
      },
      {
        "criterion_number": 6,
        "description": "The response points to published scientific studies describing the prevalence of depression in pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides prevalence figures but does not cite or point to published scientific studies."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not review core depressive symptoms (e.g., persistent low mood, anhedonia, sleep/appetite changes, concentration, energy, guilt, suicidality). Only notes possible withdrawal/irritability."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing the patient\u2019s mood with a mental health professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends counseling with therapists who specialize in serious illness."
      },
      {
        "criterion_number": 9,
        "description": "The response states that there are various treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions multiple options including counseling, medications, support groups, and routine-building."
      },
      {
        "criterion_number": 10,
        "description": "The response states that there are both pharmacologic and non-pharmacologic treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes antidepressant medications (pharmacologic) and counseling/support groups/exercise (non-pharmacologic)."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions lifestyle changes that support improvements in mental health.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests gentle exercise, social connection, maintaining routine, and meaningful activities."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that based on the ASCO guidelines, optimal care of depression should follow a stepped-care model.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of ASCO guidelines or a stepped-care model."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that Cognitive Behavioral Therapy (CBT), behavior therapy (BT), and behavioral activation (BA) are the most effective treatments for managing depressive symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specify CBT, BT, or BA as effective treatments."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that exercise both during and after treatment can significantly reduce depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions gentle exercise generally but does not state evidence that exercise during and after treatment significantly reduces depression."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that pharmacotherapy is not recommended as a first-line treatment for depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States that medication may help and is effective/safe but does not indicate pharmacotherapy is not first-line."
      }
    ],
    "question_number": 58,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:52:15.224977",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states, 'Your loved one's oncologist can provide more personalized information,' which is a clear recommendation to discuss prognosis with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states that many aspects of a patient\u2019s health impact their prognosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists multiple factors affecting prognosis: stage at diagnosis, surgical candidacy, overall health and age, treatment response, and tumor characteristics."
      },
      {
        "criterion_number": 3,
        "description": "The response defines overall survival as it is used in clinical research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not define overall survival (time from diagnosis/treatment start to death from any cause) or even mention the term."
      },
      {
        "criterion_number": 4,
        "description": "The response defines progression-free survival as it is used in clinical research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Progression-free survival is not mentioned or defined."
      },
      {
        "criterion_number": 5,
        "description": "The response explains that overall survival and progression-free survival are typically reported as medians.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While 'median survival' is defined, the response does not state that OS and PFS are typically reported as medians."
      },
      {
        "criterion_number": 6,
        "description": "The response explains the above biostatistics terms (overall survival, progression-free survival, and median) in laymen\u2019s terms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Only 'median survival' is explained in lay terms; overall survival and progression-free survival are not defined."
      },
      {
        "criterion_number": 7,
        "description": "The response explains that survival data is best reported in terms of the stage of cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Stage is listed as an important factor, but the response does not explicitly state that survival data are best interpreted/reported by stage."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the limitations of applying reported statistics to patients\u2019 individual cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly notes that statistics are historical averages from large groups and not predictions for individuals, and that some do better than average."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions the difference between overall survival and progression-free survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neither overall survival nor progression-free survival is mentioned, so no distinction is provided."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that survival is influenced by tumor characteristics such as genetic mutations (BRCA, KRAS), size, and location.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It generically references 'specific tumor characteristics' without examples such as mutations (BRCA, KRAS), tumor size, or location."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that survival depends on treatments received (chemotherapy, surgery, targeted therapy, no treatment, etc.) and treatment response.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states 'Whether surgery is possible' and 'How the cancer responds to treatment,' which addresses treatment modalities and response affecting prognosis."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that new treatments and advancements are being developed all the time, and these could potentially improve outcomes in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes that 'treatments are constantly improving,' which conveys ongoing advancements that can affect outcomes."
      }
    ],
    "question_number": 59,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:52:53.616696",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly encourages asking the medical team specific questions about stage, individualized factors, and goals, effectively directing the reader to discuss prognosis with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response states that many aspects of a patient\u2019s health impact their prognosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that age, overall health, and specific tumor characteristics influence prognosis, and that response to treatment varies widely."
      },
      {
        "criterion_number": 3,
        "description": "The response defines overall survival as it is used in clinical research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not define overall survival (time from diagnosis/treatment start to death from any cause)."
      },
      {
        "criterion_number": 4,
        "description": "The response defines progression-free survival as it is used in clinical research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Progression-free survival is not mentioned or defined."
      },
      {
        "criterion_number": 5,
        "description": "The response explains that overall survival and progression-free survival are typically reported as medians.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While median survival is discussed, it does not state that OS and PFS are typically reported as medians."
      },
      {
        "criterion_number": 6,
        "description": "The response explains the above biostatistics terms (overall survival, progression-free survival, and median) in laymen\u2019s terms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It explains median survival in lay terms but does not explain overall survival or progression-free survival."
      },
      {
        "criterion_number": 7,
        "description": "The response explains that survival data is best reported in terms of the stage of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states survival rates vary by stage and emphasizes that early-stage versus metastatic disease have very different outcomes."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the limitations of applying reported statistics to patients\u2019 individual cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states statistics are averages, not predictions; individual factors and treatment advances affect applicability."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions the difference between overall survival and progression-free survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neither overall survival nor progression-free survival are described or contrasted."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that survival is influenced by tumor characteristics such as genetic mutations (BRCA, KRAS), size, and location.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It references \"specific tumor characteristics\" but does not mention genetics (e.g., BRCA, KRAS), size, or tumor location explicitly."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that survival depends on treatments received (chemotherapy, surgery, targeted therapy, no treatment, etc.) and treatment response.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes treatment response varies and that advances may improve outcomes, but it does not explicitly state that survival depends on the treatments received or list treatment modalities."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that new treatments and advancements are being developed all the time, and these could potentially improve outcomes in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that treatment advances mean current outcomes may be better than published statistics, capturing the idea that evolving therapies can improve outcomes over time."
      }
    ],
    "question_number": 59,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:53:49.077295",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises: 'don't hesitate to ask his medical team for more details,' recommending discussion with the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that a liquid biopsy is a blood test.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit statement: 'A liquid biopsy is a simple blood test.'"
      },
      {
        "criterion_number": 3,
        "description": "The response explains that liquid biopsies involve analyzing circulating tumor DNA (ctDNA) from blood samples.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists 'Circulating tumor DNA (ctDNA) \u2013 fragments of DNA shed by cancer cells' as part of the blood test."
      },
      {
        "criterion_number": 4,
        "description": "The response explains there are many different tests which evaluate various things including circulating tumor DNA, circulating tumor cells, and proteins in the blood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions ctDNA, CTCs, and 'other markers \u2013 like proteins or RNA.'"
      },
      {
        "criterion_number": 5,
        "description": "The response says that liquid biopsies do not replace tissue biopsies in the diagnosis of cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not state that liquid biopsies do not replace tissue biopsies; instead it suggests they can help 'without needing traditional tissue biopsies,' which could imply replacement."
      },
      {
        "criterion_number": 6,
        "description": "The response says the results of liquid biopsies must be interpreted by a medical professional.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit statement that results must be interpreted by a clinician."
      },
      {
        "criterion_number": 7,
        "description": "The response says the results of liquid biopsies may be helpful when combined with imaging and pathology results.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions using tests 'alongside traditional scans,' but does not mention pathology results."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions there are liquid biopsies in various stages of development for different kinds of cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of development stage or variation across different cancers."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the limitations of liquid biopsies, including sensitivity, false positives, and cost.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No discussion of sensitivity, false positives/negatives, or cost."
      },
      {
        "criterion_number": 10,
        "description": "The response says there are currently no FDA approved liquid biopsies for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of FDA approval status for pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response says health insurance may not pay for these tests.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Insurance coverage is not addressed."
      },
      {
        "criterion_number": 12,
        "description": "The response says liquid biopsies may be able to identify genetic mutations present in the cancer which can help to guide treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states liquid biopsies can help with 'Identifying genetic mutations that might guide treatment choices.'"
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that liquid biopsies are noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes they are 'much less invasive' but does not mention expedited testing or avoiding archival blocks/new biopsy logistics."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of technical limitations regarding copy-number changes or fusion detection in cfDNA."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that this is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It calls liquid biopsies 'relatively new' but does not state they are under active research or not standard of care for all patients."
      }
    ],
    "question_number": 60,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:54:16.881321",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response encourages the family to ask the doctors what they hope to learn and how it will influence care, effectively recommending discussion with the treating team (which includes the oncologist)."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that a liquid biopsy is a blood test.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly refers to analyzing material in blood samples and mentions a simple blood draw."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that liquid biopsies involve analyzing circulating tumor DNA (ctDNA) from blood samples.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifies analysis of cell-free DNA from tumors in blood samples, which corresponds to ctDNA."
      },
      {
        "criterion_number": 4,
        "description": "The response explains there are many different tests which evaluate various things including circulating tumor DNA, circulating tumor cells, and proteins in the blood.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions CTCs and cfDNA and alludes to 'other cancer biomarkers,' it does not explicitly mention proteins."
      },
      {
        "criterion_number": 5,
        "description": "The response says that liquid biopsies do not replace tissue biopsies in the diagnosis of cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not state that tissue biopsy remains necessary for diagnosis or that liquid biopsies do not replace tissue biopsy."
      },
      {
        "criterion_number": 6,
        "description": "The response says the results of liquid biopsies must be interpreted by a medical professional.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not explicitly state that results require professional interpretation."
      },
      {
        "criterion_number": 7,
        "description": "The response says the results of liquid biopsies may be helpful when combined with imaging and pathology results.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of integrating results with imaging or pathology."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions there are liquid biopsies in various stages of development for different kinds of cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of development stages or applicability across different cancers."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the limitations of liquid biopsies, including sensitivity, false positives, and cost.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes limited detection and being less established but does not mention false positives or cost."
      },
      {
        "criterion_number": 10,
        "description": "The response says there are currently no FDA approved liquid biopsies for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of FDA approval status for pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response says health insurance may not pay for these tests.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Insurance coverage is not addressed."
      },
      {
        "criterion_number": 12,
        "description": "The response says liquid biopsies may be able to identify genetic mutations present in the cancer which can help to guide treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states liquid biopsies can identify genetic mutations to guide targeted therapy choices."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that liquid biopsies are noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Noninvasive nature is mentioned, but not the expedited testing aspect (no need for archival blocks or new biopsy)."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of copy-number or fusion testing limitations in cfDNA assays."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that this is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes that liquid biopsies are less established for some decisions but does not explicitly state that this remains under active research or not standard of care for all patients."
      }
    ],
    "question_number": 60,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:54:41.009468",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response considers the costs of travel.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly advises to factor in travel costs as part of overall expenses."
      },
      {
        "criterion_number": 2,
        "description": "The response considers the costs of healthcare abroad.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions treatment costs and checking insurance coverage for international care."
      },
      {
        "criterion_number": 3,
        "description": "The response considers logistics of travel, including the need for passports and/or visas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes visa requirements and medical visas as a logistical consideration."
      },
      {
        "criterion_number": 4,
        "description": "The response considers language and cultural barriers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It highlights language barriers and ensuring clear communication with medical staff."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions that patients receiving treatment for pancreatic cancer often require significant support from their family and friends.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes the need for a support system and who will accompany the patient."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering if the patient is medically safe for travel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises confirming the patient is medically cleared to travel."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends researching the quality of healthcare in the intended destination.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends verifying hospital accreditation (JCI/ISO), oncologist credentials, and researching specific hospitals and success rates."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing all travel plans with a medical professional prior to leaving.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises consulting with the current oncologist about travel and getting second opinions."
      },
      {
        "criterion_number": 10,
        "description": "The response says that delaying the start of treatment for pancreatic cancer can be harmful.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No statement warns that delaying pancreatic cancer treatment can be harmful."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends researching pancreatic cancer outcomes in the intended destination as compared to her home country.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It suggests researching hospitals and success rates but does not recommend comparing outcomes to those in the home country."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends understanding the patient\u2019s treatment options, including clinical trials, which may be available in her home country before making travel plans.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions second opinions and trials in various countries, it does not advise evaluating home-country clinical trials or all local options before traveling."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention considerations related to insurance funding.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises checking if international treatment is covered by insurance."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to consider local accommodations when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It includes accommodation as a cost to factor into planning."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention to consider challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It addresses continuity of care and coordination with home doctors for follow-up."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that immunizations and infection prevention are important, especially for immunosuppressed patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of immunizations or infection prevention for immunosuppressed patients."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that telemedicine and remote support can be leveraged for follow-up, symptom management, and multidisciplinary care.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not suggest using telemedicine or remote support to reduce travel and facilitate ongoing care."
      }
    ],
    "question_number": 61,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:55:17.079223",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response considers the costs of travel.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions total costs including travel."
      },
      {
        "criterion_number": 2,
        "description": "The response considers the costs of healthcare abroad.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Calls out total treatment costs and requests a total cost breakdown."
      },
      {
        "criterion_number": 3,
        "description": "The response considers logistics of travel, including the need for passports and/or visas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions travel documents and medical visa requirements."
      },
      {
        "criterion_number": 4,
        "description": "The response considers language and cultural barriers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses language barriers and communication needs, which encompasses cultural communication challenges."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions that patients receiving treatment for pancreatic cancer often require significant support from their family and friends.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Highlights the need for companion/caregiver arrangements, indicating significant support needs."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering if the patient is medically safe for travel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly advises considering the mother\u2019s current health status for travel."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends researching the quality of healthcare in the intended destination.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends verifying provider credentials, hospital accreditation, treatment technologies, and outcomes/success rates."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing all travel plans with a medical professional prior to leaving.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises consulting with the current oncologist about the foreign option and evaluating advantages."
      },
      {
        "criterion_number": 10,
        "description": "The response says that delaying the start of treatment for pancreatic cancer can be harmful.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention risks of delaying treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends researching pancreatic cancer outcomes in the intended destination as compared to her home country.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests verifying outcomes/success rates and comparing options abroad vs. at home, and assessing advantages over local treatments."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends understanding the patient\u2019s treatment options, including clinical trials, which may be available in her home country before making travel plans.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages a local second opinion for domestic options but does not mention clinical trials."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention considerations related to insurance funding.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions insurance coverage and pre-authorization requirements."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to consider local accommodations when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes accommodation and extended stay in total costs."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention to consider challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Addresses follow-up care requirements, coordination with home teams, and ongoing care after returning."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that immunizations and infection prevention are important, especially for immunosuppressed patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of immunizations or infection prevention."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that telemedicine and remote support can be leveraged for follow-up, symptom management, and multidisciplinary care.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention telemedicine or remote support."
      }
    ],
    "question_number": 61,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:55:47.157914",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that bowel changes, including diarrhea, nausea, and constipation, are common among patients undergoing treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions bowel changes are common and lists diarrhea and constipation, but it does not mention nausea."
      },
      {
        "criterion_number": 2,
        "description": "The response mentions that chemotherapy, radiation therapy, surgery, and other treatments such as pain medications can impact the bowels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Chemotherapy, radiation, surgery, and opioids (pain medications) are all explicitly mentioned as affecting digestion or causing constipation."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that bowel changes can also be due to infections.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Infections are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing specific concerns with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing symptoms with the oncology team."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping a log of events related to food intake, fluid intake, and bowel symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No log or tracking of intake/symptoms is suggested."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the above log with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No log is suggested; therefore no recommendation to review it with the care team."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends if the patient has not had a bowel movement in more than 24 hours and is not passing gas, their bowels may be obstructed, which is a medical emergency and requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No warning regarding possible bowel obstruction or emergency evaluation is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends if the patient is nauseous and unable to keep any food or drink down without vomiting, this can quickly lead to severe dehydration, which requires urgent evaluation by a medical professional and potentially intravenous fluids and medicines.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No guidance about persistent vomiting, dehydration risk, or urgent evaluation is included."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends if the patient is experiencing severe abdominal pain, this may represent a medical emergency which requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Severe abdominal pain and emergency evaluation are not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response says patients with pancreatic cancer may experience pancreatic insufficiency.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it describes enzyme deficiency, it does not explicitly use the term 'pancreatic insufficiency.'"
      },
      {
        "criterion_number": 11,
        "description": "The response explains pancreatic insufficiency is related to a deficiency in the pancreatic enzymes which break down food and can cause diarrhea and bloating.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explains that reduced pancreatic enzymes impair fat digestion causing diarrhea and greasy stools, and elsewhere mentions bloating among common changes."
      },
      {
        "criterion_number": 12,
        "description": "The response explains there are supplementary pancreatic enzymes that can be taken to alleviate the symptoms of pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states the oncology team can prescribe pancreatic enzyme supplements if needed."
      },
      {
        "criterion_number": 13,
        "description": "The response explains if the bowel changes are due to chemotherapy, the treating oncologist can often prescribe additional medications to control these side effects.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It identifies chemotherapy as a cause and notes the oncology team can provide medications to manage diarrhea or constipation."
      },
      {
        "criterion_number": 14,
        "description": "The response says proper nutrition is an important part of cancer care outcomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it offers dietary modifications, it does not state that proper nutrition is important for cancer care outcomes."
      },
      {
        "criterion_number": 15,
        "description": "The response says it is important to remain hydrated.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Hydration is not mentioned."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that it is important to determine the cause of the bowel changes to manage them effectively.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It lists multiple possible causes and suggests discussing with the team, but does not explicitly state that determining the specific cause is important for effective management."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that gastric outlet/duodenal obstruction can occur in up to 10% of patients with pancreatic cancer, leading to symptoms like early satiety, nausea, postprandial vomiting, and weight loss.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gastric outlet or duodenal obstruction and its prevalence/symptoms are not mentioned."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that patients with malignant ascites from pancreatic cancer may experience abdominal discomfort, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Malignant ascites and its symptoms are not discussed."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that diet/nutrition changes can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It does not state that diet changes themselves can cause bowel changes unrelated to cancer or treatment."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that stress/anxiety can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Stress or anxiety as causes of bowel changes are not mentioned."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that pre-existing conditions can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Pre-existing conditions as potential causes are not mentioned."
      }
    ],
    "question_number": 62,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:56:21.301389",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that bowel changes, including diarrhea, nausea, and constipation, are common among patients undergoing treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes bowel changes are common and mentions diarrhea and constipation with treatment, but does not explicitly mention nausea."
      },
      {
        "criterion_number": 2,
        "description": "The response mentions that chemotherapy, radiation therapy, surgery, and other treatments such as pain medications can impact the bowels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions chemotherapy, radiation, surgery, and pain medications (opioids) affecting bowels."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that bowel changes can also be due to infections.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Infections are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing specific concerns with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises reporting changes to the oncology team and discussing symptoms with healthcare providers."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping a log of events related to food intake, fluid intake, and bowel symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests keeping a brief log of symptoms but does not specify including food or fluid intake."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the above log with the patient\u2019s healthcare team.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises keeping a log to share with doctors."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends if the patient has not had a bowel movement in more than 24 hours and is not passing gas, their bowels may be obstructed, which is a medical emergency and requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of bowel obstruction red flags or emergency evaluation."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends if the patient is nauseous and unable to keep any food or drink down without vomiting, this can quickly lead to severe dehydration, which requires urgent evaluation by a medical professional and potentially intravenous fluids and medicines.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No guidance on dehydration risk or urgent evaluation for persistent vomiting."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends if the patient is experiencing severe abdominal pain, this may represent a medical emergency which requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Severe abdominal pain as a medical emergency is not addressed."
      },
      {
        "criterion_number": 10,
        "description": "The response says patients with pancreatic cancer may experience pancreatic insufficiency.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It discusses enzyme function interference but does not explicitly name pancreatic insufficiency."
      },
      {
        "criterion_number": 11,
        "description": "The response explains pancreatic insufficiency is related to a deficiency in the pancreatic enzymes which break down food and can cause diarrhea and bloating.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While enzyme interference is mentioned, there is no explanation linking enzyme deficiency to diarrhea/bloating."
      },
      {
        "criterion_number": 12,
        "description": "The response explains there are supplementary pancreatic enzymes that can be taken to alleviate the symptoms of pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises asking about pancreatic enzyme supplements, implying their use to address enzyme-related symptoms."
      },
      {
        "criterion_number": 13,
        "description": "The response explains if the bowel changes are due to chemotherapy, the treating oncologist can often prescribe additional medications to control these side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It states the team can provide effective management but does not specifically mention prescribing additional medications."
      },
      {
        "criterion_number": 14,
        "description": "The response says proper nutrition is an important part of cancer care outcomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Dietary modifications are mentioned, but not the importance of proper nutrition for cancer care outcomes."
      },
      {
        "criterion_number": 15,
        "description": "The response says it is important to remain hydrated.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Hydration is not mentioned."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that it is important to determine the cause of the bowel changes to manage them effectively.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes multiple possible causes but does not explicitly state that determining the cause is important for effective management."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that gastric outlet/duodenal obstruction can occur in up to 10% of patients with pancreatic cancer, leading to symptoms like early satiety, nausea, postprandial vomiting, and weight loss.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of gastric outlet/duodenal obstruction or its prevalence and symptoms."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that patients with malignant ascites from pancreatic cancer may experience abdominal discomfort, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Malignant ascites is not discussed."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that diet/nutrition changes can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It suggests dietary modifications but does not note that diet changes themselves can cause bowel changes unrelated to cancer/treatment."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that stress/anxiety can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Stress/anxiety as a cause is not mentioned."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that pre-existing conditions can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Pre-existing conditions as potential causes are not discussed."
      }
    ],
    "question_number": 62,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:56:52.109275",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises, \"Talk to his oncology team\" and emphasizes \"open communication with his medical team,\" directly recommending discussion with healthcare providers."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pancreatic cancer and its treatments may affect the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response ties chemotherapy (a treatment for pancreatic cancer) to driving safety by listing side effects that \"may affect driving.\" While it doesn't explicitly mention the disease itself, it clearly states that treatment can impair driving."
      },
      {
        "criterion_number": 3,
        "description": "The response states that pain medications may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists \"Pain medication side effects\" under common side effects that may affect driving, indicating impairment risk."
      },
      {
        "criterion_number": 4,
        "description": "The response states that symptoms such as fatigue, drowsiness, nausea, and vomiting may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions fatigue and nausea/dizziness as side effects that may affect driving, satisfying the requirement to note such symptoms can impair driving."
      },
      {
        "criterion_number": 5,
        "description": "The response states that the patient\u2019s healthcare team may have resources to assist with transportation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it recommends talking to the oncology team, it does not state that the team may have transportation resources or services available."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that chemotherapy can cause fatigue that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It lists \"Fatigue (often the biggest concern)\" as a side effect that may affect driving, directly addressing chemo-related fatigue impacting driving."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that chemotherapy can cause vision changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It includes \"Vision changes\" under side effects that may affect driving."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chemotherapy can cause neuropathy that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It mentions \"Numbness in hands or feet (peripheral neuropathy)\" as a side effect that may affect driving."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that chemotherapy can cause cognitive changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It references \"Chemo brain\" with \"difficulty concentrating or slower reaction times,\" clearly indicating cognitive effects that can impair driving."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to avoid driving after the first chemotherapy session to see how your husband tolerates it.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it suggests arranging rides for treatment days and days immediately following, it does not specifically advise avoiding driving after the first chemotherapy session to assess tolerance."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to plan for backup transportation, such as a taxi, friends/family, or public transportation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to \"Consider alternatives - arrange rides for treatment days and the days immediately following,\" which constitutes planning backup transportation, even though specific examples (taxi, family, public transit) are not listed."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the National Highway Traffic Safety Administration (NHTSA) provides information on medical conditions and driving safety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of NHTSA or similar driving safety resources is included."
      }
    ],
    "question_number": 63,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:57:43.932802",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises, \"Discuss with his oncology team,\" and adds that \"His medical team will have the best insight,\" directly recommending consultation with the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pancreatic cancer and its treatments may affect the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that driving safety during chemotherapy varies and lists treatment-related effects (e.g., concentration, reaction time) that can affect driving."
      },
      {
        "criterion_number": 3,
        "description": "The response states that pain medications may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions \"side effects from pain medications or anti-nausea drugs\" as a potential concern for driving safety."
      },
      {
        "criterion_number": 4,
        "description": "The response states that symptoms such as fatigue, drowsiness, nausea, and vomiting may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists \"fatigue and drowsiness\" and \"nausea or sudden illness episodes\" as concerns that can impair driving, covering the required symptom examples."
      },
      {
        "criterion_number": 5,
        "description": "The response states that the patient\u2019s healthcare team may have resources to assist with transportation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it suggests using ride services or medical transport, it does not state that the healthcare team may have resources to assist with transportation."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that chemotherapy can cause fatigue that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly identifies \"fatigue and drowsiness from treatment\" as a concern for driving safety."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that chemotherapy can cause vision changes that may impair driving abilities.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of vision changes or visual side effects is made."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chemotherapy can cause neuropathy that may impair driving abilities.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Neuropathy or numbness/tingling affecting pedals or grip is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that chemotherapy can cause cognitive changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It references cognitive effects, stating \"Cognitive effects ('chemo brain') affecting concentration,\" which can impair driving."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to avoid driving after the first chemotherapy session to see how your husband tolerates it.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises monitoring after each treatment and considering alternatives on treatment days, it does not specifically recommend avoiding driving after the first session."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to plan for backup transportation, such as a taxi, friends/family, or public transportation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests having family members drive and using ride services or medical transport, which constitutes planning for backup transportation."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the National Highway Traffic Safety Administration (NHTSA) provides information on medical conditions and driving safety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of NHTSA or its resources."
      }
    ],
    "question_number": 63,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:58:09.217166",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that the ability to work depends on individual circumstances such as the stage of cancer, overall health, and comorbidities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes dependence on individual factors and lists 'Stage of cancer and overall health.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states that the ability to work depends on the type of treatment (chemotherapy, radiation, surgery, targeted therapy) and related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'Type and intensity of treatment (surgery, chemotherapy, radiation)' and mentions side effects (fatigue, nausea, pain)."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the ability to work depends on the support available from friends, family, and caregivers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of support from friends, family, or caregivers; only references social workers in cancer centers."
      },
      {
        "criterion_number": 4,
        "description": "The response states that the ability to work depends on job type and flexibility (working from home, reduced hours, workplace accommodations, scheduled breaks).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses physical demands of the job, employer flexibility, and specific accommodations (remote work, flexible hours, reduced schedule, rest periods)."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pancreatic cancer and its treatment can cause symptoms which may make working challenging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights treatment side effects (fatigue, nausea, pain) as factors impacting ability to work."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing with the oncology team and states the care team can provide specific guidance."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends workplace accommodations which may make working possible during treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides concrete accommodation suggestions (remote work, flexible hours, reduced schedule) and engaging HR."
      },
      {
        "criterion_number": 9,
        "description": "The response states the patient\u2019s ability to continue working should be continually reassessed as their medical condition changes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly recommend ongoing reassessment as the condition changes; 'plan for good and bad days' is not sufficient."
      },
      {
        "criterion_number": 10,
        "description": "The response states that self-care is important while undergoing cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages self-care behaviors (build in rest periods, plan for good and bad days), implying the importance of self-care."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient may qualify for paid leave through their employer, the government, or both.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions ADA rights and social worker support but does not mention paid leave options through employer or government."
      },
      {
        "criterion_number": 12,
        "description": "The response states many patients with pancreatic cancer take time off of work during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that many patients take time off; instead emphasizes that many maintain some level of work."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that it is important for patients with pancreatic cancer to maintain their quality of life, and that work during treatment may be possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States work during treatment may be possible and discusses benefits (routine, emotional well-being), addressing quality-of-life considerations."
      }
    ],
    "question_number": 64,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:58:32.748256",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that the ability to work depends on individual circumstances such as the stage of cancer, overall health, and comorbidities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes variability by individual circumstances and lists stage/progression and overall health/energy levels as factors."
      },
      {
        "criterion_number": 2,
        "description": "The response states that the ability to work depends on the type of treatment (chemotherapy, radiation, surgery, targeted therapy) and related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names surgery, chemotherapy, and radiation, and explicitly mentions side effects as determinants of ability to work."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the ability to work depends on the support available from friends, family, and caregivers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention the role of support from friends, family, or caregivers in enabling work during treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response states that the ability to work depends on job type and flexibility (working from home, reduced hours, workplace accommodations, scheduled breaks).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple examples of workplace flexibility and accommodations, including remote work, reduced hours, modified duties, and time off for appointments."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pancreatic cancer and its treatment can cause symptoms which may make working challenging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights fluctuating energy, need for rest, and treatment side effects as factors that can make working difficult."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing work capacity with the medical team and mentions the oncology team and social workers for guidance."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends workplace accommodations which may make working possible during treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests several accommodations (flexible hours, remote work, modified duties, ergonomic adjustments, time off for appointments)."
      },
      {
        "criterion_number": 9,
        "description": "The response states the patient\u2019s ability to continue working should be continually reassessed as their medical condition changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that energy levels may fluctuate and that plans may need frequent adjustment, implying ongoing reassessment."
      },
      {
        "criterion_number": 10,
        "description": "The response states that self-care is important while undergoing cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly emphasize self-care or provide guidance about prioritizing rest, nutrition, or symptom management as self-care."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient may qualify for paid leave through their employer, the government, or both.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions FMLA and disability accommodations but does not state that paid leave may be available (FMLA is typically unpaid)."
      },
      {
        "criterion_number": 12,
        "description": "The response states many patients with pancreatic cancer take time off of work during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that many patients take time off during treatment; only refers to time off for appointments and occasional rest days."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that it is important for patients with pancreatic cancer to maintain their quality of life, and that work during treatment may be possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that many people do continue working and discusses benefits such as routine, social connection, and mental/emotional stability, aligning with quality-of-life considerations."
      }
    ],
    "question_number": 64,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T17:58:58.251443",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing the use of medical marijuana with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises consultation with clinicians: 'Talk to his oncologist first,' 'Discuss with his cancer care team,' and 'His oncologist can best advise.'"
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that medical marijuana is not an effective alternative treatment for pancreatic cancer itself.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It discusses symptom control but does not explicitly state that cannabis is not an anticancer treatment or an alternative to standard therapy."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions risks and side effects associated with medical marijuana, including psychoactive effects and potential interactions with other medications.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes potential drug interactions ('May interact with other medications') and identifies THC products as 'psychoactive,' satisfying the requirement to mention psychoactive effects."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly states that medical marijuana comes in various forms, such as oils, edibles, tinctures, and vaporizers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists multiple delivery methods: oils, capsules, and edibles, which demonstrates awareness of various forms."
      },
      {
        "criterion_number": 5,
        "description": "The response specifically mentions the risk of inhaled medical marijuana exposing patients to infectious organisms like fungi, particularly for those receiving certain chemotherapy treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of infection risks from inhaled products or fungal contamination."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that medical marijuana may be used to control symptoms associated with pancreatic cancer and its treatments, such as nausea, vomiting, loss of appetite, and pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly lists pain, nausea/vomiting, and appetite stimulation as potential benefits."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that there is mixed data on the benefit of medical marijuana for managing symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It says 'Effects vary greatly between individuals' but does not state that evidence is mixed."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses potential legal challenges with obtaining and using medical marijuana, noting that these may vary based on the patient\u2019s location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly notes 'Legal status varies by location - check your local laws.'"
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends not driving or making important decisions while under the influence of marijuana.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No statement about avoiding driving or important decisions while using cannabis."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly recommends obtaining medical marijuana only from professionals licensed to sell it.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It suggests working with a 'knowledgeable dispensary' but does not explicitly state 'licensed' professionals."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that medical marijuana refers to products derived from the cannabis plant or its extracts that contain active compounds such as THC (tetrahydrocannabinol), CBD (cannabidiol), or combinations thereof.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It identifies THC and CBD products and mentions varying CBD:THC ratios, which conveys that medical marijuana products contain these active compounds."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that preliminary data reports poor clinical outcomes in adults receiving immunotherapy while using cannabis and/or cannabinoids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of immunotherapy outcomes associated with cannabis use."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that CBD presents risks for hepatotoxicity, with a meta-analysis reporting a nearly 6-fold increase in liver enzyme elevation and drug-induced liver injury.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of CBD-related hepatotoxicity or liver enzyme/drug-induced liver injury risks."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cannabis and/or cannabinoids are one of several pharmacologic options for adults with cancer experiencing refractory nausea and vomiting despite optimal prophylaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions nausea/vomiting relief, it does not specify the context of refractory symptoms despite optimal prophylaxis or that cannabis is one of several options."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce polypharmacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of research needs regarding polypharmacy reduction."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce opioid requirements for cancer-related pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of evidence gaps about opioid-sparing effects."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of chemotherapy-induced peripheral neuropathy or research needs in this area."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that further research is needed to determine the effects of cannabis on pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists potential pain benefits but does not state that further research is needed on cannabis\u2019s effects on pain."
      }
    ],
    "question_number": 65,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T17:59:32.712177",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing the use of medical marijuana with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It says, \"Talk to his oncologist first\" and \"Discuss with his cancer care team,\" clearly directing consultation with healthcare providers."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that medical marijuana is not an effective alternative treatment for pancreatic cancer itself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \"it's not a cure or substitute for conventional cancer treatment,\" explicitly noting it is not an alternative treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions risks and side effects associated with medical marijuana, including psychoactive effects and potential interactions with other medications.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists side effects including \"drowsiness, confusion, mood changes\" (psychoactive effects) and notes it \"May interact with other medications.\""
      },
      {
        "criterion_number": 4,
        "description": "The response clearly states that medical marijuana comes in various forms, such as oils, edibles, tinctures, and vaporizers.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No forms (oils, edibles, tinctures, vaporizers) are mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response specifically mentions the risk of inhaled medical marijuana exposing patients to infectious organisms like fungi, particularly for those receiving certain chemotherapy treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of infection risk from inhaled products or fungal exposure is included."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that medical marijuana may be used to control symptoms associated with pancreatic cancer and its treatments, such as nausea, vomiting, loss of appetite, and pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists benefits including pain relief, reduction of nausea/vomiting, and appetite stimulation."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that there is mixed data on the benefit of medical marijuana for managing symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that evidence is mixed; it emphasizes symptom management without qualifying the evidence as mixed."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses potential legal challenges with obtaining and using medical marijuana, noting that these may vary based on the patient\u2019s location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says \"Legal status varies by location\" and advises to research state laws."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends not driving or making important decisions while under the influence of marijuana.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No advice about avoiding driving or important decisions while under the influence is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly recommends obtaining medical marijuana only from professionals licensed to sell it.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It suggests consulting a cannabis-specialized physician but does not advise obtaining products from licensed dispensaries or sellers."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that medical marijuana refers to products derived from the cannabis plant or its extracts that contain active compounds such as THC (tetrahydrocannabinol), CBD (cannabidiol), or combinations thereof.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of THC, CBD, or the definition of medical marijuana is included."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that preliminary data reports poor clinical outcomes in adults receiving immunotherapy while using cannabis and/or cannabinoids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of cannabis effects on immunotherapy outcomes is present."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that CBD presents risks for hepatotoxicity, with a meta-analysis reporting a nearly 6-fold increase in liver enzyme elevation and drug-induced liver injury.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of CBD-related hepatotoxicity or liver enzyme elevation is included."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cannabis and/or cannabinoids are one of several pharmacologic options for adults with cancer experiencing refractory nausea and vomiting despite optimal prophylaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes nausea/vomiting reduction but does not specify use in refractory cases after optimal prophylaxis or that it is one of several options."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce polypharmacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement about research needs regarding polypharmacy reduction is provided."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce opioid requirements for cancer-related pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not address research needs about opioid-sparing effects."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of chemotherapy-induced peripheral neuropathy or related research needs."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that further research is needed to determine the effects of cannabis on pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes symptom relief, it does not state that further research is needed regarding cannabis' effects on pain."
      }
    ],
    "question_number": 65,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:00:05.909265",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends consulting with the patient\u2019s oncologist or healthcare team, including specific roles such as nurse practitioner or palliative care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response says to \"Ask doctors to clearly explain options,\" but it does not explicitly mention the oncologist, broader healthcare team, nurse practitioner, or palliative care specialist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that the healthcare team may have a social worker available to assist with family discussions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \"Consider involving a patient advocate or social worker from the hospital who can facilitate family meetings,\" which explicitly notes availability of a social worker to assist with discussions."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends involving a neutral third party, such as a social worker, spiritual care worker, counselor, or patient advocate, to facilitate family discussions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends involving a \"patient advocate or social worker\" to facilitate meetings and also mentions \"family counseling or a mediator,\" satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly provides online resources for cancer patients and their families, including specific organizations like PANCAN, NCI, or ACS.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or specific organizations (e.g., PanCAN, NCI, ACS) are mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend scheduling a family meeting to discuss goals of care and important treatment decisions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests \"facilitate family meetings\" and to \"Set regular family update meetings,\" in the context of discussing values and options, which aligns with goals-of-care discussions."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that understanding your mother\u2019s specific goals should shape conversations about goals of care and treatment recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes focusing on \"your mother's values and wishes\" and asks, \"What are your mother's priorities and fears?\" indicating that her goals should guide discussions and decisions."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that your mother\u2019s wishes related to treatment, belief systems, and personal ways of coping should be respected by their families, cancer care team, and others who support them through the cancer experience.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it focuses on the mother's values and acknowledges different coping styles among family, it does not explicitly state that her treatment wishes, belief systems, and coping preferences should be respected by family and the care team."
      }
    ],
    "question_number": 66,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:00:24.565571",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends consulting with the patient\u2019s oncologist or healthcare team, including specific roles such as nurse practitioner or palliative care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions asking doctors to explain options and establishing a point of contact with the medical team, it does not explicitly reference the oncologist, nurse practitioner, or palliative care specialist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that the healthcare team may have a social worker available to assist with family discussions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests involving a social worker and notes that many hospitals have family meeting coordinators, but it does not explicitly state that the healthcare team may have a social worker available."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends involving a neutral third party, such as a social worker, spiritual care worker, counselor, or patient advocate, to facilitate family discussions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly recommends involving a social worker or counselor and mentions hospital family meeting coordinators to facilitate conversations."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly provides online resources for cancer patients and their families, including specific organizations like PANCAN, NCI, or ACS.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or organizations (e.g., PANCAN, NCI, ACS) are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend scheduling a family meeting to discuss goals of care and important treatment decisions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests having doctors explain options to the whole family and references hospital family meeting coordinators, effectively recommending a family meeting."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that understanding your mother\u2019s specific goals should shape conversations about goals of care and treatment recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes focusing on the mother's expressed wishes and values and keeping her voice central, aligning discussions and decisions with her goals."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that your mother\u2019s wishes related to treatment, belief systems, and personal ways of coping should be respected by their families, cancer care team, and others who support them through the cancer experience.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it centers the mother's voice and values, it does not explicitly mention belief systems, coping styles, or the need for respect by family, the cancer care team, and others."
      }
    ],
    "question_number": 66,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:00:50.966106",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention the oncologist or suggest discussing these concerns with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual care worker, palliative care professional, or counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises connecting with a social worker and considering hospice support, which involves palliative care resources."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends support groups and other online resources for cancer patients and their families.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of support groups or online resources was made."
      },
      {
        "criterion_number": 4,
        "description": "The response states that depression is highly prevalent in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Depression prevalence in pancreatic cancer is not discussed."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No signs or symptoms of depression are reviewed."
      },
      {
        "criterion_number": 6,
        "description": "The response states that if the patient is experiencing thoughts of harming themselves or others, they should seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no safety guidance about urgent evaluation for self-harm or harm-to-others thoughts."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that it\u2019s important to have open and honest conversations about their concerns, including feeling like a burden to their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends having an open conversation and directly addresses feelings of being a burden."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage the patient to express their fears and anxieties about the impact of their illness on their loved ones, and acknowledge and validate their feelings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises acknowledging feelings without dismissing them and invites discussion of specific concerns, validating and encouraging expression."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to ask about the patient\u2019s preferences and personal goals of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests involving the patient in care decisions, it does not explicitly mention asking about preferences or personal goals of care."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention it is important to emphasize working together to manage the challenges.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes collaboration (e.g., focusing on remaining time together, accepting help, involving them in decisions), which conveys working together to manage challenges."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention support networks such as PanCAN, CancerCare, ASCO.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations (PanCAN, CancerCare, ASCO) are mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that professional counseling can help process these emotions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Professional counseling is not explicitly recommended as a means to process emotions."
      }
    ],
    "question_number": 67,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:01:14.109961",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions palliative care teams, social workers, and counselors but does not mention the oncologist or discussing these concerns with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual care worker, palliative care professional, or counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends social workers and counselors and highlights palliative care teams as well (\"Consider professional support (social workers, counselors)\" and \"Palliative care teams are excellent at addressing these concerns\")."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends support groups and other online resources for cancer patients and their families.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends connecting with support groups but does not mention online resources specifically, which the criterion requires."
      },
      {
        "criterion_number": 4,
        "description": "The response states that depression is highly prevalent in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Depression prevalence in pancreatic cancer is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No signs or symptoms of depression are described."
      },
      {
        "criterion_number": 6,
        "description": "The response states that if the patient is experiencing thoughts of harming themselves or others, they should seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no safety statement about seeking immediate help for thoughts of self-harm or harm to others."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that it\u2019s important to have open and honest conversations about their concerns, including feeling like a burden to their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly emphasizes \"Have open, honest conversations\" and provides concrete steps for discussing concerns."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage the patient to express their fears and anxieties about the impact of their illness on their loved ones, and acknowledge and validate their feelings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises listening without dismissing concerns, asking what support would be meaningful, and acknowledging their value\u2014validating and encouraging expression of fears."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to ask about the patient\u2019s preferences and personal goals of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests letting them contribute to care decisions and asking what support is meaningful, it does not explicitly address asking about personal goals of care."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention it is important to emphasize working together to manage the challenges.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes inclusion in planning, shared decision-making, and reframing caregiving as mutual support (\"being there for each other is what families do\")."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention support networks such as PanCAN, CancerCare, ASCO.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations such as PanCAN, CancerCare, or ASCO are mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that professional counseling can help process these emotions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends counselors and states they can help the whole family, indicating counseling can assist with these emotional concerns."
      }
    ],
    "question_number": 67,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:01:58.296403",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states targeted therapies work against cancer with specific genetic mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states targeted therapy focuses on specific molecular targets and genetic mutations/proteins in tumors."
      },
      {
        "criterion_number": 2,
        "description": "The response states that not all pancreatic cancers will have mutations for which targeted therapy can be used.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly notes, \"Not all pancreatic cancers have targetable mutations.\""
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of targetable mutations in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples: BRCA mutations, NTRK fusions, MSI-H/dMMR, and KRAS G12C."
      },
      {
        "criterion_number": 4,
        "description": "The response states targeted therapies can be given alone or sometimes in combination with chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions \"alone or with other treatments\" but does not explicitly state combination with chemotherapy as required."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing testing and treatment options with the oncologist explicitly."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that targeted therapy for pancreatic cancer involves using drugs to specifically target proteins, genes, or pathways of cancer cells, potentially causing less damage to normal cells compared to chemotherapy or radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States targeted therapy focuses on molecular targets and aims to cause less damage to normal cells compared with traditional chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that while targeted therapy is an option, it is important to consider all potential treatment options, outcomes, and adverse events to make an informed decision.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly advise weighing all treatment options, outcomes, and adverse events for informed decision-making."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention examples of targeted therapies, such as Dabrafenib + trametinib, Entrectinib, Larotrectinib, Repotrectinib, Selpercatinib, Rucaparib, Olaparib, Adagrasib, Sotorasib, Erdafitinib, Fam-trastuzumab deruxtecan-nxki, Zenocutuzumab-zbco.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides mutation categories but does not name specific targeted agents."
      },
      {
        "criterion_number": 9,
        "description": "Negative points if targeted therapies are discussed that are not approved for pancreatic cancer, such as osimertinib, regorafenib, mTOR inhibitors.",
        "score_given": 0,
        "max_points": 0,
        "justification": "No disallowed agents were mentioned."
      }
    ],
    "question_number": 68,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:02:25.047285",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states targeted therapies work against cancer with specific genetic mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that targeted therapy attacks specific features of cancer cells and explicitly mentions genetic mutations (e.g., BRCA1/2, KRAS G12C)."
      },
      {
        "criterion_number": 2,
        "description": "The response states that not all pancreatic cancers will have mutations for which targeted therapy can be used.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that some pancreatic cancers lack targetable mutations; it does not clarify that targeted options are not available for all patients."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of targetable mutations in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It gives specific examples such as BRCA1/2 and KRAS G12C, and mentions DNA repair deficiencies."
      },
      {
        "criterion_number": 4,
        "description": "The response states targeted therapies can be given alone or sometimes in combination with chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes that therapy is often combined with other treatments but does not explicitly mention chemotherapy or that targeted therapy can be given alone."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages asking the oncologist about specific tests and targeted therapy options."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that targeted therapy for pancreatic cancer involves using drugs to specifically target proteins, genes, or pathways of cancer cells, potentially causing less damage to normal cells compared to chemotherapy or radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains targeting specific features such as proteins and genetic mutations and notes often fewer side effects than chemotherapy, capturing the concept of less damage to normal cells."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that while targeted therapy is an option, it is important to consider all potential treatment options, outcomes, and adverse events to make an informed decision.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not advise weighing all treatment options, outcomes, and adverse events for an informed decision."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention examples of targeted therapies, such as Dabrafenib + trametinib, Entrectinib, Larotrectinib, Repotrectinib, Selpercatinib, Rucaparib, Olaparib, Adagrasib, Sotorasib, Erdafitinib, Fam-trastuzumab deruxtecan-nxki, Zenocutuzumab-zbco.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions classes (PARP inhibitors, KRAS G12C inhibitors) and erlotinib, it does not list any of the specified agents by name."
      },
      {
        "criterion_number": 9,
        "description": "Negative points if targeted therapies are discussed that are not approved for pancreatic cancer, such as osimertinib, regorafenib, mTOR inhibitors.",
        "score_given": 0,
        "max_points": 0,
        "justification": "No non-approved examples from the disallowed list (osimertinib, regorafenib, mTOR inhibitors) were mentioned, so no penalty applies."
      }
    ],
    "question_number": 68,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:03:27.348898",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing integrative medicine with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises: 'Inform your oncology team about everything you're considering,' which includes the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states integrative medicine is not as effective as standard of care treatments for pancreatic cancer like chemotherapy, radiation, surgery, and targeted therapies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit statement comparing the efficacy of integrative approaches versus standard of care treatments is provided."
      },
      {
        "criterion_number": 3,
        "description": "The response states integrative medicine can be a helpful adjunct to standard of care treatments for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines integrative oncology as combining conventional treatment with complementary therapies and presents them for symptom management and quality of life, indicating adjunctive use."
      },
      {
        "criterion_number": 4,
        "description": "The response defines integrative medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that integrative oncology combines conventional cancer treatment with evidence-based complementary therapies and lists goals."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of integrative medicine interventions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Examples include acupuncture, massage therapy, mind-body practices (meditation, yoga, breathing), nutritional counseling, and specific supplements (vitamin D, pancreatic enzymes, probiotics)."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends telling the patient\u2019s oncologist if they plan to include integrative medicine interventions into their care plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says to inform the oncology team about everything being considered, which covers planned integrative interventions."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends telling the patient\u2019s oncologist about all supplements they are taking.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a section 'Supplements to Discuss with Your Team' and advises informing the oncology team about everything considered."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with the treatments being prescribed for their pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It cautions specifically about antioxidant supplements during chemotherapy, implying potential interaction/interference with treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response states there is data to support some integrative medicine interventions for specific uses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It characterizes the complementary therapies as 'evidence-based' and ties specific modalities to symptom relief (e.g., acupuncture for pain/nausea/neuropathy)."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that safety concerns and risks related to integrative medicine approaches are heightened with self-prescription or use of non-standardized products.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises working with experienced practitioners and warns against 'miracle' treatments, it does not specifically address the heightened risks of self-prescribing or non-standardized products."
      }
    ],
    "question_number": 69,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:03:58.432860",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing integrative medicine with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly advises coordination with the oncology team: 'Always discuss any supplements/herbs with the oncology team' and 'The best integrative care works alongside your oncologist.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states integrative medicine is not as effective as standard of care treatments for pancreatic cancer like chemotherapy, radiation, surgery, and targeted therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states 'Never replace conventional treatment\u2014pancreatic cancer is aggressive and needs proven medical intervention,' conveying that integrative therapies should not replace standard-of-care."
      },
      {
        "criterion_number": 3,
        "description": "The response states integrative medicine can be a helpful adjunct to standard of care treatments for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response emphasizes adjunctive use: 'The best integrative care works alongside your oncologist' and highlights symptom management and quality-of-life support."
      },
      {
        "criterion_number": 4,
        "description": "The response defines integrative medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It effectively defines integrative medicine as combining 'evidence-based complementary therapies with standard treatment,' which constitutes a clear definition."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of integrative medicine interventions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Examples provided include acupuncture, massage therapy, nutritional counseling, mind\u2013body practices, and support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends telling the patient\u2019s oncologist if they plan to include integrative medicine interventions into their care plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response promotes active coordination with the oncology team ('works alongside your oncologist') and warns against practitioners who discourage communication, implying the patient should inform their oncologist of planned integrative interventions."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends telling the patient\u2019s oncologist about all supplements they are taking.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states: 'Always discuss any supplements/herbs with the oncology team.'"
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with the treatments being prescribed for their pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that 'some can interfere with chemotherapy,' which directly addresses potential interactions."
      },
      {
        "criterion_number": 9,
        "description": "The response states there is data to support some integrative medicine interventions for specific uses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response references 'evidence-based complementary therapies' and gives specific examples like acupuncture for nausea and pain, indicating data-supported uses."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that safety concerns and risks related to integrative medicine approaches are heightened with self-prescription or use of non-standardized products.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it warns about interactions and general red flags, it does not specifically address heightened risks from self-prescription or non-standardized products."
      }
    ],
    "question_number": 69,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:04:43.908398",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the skin changes with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises to report all skin changes to the oncology team and to contact his doctor immediately for concerning symptoms."
      },
      {
        "criterion_number": 2,
        "description": "The response states that skin changes are a common side effect of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \"Skin changes are indeed common with chemotherapy for pancreatic cancer.\""
      },
      {
        "criterion_number": 3,
        "description": "The response states that skin changes related to treatment for pancreatic cancer can range from mild to life-threatening.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes some reactions can be more serious but does not state that they can be life-threatening or explicitly describe the full range."
      },
      {
        "criterion_number": 4,
        "description": "The response provides at least two examples of skin changes, including hand-foot syndrome, allergic reactions, or infections.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple examples are provided, including hand-foot syndrome, rash/redness, dry/peeling skin, sun sensitivity, darkening of skin or nails, and acne-like breakouts."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate evaluation by a healthcare provider if the patient shows signs of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to contact the doctor immediately if there are signs of infection."
      },
      {
        "criterion_number": 6,
        "description": "The response provides at least one example of signs and symptoms of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions \"signs of infection\" but gives no specific examples (e.g., fever, pus, warmth, spreading redness)."
      },
      {
        "criterion_number": 7,
        "description": "The response states that skin changes related to treatment for pancreatic cancer should be treated by a healthcare professional experienced in caring for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directs management to the oncology team and notes they see these issues regularly, implying care by experienced cancer clinicians."
      },
      {
        "criterion_number": 8,
        "description": "The response states that skin changes related to treatment for pancreatic cancer often require specific interventions or escalation of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that some reactions may require dose modifications or supportive medications, indicating specific interventions."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions at least three specific manifestations of skin changes related to chemotherapy, such as new or worsening skin lesions, itch, acne-like symptoms, bullous dermatoses, allergic reactions, hand-foot syndrome, nail changes, or inflammatory dermatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists acne-like breakouts, hand-foot syndrome, nail/skin darkening, rash/redness, dryness/peeling, and sun sensitivity\u2014exceeding three manifestations."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that skin changes could also be due to other conditions, such as infection, other medications, or unrelated skin disorders.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly state that skin changes may be due to other conditions or medications; it only advises contacting a doctor if there are signs of infection."
      },
      {
        "criterion_number": 12,
        "description": "The response states the importance of correctly identifying skin changes to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss the importance of accurate diagnosis to avoid unnecessary treatment interruptions; it only mentions potential dose modifications or supportive care."
      }
    ],
    "question_number": 70,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:05:22.580235",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the skin changes with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises contacting the oncology team and notes they should monitor and provide treatments: \u201cThe oncology team should be monitoring\u2026 Don\u2019t hesitate to contact his oncology team about any skin changes.\u201d"
      },
      {
        "criterion_number": 2,
        "description": "The response states that skin changes are a common side effect of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States skin changes during chemotherapy are \u201cvery common and usually expected side effects.\u201d Given the pancreatic cancer context of the question, this applies to pancreatic cancer chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response states that skin changes related to treatment for pancreatic cancer can range from mild to life-threatening.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state or imply the full range up to life-threatening; mentions severe reactions but does not characterize them as potentially life-threatening."
      },
      {
        "criterion_number": 4,
        "description": "The response provides at least two examples of skin changes, including hand-foot syndrome, allergic reactions, or infections.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple examples including hand-foot syndrome, nail changes, rash/redness, dryness/itching. Also references infection-related skin signs."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate evaluation by a healthcare provider if the patient shows signs of infection.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises to contact the medical team for signs of infection but does not specify immediate or urgent evaluation."
      },
      {
        "criterion_number": 6,
        "description": "The response provides at least one example of signs and symptoms of infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists specific infection signs: \u201cwarmth, pus, red streaking.\u201d"
      },
      {
        "criterion_number": 7,
        "description": "The response states that skin changes related to treatment for pancreatic cancer should be treated by a healthcare professional experienced in caring for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Indicates the oncology team should monitor and can provide specific treatments or adjustments, implying management by cancer-experienced professionals."
      },
      {
        "criterion_number": 8,
        "description": "The response states that skin changes related to treatment for pancreatic cancer often require specific interventions or escalation of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions the team can provide treatments if needed but does not state that such skin changes often require specific interventions or escalation."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions at least three specific manifestations of skin changes related to chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes multiple manifestations: dryness, itching, flaking, rash/redness, sun sensitivity, skin color changes, hand-foot syndrome, and nail changes."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that skin changes could also be due to other conditions, such as infection, other medications, or unrelated skin disorders.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state alternative causes beyond chemotherapy; mentions signs of infection but not that skin changes could be from other conditions or medications."
      },
      {
        "criterion_number": 12,
        "description": "The response states the importance of correctly identifying skin changes to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss the need for correct identification to guide management or to avoid unnecessary treatment interruptions."
      }
    ],
    "question_number": 70,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:05:55.609050",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response suggests asking about the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly asks, 'What stage is the cancer and what does that mean?'"
      },
      {
        "criterion_number": 2,
        "description": "The response suggests asking about available treatment options.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes, 'What are all the treatment options available?'"
      },
      {
        "criterion_number": 3,
        "description": "The response suggests asking about prognosis if the patient wants to know this information.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of prognosis, outlook, survival, or expected course."
      },
      {
        "criterion_number": 4,
        "description": "The response suggests asking about potential side effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes, 'What are the potential side effects and how can we manage them?'"
      },
      {
        "criterion_number": 5,
        "description": "The response suggests asking about when the patient should follow up next.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit question about follow-up timing or next appointment."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends writing down questions ahead of time and bringing them to the appointment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends bringing a notebook/recorder to remember answers, but does not suggest writing down questions ahead of time."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests asking about symptoms affecting the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses pain and other symptoms, dietary changes, and activity recommendations."
      },
      {
        "criterion_number": 8,
        "description": "The response suggests asking about clinical trial availability.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes, 'Are there clinical trials she might qualify for?'"
      },
      {
        "criterion_number": 9,
        "description": "The response suggests asking about how palliative care can help with the patient\u2019s care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks, 'Do you work with a palliative care team?' which prompts discussion of palliative care involvement and benefits."
      },
      {
        "criterion_number": 10,
        "description": "The response suggests asking if genetic testing is available for germline inheritable cancer predisposition syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of genetic or germline testing."
      },
      {
        "criterion_number": 11,
        "description": "The response suggests asking about nutrition and if a nutritionist is available to help with dietary recommendations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes 'What dietary changes might help?' and requests for a nutritionist among support resources."
      },
      {
        "criterion_number": 12,
        "description": "The response suggests asking about support groups for patients with pancreatic cancer and their families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions support groups as a resource to ask about."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests asking about how to contact the oncology team in case of questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes, 'Who should we contact with urgent questions or emergencies?'"
      },
      {
        "criterion_number": 14,
        "description": "The response suggests asking if lifestyle changes need to be made.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks, 'What activities should she continue or avoid?' which addresses lifestyle changes."
      },
      {
        "criterion_number": 15,
        "description": "The response suggests asking about mental health and resources for mental health support.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit mention of mental health, counseling, or psychological support resources."
      },
      {
        "criterion_number": 16,
        "description": "The response recommends writing down important information during the appointment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests bringing a notebook or recording device to help remember answers."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention to ask questions related to goals of treatment (palliative, curative, etc).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes, 'What are the goals of treatment (cure, control, comfort)?'"
      },
      {
        "criterion_number": 18,
        "description": "The response should mention bringing a family member or a friend to help listen and take notes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No suggestion to bring a family member or friend to appointments."
      }
    ],
    "question_number": 71,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:06:21.189507",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response suggests asking about the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly asks: 'What type and stage of pancreatic cancer is it?'"
      },
      {
        "criterion_number": 2,
        "description": "The response suggests asking about available treatment options.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: 'What treatment options are available?'"
      },
      {
        "criterion_number": 3,
        "description": "The response suggests asking about prognosis if the patient wants to know this information.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: 'What can we expect going forward?' which addresses prognosis."
      },
      {
        "criterion_number": 4,
        "description": "The response suggests asking about potential side effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: 'What are the potential benefits and side effects?'"
      },
      {
        "criterion_number": 5,
        "description": "The response suggests asking about when the patient should follow up next.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit suggestion to ask about timing of the next follow-up or appointment."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends writing down questions ahead of time and bringing them to the appointment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests bringing a notebook to write down answers but does not recommend preparing and bringing written questions in advance."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests asking about symptoms affecting the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks 'What symptoms should we watch for?' and 'How will treatments affect quality of life?' directly addressing symptoms and QoL."
      },
      {
        "criterion_number": 8,
        "description": "The response suggests asking about clinical trial availability.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of clinical trials."
      },
      {
        "criterion_number": 9,
        "description": "The response suggests asking about how palliative care can help with the patient\u2019s care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention palliative care services or how they can help."
      },
      {
        "criterion_number": 10,
        "description": "The response suggests asking if genetic testing is available for germline inheritable cancer predisposition syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of germline genetic testing."
      },
      {
        "criterion_number": 11,
        "description": "The response suggests asking about nutrition and if a nutritionist is available to help with dietary recommendations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions 'support services... (nutrition...)' and asks about 'dietary... restrictions,' implying nutrition support."
      },
      {
        "criterion_number": 12,
        "description": "The response suggests asking about support groups for patients with pancreatic cancer and their families.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Support groups are not specifically mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests asking about how to contact the oncology team in case of questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: 'How do we reach someone with urgent questions?'"
      },
      {
        "criterion_number": 14,
        "description": "The response suggests asking if lifestyle changes need to be made.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes: 'Are there dietary or activity restrictions?' which addresses lifestyle changes."
      },
      {
        "criterion_number": 15,
        "description": "The response suggests asking about mental health and resources for mental health support.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of mental health or psychological support resources."
      },
      {
        "criterion_number": 16,
        "description": "The response recommends writing down important information during the appointment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests bringing 'A notebook to write down answers,' directly encouraging note-taking."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention to ask questions related to goals of treatment (palliative, curative, etc).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly asks: 'What are the goals of each treatment (cure, control, comfort)?'"
      },
      {
        "criterion_number": 18,
        "description": "The response should mention bringing a family member or a friend to help listen and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: 'A trusted family member or friend' in the 'Consider bringing' section."
      }
    ],
    "question_number": 71,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:06:45.784708",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly suggests consulting the oncology team about prognosis and whether treatments can be modified or paused."
      },
      {
        "criterion_number": 2,
        "description": "The response states quality of life is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Quality of life is directly addressed multiple times, including weighing more time versus the quality of that time."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends considering the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It focuses on values, wishes, and advance directives, which are core to goals-of-care discussions."
      },
      {
        "criterion_number": 4,
        "description": "The response states pancreatic cancer is an aggressive cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of the aggressiveness of pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response states stopping treatment without consulting the treating oncologist is dangerous.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests consulting the oncology team, it does not state that stopping without consultation is dangerous."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering access to emergency care at the travel destination.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions arranging medical support at destinations, but does not explicitly address access to emergency care."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends refilling all prescription medications prior to travel.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to refill prescriptions before travel is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends considering if travel is safe.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly asks whether travel is medically feasible and safe."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends considering if the patient is strong enough to travel.",
        "score_given": 0,
        "max_points": 4,
        "justification": "There is no explicit recommendation to assess the patient\u2019s strength or functional status for travel."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly clarify what \u201cstopping treatment\u201d means, such as stopping all therapies, only chemotherapy, or supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not clarify the scope of 'stopping treatment' (e.g., chemotherapy vs all disease-directed therapy vs continuing supportive care)."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly discuss the effects of a (temporary) treatment break on the prognosis of the cancer, symptoms, and other risks involved.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests asking the oncology team about prognosis but does not itself discuss how a treatment break could affect prognosis, symptoms, or risks."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that stopping treatment may affect the patient\u2019s medical stability, ability to travel safely, and access to care and support while away.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly connect stopping treatment with potential impacts on medical stability, travel safety, or access to care while away."
      }
    ],
    "question_number": 72,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:07:05.648449",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states: 'Have an honest conversation with the oncologist about prognosis with and without treatment.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states quality of life is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'Quality of life with vs. without treatment' as a key consideration."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends considering the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages reflection on 'what matters most,' 'definition of meaningful time,' and personal values, which aligns with goals-of-care discussions."
      },
      {
        "criterion_number": 4,
        "description": "The response states pancreatic cancer is an aggressive cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state or characterize pancreatic cancer as aggressive."
      },
      {
        "criterion_number": 5,
        "description": "The response states stopping treatment without consulting the treating oncologist is dangerous.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Recommends consulting the oncologist but does not warn that stopping treatment without consultation is dangerous."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering access to emergency care at the travel destination.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'medical support options while away' but does not explicitly address access to emergency care."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends refilling all prescription medications prior to travel.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of refilling prescriptions before travel."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends considering if travel is safe.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Directly addresses 'travel safety' and 'physical ability to travel safely.'"
      },
      {
        "criterion_number": 9,
        "description": "The response recommends considering if the patient is strong enough to travel.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Notes 'Physical ability to travel safely,' which encompasses assessing strength/fitness to travel."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly clarify what \u201cstopping treatment\u201d means, such as stopping all therapies, only chemotherapy, or supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not define what 'stopping treatment' entails; mentions palliative care but does not clarify distinctions between disease-directed therapy and supportive care."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly discuss the effects of a (temporary) treatment break on the prognosis of the cancer, symptoms, and other risks involved.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests discussing prognosis with/without treatment but does not itself describe effects on prognosis, symptom control, or risks of a treatment break."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that stopping treatment may affect the patient\u2019s medical stability, ability to travel safely, and access to care and support while away.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions travel safety and medical support in general but does not explicitly connect stopping treatment to potential changes in medical stability, travel safety, or access to care while away."
      }
    ],
    "question_number": 72,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:07:35.002683",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to contact the oncology team immediately and states the oncology team is best positioned to recommend alternatives."
      },
      {
        "criterion_number": 2,
        "description": "The response states that if there are signs or symptoms of infection at the port site, to seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of infection-specific warning or instructions to seek immediate evaluation for infection."
      },
      {
        "criterion_number": 3,
        "description": "The response offers examples of signs or symptoms of infection, including fever, chills, redness or pain at the port site, and pus coming from the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No examples of infection signs (fever, chills, redness, pain, pus) are provided."
      },
      {
        "criterion_number": 4,
        "description": "The response states many chemotherapy drugs must be given through central venous catheters.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that some chemotherapy agents require central access due to their properties, conveying the need for central venous catheters."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of central venous catheters.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides examples including PICC, Hickman/Groshong (tunneled), and femoral line (central line)."
      },
      {
        "criterion_number": 6,
        "description": "The response states different central venous catheters have pros and cons.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that each option has different maintenance requirements and potential complications, implying pros and cons."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends asking the patient\u2019s oncologist about alternative treatment regimens that may not require administration through a central venous catheter.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not suggest discussing regimens that avoid central venous access (e.g., oral therapies)."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends avoiding touching, rubbing, and bumping the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice provided about avoiding manipulation or trauma to the port site."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include peripherally inserted central catheters (PICC lines).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists PICC lines as an alternative."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a tunneled central venous catheter (Hickman, Broviac, Groshong).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions Hickman and Groshong catheters as tunneled options."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a non-tunneled central venous catheter (jugular or subclavian line).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a femoral line (a non-tunneled central venous catheter), satisfying the requirement to mention a non-tunneled CVC."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include oral chemotherapy such as capecitabine.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of oral chemotherapy options (e.g., capecitabine)."
      },
      {
        "criterion_number": 14,
        "description": "The response should not mention that chemotherapy for pancreatic cancer can be given via subcutaneous injection.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response does not mention subcutaneous chemotherapy; no penalty applied."
      }
    ],
    "question_number": 73,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:08:27.321995",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: \"Discuss with the oncologist which option works best for his specific treatment plan.\""
      },
      {
        "criterion_number": 2,
        "description": "The response states that if there are signs or symptoms of infection at the port site, to seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No instruction to seek immediate evaluation for suspected infection was provided."
      },
      {
        "criterion_number": 3,
        "description": "The response offers examples of signs or symptoms of infection, including fever, chills, redness or pain at the port site, and pus coming from the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Infection risk is mentioned generally, but no specific signs (fever, chills, redness, pain, pus) are listed."
      },
      {
        "criterion_number": 4,
        "description": "The response states many chemotherapy drugs must be given through central venous catheters.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement that many chemotherapies require central venous access."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of central venous catheters.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides examples: PICC line, tunneled central line, temporary central line."
      },
      {
        "criterion_number": 6,
        "description": "The response states different central venous catheters have pros and cons.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists factors to consider for each option (comfort, duration, type of chemo, vein condition, infection risk), indicating tradeoffs among catheter types."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends asking the patient\u2019s oncologist about alternative treatment regimens that may not require administration through a central venous catheter.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not suggest discussing alternative regimens (e.g., oral options) that avoid central venous access."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends avoiding touching, rubbing, and bumping the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice provided about avoiding manipulation of the port site."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include peripherally inserted central catheters (PICC lines).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions a PICC line as an alternative."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a tunneled central venous catheter (Hickman, Broviac, Groshong).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions a tunneled central line; while brand names are not listed, the catheter type is correctly identified."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a non-tunneled central venous catheter (jugular or subclavian line).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Refers to a \"temporary central line\" through neck or chest, consistent with a non-tunneled central venous catheter."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include oral chemotherapy such as capecitabine.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of oral chemotherapy options like capecitabine."
      },
      {
        "criterion_number": 14,
        "description": "The response should not mention that chemotherapy for pancreatic cancer can be given via subcutaneous injection.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Does not claim chemotherapy can be given subcutaneously."
      }
    ],
    "question_number": 73,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:08:50.771648",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises consulting the oncology team for guidance and vaccinations."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends avoiding people who have signs or symptoms of an infectious illness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States to limit contact with people who are sick and to ask unwell visitors to postpone."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends frequent hand washing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends frequent handwashing for 20 seconds with soap."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends wearing a face mask while in crowds.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions considering masks in medical facilities but does not recommend wearing a mask while in crowds."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing asking the patient\u2019s healthcare team about which vaccinations are recommended.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises staying current with vaccinations and to consult the oncologist first."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reporting signs and symptoms of infection to the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises reporting fever over 100.4\u00b0F immediately and contacting the oncology team with concerns."
      },
      {
        "criterion_number": 7,
        "description": "The response provides examples of signs and symptoms of infection, including fever, chills, cough, runny nose, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists fever, chills, cough, sore throat, and dysuria but does not include runny nose, nausea, or vomiting."
      },
      {
        "criterion_number": 8,
        "description": "The response states the patient\u2019s oncologist may prescribe antibiotics, antivirals, and antifungals to prevent infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of potential prophylactic antibiotics, antivirals, or antifungals."
      },
      {
        "criterion_number": 9,
        "description": "The response instructs the patient to take all medications as prescribed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not instruct adherence to prescribed medications."
      },
      {
        "criterion_number": 10,
        "description": "The response states some treatments for pancreatic cancer can lower white blood cell counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that pancreatic cancer treatments can lower WBC counts."
      },
      {
        "criterion_number": 11,
        "description": "The response states white blood cells fight off infections.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No explanation of the role of white blood cells in fighting infection."
      },
      {
        "criterion_number": 12,
        "description": "The response states a low white blood cell count can increase the risk of infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that low WBC increases infection risk."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that prevention includes vaccination for COVID-19 and flu for the patient and household members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions staying current with vaccines but does not specify COVID-19 and flu or advise vaccination of household members."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention includes avoiding exposure to fungal spores. Patients with neutropenia should avoid prolonged contact with environments that have high concentrations of airborne fungal spores, such as construction and demolition sites, intensive exposure to soil through gardening or digging, and household renovation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice regarding avoidance of environments with high fungal spore exposure."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address antimicrobial prophylaxis recommendations for most solid tumors with short-duration neutropenia."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of lack of evidence for footwear exchange, protected environments, neutropenic diet, or supplements."
      }
    ],
    "question_number": 74,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:09:20.309578",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly says to work closely with the oncology team and get specific guidance based on treatment plan and blood counts."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends avoiding people who have signs or symptoms of an infectious illness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States to stay away from people who are sick and limit visitors, especially anyone with recent illness."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends frequent hand washing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends frequent, thorough handwashing for 20+ seconds and alcohol-based sanitizer."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends wearing a face mask while in crowds.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to consider wearing masks in public spaces and to avoid crowded places, which encompasses mask use in crowds."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing asking the patient\u2019s healthcare team about which vaccinations are recommended.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of vaccinations or discussing vaccine recommendations with the healthcare team."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reporting signs and symptoms of infection to the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Says not to hesitate to contact the medical team immediately if any signs of infection are noticed."
      },
      {
        "criterion_number": 7,
        "description": "The response provides examples of signs and symptoms of infection, including fever, chills, cough, runny nose, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists fever, chills, and new cough, but does not include runny nose, nausea, or vomiting as examples."
      },
      {
        "criterion_number": 8,
        "description": "The response states the patient\u2019s oncologist may prescribe antibiotics, antivirals, and antifungals to prevent infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of prophylactic antibiotics, antivirals, or antifungals."
      },
      {
        "criterion_number": 9,
        "description": "The response instructs the patient to take all medications as prescribed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not instruct to take medications exactly as prescribed."
      },
      {
        "criterion_number": 10,
        "description": "The response states some treatments for pancreatic cancer can lower white blood cell counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions chemotherapy weakens the immune system but does not explicitly state it can lower white blood cell counts."
      },
      {
        "criterion_number": 11,
        "description": "The response states white blood cells fight off infections.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No statement about the role of white blood cells in fighting infections."
      },
      {
        "criterion_number": 12,
        "description": "The response states a low white blood cell count can increase the risk of infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that low white blood cell counts increase infection risk."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that prevention includes vaccination for COVID-19 and flu for the patient and household members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of COVID-19 or influenza vaccination for the patient or household."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention includes avoiding exposure to fungal spores (construction/demolition sites, intensive soil exposure, household renovation).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address avoidance of environments with high concentrations of airborne fungal spores."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of when antimicrobial prophylaxis is or is not recommended for solid tumors."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention the lack of evidence for these specific interventions."
      }
    ],
    "question_number": 74,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:09:46.779288",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines precision medicine as tailoring cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states precision medicine means using specific information about the tumor to guide treatment and notes potential for more effective treatment with fewer side effects."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises, \u201cYour father's oncology team can explain which specific tests they're recommending...\u201d"
      },
      {
        "criterion_number": 3,
        "description": "Mentions testing the patient\u2019s tumor for genetic mutations which can be targeted with certain therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions testing tumor tissue for genetic mutations/biomarkers and that targeted therapies may be available if certain mutations are found."
      },
      {
        "criterion_number": 4,
        "description": "States PARP inhibitors may be used in patients with mutations in the BRCA gene.",
        "score_given": 0,
        "max_points": 5,
        "justification": "BRCA is mentioned, but PARP inhibitors are not specified."
      },
      {
        "criterion_number": 5,
        "description": "States immunotherapy may be used in patients if their tumors have high microsatellite instability (MSI-high).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Immunotherapy is mentioned only generally as based on specific markers; MSI-high is not referenced."
      },
      {
        "criterion_number": 6,
        "description": "Mentions testing the patient\u2019s tumor for expression of certain proteins which can be targeted with certain therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes \u201cbiomarkers\u201d but does not specifically mention protein expression testing or targets."
      },
      {
        "criterion_number": 7,
        "description": "Provides examples of targeted therapies in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No targeted therapy agents (e.g., PARP inhibitors, TRK inhibitors, HER2-targeted drugs) are named."
      },
      {
        "criterion_number": 8,
        "description": "Provides examples of therapies targeting protein expression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No examples of protein expression\u2013targeted therapies (e.g., HER2-directed, PD-L1) are provided."
      },
      {
        "criterion_number": 9,
        "description": "Mentions that not every patient will have genetic mutations or protein expression which can be targeted with precision medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \u201cNot all patients have actionable mutations,\u201d which conveys that not all patients will have targetable alterations."
      },
      {
        "criterion_number": 10,
        "description": "States precision medicine helps the patient\u2019s oncologist identify treatments which will not be helpful.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses finding effective treatments but does not state that testing helps rule out non-beneficial treatments."
      },
      {
        "criterion_number": 11,
        "description": "Mentions that comprehensive genomic profiling using next-generation sequencing (NGS) is now standard for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "NGS or comprehensive genomic profiling being standard is not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "Mentions that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to germline and somatic testing recommendations or applicability irrespective of family history."
      },
      {
        "criterion_number": 13,
        "description": "Mentions that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 0,
        "max_points": 5,
        "justification": "TRK inhibitors and NTRK fusions are not mentioned."
      }
    ],
    "question_number": 75,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:10:10.970338",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines precision medicine as tailoring cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines precision medicine as tailoring treatment to unique cancer characteristics and notes potential for greater effectiveness and fewer side effects."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises engaging the oncologist and the medical team about tests, timelines, and treatment implications."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions testing the patient\u2019s tumor for genetic mutations which can be targeted with certain therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States tumor tissue is tested for genetic mutations/biomarkers and links findings to targeted therapy selection."
      },
      {
        "criterion_number": 4,
        "description": "The response states PARP inhibitors may be used in patients with mutations in the BRCA gene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides the example: PARP inhibitors for tumors with BRCA mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response states immunotherapy may be used in patients if their tumors have high microsatellite instability (MSI-high).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions immunotherapy for certain molecular features and mismatch repair genes but does not explicitly state MSI-high/MMR-deficient as the indication."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions testing the patient\u2019s tumor for expression of certain proteins which can be targeted with certain therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention protein expression testing (e.g., HER2, PD-L1) or therapies based on protein expression."
      },
      {
        "criterion_number": 7,
        "description": "The response provides examples of targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Gives PARP inhibitors as a concrete targeted therapy example."
      },
      {
        "criterion_number": 8,
        "description": "The response provides examples of therapies targeting protein expression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No examples provided of therapies guided by protein expression (e.g., HER2-directed therapy)."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions that not every patient will have genetic mutations or protein expression which can be targeted with precision medicine.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not caution that some patients will lack actionable alterations."
      },
      {
        "criterion_number": 10,
        "description": "The response states precision medicine helps the patient\u2019s oncologist identify treatments which will not be helpful.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not note that precision testing can rule out ineffective treatments."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that comprehensive genomic profiling using next-generation sequencing (NGS) is now standard for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of NGS or comprehensive genomic profiling being standard."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that normal DNA testing may be done but does not state that germline and somatic testing are recommended for all patients regardless of family history."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of NTRK fusions or TRK inhibitors."
      }
    ],
    "question_number": 75,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:10:30.782299",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to ask the oncologist about mouth rinses and notes the oncologist may prescribe medications or adjust treatment; also advises contacting the oncology team for concerning symptoms."
      },
      {
        "criterion_number": 2,
        "description": "The response states mouth sores are a common side effect of some chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States mouth sores (oral mucositis) are a common side effect of chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response states drugs like 5-FU and capecitabine can cause mouth sores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention specific agents such as 5-FU or capecitabine."
      },
      {
        "criterion_number": 4,
        "description": "The response states these are sometimes related to having low white blood cell counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neutropenia or low white blood cell counts contributing to mucositis."
      },
      {
        "criterion_number": 5,
        "description": "The response states that having low white blood cell counts can increase the likelihood of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not connect low white blood cell counts with increased infection risk."
      },
      {
        "criterion_number": 6,
        "description": "The response states mouth sores in patients on chemotherapy can also be related to infections from viruses or bacteria.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions signs of infection but does not state that mucositis can be due to viral or bacterial infections."
      },
      {
        "criterion_number": 7,
        "description": "The response states the patient\u2019s healthcare team may swab the mouth sores to test them for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of swabbing or diagnostic testing of sores."
      },
      {
        "criterion_number": 8,
        "description": "The response states there are medications which can help prevent and improve mouth sores in the form of both topical drugs and specialized mouthwashes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions numbing rinses and topical gels for relief, but does not address prevention."
      },
      {
        "criterion_number": 9,
        "description": "The response states there are medications which can improve symptoms related to mouth sores, like pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends prescription mouth rinses with numbing agents, OTC oral gels, and pain medication before meals."
      },
      {
        "criterion_number": 10,
        "description": "The response instructs the patient to immediately seek evaluation by a healthcare provider if they are experiencing a fever or other signs or symptoms of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises contacting the oncology team if signs of infection such as fever occur."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends gentle oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests soft-bristled toothbrush or foam swabs, salt/baking soda rinses, avoiding alcohol-based mouthwashes, and lip moisturization."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations due to lack of efficacy and potential for adverse effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of chlorhexidine or its lack of recommendation."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical anesthetics (lidocaine viscous, 2% solution) and mixed medication mouthwashes (\u201cmagic mouthwash\u201d) may be used for pain control, though evidence for specific formulations is variable.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References numbing rinses in general but does not specify viscous lidocaine 2% or mixed medication mouthwashes nor comment on variable evidence."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Gabapentin may be considered for mucositis-related pain, often in combination with other analgesics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of gabapentin."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that topical and systemic antifungals (e.g., clotrimazole troches, systemic fluconazole) are indicated for secondary candidiasis, which is common in the setting of mucositis and xerostomia.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not discuss antifungals or secondary candidiasis."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of antibiotic stewardship or restricting antibiotics to confirmed bacterial infections."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen, but that stronger prescription medicines may be indicated.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specify OTC analgesics (e.g., acetaminophen, ibuprofen) or escalation to stronger prescription analgesics."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "References involvement of the oncology team and availability of nutritionists for personalized guidance, indicating multidisciplinary supportive care."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, nutritional support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends soft, bland foods, cold/room-temperature foods, using a straw, and hydration\u2014clearly addressing dietary adjustments; also mentions nutritionist support."
      }
    ],
    "question_number": 76,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:10:59.632455",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to contact the oncology team right away and highlights their role in management."
      },
      {
        "criterion_number": 2,
        "description": "The response states mouth sores are a common side effect of some chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that mouth sores (oral mucositis) are a common side effect of chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response states drugs like 5-FU and capecitabine can cause mouth sores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention 5-FU or capecitabine by name."
      },
      {
        "criterion_number": 4,
        "description": "The response states these are sometimes related to having low white blood cell counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of low WBC or neutropenia as a related factor."
      },
      {
        "criterion_number": 5,
        "description": "The response states that having low white blood cell counts can increase the likelihood of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss infection risk associated with low white blood cell counts."
      },
      {
        "criterion_number": 6,
        "description": "The response states mouth sores in patients on chemotherapy can also be related to infections from viruses or bacteria.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions checking for infections but does not state that mucositis may be due to viral or bacterial infections."
      },
      {
        "criterion_number": 7,
        "description": "The response states the patient\u2019s healthcare team may swab the mouth sores to test them for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of swabbing or specific diagnostic testing of sores."
      },
      {
        "criterion_number": 8,
        "description": "The response states there are medications which can help prevent and improve mouth sores in the form of both topical drugs and specialized mouthwashes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Refers to prescription mouth rinses in general but does not mention preventive agents or both topical drugs and specialized mouthwashes."
      },
      {
        "criterion_number": 9,
        "description": "The response states there are medications which can improve symptoms related to mouth sores, like pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that the team can prescribe medications for pain relief."
      },
      {
        "criterion_number": 10,
        "description": "The response instructs the patient to immediately seek evaluation by a healthcare provider if they are experiencing a fever or other signs or symptoms of infection.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No instruction to seek immediate care for fever or infection symptoms."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends gentle oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends soft-bristled toothbrush/foam swabs and gentle salt-water rinses."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations due to lack of efficacy and potential for adverse effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address chlorhexidine or its lack of benefit/potential harms for prevention."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical anesthetics (lidocaine viscous, 2% solution) and mixed medication mouthwashes (\u201cmagic mouthwash\u201d) may be used for pain control, though evidence for specific formulations is variable.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention topical anesthetics like viscous lidocaine or mixed medication mouthwashes."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Gabapentin may be considered for mucositis-related pain, often in combination with other analgesics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of gabapentin."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that topical and systemic antifungals (e.g., clotrimazole troches, systemic fluconazole) are indicated for secondary candidiasis, which is common in the setting of mucositis and xerostomia.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address antifungal therapy for secondary candidiasis."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No guidance provided on antibiotic use for bacterial infections."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen, but that stronger prescription medicines may be indicated.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention OTC analgesics (e.g., acetaminophen/ibuprofen) or compare with stronger prescription options."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References the oncology team but does not emphasize multidisciplinary/supportive care explicitly."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, nutritional support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides dietary guidance: soft/bland foods, lukewarm liquids, small frequent meals, and nutritional supplements."
      }
    ],
    "question_number": 76,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:11:27.911575",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests asking the trial team and coordinators questions but does not explicitly recommend discussing the decision with the patient's oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the design of clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains typical control vs. experimental arms, the use of placebo as an add-on rather than alone when standard therapy exists, and provides an overview of how trial groups are structured."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses Phases I\u2013III but does not mention Phase IV."
      },
      {
        "criterion_number": 4,
        "description": "The response defines placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses how placebos are used, it does not define what a placebo is (e.g., an inactive substance or intervention without active therapeutic effect)."
      },
      {
        "criterion_number": 5,
        "description": "The response states that patients in clinical trials for cancer are seldom given a placebo, as this may cause harm.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It states that placebo-only arms are uncommon when effective treatments exist and that placebo may be used only as an add-on, but it does not explicitly connect this to avoiding patient harm."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews informed consent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of the informed consent process, what it includes, or the patient's right to withdraw after consenting."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the placebo effect.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The placebo effect is not defined or described."
      },
      {
        "criterion_number": 8,
        "description": "The response states that patients in the control arm of clinical trials often receive the standard of care treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states participants typically receive either standard treatment or standard treatment plus the new therapy and asks whether everyone will receive at least standard care."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to discover new, effective treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that Phase II tests effectiveness and Phase III compares a new treatment to standard care, implying trials are designed to find effective therapies."
      },
      {
        "criterion_number": 10,
        "description": "The response states clinical trials are designed to minimize patient harm.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it describes ethical trial structures (e.g., placebo as add-on), it does not explicitly state that trials are designed to minimize patient harm."
      },
      {
        "criterion_number": 11,
        "description": "The response states that patients participating in clinical trials are monitored closely for side effects from the disease and the treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions 'closer monitoring' but does not specify monitoring for side effects from the disease and the treatment."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends researching clinical trials before participating.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages asking specific questions to the trial team and offers help preparing questions or finding trials, which amounts to recommending research before participation."
      },
      {
        "criterion_number": 13,
        "description": "The response offers resources for researching clinical trials, including ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No resources are provided, and ClinicalTrials.gov is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response states clinical trials are designed to be ethical and are monitored closely.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that trials are designed to be ethical or that they are overseen/monitored by ethics boards or regulators."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that trials are essential for improving current and future cancer therapies."
      }
    ],
    "question_number": 77,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:12:02.734545",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response encourages speaking with the research team and seeking a second opinion but does not specifically recommend discussing with the patient\u2019s oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the design of clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly reviews common designs: new treatment vs standard care, add-on studies with placebo vs investigational agent on top of standard care, and dose comparison."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of Phase I\u2013IV clinical trial phases."
      },
      {
        "criterion_number": 4,
        "description": "The response defines placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While placebo is mentioned, it is not defined (e.g., as an inactive or dummy treatment)."
      },
      {
        "criterion_number": 5,
        "description": "The response states that patients in clinical trials for cancer are seldom given a placebo, as this may cause harm.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It states placebo-only trials are rare in serious cancers but does not provide the rationale that giving placebo alone may cause harm."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews informed consent.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes patient rights to clear explanations, the ability to ask questions until fully understood, and the ability to leave a trial, which are key elements of informed consent, though the term is not explicitly used."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the placebo effect.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no explanation of the placebo effect."
      },
      {
        "criterion_number": 8,
        "description": "The response states that patients in the control arm of clinical trials often receive the standard of care treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states trials typically compare new treatment to standard of care and that in add-on studies everyone receives standard care."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to discover new, effective treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes experimental treatments may be based on promising results but does not explicitly state the purpose of trials is to discover new, effective treatments."
      },
      {
        "criterion_number": 10,
        "description": "The response states clinical trials are designed to minimize patient harm.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit statement about harm minimization or safety-focused design is provided."
      },
      {
        "criterion_number": 11,
        "description": "The response states that patients participating in clinical trials are monitored closely for side effects from the disease and the treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of close monitoring for side effects."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends researching clinical trials before participating.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages asking detailed questions about the specific trial and suggests getting a second opinion, which constitutes advising research before participating."
      },
      {
        "criterion_number": 13,
        "description": "The response offers resources for researching clinical trials, including ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No resources are provided; ClinicalTrials.gov is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response states clinical trials are designed to be ethical and are monitored closely.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of ethics oversight or close monitoring by review boards or data safety monitoring committees."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that trials are essential for improving current and future cancer therapies."
      }
    ],
    "question_number": 77,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:12:33.759362",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly prompts engagement with the oncologist by listing 'Important questions for your oncologist,' clearly recommending discussion."
      },
      {
        "criterion_number": 2,
        "description": "The response states there are many different types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes 'multiple treatment approaches' and lists several modalities (chemotherapy, radiation, surgery), indicating there are various treatment types."
      },
      {
        "criterion_number": 3,
        "description": "The response includes surgery, chemotherapy, immunotherapy, targeted therapy, and radiation therapy as types of treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions surgery, chemotherapy, and radiation but does not mention immunotherapy or targeted therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response states combination therapy may mean two or more different types of treatment or two or more chemotherapy medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides examples of multiple chemo drugs together (FOLFIRINOX; gemcitabine+nab-paclitaxel) and mixed modalities (chemotherapy plus radiation; surgery plus chemotherapy), covering both interpretations."
      },
      {
        "criterion_number": 5,
        "description": "The response gives the example of FOLFIRINOX.",
        "score_given": 5,
        "max_points": 5,
        "justification": "FOLFIRINOX is explicitly listed as a common combination."
      },
      {
        "criterion_number": 6,
        "description": "The response states that FOLFIRINOX is a combination chemotherapy regimen which contains 5-FU, leucovorin, irinotecan, and oxaliplatin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifies FOLFIRINOX contains fluorouracil (5-FU), leucovorin, irinotecan, and oxaliplatin and identifies it as a chemotherapy regimen."
      },
      {
        "criterion_number": 7,
        "description": "The response states the treatment plan for patients with pancreatic cancer is individualized to their overall health and the cancer\u2019s type, stage, and genetic signature.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions overall health, stage, surgery candidacy, and 'specific tumor characteristics' but does not explicitly state cancer type or genetic signature."
      },
      {
        "criterion_number": 8,
        "description": "The response states the decision to use any cancer treatment weighs the likelihood of benefit with the risk of side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists potential benefits and suggests asking about side effects, it does not state the explicit risk-benefit tradeoff in decision-making."
      },
      {
        "criterion_number": 9,
        "description": "The response states the goal of combination therapy is to achieve the best anti-cancer effect.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states combination therapy is 'often more effective than single treatments,' can 'help control cancer growth,' and 'may improve survival rates,' which conveys the goal of maximizing anti-cancer effect."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that examples of combination therapy include chemoradiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'Chemotherapy plus radiation,' which is chemoradiation."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that examples of combination therapy include chemotherapy and surgery, with neoadjuvant chemotherapy given before surgery and adjuvant chemotherapy given after surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions 'Surgery plus chemotherapy' but does not specify neoadjuvant vs adjuvant or explain chemo before vs after surgery."
      }
    ],
    "question_number": 78,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:13:31.188848",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises to ask the oncologist to explain the specific combination, and to discuss benefits, side effects, and timeline."
      },
      {
        "criterion_number": 2,
        "description": "The response states there are many different types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple treatment types (chemotherapy, surgery, radiation, targeted therapy), indicating variety."
      },
      {
        "criterion_number": 3,
        "description": "The response includes surgery, chemotherapy, immunotherapy, targeted therapy, and radiation therapy as types of treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions surgery, chemotherapy, targeted therapy, and radiation therapy but does not mention immunotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response states combination therapy may mean two or more different types of treatment or two or more chemotherapy medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines combination therapy as multiple treatments and provides examples of multiple chemo drugs together and multimodal combinations (surgery with chemo/radiation)."
      },
      {
        "criterion_number": 5,
        "description": "The response gives the example of FOLFIRINOX.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly cites FOLFIRINOX as an example."
      },
      {
        "criterion_number": 6,
        "description": "The response states that FOLFIRINOX is a combination chemotherapy regimen which contains 5-FU, leucovorin, irinotecan, and oxaliplatin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list the component drugs of FOLFIRINOX."
      },
      {
        "criterion_number": 7,
        "description": "The response states the treatment plan for patients with pancreatic cancer is individualized to their overall health and the cancer\u2019s type, stage, and genetic signature.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions overall health, stage, location, previous treatments, and genetic characteristics but does not explicitly mention cancer type; criterion requires all elements."
      },
      {
        "criterion_number": 8,
        "description": "The response states the decision to use any cancer treatment weighs the likelihood of benefit with the risk of side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes combination therapy may be more effective but with more side effects and advises discussing benefits and side effects, implying weighing risks and benefits."
      },
      {
        "criterion_number": 9,
        "description": "The response states the goal of combination therapy is to achieve the best anti-cancer effect.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States combination therapy uses multiple treatments together to improve effectiveness, aligning with achieving the best anti-cancer effect."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that examples of combination therapy include chemoradiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions radiation therapy combined with chemotherapy."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that examples of combination therapy include chemotherapy and surgery, with neoadjuvant chemotherapy given before surgery and adjuvant chemotherapy given after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes surgery combined with chemotherapy and/or radiation and clarifies neoadjuvant (before surgery) and adjuvant (after surgery)."
      }
    ],
    "question_number": 78,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:14:02.328865",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises working with the oncologist's office, including requesting a peer-to-peer review and obtaining a letter from the oncologist, which clearly involves the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response states oncology practices often have team members who help patients with insurance issues.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions a hospital financial counselor and patient advocate, it does not explicitly state that oncology practices typically have dedicated staff who help with insurance/authorization issues."
      },
      {
        "criterion_number": 3,
        "description": "The response states pre-authorization issues are not uncommon in oncology care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state or imply that pre-authorization problems are common or not uncommon in oncology."
      },
      {
        "criterion_number": 4,
        "description": "The response states that denials should be appealed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly instructs to file an urgent appeal immediately and references expedited appeal timelines."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends contacting the insurance company.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly says to call the insurance company directly, ask for a case manager, and request an expedited review."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends understanding the patient\u2019s insurance plan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit recommendation to review or understand the plan benefits, coverage criteria, or formulary; it focuses on actions rather than plan comprehension."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends understanding the insurance company\u2019s denial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not advise obtaining or reviewing the denial letter/reason codes or understanding the rationale for denial."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends contacting patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends reaching out to the Patient Advocate Foundation and PanCAN's Patient Services."
      },
      {
        "criterion_number": 9,
        "description": "The response offers examples of patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides concrete examples: Patient Advocate Foundation (with phone number) and PanCAN (with phone number)."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends clearly documenting all communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to document all conversations, including date, time, representative's name, and reference numbers."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends obtaining written documentation for all approved pre-authorizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of securing or keeping written approval documentation once authorization is granted."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that prior authorization is a process in which payers require clinicians to obtain approval before a medication is covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not define prior authorization or explain that payers require clinician approval before coverage of medications or services."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that the appeal process involves submitting a formal appeal with supporting evidence, such as clinical guidelines, published trial data, and, for targeted or off-label therapies, molecular profiling results.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It only mentions including a letter from the oncologist; it does not reference submitting clinical guidelines, trial data, or molecular profiling as supporting evidence."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention that if appeals are unsuccessful or delays persist, alternative access strategies should be pursued, including patient assistance programs, manufacturer co-pay cards, and foundation grants, which require application and documentation of financial need.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No alternative access strategies (patient assistance programs, co-pay cards, foundation grants) are mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response must specifically mention patient advocacy organizations such as PanCAN and CancerCare as resources.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While PanCAN is mentioned, CancerCare is not referenced."
      }
    ],
    "question_number": 79,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:14:26.887845",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking the doctor's office to expedite the pre-auth and to involve the cancer center's financial advocate or social worker."
      },
      {
        "criterion_number": 2,
        "description": "The response states oncology practices often have team members who help patients with insurance issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes that many cancer centers have financial counselors and mentions patient financial advocates or social workers who specialize in insurance issues."
      },
      {
        "criterion_number": 3,
        "description": "The response states pre-authorization issues are not uncommon in oncology care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly state that pre-authorization issues are common or not uncommon in oncology."
      },
      {
        "criterion_number": 4,
        "description": "The response states that denials should be appealed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to file an immediate appeal and request an external review if internal appeals fail."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends contacting the insurance company.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises contacting the insurance company directly to understand what's needed for approval."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends understanding the patient\u2019s insurance plan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not recommend reviewing plan benefits or coverage details; it only suggests understanding what's needed for approval."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends understanding the insurance company\u2019s denial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises appealing denials, it does not explicitly recommend obtaining or understanding the rationale for the denial."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends contacting patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends reaching out to patient advocacy organizations for assistance."
      },
      {
        "criterion_number": 9,
        "description": "The response offers examples of patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides a specific example: the Pancreatic Cancer Action Network (PanCAN)."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends clearly documenting all communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises keeping detailed records of calls, including dates, names, reference numbers, and getting everything in writing."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends obtaining written documentation for all approved pre-authorizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It generally says to get everything in writing but does not specifically instruct obtaining written approval documentation for pre-authorizations."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that prior authorization is a process in which payers require clinicians to obtain approval before a medication is covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit definition of prior authorization is provided."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that the appeal process involves submitting a formal appeal with supporting evidence, such as clinical guidelines, published trial data, and, for targeted or off-label therapies, molecular profiling results.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions a letter of medical necessity but not the inclusion of clinical guidelines, trial data, or molecular profiling results."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention that if appeals are unsuccessful or delays persist, alternative access strategies should be pursued, including patient assistance programs, manufacturer co-pay cards, and foundation grants, which require application and documentation of financial need.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No alternative access strategies (patient assistance programs, co-pay cards, or foundation grants) are mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response must specifically mention patient advocacy organizations such as PanCAN and CancerCare as resources.",
        "score_given": 0,
        "max_points": 3,
        "justification": "PanCAN is mentioned, but CancerCare is not."
      }
    ],
    "question_number": 79,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:14:57.113401",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises, \u201cBring this up with his oncology team immediately,\u201d satisfying the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response states that infections can cause cognitive changes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Infections are not mentioned as a cause of cognitive changes."
      },
      {
        "criterion_number": 3,
        "description": "The response states that cancer and its treatments may cause symptoms that can mimic cognitive changes, including fatigue, pain, poor sleep, dehydration, and depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While fatigue and depression/anxiety are mentioned, the response does not address pain, poor sleep, or dehydration as mimicking cognitive changes; hydration is recommended but not linked as a cause. The criterion as written is not fully met."
      },
      {
        "criterion_number": 4,
        "description": "The response states sudden changes in cognition may be a medical emergency and to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement that sudden cognitive changes can be emergencies or require immediate evaluation."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate medical evaluation if the patient has stroke symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of stroke symptoms or the need for urgent evaluation if present."
      },
      {
        "criterion_number": 6,
        "description": "The response states if the patient has a fever or other signs or symptoms of infection, to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Fever or infection warning signs and the need for immediate evaluation are not discussed."
      },
      {
        "criterion_number": 7,
        "description": "The response states patients commonly experience mental fogginess, or \u201cchemo brain.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly mentions chemotherapy causing concentration/memory issues (\u201cchemo brain\u201d)."
      },
      {
        "criterion_number": 8,
        "description": "The response states that cognitive changes from cancer treatment may improve if the treatment is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit statement that stopping treatment may improve cognitive changes."
      },
      {
        "criterion_number": 9,
        "description": "The response states that if treatment side effects are severe enough, the patient\u2019s oncologist may choose to decrease the dose of the treatment so it is better tolerated or switch to a different therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions medication adjustments generally but does not specify cancer treatment dose reduction or switching therapies."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends tracking the cognitive changes and sharing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises keeping a journal of changes and bringing this up with the oncology team."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that cancer treatment (including radiation, chemotherapy, and pain medications such as opioids) can affect a person\u2019s cognitive functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotherapy and opioids are mentioned, but radiation is not; criterion requires inclusion of these treatments."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that other factors unrelated to treatment could also cause cognitive changes, such as cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes disease-related causes including liver involvement if cancer has spread, which implies progression."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that stress/anxiety can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions depression and anxiety affecting thinking."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pre-existing conditions can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No reference to pre-existing conditions (e.g., dementia, prior stroke, thyroid disease) as possible contributors."
      }
    ],
    "question_number": 80,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:15:41.473786",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly says to discuss the symptoms with his oncology team promptly and to bring it up at the next appointment."
      },
      {
        "criterion_number": 2,
        "description": "The response states that infections can cause cognitive changes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Infections or fever are not mentioned as a cause of cognitive changes."
      },
      {
        "criterion_number": 3,
        "description": "The response states that cancer and its treatments may cause symptoms that can mimic cognitive changes, including fatigue, pain, poor sleep, dehydration, and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists dehydration/electrolyte imbalance, sleep disruption (from pain/anxiety), depression/anxiety, and fatigue from the cancer itself, addressing the specified factors."
      },
      {
        "criterion_number": 4,
        "description": "The response states sudden changes in cognition may be a medical emergency and to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no warning about sudden cognitive changes being a medical emergency or seeking immediate evaluation."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate medical evaluation if the patient has stroke symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Stroke symptoms and the need for urgent evaluation are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response states if the patient has a fever or other signs or symptoms of infection, to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Fever or signs of infection and the need for immediate evaluation are not addressed."
      },
      {
        "criterion_number": 7,
        "description": "The response states patients commonly experience mental fogginess, or \u201cchemo brain.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states chemotherapy can cause 'chemo brain' with memory and concentration issues."
      },
      {
        "criterion_number": 8,
        "description": "The response states that cognitive changes from cancer treatment may improve if the treatment is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions changes may be reversible, it does not state that stopping treatment may improve cognition."
      },
      {
        "criterion_number": 9,
        "description": "The response states that if treatment side effects are severe enough, the patient\u2019s oncologist may choose to decrease the dose of the treatment so it is better tolerated or switch to a different therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests asking about medication adjustments but does not mention dose reductions or switching therapies."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends tracking the cognitive changes and sharing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises documenting specific changes and discussing them with the oncology team."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that cancer treatment (including radiation, chemotherapy, and pain medications such as opioids) can affect a person\u2019s cognitive functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotherapy and opioids are mentioned, but radiation is not included."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that other factors unrelated to treatment could also cause cognitive changes, such as cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists several non-treatment-related contributors (nutritional deficiencies, dehydration, sleep disruption, depression/anxiety, fatigue from cancer itself), satisfying the criterion."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that stress/anxiety can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Anxiety and depression are explicitly listed as potential factors."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pre-existing conditions can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No pre-existing conditions (e.g., dementia, metabolic or endocrine disorders) are mentioned."
      }
    ],
    "question_number": 80,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:16:18.352653",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises, \"I'd strongly encourage discussing with her oncology team,\" which includes the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states feeding tubes can help patients get the nutrition and hydration they need when they are unable to eat or drink on their own.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions inadequate oral intake and maintaining strength, but does not clearly state that feeding tubes provide nutrition and hydration when unable to eat or drink."
      },
      {
        "criterion_number": 3,
        "description": "The response states the most common types of feeding tubes are placed through the skin of the abdomen and into the stomach or small bowel.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists nasojejunal, jejunostomy, and gastrostomy tubes but does not state that common tubes are placed through the abdominal skin into the stomach or small bowel."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the patient is not eating or drinking enough because they do not want to, this may be the body\u2019s way of signaling that the patient is nearing the end of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention decreased intake as a possible end-of-life signal; only notes feeding tubes are more helpful in active treatment than end-stage care."
      },
      {
        "criterion_number": 6,
        "description": "The response states studies have shown that in the absence of a bowel obstruction, feeding tubes do not typically increase survival in patients with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of survival impact or study findings regarding feeding tubes without obstruction."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends considering hospice care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response states that malnutrition is common in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions malnutrition as an indication but does not state its commonality in pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of feeding tubes, including discomfort and infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References \"potential complications\" without specifying risks such as discomfort or infection."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends discussing the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises discussing treatment goals, quality of life preferences, and personal wishes."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked bile duct.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of bile duct blockage or related symptoms (e.g., jaundice)."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked stomach.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States \"Obstruction from the tumor blocking food passage,\" which aligns with gastric outlet obstruction/blocked stomach."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to low levels of digestive enzymes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of pancreatic exocrine insufficiency or low digestive enzymes."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically mentions poor appetite as a cause of inadequate intake."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to cancer-related pain.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention pain as a contributor to eating difficulties."
      },
      {
        "criterion_number": 16,
        "description": "The response states that nutritional counseling is recommended for patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends considering \"nutritional counseling\" as an alternative/supportive option."
      }
    ],
    "question_number": 81,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:16:47.464607",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussion with her oncologist and mentions involving a palliative care specialist."
      },
      {
        "criterion_number": 2,
        "description": "The response states feeding tubes can help patients get the nutrition and hydration they need when they are unable to eat or drink on their own.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists indications for feeding tubes but does not explicitly state that feeding tubes provide nutrition/hydration when the patient cannot eat or drink."
      },
      {
        "criterion_number": 3,
        "description": "The response states the most common types of feeding tubes are placed through the skin of the abdomen and into the stomach or small bowel.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of common tube types (e.g., PEG/PEJ) or their placement into stomach or small bowel."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the patient is not eating or drinking enough because they do not want to, this may be the body\u2019s way of signaling that the patient is nearing the end of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address decreased intake as a potential end-of-life sign."
      },
      {
        "criterion_number": 6,
        "description": "The response states studies have shown that in the absence of a bowel obstruction, feeding tubes do not typically increase survival in patients with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of survival impact or evidence regarding feeding tubes in the absence of obstruction."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends considering hospice care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions palliative care but does not recommend hospice care."
      },
      {
        "criterion_number": 8,
        "description": "The response states that malnutrition is common in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References malnutrition as an indication but does not state it is common in pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of feeding tubes, including discomfort and infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists potential complications: infection, discomfort, and limited mobility."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends discussing the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights goals of care and aligning feeding tube decisions with overall treatment goals."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked bile duct.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of bile duct obstruction or related digestive issues."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked stomach.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not specifically mention gastric outlet obstruction or a blocked stomach."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to low levels of digestive enzymes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No discussion of pancreatic exocrine insufficiency or low digestive enzymes."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to loss of appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not state that loss of appetite from pancreatic cancer contributes to digestive/nutritional issues."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to cancer-related pain.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of cancer-related pain impacting eating or digestion."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that nutritional counseling is recommended for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not recommend nutritional counseling or referral to a dietitian."
      }
    ],
    "question_number": 81,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:17:09.721932",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention consulting the oncologist or oncology team for guidance on talking with children."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends involving a professional who can help with these challenging conversations, like a social worker or spiritual counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends involving a child psychologist, school counselor, or social worker."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends online resources for patients with cancer, including cancer.org.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests guiding teens to reliable sources, it does not name any specific online resources or cancer.org."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends clear and honest language.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises using simple, clear language, avoiding euphemisms, and being honest while remaining hopeful."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tailoring the conversation to the children\u2019s ages.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides specific guidance for young children, school-age children, and teenagers."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention to avoid overwhelming the child with too much information at once; provide information in small doses, stopping frequently to check for comprehension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it suggests encouraging questions and checking understanding, it does not advise giving information in small doses or explicitly avoiding overwhelming the child."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention to arrange for an appropriate location for the conversation and ensure there is enough time to give the information and answer questions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of choosing a suitable setting or ensuring adequate time for the discussion and questions."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention to provide information that is relevant to what the child wants to know.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises encouraging questions and checking understanding, which supports providing information aligned with what the child wants to know; it also emphasizes focusing on what children will see and experience."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to respond empathically to the child\u2019s emotions and acknowledge their feelings throughout the conversation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It normalizes emotions (anger, sadness, fear) and suggests preparing for various reactions, reflecting empathy and acknowledgment of feelings."
      }
    ],
    "question_number": 82,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:17:28.313157",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response advises involving the medical team but does not specifically recommend discussing the plan with the patient\u2019s oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends involving a professional who can help with these challenging conversations, like a social worker or spiritual counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions social workers, child life specialists, family counseling, support groups, and school counselors."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends online resources for patients with cancer, including cancer.org.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources are provided and cancer.org is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends clear and honest language.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises using honest, age-appropriate language and avoiding confusing euphemisms."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tailoring the conversation to the children\u2019s ages.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides age-specific guidance for young children, school-aged children, and teens."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention to avoid overwhelming the child with too much information at once; provide information in small doses, stopping frequently to check for comprehension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests answering what the child is actually asking, it does not explicitly advise giving information in small doses or stopping to check for comprehension."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention to arrange for an appropriate location for the conversation and ensure there is enough time to give the information and answer questions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of choosing an appropriate setting or ensuring adequate time for the conversation."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention to provide information that is relevant to what the child wants to know.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises letting children ask questions and answering what they are actually asking, aligning with providing relevant information."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to respond empathically to the child\u2019s emotions and acknowledge their feelings throughout the conversation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It encourages allowing children to express feelings but does not specifically instruct caregivers to acknowledge or validate those feelings or to respond empathically during the conversation."
      }
    ],
    "question_number": 82,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:17:45.733489",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that sleep patterns can be disturbed by cancer and its treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states sleep changes are common with pancreatic cancer and lists treatment side effects and medications as possible causes."
      },
      {
        "criterion_number": 2,
        "description": "The response states that sleep patterns can be disturbed by symptoms like fatigue, pain, and nausea.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions pain as a cause and lists digestive symptoms, but does not clearly state nausea or fatigue as causes of sleep disturbance."
      },
      {
        "criterion_number": 3,
        "description": "The response states that sleep patterns can be a symptom of anxiety and depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Anxiety and stress are cited, but depression is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises talking to his medical team and bringing it up at the next appointment, which encompasses the oncologist."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tracking the sleep disturbances and sharing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No suggestion to track sleep patterns or share a log with the care team."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends sleep hygiene techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides sleep hygiene advice such as a consistent routine, a comfortable/dark room, and daytime activity."
      },
      {
        "criterion_number": 7,
        "description": "The response states other options for treatment may include supplements like melatonin, cognitive behavioral therapy, or prescribed medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions that the medical team can prescribe sleep aids and adjust medications, fulfilling the prescribed medications component."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends seeking immediate medical evaluation if the changes in sleep patterns are sudden or severe.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No guidance is given to seek urgent evaluation for sudden or severe changes."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that non-pharmacological interventions like relaxation techniques, cognitive behavioral therapy for insomnia, and mindfulness can be beneficial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Non-pharmacological techniques such as relaxation, CBT-I, or mindfulness are not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that addressing underlying causes of sleep disruption, such as pain management or treatment of anxiety/depression, is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes adjusting pain medications and addressing anxiety with a doctor or counselor as important contributors to improving sleep."
      }
    ],
    "question_number": 83,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:18:05.048247",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that sleep patterns can be disturbed by cancer and its treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that dramatic sleep changes are common with pancreatic cancer and cites treatment side effects and medications as contributors."
      },
      {
        "criterion_number": 2,
        "description": "The response states that sleep patterns can be disturbed by symptoms like fatigue, pain, and nausea.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists pain and discomfort, physical symptoms like nausea and fatigue as causes of disturbed sleep."
      },
      {
        "criterion_number": 3,
        "description": "The response states that sleep patterns can be a symptom of anxiety and depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions anxiety and emotional stress but does not mention depression."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing the issue with his medical team and bringing it up at the next appointment, which reasonably includes the oncologist."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tracking the sleep disturbances and sharing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not suggest tracking or keeping a sleep log to share with the care team."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends sleep hygiene techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends maintaining consistent routines and creating a comfortable sleep environment, which are core sleep hygiene practices."
      },
      {
        "criterion_number": 7,
        "description": "The response states other options for treatment may include supplements like melatonin, cognitive behavioral therapy, or prescribed medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that the team can prescribe sleep aids, addressing the prescribed medications component, though it does not mention melatonin or CBT specifically."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends seeking immediate medical evaluation if the changes in sleep patterns are sudden or severe.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to seek urgent evaluation for sudden or severe sleep changes."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that non-pharmacological interventions like relaxation techniques, cognitive behavioral therapy for insomnia, and mindfulness can be beneficial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention relaxation techniques, CBT-I, or mindfulness."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that addressing underlying causes of sleep disruption, such as pain management or treatment of anxiety/depression, is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes managing pain effectively and adjusting medications, which addresses underlying causes of sleep disturbance."
      }
    ],
    "question_number": 83,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:18:24.466052",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing complementary therapies with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states, \"Always inform the oncology team before starting any complementary therapy\" and encourages open discussion with oncologists."
      },
      {
        "criterion_number": 2,
        "description": "The response states complementary therapies like acupuncture may improve symptoms related to cancer and its treatments and may improve cancer patients\u2019 quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists symptom benefits (nausea, pain, fatigue, anxiety) but does not explicitly state that these therapies may improve quality of life, which is required for full credit under the binary rule."
      },
      {
        "criterion_number": 3,
        "description": "The response states complementary therapies are not a safe alternative to standard cancer treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states, \"these should complement, not replace, conventional treatment,\" indicating they are not an alternative to standard care."
      },
      {
        "criterion_number": 4,
        "description": "The response states complementary therapies are not as effective as standard of care cancer treatments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No statement comparing the effectiveness of complementary therapies to standard-of-care treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response defines complementary therapies and provides examples, including acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a functional definition (to complement, not replace conventional treatment) and examples including acupuncture, meditation, yoga, massage, music/art therapy, and nutritional counseling."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends informing the patient\u2019s oncologist of any supplements the patient starts taking.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises informing the oncology team before starting complementary therapy but does not specifically mention supplements."
      },
      {
        "criterion_number": 7,
        "description": "The response states supplements are not regulated by the FDA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of FDA regulation of supplements."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with certain treatments for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of supplement\u2013treatment interactions."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of acupuncture, including bleeding and infection, which may be increased in patients receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses infection risk and sterile technique during chemotherapy and mentions avoiding acupuncture with low platelets or on blood thinners, implicating bleeding risk."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends utilizing a practitioner licensed in acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises, \"Use only licensed acupuncturists experienced with cancer patients.\""
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that acupuncture is generally safe for cancer patients, with no increased risk of serious adverse events compared to sham or standard care, though mild side effects such as bruising, soreness, or transient discomfort may occur.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States acupuncture is generally considered safe but does not mention comparative serious adverse event risk versus sham/standard care or list common mild side effects (e.g., bruising, soreness)."
      }
    ],
    "question_number": 84,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:18:48.208999",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing complementary therapies with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly emphasizes coordination with the oncology team and open communication with the healthcare team about complementary therapies."
      },
      {
        "criterion_number": 2,
        "description": "The response states complementary therapies like acupuncture may improve symptoms related to cancer and its treatments and may improve cancer patients\u2019 quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes acupuncture may help with nausea, pain, and side effects (symptom relief), it does not explicitly state improvements in quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response states complementary therapies are not a safe alternative to standard cancer treatments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises using complementary therapies alongside conventional treatment but does not explicitly state they are not a safe alternative to standard treatments."
      },
      {
        "criterion_number": 4,
        "description": "The response states complementary therapies are not as effective as standard of care cancer treatments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit statement compares the effectiveness of complementary therapies to standard of care."
      },
      {
        "criterion_number": 5,
        "description": "The response defines complementary therapies and provides examples, including acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains complementary therapies are used alongside conventional treatment and lists examples including acupuncture, meditation, massage, nutritional counseling, and art/music therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends informing the patient\u2019s oncologist of any supplements the patient starts taking.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it recommends informing the oncology team about complementary therapies, it does not specifically mention supplements."
      },
      {
        "criterion_number": 7,
        "description": "The response states supplements are not regulated by the FDA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of FDA regulation of supplements."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with certain treatments for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes that some treatments may interact with chemotherapy or medications but does not specifically call out supplements or interactions specific to pancreatic cancer treatments."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of acupuncture, including bleeding and infection, which may be increased in patients receiving chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of acupuncture risks such as bleeding or infection or their increased risk during chemotherapy."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends utilizing a practitioner licensed in acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises choosing a licensed acupuncturist and notes sterile needle use."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that acupuncture is generally safe for cancer patients, with no increased risk of serious adverse events compared to sham or standard care, though mild side effects such as bruising, soreness, or transient discomfort may occur.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states acupuncture is generally well-tolerated but does not mention the lack of increased serious adverse events or list typical mild side effects."
      }
    ],
    "question_number": 84,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:19:06.871886",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing balance problems with the patient\u2019s oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, \"Report this to his oncology team immediately\" and notes that the medical team needs to evaluate promptly."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that symptoms from pancreatic cancer and its treatment, such as fatigue, headache, muscle weakness, and peripheral neuropathy, may contribute to sensations of imbalance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies treatment-related factors (peripheral neuropathy, fatigue, general weakness) and disease-related contributors (nutritional deficiencies, dehydration, spread affecting nervous system) as causes of imbalance. While headache is not mentioned, the response clearly conveys that cancer and treatment symptoms can contribute."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that chemotherapy can cause peripheral neuropathy, fatigue, anemia, and generalized weakness, which can all cause instability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotherapy is linked to peripheral neuropathy, and fatigue/weakness are mentioned as treatment-related, but anemia is not tied to chemotherapy and the response does not explicitly state that chemotherapy causes fatigue and generalized weakness. Thus it does not meet the full, specific requirement."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that pancreatic cancer itself increases the risk of thromboembolic events, including cerebral ischemic strokes, which may present with acute balance disturbances or ataxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of thromboembolic events, stroke, or ataxia is made."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly instructs seeking immediate medical evaluation if symptoms are abrupt, severe, or accompanied by other neurologic deficits.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it asks about other symptoms (e.g., numbness, vision changes), it does not explicitly instruct immediate medical evaluation in the presence of abrupt, severe symptoms or accompanying neurologic deficits."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that balance problems can lead to falls.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Fall risk is implied by safety advice, but the response does not explicitly state that balance problems can lead to falls."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends ensuring the patient drinks plenty of fluids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Dehydration is listed as a possible cause, but there is no explicit recommendation to increase fluid intake."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends the patient stand and walk with assistance until they can be evaluated by their healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises, \"Consider using walking aids for safety\" and \"Stay with him when he's moving around,\" which constitute standing and walking with assistance, and it also recommends contacting the oncology team immediately, implying this guidance applies until evaluation."
      }
    ],
    "question_number": 85,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:19:26.857386",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing balance problems with the patient\u2019s oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, \"Contact his oncology team immediately to report these symptoms,\" which directly meets the requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that symptoms from pancreatic cancer and its treatment, such as fatigue, headache, muscle weakness, and peripheral neuropathy, may contribute to sensations of imbalance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes treatment-related causes (peripheral neuropathy, fatigue and weakness) and cancer-related causes (general weakness, dehydration), linking them to balance problems. While headache is not mentioned, the criterion uses \"such as,\" and the response adequately covers multiple relevant symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that chemotherapy can cause peripheral neuropathy, fatigue, anemia, and generalized weakness, which can all cause instability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions chemotherapy-associated peripheral neuropathy and mentions fatigue/weakness from treatment in general, but it does not mention anemia at all and does not explicitly link fatigue/weakness specifically to chemotherapy. Therefore, it does not meet the full criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that pancreatic cancer itself increases the risk of thromboembolic events, including cerebral ischemic strokes, which may present with acute balance disturbances or ataxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of thromboembolic events, stroke, acute balance disturbance, or ataxia."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly instructs seeking immediate medical evaluation if symptoms are abrupt, severe, or accompanied by other neurologic deficits.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it advises contacting the oncology team immediately, it does not specifically instruct urgent evaluation for abrupt or severe symptoms or when accompanied by other neurologic deficits."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that balance problems can lead to falls.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention fall risk."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends ensuring the patient drinks plenty of fluids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While dehydration is listed as a possible cause, there is no explicit recommendation to increase fluid intake."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends the patient stand and walk with assistance until they can be evaluated by their healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice is given to use assistance for standing or walking prior to evaluation."
      }
    ],
    "question_number": 85,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:19:39.914004",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends reviewing the pathology report with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to bring the report to appointments and ask the oncologist to explain unclear items; references discussions with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pathology reports are written by doctors called pathologists who view tissue under the microscope to diagnose diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of pathologists or microscopic examination."
      },
      {
        "criterion_number": 3,
        "description": "The response states the pathology report will contain a tumor type.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section titled 'Tumor Type' and gives examples (adenocarcinoma, neuroendocrine tumors)."
      },
      {
        "criterion_number": 4,
        "description": "The response states the pathology report may contain a stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Size and Stage' and references overall stage I\u2013IV."
      },
      {
        "criterion_number": 5,
        "description": "The response states the pathology report may contain a tumor size.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'T (tumor size)' under 'Size and Stage'."
      },
      {
        "criterion_number": 6,
        "description": "The response states the pathology report may contain a tumor grade.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Grade' with descriptions of well/moderately/poorly differentiated."
      },
      {
        "criterion_number": 7,
        "description": "The response states the pathology report may mention vascular invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'Vascular invasion' under additional features."
      },
      {
        "criterion_number": 8,
        "description": "The response states the pathology report may mention perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'Perineural invasion (spread along nerves)'."
      },
      {
        "criterion_number": 9,
        "description": "The response states the pathology report may contain special stains which can sometimes be used to determine additional treatment options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of special stains, immunohistochemistry, or how they might guide treatment."
      },
      {
        "criterion_number": 10,
        "description": "The response states the final stage ranges from I to IV and is a sum of a tumor (T) score, a node (N) score, and a metastasis (M) score.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists T, N, and M components and mentions overall stage I\u2013IV together, conveying that TNM determines the final stage."
      },
      {
        "criterion_number": 11,
        "description": "The response states the pathology report helps the oncologist determine which treatment may be the most effective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'The report helps determine treatment options,' implying its role in guiding therapy decisions."
      },
      {
        "criterion_number": 12,
        "description": "The response states the pathology report may include results from genetic testing of the tumor which may help in identifying targeted therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of genetic or molecular testing or targeted therapies."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention margin status, including the presence of the tumor at or within 1 mm of any resection margin (R1), and its impact on prognosis and adjuvant therapy decisions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions R0 vs R1/R2 but does not note the within 1 mm definition or discuss prognostic/adjuvant therapy implications."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the importance of the number of lymph nodes examined and number positive, and explicitly link perineural and vascular invasion to higher recurrence risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions number of lymph nodes involved but not number examined, and does not link vascular/perineural invasion to higher recurrence risk."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention tumor location (head, body, tail) as required for accurate pathologic staging (pT), and reference the AJCC staging system using pT, pN, pM nomenclature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes tumor location (head, body, tail) but does not tie it to pT requirements nor mention AJCC pT/pN/pM nomenclature."
      }
    ],
    "question_number": 86,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:20:02.911066",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends reviewing the pathology report with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing the report with her medical team and specifically mentions bringing questions to the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pathology reports are written by doctors called pathologists who view tissue under the microscope to diagnose diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of pathologists or microscopic examination."
      },
      {
        "criterion_number": 3,
        "description": "The response states the pathology report will contain a tumor type.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists 'Type of cancer (adenocarcinoma is most common)'."
      },
      {
        "criterion_number": 4,
        "description": "The response states the pathology report may contain a stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'Staging information' with T, N, M and 'Overall stage (I-IV)'."
      },
      {
        "criterion_number": 5,
        "description": "The response states the pathology report may contain a tumor size.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists 'Size of the primary tumor'."
      },
      {
        "criterion_number": 6,
        "description": "The response states the pathology report may contain a tumor grade.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists 'Grade'."
      },
      {
        "criterion_number": 7,
        "description": "The response states the pathology report may mention vascular invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions 'Vascular invasion'."
      },
      {
        "criterion_number": 8,
        "description": "The response states the pathology report may mention perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions 'Perineural invasion'."
      },
      {
        "criterion_number": 9,
        "description": "The response states the pathology report may contain special stains which can sometimes be used to determine additional treatment options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions molecular markers guiding treatment but does not mention special stains or immunohistochemistry."
      },
      {
        "criterion_number": 10,
        "description": "The response states the final stage ranges from I to IV and is a sum of a tumor (T) score, a node (N) score, and a metastasis (M) score.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While T, N, M and overall stage (I\u2013IV) are listed, it does not explicitly state that the overall stage is determined by (or a sum of) T, N, and M."
      },
      {
        "criterion_number": 11,
        "description": "The response states the pathology report helps the oncologist determine which treatment may be the most effective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes the findings can guide treatment decisions and discusses reviewing findings with the oncologist regarding treatment options."
      },
      {
        "criterion_number": 12,
        "description": "The response states the pathology report may include results from genetic testing of the tumor which may help in identifying targeted therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions 'Molecular markers (if tested)' guiding treatment but does not explicitly reference genetic testing or targeted therapy."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention margin status, including the presence of the tumor at or within 1 mm of any resection margin (R1), and its impact on prognosis and adjuvant therapy decisions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Margins are mentioned generally, but there is no mention of R1 (within 1 mm) or its impact on prognosis/adjuvant therapy."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the importance of the number of lymph nodes examined and number positive, and explicitly link perineural and vascular invasion to higher recurrence risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes how many lymph nodes examined/positive but does not explicitly link perineural and vascular invasion to higher recurrence risk."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention tumor location (head, body, tail) as required for accurate pathologic staging (pT), and reference the AJCC staging system using pT, pN, pM nomenclature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions location within the pancreas but does not specify head/body/tail, pT requirements, AJCC, or pT/pN/pM nomenclature."
      }
    ],
    "question_number": 86,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:20:27.408682",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the case with an oncologist to review the trial details and discuss the pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response says, 'Discuss with your oncologist how it fits your overall treatment plan,' and encourages getting a second opinion, which effectively recommends discussing details and weighing pros and cons with an oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that there are no FDA-approved cancer vaccines for pancreatic cancer and that all vaccines for pancreatic cancer are experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of FDA approval status or that pancreatic cancer vaccines are experimental."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how a cancer vaccine works.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists vaccine types but does not explain the mechanism (e.g., priming the immune system/T cells to recognize tumor antigens)."
      },
      {
        "criterion_number": 4,
        "description": "The response states clinical trials are how treatments are tested for diseases like pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response notes, 'Phase 1 tests safety, Phase 2/3 test effectiveness,' which communicates that trials are the mechanism for testing treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Only Phase 1 (safety) and Phase 2/3 (effectiveness) are mentioned; Phase 4 is not discussed, and phases are not comprehensively explained."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends researching clinical trials prior to enrolling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It provides a list of questions to ask the trial team and references resources, indicating the need to research trials before enrolling."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends ClinicalTrials.gov as a resource.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly lists 'ClinicalTrials.gov for trial listings.'"
      },
      {
        "criterion_number": 8,
        "description": "The response states patients should consider all of their treatment options prior to enrolling in a clinical trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises to discuss with the oncologist how the trial fits the overall treatment plan, to ask about standard of care, and how it fits with other treatments, which collectively prompt considering all options."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to minimize patient harm and closely follow ethical standards.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit mention of ethical oversight, IRB review, informed consent safeguards, or harm minimization design."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential benefits and risks of clinical trial participation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It suggests asking about potential side effects and quality of life but does not explicitly review benefits (e.g., access to novel therapy, contribution to science) or risks beyond prompting questions."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends discussing with the clinical trial research team about costs to the patient for participating in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly asks, 'Are there costs involved? What's covered?' which is a clear recommendation to discuss costs with the trial team."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention that vaccine clinical trials in pancreatic cancer are designed to address the poor response of this malignancy to standard immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of pancreatic cancer\u2019s poor response to standard immunotherapy as a rationale for vaccine trials."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that vaccine trials aim to stimulate tumor-specific T cell (immune cell) responses to enhance the immune system\u2019s effectiveness in killing cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of tumor-specific T cell responses or immune activation mechanisms."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention at least two of the following vaccine platforms: peptide-based vaccines targeting defined tumor antigens, dendritic cell vaccines loaded with tumor lysates, or personalized mRNA/neoantigen vaccines that encode patient-specific tumor mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It generally mentions 'personalized vaccines' and 'vaccines targeting specific proteins' but does not explicitly identify any of the specified platforms (peptide-based, dendritic cell with tumor lysate, or personalized mRNA/neoantigen)."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention that safety data from recent trials indicate that most vaccine regimens are well-tolerated, with adverse events generally limited to mild-to-moderate injection site reactions, flu-like symptoms, or transient fever.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of safety data or typical adverse event profiles for vaccine trials."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that most data on vaccine trials in pancreatic cancer are derived from early-phase studies with small sample sizes and limited long-term follow-up.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to the evidence base being early-phase, small sample sizes, or limited follow-up."
      },
      {
        "criterion_number": 17,
        "description": "The response must explicitly define clinical trials as research studies that explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although phases are briefly noted, there is no explicit definition of clinical trials as research studies assessing safety and efficacy in humans."
      },
      {
        "criterion_number": 18,
        "description": "The response must explicitly state that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state the essential role of clinical trials in optimizing current and future cancer therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response must mention that the patient will be informed, verbally and in writing, if a placebo is part of a clinical trial before they enroll.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of placebo disclosure procedures or informed consent specifics regarding placebo use."
      }
    ],
    "question_number": 87,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:20:58.325218",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the case with an oncologist to review the trial details and discuss the pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises seeking second opinions from pancreatic cancer specialists at major cancer centers to evaluate whether the trial is the best option, which constitutes discussing the case with oncology experts to weigh pros and cons."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that there are no FDA-approved cancer vaccines for pancreatic cancer and that all vaccines for pancreatic cancer are experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of FDA approval status or that pancreatic cancer vaccines are experimental."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how a cancer vaccine works.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanism of action for cancer vaccines is described."
      },
      {
        "criterion_number": 4,
        "description": "The response states clinical trials are how treatments are tested for diseases like pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It notes earlier phases test safety and later phases compare effectiveness, effectively stating that trials are used to test treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Only phases I\u2013III are mentioned without describing all four phases, and no details of each phase are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends researching clinical trials prior to enrolling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends requesting all information in writing, asking detailed questions, and connecting with organizations\u2014clear guidance to research before enrolling."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends ClinicalTrials.gov as a resource.",
        "score_given": 0,
        "max_points": 3,
        "justification": "ClinicalTrials.gov is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response states patients should consider all of their treatment options prior to enrolling in a clinical trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It encourages exploring all treatment options and consulting specialists to determine if the trial is the best option, implying consideration of all options before enrolling."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to minimize patient harm and closely follow ethical standards.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No reference to ethical safeguards or harm minimization is made."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential benefits and risks of clinical trial participation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes benefits (access to promising new treatments) and outlines risks/burdens (time commitment, travel, monitoring, QoL impact) and advises asking about side effects."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends discussing with the clinical trial research team about costs to the patient for participating in the trial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Costs and financial considerations are not addressed."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention that vaccine clinical trials in pancreatic cancer are designed to address the poor response of this malignancy to standard immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of pancreatic cancer\u2019s poor response to standard immunotherapy or that vaccine trials aim to address it."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that vaccine trials aim to stimulate tumor-specific T cell (immune cell) responses to enhance the immune system\u2019s effectiveness in killing cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of tumor-specific T cells or immune activation by vaccines."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention at least two of the following vaccine platforms: peptide-based vaccines targeting defined tumor antigens, dendritic cell vaccines loaded with tumor lysates, or personalized mRNA/neoantigen vaccines that encode patient-specific tumor mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific vaccine platforms are mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention that safety data from recent trials indicate that most vaccine regimens are well-tolerated, with adverse events generally limited to mild-to-moderate injection site reactions, flu-like symptoms, or transient fever.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No safety data or typical adverse events are discussed."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that most data on vaccine trials in pancreatic cancer are derived from early-phase studies with small sample sizes and limited long-term follow-up.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No comment on the evidence base (early-phase, small samples, limited follow-up) is provided."
      },
      {
        "criterion_number": 17,
        "description": "The response must explicitly define clinical trials as research studies that explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 0,
        "max_points": 5,
        "justification": "An explicit definition of clinical trials as research studies testing safety and effectiveness in humans is not provided."
      },
      {
        "criterion_number": 18,
        "description": "The response must explicitly state that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The essential role of clinical trials in optimizing therapies is not explicitly stated."
      },
      {
        "criterion_number": 20,
        "description": "The response must mention that the patient will be informed, verbally and in writing, if a placebo is part of a clinical trial before they enroll.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of placebo disclosure is made."
      }
    ],
    "question_number": 87,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:21:29.289007",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing care coordination concerns directly with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response suggests identifying a primary point person and notes an oncologist often serves as the 'quarterback,' but it does not explicitly instruct the reader to discuss care coordination concerns directly with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that the medical oncologist typically serves as the coordinating physician among the different specialists on the healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states 'Often an oncologist serves as the \"quarterback\",' which clearly conveys that the oncologist typically coordinates care."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a patient navigator or social worker.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises 'Ask about a nurse navigator or care coordinator' and notes 'Social workers can also help coordinate services,' which explicitly recommends engaging these roles for coordination."
      },
      {
        "criterion_number": 4,
        "description": "The response states that most oncology clinics have nurses who specialize in helping patients coordinate care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions nurse navigators and says 'Many cancer centers offer these services,' it does not state that most oncology clinics have such specialized nurses."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends trying to schedule multiple appointments on one day to limit life interruptions.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no suggestion to consolidate appointments on the same day."
      },
      {
        "criterion_number": 6,
        "description": "The response states that the different specialists will communicate with one another and document their assessments in the electronic medical record.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises asking if a shared EHR is used and requesting summaries be sent, and cautions not to assume communication. It does not state that specialists will communicate and document in the EMR."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends asking about a multidisciplinary meeting with the involved specialists, sometimes called a \u201cTumor Board.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of a multidisciplinary meeting or Tumor Board."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention a structured multidisciplinary approach for coordinating care among multiple specialists for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although multiple specialists and coordination strategies are mentioned, there is no explicit reference to a structured multidisciplinary approach specific to pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response must list all required specialists: surgical oncology, medical oncology, radiation oncology, gastroenterology, genetics, nutrition, and palliative care, and mention their distinct roles in diagnosis, staging, treatment, and supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not list these specialists nor describe their distinct roles."
      },
      {
        "criterion_number": 11,
        "description": "The response must emphasize the necessity of clear patient-centered communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes identifying a main contact, using communication tools (patient portals, shared EHR), requesting summaries, and proactively addressing conflicting advice\u2014all reinforcing clear, patient-centered communication."
      }
    ],
    "question_number": 88,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:21:51.254363",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing care coordination concerns directly with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response notes that the oncologist often serves as the primary coordinator, but it does not explicitly recommend discussing care coordination concerns directly with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that the medical oncologist typically serves as the coordinating physician among the different specialists on the healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \"The oncologist often serves as the primary coordinator,\" which conveys the intended role, even though it does not specify \"medical oncologist.\""
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a patient navigator or social worker.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises asking if the hospital has a patient navigator or care coordinator, meeting the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response states that most oncology clinics have nurses who specialize in helping patients coordinate care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of oncology nurses or nurse navigators specializing in coordination."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends trying to schedule multiple appointments on one day to limit life interruptions.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While organization tools are suggested, there is no recommendation to cluster multiple appointments on the same day."
      },
      {
        "criterion_number": 6,
        "description": "The response states that the different specialists will communicate with one another and document their assessments in the electronic medical record.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests requesting providers copy each other and using patient portals, but does not state that specialists will communicate and document in the EMR as a standard practice."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends asking about a multidisciplinary meeting with the involved specialists, sometimes called a \u201cTumor Board.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of tumor boards or multidisciplinary case conferences."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention a structured multidisciplinary approach for coordinating care among multiple specialists for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although coordination is discussed generally, there is no explicit mention of a structured multidisciplinary approach."
      },
      {
        "criterion_number": 9,
        "description": "The response must list all required specialists: surgical oncology, medical oncology, radiation oncology, gastroenterology, genetics, nutrition, and palliative care, and mention their distinct roles in diagnosis, staging, treatment, and supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No list of specific specialists or description of their distinct roles is provided."
      },
      {
        "criterion_number": 11,
        "description": "The response must emphasize the necessity of clear patient-centered communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response emphasizes communication strategies such as requesting visit summaries, sharing updated medication/symptom lists, and encouraging direct communication between specialists, which supports clear patient-centered communication."
      }
    ],
    "question_number": 88,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:22:08.014763",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises calling the oncology team immediately for severe pain and keeping the oncologist\u2019s after-hours contact number readily available."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews common medical emergencies experienced by patients with pancreatic cancer, including biliary obstruction and bowel obstruction.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Biliary obstruction is clearly addressed via jaundice, dark urine, and itching, but bowel obstruction is not explicitly mentioned or described."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends having an Advance Directive or Living Will in place to guide the patient\u2019s care if they are unable to speak for themselves.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of Advance Directive, Living Will, or similar documentation."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends seeking help from a professional in talking about these challenging questions, like a social worker, spiritual worker, or palliative care professional.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to involve palliative care, social work, chaplaincy, or similar professionals."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends ensuring supportive care medications are refilled for symptoms like pain and nausea.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice to check or refill supportive medications (e.g., analgesics, antiemetics)."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that pancreatic cancer patients are at high risk for acute emergencies due to tumor progression, treatment effects, or comorbidities.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response notes weakened immunity and mentions disease progression as a cause of pain but does not explicitly state that pancreatic cancer patients are at high risk for acute emergencies due to tumor progression, treatment effects, or comorbidities."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that biliary obstruction presents with jaundice, dark urine, and pruritus.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly includes jaundice with dark urine and itching (pruritus), also noting pale stools, consistent with biliary obstruction."
      },
      {
        "criterion_number": 9,
        "description": "The response must describe gastric outlet obstruction as persistent vomiting, inability to tolerate oral intake, and abdominal distension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions severe nausea/vomiting and inability to keep fluids down but does not label gastric outlet obstruction or include abdominal distension."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention VTE and include symptoms like sudden leg swelling, pain, shortness of breath, or chest pain, and state that pulmonary embolism is a leading cause of death after cancer itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "VTE and PE symptoms are described, but it does not state that pulmonary embolism is a leading cause of death after cancer itself."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention febrile neutropenia as a life-threatening complication of chemotherapy, characterized by fever and signs of infection in the context of neutropenia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Fever and infection are noted, but febrile neutropenia, chemotherapy context, and its life-threatening nature are not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention metabolic derangements such as hypercalcemia (confusion, weakness, constipation) or hyponatremia (confusion, seizures).",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references \u2018metabolic changes\u2019 and confusion but does not specify hypercalcemia or hyponatremia or their characteristic symptoms."
      },
      {
        "criterion_number": 13,
        "description": "The response must describe bowel obstruction as presenting with abdominal pain, vomiting, and constipation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Obstruction is mentioned generally and vomiting is noted, but bowel obstruction with the triad of abdominal pain, vomiting, and constipation is not described."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention spinal cord compression and its symptoms, such as new-onset weakness, sensory changes, or loss of bowel/bladder control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of spinal cord compression or related neurological red flags."
      }
    ],
    "question_number": 89,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:22:28.453486",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises engagement with the oncology team: 'Keep emergency contacts readily available (oncologist...)' and 'Ask the oncology team about specific warning signs... Clarify when to call the doctor vs. going to the ER.'"
      },
      {
        "criterion_number": 2,
        "description": "The response reviews common medical emergencies experienced by patients with pancreatic cancer, including biliary obstruction and bowel obstruction.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it lists general alarming symptoms (e.g., jaundice, vomiting), it does not explicitly review biliary obstruction or bowel obstruction as entities, nor describe their hallmark symptom clusters."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends having an Advance Directive or Living Will in place to guide the patient\u2019s care if they are unable to speak for themselves.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states: 'Consider advance directives if not already in place,' directly fulfilling the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends seeking help from a professional in talking about these challenging questions, like a social worker, spiritual worker, or palliative care professional.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends 'Discuss palliative care options early' and 'consider connecting with a social worker or patient navigator,' meeting the requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends ensuring supportive care medications are refilled for symptoms like pain and nausea.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions 'Discuss pain management plans,' it does not advise ensuring refills of supportive medications (e.g., pain or antiemetics)."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that pancreatic cancer patients are at high risk for acute emergencies due to tumor progression, treatment effects, or comorbidities.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit statement about elevated acute-emergency risk or its causes (tumor progression, treatment effects, comorbidities)."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that biliary obstruction presents with jaundice, dark urine, and pruritus.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions jaundice but not dark urine or pruritus, and does not label the syndrome as biliary obstruction."
      },
      {
        "criterion_number": 9,
        "description": "The response must describe gastric outlet obstruction as persistent vomiting, inability to tolerate oral intake, and abdominal distension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions persistent vomiting and inability to keep fluids down but does not include abdominal distension or identify gastric outlet obstruction."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention VTE and include symptoms like sudden leg swelling, pain, shortness of breath, or chest pain, and state that pulmonary embolism is a leading cause of death after cancer itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references 'Signs of blood clots (leg swelling, sudden shortness of breath)' and chest pain, but does not state that pulmonary embolism is a leading cause of death after the cancer itself."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention febrile neutropenia as a life-threatening complication of chemotherapy, characterized by fever and signs of infection in the context of neutropenia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it lists 'High fever with chills,' it does not connect this to neutropenia or chemotherapy nor identify febrile neutropenia."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention metabolic derangements such as hypercalcemia (confusion, weakness, constipation) or hyponatremia (confusion, seizures).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Confusion and weakness are mentioned generically, but metabolic derangements (hypercalcemia or hyponatremia) are not named or described."
      },
      {
        "criterion_number": 13,
        "description": "The response must describe bowel obstruction as presenting with abdominal pain, vomiting, and constipation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Abdominal pain and vomiting are listed, but constipation and explicit mention of bowel obstruction are absent."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention spinal cord compression and its symptoms, such as new-onset weakness, sensory changes, or loss of bowel/bladder control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Spinal cord compression and associated neurologic red flags (new weakness, sensory changes, bowel/bladder dysfunction) are not mentioned."
      }
    ],
    "question_number": 89,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:22:50.500289",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the hearing changes with his oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states, 'Report this to his oncology team immediately' and reiterates that the medical team needs to know."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments, like oxaliplatin, which is frequently used in treating pancreatic cancer as part of combination chemotherapy, can cause hearing changes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions cisplatin and carboplatin but does not mention oxaliplatin."
      },
      {
        "criterion_number": 3,
        "description": "The response states that platinum-based chemotherapy, such as cisplatin, is well-known to cause hearing loss (ototoxicity).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes cisplatin and carboplatin are known to cause hearing loss or tinnitus, meeting the requirement."
      },
      {
        "criterion_number": 4,
        "description": "The response states the hearing changes may be related to other conditions like fatigue, infection, dehydration, malnutrition, or metabolic abnormalities from the cancer or its treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It cites dehydration, infection risk, medications, and general fatigue as potential contributors."
      },
      {
        "criterion_number": 5,
        "description": "The response states it is important for the patient\u2019s oncologist to know about new symptoms because they may need to adjust the dose of the chemotherapy or consider a different treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says the team may need to adjust medications or dosages and potentially modify the care plan."
      },
      {
        "criterion_number": 6,
        "description": "The response states that treatment-related side effects may become worse or permanent if changes are not made to the treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It warns that early intervention can sometimes prevent permanent damage, implying risk of permanence if unaddressed."
      },
      {
        "criterion_number": 7,
        "description": "The response states hearing changes may be related to cancer spreading to the brain if there are other neurologic symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of brain metastases or associated neurologic symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response states the hearing changes may be related to normal age-related hearing loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Normal age-related hearing loss is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the risk of hearing loss increases with cumulative doses and patient age.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of cumulative dose effects or age-related risk increase."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that other therapies, including aminoglycoside antibiotics, loop diuretics, and radiation to the head/neck, can also contribute to hearing loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions medications for pain or nausea, it does not specifically note aminoglycosides, loop diuretics, or head/neck radiation."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that referral for audiologic evaluation is advised.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends an 'audiologist evaluation,' satisfying the criterion."
      }
    ],
    "question_number": 90,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:23:10.462766",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the hearing changes with his oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says, \"Report this to his oncology team immediately\" and reiterates contacting the medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments, like oxaliplatin, which is frequently used in treating pancreatic cancer as part of combination chemotherapy, can cause hearing changes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Oxaliplatin is not mentioned. The response mentions cisplatin and high-dose carboplatin only."
      },
      {
        "criterion_number": 3,
        "description": "The response states that platinum-based chemotherapy, such as cisplatin, is well-known to cause hearing loss (ototoxicity).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names cisplatin as causing hearing loss and mentions ototoxicity explicitly."
      },
      {
        "criterion_number": 4,
        "description": "The response states the hearing changes may be related to other conditions like fatigue, infection, dehydration, malnutrition, or metabolic abnormalities from the cancer or its treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions \"fluid retention or electrolyte imbalances\" (metabolic abnormalities) and other non-treatment causes."
      },
      {
        "criterion_number": 5,
        "description": "The response states it is important for the patient\u2019s oncologist to know about new symptoms because they may need to adjust the dose of the chemotherapy or consider a different treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes symptoms should be reported and that treatment may be modified/adjusted by the team to reverse changes."
      },
      {
        "criterion_number": 6,
        "description": "The response states that treatment-related side effects may become worse or permanent if changes are not made to the treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses potential reversibility if caught early but does not state the risk of worsening or permanent damage without changes."
      },
      {
        "criterion_number": 7,
        "description": "The response states hearing changes may be related to cancer spreading to the brain if there are other neurologic symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of brain metastases or associated neurologic symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response states the hearing changes may be related to normal age-related hearing loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists \"Unrelated age-related hearing changes.\""
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the risk of hearing loss increases with cumulative doses and patient age.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not reference cumulative dose effects or increased ototoxic risk with age."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that other therapies, including aminoglycoside antibiotics, loop diuretics, and radiation to the head/neck, can also contribute to hearing loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions antibiotics, diuretics, and radiation near the head/neck as contributors to hearing loss."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that referral for audiologic evaluation is advised.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to \"Request a hearing evaluation\" which implies audiologic assessment."
      }
    ],
    "question_number": 90,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:23:43.868210",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states proton therapy is a type of radiation therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states: 'Proton therapy is a type of radiation treatment...'"
      },
      {
        "criterion_number": 2,
        "description": "The response states proton therapy uses protons rather than photons to deliver highly conformal radiation doses to tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it uses 'protons (positively charged particles) instead of traditional X-rays' and explains depth control/energy release at tumor, implying conformality."
      },
      {
        "criterion_number": 3,
        "description": "The response states proton therapy may be more precise in its target field compared to traditional radiation therapy techniques, which may reduce treatment-related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it 'delivers radiation more precisely than conventional radiation' and 'potentially reduces damage to surrounding healthy tissue.'"
      },
      {
        "criterion_number": 4,
        "description": "The response states proton therapy is a safe and feasible option for select patients with locally advanced or recurrent pancreatic cancer, especially when minimizing toxicity to surrounding organs is critical.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Indicates it 'may be considered' for 'locally advanced tumors that can't be surgically removed' and when reducing dose to nearby organs is critical, aligning with selective use to minimize toxicity."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use proton therapy is influenced by the cancer\u2019s stage, location, size, proximity to other organs, among others.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions factors including tumor location, locally advanced stage, and proximity to organs; also advises individualized evaluation by the oncology team."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a Radiation Oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises discussing with the 'oncology team' but does not specifically mention a Radiation Oncologist."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends discussing with the patient's 'oncology team' and 'medical team,' which includes the oncologist."
      },
      {
        "criterion_number": 8,
        "description": "The response states proton therapy has proven benefit in some cancers, like head and neck cancer, though has unclear benefit over traditional radiation therapy and is considered experimental in most types of cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes evidence is still evolving for superiority but does not mention proven benefit in specific cancers (e.g., head and neck) or that it is considered experimental in most cancers."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all cancer centers have the capability to provide proton therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Proton therapy centers are less common than conventional radiation facilities,' indicating limited availability."
      },
      {
        "criterion_number": 10,
        "description": "The response states proton therapy still carries the risk of side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses potential for reduced damage but does not explicitly state that side effects can still occur."
      },
      {
        "criterion_number": 11,
        "description": "The response states proton therapy is often used in combination with chemotherapy (such as gemcitabine) as part of concurrent chemoradiation protocols.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of concurrent chemotherapy or specific agents like gemcitabine."
      },
      {
        "criterion_number": 12,
        "description": "The response states proton therapy can be used for locally advanced, unresectable, or recurrent disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions use 'for locally advanced tumors that can't be surgically removed,' which addresses locally advanced unresectable disease."
      }
    ],
    "question_number": 91,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:24:05.505082",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states proton therapy is a type of radiation therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, \"Proton therapy is an advanced form of radiation treatment,\" clearly identifying it as radiation therapy."
      },
      {
        "criterion_number": 2,
        "description": "The response states proton therapy uses protons rather than photons to deliver highly conformal radiation doses to tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says proton therapy uses protons instead of traditional X-rays and describes targeted energy deposition at the tumor with minimal exit dose, implying conformality."
      },
      {
        "criterion_number": 3,
        "description": "The response states proton therapy may be more precise in its target field compared to traditional radiation therapy techniques, which may reduce treatment-related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response highlights precision and minimal radiation to healthy tissues and lists \"Reduced side effects to surrounding organs\" as an advantage."
      },
      {
        "criterion_number": 4,
        "description": "The response states proton therapy is a safe and feasible option for select patients with locally advanced or recurrent pancreatic cancer, especially when minimizing toxicity to surrounding organs is critical.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes proton therapy may be an option for some and is useful near critical organs, it does not specifically mention locally advanced or recurrent pancreatic cancer or explicitly address safety/feasibility in those groups."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use proton therapy is influenced by the cancer\u2019s stage, location, size, proximity to other organs, among others.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references stage (\"localized, non-metastatic\"), tumor location, proximity to critical organs, and overall health as factors, satisfying the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a Radiation Oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises discussing with the oncology team but does not specifically mention a Radiation Oncologist."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends discussion with the patient's oncology team/oncologist."
      },
      {
        "criterion_number": 8,
        "description": "The response states proton therapy has proven benefit in some cancers, like head and neck cancer, though has unclear benefit over traditional radiation therapy and is considered experimental in most types of cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions ongoing study/clinical trials for pancreatic cancer but does not state proven benefit in other cancers or that proton therapy\u2019s benefit over traditional radiation is unclear/experimental broadly."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all cancer centers have the capability to provide proton therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states \"Limited availability - fewer centers offer proton therapy\" and potential need for travel."
      },
      {
        "criterion_number": 10,
        "description": "The response states proton therapy still carries the risk of side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes reduced side effects, it does not explicitly acknowledge that proton therapy still carries risks of side effects."
      },
      {
        "criterion_number": 11,
        "description": "The response states proton therapy is often used in combination with chemotherapy (such as gemcitabine) as part of concurrent chemoradiation protocols.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of combination with chemotherapy or concurrent chemoradiation regimens."
      },
      {
        "criterion_number": 12,
        "description": "The response states proton therapy can be used for locally advanced, unresectable, or recurrent disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists candidates such as localized non-metastatic disease and pre-surgery settings, but does not state locally advanced, unresectable, or recurrent disease."
      }
    ],
    "question_number": 91,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:24:26.158336",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist, as they likely have financial experts who are knowledgeable in this area.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises speaking with the treating oncologist's office about financial counselors and lists hospital financial counselors and social workers as resources."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends learning about the patient\u2019s insurance plan, including out-of-pocket costs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no recommendation to review the patient's insurance plan or out-of-pocket costs."
      },
      {
        "criterion_number": 3,
        "description": "The response states pharmaceutical companies have programs to help patients cover the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes most manufacturers offer patient assistance programs and gives examples: Genentech Access Solutions, Lilly Cares, and Pfizer Oncology Together."
      },
      {
        "criterion_number": 4,
        "description": "The response states large hospital systems and cancer centers may have assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references hospital financial counselors and social workers and advises contacting the oncologist\u2019s office for financial counseling, implying hospital-based assistance programs."
      },
      {
        "criterion_number": 5,
        "description": "The response states patient assistance programs may cover all or most of the cost of medications for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says programs often provide free or reduced-cost medications, which corresponds to covering all or most of the cost."
      },
      {
        "criterion_number": 6,
        "description": "The response states government programs may offer assistance with the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists Medicare Extra Help/Low Income Subsidy and state pharmaceutical assistance programs as government options."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of non-profit organizations with patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides examples including CancerCare Co-Payment Assistance Foundation, Patient Advocate Foundation, HealthWell Foundation, and The Assistance Fund."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of pancreatic cancer-specific patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions PanCAN Patient Central (pancreatic cancer\u2013specific) with a phone number for assistance."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends applying for assistance early as the process may take time and delay treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests applying to multiple programs, it does not advise applying early or warn about delays."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention federal, state, manufacturer, and independent charity options for medication cost assistance for pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Federal (Medicare Extra Help), state (state pharmaceutical assistance), manufacturer (company PAPs), and independent charities (CancerCare, HealthWell, The Assistance Fund) are all mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that Medicaid offers comprehensive prescription drug coverage with minimal co-payments and is the most effective public program for low-income patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Medicaid is not mentioned, nor is its comprehensive coverage or role as the most effective public program for low-income patients."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention that manufacturer-sponsored assistance programs provide free or discounted medications to eligible uninsured or underinsured patients, requiring proof of financial hardship and doctor certification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While free or reduced-cost meds are noted, it does not specify uninsured/underinsured eligibility or requirements for proof of financial hardship and physician certification."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that independent nonprofits like HealthWell and PAN Foundation offer co-pay and premium assistance to insured patients with incomes below 400-500% of the federal poverty level.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention income thresholds (400\u2013500% FPL), the insured-patient focus, or premium assistance; PAN Foundation is not cited."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the complexity of accessing assistance programs and disparities among non-English speakers and some ethnic groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of complexity or disparities related to language or ethnicity."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention financial navigators and online tools such as NeedyMeds or RxAssist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references hospital financial counselors/social workers (financial navigator role) and names NeedyMeds.org as an online tool."
      }
    ],
    "question_number": 92,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:24:53.199903",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist, as they likely have financial experts who are knowledgeable in this area.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to speak with the oncology team's social worker or financial counselor and to ask the oncologist's office to help apply."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends learning about the patient\u2019s insurance plan, including out-of-pocket costs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit recommendation to review insurance benefits or out-of-pocket costs."
      },
      {
        "criterion_number": 3,
        "description": "The response states pharmaceutical companies have programs to help patients cover the cost of medications and provides examples.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States that most manufacturers offer PAPs and that they may be free or reduced-cost, but does not provide specific manufacturer program examples."
      },
      {
        "criterion_number": 4,
        "description": "The response states large hospital systems and cancer centers may have assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that many hospitals have financial assistance and charity care programs; advises working with social workers."
      },
      {
        "criterion_number": 5,
        "description": "The response states patient assistance programs may cover all or most of the cost of medications for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States PAPs often provide free or reduced-cost drugs, indicating coverage of all or most costs."
      },
      {
        "criterion_number": 6,
        "description": "The response states government programs may offer assistance with the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions Medicare Extra Help, Medicaid, and state pharmaceutical assistance programs."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of non-profit organizations with patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists CancerCare, Patient Advocate Foundation, Pancreatic Cancer Action Network, American Cancer Society, and LLS."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of pancreatic cancer-specific patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions the Pancreatic Cancer Action Network as a resource."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends applying for assistance early as the process may take time and delay treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice about applying early or potential delays."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention federal, state, manufacturer, and independent charity options for medication cost assistance for pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions federal (Medicare Extra Help, Medicaid), state (state pharmaceutical assistance programs), manufacturer (PAPs), and independent charities (CancerCare, PAF, ACS, PanCAN)."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that Medicaid offers comprehensive prescription drug coverage with minimal co-payments and is the most effective public program for low-income patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions Medicaid but does not describe comprehensive coverage, minimal co-pays, or that it is the most effective public program for low-income patients."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention that manufacturer-sponsored assistance programs provide free or discounted medications to eligible uninsured or underinsured patients, requiring proof of financial hardship and doctor certification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes free or reduced-cost PAPs but does not specify uninsured/underinsured eligibility, proof of financial hardship, or physician certification requirements."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that independent nonprofits like HealthWell and PAN Foundation offer co-pay and premium assistance to insured patients with incomes below 400-500% of the federal poverty level.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention HealthWell or PAN Foundation, nor FPL thresholds or that assistance targets insured patients."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the complexity of accessing assistance programs and disparities among non-English speakers and some ethnic groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of complexity or disparities in access for non-English speakers or specific ethnic groups."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention financial navigators and online tools such as NeedyMeds or RxAssist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions social workers/financial counselors but not financial navigators or online tools like NeedyMeds or RxAssist."
      }
    ],
    "question_number": 92,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:25:17.072195",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises discussing the maintenance approach, schedule, side effects, and monitoring with the oncologist and frames decisions as guided by the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states maintenance therapy is typically used in pancreatic cancer after the initial induction therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly defines maintenance as treatment after initial, more intensive therapy and specifies use after initial chemotherapy (and after surgery plus chemo) once disease has responded or stabilized."
      },
      {
        "criterion_number": 3,
        "description": "The response states maintenance therapy typically involves fewer anti-cancer drugs with the goal of limiting side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states maintenance may use lower doses and fewer chemotherapy drugs and notes the benefit of fewer side effects compared with initial intensive treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response states the oncologist will continue to monitor the cancer closely while the patient is on maintenance therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions discussing expectations around monitoring, it does not explicitly state that the oncologist will continue close monitoring during maintenance therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the cancer grows while on maintenance therapy, combination therapy may be reintroduced to get the cancer back under control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention is made of re-escalating to combination therapy or changing treatment if disease progression occurs during maintenance."
      },
      {
        "criterion_number": 6,
        "description": "The response states chemotherapy side effects are typically cumulative, so using maintenance therapy may help the patient tolerate treatment for a longer period of time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes fewer side effects with maintenance but does not mention the cumulative nature of chemotherapy toxicities or how maintenance may enable longer tolerability."
      },
      {
        "criterion_number": 7,
        "description": "The response states maintenance therapy may involve chemotherapy, targeted therapy, or immunotherapy depending upon the characteristics of the patient\u2019s tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists chemotherapy (lower dose/fewer drugs), targeted therapy, and sometimes immunotherapy depending on tumor characteristics."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the decision to initiate maintenance therapy should be individualized, considering disease response, cumulative toxicities, patient preference, and goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes decisions depend on response, overall health, and tumor characteristics, it does not mention cumulative toxicities, patient preferences, or goals of care."
      }
    ],
    "question_number": 93,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:25:32.482820",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly encourages discussion with the oncologist by listing 'Important questions to ask the oncologist' and stating 'The oncologist can provide more detailed information about what this means for his particular case.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states maintenance therapy is typically used in pancreatic cancer after the initial induction therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines maintenance therapy as 'continuing treatment after the initial intensive treatment phase,' which aligns with post-induction use."
      },
      {
        "criterion_number": 3,
        "description": "The response states maintenance therapy typically involves fewer anti-cancer drugs with the goal of limiting side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes 'Switching to a single, less intensive drug' and that maintenance 'usually involves milder side effects than initial treatment,' meeting both the 'fewer drugs' and 'limit side effects' components."
      },
      {
        "criterion_number": 4,
        "description": "The response states the oncologist will continue to monitor the cancer closely while the patient is on maintenance therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states 'Regular monitoring through scans and blood tests,' which conveys ongoing close monitoring during maintenance."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the cancer grows while on maintenance therapy, combination therapy may be reintroduced to get the cancer back under control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions treatment continues until progression, it does not state that combination therapy may be reintroduced upon progression."
      },
      {
        "criterion_number": 6,
        "description": "The response states chemotherapy side effects are typically cumulative, so using maintenance therapy may help the patient tolerate treatment for a longer period of time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions milder side effects but does not state that chemotherapy toxicities are cumulative or that maintenance facilitates longer tolerability."
      },
      {
        "criterion_number": 7,
        "description": "The response states maintenance therapy may involve chemotherapy, targeted therapy, or immunotherapy depending upon the characteristics of the patient\u2019s tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes chemotherapy-based approaches and 'Sometimes targeted therapies, depending on genetic testing results,' which reflects modality choice based on tumor characteristics. Although immunotherapy is not explicitly mentioned, the required concept that maintenance may involve chemotherapy or targeted therapy depending on tumor features is present."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the decision to initiate maintenance therapy should be individualized, considering disease response, cumulative toxicities, patient preference, and goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states 'Every situation is unique' and that the approach depends on 'how he responded to initial treatment' and 'personal preferences,' with emphasis on balancing quality of life. This conveys individualized decision-making considering response, patient preferences, and overall tolerability/goals."
      }
    ],
    "question_number": 93,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:26:03.877550",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the oncology team for referrals to oncology social workers or psycho-oncologists, explicitly encouraging discussion with the cancer care team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a licensed mental health care provider.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends referrals to psycho-oncologists and oncology social workers and highlights counseling services, which are licensed mental health providers."
      },
      {
        "criterion_number": 3,
        "description": "The response instructs the patient to seek immediate medical evaluation if they are experiencing thoughts of harming themselves or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No guidance is provided about urgent evaluation or crisis resources for suicidal or homicidal ideation."
      },
      {
        "criterion_number": 4,
        "description": "The response states anxiety is a common occurrence in patients with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it emphasizes the importance of managing anxiety, it does not explicitly state that anxiety is common among cancer patients."
      },
      {
        "criterion_number": 5,
        "description": "The response states treatments like cognitive behavioral therapy may help to control anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cognitive behavioral therapy (CBT) is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response states medications may help to control anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of pharmacologic treatments for anxiety."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention psychotherapy, psychoeducation, supportive therapy, and integrative modalities as available resources for treatment-related anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "None of the required terms\u2014psychotherapy, psychoeducation, supportive therapy, or integrative modalities\u2014are explicitly named."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention mindfulness-based interventions or mindfulness-based stress reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions meditation apps and breathing exercises but does not explicitly reference mindfulness-based interventions or MBSR."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends mindfulness and relaxation techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests meditation apps, breathing exercises, and progressive muscle relaxation."
      },
      {
        "criterion_number": 11,
        "description": "The response offers pancreatic cancer-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN with contact information and pancreatic cancer-specific support groups."
      },
      {
        "criterion_number": 12,
        "description": "The response offers mental health-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes CancerCare counseling from oncology social workers and references integrated behavioral health services and psycho-oncologists."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends participation in cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends local and virtual cancer support groups, including caregiver-specific options."
      }
    ],
    "question_number": 94,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:26:22.586132",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response suggests contacting the oncology team's social worker/patient navigator but does not explicitly recommend discussing anxiety with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a licensed mental health care provider.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly directs to counseling resources (CancerCare), therapist directories, and online therapy platforms, which imply licensed mental health professionals."
      },
      {
        "criterion_number": 3,
        "description": "The response instructs the patient to seek immediate medical evaluation if they are experiencing thoughts of harming themselves or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No crisis/safety guidance or instruction to seek immediate help for suicidal or homicidal thoughts is included."
      },
      {
        "criterion_number": 4,
        "description": "The response states anxiety is a common occurrence in patients with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state or normalize that anxiety is common among cancer patients."
      },
      {
        "criterion_number": 5,
        "description": "The response states treatments like cognitive behavioral therapy may help to control anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cognitive behavioral therapy (CBT) is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response states medications may help to control anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of pharmacologic options for anxiety."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention psychotherapy, psychoeducation, supportive therapy, and integrative modalities as available resources for treatment-related anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While counseling/therapy and meditation are mentioned, the response does not explicitly name psychotherapy, psychoeducation, supportive therapy, and integrative modalities."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention mindfulness-based interventions or mindfulness-based stress reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Meditation apps are listed, but there is no explicit mention of mindfulness-based interventions or MBSR."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends mindfulness and relaxation techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends meditation apps (Calm, Headspace), which are mindfulness/relaxation techniques."
      },
      {
        "criterion_number": 11,
        "description": "The response offers pancreatic cancer-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides Pancreatic Cancer Action Network (PanCAN) patient services and PanCAN support groups."
      },
      {
        "criterion_number": 12,
        "description": "The response offers mental health-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes CancerCare counseling, therapist directories, insurance mental health provider directories, and online therapy platforms."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends participation in cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends cancer center support groups, PanCAN support groups, and local hospital support groups."
      }
    ],
    "question_number": 94,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:26:45.043746",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: 'Ask the oncologist to clarify,' and suggests seeking a second opinion; encourages discussion with the medical team."
      },
      {
        "criterion_number": 3,
        "description": "The response states cryotherapy is a procedure that uses metal instruments cooled to subzero temperatures in order to kill tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'freezing' and a 'probe,' but does not state metal instruments cooled to subzero temperatures."
      },
      {
        "criterion_number": 4,
        "description": "Mentions that cryotherapy (cryoablation) is a minimally invasive locoregional treatment that destroys tumor tissue by freezing it, typically using probes inserted percutaneously or intraoperatively under imaging guidance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes 'cryoablation' and a 'probe freezes cancer cells,' but does not describe it as minimally invasive/locoregional or mention percutaneous/intraoperative approaches or imaging guidance."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use cryotherapy involves the cancer\u2019s size, location, proximity to other organs, among other things.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention size, location, or proximity to critical structures as determinants."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the benefits and risks of this procedure with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages clarification and understanding but does not explicitly recommend discussing benefits and risks."
      },
      {
        "criterion_number": 7,
        "description": "The response states cryotherapy may be used in conjunction with other treatment modalities like chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of combining cryotherapy with chemotherapy or other modalities."
      },
      {
        "criterion_number": 8,
        "description": "The response states cryotherapy is not typically used to cure cancer but may be used to debulk tumors that are not operable.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not describe non-curative intent or debulking for inoperable tumors."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all patients benefit from cryotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Says it's rare and for specific cases, but does not explicitly state that not all patients benefit."
      },
      {
        "criterion_number": 10,
        "description": "Mentions that in pancreatic cancer, cryotherapy is not a standard first-line therapy but is considered for unresectable, locally advanced, or metastatic disease in non-surgical candidates or after failure of systemic therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes it is not standard, but does not specify the typical indications (unresectable/locally advanced/metastatic or post-systemic therapy failure)."
      },
      {
        "criterion_number": 11,
        "description": "Mentions that its primary role is palliative, aiming to reduce tumor burden, alleviate pain, and potentially improve quality of life and local disease control.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No discussion of palliative intent, symptom relief, quality of life, or local control goals."
      }
    ],
    "question_number": 95,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:27:04.741617",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages discussing candidacy, benefits vs. risks, and overall plan with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response states cryotherapy is a procedure that uses metal instruments cooled to subzero temperatures in order to kill tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes use of a cryoprobe cooled with liquid nitrogen/argon to subzero temperatures to destroy cancer cells; a cryoprobe is a metal instrument."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that cryotherapy (also called cryoablation) is a minimally invasive locoregional treatment that destroys tumor tissue by freezing it, typically using probes inserted through the skin (percutaneously) or intraoperatively under imaging guidance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains freezing to destroy cancer cells and describes percutaneous and surgical approaches under imaging guidance, conveying a minimally invasive, locoregional procedure."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use cryotherapy involves the cancer\u2019s size, location, proximity to other organs, among other things.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes effectiveness varies by tumor size and stage and that some locations may be unsuitable due to nearby critical structures."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the benefits and risks of this procedure with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically advises discussing expected benefits vs. risks with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response states cryotherapy may be used in conjunction with other treatment modalities like chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention use alongside chemotherapy or other systemic therapies."
      },
      {
        "criterion_number": 8,
        "description": "The response states cryotherapy is not typically used to cure cancer but may be used to debulk tumors that are not operable.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions palliative use and when surgery is not an option, but does not explicitly state non-curative intent nor that it is used to debulk inoperable tumors."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all patients benefit from cryotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States effectiveness varies by tumor size and stage and that some locations are unsuitable, implying not all patients benefit."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in pancreatic cancer, cryotherapy is not a standard first-line therapy but is considered for patients with unresectable, locally advanced, or metastatic disease who are not candidates for surgical resection or have failed systemic therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specify non\u2013first-line status or the typical indications (unresectable locally advanced/metastatic disease or after failed systemic therapy)."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that its primary role is palliative, aiming to reduce tumor burden, alleviate pain, and potentially improve quality of life and local disease control.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions palliative use and pain relief, it does not clearly state the primary palliative role nor address quality of life and local disease control aims."
      }
    ],
    "question_number": 95,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:27:46.230710",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, 'Your mother's oncologist will determine which markers are most useful for her specific situation,' which directs the reader to discuss with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states CA 19-9 is the tumor marker most commonly used to track disease status in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references CA 19-9 but does not explicitly state it is the most commonly used marker for tracking disease status."
      },
      {
        "criterion_number": 3,
        "description": "The response states other tumor markers, like CEA and CA 125, are less reliable than CA 19-9 for disease monitoring in pancreatic cancer and are used more frequently in other gastrointestinal or genitourinary cancers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While CA 125 is noted as more commonly associated with ovarian cancer, the response does not state that CEA or CA 125 are less reliable than CA 19-9 for monitoring, nor does it clearly situate them as used more in GI/GU cancers."
      },
      {
        "criterion_number": 4,
        "description": "The response states tumor markers may be used to monitor the course of disease in patients with pancreatic cancer, along with imaging studies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that markers help monitor treatment response and detect recurrence and that clinicians use a combination of markers, imaging, and clinical assessment."
      },
      {
        "criterion_number": 5,
        "description": "The response states tumor markers are not reliable markers of disease in all patients with pancreatic cancer, as not all tumors secrete the markers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states 'Not all patients have elevated markers,' conveying that markers are not reliable in all patients."
      },
      {
        "criterion_number": 6,
        "description": "The response states circulating tumor DNA (ctDNA) is an emerging technology aimed at detecting early cancer progression and recurrence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ctDNA is listed under 'Newer/Research Markers,' but the response does not specify its aim in detecting early progression and recurrence."
      },
      {
        "criterion_number": 7,
        "description": "The response states circulating tumor DNA (ctDNA) is not FDA approved for disease monitoring in pancreatic cancer and remains experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention is made of FDA approval status or that ctDNA remains experimental for pancreatic cancer monitoring."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that CEA is elevated in 30-60% of pancreatic cancer cases and is particularly useful in Lewis-negative patients who do not secrete CA19-9.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not include the 30\u201360% prevalence figure or the utility of CEA in Lewis-negative patients."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that both CEA and CA125 have demonstrated value for diagnosis, prognosis, and monitoring, especially when CA19-9 is not informative. CA125, when combined with CA19-9, improves diagnostic accuracy and is associated with tumor burden and metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not discuss diagnostic/prognostic value of CEA and CA125, their role when CA19-9 is uninformative, combination benefit, or association with tumor burden/metastasis."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that emerging markers such as LAMC2, POSTN are not yet standard in routine clinical practice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "LAMC2 and POSTN are not mentioned; the response lists other research markers but does not specify these or note their non-standard status."
      }
    ],
    "question_number": 96,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:28:08.145735",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a section titled 'Questions for the medical team' and explicitly states that 'The oncology team can provide the most relevant information,' which is a clear recommendation to discuss with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states CA 19-9 is the tumor marker most commonly used to track disease status in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states 'CA 19-9 remains the most widely used and studied marker,' which conveys it is the primary marker used to track disease."
      },
      {
        "criterion_number": 3,
        "description": "The response states other tumor markers, like CEA and CA 125, are less reliable than CA 19-9 for disease monitoring in pancreatic cancer and are used more frequently in other gastrointestinal or genitourinary cancers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes CEA is not specific and CA125 is sometimes elevated, it does not explicitly state they are less reliable than CA19-9 for pancreatic cancer nor that they are used more frequently in other GI/GU cancers."
      },
      {
        "criterion_number": 4,
        "description": "The response states tumor markers may be used to monitor the course of disease in patients with pancreatic cancer, along with imaging studies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says markers are used 'alongside imaging and clinical assessment' and mentions ctDNA is being studied for 'monitoring treatment response,' indicating use in monitoring with imaging."
      },
      {
        "criterion_number": 5,
        "description": "The response states tumor markers are not reliable markers of disease in all patients with pancreatic cancer, as not all tumors secrete the markers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes 'About 5-10% of people don't produce CA 19-9 due to genetic factors,' conveying that markers may be non-informative in some patients, and also mentions non-specific elevations."
      },
      {
        "criterion_number": 6,
        "description": "The response states circulating tumor DNA (ctDNA) is an emerging technology aimed at detecting early cancer progression and recurrence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It describes ctDNA as 'being studied for monitoring treatment response' but does not mention detection of early progression or recurrence."
      },
      {
        "criterion_number": 7,
        "description": "The response states circulating tumor DNA (ctDNA) is not FDA approved for disease monitoring in pancreatic cancer and remains experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of FDA approval status or explicit statement that ctDNA remains experimental for monitoring pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that CEA is elevated in 30-60% of pancreatic cancer cases and is particularly useful in Lewis-negative patients who do not secrete CA19-9.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not provide the 30\u201360% elevation rate nor the utility of CEA in Lewis-negative (CA19-9 non-secreting) patients."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that both CEA and CA125 have demonstrated value for diagnosis, prognosis, and monitoring, especially when CA19-9 is not informative. CA125, when combined with CA19-9, improves diagnostic accuracy and is associated with tumor burden and metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of diagnostic/prognostic value, synergy of CA125 with CA19-9, or associations with tumor burden/metastases."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that emerging markers such as LAMC2, POSTN are not yet standard in routine clinical practice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references microRNAs and PAM4 as research-based but does not mention LAMC2 or POSTN or explicitly state their non-standard status."
      }
    ],
    "question_number": 96,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:28:30.603759",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that hand-foot syndrome is a common side effect of some chemotherapy drugs used to treat pancreatic cancer, including capecitabine and 5-FU.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes HFS is a common side effect of chemotherapy but does not mention capecitabine or 5-FU specifically."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s oncologist and healthcare team immediately.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises contacting the healthcare team if symptoms worsen or signs of infection occur, but does not recommend immediate discussion universally."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the patient\u2019s oncologist may recommend reducing the chemotherapy dose.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states the oncologist may reduce the chemotherapy dose or delay treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response instructs the patient to seek immediate medical evaluation if the patient experiences fever, chills, blisters, or pus draining from the affected area.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists fever, pus, and blistering as reasons to contact the healthcare team but does not state the need for immediate medical evaluation and does not mention chills."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s oncology team will grade the severity of the hand-foot syndrome, which will determine the recommended treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions guidance based on severity, it does not state that the oncology team will formally grade HFS to determine treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends hand hygiene with a gentle soap.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation for hand hygiene with gentle soap is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response states pain may be controlled with over-the-counter medications like Tylenol or ibuprofen, though the patient should check with their healthcare team first.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions considering pain medications but does not specify Tylenol or ibuprofen or advise checking with the healthcare team first for OTC analgesics."
      },
      {
        "criterion_number": 8,
        "description": "The response states oral or topical prescription pain medications may be needed if pain is severe.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references topical pain relievers as recommended by the oncologist but does not state that oral or prescription pain medications may be needed for severe pain."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends utilizing topical moisturizers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends frequent moisturizing with fragrance-free creams and thick emollients, including urea-containing products."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends skin protection with loose clothing and soft shoe soles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests loose-fitting socks and comfortable shoes but does not mention loose clothing or soft shoe soles specifically."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends cooling the skin with cold compresses.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises keeping hands and feet cool and using cool compresses and soaks."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends avoiding hot showers and activities that cause rubbing on the skin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends avoiding hot water and avoiding friction and pressure on hands and feet."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention strategies include celecoxib and urea cream.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While urea-containing creams are mentioned, celecoxib is not mentioned as a prevention strategy."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cooling procedures, such as frozen gloves or socks applied during taxane infusions, may prevent or reduce HFS severity and are recommended by the Oncology Nursing Society for taxane-based regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of frozen gloves/socks during taxane infusions or ONS recommendations."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that prevention strategies such as Pyridoxine (vitamin B6) and lactic acid have not shown consistent benefit for prevention or treatment of HFS in randomized trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends vitamin B6 rather than noting the lack of consistent benefit; lactic acid is not discussed."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that omeprazole (a proton pump inhibitor) and tipiracil (a thymidine phosphorylase inhibitor) may have prophylactic effects, but these are not yet standard practice.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of omeprazole or tipiracil as potential prophylactic options."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that management of established HFS includes topical urea and corticosteroids.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes both topical corticosteroids and urea-containing emollients as part of management."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Photobiomodulation (low-level laser therapy) has shown promise as an adjunct for pain and symptom control.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Photobiomodulation or low-level laser therapy is not mentioned."
      }
    ],
    "question_number": 97,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:29:03.421995",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that hand-foot syndrome is a common side effect of some chemotherapy drugs used to treat pancreatic cancer, including capecitabine and 5-FU.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention specific pancreatic cancer chemotherapies (e.g., capecitabine, 5-FU) or note that HFS is common with these agents."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s oncologist and healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says: \"Report symptoms to the oncology team immediately\" and includes guidance to contact the medical team."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the patient\u2019s oncologist may recommend reducing the chemotherapy dose.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states: \"Dose reduction or temporary treatment breaks if severe\" and \"they may need to adjust the chemotherapy regimen.\""
      },
      {
        "criterion_number": 4,
        "description": "The response instructs the patient to seek immediate medical evaluation if the patient experiences fever, chills, blisters, or pus draining from the affected area.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions \"infection signs\" but does not explicitly list fever, chills, blisters, or pus drainage."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s oncology team will grade the severity of the hand-foot syndrome, which will determine the recommended treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of formal grading or that treatment depends on grade."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends hand hygiene with a gentle soap.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hand hygiene or use of gentle soap is not discussed."
      },
      {
        "criterion_number": 7,
        "description": "The response states pain may be controlled with over-the-counter medications like Tylenol or ibuprofen, though the patient should check with their healthcare team first.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes \"Pain medications for discomfort\" but does not specify OTC options (acetaminophen/ibuprofen) or advise checking with the healthcare team first."
      },
      {
        "criterion_number": 8,
        "description": "The response states oral or topical prescription pain medications may be needed if pain is severe.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Prescription analgesics are not mentioned; only general \"Pain medications\" are referenced."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends utilizing topical moisturizers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to \"Keep hands and feet moisturized with thick creams.\""
      },
      {
        "criterion_number": 10,
        "description": "The response recommends skin protection with loose clothing and soft shoe soles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Soft shoe soles are mentioned (\"well-fitting shoes with soft soles\"), but loose clothing is not; the full required recommendation is not present."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends cooling the skin with cold compresses.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says: \"Apply cold compresses for pain relief.\""
      },
      {
        "criterion_number": 12,
        "description": "The response recommends avoiding hot showers and activities that cause rubbing on the skin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to \"Avoid hot water\" and \"excessive friction,\" which align with avoiding hot showers and rubbing."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention strategies include celecoxib and urea cream.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Urea creams are mentioned for treatment, but celecoxib is not discussed, and prevention framing is not provided."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cooling procedures, such as frozen gloves or socks applied during taxane infusions, may prevent or reduce HFS severity and are recommended by the Oncology Nursing Society for taxane-based regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of frozen gloves/socks during taxane infusions or ONS recommendations."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that prevention strategies such as Pyridoxine (vitamin B6) and lactic acid have not shown consistent benefit for prevention or treatment of HFS in randomized trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Vitamin B6 is noted as \"evidence is mixed,\" but lactic acid and the specific point about randomized trials are not included."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that omeprazole (a proton pump inhibitor) and tipiracil (a thymidine phosphorylase inhibitor) may have prophylactic effects, but these are not yet standard practice.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of omeprazole or tipiracil for prophylaxis."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that management of established HFS includes topical urea and corticosteroids.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists \"Topical treatments (urea-based creams, corticosteroids).\""
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Photobiomodulation (low-level laser therapy) has shown promise as an adjunct for pain and symptom control.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Photobiomodulation/low-level laser therapy is not mentioned."
      }
    ],
    "question_number": 97,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:29:25.337838",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The decision between a cancer center and community oncology is often based on the type and stage of cancer, the patient\u2019s insurance, location, and preference.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions convenience/location and patient experience (preference) but does not address type/stage of cancer or insurance/cost considerations explicitly."
      },
      {
        "criterion_number": 2,
        "description": "Cancer centers may have access to more advanced therapies and clinical trials than community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes access to cutting-edge clinical trials and experimental treatments at cancer centers."
      },
      {
        "criterion_number": 3,
        "description": "Pancreatic cancer requires multidisciplinary care involving medical oncology, radiation oncology, and surgical oncology, which may be more readily available at a large cancer center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response highlights multidisciplinary teams, coordinated care among multiple specialists, and specialized pancreatic surgeons at cancer centers."
      },
      {
        "criterion_number": 4,
        "description": "Cancer centers may be more equipped to handle complex care for advanced disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states cancer centers have more experience with complex cases, aligning with handling advanced disease."
      },
      {
        "criterion_number": 5,
        "description": "Community oncology programs may be more convenient and closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly mentions community oncology being closer to home with less travel burden."
      },
      {
        "criterion_number": 6,
        "description": "There may be differences in cost between cancer centers and community oncology programs based on the patient\u2019s insurance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of cost or insurance differences is included."
      },
      {
        "criterion_number": 7,
        "description": "Cancer centers may offer more support services to patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions comprehensive support services available under one roof at cancer centers."
      },
      {
        "criterion_number": 8,
        "description": "Most standard cancer care can be delivered at community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states community oncology can provide standard chemotherapy and radiation."
      },
      {
        "criterion_number": 9,
        "description": "Cancer centers include NCI-designated comprehensive cancer centers and academic medical centers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions NCI-designated centers, it does not explicitly include academic medical centers."
      },
      {
        "criterion_number": 10,
        "description": "Cancer centers are often located in major cities, which can mean longer travel times, more complex scheduling, and larger, busier environments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly discuss the urban location or logistical complexities of cancer centers."
      },
      {
        "criterion_number": 11,
        "description": "In some cases, initial treatment planning can be done at a cancer center, and follow-up care can be done at a community center closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends an initial evaluation at a cancer center with the option to continue care locally and gives an example (surgery at a center, chemotherapy locally)."
      }
    ],
    "question_number": 98,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:29:43.731590",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The decision between a cancer center and community oncology is often based on the type and stage of cancer, the patient\u2019s insurance, location, and preference.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly prompts consideration of stage/type, insurance coverage, travel/location convenience, and personal priorities/preferences (what aspects matter most), aligning with all listed decision factors."
      },
      {
        "criterion_number": 2,
        "description": "Cancer centers may have access to more advanced therapies and clinical trials than community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states cancer centers offer 'Access to clinical trials and experimental treatments' and 'Latest technology,' directly addressing advanced therapies and trials."
      },
      {
        "criterion_number": 3,
        "description": "Pancreatic cancer requires multidisciplinary care involving medical oncology, radiation oncology, and surgical oncology, which may be more readily available at a large cancer center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response highlights 'Multidisciplinary teams (surgeons, oncologists, radiologists working together)' and asks if surgery is being considered, indicating multidisciplinary care availability at cancer centers."
      },
      {
        "criterion_number": 4,
        "description": "Cancer centers may be more equipped to handle complex care for advanced disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes 'Often more complex cases are referred here,' indicating cancer centers\u2019 capability for complex/advanced cases."
      },
      {
        "criterion_number": 5,
        "description": "Community oncology programs may be more convenient and closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states community oncology is 'More convenient location, closer to home.'"
      },
      {
        "criterion_number": 6,
        "description": "There may be differences in cost between cancer centers and community oncology programs based on the patient\u2019s insurance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response mentions community settings are 'Generally less expensive' and includes 'What does your insurance cover?' in decision questions, acknowledging cost considerations tied to insurance coverage."
      },
      {
        "criterion_number": 7,
        "description": "Cancer centers may offer more support services to patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of support services (e.g., nutrition, social work, genetic counseling, navigation, palliative care) was made."
      },
      {
        "criterion_number": 8,
        "description": "Most standard cancer care can be delivered at community oncology programs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes community sites may have limitations on specialized procedures/clinical trials, it does not explicitly state that most standard care can be delivered there."
      },
      {
        "criterion_number": 9,
        "description": "Cancer centers include NCI-designated comprehensive cancer centers and academic medical centers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It labels 'Cancer Centers (Academic/Comprehensive)' but does not explicitly reference NCI-designated comprehensive cancer centers."
      },
      {
        "criterion_number": 10,
        "description": "Cancer centers are often located in major cities, which can mean longer travel times, more complex scheduling, and larger, busier environments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes cancer centers 'May require travel and longer wait times' and asks how travel affects quality of life, capturing key access/logistics burdens."
      },
      {
        "criterion_number": 11,
        "description": "In some cases, initial treatment planning can be done at a cancer center, and follow-up care can be done at a community center closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends a hybrid approach: initial planning/second opinion at a cancer center with ongoing care locally."
      }
    ],
    "question_number": 98,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:30:10.264687",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises to \"Talk with the oncology team about specific side effects that might affect intimacy\" and to ask for referrals from the cancer center."
      },
      {
        "criterion_number": 2,
        "description": "The response states patients undergoing treatment for pancreatic cancer may experience a decrease in libido related to symptoms from treatment or the cancer itself, like fatigue, nausea, pain, malnutrition, anxiety, and depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions fatigue and treatment-related physical changes, it does not explicitly state decreased libido or link it to specific symptoms such as nausea, pain, malnutrition, anxiety, or depression."
      },
      {
        "criterion_number": 3,
        "description": "The response specifically mentions at least one of the following changes in intimacy: decreased desire, arousal disorders, pain, erectile dysfunction, altered body image, or emotional distress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly mention any of the listed changes (e.g., decreased desire, pain, erectile dysfunction, altered body image, emotional distress)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly advises to \"Communicate openly about fears, desires, and boundaries.\""
      },
      {
        "criterion_number": 5,
        "description": "The response recommends seeking input from a professional trained in intimacy problems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends \"couples counseling specialized in chronic illness\" and notes that many cancer centers have counselors specializing in sexuality and relationships."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly mentions at least one of the following interventions: psychosocial therapy, psychosexual therapy, or couples-based therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests \"couples counseling,\" which qualifies as couples-based therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least one of the following referral options: medical sexologist, psycho-sexologist, social worker, or psychologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It refers generally to counselors but does not specify a medical sexologist, psycho-sexologist, social worker, or psychologist."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly states that concerns about intimacy during treatment for a loved one with pancreatic cancer are common.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states these concerns are \"completely normal\" and \"very common.\""
      }
    ],
    "question_number": 99,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:30:32.855106",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises, \"Talk with the medical team about treatment effects\" and \"Your medical team can provide specific guidance,\" directly recommending discussion with the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response states patients undergoing treatment for pancreatic cancer may experience a decrease in libido related to symptoms from treatment or the cancer itself, like fatigue, nausea, pain, malnutrition, anxiety, and depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it references energy changes and pain, it does not explicitly mention decreased libido nor link it to specific symptoms such as fatigue, nausea, malnutrition, anxiety, or depression."
      },
      {
        "criterion_number": 3,
        "description": "The response specifically mentions at least one of the following changes in intimacy: decreased desire, arousal disorders, pain, erectile dysfunction, altered body image, or emotional distress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly references pain and includes \"Discuss pain management strategies,\" satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "There is a dedicated \"Open Communication\" section advising honest conversations about fears, physical changes, and needs."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends seeking input from a professional trained in intimacy problems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends \"couples counseling\" and consulting \"sex therapists who work with cancer patients,\" which are professionals trained in intimacy issues."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states, \"Consider support groups for couples facing cancer,\" directly fulfilling this criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly mentions at least one of the following interventions: psychosocial therapy, psychosexual therapy, or couples-based therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends \"couples counseling,\" which constitutes couples-based therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least one of the following referral options: medical sexologist, psycho-sexologist, social worker, or psychologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions \"oncology social workers\" and \"sex therapists,\" meeting the referral requirement."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly states that concerns about intimacy during treatment for a loved one with pancreatic cancer are common.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It opens with, \"This is a deeply personal concern that many couples face during cancer treatment,\" clearly indicating the concern is common in this context."
      }
    ],
    "question_number": 99,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:30:53.795152",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines radiofrequency ablation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines RFA as a treatment that uses heat (high-frequency electrical currents) to destroy cancer cells and explains the mechanism."
      },
      {
        "criterion_number": 2,
        "description": "The response states radiofrequency ablation is minimally invasive and typically does not require surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes RFA as minimally invasive and outlines image-guided needle placement, implying a non-surgical approach; also contrasts with surgery and mentions outpatient feasibility."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly advises discussing with the doctors and lists specific discussion points."
      },
      {
        "criterion_number": 4,
        "description": "The response states not all patients with pancreatic cancer benefit from radiofrequency ablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes RFA may be used only in certain situations (e.g., small tumors, when surgery isn't possible), implying it is not appropriate for all patients."
      },
      {
        "criterion_number": 5,
        "description": "The response considers the potential risks and benefits of radiofrequency ablation for the treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists several benefits but does not describe any specific risks or side effects; merely suggests discussing them with doctors."
      },
      {
        "criterion_number": 6,
        "description": "The response states radiofrequency ablation is typically used in a multidisciplinary treatment plan along with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States RFA can be combined with other treatments like chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response states radiofrequency ablation is a procedure performed by specially trained Interventional Radiologists.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention who performs the procedure or interventional radiology."
      },
      {
        "criterion_number": 8,
        "description": "The response states this is typically an outpatient procedure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly states it can often be done as an outpatient procedure."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that in pancreatic cancer, RFA is most commonly delivered via endoscopic ultrasound guidance (EUS-RFA), allowing precise targeting of the tumor while minimizing injury to surrounding structures.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions CT or ultrasound guidance but does not reference endoscopic ultrasound (EUS-RFA)."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that radiofrequency ablation is used in pancreatic cancer primarily for unresectable or inoperable tumors as a palliative or adjunctive therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is used when surgery isn't possible and notes goals of controlling growth or relieving symptoms, consistent with palliative/adjunctive use."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA is not a substitute for surgery or systemic therapy in resectable disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state that RFA is not a substitute for surgery or systemic therapy in resectable disease."
      }
    ],
    "question_number": 100,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:31:18.408239",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines radiofrequency ablation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly defines RFA as a minimally invasive treatment that uses heat generated by radio waves to destroy cancer cells and explains probe insertion and tissue heating."
      },
      {
        "criterion_number": 2,
        "description": "The response states radiofrequency ablation is minimally invasive and typically does not require surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it calls RFA \"minimally invasive\" and describes needle-based ablation, it does not explicitly state that it typically does not require surgery."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly encourages asking the father\u2019s medical team specific questions about rationale, goals, risks, and the overall plan."
      },
      {
        "criterion_number": 4,
        "description": "The response states not all patients with pancreatic cancer benefit from radiofrequency ablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that not all patients or tumors are suitable candidates, which conveys that not everyone benefits."
      },
      {
        "criterion_number": 5,
        "description": "The response considers the potential risks and benefits of radiofrequency ablation for the treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Benefits are listed (less invasive, shorter recovery, repeatable, pain management), but potential risks/complications are not explicitly discussed."
      },
      {
        "criterion_number": 6,
        "description": "The response states radiofrequency ablation is typically used in a multidisciplinary treatment plan along with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes RFA may be combined with other treatments like chemotherapy, indicating its adjunctive role within a broader treatment plan."
      },
      {
        "criterion_number": 7,
        "description": "The response states radiofrequency ablation is a procedure performed by specially trained Interventional Radiologists.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not indicate which specialists perform the procedure and does not mention Interventional Radiologists."
      },
      {
        "criterion_number": 8,
        "description": "The response states this is typically an outpatient procedure.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not state whether the procedure is typically outpatient."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that in pancreatic cancer, RFA is most commonly delivered via endoscopic ultrasound guidance (EUS-RFA), allowing precise targeting of the tumor while minimizing injury to surrounding structures.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Guidance is described as CT or ultrasound, but it does not mention endoscopic ultrasound (EUS) or EUS-RFA, which is most common for pancreatic applications."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that radiofrequency ablation is used in pancreatic cancer primarily for unresectable or inoperable tumors as a palliative or adjunctive therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states RFA is usually for tumors that cannot be surgically removed and discusses symptom relief and combination with other treatments, consistent with palliative/adjunctive use."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA is not a substitute for surgery or systemic therapy in resectable disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not specify that RFA is not a replacement for surgery or systemic therapy in resectable disease."
      }
    ],
    "question_number": 100,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:31:40.862189",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises a medication review with her oncologist or pharmacist and references the care team/pharmacists for support."
      },
      {
        "criterion_number": 2,
        "description": "The response states it is normal for patients with pancreatic cancer to be on multiple medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States, \"Managing multiple medications is indeed very common with pancreatic cancer,\" directly normalizing polypharmacy."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may need medications for symptom control, including acid reflux, nausea, pain, diarrhea, and enzyme replacement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions nausea/vomiting, pain management, and digestive enzymes, but does not mention acid reflux or diarrhea; therefore it does not include the full set specified."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends utilizing a pill organizer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a clear recommendation: \"Use a pill organizer.\""
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping an updated medication list with administration times.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends creating a medication schedule/chart (implying timing) and keeping a list of all medications, fulfilling the intent of maintaining an updated list with times."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reviewing the patient\u2019s medication list with the healthcare team to identify strategies to make handling the medications easier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises a medication review with the oncologist or pharmacist and notes they can simplify the schedule or identify unnecessary medications."
      }
    ],
    "question_number": 101,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:31:55.449274",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises to ask the oncology team about each medication, to consider a medication review, and to ask the healthcare team questions, clearly recommending discussion with the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response states it is normal for patients with pancreatic cancer to be on multiple medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \"Yes, it's very common for pancreatic cancer patients to be on multiple medications,\" directly addressing normalcy."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may need medications for symptom control, including acid reflux, nausea, pain, diarrhea, and enzyme replacement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions nausea, pain, diarrhea/constipation, and digestive enzyme supplements, it does not mention acid reflux. Because the criterion specifies inclusion of acid reflux, full credit cannot be awarded under binary scoring."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends utilizing a pill organizer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends using a pill organizer or app."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping an updated medication list with administration times.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to keep a detailed medication list with times and purposes."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reviewing the patient\u2019s medication list with the healthcare team to identify strategies to make handling the medications easier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests asking about a medication review to eliminate unnecessary items and notes the medical team can help simplify the regimen."
      }
    ],
    "question_number": 101,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:32:06.410973",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing yoga with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states, 'Always consult the oncology team first,' clearly recommending discussion with the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response states yoga may improve a cancer patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists 'Improved mood and quality of life' under Potential Benefits, directly addressing this criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends gentle and slow yoga practice to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends gentle forms (restorative, chair, yin), avoiding intense/heated styles, and starting slowly with short sessions (10\u201315 minutes)."
      },
      {
        "criterion_number": 4,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions fatigue, hydration, tenderness, and pain-related caution, it does not state increased injury risk nor reference malnutrition; therefore it does not meet the full requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of cancer support groups is made."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No studies are cited; the response provides general statements without references."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are yoga classes specifically for cancer patients and provides resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes that many cancer centers offer specialized yoga programs and that online resources exist, but it does not provide any specific resources."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that yoga is generally safe for people with cancer, including those undergoing treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It says yoga can be beneficial and emphasizes safety, but does not explicitly state that yoga is generally safe for people with cancer, including during pancreatic cancer treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that yoga may help reduce cancer-related fatigue, anxiety, and depression, and improve emotional well-being during and after treatment, though effects are typically small to moderate and the certainty of evidence is low to moderate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions reduced anxiety, decreased fatigue, and improved mood, but does not mention depression, effect sizes (small to moderate), or the low-to-moderate certainty of evidence."
      }
    ],
    "question_number": 102,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:32:23.005922",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing yoga with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises medical clearance and states the oncology team must approve any exercise program; also emphasizes ongoing communication with the medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response states yoga may improve a cancer patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists benefits such as stress reduction, improved mood, better sleep, reduced fatigue, and enhanced well-being, all of which reflect quality-of-life improvement."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends gentle and slow yoga practice to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends gentle/restorative yoga, focusing on gentle poses, breathing, and meditation; advises avoiding overly strenuous practices and listening to the body."
      },
      {
        "criterion_number": 4,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions fatigue, neuropathy, and surgical recovery and notes fluctuating energy, but does not explicitly link increased injury risk to fatigue, malnutrition, dehydration, and pain; malnutrition and dehydration are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of cancer support groups or recommending participation in them."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No studies are cited; benefits are presented without references."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are yoga classes specifically for cancer patients and provides resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States there are classes specifically for cancer patients and that cancer centers may offer programs, but does not provide specific resources or organizations."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that yoga is generally safe for people with cancer, including those undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States yoga can often be a beneficial complementary practice during pancreatic cancer treatment and frames it as safe with medical guidance, conveying general safety."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that yoga may help reduce cancer-related fatigue, anxiety, and depression, and improve emotional well-being during and after treatment, though effects are typically small to moderate and the certainty of evidence is low to moderate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions fatigue reduction and mood benefits but does not explicitly address anxiety and depression together with effect sizes or evidence certainty."
      }
    ],
    "question_number": 102,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:32:45.733870",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises 'Regular follow-ups with your oncology team' and notes the healthcare team can provide guidance, which constitutes recommending discussion with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states many side effects from cancer treatment improve and disappear once treatment stops.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit statement that many side effects improve or resolve after treatment ends."
      },
      {
        "criterion_number": 3,
        "description": "The response states some side effects like peripheral neuropathy may become permanent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Peripheral neuropathy or permanence of certain side effects is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response states some side effects from treatment may take time to improve or disappear, as long as many months.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of the timeline for side effect resolution; it mentions diabetes may occur months or years later but not that side effects can take months to improve or disappear."
      },
      {
        "criterion_number": 5,
        "description": "The response states many side effects from treatment can be controlled with medications, for example pancreatic enzyme supplementation for pancreatic insufficiency or vitamins for malabsorption after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes 'Need for enzyme supplements with meals' and identifies vitamin deficiencies, implying management with enzyme replacement and vitamin supplementation."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews potential side effects of surgery for pancreatic cancer (e.g., Whipple procedure).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes diabetes may develop if significant pancreatic tissue is removed and discusses exocrine insufficiency and nutritional deficiencies, which are known surgical sequelae."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews potential side effects of chemotherapy for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No chemotherapy-specific late effects (e.g., neuropathy, myelosuppression, hair loss, cognitive changes) are discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the potential for long-term heart or kidney damage and fertility issues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of cardiotoxicity, nephrotoxicity, or fertility concerns."
      },
      {
        "criterion_number": 9,
        "description": "The response states the treating team will work within the patient\u2019s goals of care to maximize treatment efficacy while limiting side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit statement about aligning treatment with the patient's goals of care while balancing efficacy and side effects."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential side effects of radiation therapy for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Radiation therapy and its long-term effects are not addressed."
      },
      {
        "criterion_number": 11,
        "description": "The response states some cancer treatments can increase the likelihood of developing second cancers in the future.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of treatment-related secondary malignancy risk."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends open communication with the patient\u2019s healthcare team about symptoms and symptom control to limit the long-term effects of treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests regular follow-ups, it does not explicitly recommend open communication about symptoms and symptom control to mitigate long-term effects."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that long-term side effects are common in patients treated for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It uses the heading 'Common long-term effects may include,' explicitly indicating that long-term effects are common."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the cumulative impact of surgery, chemotherapy, radiation, and the underlying disease as sources of long-term side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention chemotherapy or radiation, nor the cumulative impact of multiple modalities plus the disease itself."
      }
    ],
    "question_number": 103,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:33:11.479125",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises to work closely with the oncology team and to ask the medical team specific questions about the treatment plan."
      },
      {
        "criterion_number": 2,
        "description": "The response states many side effects from cancer treatment improve and disappear once treatment stops.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that many side effects improve or resolve after treatment ends."
      },
      {
        "criterion_number": 3,
        "description": "The response states some side effects like peripheral neuropathy may become permanent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neuropathy is mentioned, but there is no indication that it can be permanent."
      },
      {
        "criterion_number": 4,
        "description": "The response states some side effects from treatment may take time to improve or disappear, as long as many months.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of timelines or that some effects can take months to improve."
      },
      {
        "criterion_number": 5,
        "description": "The response states many side effects from treatment can be controlled with medications, for example pancreatic enzyme supplementation for pancreatic insufficiency or vitamins for malabsorption after surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While supportive care is mentioned, there is no explicit statement about medication-based control or examples like enzyme supplementation or vitamins."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews potential side effects of surgery for pancreatic cancer (e.g., Whipple procedure).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes blood sugar changes especially after pancreatic surgery, which is a surgery-related side effect."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews potential side effects of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions neuropathy from certain chemotherapies and increased infection risk during active treatment, along with fatigue and digestive issues common with chemotherapy."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the potential for long-term heart or kidney damage and fertility issues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of cardiac, renal, or fertility risks."
      },
      {
        "criterion_number": 9,
        "description": "The response states the treating team will work within the patient\u2019s goals of care to maximize treatment efficacy while limiting side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although palliative care is encouraged, the response does not explicitly state aligning treatment with the patient\u2019s goals to balance efficacy and side effects."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential side effects of radiation therapy for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Radiation therapy and its side effects are not discussed."
      },
      {
        "criterion_number": 11,
        "description": "The response states some cancer treatments can increase the likelihood of developing second cancers in the future.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of treatment-related risk of second malignancies."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends open communication with the patient\u2019s healthcare team about symptoms and symptom control to limit the long-term effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends working closely with the oncology team and discussing expected side effects and management strategies with the medical team."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that long-term side effects are common in patients treated for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists common treatment-related effects but does not explicitly state that long-term side effects are common in pancreatic cancer survivors."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the cumulative impact of surgery, chemotherapy, radiation, and the underlying disease as sources of long-term side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention the cumulative impact of multimodal therapy and the disease itself on long-term side effects."
      }
    ],
    "question_number": 103,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:33:42.296205",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response offers recommendations for organizations and includes key initiatives of the organizations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple pancreatic cancer organizations (PanCAN, Lustgarten Foundation, Hirshberg Foundation, American Cancer Society, National Pancreatic Cancer Foundation) and notes specific initiatives or focus areas for each (e.g., largest private funder, 100% to research, early detection focus, dedicated pancreatic research initiatives, funding early-career researchers)."
      },
      {
        "criterion_number": 2,
        "description": "The response includes Charity Navigator ratings for the mentioned organizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions using Charity Navigator/GuideStar but does not provide actual ratings for any listed organizations."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly state that nonprofit organizations are vital for supporting innovative research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that nonprofit organizations are vital for supporting innovative research; it describes organizations and their roles but lacks the required explicit statement."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that donations to nonprofit organizations can support research, clinical trials, and patient support initiatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Indicates donations can go directly to research (Lustgarten), notes donors can designate funds for research vs. patient support, and mentions funding clinical trials as an option, thereby covering all three areas."
      }
    ],
    "question_number": 104,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:33:56.509619",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response offers recommendations for organizations and includes key initiatives of the organizations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends multiple organizations (PanCAN, Lustgarten Foundation, Hirshberg Foundation, as well as programs at Johns Hopkins, Dana-Farber, MD Anderson, and MSK). It also includes key initiatives for major nonprofits: PanCAN funds research and provides patient services; Lustgarten directs 100% of donations to research; Hirshberg focuses on seed funding for innovative projects. This satisfies the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response includes Charity Navigator ratings for the mentioned organizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No Charity Navigator ratings are provided. The response only suggests using Charity Navigator and GuideStar for further insight without listing any actual ratings."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly state that nonprofit organizations are vital for supporting innovative research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly state that nonprofit organizations are vital for supporting innovative research in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that donations to nonprofit organizations can support research, clinical trials, and patient support initiatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes Lustgarten directs donations to research and mentions clinical trials and patient support as considerations, it does not explicitly state that donations to nonprofit organizations support research, clinical trials, and patient support initiatives."
      }
    ],
    "question_number": 104,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:34:11.541731",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s oncologist immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing with the oncology team promptly and to report the changes to his doctor immediately."
      },
      {
        "criterion_number": 2,
        "description": "The response instructs the patient to seek immediate medical evaluation if the vision changes are abrupt in onset, severe, or accompanied by other symptoms including dizziness, pain, confusion, fever, or other neurologic symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No red-flag guidance on abrupt/severe onset or associated neurologic/systemic symptoms was provided."
      },
      {
        "criterion_number": 3,
        "description": "The response states vision changes related to treatment are not typical, though can be related to dry eyes or peripheral neuropathy from chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While dry eyes are mentioned, it does not state that treatment-related vision changes are not typical and does not reference peripheral neuropathy causing vision changes."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that chemotherapy can cause vision changes (ocular toxicity). For example, gemcitabine and 5-fluorouracil have been associated with retinal findings including cotton-wool spots and other visual disturbances.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly states chemotherapy can cause blurred vision/light sensitivity and rarely optic nerve effects, satisfying chemotherapy-related ocular toxicity, though it does not list specific agents."
      },
      {
        "criterion_number": 5,
        "description": "The response states the oncologist may recommend dose reducing treatment or changing to a different treatment if the vision changes are felt to be treatment-related.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It only notes that the medical team can determine if adjustments are needed without specifically mentioning dose reduction or switching therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response states vision changes may be related to metastasis to the brain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions metastases could affect vision but does not specify brain metastases."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that ocular metastases may cause vision changes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Ocular metastases are not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response states vision changes may be related to paraneoplastic processes and explains what this is.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Paraneoplastic syndromes are not discussed."
      },
      {
        "criterion_number": 10,
        "description": "The response states the patient\u2019s oncologist may prescribe medications to improve the vision changes, including eye drops, steroids, or antibiotics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No treatment options such as eye drops, steroids, or antibiotics are suggested for managing vision changes."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient\u2019s vision changes may be due to infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Infectious causes are not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response states the patient\u2019s vision changes may be due to age-related vision changes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Age-related vision changes are not addressed."
      }
    ],
    "question_number": 105,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:34:38.212764",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s oncologist immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly says, \"Report these changes to his oncology team immediately,\" which directly meets this criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response instructs the patient to seek immediate medical evaluation if the vision changes are abrupt in onset, severe, or accompanied by other symptoms including dizziness, pain, confusion, fever, or other neurologic symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends urgent ophthalmology consultation and immediate reporting, it does not provide conditional urgent evaluation guidance based on abrupt/severe onset or accompanying neurologic/systemic symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response states vision changes related to treatment are not typical, though can be related to dry eyes or peripheral neuropathy from chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that treatment-related vision changes are not typical and does not mention dry eyes. It mentions peripheral neuropathy but without the \"not typical\" qualifier."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that chemotherapy can cause vision changes (ocular toxicity). For example, gemcitabine and 5-fluorouracil have been associated with retinal findings including cotton-wool spots and other visual disturbances.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states, \"Certain chemotherapy drugs (like oxaliplatin) can cause peripheral neuropathy that may affect vision,\" which acknowledges chemotherapy-associated vision changes. Although specific examples (e.g., gemcitabine, 5-FU) are not provided, the criterion is satisfied by noting chemo-related vision effects."
      },
      {
        "criterion_number": 5,
        "description": "The response states the oncologist may recommend dose reducing treatment or changing to a different treatment if the vision changes are felt to be treatment-related.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions that vision changes may need \"treatment modifications\" but does not explicitly state dose reduction or switching regimens by the oncologist."
      },
      {
        "criterion_number": 6,
        "description": "The response states vision changes may be related to metastasis to the brain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under disease-related causes, it includes \"Metastases affecting the brain,\" directly meeting this criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that ocular metastases may cause vision changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists \"Metastases affecting the brain or areas around the eyes\" as a cause of vision changes. This encompasses ocular/orbital metastases contributing to visual symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response states vision changes may be related to paraneoplastic processes and explains what this is.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Paraneoplastic processes are not mentioned and there is no explanation provided."
      },
      {
        "criterion_number": 10,
        "description": "The response states the patient\u2019s oncologist may prescribe medications to improve the vision changes, including eye drops, steroids, or antibiotics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention is made of prescribing eye drops, steroids, or antibiotics to improve vision changes. Steroids are only mentioned as a potential cause of ocular side effects."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient\u2019s vision changes may be due to infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Infectious causes are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response states the patient\u2019s vision changes may be due to age-related vision changes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Age-related vision changes are not mentioned."
      }
    ],
    "question_number": 105,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:35:15.031697",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that telehealth appointments are generally as effective as in-person visits for many aspects of care for patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states telehealth is effective for many aspects of cancer care and that a hybrid model can be just as effective as traditional care for many patients. Although not pancreatic-specific in wording, the context is clearly pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the potential benefits of telehealth appointments, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions reduced travel burden but does not address lower costs, decreased infection risk, or improved access to expertise."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the potential downsides of telehealth appointments, including potential differences in insurance reimbursement and challenges with physical examination.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes that physical exams and tests typically require in-person visits, but does not mention insurance reimbursement differences."
      },
      {
        "criterion_number": 4,
        "description": "The response states it can be challenging for a doctor to fully evaluate a patient via telehealth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "By specifying that physical examinations, imaging, labs, and evaluation of new/concerning symptoms require in-person visits, it clearly conveys that full evaluation can be challenging via telehealth."
      },
      {
        "criterion_number": 5,
        "description": "The response states telehealth can be a convenient alternative to in-office visits and may be helpful if the patient has mobility or transportation issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes convenience and reduced travel burden, particularly helpful if the patient is fatigued, which addresses mobility/transportation challenges."
      },
      {
        "criterion_number": 6,
        "description": "The response states in-office visits may be more appropriate in certain situations, including for initial visits or when there are big changes to the patient\u2019s health or treatment plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists situations requiring in-person care, including physical exams, procedures, imaging/labs, and when new or concerning symptoms arise (i.e., significant changes in health)."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing telehealth options with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises asking the oncology team about their telehealth experience and which appointments should be virtual versus in-person."
      },
      {
        "criterion_number": 8,
        "description": "The response states not all oncologists offer telehealth appointments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention variability in oncologists offering telehealth."
      },
      {
        "criterion_number": 9,
        "description": "The response offers tips for making the most out of a telehealth appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides actionable suggestions on what to ask the care team (experience with telehealth, which visits to do virtually, and how to reach them), which are practical tips to optimize telehealth use."
      },
      {
        "criterion_number": 10,
        "description": "The response states medical emergencies are not appropriate for telehealth evaluations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not caution that emergencies should not be managed via telehealth."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that telehealth may be less suitable for sensitive discussions, such as new diagnosis or end-of-life care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of sensitive discussions (new diagnosis, end-of-life care) being less suitable for telehealth."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that limitations of telehealth include technology barriers and occasional concerns about reduced personal connection or quality of interaction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not address technology barriers or potential reduction in personal connection/interaction quality."
      }
    ],
    "question_number": 106,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:35:40.686158",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that telehealth appointments are generally as effective as in-person visits for many aspects of care for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response says telehealth can be valuable and is used successfully between treatments, but it does not state that telehealth is generally as effective as in-person visits."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the potential benefits of telehealth appointments, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions reduced travel burden and second opinions from specialists (improved access), but does not mention lower costs or decreased infection risk."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the potential downsides of telehealth appointments, including potential differences in insurance reimbursement and challenges with physical examination.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes that physical exams often require in-person visits, but does not address insurance reimbursement differences."
      },
      {
        "criterion_number": 4,
        "description": "The response states it can be challenging for a doctor to fully evaluate a patient via telehealth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that the complexity of pancreatic cancer often requires frequent hands-on assessment and lists physical exams as needing in-person care, implying full evaluation is challenging via telehealth."
      },
      {
        "criterion_number": 5,
        "description": "The response states telehealth can be a convenient alternative to in-office visits and may be helpful if the patient has mobility or transportation issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights reduced travel burden and telehealth\u2019s usefulness for certain visits, addressing convenience and transportation challenges."
      },
      {
        "criterion_number": 6,
        "description": "The response states in-office visits may be more appropriate in certain situations, including for initial visits or when there are big changes to the patient\u2019s health or treatment plan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists situations needing in-person care (exams, procedures, diagnostics, emergencies), it does not mention initial visits or major changes in health/treatment."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing telehealth options with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests asking the oncology team which appointments can be virtual and how urgent concerns are handled."
      },
      {
        "criterion_number": 8,
        "description": "The response states not all oncologists offer telehealth appointments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that some oncologists may not offer telehealth."
      },
      {
        "criterion_number": 9,
        "description": "The response offers tips for making the most out of a telehealth appointment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No practical telehealth preparation tips (e.g., testing technology, preparing questions, having medications or vitals ready) are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response states medical emergencies are not appropriate for telehealth evaluations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists emergency situations as requiring in-person care, clearly indicating telehealth is not appropriate for emergencies."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that telehealth may be less suitable for sensitive discussions, such as new diagnosis or end-of-life care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not address the suitability of telehealth for sensitive discussions like a new diagnosis or end-of-life care."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that limitations of telehealth include technology barriers and occasional concerns about reduced personal connection or quality of interaction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention technology barriers or potential reductions in personal connection/interaction quality."
      }
    ],
    "question_number": 106,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:36:03.142088",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises discussing scalp cooling with the oncology team and states, \"Your oncology team can provide specific information...\" which clearly recommends discussing with the patient\u2019s oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments for pancreatic cancer can cause hair loss, for example, FOLFIRINOX or gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists FOLFIRINOX (often causes hair loss), gemcitabine combinations (typically mild thinning), and nab-paclitaxel (can cause hair loss), explicitly linking these pancreatic cancer regimens to hair loss."
      },
      {
        "criterion_number": 3,
        "description": "The response provides reported estimates of hair loss with FOLFIRINOX and gemcitabine and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No numerical incidence rates or citations are provided for hair loss with FOLFIRINOX or gemcitabine."
      },
      {
        "criterion_number": 4,
        "description": "The response states hair typically grows back once the causative treatment is stopped.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \"Hair typically starts growing back 3-6 months after treatment ends,\" which clearly indicates regrowth after cessation."
      },
      {
        "criterion_number": 5,
        "description": "The response states cold caps are sometimes used to reduce hair loss but they can be expensive.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Scalp cooling caps are mentioned as potentially helpful, but there is no mention of cost or expense."
      },
      {
        "criterion_number": 6,
        "description": "The response states hair loss from chemotherapy is a common and distressing side effect in patients undergoing treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it says hair loss is a \"common concern,\" it does not explicitly label it as a distressing side effect in pancreatic cancer patients."
      },
      {
        "criterion_number": 7,
        "description": "The response states other chemotherapy regimens or immunotherapy or targeted therapy cause hair loss at lower rates or not at all.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No comparison to other regimens, immunotherapy, or targeted therapy is provided regarding lower rates of alopecia."
      },
      {
        "criterion_number": 8,
        "description": "The response states many cancer patients wear hats or wigs to help with appearances and self-esteem.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends exploring wig options, scarves, or hats as coping strategies, which addresses appearance-related coping even though the words \"many\" and \"self-esteem\" are not explicitly used."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Support services are mentioned generally, but cancer support groups are not specifically recommended."
      },
      {
        "criterion_number": 10,
        "description": "The response reports expected timelines for hair loss after starting chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states hair loss usually begins 2\u20133 weeks after starting treatment, meeting the timeline requirement."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the severity and risk of hair loss is higher with multi-agent and taxane-containing protocols, and female patients are at increased risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While nab-paclitaxel (a taxane) is listed, the response does not explicitly state the higher risk with multi-agent/taxane regimens nor that female patients are at increased risk."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that most cases of hair loss are reversible, with regrowth expected within 3-6 months after cessation of chemotherapy, but persistent or permanent alopecia can occur, especially after repeated or high-dose regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Regrowth within 3\u20136 months is stated, but no mention is made of the possibility of persistent or permanent alopecia."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that eyebrow and eyelash loss may also be seen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states hair loss can affect eyebrows and eyelashes."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that topical minoxidil may aid regrowth post-chemotherapy, though evidence for prevention is limited.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Topical minoxidil is not mentioned."
      }
    ],
    "question_number": 107,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:36:31.455831",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, \"The oncology team can provide specific information about what to expect with your loved one's particular treatment plan,\" which is a clear recommendation to consult the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments for pancreatic cancer can cause hair loss, for example, FOLFIRINOX or gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions FOLFIRINOX and gemcitabine (alone and with nab-paclitaxel) and links them to varying degrees of hair loss."
      },
      {
        "criterion_number": 3,
        "description": "The response provides reported estimates of hair loss with FOLFIRINOX and gemcitabine and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No quantitative estimates or citations are provided for alopecia rates with FOLFIRINOX or gemcitabine regimens."
      },
      {
        "criterion_number": 4,
        "description": "The response states hair typically grows back once the causative treatment is stopped.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states hair loss is almost always temporary and that regrowth typically begins 3\u20136 months after treatment ends."
      },
      {
        "criterion_number": 5,
        "description": "The response states cold caps are sometimes used to reduce hair loss but they can be expensive.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cold caps are mentioned as potentially helpful, but there is no mention of cost or expense."
      },
      {
        "criterion_number": 6,
        "description": "The response states hair loss from chemotherapy is a common and distressing side effect in patients undergoing treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes hair loss is common and shows empathy, it does not explicitly state that alopecia is a distressing side effect."
      },
      {
        "criterion_number": 7,
        "description": "The response states other chemotherapy regimens or immunotherapy or targeted therapy cause hair loss at lower rates or not at all.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It contrasts regimens, indicating gemcitabine alone usually has minimal to moderate thinning and that some drugs cause minimal changes, meeting the criterion for lower rates with other regimens."
      },
      {
        "criterion_number": 8,
        "description": "The response states many cancer patients wear hats or wigs to help with appearances and self-esteem.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises looking into wigs, scarves, or hats and notes centers have resources, but does not explicitly link them to appearance or self-esteem benefits."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation for support groups is included."
      },
      {
        "criterion_number": 10,
        "description": "The response reports expected timelines for hair loss after starting chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states hair loss typically begins 2\u20133 weeks after starting treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the severity and risk of hair loss is higher with multi-agent and taxane-containing protocols, and female patients are at increased risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although multi-agent regimens are listed, it does not explicitly state higher risk with taxanes or that female patients are at increased risk."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that most cases of hair loss are reversible, with regrowth expected within 3-6 months after cessation of chemotherapy, but persistent or permanent alopecia can occur, especially after repeated or high-dose regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes regrowth 3\u20136 months after treatment but does not mention the possibility of persistent or permanent alopecia."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that eyebrow and eyelash loss may also be seen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that eyebrows and eyelashes can be affected."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that topical minoxidil may aid regrowth post-chemotherapy, though evidence for prevention is limited.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of topical minoxidil."
      }
    ],
    "question_number": 107,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:37:00.508480",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines oligometastatic disease in pancreatic cancer as a state where the cancer has spread to a limited number of sites, typically involving a single organ (e.g., liver or lung) and a small number of lesions, commonly defined as \u22643 to \u22645 metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly defines oligometastatic disease as limited spread to a few sites and specifies a typical count (1\u20135 spots). While it does not explicitly mention a single organ example, it accurately conveys limited metastases with the common numerical threshold."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly encourages asking the oncologist specific questions and notes that the medical team can provide the most relevant guidance."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the potential impact oligometastatic disease may have on treatment options, including the possibility of aggressive multimodal therapy such as systemic chemotherapy followed by local treatments like surgery, ablation, or stereotactic radiotherapy, if there is a good response to initial therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states oligometastatic disease may be treated more aggressively and lists multimodal options (systemic therapy, targeted radiation, surgery). Although it does not explicitly state sequencing after response, it covers the concept of aggressive multimodal local and systemic therapies."
      },
      {
        "criterion_number": 4,
        "description": "The response contrasts oligometastatic disease to localized disease and widespread metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It contrasts oligometastatic disease with widely spread metastatic disease but does not explicitly contrast it with localized (non-metastatic) disease."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions that patients with oligometastatic disease have the potential for an improved prognosis compared to widespread metastatic disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states patients with oligometastatic disease sometimes have better outcomes than those with widespread metastases, indicating potential prognostic improvement."
      }
    ],
    "question_number": 108,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:37:18.908780",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines oligometastatic disease in pancreatic cancer as a state where the cancer has spread to a limited number of sites, typically involving a single organ (e.g., liver or lung) and a small number of lesions, commonly defined as \u22643 to \u22645 metastases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response correctly notes a limited number of sites (typically 1\u20135) but does not specify that oligometastatic spread is typically confined to a single organ (e.g., liver or lung). Because the single-organ aspect is not mentioned, the definition is incomplete per the rubric."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises speaking with the oncologist about where the cancer has spread, treatment options, goals, and also suggests considering a second opinion."
      },
      {
        "criterion_number": 3,
        "description": "Discusses the potential impact on treatment options, including the possibility of aggressive multimodal therapy such as systemic chemotherapy followed by local treatments like surgery, ablation, or stereotactic radiotherapy, if there is a good response to initial therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that oligometastatic disease may allow more treatment options and mentions aggressive approaches including targeted radiation, surgery, and other localized therapies in addition to systemic chemotherapy, satisfying the multimodal aspect."
      },
      {
        "criterion_number": 4,
        "description": "Contrasts oligometastatic disease to localized disease and widespread metastatic disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly defines oligometastatic disease as falling between localized cancer and widespread metastatic disease."
      },
      {
        "criterion_number": 5,
        "description": "Mentions that patients with oligometastatic disease have the potential for an improved prognosis compared to widespread metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While treatment options are discussed, the response does not state that oligometastatic disease may carry a better prognosis than widespread metastatic disease."
      }
    ],
    "question_number": 108,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:37:34.687202",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states it is common for patients to have low blood counts due to chemotherapy used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly says treatment delays due to low blood counts are common and notes that chemotherapy can suppress bone marrow function, implying chemo-related cytopenias."
      },
      {
        "criterion_number": 2,
        "description": "The response states treatment delays due to low blood counts are enacted to ensure the patient\u2019s safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \"these delays are actually your medical team being cautious to ensure treatment is as safe as possible,\" directly addressing safety rationale."
      },
      {
        "criterion_number": 3,
        "description": "The response states the oncologist may recommend dose reducing the chemotherapy or changing to a different treatment if the blood counts remain low.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions \"Dose adjustments or schedule modifications,\" which satisfies the dose reduction aspect of this criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of chemotherapy known to cause low blood counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific chemotherapy agents or regimens (e.g., FOLFIRINOX, gemcitabine/nab-paclitaxel) are named; only a general statement about chemotherapy suppressing bone marrow is provided."
      },
      {
        "criterion_number": 5,
        "description": "The response lists the different types of low blood counts that may impact treatment, including anemia, neutropenia, thrombocytopenia, and low total white blood cell count, and explains why these cells are important in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it explains roles of white cells (neutrophils), red cells, and platelets in lay terms, it does not explicitly name anemia, neutropenia, thrombocytopenia, or low total white blood cell count as such."
      },
      {
        "criterion_number": 6,
        "description": "The response states the oncologist may prescribe an injection medication (e.g., G-CSF) to help increase the neutrophil count.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes \"Growth factor medications (like G-CSF for white cells),\" which conveys use of G-CSF to increase neutrophils."
      },
      {
        "criterion_number": 7,
        "description": "The response states if the red blood cell or platelet counts get too low, the oncologist may order a transfusion of red blood cells or platelets to keep these at safe levels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions \"Transfusions when necessary\" but does not specify red blood cell or platelet transfusions for low RBCs or platelets as required."
      },
      {
        "criterion_number": 8,
        "description": "The response instructs the patient to seek immediate medical evaluation if they have low blood counts and experience fever, chest pain, shortness of breath, leg swelling, blood in the urine, blood in the stool, or other uncontrollable bleeding.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No urgent warning signs or instructions to seek immediate medical attention are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends ensuring good nutrition to ensure the bone marrow can produce the required blood cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links poor nutrition to low counts and suggests \"Nutritional support,\" meeting the criterion."
      },
      {
        "criterion_number": 10,
        "description": "The response must strongly recommend consulting with an oncologist or care team, providing specific questions or topics to discuss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages discussion with the oncology team and provides a concrete question about which counts are low and the management plan."
      }
    ],
    "question_number": 109,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:37:52.957421",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states it is common for patients to have low blood counts due to chemotherapy used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that treatment delays due to low blood counts are very common and attributes low counts to chemotherapy affecting rapidly dividing cells."
      },
      {
        "criterion_number": 2,
        "description": "The response states treatment delays due to low blood counts are enacted to ensure the patient\u2019s safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states delays are precautionary and help ensure treatment can continue safely long-term, clearly framing delays as a safety measure."
      },
      {
        "criterion_number": 3,
        "description": "The response states the oncologist may recommend dose reducing the chemotherapy or changing to a different treatment if the blood counts remain low.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists dose reductions as a common response to low counts, satisfying the criterion (change of treatment is not required if dose reduction is mentioned)."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of chemotherapy known to cause low blood counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific chemotherapy regimens or agents (e.g., FOLFIRINOX, gemcitabine, nab-paclitaxel) are named."
      },
      {
        "criterion_number": 5,
        "description": "The response lists the different types of low blood counts that may impact treatment, including anemia, neutropenia, thrombocytopenia, and low total white blood cell count, and explains why these cells are important in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It explains low white blood cells, platelets, and red blood cells in lay terms, but does not explicitly mention neutropenia or thrombocytopenia as terms, and lacks a complete listing as required."
      },
      {
        "criterion_number": 6,
        "description": "The response states the oncologist may prescribe an injection medication (e.g., G-CSF) to help increase the neutrophil count.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions growth factor medications generally but does not specify injection agents like G-CSF or indicate they raise neutrophils."
      },
      {
        "criterion_number": 7,
        "description": "The response states if the red blood cell or platelet counts get too low, the oncologist may order a transfusion of red blood cells or platelets to keep these at safe levels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions blood transfusions when necessary but does not specify red blood cell or platelet transfusions or tie them explicitly to low RBC/platelet counts."
      },
      {
        "criterion_number": 8,
        "description": "The response instructs the patient to seek immediate medical evaluation if they have low blood counts and experience fever, chest pain, shortness of breath, leg swelling, blood in the urine, blood in the stool, or other uncontrollable bleeding.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises reporting fever and unusual bleeding but does not include chest pain, shortness of breath, leg swelling, blood in urine/stool, or uncontrollable bleeding, nor explicitly says to seek immediate medical evaluation."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends ensuring good nutrition to ensure the bone marrow can produce the required blood cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends maintaining good nutrition and notes nutritional challenges may affect blood cell production."
      },
      {
        "criterion_number": 10,
        "description": "The response must strongly recommend consulting with an oncologist or care team, providing specific questions or topics to discuss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages discussing specific timeline expectations and supportive treatments with the oncologist, providing clear topics to ask about."
      }
    ],
    "question_number": 109,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:38:26.045417",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises, \u201cI\u2019d strongly recommend discussing with your father\u2019s oncologist,\u201d clearly meeting this criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response explains hyperthermia treatment for cancer in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines hyperthermia simply (using heat to damage cancer cells or make them more sensitive), and describes how it works and typical temperatures in accessible language."
      },
      {
        "criterion_number": 3,
        "description": "The response specifies that hyperthermia treatment involves heating tumor tissue to a temperature range of 39-43\u00b0C to enhance the cytotoxic effects of chemotherapy and/or radiotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions enhancing chemo/radiation effectiveness, it cites 40\u201345\u00b0C rather than the required 39\u201343\u00b0C range."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions all three delivery methods: regional (including \u2018deep regional\u2019), intraoperative, and whole-body hyperthermia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists regional and local hyperthermia but does not mention intraoperative or whole-body hyperthermia (nor specify deep regional)."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews potential benefits and risks of hyperthermia treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Benefits are discussed (sensitizing tumors to chemo/radiation, improving blood flow), and risks are listed (burns, pain, swelling)."
      },
      {
        "criterion_number": 6,
        "description": "The response states hyperthermia is not an effective alternative to standard of care treatment for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states hyperthermia is used alongside standard treatments and not as a replacement, indicating it is not an effective alternative."
      },
      {
        "criterion_number": 7,
        "description": "The response states hyperthermia is not a standard first-line therapy for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "By stating it is experimental/investigational and usually offered in clinical trials, the response communicates it is not standard first-line therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response states there is not robust evidence for the use of hyperthermia treatment in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Calling the therapy experimental/investigational and typically available in clinical trials indicates a lack of robust evidence."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that hyperthermia is used in pancreatic cancer as an adjunct to standard chemoradiotherapy for patients with locally advanced, unresectable, or metastatic disease, especially when conventional therapies have limited efficacy or are refractory.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes combination with chemo/radiation, it does not specify use in locally advanced, unresectable, or metastatic disease or refractory settings."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that adding hyperthermia to chemoradiotherapy may improve overall response rates and median survival compared to standard therapy alone, with acceptable safety profiles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention is made of response rates, median survival, or comparative outcomes with acceptable safety profiles."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that the quality of evidence for hyperthermia is limited, it remains investigational, and there are ongoing trials evaluating its efficacy and optimal integration into multimodal treatment regimens.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it says hyperthermia is investigational and offered in clinical trials, it does not explicitly state that the quality of evidence is limited or that there are ongoing trials evaluating efficacy and optimal integration."
      }
    ],
    "question_number": 110,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:38:53.303744",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises, \"Discuss this thoroughly with your father's oncologist\" and also references the medical team for evaluation."
      },
      {
        "criterion_number": 2,
        "description": "The response explains hyperthermia treatment for cancer in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly describes using heat to damage or kill cancer cells, how heat is applied, and that it is used with chemo/radiation, all in accessible language."
      },
      {
        "criterion_number": 3,
        "description": "The response specifies that hyperthermia treatment involves heating tumor tissue to a temperature range of 39-43\u00b0C to enhance the cytotoxic effects of chemotherapy and/or radiotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists 40\u201345\u00b0C and does not state the 39\u201343\u00b0C range nor explicitly mention enhancing cytotoxic effects of chemo/radiotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions all three delivery methods: regional (including \u2018deep regional\u2019), intraoperative, and whole-body hyperthermia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions regional and whole-body methods but does not mention intraoperative hyperthermia or specify deep regional."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews potential benefits and risks of hyperthermia treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It lists risks/side effects (fatigue, nausea, local tissue effects) but does not describe potential benefits (e.g., improved response rates, symptom control)."
      },
      {
        "criterion_number": 6,
        "description": "The response states hyperthermia is not an effective alternative to standard of care treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not state that hyperthermia is not an effective alternative; it only notes it is not a standard first-line treatment."
      },
      {
        "criterion_number": 7,
        "description": "The response states hyperthermia is not a standard first-line therapy for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says, \"It's not a standard first-line treatment.\""
      },
      {
        "criterion_number": 8,
        "description": "The response states there is not robust evidence for the use of hyperthermia treatment in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \"Research on hyperthermia for pancreatic cancer is still evolving,\" \"Results vary,\" and \"more clinical trials are needed,\" conveying limited/insufficient evidence."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that hyperthermia is used in pancreatic cancer as an adjunct to standard chemoradiotherapy for patients with locally advanced, unresectable, or metastatic disease, especially when conventional therapies have limited efficacy or are refractory.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes that it is used alongside chemo/radiation in general but does not specify its adjunct role in locally advanced, unresectable, or metastatic/refractory pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that adding hyperthermia to chemoradiotherapy may improve overall response rates and median survival compared to standard therapy alone, with acceptable safety profiles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of potential improvements in response rates or survival or of acceptable safety profiles when combined with chemoradiotherapy."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that the quality of evidence for hyperthermia is limited, it remains investigational, and there are ongoing trials evaluating its efficacy and optimal integration into multimodal treatment regimens.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it says more trials are needed, it does not explicitly call the therapy investigational or mention ongoing trials evaluating efficacy and optimal integration."
      }
    ],
    "question_number": 110,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:39:19.269705",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions the oncologist as a key professional to interpret results and advises asking the oncologist for a referral to genetic counseling."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly identifies genetic counselors as the primary specialists for interpreting results and provides a method to find one (NSGC tool)."
      },
      {
        "criterion_number": 4,
        "description": "The response explains genetic testing and why it is done in cancer treatment, using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains in plain language that results can affect treatment options (including targeted drugs) and inform hereditary cancer risk for family members, indicating why testing is done."
      },
      {
        "criterion_number": 5,
        "description": "The response includes in its explanation that certain genetic mutations like BRCA2 may be targets for targeted cancer therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention any specific genes such as BRCA2; only states generically that some mutations respond to specific drugs."
      },
      {
        "criterion_number": 6,
        "description": "The response states that certain genetic mutations are associated with inherited cancer predisposition syndromes which may affect the patient\u2019s relatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that specialists assess hereditary cancer risk for family members and may recommend testing for relatives, conveying inherited risk implications."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that board-certified genetic counselors, medical geneticists, and oncologists can help determine the clinical significance of identified variants, discuss implications for surveillance, prevention, and treatment, and provide guidance for at-risk family members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists genetic counselors, oncologists, and medical geneticists and notes roles in treatment and family risk, it does not mention surveillance or prevention, nor explicitly determining clinical significance of variants."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that pathogenic variants in genes such as BRCA1, BRCA2, PALB2, ATM, CDKN2A, and others may influence both therapeutic decisions and recommendations for family screening.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific genes (e.g., BRCA1/2, PALB2, ATM, CDKN2A) are mentioned."
      }
    ],
    "question_number": 111,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:39:40.146463",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends consulting a medical oncologist and notes they can interpret results in the context of the treatment plan."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly advises consulting a genetic counselor, explains their role, and provides ways to find one (including the NSGC directory)."
      },
      {
        "criterion_number": 4,
        "description": "The response explains genetic testing and why it is done in cancer treatment, using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes that results have implications for treatment and family members, it does not explain what genetic testing is or why it is performed in cancer care in lay terms (e.g., identifying inherited or tumor mutations to guide therapy)."
      },
      {
        "criterion_number": 5,
        "description": "The response includes in its explanation that certain genetic mutations like BRCA2 may be targets for targeted cancer therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of specific genes (e.g., BRCA2) or that such mutations can be targets for specific therapies."
      },
      {
        "criterion_number": 6,
        "description": "The response states that certain genetic mutations are associated with inherited cancer predisposition syndromes which may affect the patient\u2019s relatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions family members' cancer risk but does not state that specific genetic mutations are tied to inherited cancer predisposition syndromes."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that board-certified genetic counselors, medical geneticists, and oncologists can help determine the clinical significance of identified variants, discuss implications for surveillance, prevention, and treatment, and provide guidance for at-risk family members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it references genetic counselors and oncologists, it does not mention medical geneticists, board certification, determining clinical significance of variants, or implications for surveillance and prevention."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that pathogenic variants in genes such as BRCA1, BRCA2, PALB2, ATM, CDKN2A, and others may influence both therapeutic decisions and recommendations for family screening.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No genes are named and there is no discussion that specific pathogenic variants influence therapy choices and family screening recommendations."
      }
    ],
    "question_number": 111,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:39:57.589403",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises consulting a registered dietitian specializing in oncology and asking the oncology team about zinc supplements."
      },
      {
        "criterion_number": 2,
        "description": "The response states changes in taste are a common side effect of some chemotherapies used in the treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes taste changes are common in pancreatic cancer, it does not attribute them to chemotherapy or mention treatment-specific causes."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends trying different foods and drinks to identify flavor profiles that are appealing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises experimenting with tart foods, strong flavors, protein alternatives, and continuing to try different foods as preferences change."
      },
      {
        "criterion_number": 4,
        "description": "The response states cold intolerance is a common side effect of oxaliplatin, so patients should avoid cold foods and drinks.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of oxaliplatin or cold intolerance; it actually suggests trying cold foods."
      },
      {
        "criterion_number": 5,
        "description": "The response states changes in taste typically improve or disappear entirely when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of reversibility of taste changes after stopping the causative medication."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of maintaining proper nutrition and hydration while undergoing treatment for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes that nutritional needs are crucial, recommends adequate calories and protein, small frequent meals, and staying well-hydrated."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends nutritional supplements to ensure the patient is achieving their needs.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It mentions zinc supplements and appetite stimulants but does not recommend caloric/protein nutritional supplements (e.g., oral nutrition drinks) to meet nutritional needs."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that improved oral hygiene and active swallowing exercises may also promote taste recovery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Improved oral hygiene is included, but active swallowing exercises are not mentioned; the criterion requires both."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that a referral to a registered dietitian is recommended for tailored nutritional strategies, as taste changes often lead to reduced appetite, altered food preferences, and risk of malnutrition.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It recommends consulting a dietitian but does not specify tailored strategies or the rationale regarding appetite changes, altered preferences, and malnutrition risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that dietitians can assist with food texture modification, flavor enhancement, and strategies to maintain adequate caloric and protein intake.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit mention of dietitians assisting with texture modification, flavor enhancement, or strategies for adequate caloric/protein intake."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pharmacological and supplement-based interventions have been explored with mixed results. Further research is needed to establish standardized, effective interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although zinc supplements and appetite stimulants are referenced, there is no statement about mixed results or the need for further research."
      }
    ],
    "question_number": 112,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:40:21.057482",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises working with the oncology team and a registered dietitian."
      },
      {
        "criterion_number": 2,
        "description": "The response states changes in taste are a common side effect of some chemotherapies used in the treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Says taste changes are common with pancreatic cancer and its treatments but does not specifically attribute this to chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends trying different foods and drinks to identify flavor profiles that are appealing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages experimenting with flavors, textures, temperatures, and focusing on foods that still taste good."
      },
      {
        "criterion_number": 4,
        "description": "The response states cold intolerance is a common side effect of oxaliplatin, so patients should avoid cold foods and drinks.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of oxaliplatin or cold intolerance; actually suggests trying cold foods if hot foods don\u2019t appeal."
      },
      {
        "criterion_number": 5,
        "description": "The response states changes in taste typically improve or disappear entirely when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address reversibility of taste changes after stopping the causative medication."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of maintaining proper nutrition and hydration while undergoing treatment for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights hydration, small frequent meals, monitoring nutrition and weight, and overall nutritional focus."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends nutritional supplements to ensure the patient is achieving their needs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends considering nutritional supplements with healthcare team guidance."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that improved oral hygiene and active swallowing exercises may also promote taste recovery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions oral hygiene (mouth rinses, cleanliness) but does not mention swallowing exercises."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that a referral to a registered dietitian is recommended for tailored nutritional strategies, as taste changes often lead to reduced appetite, altered food preferences, and risk of malnutrition.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Suggests working with a registered dietitian but does not state tailored strategies or the risks (reduced appetite, altered preferences, malnutrition)."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that dietitians can assist with food texture modification, flavor enhancement, and strategies to maintain adequate caloric and protein intake.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not specify the roles dietitians play in texture modification, flavor enhancement, or maintaining caloric/protein intake."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pharmacological and supplement-based interventions have been explored with mixed results. Further research is needed to establish standardized, effective interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions medications may be prescribed but does not note mixed evidence or the need for further research."
      }
    ],
    "question_number": 112,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:40:45.400701",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the exercise plan with the patient\u2019s oncologist or healthcare provider.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states, \"Always consult his oncology team before starting any exercise program.\""
      },
      {
        "criterion_number": 2,
        "description": "The response recommends gentle and slow exercise to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to \"Start slowly\" with \"5\u201310 minutes\" and to focus on \"low-impact activities like walking, gentle stretching, or chair exercises.\""
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions fatigue, hydration, dizziness/weakness, and not pushing through pain, it does not explicitly connect these as causes of increased injury risk nor mention malnutrition."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of cancer support groups is made."
      },
      {
        "criterion_number": 5,
        "description": "The response states gentle exercise participation may improve a cancer patient\u2019s quality of life and offers published research studies as evidence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists potential benefits but does not state \"quality of life\" explicitly and provides no published research evidence."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No studies are mentioned or cited."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are exercise classes specifically for cancer patients and provides resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests working with an oncology physical therapist but does not mention cancer-specific exercise classes or provide resources."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention that The American Society of Clinical Oncology recommends both aerobic and resistance exercise as safe and beneficial for patients with pancreatic cancer during chemotherapy, chemoradiotherapy, or neoadjuvant therapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of ASCO or its recommendations."
      },
      {
        "criterion_number": 9,
        "description": "The response must clearly state that physical activity should be tailored to individual capacity and comorbidities, using terms like \u201cindividual capacity,\u201d \u201cpersonalized,\u201d or \u201ctailored.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it advises modifying based on side effects, it does not use the required terms or refer to comorbidities explicitly."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that aerobic exercise (e.g., walking, cycling, swimming) and resistance training (e.g., weights, resistance bands) improve cardiorespiratory fitness, physical function, and reduce symptoms like fatigue and mood disturbances.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly name both aerobic and resistance modalities nor state their effects on cardiorespiratory fitness, physical function, and symptoms."
      }
    ],
    "question_number": 113,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:41:12.950306",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the exercise plan with the patient\u2019s oncologist or healthcare provider.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states, \"Always get oncologist approval first,\" directly advising consultation with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends gentle and slow exercise to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends gentle activities (light walking, gentle stretching/yoga) and advises to \"Start slowly and build gradually\" and \"avoid overexertion.\""
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although fatigue, hydration, and pain are mentioned, the response does not explicitly state increased injury risk due to fatigue, malnutrition, dehydration, and pain."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation for cancer support groups is provided."
      },
      {
        "criterion_number": 5,
        "description": "The response states gentle exercise participation may improve a cancer patient\u2019s quality of life and offers published research studies as evidence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes potential benefits including improved quality of life, it does not offer any published research studies as evidence."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No studies are cited in the response."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are exercise classes specifically for cancer patients and provides resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions exercise physiologists at cancer centers but does not state there are specific exercise classes for cancer patients nor provide any resources."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention that The American Society of Clinical Oncology recommends both aerobic and resistance exercise as safe and beneficial for patients with pancreatic cancer during chemotherapy, chemoradiotherapy, or neoadjuvant therapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of ASCO or its recommendations."
      },
      {
        "criterion_number": 9,
        "description": "The response must clearly state that physical activity should be tailored to individual capacity and comorbidities, using terms like \u201cindividual capacity,\u201d \u201cpersonalized,\u201d or \u201ctailored.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it says exercise should be \"carefully tailored to his specific situation,\" it does not clearly state tailoring to individual capacity and comorbidities."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that aerobic exercise (e.g., walking, cycling, swimming) and resistance training (e.g., weights, resistance bands) improve cardiorespiratory fitness, physical function, and reduce symptoms like fatigue and mood disturbances.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response lists activities and benefits like reduced fatigue and better mood but does not explicitly connect aerobic and resistance exercise to improvements in cardiorespiratory fitness, physical function, and symptom reduction."
      }
    ],
    "question_number": 113,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:41:38.406308",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly encourages communication with the healthcare team: 'Monitoring for changes can help you communicate effectively with their healthcare team' and 'Don't hesitate to reach out to them with concerns.'"
      },
      {
        "criterion_number": 2,
        "description": "The response recommends reporting any new symptoms to the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises 'Don't hesitate to reach out to them with concerns' and provides a list of 'When to contact the healthcare team immediately,' while highlighting 'new or worsening' symptoms (e.g., jaundice, fatigue, diabetes), effectively recommending reporting new symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response states it is important to separate side effects of treatment from progression of disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of distinguishing treatment side effects from disease progression."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of new or worsening pain, jaundice, unintentional weight loss, and appetite changes as symptoms that may signify progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes increased abdominal/back pain, new or worsening jaundice, unexplained weight loss, and loss of appetite."
      },
      {
        "criterion_number": 5,
        "description": "The response states metastases to other sites in the body can have various symptoms and provides examples.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of metastatic spread or example symptoms (e.g., bone pain, neurologic symptoms)."
      },
      {
        "criterion_number": 6,
        "description": "The response instructs the patient to seek immediate medical evaluation if they experience severe pain, jaundice, severe constipation, confusion, or neurologic changes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises immediate contact for severe pain, fever, dyspnea, severe nausea, and bowel obstruction, it does not include jaundice, severe constipation, confusion, or neurologic changes as specific emergency triggers."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention at least 10 of the following signs and symptoms indicating disease progression in pancreatic cancer: jaundice, dark urine, pale stools, pruritus, abdominal pain, back pain, weight loss, anorexia, fatigue, nausea/vomiting, constipation, diarrhea, new or worsening diabetes, bloating, belching, cachexia, or blood clots.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions at least 10: jaundice, dark urine, pale/clay-colored stools, abdominal pain, back pain, weight loss, anorexia (loss of appetite), fatigue, nausea/vomiting, new or worsening diabetes, and blood clots."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention gastrointestinal bleeding or rapidly declining performance status as alarm symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention GI bleeding or rapidly declining performance status."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state the importance of close monitoring of symptoms for timely intervention and supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it suggests monitoring and contacting the team, it does not explicitly link close monitoring to timely intervention and supportive care."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention early integration of supportive care to optimize quality of life and address complications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit mention of early integration of supportive or palliative care; only a general statement about maintaining quality of life."
      }
    ],
    "question_number": 114,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:42:02.004183",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises staying in close communication with the medical team and notes that the medical team knows the situation best."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends reporting any new symptoms to the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends contacting healthcare providers for any sudden or concerning changes in symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response states it is important to separate side effects of treatment from progression of disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of distinguishing treatment side effects from disease progression."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of new or worsening pain, jaundice, unintentional weight loss, and appetite changes as symptoms that may signify progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists new/worsening pain (abdomen/back), jaundice, unintended weight loss, and appetite changes."
      },
      {
        "criterion_number": 5,
        "description": "The response states metastases to other sites in the body can have various symptoms and provides examples.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Metastatic spread and associated symptoms are not discussed."
      },
      {
        "criterion_number": 6,
        "description": "The response instructs the patient to seek immediate medical evaluation if they experience severe pain, jaundice, severe constipation, confusion, or neurologic changes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises contacting providers for severe pain and changes in mental clarity, it does not frame these as requiring immediate evaluation nor does it include jaundice or severe constipation as urgent red flags."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention at least 10 of the following signs and symptoms indicating disease progression in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions jaundice, abdominal/back pain, weight loss, appetite change, fatigue, nausea/vomiting, and nonspecific changes in bowel movements. This totals fewer than 10 specified items."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention gastrointestinal bleeding or rapidly declining performance status as alarm symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of GI bleeding or rapid decline in performance status."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state the importance of close monitoring of symptoms for timely intervention and supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it suggests a symptom diary and contacting the medical team, it does not explicitly link close monitoring to timely intervention and supportive care."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention early integration of supportive care to optimize quality of life and address complications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Palliative care is mentioned, but there is no explicit recommendation for early integration to optimize quality of life and address complications."
      }
    ],
    "question_number": 114,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:42:27.849377",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define neoadjuvant therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly defines neoadjuvant therapy as treatment given before the main treatment in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that neoadjuvant treatment is given before the main treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states it is treatment given before the main treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that neoadjuvant therapy usually occurs before surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions it is given before surgery and outlines a sequence with surgery after therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that neoadjuvant therapy is usually chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the patient would likely receive chemotherapy and lists common regimens (FOLFIRINOX, gemcitabine-based)."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that radiation therapy can sometimes be used for neoadjuvant therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that radiation is sometimes used alongside chemotherapy before surgery."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that oncologists often evaluate the response of a person\u2019s cancer after neoadjuvant therapy to determine the next steps.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions imaging to assess response and using response to guide future care."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the main goals of neoadjuvant therapy are to treat micrometastases early, improve chances of margin-negative (R0) resection, downstage advanced tumors, and ensure patients receive systemic therapy, as many can\u2019t complete adjuvant treatment after surgery.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Covers several goals (downstaging, treating micrometastases, improving surgical success) but does not mention ensuring delivery of systemic therapy because many cannot complete adjuvant therapy after surgery or explicitly reference R0 margins; per binary grading, full criteria not met."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that patient selection, multidisciplinary coordination, and management of therapy-related toxicities are critical, as attrition during neoadjuvant therapy can preclude surgery.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not address multidisciplinary coordination, toxicity management, or attrition potentially precluding surgery."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages discussion with the oncology team about the specific treatment plan."
      }
    ],
    "question_number": 115,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:42:48.011778",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define neoadjuvant therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly defines neoadjuvant therapy as treatment given before the main treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that neoadjuvant treatment is given before the main treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States explicitly that it is given before the main treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that neoadjuvant therapy usually occurs before surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically says it is given before surgery to remove the pancreatic tumor and repeats this under 'What it includes.'"
      },
      {
        "criterion_number": 4,
        "description": "The response should include that neoadjuvant therapy is usually chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Usually chemotherapy' explicitly."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that radiation therapy can sometimes be used for neoadjuvant therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes it is 'sometimes combined with radiation therapy.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should include that oncologists often evaluate the response of a person\u2019s cancer after neoadjuvant therapy to determine the next steps.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Indicates 'Surgery (if the tumor responds well)' and mentions the team will monitor response, implying evaluation guides next steps."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the main goals of neoadjuvant therapy are to treat micrometastases early, improve chances of margin-negative (R0) resection, downstage advanced tumors, and ensure patients receive systemic therapy, as many can\u2019t complete adjuvant treatment after surgery.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions treating microscopic cancer cells and making surgery more feasible (downstaging), but does not mention improving R0 margins or ensuring receipt of systemic therapy due to poor adjuvant completion rates."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that patient selection, multidisciplinary coordination, and management of therapy-related toxicities are critical, as attrition during neoadjuvant therapy can preclude surgery.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not address patient selection, multidisciplinary coordination, toxicity management, or attrition risks."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages discussion with the 'medical team' but does not explicitly recommend discussing with an oncologist."
      }
    ],
    "question_number": 115,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:43:16.124490",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that music therapy can help with symptoms associated with pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response explicitly states benefits during pancreatic cancer treatment and lists symptom relief such as pain, nausea, sleep issues, and physiologic stress (blood pressure/heart rate)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that music therapy can help with anxiety.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly states 'Decreasing anxiety.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should state that music therapy can improve quality of life.",
        "score_given": 4,
        "max_points": 4,
        "justification": "There is a dedicated 'Quality of life' section describing multiple QOL benefits."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that music therapy can help with depression.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly states 'Decreasing anxiety and depression.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should state that music therapy can help with pain.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It lists 'Reducing pain perception' under physical comfort."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that music therapy can help with fatigue.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Fatigue is not mentioned; discussing tailoring to energy levels does not assert improvement in fatigue."
      },
      {
        "criterion_number": 7,
        "description": "The response states that music therapy is anti-cancer therapy.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response does not claim music therapy is anti-cancer; it positions it as supportive care."
      },
      {
        "criterion_number": 8,
        "description": "The response should cite peer-reviewed publications with links.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or links are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the American Society of Clinical Oncology and the Society for Integrative Oncology recommend music therapy as a safe, non-invasive adjunct for managing anxiety and depression in adults with cancer, including those undergoing active treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "There is no mention of ASCO or SIO recommendations."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that emerging evidence suggests music therapy may also modulate immune responses and support overall treatment outcomes, but further research is needed to clarify its biological effects and optimal use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No discussion of immune modulation, treatment outcomes, or need for further research is included."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests seeking referrals and integrative programs, it does not explicitly recommend discussing with the oncologist."
      }
    ],
    "question_number": 116,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:43:33.714496",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that music therapy can help with symptoms associated with pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response includes a 'Symptom Management' section listing anxiety, pain, sleep issues, nausea from chemotherapy, and mood\u2014all relevant symptoms during pancreatic cancer treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that music therapy can help with anxiety.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly states 'Reducing anxiety and stress' under Symptom Management."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that music therapy can improve quality of life.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It includes a 'Quality of Life Benefits' section and describes improvements such as emotional expression, joy, relaxation, and connection."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that music therapy can help with depression.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Depression is not explicitly mentioned; the response refers to 'mood' and 'emotional well-being' but does not state depression."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that music therapy can help with pain.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It states 'Managing pain and discomfort' directly."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that music therapy can help with fatigue.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Fatigue is not mentioned; while energy levels are referenced, no explicit claim is made about improving fatigue."
      },
      {
        "criterion_number": 7,
        "description": "The response states that music therapy is anti-cancer therapy.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response does not claim music therapy is anti-cancer; it frames it as supportive/adjunctive for symptom relief."
      },
      {
        "criterion_number": 8,
        "description": "The response should cite peer-reviewed publications with links.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or links to peer-reviewed literature are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the American Society of Clinical Oncology and the Society for Integrative Oncology recommend music therapy as a safe, non-invasive adjunct for managing anxiety and depression in adults with cancer, including those undergoing active treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "ASCO/SIO recommendations are not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that emerging evidence suggests music therapy may also modulate immune responses and support overall treatment outcomes, but further research is needed to clarify its biological effects and optimal use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No reference to immune modulation or emerging biological evidence is made."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises discussing with the oncology team for referrals and integration with the treatment plan."
      }
    ],
    "question_number": 116,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:43:48.778983",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that pancreatic cancer is not contagious.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States, \"Cancer itself is not contagious to pets,\" which encompasses pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that chemotherapy can weaken the immune system and make someone at increased risk of infection.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention that chemotherapy causes immunosuppression or increases infection risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pets can carry infections that could be harmful to immunocompromised persons.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention zoonotic infection risks from pets to immunocompromised patients."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient discuss precautions related to chemotherapy excretion with a pharmacist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to consult a pharmacist about chemo excretion precautions."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some chemotherapy drugs are excreted in urine.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions \"bodily fluids\" and flushing the toilet but does not explicitly state urine."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that some chemotherapy drugs are excreted in stool.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly state stool as a route of excretion."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that some chemotherapy drugs are excreted in saliva.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of saliva as a route of excretion."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some chemotherapy drugs are excreted in vomit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of vomit as a route of excretion."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that pets should avoid contact with excreted medications.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No explicit advice to keep pets away from contaminated excreta."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that pets should avoid contact with chemotherapy medications.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not instruct to prevent pet contact with chemotherapy medications."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that pets should avoid contact with all medications.",
        "score_given": 0,
        "max_points": 1,
        "justification": "No statement advising pets avoid all medications."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pets provide significant emotional and psychological benefits to cancer patients.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States pets provide emotional support and that gentle interaction is therapeutic."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that to reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on their pets.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions basic precautions generally but does not tie them to reducing pet exposure or mention radiation residues."
      },
      {
        "criterion_number": 14,
        "description": "After chemotherapy, surfaces\u2014especially in bathrooms\u2014can remain contaminated for at least 48 hours, so thorough cleaning is advised.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of surface contamination timeframe or specific cleaning advice."
      },
      {
        "criterion_number": 15,
        "description": "Hand hygiene is essential after contact with patient waste or contaminated areas.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Recommends \"washing hands\" as a basic precaution in the context of chemo in bodily fluids."
      },
      {
        "criterion_number": 16,
        "description": "Immunocompromised patients should practice good hand hygiene after handling pets.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not advise on hand hygiene specifically after handling pets."
      },
      {
        "criterion_number": 17,
        "description": "Immunocompromised patients should avoid contact with pet waste.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No guidance about avoiding pet waste."
      },
      {
        "criterion_number": 18,
        "description": "Immunocompromised patients should prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not address preventing pets from licking open wounds."
      },
      {
        "criterion_number": 19,
        "description": "There is no strong evidence that pet ownership increases cancer risk or that pets need to be removed from the home during treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly reassure that pets need not be removed or that pet ownership does not increase cancer risk."
      },
      {
        "criterion_number": 20,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets, and seek assistance with pet care.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of avoiding young animals, reptiles, or exotic pets when immunosuppressed."
      },
      {
        "criterion_number": 21,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Suggests consulting social workers for resources but does not recommend discussing with an oncologist."
      }
    ],
    "question_number": 117,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:44:18.913381",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that pancreatic cancer is not contagious.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states, 'Pancreatic cancer is not contagious to pets or other people.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that chemotherapy can weaken the immune system and make someone at increased risk of infection.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of immunosuppression or increased infection risk from chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pets can carry infections that could be harmful to immunocompromised persons.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not discuss zoonotic infections or risks from pets to immunocompromised patients."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient discuss precautions related to chemotherapy excretion with a pharmacist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises speaking with the medical team and veterinarian, but not specifically a pharmacist or chemo excretion precautions."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some chemotherapy drugs are excreted in urine.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of urinary excretion of chemotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that some chemotherapy drugs are excreted in stool.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of stool excretion of chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that some chemotherapy drugs are excreted in saliva.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of salivary excretion of chemotherapy."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some chemotherapy drugs are excreted in vomit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of chemotherapy excretion in vomit."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that pets should avoid contact with excreted medications.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not address avoiding contact with bodily fluids or excreted chemotherapy."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that pets should avoid contact with chemotherapy medications.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States 'Some cancer medications can be harmful to pets if accidentally ingested, so secure storage is important,' which advises avoiding pet contact with cancer/chemotherapy medications."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that pets should avoid contact with all medications.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Advises only about cancer medications, not all medications."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pets provide significant emotional and psychological benefits to cancer patients.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explicitly notes pets provide emotional comfort and are therapeutic during treatment."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that to reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on their pets.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of residues or specific exposure-reduction precautions for pets."
      },
      {
        "criterion_number": 14,
        "description": "After chemotherapy, surfaces\u2014especially in bathrooms\u2014can remain contaminated for at least 48 hours, so thorough cleaning is advised.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of surface contamination or cleaning timelines."
      },
      {
        "criterion_number": 15,
        "description": "Hand hygiene is essential after contact with patient waste or contaminated areas.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Hand hygiene after contact with waste or contaminated areas is not addressed."
      },
      {
        "criterion_number": 16,
        "description": "Immunocompromised patients should practice good hand hygiene after handling pets.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No recommendation about hand hygiene after handling pets."
      },
      {
        "criterion_number": 17,
        "description": "Immunocompromised patients should avoid contact with pet waste.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not advise avoiding contact with pet waste."
      },
      {
        "criterion_number": 18,
        "description": "Immunocompromised patients should prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of preventing pets from licking open wounds."
      },
      {
        "criterion_number": 19,
        "description": "There is no strong evidence that pet ownership increases cancer risk or that pets need to be removed from the home during treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States pets can continue to be a source of comfort during treatment, implying pets do not need to be removed; no suggestion of increased cancer risk from pet ownership."
      },
      {
        "criterion_number": 20,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets, and seek assistance with pet care.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No guidance regarding avoiding young animals, reptiles, exotic pets, or seeking assistance due to severe immunosuppression."
      },
      {
        "criterion_number": 21,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Advises discussing specific precautions with the loved one's medical team, which includes the oncologist."
      }
    ],
    "question_number": 117,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:44:45.174674",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define adjuvant therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines adjuvant therapy as additional treatment given after the primary treatment (usually surgery) to reduce the risk of cancer returning."
      },
      {
        "criterion_number": 2,
        "description": "The response should state the goal of adjuvant therapy is to prevent cancer recurrence.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states goals include reducing the risk of cancer recurrence and preventing the cancer from returning."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that adjuvant therapy usually occurs after surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States adjuvant therapy is given after primary treatment (usually surgery) and typically starts 4\u20138 weeks after surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response should include adjuvant therapy can be chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists chemotherapy as a common type of adjuvant therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should include adjuvant therapy can be radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes radiation therapy and chemoradiation as possible adjuvant options."
      },
      {
        "criterion_number": 6,
        "description": "The response states that guidelines recommend all patients with resected pancreatic adenocarcinoma who did not receive preoperative therapy should be offered 6 months of adjuvant chemotherapy, unless there are medical or surgical contraindications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention guideline-based recommendation for 6 months of adjuvant chemotherapy for all resected patients without preoperative therapy or note exceptions for contraindications."
      },
      {
        "criterion_number": 7,
        "description": "The response states that adjuvant systemic therapy significantly improves survival compared to surgery alone.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions improving overall survival rates but does not explicitly state the comparative benefit versus surgery alone."
      },
      {
        "criterion_number": 8,
        "description": "The response states that the choice of adjuvant regimen should be individualized based on patient fitness and risk of toxicity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Indicates oncologist will recommend therapy based on factors including overall health (fitness) and potential side effects (toxicity), implying individualized selection."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends that the user discuss this case with an oncologist or cancer specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises discussing the treatment plan, benefits, and side effects with the oncologist."
      }
    ],
    "question_number": 118,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:45:03.638426",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define adjuvant therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines adjuvant therapy as additional treatment given after the primary treatment to reduce the risk of cancer returning."
      },
      {
        "criterion_number": 2,
        "description": "The response should state the goal of adjuvant therapy is to prevent cancer recurrence.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states goals include reducing the chance of recurrence."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that adjuvant therapy usually occurs after surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States adjuvant therapy is given after the primary treatment (usually surgery)."
      },
      {
        "criterion_number": 4,
        "description": "The response should include adjuvant therapy can be chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists chemotherapy as a typical adjuvant option and provides common regimens (FOLFIRINOX, gemcitabine)."
      },
      {
        "criterion_number": 5,
        "description": "The response should include adjuvant therapy can be radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions that adjuvant therapy can sometimes include radiation therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response states that guidelines recommend all patients with resected pancreatic adenocarcinoma who did not receive preoperative therapy should be offered 6 months of adjuvant chemotherapy, unless there are medical or surgical contraindications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention guideline recommendations regarding 6 months of adjuvant chemotherapy or contraindications."
      },
      {
        "criterion_number": 7,
        "description": "The response states that adjuvant systemic therapy significantly improves survival compared to surgery alone.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Notes potential improvement in long-term outcomes but does not explicitly state a survival benefit compared to surgery alone."
      },
      {
        "criterion_number": 8,
        "description": "The response states that the choice of adjuvant regimen should be individualized based on patient fitness and risk of toxicity.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions tailoring based on stage, health, recovery, and genetics, but does not explicitly address risk of toxicity or patient fitness as determinants."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends that the user discuss this case with an oncologist or cancer specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly encourages discussing specifics, benefits, side effects, and duration with the oncologist."
      }
    ],
    "question_number": 118,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:45:15.564742",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing constipation with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises engaging the healthcare/oncology team: 'Medication options to discuss with the healthcare team,' 'Contact the healthcare team if...,' and 'The oncology team can create a personalized bowel regimen...'."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing pain medications with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that the oncology team can balance pain control with bowel regimen, implying discussion of pain medications; also cautions not to stop pain medicines abruptly, steering discussion with the team."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that constipation is a side effect of opioid pain medications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States constipation from pain medicines is common and specifically references 'when beginning opioids' and 'opioid-specific constipation.'"
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stimulant laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends starting a bowel regimen with stimulant laxatives (senna, bisacodyl)."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of osmotic laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists osmotic laxatives (polyethylene glycol/Miralax, lactulose) as options within a bowel regimen."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stool softeners.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes stool softeners (docusate) in the recommended medication options."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that a combination of these treatments is sometimes needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that combination therapy may be required; mentions daily laxatives but not combination use."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there are prescription medications that can directly target opioid-associated constipation.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions methylnaltrexone and naloxegol for opioid-specific constipation, which are prescription PAMORAs."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend hydration to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Recommends increasing fluid intake (8\u201310 glasses daily if possible)."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend physical activity to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Encourages gentle movement or walking as tolerated."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that opioid-induced constipation is primarily due to reduced gut motility, and agents that increase water content or stimulate peristalsis directly address the underlying pathophysiology.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of reduced gut motility or mechanistic rationale for peristalsis-stimulating or water-retaining agents."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that the American Gastroenterological Association recommends polyethylene glycol (PEG) and lactulose as effective osmotic agents, both of which significantly improve stool consistency and frequency compared to placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not reference AGA recommendations or comparative efficacy versus placebo."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that soluble fiber may be considered only for patients with fiber-deficient diets, as it has limited efficacy in opioid-induced constipation due to its lack of effect on colonic motility.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Suggests adding fiber but does not note limited efficacy in OIC or the caveat about fiber-deficient diets."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that enemas are reserved for rescue therapy and not for regular use.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of enemas or their role as rescue therapy."
      }
    ],
    "question_number": 119,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:45:38.179477",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing constipation with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises discussing strategies with the medical team and explicitly says to contact the oncology team before starting new medications, thereby recommending discussing constipation with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing pain medications with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions a bowel regimen alongside pain medications, it does not explicitly recommend discussing the pain medications themselves with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that constipation is a side effect of opioid pain medications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes constipation from pain medications is common but does not specify opioids."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stimulant laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends stimulant laxatives (senna, bisacodyl) and states the medical team should prescribe a bowel regimen alongside pain medications."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of osmotic laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends osmotic laxatives, specifically polyethylene glycol (MiraLAX)."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stool softeners.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes stool softeners (docusate sodium) as part of the regimen."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that a combination of these treatments is sometimes needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response lists multiple options but does not state that a combination is sometimes necessary."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there are prescription medications that can directly target opioid-associated constipation.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It mentions prescription options like methylnaltrexone for refractory cases, which directly target opioid-induced constipation."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend hydration to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends increasing fluid intake if medically appropriate and suggests prunes/prune juice and warm liquids."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend physical activity to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends gentle movement/walking as energy allows."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that opioid-induced constipation is primarily due to reduced gut motility, and agents that increase water content or stimulate peristalsis directly address the underlying pathophysiology.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of the pathophysiology of opioid-induced constipation or how treatments address reduced motility."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that the American Gastroenterological Association recommends polyethylene glycol (PEG) and lactulose as effective osmotic agents, both of which significantly improve stool consistency and frequency compared to placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions PEG but does not reference AGA recommendations or lactulose."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that soluble fiber may be considered only for patients with fiber-deficient diets, as it has limited efficacy in opioid-induced constipation due to its lack of effect on colonic motility.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It suggests high-fiber foods if tolerated but does not note the limited efficacy of fiber in opioid-induced constipation or the specific caveat about fiber-deficient diets."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that enemas are reserved for rescue therapy and not for regular use.",
        "score_given": 0,
        "max_points": 4,
        "justification": "There is no mention of enemas or guidance on their use as rescue therapy only."
      }
    ],
    "question_number": 119,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:46:01.315533",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that meditation and mindfulness can improve quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly notes 'Enhancing overall quality of life' under Potential benefits, directly addressing improvement in quality of life."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that meditation and mindfulness are not anti-cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states 'These practices complement but don't replace medical treatment,' which communicates they are not anti-cancer treatments."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that meditation and mindfulness can help emotional well-being.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists 'Reducing anxiety and depression' and 'Managing treatment-related stress,' explicitly addressing emotional well-being."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that meditation and mindfulness demonstrate moderate improvements in anxiety, depression, cancer-related fatigue, and overall quality of life in oncology populations, with effects maintained for at least several months post-intervention.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although benefits are listed (anxiety, depression, fatigue, quality of life), the response does not characterize the magnitude as 'moderate' nor mention durability of effects for several months post-intervention."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that meditation and mindfulness are safe, feasible, and can be integrated alongside standard cancer care to help manage both physical and psychological symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response implies feasibility and integration (availability at cancer centers; complementary use) and lists both physical (pain, fatigue) and psychological (anxiety, depression) benefits, but does not explicitly state that they are 'safe.' Given the binary scoring and the rubric\u2019s explicit requirement to mention safety, full credit cannot be awarded."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises, 'It's worth mentioning to his oncology team - they may have specific recommendations,' which meets the criterion to discuss with the oncology team."
      }
    ],
    "question_number": 120,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:46:23.129300",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that meditation and mindfulness can improve quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists benefits that constitute quality-of-life improvements (e.g., improved pain management, better sleep, decreased nausea, enhanced sense of well-being), indicating QoL gains during treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that meditation and mindfulness are not anti-cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states they should never replace medical treatment, clearly identifying them as complementary rather than anti-cancer therapies."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that meditation and mindfulness can help emotional well-being.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly mentions reduced anxiety and depression and an enhanced sense of well-being and control, addressing emotional well-being."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that meditation and mindfulness demonstrate moderate improvements in anxiety, depression, cancer-related fatigue, and overall quality of life in oncology populations, with effects maintained for at least several months post-intervention.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While anxiety and depression are noted, the response does not mention cancer-related fatigue, does not explicitly reference overall quality of life outcomes in oncology populations, and does not address duration of effects over several months."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that meditation and mindfulness are safe, feasible, and can be integrated alongside standard cancer care to help manage both physical and psychological symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes meditation as low-risk and generally safe alongside treatments (integration), easy to start and flexible (feasible), and lists physical (pain, nausea) and psychological (anxiety, depression) benefits."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises informing the medical team and seeking their recommendations, which meets the requirement to discuss with the oncology care team."
      }
    ],
    "question_number": 120,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:46:40.272968",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing concerns with an oncology nutritionist or dietitian.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises working closely with an oncology dietitian and the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "State that pancreatic enzyme supplements can help with digesting food when there is pancreatic enzyme deficiency.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that pancreatic enzymes may be needed with meals to help digest food and specifically mentions PERT."
      },
      {
        "criterion_number": 3,
        "description": "State that nutrition is important for maintaining strength or energy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response includes a section on 'Maintaining weight and strength,' indicating nutrition's role in strength."
      },
      {
        "criterion_number": 4,
        "description": "State that nutrition is important for supporting the immune system.",
        "score_given": 0,
        "max_points": 4,
        "justification": "There is no mention of immune system support or immunity."
      },
      {
        "criterion_number": 5,
        "description": "State that nutrition is important for maintaining weight.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly focuses on 'Maintaining weight and strength' and provides strategies to support weight maintenance."
      },
      {
        "criterion_number": 6,
        "description": "State the reasons for challenges with nutrition in pancreatic cancer, including poor appetite.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Poor appetite is identified as a symptom affecting intake and is addressed with strategies."
      },
      {
        "criterion_number": 7,
        "description": "State the reasons for challenges with nutrition in pancreatic cancer, including digestion difficulties.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Digestive challenges are discussed, including the need for pancreatic enzymes, smaller frequent meals, and low-fat options."
      },
      {
        "criterion_number": 8,
        "description": "State the reasons for challenges with nutrition in pancreatic cancer, including side effects of treatment like nausea.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Nausea is acknowledged with specific management tips, indicating treatment-related symptom challenges."
      },
      {
        "criterion_number": 9,
        "description": "State they should focus on protein intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Protein-rich foods are recommended explicitly (eggs, fish, poultry, Greek yogurt)."
      },
      {
        "criterion_number": 10,
        "description": "State they should focus on calorie intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Calorie-dense options are recommended (nut butters, avocados, smoothies)."
      },
      {
        "criterion_number": 11,
        "description": "Recommend trying to manage nausea.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Specific nausea management strategies are provided (ginger tea, bland foods, avoid strong smells)."
      },
      {
        "criterion_number": 12,
        "description": "Recommend hydration.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises staying hydrated with small, frequent sips."
      },
      {
        "criterion_number": 13,
        "description": "Mention high risk of malnutrition, cachexia, and weight loss necessitating early and ongoing nutritional assessment and intervention.",
        "score_given": 0,
        "max_points": 9,
        "justification": "Does not explicitly mention high risk of malnutrition/cachexia/weight loss or the need for early and ongoing nutritional assessment."
      },
      {
        "criterion_number": 14,
        "description": "Mention prioritizing enteral nutrition over parenteral when oral intake is inadequate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of enteral versus parenteral nutrition strategies."
      },
      {
        "criterion_number": 15,
        "description": "Mention that oral nutritional supplements, especially omega-3 enriched, support body weight and lean body mass.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Supplements are mentioned generally, but there is no mention of omega-3 enrichment or benefits to body weight/lean mass."
      },
      {
        "criterion_number": 16,
        "description": "Mention that diet composition should emphasize a plant-enriched diet for overall health and cancer risk reduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to emphasize a plant-enriched diet."
      },
      {
        "criterion_number": 17,
        "description": "Mention that current evidence does not support ketogenic diets for treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of ketogenic diets or the evidence base regarding them."
      }
    ],
    "question_number": 121,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:47:01.564674",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with an oncology nutritionist or dietitian.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises working with a registered dietitian specializing in oncology and asks if they have connected with an oncology dietitian."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme supplements can help with digesting food when there is pancreatic enzyme deficiency.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions digestive enzyme deficiency with possible need for supplements and references enzyme replacement therapy, implying use to aid digestion."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutrition is important for maintaining strength or energy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists \u201cSupporting overall strength and energy\u201d as a priority goal of nutrition."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that nutrition is important for supporting the immune system.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of immune system support."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that nutrition is important for maintaining weight.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States \u201cMaintaining weight and muscle mass\u201d as a priority goal."
      },
      {
        "criterion_number": 6,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including poor appetite.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies \u201cAppetite loss\u201d as a common nutritional challenge."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including digestion difficulties.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes \u201cDigestive enzyme deficiency\u201d and \u201cFat malabsorption,\u201d indicating digestion difficulties."
      },
      {
        "criterion_number": 8,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including side effects of treatment like nausea.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists \u201cAppetite loss and nausea\u201d and mentions managing treatment side effects."
      },
      {
        "criterion_number": 9,
        "description": "The response should state they should focus on protein intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes \u201cAdequate protein intake\u201d in general strategies."
      },
      {
        "criterion_number": 10,
        "description": "The response should state they should focus on calorie intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Recommends \u201cHigh-calorie, nutrient-dense foods.\u201d"
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend trying to manage nausea.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions nausea as a challenge but does not explicitly recommend nausea management or specific strategies for it."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend hydration.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises \u201cStaying hydrated.\u201d"
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that patients with pancreatic cancer undergoing treatment are at high risk of malnutrition, cachexia, and weight loss, necessitating early and ongoing nutritional assessment and intervention.",
        "score_given": 0,
        "max_points": 9,
        "justification": "Notes unintentional weight loss but does not state high risk of malnutrition/cachexia or emphasize early and ongoing assessment/intervention."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that dietary strategies should prioritize enteral nutrition over parenteral nutrition when oral intake is inadequate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of enteral versus parenteral nutrition."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that oral nutritional supplements, especially those enriched with omega-3 fatty acids, are beneficial for supporting body weight and lean body mass.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention oral nutritional supplements or omega-3 fatty acids."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that diet composition should emphasize a plant-enriched diet for overall health and cancer risk reduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation about a plant-enriched diet."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that current evidence does not support ketogenic diets for treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not address ketogenic diets or evidence regarding them."
      }
    ],
    "question_number": 121,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:47:28.383559",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that memory issues can be associated with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that chemotherapy can cause 'chemo brain' with memory problems."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing memory concerns with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing medications with the oncology team and bringing concerns to the healthcare team."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that memory issues can be associated with pain medications.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically notes that pain medications, especially opioids, can affect memory and concentration."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that memory issues can be associated with poor nutrition.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions nutritional deficiencies from poor appetite or digestive issues as a cause."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that memory issues can be associated with dehydration.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes dehydration or electrolyte imbalances as potential contributors."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that memory issues can be associated with anxiety.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists anxiety as affecting cognitive function."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that memory issues can be associated with depression.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists depression as affecting cognitive function."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that memory issues can be associated with fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions fatigue and sleep disturbances impacting memory."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that memory issues can be associated with stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention stress explicitly."
      },
      {
        "criterion_number": 10,
        "description": "The response should cite peer-reviewed articles with links.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No citations or links to peer-reviewed literature are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that memory issues in pancreatic cancer patients are frequently related to cancer treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States that memory issues can be related to treatment but does not indicate they are frequently related."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that biological mechanisms underlying chemotherapy-induced cognitive changes include direct neurotoxic effects of chemotherapy, neuroinflammation, changes in brain structure and connectivity, and involvement of specific biomarkers and genetic predispositions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanistic details such as neurotoxicity, neuroinflammation, structural/functional brain changes, biomarkers, or genetics are discussed."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that cognitive impairment may also be influenced by the cancer itself, paraneoplastic effects, and other factors such as age, comorbidities, and emotional distress.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions emotional distress and some disease-related factors, but does not reference paraneoplastic effects, age, or comorbidities explicitly."
      }
    ],
    "question_number": 122,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:47:50.379813",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that memory issues can be associated with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions chemotherapy causing 'chemo brain' with memory problems."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing memory concerns with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly advises discussing the issue with the oncology team and notes they may adjust medications or management."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that memory issues can be associated with pain medications.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically states opioids and other pain relievers can affect memory and thinking."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that memory issues can be associated with poor nutrition.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Nutritional changes' under other factors contributing to memory issues in context of pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that memory issues can be associated with dehydration.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Dehydration is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that memory issues can be associated with anxiety.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States 'Depression/anxiety ... can impact memory.'"
      },
      {
        "criterion_number": 7,
        "description": "The response should state that memory issues can be associated with depression.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States 'Depression/anxiety ... can impact memory.'"
      },
      {
        "criterion_number": 8,
        "description": "The response should state that memory issues can be associated with fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'Fatigue' under other factors contributing to cognitive/memory issues."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that memory issues can be associated with stress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'stress' alongside fatigue as factors affecting cognition."
      },
      {
        "criterion_number": 10,
        "description": "The response should cite peer-reviewed articles with links.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No citations or links are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that memory issues in pancreatic cancer patients are frequently related to cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States memory issues can be related to pancreatic cancer treatment and lists multiple treatment-related causes."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that biological mechanisms underlying chemotherapy-induced cognitive changes include direct neurotoxic effects of chemotherapy, neuroinflammation, changes in brain structure and connectivity, and involvement of specific biomarkers and genetic predispositions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss mechanistic pathways or biomarkers/genetic predispositions."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that cognitive impairment may also be influenced by the cancer itself, paraneoplastic effects, and other factors such as age, comorbidities, and emotional distress.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions emotional distress (depression/anxiety) but does not address the cancer itself, paraneoplastic effects, age, or comorbidities."
      }
    ],
    "question_number": 122,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:48:12.463003",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ablative techniques in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines ablative techniques as treatments that directly destroy or remove tumor tissue in the context of pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that ablative techniques in pancreatic cancer are used when surgery isn\u2019t possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes ablation is considered when tumors are locally advanced and not surgically removable or when surgery isn't an option due to health factors."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including radiofrequency ablation (RFA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "RFA is listed with a brief description of mechanism and approaches."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including microwave ablation (MWA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "MWA is listed with a description that it uses microwave energy and can achieve higher temperatures more quickly."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that ablative techniques are not curative.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not explicitly state that ablation is not curative."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that ablative techniques in pancreatic cancer are used to manage symptoms.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Symptom management or palliation is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including cryoablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cryoablation is included with a brief description."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these techniques are typically considered after or in conjunction with systemic chemotherapy, which remains the first-line treatment for locally advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions ablation can be combined with chemotherapy or radiation, it does not state that systemic chemotherapy is first-line for locally advanced disease or that ablation is typically considered after/in conjunction with it."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including irreversible electroporation (IRE).",
        "score_given": 5,
        "max_points": 5,
        "justification": "IRE is described as using electrical pulses, non-thermal, and useful near critical structures."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including high-intensity focused ultrasound (HIFU).",
        "score_given": 0,
        "max_points": 5,
        "justification": "HIFU is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA delivers thermal energy via a probe to induce coagulative necrosis of tumor cells. RFA can be performed percutaneously, surgically, or via endoscopic ultrasound (EUS) guidance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It mentions heat via a probe and percutaneous/surgical approaches but does not mention coagulative necrosis or EUS guidance."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that RFA is the most studied thermal technique and has demonstrated feasibility and safety, with some evidence of improved survival and immune modulation.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No discussion of RFA being the most studied, feasibility/safety data, survival, or immune effects."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that MWA uses electromagnetic waves to generate heat and destroy tumor tissue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It states MWA uses microwave energy (electromagnetic) and creates higher temperatures; within the context of ablation destroying tumor/cancer cells, this criterion is met."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that MWA is emerging as an alternative to RFA, with potential advantages in speed and ablation volume, but clinical data remain limited.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Advantages in speed and size are implied, but it does not state that data are limited or that it is emerging as an alternative."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that IRE is a non-thermal technique that uses high-voltage electrical pulses to create permanent nanopores in cell membranes, leading to apoptosis.",
        "score_given": 0,
        "max_points": 4,
        "justification": "It notes non-thermal electrical pulses creating holes in membranes, but does not mention apoptosis."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that IRE is particularly attractive for tumors near critical structures, as it spares connective tissue and vessels. It is increasingly used in locally advanced pancreatic cancer and is under investigation in randomized trials.",
        "score_given": 0,
        "max_points": 4,
        "justification": "It mentions safety near vessels/critical structures but not connective tissue sparing, increasing use in locally advanced disease, or randomized trials."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that HIFU delivers focused ultrasound waves to induce thermal and mechanical destruction of tumor cells.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of HIFU."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that HIFU is less commonly used but has shown feasibility in clinical studies.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of HIFU or its clinical feasibility."
      },
      {
        "criterion_number": 19,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It invites questions for the medical team but does not explicitly recommend discussing with an oncologist."
      }
    ],
    "question_number": 123,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:48:47.102241",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ablative techniques in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines ablative techniques as treatments that destroy cancer tissue using energy or extreme temperatures, directly in the pancreatic cancer context."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that ablative techniques in pancreatic cancer are used when surgery isn\u2019t possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states they may be considered when surgery isn't possible due to tumor location or patient health."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including radiofrequency ablation (RFA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists RFA and briefly describes it as using heat generated by radio waves."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including microwave ablation (MWA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists microwave ablation and notes it uses microwave energy to heat and destroy tissue."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that ablative techniques are not curative.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state that these techniques are not curative; instead suggests clarifying goals (curative vs. palliative) without asserting non-curative intent."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that ablative techniques in pancreatic cancer are used to manage symptoms.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions they may be used to help relieve symptoms."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including cryoablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists cryoablation and describes it as freezing cancer cells with extremely cold temperatures."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these techniques are typically considered after or in conjunction with systemic chemotherapy, which remains the first-line treatment for locally advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention systemic chemotherapy or its first-line role in locally advanced pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including irreversible electroporation (IRE).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists IRE and provides a brief description (electrical pulses damaging cell membranes)."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including high-intensity focused ultrasound (HIFU).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention HIFU."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA delivers thermal energy via a probe to induce coagulative necrosis of tumor cells. RFA can be performed percutaneously, surgically, or via endoscopic ultrasound (EUS) guidance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions heat from radio waves but does not discuss coagulative necrosis, probe-based delivery, or percutaneous/surgical/EUS approaches."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that RFA is the most studied thermal technique and has demonstrated feasibility and safety, with some evidence of improved survival and immune modulation.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Provides no comment on RFA\u2019s evidence base, feasibility/safety, survival, or immune effects."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that MWA uses electromagnetic waves to generate heat and destroy tumor tissue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States MWA uses microwave energy to heat and destroy tissue, which accurately reflects electromagnetic wave heating."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that MWA is emerging as an alternative to RFA, with potential advantages in speed and ablation volume, but clinical data remain limited.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not address MWA\u2019s comparative status, advantages, or limitations in clinical data."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that IRE is a non-thermal technique that uses high-voltage electrical pulses to create permanent nanopores in cell membranes, leading to apoptosis.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions electrical pulses damaging membranes but omits non-thermal nature, high voltage, nanopores, and apoptosis."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that IRE is particularly attractive for tumors near critical structures, as it spares connective tissue and vessels. It is increasingly used in locally advanced pancreatic cancer and is under investigation in randomized trials.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention tissue-sparing near critical structures, use in locally advanced disease, or ongoing trials."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that HIFU delivers focused ultrasound waves to induce thermal and mechanical destruction of tumor cells.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of HIFU or its mechanism."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that HIFU is less commonly used but has shown feasibility in clinical studies.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of HIFU use or feasibility data."
      },
      {
        "criterion_number": 19,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Advises speaking with the 'medical team' but does not specifically recommend discussing with an oncologist."
      }
    ],
    "question_number": 123,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:49:12.407568",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends that the patient or family discuss goals of care (e.g., treatment goals, quality of life preferences, advanced care planning) with their oncologist or oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response encourages regular communication with the healthcare team and asks about quality-of-life priorities, but it does not explicitly recommend discussing goals of care or advance care planning with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing symptom management (e.g., pain, nausea, fatigue) with the oncology team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, 'Work closely with the oncology team to stay ahead of pain' and encourages reporting pain/discomfort, clearly directing symptom management discussions to the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly includes information about palliative care (e.g., mentions \u201cpalliative care,\u201d \u201csupportive care,\u201d or \u201cpalliative care specialists\u201d as a resource for symptom or quality of life management).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to 'Consider palliative care specialists early' and notes their focus on comfort, directly addressing palliative care as a resource."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly states or clearly implies that mental health professionals (e.g., counselor, psychologist, psychiatrist, mental health provider) can help patients deal with the emotional or psychological burden of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends 'Consider counseling or support groups,' which clearly implies involvement of mental health professionals."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends discussing side effect management (e.g., side effects of treatment, managing adverse effects) with the oncology team or oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to 'Communicate openly with the medical team about side effects,' explicitly recommending discussion of side effects with clinicians."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy associated with a high symptom burden, including pain, gastrointestinal symptoms, fatigue, and significant psychological distress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not characterize pancreatic cancer as aggressive or note its high symptom burden explicitly."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that palliative care is not synonymous with hospice; rather, it is an active, multidisciplinary approach to symptom management and psychosocial support that can be provided at any stage of disease, including during active cancer-directed therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It states palliative care specialists should be involved early and 'focus on comfort, not just end-of-life care,' conveying that palliative care is not synonymous with hospice and can be used earlier in the disease course."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that multidisciplinary collaboration can impact quality of life during treatment of pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It references collaboration with the oncology team, palliative care specialists, a dietitian, and physical therapy, demonstrating a multidisciplinary approach."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that advance care planning can impact quality of life during treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of advance care planning (e.g., goals-of-care conversations, directives, POLST) and its impact on quality of life."
      }
    ],
    "question_number": 124,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:49:32.576430",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends that the patient or family discuss goals of care (e.g., treatment goals, quality of life preferences, advanced care planning) with their oncologist or oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states: \"Discuss goals of care openly with the oncology team.\" This directly meets the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing symptom management (e.g., pain, nausea, fatigue) with the oncology team or oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises to work with the \"medical team\" for pain and symptom management but does not explicitly specify the oncology team or oncologist for symptom management."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly includes information about palliative care (e.g., mentions \u201cpalliative care,\u201d \u201csupportive care,\u201d or \u201cpalliative care specialists\u201d as a resource for symptom or quality of life management).",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions palliative care directly: \"Ask about palliative care services (which can complement treatment)\" and notes \"The palliative care team can be invaluable partners... helping optimize comfort.\""
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly states or clearly implies that mental health professionals (e.g., counselor, psychologist, psychiatrist, mental health provider) can help patients deal with the emotional or psychological burden of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends \"Consider counseling or support groups for both patient and family,\" which implies involvement of mental health professionals."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends discussing side effect management (e.g., side effects of treatment, managing adverse effects) with the oncology team or oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests managing nausea and keeping a symptom diary to help the medical team adjust treatments, it does not explicitly recommend discussing side effect management with the oncology team or oncologist."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy associated with a high symptom burden, including pain, gastrointestinal symptoms, fatigue, and significant psychological distress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not describe pancreatic cancer as aggressive nor explicitly note its high symptom burden."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that palliative care is not synonymous with hospice; rather, it is an active, multidisciplinary approach to symptom management and psychosocial support that can be provided at any stage of disease, including during active cancer-directed therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States palliative care \"can complement treatment\" and describes the palliative \"team\" coordinating with oncology, implying active, concurrent, multidisciplinary supportive care during therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that multidisciplinary collaboration can impact quality of life during treatment of pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "References multiple team members (oncology team, medical team, palliative care team, registered dietitian) and coordination, reflecting multidisciplinary collaboration."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that advance care planning can impact quality of life during treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it advises discussing goals of care, it does not explicitly mention advance care planning or advance directives and their impact on quality of life."
      }
    ],
    "question_number": 124,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:50:05.113893",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the Pancreatic Cancer Action Network (PanCAN) as a major pancreatic cancer advocacy organization.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists the Pancreatic Cancer Action Network (PanCAN) as a prominent organization and describes it as the largest patient advocacy organization."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing advocacy options with their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no recommendation to speak with the oncology team about advocacy options."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that PanCAN is a leading national organization dedicated to patient advocacy, support, research funding, and public policy initiatives for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response calls PanCAN the largest patient advocacy organization, it does not state that it is dedicated to support, research funding, and public policy initiatives."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that PanCAN offers structured opportunities for patients and families to engage in advocacy, including legislative outreach, awareness campaigns, and peer support programs such as the Patient and Liaison Services (PALS) program.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions general advocacy activities and PanCAN opportunities (volunteering, training, community events) but does not identify PanCAN\u2019s structured programs such as legislative outreach tied to PanCAN or the PALS program."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the American Society of Clinical Oncology\u2019s patient-facing website, Cancer.Net, provides information on advocacy opportunities and connects patients to broader cancer advocacy networks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cancer.Net is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that both PanCAN and Cancer.Net are specifically recommended by the American Society of Clinical Oncology in its clinical practice guidelines as key resources for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no reference to ASCO, its clinical practice guidelines, or recommendations of PanCAN and Cancer.Net."
      }
    ],
    "question_number": 125,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:50:22.184485",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Include the Pancreatic Cancer Action Network (PanCAN) as a major pancreatic cancer advocacy organization.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists the Pancreatic Cancer Action Network (PanCAN) under 'Major Pancreatic Cancer Organizations.'"
      },
      {
        "criterion_number": 2,
        "description": "Recommend discussing advocacy options with their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response suggests contacting social workers and local cancer centers, it does not specifically recommend discussing advocacy options with the patient's oncology team."
      },
      {
        "criterion_number": 3,
        "description": "State that PanCAN is a leading national organization dedicated to patient advocacy, support, research funding, and public policy initiatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response describes PanCAN as the largest advocacy organization and mentions patient services and research funding, but it does not explicitly mention public policy initiatives or frame PanCAN in the full scope specified."
      },
      {
        "criterion_number": 4,
        "description": "Mention that PanCAN offers structured opportunities for advocacy, including legislative outreach, awareness campaigns, and peer support programs such as PALS.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although the response lists types of advocacy (e.g., legislative advocacy, awareness campaigns, peer support) and notes PanCAN's Patient Services, it does not explicitly attribute these structured opportunities to PanCAN nor mention the PALS program."
      },
      {
        "criterion_number": 5,
        "description": "Mention that ASCO\u2019s patient-facing website, Cancer.Net, provides advocacy information and connections to broader advocacy networks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cancer.Net is not mentioned in the response."
      },
      {
        "criterion_number": 6,
        "description": "State that both PanCAN and Cancer.Net are recommended by ASCO clinical practice guidelines as key resources for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not reference ASCO clinical practice guidelines or note any recommendations of PanCAN or Cancer.Net by ASCO."
      }
    ],
    "question_number": 125,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:50:42.601548",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly highlights stage as central ('If surgery is being considered... earlier stage') and includes 'What stage is the cancer?' among key questions, indicating treatment planning depends on stage."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include surgery.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It lists multiple treatment approaches (surgery, chemotherapy, radiation, targeted therapy, clinical trials), indicating multimodal treatment and including surgery."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include chemotherapy.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Chemotherapy is explicitly listed as a treatment option."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include radiation.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Radiation therapy is explicitly listed as a treatment option."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that chemotherapy can be used before or after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states 'Chemotherapy (before or after surgery, or as primary treatment)'."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer management should involve a multidisciplinary team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises meeting with a multidisciplinary team and specifies roles (surgeon, oncologist, radiologist)."
      },
      {
        "criterion_number": 7,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe the Whipple procedure.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It lists the Whipple procedure and describes it as removing part of the pancreas, small intestine, and nearby tissues."
      },
      {
        "criterion_number": 8,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe distal pancreatectomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It lists distal pancreatectomy and describes it as removing the tail/body of the pancreas."
      },
      {
        "criterion_number": 9,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe total pancreatectomy.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It lists total pancreatectomy and describes it as removing the entire pancreas."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that surgical resection is the only potentially curative option for pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "The response does not state that surgery is the only potentially curative option."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that deciding on surgery requires multidisciplinary evaluation and mention anatomical, biological, or patient factors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends multidisciplinary evaluation and references resectability and stage (anatomic/biologic factors) and quality-of-life considerations (patient factors)."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises a second opinion from a pancreatic cancer specialist and meeting with a multidisciplinary team that includes an oncologist."
      }
    ],
    "question_number": 126,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:51:10.517634",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response emphasizes staging multiple times (e.g., asks 'What stage is the cancer?' and notes that surgery being an option often indicates an earlier, more treatable stage), and advises working with a team to explain staging and options, implying treatment decisions depend on stage."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include surgery.",
        "score_given": 0,
        "max_points": 4,
        "justification": "While surgery is mentioned, the response does not state that treatment is multimodality or explicitly describe multiple coordinated modalities."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include chemotherapy.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Chemotherapy is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include radiation.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Radiation therapy is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that chemotherapy can be used before or after surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of neoadjuvant or adjuvant chemotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer management should involve a multidisciplinary team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it references an 'experienced oncology team' and a 'surgical team', it does not explicitly state the need for a multidisciplinary team approach or describe multi-specialty involvement in management."
      },
      {
        "criterion_number": 7,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe the Whipple procedure.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No surgical procedure types are named; the Whipple procedure is not described."
      },
      {
        "criterion_number": 8,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe distal pancreatectomy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention or description of distal pancreatectomy."
      },
      {
        "criterion_number": 9,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe total pancreatectomy.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention or description of total pancreatectomy."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that surgical resection is the only potentially curative option for pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Curative versus palliative goals are mentioned, but it does not state that surgical resection is the only potentially curative option."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that deciding on surgery requires multidisciplinary evaluation and mention anatomical, biological, or patient factors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit mention that surgery decisions require multidisciplinary evaluation or specific anatomical, biological, or patient-related factors."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises working closely with an experienced oncology team and seeking a second opinion at a major cancer center."
      }
    ],
    "question_number": 126,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:51:42.910764",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response suggests asking about stage, it does not explicitly state that treatment choices depend on the stage."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention that tumor location (e.g., head vs body/tail) influences treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends learning about multimodal options and explicitly lists surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Chemotherapy is explicitly included among treatment options."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes radiation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Radiation therapy is explicitly included among treatment options."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that early, multidisciplinary management is essential to optimize outcomes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises a multidisciplinary team approach, referrals to multiple specialists, and immediate discussion of trials, emphasizing early coordinated care."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that care is best coordinated at high-volume centers with expertise in pancreatic malignancies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends seeking care at a high-volume pancreatic cancer center."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that symptom management is an important part of the care of patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes referrals to pain management, recommends palliative care for symptom management at any stage, and emphasizes practical symptom tracking."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the basics of pancreatic cancer, including that the most common type is pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of disease basics or mention that adenocarcinoma is the most common type."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how pancreatic cancer is staged based on the NCCN guidelines (version 2.2025).",
        "score_given": 0,
        "max_points": 2,
        "justification": "No TNM or AJCC staging details are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy with a poor prognosis, often presenting at an advanced stage.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Aggressiveness, prognosis, and typical stage at presentation are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend writing down questions in advance to ensure that all concerns are addressed during consultations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises preparing questions for the medical team and documenting questions between appointments."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that advocacy for comprehensive testing is important, including somatic and germline genetic testing.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests asking if genetic testing is recommended but does not specify both somatic tumor profiling and germline testing."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to inquire about clinical trial opportunities, as participation may provide access to novel therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends asking about clinical trials immediately and lists trials among treatment options."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information, support services, and advocacy opportunities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "PanCAN is mentioned, but cancer.net is not referenced; criterion requires both."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends referrals to an oncologist as part of building the medical team."
      }
    ],
    "question_number": 127,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:52:15.570090",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states, \"Treatment options vary greatly depending on stage and location,\" and recommends asking, \"What stage is the cancer?\""
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly includes, \"Treatment options vary greatly depending on stage and location.\""
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes surgery.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions surgery as an option but does not state that treatment is multimodality or that surgery is part of a multimodal approach."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Chemotherapy is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes radiation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Radiation therapy is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that early, multidisciplinary management is essential to optimize outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes that time can be critical and suggests consulting a specialist, it does not mention multidisciplinary/team-based management or its importance."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that care is best coordinated at high-volume centers with expertise in pancreatic malignancies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises seeking a second opinion at a major cancer center and researching major cancer centers (e.g., MD Anderson, MSK, Johns Hopkins), implying high-volume, expert centers."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that symptom management is an important part of the care of patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States, \"Palliative care (comfort/quality of life) is valuable alongside treatment,\" which encompasses symptom management."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the basics of pancreatic cancer, including that the most common type is pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not describe pancreatic cancer basics or mention that adenocarcinoma is the most common type."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how pancreatic cancer is staged based on the NCCN guidelines (version 2.2025).",
        "score_given": 0,
        "max_points": 2,
        "justification": "No TNM or AJCC staging details are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy with a poor prognosis, often presenting at an advanced stage.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention aggressiveness, poor prognosis, or late-stage presentation."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend writing down questions in advance to ensure that all concerns are addressed during consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Provides example questions and suggests taking notes but does not recommend writing down questions in advance."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that advocacy for comprehensive testing is important, including somatic and germline genetic testing.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention somatic or germline genetic testing."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to inquire about clinical trial opportunities, as participation may provide access to novel therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises asking about \"clinical trials\" and notes they may offer additional options."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information, support services, and advocacy opportunities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions PanCAN but does not mention cancer.net, so the full criterion is not met."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Suggests consulting a pancreatic cancer specialist and major centers, but does not explicitly recommend discussing with an oncologist."
      }
    ],
    "question_number": 127,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:52:53.528201",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic neuroendocrine tumors (pNETs) are usually sporadic.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses hereditary components but never explicitly states that most pNETs are sporadic."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that pancreatic neuroendocrine tumors (pNETs) do tend to have a genetic component in a significant minority of cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that pNETs can have a genetic component and gives a percentage (10\u201317%), indicating a significant minority."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that some cases of pancreatic neuroendocrine tumors (pNETs) are associated with hereditary syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly says pNETs can occur as part of hereditary syndromes and lists examples."
      },
      {
        "criterion_number": 4,
        "description": "The response should include multiple endocrine neoplasia type 1 (MEN1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "MEN1 is listed as the most common associated syndrome."
      },
      {
        "criterion_number": 5,
        "description": "The response should include von Hippel-Lindau disease (VHL).",
        "score_given": 3,
        "max_points": 3,
        "justification": "VHL is explicitly listed among the associated syndromes."
      },
      {
        "criterion_number": 6,
        "description": "The response should include neurofibromatosis type 1 (NF1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "NF1 is explicitly listed among the associated syndromes."
      },
      {
        "criterion_number": 7,
        "description": "The response should include tuberous sclerosis complex (TSC).",
        "score_given": 3,
        "max_points": 3,
        "justification": "TSC is explicitly listed among the associated syndromes."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that genetic testing is available for pancreatic neuroendocrine tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \u201cYes, genetic testing is available for these conditions,\u201d and describes sample types and target genes."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that they have concerns about the risk of cancer, they should talk with a genetic counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends consulting a genetic counselor and offers help connecting with one."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 10\u201317% of pancreatic neuroendocrine tumors (pNETs) are associated with inherited syndromes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \u201cAbout 10\u201317% of PNETs are associated with hereditary syndromes.\u201d"
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that these inherited syndromes often present at a younger age.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises testing consideration \u201cespecially if diagnosed at a younger age,\u201d indicating younger age is a feature suggestive of hereditary syndromes."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that germline mutations are also found in sporadic-appearing pancreatic neuroendocrine tumors (pNETs), including mutations in DNA repair genes such as MUTYH, CHEK2, and BRCA2, as well as MEN1 and VHL.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of germline mutations in apparently sporadic cases or specific genes like MUTYH, CHEK2, BRCA2."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that multigene panel testing is recommended, as it can identify both syndromic and non-syndromic germline variants relevant for familial risk assessment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It lists testing for specific syndrome genes but does not mention multigene panel testing or its benefits for non-syndromic variants."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the user discuss this case with a medical professional.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It recommends consultation with a genetic counselor, a relevant healthcare professional."
      }
    ],
    "question_number": 128,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:53:23.728343",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic neuroendocrine tumors (pNETs) are usually sporadic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that most PNETs are sporadic (not inherited)."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that pancreatic neuroendocrine tumors (pNETs) do tend to have a genetic component in a significant minority of cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes that PNETs can have a genetic component in some cases, indicating a minority with genetic etiology."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that some cases of pancreatic neuroendocrine tumors (pNETs) are associated with hereditary syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists hereditary syndromes associated with PNETs, confirming syndromic associations."
      },
      {
        "criterion_number": 4,
        "description": "The response should include multiple endocrine neoplasia type 1 (MEN1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "MEN1 is specifically listed as the most common associated syndrome."
      },
      {
        "criterion_number": 5,
        "description": "The response should include von Hippel-Lindau disease (VHL).",
        "score_given": 3,
        "max_points": 3,
        "justification": "VHL is explicitly listed among the syndromes."
      },
      {
        "criterion_number": 6,
        "description": "The response should include neurofibromatosis type 1 (NF1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "NF1 is explicitly listed among the syndromes."
      },
      {
        "criterion_number": 7,
        "description": "The response should include tuberous sclerosis complex (TSC).",
        "score_given": 3,
        "max_points": 3,
        "justification": "TSC is explicitly listed among the syndromes."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that genetic testing is available for pancreatic neuroendocrine tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly states that genetic testing is available and describes sample types."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that they have concerns about the risk of cancer, they should talk with a genetic counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly recommends speaking with a genetic counselor."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 10\u201317% of pancreatic neuroendocrine tumors (pNETs) are associated with inherited syndromes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No numerical estimate (10\u201317%) of inherited cases is provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that these inherited syndromes often present at a younger age.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists early age of diagnosis as a factor for considering genetic testing, implying younger presentation in hereditary cases."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that germline mutations are also found in sporadic-appearing pancreatic neuroendocrine tumors (pNETs), including mutations in DNA repair genes such as MUTYH, CHEK2, and BRCA2, as well as MEN1 and VHL.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of germline findings in sporadic-appearing cases or specific genes like MUTYH, CHEK2, BRCA2."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that multigene panel testing is recommended, as it can identify both syndromic and non-syndromic germline variants relevant for familial risk assessment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Testing is described generally but multigene panel testing and its rationale are not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the user discuss this case with a medical professional.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response recommends speaking with a genetic counselor, the oncologist, the primary care physician, and a specialist in hereditary cancer syndromes."
      }
    ],
    "question_number": 128,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:53:50.319954",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions the Pancreatic Cancer Action Network (PanCAN) as a source for survivor stories.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions PanCAN and notes its 'Survivor Stories' and 'Patient Stories' sections."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends asking the oncology team for additional support group recommendations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests asking the oncology team about connecting with long-term survivors, but does not specifically recommend asking for support group recommendations."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions Cancer Support Community (CSC) as a resource for support or survivor stories.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly references Cancer Support Community and notes it offers online support groups."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions Let\u2019s Win! Pancreatic Cancer survivor stories.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Let\u2019s Win! Pancreatic Cancer is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the American Society of Clinical Oncology\u2019s patient-facing website (www.cancer.net) as a source for stories of hope.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ASCO\u2019s Cancer.Net is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that organizations provide patient and survivor stories, peer support networks, and opportunities to connect with others who have faced similar diagnoses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists organizations with survivor stories and online communities, and states PanCAN\u2019s network connects patients with others who have faced the diagnosis."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that peer support and shared experiences are recognized as powerful tools for maintaining motivation and a sense of hope during the cancer journey.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it encourages connecting with others, it does not explicitly state that peer support/shared experiences are recognized as powerful tools for maintaining motivation and hope."
      }
    ],
    "question_number": 129,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:54:05.216461",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions the Pancreatic Cancer Action Network (PanCAN) as a source for survivor stories.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions PanCAN and notes it has patient stories and support resources."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends asking the oncology team for additional support group recommendations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions local cancer center support groups but does not advise asking the oncology team specifically."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions Cancer Support Community (CSC) as a resource for support or survivor stories.",
        "score_given": 0,
        "max_points": 5,
        "justification": "CSC is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions Let\u2019s Win! Pancreatic Cancer survivor stories.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Let\u2019s Win! Pancreatic Cancer is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the American Society of Clinical Oncology\u2019s patient-facing website (www.cancer.net) as a source for stories of hope.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer.Net is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that organizations provide patient and survivor stories, peer support networks, and opportunities to connect with others who have faced similar diagnoses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes PanCAN has patient stories and support resources, references PanCAN\u2019s support groups and local cancer center groups, and emphasizes connecting with others."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that peer support and shared experiences are recognized as powerful tools for maintaining motivation and a sense of hope during the cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that connecting with others provides practical support and emotional strength, reflecting the value of peer support for hope and motivation."
      }
    ],
    "question_number": 129,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:54:18.753727",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define stage IV pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response acknowledges stage IV disease but does not define it as metastatic cancer with distant spread (e.g., to liver, lungs, peritoneum)."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that the disease is not curable.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit statement that stage IV pancreatic cancer is not curable."
      },
      {
        "criterion_number": 3,
        "description": "The response should include the goal of treatment is to control the cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While therapies are listed, the response does not explicitly state that the goal is disease control."
      },
      {
        "criterion_number": 4,
        "description": "The response should include the goal of treatment to improve symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly emphasizes symptom improvement via palliative care (managing pain, nausea, fatigue) to enhance quality of life."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the cornerstone of treatment for stage IV pancreatic cancer is systemic chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists first-line systemic chemotherapy regimens as standard therapies, indicating chemotherapy as the primary treatment approach."
      },
      {
        "criterion_number": 6,
        "description": "The response should include chemotherapy regimens listed in NCCN guidelines (version 2.2025) for treatment of metastatic pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes FOLFIRINOX and gemcitabine plus nab-paclitaxel, both NCCN-recommended regimens for metastatic disease."
      },
      {
        "criterion_number": 7,
        "description": "The response should discuss that clinical trials are another option.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends clinical trials and provides resources (ClinicalTrials.gov, PanCAN)."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there may be targeted treatments based on genetic mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes BRCA1/2 (PARP inhibitors), MSI-H/dMMR (immunotherapy), and NTRK fusions as actionable targets."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the tumor have genetic testing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States genetic/biomarker testing is crucial and reiterates it in key actions."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that early palliative care referral is recommended at diagnosis to optimize symptom management, psychological support, and advance care planning.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends early palliative care consultation and highlights benefits for symptom and emotional support; while advance care planning is not explicitly named, early referral and supportive goals are clearly conveyed."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that aggressive symptom management, such as management of pain, fatigue, nausea, and gastrointestinal symptoms is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions managing pain, nausea, fatigue and includes GI-related support (PERT, dietitian, addressing weight loss)."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic enzyme replacement therapy should be considered for exocrine insufficiency, and nutritional support is important for maintaining weight and strength.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends PERT and emphasizes dietary strategies and addressing weight loss; also mentions maintaining strength via activity and dietitian support."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that psychosocial support, including counseling and peer support, is critical for both patients and families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes counseling/therapy for patient and family and support groups."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises getting a second opinion at a high-volume pancreatic cancer center, effectively recommending consultation with oncology specialists."
      }
    ],
    "question_number": 130,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:55:11.054358",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define stage IV pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not define stage IV pancreatic cancer as metastatic disease with spread to distant organs."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that the disease is not curable.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No statement is made that stage IV pancreatic cancer is generally not curable."
      },
      {
        "criterion_number": 3,
        "description": "The response should include the goal of treatment is to control the cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that a primary goal of treatment is to control or slow the cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should include the goal of treatment to improve symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response highlights palliative care for specialized symptom management and multiple quality-of-life measures, indicating the goal of improving symptoms."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the cornerstone of treatment for stage IV pancreatic cancer is systemic chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Systemic chemotherapy is not mentioned as the cornerstone of treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response should include chemotherapy regimens listed in NCCN guidelines (version 2.2025) for treatment of metastatic pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No specific chemotherapy regimens (e.g., FOLFIRINOX, gemcitabine+nab-paclitaxel) are named."
      },
      {
        "criterion_number": 7,
        "description": "The response should discuss that clinical trials are another option.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clinical trials are explicitly recommended, with guidance to search ClinicalTrials.gov."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there may be targeted treatments based on genetic mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response mentions precision medicine and that genetic testing may identify targeted therapies."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the tumor have genetic testing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends tumor genetic testing as part of precision medicine to identify targeted options."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that early palliative care referral is recommended at diagnosis to optimize symptom management, psychological support, and advance care planning.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While palliative care is mentioned, the response does not specify early referral at diagnosis nor explicitly tie it to psychological support and advance care planning."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that aggressive symptom management, such as management of pain, fatigue, nausea, and gastrointestinal symptoms is essential.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Pain management and digestive support are mentioned, but there is no explicit emphasis on aggressive symptom management or mention of fatigue and nausea as essential components."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic enzyme replacement therapy should be considered for exocrine insufficiency, and nutritional support is important for maintaining weight and strength.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Pancreatic enzymes and nutrition are noted, but exocrine insufficiency and the goals of maintaining weight and strength are not explicitly stated."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that psychosocial support, including counseling and peer support, is critical for both patients and families.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Counseling and support groups are mentioned, but the response does not state that such support is critical or that it is for both patients and families."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly advises discussing all options with her oncology team and emphasizes having an experienced oncology team."
      }
    ],
    "question_number": 130,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:55:49.680657",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that management of pancreatic tumors involves a multidisciplinary team of surgeons, medical oncologists, and radiation oncologists.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response advises to seek multidisciplinary teams and lists 'surgeon, oncologist, radiologist working together' but does not specifically mention medical oncologists and radiation oncologists. A radiologist is not a radiation oncologist, so the required team composition was not clearly stated."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that outcomes are significantly improved when care is delivered by a multidisciplinary team at high-volume centers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While the response notes better outcomes for surgeons with 15+ annual pancreatic surgeries and recommends multidisciplinary teams, it does not explicitly state that outcomes are significantly improved when care is delivered by a multidisciplinary team at high-volume centers."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly references the Pancreatic Cancer Action Network (pancan.org) and its Patient Central service for personalized searches."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide information for the American Cancer Society (ACS).",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of the American Cancer Society or ACS resources."
      },
      {
        "criterion_number": 5,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It includes 'NCI Cancer Centers (cancer.gov) - lists designated comprehensive cancer centers,' which directs users to the NCI website for cancer centers."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that high-volume centers\u2014defined as institutions performing at least 15 pancreatic resections annually\u2014demonstrate superior survival rates, lower postoperative morbidity, improved lymphadenectomy, shorter hospital stays, and better access to adjuvant therapies.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Although it mentions 'surgeons who perform 15+ pancreatic surgeries annually have better outcomes,' it does not define high-volume centers at the institutional level nor enumerate the specific outcome advantages (survival, morbidity, lymphadenectomy, length of stay, adjuvant therapy access)."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that high-volume centers are typically academic medical centers, National Cancer Institute-designated cancer centers, or hospitals with established pancreatic cancer programs.",
        "score_given": 0,
        "max_points": 8,
        "justification": "It recommends affiliation with NCI-designated centers or high-volume programs but does not explicitly state that high-volume centers are typically academic medical centers, NCI-designated centers, or hospitals with established pancreatic programs."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to request referrals from local oncologists or primary care providers, who can direct patients to high-volume centers and experienced teams.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no suggestion to obtain referrals from local oncologists or primary care providers."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly recommend discussing the case with an oncologist."
      }
    ],
    "question_number": 131,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:56:30.408991",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that management of pancreatic tumors involves a multidisciplinary team of surgeons, medical oncologists, and radiation oncologists.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention a multidisciplinary team or specify surgeons, medical oncologists, and radiation oncologists."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that outcomes are significantly improved when care is delivered by a multidisciplinary team at high-volume centers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No statement links improved outcomes to multidisciplinary care at high-volume centers."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 0,
        "max_points": 3,
        "justification": "PanCAN is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide information for the American Cancer Society (ACS).",
        "score_given": 0,
        "max_points": 3,
        "justification": "ACS is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While NCI designation is referenced, no link to the NCI website or its center finder is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that high-volume centers\u2014defined as institutions performing at least 15 pancreatic resections annually\u2014demonstrate superior survival rates, lower postoperative morbidity, improved lymphadenectomy, shorter hospital stays, and better access to adjuvant therapies.",
        "score_given": 0,
        "max_points": 8,
        "justification": "High case volume is mentioned generally, but no definition (\u226515 resections/year) or associated outcome advantages are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that high-volume centers are typically academic medical centers, National Cancer Institute-designated cancer centers, or hospitals with established pancreatic cancer programs.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Academic centers, NCI designation, and dedicated programs are listed, but the response does not explicitly connect these to being high-volume centers."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to request referrals from local oncologists or primary care providers, who can direct patients to high-volume centers and experienced teams.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises asking the father's current oncologist for specialist referrals, satisfying the referral recommendation."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends engaging the current oncologist for referrals, which constitutes advising discussion with an oncologist."
      }
    ],
    "question_number": 131,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:56:58.898328",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly states that some chemotherapy can have negative effects on the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that some chemotherapy drugs can cause chest pain, arrhythmias, or heart spasms."
      },
      {
        "criterion_number": 2,
        "description": "The response specifically mentions that 5-fluorouracil (or \u201c5-FU\u201d) can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Explicitly mentions 5-FU and associates it with cardiac effects."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends monitoring for shortness of breath.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Unusual shortness of breath' under What to Monitor."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends monitoring for chest pain.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Chest pain or tightness' under What to Monitor."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends monitoring for fast heart rate.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Recommends monitoring for 'Irregular heartbeat or palpitations', which includes tachycardia/fast heart rate."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends monitoring for dizziness.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Dizziness or lightheadedness' under What to Monitor."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends monitoring for unusual fatigue.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Extreme fatigue beyond expected treatment effects' under What to Monitor."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends discussing any new symptom with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises to report cardiac symptoms but does not explicitly state discussing any new symptom with the oncology team."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends discussing any concerning symptom with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly direct the user to discuss concerning symptoms with the oncology team; only broadly says to report cardiac symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response states that electrocardiograms can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends baseline EKG before treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response states that echocardiogram can be used to monitor heart function.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends baseline echocardiogram before treatment."
      },
      {
        "criterion_number": 12,
        "description": "The response states that blood pressure can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes 'Blood pressure changes' in What to Monitor."
      },
      {
        "criterion_number": 13,
        "description": "The response specifically mentions that capecitabine can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Explicitly mentions capecitabine with cardiac effects."
      },
      {
        "criterion_number": 14,
        "description": "The response specifically mentions that some targeted therapies can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "States targeted therapies may affect blood pressure or heart function."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly states that pancreatic cancer treatments can cause at least three cardiac issues: heart failure, arrhythmias, hypertension, ischemia, or cardiomyopathy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions arrhythmias, chest pain (ischemia), and blood pressure effects (hypertension)."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly states that the risk of cardiac side effects is higher in patients with preexisting cardiovascular conditions or those receiving specific agents such as anthracyclines or fluoropyrimidines.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not discuss higher risk in preexisting CVD or name anthracyclines; mentions fluoropyrimidines but not risk stratification."
      },
      {
        "criterion_number": 17,
        "description": "The response explicitly recommends baseline cardiac risk assessment and regular monitoring with echocardiography, cardiac biomarkers, and clinical evaluation for early/asymptomatic cardiac dysfunction.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Recommends baseline EKG/echo and regular monitoring but does not mention cardiac biomarkers or early/asymptomatic dysfunction assessment."
      },
      {
        "criterion_number": 18,
        "description": "The response explicitly references recommendations from the American College of Cardiology and/or the American Society of Clinical Oncology, stating that pretherapy evaluation and ongoing surveillance are recommended for patients with cardiovascular risk factors or those receiving cardiotoxic agents.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No reference to ACC or ASCO guidelines."
      },
      {
        "criterion_number": 19,
        "description": "The response explicitly recommends that the user discuss the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a section 'Questions for Her Oncologist', implying and encouraging discussion with the oncologist."
      }
    ],
    "question_number": 132,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:57:44.635321",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly states that some chemotherapy can have negative effects on the heart.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response discusses cardiotoxic effects of 'treatment' in general but does not explicitly mention chemotherapy as having negative cardiac effects."
      },
      {
        "criterion_number": 2,
        "description": "The response specifically mentions that 5-fluorouracil (or \u201c5-FU\u201d) can harm the heart.",
        "score_given": 0,
        "max_points": 1,
        "justification": "5-fluorouracil/5-FU is not mentioned."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends monitoring for shortness of breath.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It lists 'Shortness of breath, especially when lying down' under symptoms to watch."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends monitoring for chest pain.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It includes 'Chest pain or pressure' in the symptom list."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends monitoring for fast heart rate.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It includes 'Changes in heart rhythm or palpitations,' which encompasses episodes of fast heart rate."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends monitoring for dizziness.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It includes 'Dizziness or fainting' among symptoms to watch."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends monitoring for unusual fatigue.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It lists 'Unusual fatigue or weakness' as a symptom to monitor."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends discussing any new symptom with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises to 'report new or worsening symptoms immediately,' it does not explicitly state to discuss these with the oncology team."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends discussing any concerning symptom with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not explicitly instruct to discuss concerning symptoms with the oncology team; it only generally advises reporting symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response states that electrocardiograms can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists 'EKGs (check heart rhythm)' as a monitoring test."
      },
      {
        "criterion_number": 11,
        "description": "The response states that echocardiogram can be used to monitor heart function.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists 'Echocardiograms or MUGA scans (assess heart function)'."
      },
      {
        "criterion_number": 12,
        "description": "The response states that blood pressure can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly includes 'Blood pressure monitoring'."
      },
      {
        "criterion_number": 13,
        "description": "The response specifically mentions that capecitabine can harm the heart.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Capecitabine is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response specifically mentions that some targeted therapies can harm the heart.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Targeted therapies and their cardiac risks are not mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly states that pancreatic cancer treatments can cause at least three cardiac issues: heart failure, arrhythmias, hypertension, ischemia, or cardiomyopathy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it lists symptoms such as arrhythmias (changes in rhythm), it does not explicitly state that treatments can cause three of the specified conditions."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly states that the risk of cardiac side effects is higher in patients with preexisting cardiovascular conditions or those receiving specific agents such as anthracyclines or fluoropyrimidines.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It advises informing the team about pre-existing conditions but does not explicitly state the increased risk nor mention anthracyclines/fluoropyrimidines."
      },
      {
        "criterion_number": 17,
        "description": "The response explicitly recommends baseline cardiac risk assessment and regular monitoring with echocardiography, cardiac biomarkers, and clinical evaluation for early/asymptomatic cardiac dysfunction.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Although it lists echo, EKG, BP, and biomarkers, it does not explicitly recommend baseline risk assessment or regular surveillance for early/asymptomatic dysfunction."
      },
      {
        "criterion_number": 18,
        "description": "The response explicitly references recommendations from the American College of Cardiology and/or the American Society of Clinical Oncology, stating that pretherapy evaluation and ongoing surveillance are recommended for patients with cardiovascular risk factors or those receiving cardiotoxic agents.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No ACC or ASCO recommendations are referenced."
      },
      {
        "criterion_number": 19,
        "description": "The response explicitly recommends that the user discuss the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages engagement with the oncology team ('Ensure her oncology team knows...'; 'Request cardio-oncology consultation'; provides 'Questions for Her Medical Team'), which constitutes an explicit recommendation to discuss with the oncologist."
      }
    ],
    "question_number": 132,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:58:28.471918",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that treatment decisions are personal decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states, \u201cAcknowledge their right to make this deeply personal decision,\u201d and emphasizes respect for autonomy."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend listening to their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Says, \u201cListen without judgment when they express their feelings.\u201d"
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend validating their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly states, \u201cValidate their feelings\u2014exhaustion from treatment is real and valid.\u201d"
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend respecting their autonomy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions \u201crespect for their autonomy\u201d and \u201cAcknowledge their right to make this deeply personal decision.\u201d"
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supporting their quality of life.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Recommends palliative care focused on comfort and quality of life and emphasizes comfort, dignity, and wishes."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend offering reassurance.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides reassurance with statements like \u201cStopping treatment doesn't mean stopping care\u201d and that the decision can be revisited."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that clear, compassionate communication about prognosis, treatment options, and goals of care is important.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions discussing options with the oncology team and communicating decisions to family, but does not explicitly address prognosis or goals-of-care conversations."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that transitioning to hospice care may be appropriate when the focus shifts entirely to comfort and dignity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Specifically mentions hospice care for comprehensive comfort support and emphasizes comfort and dignity, aligning with transition when focus shifts to comfort."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that hospice provides intensive symptom management, psychosocial and spiritual support, and home-based care, while avoiding non-beneficial interventions such as hospitalization or aggressive procedures.",
        "score_given": 0,
        "max_points": 6,
        "justification": "References hospice generally but does not describe symptom management, psychosocial/spiritual support, home-based care, or avoidance of non-beneficial interventions."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention addressing practical issues related to end-of-life decision-making, such as managing costs and accessing resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes practical steps and recommends involving a social worker/counselor specializing in end-of-life decisions, which facilitates accessing resources."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises arranging consultations with their oncology team to fully understand options."
      }
    ],
    "question_number": 133,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T18:59:05.113161",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that treatment decisions are personal decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states autonomy and that it is their choice: \u201cAcknowledge that this is their choice to make,\u201d conveying treatment decisions are personal."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend listening to their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises to \u201cListen without trying to change their mind\u201d and \u201cAllow them to talk about their fears or hopes,\u201d which entails listening to feelings."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend validating their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages validation by acknowledging emotions: \u201cDon\u2019t feel pressure to always stay positive - acknowledge the sadness.\u201d"
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend respecting their autonomy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Has a section titled \u201cRespecting their autonomy\u201d and states \u201cAcknowledge that this is their choice to make\u201d and \u201cFollow their lead.\u201d"
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supporting their quality of life.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Recommends palliative care for comfort and pain management, considering hospice, and asking how they want to spend remaining time\u2014directly supporting quality of life."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend offering reassurance.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides reassurance: \u201cChoosing comfort over aggressive treatment can be a thoughtful, valid decision\u201d and \u201cYour presence and love matter more than having the 'right' words.\u201d"
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that clear, compassionate communication about prognosis, treatment options, and goals of care is important.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests family meetings and discussing wishes, it does not explicitly emphasize clear, compassionate communication about prognosis, treatment options, and goals of care with clinicians."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that transitioning to hospice care may be appropriate when the focus shifts entirely to comfort and dignity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It advises to \u201cConsider hospice care when appropriate\u201d and frames the decision as choosing comfort over aggressive treatment, implying appropriateness when the focus is on comfort."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that hospice provides intensive symptom management, psychosocial and spiritual support, and home-based care, while avoiding non-beneficial interventions such as hospitalization or aggressive procedures.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Hospice is mentioned but without details about the scope of services (symptom management, psychosocial/spiritual support, home-based care) or avoidance of non-beneficial interventions."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention addressing practical issues related to end-of-life decision-making, such as managing costs and accessing resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses practicalities (advance directives, end-of-life planning, organizing practical matters) and accessing resources (social workers, hospice organizations, cancer support organizations)."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not advise discussing the decision with an oncologist; mentions palliative care teams and social workers but not the oncology team."
      }
    ],
    "question_number": 133,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T18:59:49.890139",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing legal planning with a qualified professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends consulting with an estate planning attorney and notes they can address the specific situation, meeting the requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that laws can vary state to state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that an attorney can ensure documents comply with \"your state's laws,\" clearly indicating state-by-state variation."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a description of an advance healthcare directive or living will.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines Advance Healthcare Directive/Living Will as outlining wishes for medical treatment, which is an accurate description."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of a medical power of attorney.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes Healthcare Power of Attorney as designating someone to make medical decisions if he cannot, which is correct."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of a durable power of attorney for finances.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains Financial Power of Attorney as authorizing someone to handle financial matters; while not labeled \"durable,\" it matches the intended function."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of a last will and testament.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that a Will or Trust ensures assets are distributed according to his wishes, which captures the core purpose of a will."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that POLST forms translate preferences into actionable medical orders for emergency settings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of POLST or similar medical order forms."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these documents ensure that care aligns with the patient\u2019s values and preferences, especially if the patient loses decision-making capacity due to disease progression or treatment effects.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that the advance directive outlines treatment wishes and that the healthcare power of attorney makes decisions if he cannot, which conveys alignment with preferences in the context of potential loss of capacity."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that it is essential to have ongoing, structured conversations about goals of care, as patient preferences may change over time.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Invites starting conversations but does not emphasize ongoing or structured goals-of-care discussions or that preferences may change over time."
      }
    ],
    "question_number": 134,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:00:14.113602",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing legal planning with a qualified professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends meeting with an estate planning attorney and notes that many attorneys offer expedited services; also suggests hospital social workers can connect them with legal resources."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that laws can vary state to state.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention that legal requirements differ by state or jurisdiction."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a description of an advance healthcare directive or living will.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines Advance Healthcare Directive/Living Will as documenting healthcare wishes."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of a medical power of attorney.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States Healthcare Power of Attorney names someone to make medical decisions if needed."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of a durable power of attorney for finances.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains that Durable Power of Attorney for Finances allows management of financial matters if he becomes unable to do so."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of a last will and testament.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that a Will ensures assets go where intended."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that POLST forms translate preferences into actionable medical orders for emergency settings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to POLST or physician orders for life-sustaining treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these documents ensure that care aligns with the patient\u2019s values and preferences, especially if the patient loses decision-making capacity due to disease progression or treatment effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions documenting healthcare wishes and naming a medical decision-maker, it does not explicitly connect these documents to ensuring care aligns with values/preferences in the context of loss of decision-making capacity due to disease progression or treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that it is essential to have ongoing, structured conversations about goals of care, as patient preferences may change over time.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Encourages discussing wishes and reviewing/updating documents, but does not explicitly mention ongoing, structured goals-of-care conversations or that preferences may change over time."
      }
    ],
    "question_number": 134,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:00:48.214161",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention discussing financial concerns with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their concerns with a social worker.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no reference to consulting a social worker."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend discussing their concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises: \"Ask to speak with a financial counselor or patient advocate.\""
      },
      {
        "criterion_number": 4,
        "description": "The response should state that patient advocacy organizations can help and include information on the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists the Pancreatic Cancer Action Network (PanCAN) under Disease-Specific Support and notes it offers financial assistance information."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that patient advocacy organizations can help and include information on CancerCare.org.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions CancerCare and states it provides limited financial assistance and co-payment help."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that patient advocacy organizations can help and include information for the American Cancer Society.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The American Cancer Society is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that patients with pancreatic cancer who are facing significant medical bills have access to several financial assistance options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It clearly introduces \"several financial assistance options available\" in direct response to pancreatic cancer-related financial stress."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that financial assistance options include patient assistance programs (PAPs) from independent charity foundations, pharmaceutical company programs, and direct grants from nonprofit organizations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions pharmaceutical company patient assistance programs and a nonprofit (CancerCare) providing assistance, it does not explicitly mention PAPs from independent charity foundations (e.g., HealthWell, PAN Foundation) or categorize assistance as direct grants."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that these programs may provide co-payment assistance, help with insurance premiums, and sometimes support for non-medical expenses such as transportation or housing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Co-payment assistance and non-medical support (transportation, lodging) are mentioned, but help with insurance premiums is not addressed."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that eligibility is generally based on annual household income (often up to 400\u2013500% of the federal poverty level), insurance status, and physician endorsement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No eligibility criteria (income thresholds, insurance status, or physician endorsement) are discussed."
      }
    ],
    "question_number": 135,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:01:17.791858",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly advise discussing financial concerns with the oncology team or oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends speaking with a social worker at the treatment center and notes a hospital social worker as an excellent first contact."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend discussing their concerns with a financial counselor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it mentions hospital financial aid programs and negotiation, it does not recommend speaking with a financial counselor or financial navigator."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that patient advocacy organizations can help and include information on the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists the Pancreatic Cancer Action Network as a potential funding source, implying advocacy organizations can help."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that patient advocacy organizations can help and include information on CancerCare.org.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes CancerCare and notes it offers limited financial assistance for treatment-related costs."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that patient advocacy organizations can help and include information for the American Cancer Society.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The American Cancer Society is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that patients with pancreatic cancer who are facing significant medical bills have access to several financial assistance options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It clearly introduces and lists multiple financial assistance options to explore."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that financial assistance options include patient assistance programs (PAPs) from independent charity foundations, pharmaceutical company programs, and direct grants from nonprofit organizations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions drug manufacturer prescription assistance programs and nonprofits like CancerCare, but does not mention independent charity foundation PAPs (e.g., PAN Foundation, HealthWell, Good Days)."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that these programs may provide co-payment assistance, help with insurance premiums, and sometimes support for non-medical expenses such as transportation or housing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not specify the types of assistance such as copay help, insurance premiums, or non-medical supports like transportation or housing."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that eligibility is generally based on annual household income (often up to 400\u2013500% of the federal poverty level), insurance status, and physician endorsement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No eligibility criteria (income thresholds, insurance status, or physician attestation) are discussed."
      }
    ],
    "question_number": 135,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:01:40.715238",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe PARP inhibitors as a class of targeted agents that block the PARP enzyme, which is involved in repairing single-strand DNA breaks.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response calls PARP inhibitors a \"type of targeted cancer therapy\" and explains they \"block proteins involved in repairing damaged DNA,\" which reflects blocking the PARP enzyme involved in DNA repair. Although it does not explicitly say \"single-strand DNA breaks,\" it accurately conveys the mechanism and targeted nature."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that PARP inhibitors can be used in advanced pancreatic cancer when there is a germline mutation in a BRCA gene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states PARP inhibitors are for patients with \"BRCA1 or BRCA2 gene mutations (inherited or in the tumor)\" and in \"advanced or metastatic disease,\" thereby explicitly including inherited (germline) mutations in the applicable setting."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that PARP inhibitors are used as maintenance therapy in patients with metastatic pancreatic cancer who have a germline BRCA1 or BRCA2 mutation and whose cancer has not progressed after at least 16 weeks of first-line platinum-based chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it correctly mentions use as maintenance after \"at least 16 weeks of first-line platinum-based chemotherapy\" and in advanced/metastatic disease, it does not specify that the maintenance indication is restricted to germline BRCA1/2 mutations. It broadens eligibility to include tumor (somatic) BRCA mutations, which does not meet the precise requirement."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that comprehensive germline testing for BRCA mutations is recommended for all patients with pancreatic cancer to identify those eligible for this targeted approach.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It says \"Genetic testing is needed to determine eligibility\" but does not state that comprehensive germline testing is recommended for all patients with pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the American Society of Clinical Oncology specifically recommends olaparib, based on the POLO trial, which demonstrated a significant improvement in progression-free survival compared to placebo, without compromising quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It identifies olaparib as FDA-approved maintenance therapy but does not mention ASCO recommendations, the POLO trial, progression-free survival benefit, or quality-of-life findings."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that other PARP inhibitors and combination strategies are under investigation, but their use remains investigational at this time. Based on the NCCN Guidelines Version 2.2025: Principles of Systemic Therapy for Pancreatic Adenocarcinoma (Metastatic Disease, First-Line Therapy) across performance status groups.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention is made of other PARP inhibitors or combination strategies being investigational, nor is there any reference to NCCN-recommended first-line regimens by performance status."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises, \"Your father's oncology team will determine if genetic testing and PARP inhibitors are appropriate\" and encourages asking them about testing and options, clearly recommending discussion with the oncology team."
      }
    ],
    "question_number": 136,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:02:25.847378",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe PARP inhibitors as targeted agents that block the PARP enzyme, which is involved in repairing single-strand DNA breaks.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response correctly identifies PARP inhibitors as targeted therapies that block PARP involved in DNA repair, but it does not specify that PARP repairs single-strand DNA breaks, which is required for full credit."
      },
      {
        "criterion_number": 2,
        "description": "Mention that PARP inhibitors can be used in advanced pancreatic cancer when there is a germline mutation in a BRCA gene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states PARP inhibitors are primarily for patients with inherited BRCA1/2 mutations and notes FDA approval of olaparib for patients with germline BRCA mutations, implying use in advanced disease."
      },
      {
        "criterion_number": 3,
        "description": "Mention that PARP inhibitors are used as maintenance therapy in metastatic pancreatic cancer with germline BRCA1/2 mutation after at least 16 weeks of first-line platinum-based chemotherapy without progression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions possible use as maintenance after chemotherapy has controlled the cancer, it does not specify metastatic disease, the requirement for at least 16 weeks, or that the chemotherapy should be platinum-based."
      },
      {
        "criterion_number": 4,
        "description": "Mention that comprehensive germline testing for BRCA mutations is recommended for all patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response says genetic testing is usually required and highlights certain risk groups, but it does not state that comprehensive germline testing is recommended for all patients with pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "Mention that ASCO recommends olaparib based on the POLO trial showing improved PFS vs placebo without compromising quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ASCO recommendations, the POLO trial, progression-free survival, or quality-of-life outcomes."
      },
      {
        "criterion_number": 6,
        "description": "Mention that other PARP inhibitors and combination strategies are investigational, and reference NCCN V2.2025 systemic therapy context.",
        "score_given": 0,
        "max_points": 4,
        "justification": "The response does not mention investigational status of other PARP inhibitors/combos or provide any NCCN guideline context for systemic therapy options."
      },
      {
        "criterion_number": 7,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages discussing specifics with the father's oncology team, including testing and treatment timing."
      }
    ],
    "question_number": 136,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:02:50.816403",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend considering proximity to the treatment center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states: 'Consider proximity to the center for frequent appointments.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend considering housing options near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'Housing costs and availability near the treatment center' and whether temporary vs. permanent relocation makes sense."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend considering transportation to and from the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Transportation options (especially if driving becomes difficult)'."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering financial considerations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses financial factors such as 'Housing costs' and the logistics of temporary vs. permanent relocation, which are financial considerations."
      },
      {
        "criterion_number": 5,
        "description": "The response should include insurance coverage.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States 'Verify insurance coverage and whether the center is in-network.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend considering the social support system near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes 'Proximity to existing support network vs. building new connections' and availability of 'respite care and home health services.'"
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN) Patient services.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of PanCAN or its Patient Services."
      },
      {
        "criterion_number": 8,
        "description": "The response should provide information for the American Cancer Society (ACS) page on finding a doctor.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not reference ACS or its resources for finding a doctor."
      },
      {
        "criterion_number": 9,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No NCI link or reference to NCI-designated cancer centers is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of NCCN recommendations, version 2.2025, high-volume centers, or high-volume imaging."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly mentions patient preferences, goals of care, or quality of life as central to the decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Your mother's preferences and comfort level with relocating' and a 'Quality of Life' section."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly addresses open communication about expectations, prognosis, or the impact of relocation on daily life.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it notes impacts on daily life, it does not explicitly recommend open communication about expectations or prognosis with the care team or family."
      },
      {
        "criterion_number": 13,
        "description": "The response explicitly mentions continuity of care, transferring medical records, coordinating with the current care team, or ensuring uninterrupted access to medications/supportive services.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions 'Access to pharmacies, medical supply stores, and support services' but does not address continuity of care, transferring records, coordination with the current team, or ensuring uninterrupted access."
      },
      {
        "criterion_number": 14,
        "description": "The response explicitly mentions access to multidisciplinary care and/or clinical trials as important factors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to 'Research cancer centers... with strong multidisciplinary teams' and to 'Compare clinical trial availability.'"
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly recommends discussing the case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not advise discussing the case with an oncologist."
      }
    ],
    "question_number": 137,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:03:22.191755",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend considering proximity to the treatment center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly recommend considering proximity or travel time to the treatment center; transportation and parking are mentioned, but not proximity."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend considering housing options near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions 'Housing costs and availability near the cancer center.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend considering transportation to and from the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly includes 'Transportation and parking at the facility,' addressing travel logistics."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering financial considerations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Financial aspects are addressed through 'Housing costs,' 'Insurance coverage,' and implications for work/life flexibility."
      },
      {
        "criterion_number": 5,
        "description": "The response should include insurance coverage.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It mentions 'Insurance coverage at the new location' and questions about 'out-of-network care.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend considering the social support system near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes 'Distance from current support network (family, friends).' "
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN) Patient services.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of PanCAN or its patient services."
      },
      {
        "criterion_number": 8,
        "description": "The response should provide information for the American Cancer Society (ACS) page on finding a doctor.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of ACS resources for finding a doctor."
      },
      {
        "criterion_number": 9,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No link or reference to the NCI-designated cancer center finder."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No reference to NCCN guidance, version 2.2025, multidisciplinary teams, or high-volume imaging."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly mentions patient preferences, goals of care, or quality of life as central to the decision.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly mention goals of care, patient preferences, or quality of life as central, only that the 'best choice depends on her specific situation.'"
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly addresses open communication about expectations, prognosis, or the impact of relocation on daily life.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While practical impacts (work/life flexibility) are listed, there is no explicit guidance on open communication about expectations or prognosis."
      },
      {
        "criterion_number": 13,
        "description": "The response explicitly mentions continuity of care, transferring medical records, coordinating with the current care team, or ensuring uninterrupted access to medications/supportive services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It addresses 'How transfer might affect treatment continuity' and suggests coordination with the current oncologist and the cancer center."
      },
      {
        "criterion_number": 14,
        "description": "The response explicitly mentions access to multidisciplinary care and/or clinical trials as important factors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists 'clinical trial access' as a medical factor."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly recommends discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends, 'Consult with her current oncologist about the potential benefits.'"
      }
    ],
    "question_number": 137,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:04:12.558990",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the anxiety with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly advises, 'Talk to the oncology team about anti-anxiety medications if appropriate' and to 'write down questions and concerns to discuss with the doctor,' which constitutes discussing anxiety with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should include considering relaxation techniques prior to the scan.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends 'Practice relaxation techniques like deep breathing or guided meditation' before the scan."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend asking the oncology team about what will happen during the scan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests writing down questions for the doctor, it does not specifically recommend asking what will happen during the scan."
      },
      {
        "criterion_number": 4,
        "description": "The response should include talking to a mental health professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises 'Consider asking about counseling services through the cancer center,' which implies engaging with a mental health professional."
      },
      {
        "criterion_number": 5,
        "description": "The response should include talking to a social worker.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It explicitly mentions 'social workers or patient navigators who specialize in helping with scan-related anxiety.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should discuss medical interventions to help with anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends discussing 'anti-anxiety medications' with the oncology team, which are medical interventions."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that severe anxiety related to upcoming scans is highly prevalent or very common among patients with pancreatic cancer or cancer in general.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The opening sentence states, 'Scan anxiety is very common with pancreatic cancer.'"
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least two of the following resource types for managing treatment-related anxiety: psychotherapy, psychoeducation, supportive therapy, or integrative modalities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions 'counseling services' (psychotherapy) and 'relaxation techniques like deep breathing or guided meditation' (integrative modalities)."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly identifies Cognitive Behavioral Therapy (CBT) as the first-line or primary intervention for treatment-related anxiety in pancreatic cancer or cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 6,
        "justification": "CBT is not mentioned, nor is any attribution to a major oncology guideline provided."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions mindfulness-based interventions (MBIs) or mindfulness-based stress reduction (MBSR) as recommended for anxiety in cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mindfulness-based interventions or MBSR and guideline attribution are not explicitly mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that pharmacologic therapy may be considered for severe anxiety or when first-line psychological interventions are insufficient, and that this is a secondary option with weaker evidence, as per a major oncology guideline.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although medications are mentioned, the response does not frame them as secondary/for severe cases nor attribute this stance to a major oncology guideline."
      }
    ],
    "question_number": 138,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:04:42.535196",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the anxiety with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to ask the oncology team about anti-anxiety medication and the timing for results, indicating discussion with the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response should include considering relaxation techniques prior to the scan.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends relaxation techniques before the scan, including deep breathing, progressive muscle relaxation, and meditation apps."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend asking the oncology team about what will happen during the scan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests asking about timing for results but does not recommend asking the team what will happen during the scan itself."
      },
      {
        "criterion_number": 4,
        "description": "The response should include talking to a mental health professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends counseling with someone who specializes in medical anxiety or cancer support."
      },
      {
        "criterion_number": 5,
        "description": "The response should include talking to a social worker.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It specifically mentions that many cancer centers have social workers and encourages reaching out to them."
      },
      {
        "criterion_number": 6,
        "description": "The response should discuss medical interventions to help with anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking the oncology team about anti-anxiety medication if appropriate."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that severe anxiety related to upcoming scans is highly prevalent or very common among patients with pancreatic cancer or cancer in general.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states that 'scanxiety' is very real and common for cancer patients."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least two of the following resource types for managing treatment-related anxiety: psychotherapy, psychoeducation, supportive therapy, or integrative modalities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions counseling (psychotherapy), support groups (supportive therapy), and mind-body practices like relaxation/meditation (integrative modalities). At least two are clearly present."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly identifies Cognitive Behavioral Therapy (CBT) as the first-line or primary intervention for treatment-related anxiety in pancreatic cancer or cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 6,
        "justification": "CBT and guideline-based first-line status are not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions mindfulness-based interventions (MBIs) or mindfulness-based stress reduction (MBSR) as recommended for anxiety in cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mindfulness/MBSR and any guideline attribution are not explicitly mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that pharmacologic therapy may be considered for severe anxiety or when first-line psychological interventions are insufficient, and that this is a secondary option with weaker evidence, as per a major oncology guideline.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions medication, it does not frame it as secondary/for severe cases nor cite guideline-based evidence strength."
      }
    ],
    "question_number": 138,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:05:13.584594",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include open communication with the family.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit guidance to be honest but age-appropriate with children, encourage open dialogue, and hold family meetings directly promotes open family communication."
      },
      {
        "criterion_number": 2,
        "description": "The response should include maintaining daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated 'Daily Routines' section advises keeping regular schedules and creating new routines around treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include continuing to do activities that bring enjoyment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The 'Creating Positive Moments' section suggests small enjoyable activities, celebrating milestones, and making memories."
      },
      {
        "criterion_number": 4,
        "description": "The response should include letting the support system help.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The 'Practical Support' section encourages accepting help from friends/family, coordinating assistance, and using tools to manage it."
      },
      {
        "criterion_number": 5,
        "description": "The response should include ensuring self-care for the patient.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Self-care advice is directed to the caregiver ('your own health') and family members; it does not explicitly address the patient's self-care needs."
      },
      {
        "criterion_number": 6,
        "description": "The response should include ensuring self-care for the support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises the caregiver to maintain their own health, consider counseling, and connect with support groups\u2014clear support system self-care."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that pancreatic cancer imposes profound emotional, social, and practical upheaval on both the patient and family, disrupting established routines, roles, and relationships.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it acknowledges the challenge, it does not explicitly state the broader emotional, social, and practical upheaval or disruptions to roles and relationships."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that early integration of supportive and palliative care is recommended.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of supportive or palliative care integration."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that referrals to registered dietitians and symptom management specialists can help minimize disruptions to family life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to dietitians or symptom management specialists."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that caregiver and family support resources can provide education, emotional support, and practical assistance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Support groups are mentioned, but the response does not state that caregiver/family resources provide education, emotional support, and practical assistance."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the literature notes persistent gaps in support for caregivers and families affected by pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of literature or gaps in caregiver/family support."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not advise discussing with the oncologist."
      }
    ],
    "question_number": 139,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:05:42.453187",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include open communication with the family.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit guidance on honest, age-appropriate sharing, regular family check-ins, encouraging expression, and considering family counseling demonstrates open communication."
      },
      {
        "criterion_number": 2,
        "description": "The response should include maintaining daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specific recommendations to keep regular meal times, bedtimes, and family activities directly address maintaining routines."
      },
      {
        "criterion_number": 3,
        "description": "The response should include continuing to do activities that bring enjoyment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Suggestions to continue traditions and celebrations, plan small outings on good days, and create memory-making opportunities clearly promote enjoyable activities."
      },
      {
        "criterion_number": 4,
        "description": "The response should include letting the support system help.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages accepting help from friends/family with meals, errands, childcare, and connecting with support groups, meeting the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response should include ensuring self-care for the patient.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Self-care recommendations are directed to the caregiver, not the patient; no explicit patient self-care strategies are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should include ensuring self-care for the support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated section advises caregiver breaks, respite care, and staying connected with a support network."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that pancreatic cancer imposes profound emotional, social, and practical upheaval on both the patient and family, disrupting established routines, roles, and relationships.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While empathetic, it does not explicitly state the profound emotional, social, and practical disruptions to routines, roles, and relationships."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that early integration of supportive and palliative care is recommended.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of supportive or palliative care integration."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that referrals to registered dietitians and symptom management specialists can help minimize disruptions to family life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No referrals to dietitians or symptom-management specialists are discussed."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that caregiver and family support resources can provide education, emotional support, and practical assistance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Support groups and CancerCare are mentioned, but their roles in providing education, emotional support, and practical assistance are not explicitly described."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the literature notes persistent gaps in support for caregivers and families affected by pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No reference to literature noting gaps in caregiver/family support."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No recommendation to consult the oncologist about these concerns."
      }
    ],
    "question_number": 139,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:06:20.300706",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing genetic counseling with the oncology team or healthcare provider in the context of pancreatic cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises, \"Your oncologist can provide a referral to a genetic counselor,\" directly recommending engagement with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should accurately describe the role of a genetic counselor as a trained professional who helps individuals and families understand the genetic aspects of disease, provides information, guidance, and support for informed decision-making, and assists with risk assessment and testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes an initial consultation with a cancer genetics specialist, review of personal/family history (risk assessment), discussion of testing options/benefits/limitations, and results interpretation/follow-up counseling\u2014capturing education, guidance, and support for decision-making."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that genetic counseling involves a structured evaluation of personal and family cancer history.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states \"Review of personal and family medical history (3+ generations),\" clearly indicating a structured history evaluation."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that genetic counseling involves education about hereditary cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It references hereditary cancer syndromes (e.g., BRCA1/2, Lynch) and places them within the counseling/testing context, implying education about these syndromes."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that genetic counseling involves a discussion of the risks, benefits, and limitations of genetic testing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly includes \"Discussion about genetic testing options, benefits, and limitations.\""
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that genetic counseling addresses the psychological and ethical aspects of genetic information, including communication of results to family members and consideration of reproductive implications.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes emotional implications and potential insurance impacts, it does not explicitly address communication of results to family members nor reproductive implications."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the American Society of Clinical Oncology recommends that this process be conducted with providers experienced in hereditary cancer syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ASCO or its recommendation regarding provider expertise."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the American Society of Clinical Oncology recommends that germline genetic testing be offered early in the disease course, ideally using a multigene panel that includes genes linked to pancreatic cancer risk such as BRCA1, BRCA2, and others.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although BRCA1/2 are referenced, the response does not cite ASCO recommendations, timing (early in disease course), or specify multigene panel testing."
      }
    ],
    "question_number": 140,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:06:54.579732",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing genetic counseling with the oncology team or healthcare provider in the context of pancreatic cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states, \"Your oncologist can refer you to a genetic counselor,\" which clearly recommends involving the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should accurately describe the role of a genetic counselor as a trained professional who helps individuals and families understand the genetic aspects of disease, provides information, guidance, and support for informed decision-making, and assists with risk assessment and testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes meeting with a certified genetic counselor, reviewing family/medical history, discussing hereditary syndromes, and considering genetic testing; it also highlights benefits such as treatment guidance, risk assessment, screening recommendations, and family planning\u2014all core functions of genetic counseling."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that genetic counseling involves a structured evaluation of personal and family cancer history.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states \"Detailed family and medical history review,\" which directly addresses structured evaluation."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that genetic counseling involves education about hereditary cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes \"Discussion of hereditary cancer syndromes linked to pancreatic cancer,\" satisfying this criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that genetic counseling involves a discussion of the risks, benefits, and limitations of genetic testing.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While benefits are listed and testing is mentioned, there is no explicit discussion of risks or limitations of genetic testing."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that genetic counseling addresses the psychological and ethical aspects of genetic information, including communication of results to family members and consideration of reproductive implications.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions \"family planning considerations\" (reproductive implications) but does not address psychological or ethical aspects or the communication of results to family members."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the American Society of Clinical Oncology recommends that this process be conducted with providers experienced in hereditary cancer syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no reference to ASCO recommendations or the stipulation about providers experienced in hereditary cancer syndromes."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the American Society of Clinical Oncology recommends that germline genetic testing be offered early in the disease course, ideally using a multigene panel that includes genes linked to pancreatic cancer risk such as BRCA1, BRCA2, and others.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although relevant genes are listed, the response does not mention ASCO guidance, timing (early in the disease course), or explicitly recommend a multigene panel."
      }
    ],
    "question_number": 140,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:07:40.687894",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that neuropathy is a common side effect from certain chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states neuropathy is a common side effect and cites chemotherapy drugs, especially oxaliplatin and paclitaxel."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing options with the oncology team and notes a personalized plan based on the patient's situation."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that neuropathy from chemotherapy can be managed by dose reduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly states the oncologist may reduce chemotherapy doses."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that neuropathy from chemotherapy can be managed by schedule modification.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions adjusting the treatment schedule."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that neuropathy from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that switching to different chemotherapy drugs may be done."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that neuropathy from chemotherapy can be managed using supportive medications, including gabapentin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Lists gabapentin as a medication option for neuropathic pain."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Mentions oxaliplatin as a cause and lists duloxetine (an SNRI) as often first-line for chemotherapy-induced neuropathy."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Includes pregabalin among medication options."
      },
      {
        "criterion_number": 10,
        "description": "The response should include physical therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly lists physical therapy."
      },
      {
        "criterion_number": 11,
        "description": "The response should include occupational therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly lists occupational therapy."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that peripheral neuropathy could arise from chemotherapy (notably platinum agents), direct tumor involvement, or paraneoplastic syndromes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions chemotherapy (including oxaliplatin) and the cancer itself, but does not mention paraneoplastic syndromes."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that peripheral neuropathy significantly impairs quality of life and functional status.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes balance and fall prevention but does not explicitly state significant impacts on quality of life or functional status."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that management should be individualized, balancing efficacy, side effects, and patient-specific factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages a personalized plan based on the patient\u2019s situation and symptom severity."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that Duloxetine is the only agent with moderate evidence-based recommendation for the treatment of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Identifies duloxetine as often first-line but does not state it is the only agent with moderate evidence-based recommendation."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that the typical starting dose of duloxetine is 30 mg daily, titrated to 60 mg daily as tolerated, with slow tapering recommended to avoid withdrawal symptoms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No dosing, titration, or tapering details for duloxetine are provided."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that other pharmacologic options include tricyclic antidepressants (nortriptyline, amitriptyline), gabapentin, and pregabalin, which are supported by guidelines for cancer-related neuropathic pain but have inconclusive evidence.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Lists TCAs, gabapentin, and pregabalin but does not discuss guideline support or that evidence is inconclusive."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical agents such as lidocaine and capsaicin patches may be considered for localized neuropathic pain, though evidence is limited.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions lidocaine and capsaicin but does not specify use for localized pain or note limited evidence."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that opioids are not preferred for chronic neuropathic pain due to risk of tolerance, dependence, and adverse effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "States opioids may be considered for severe cases without noting they are not preferred for chronic neuropathic pain or discussing associated risks."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that interventional approaches, notably neurolytic celiac plexus block, are effective for refractory pain in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neurolytic celiac plexus block or other interventional approaches."
      }
    ],
    "question_number": 141,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:08:35.540612",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that neuropathy is a common side effect from certain chemotherapy drugs.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response notes neuropathy can result from chemotherapy but does not state it is a common side effect or identify specific chemotherapy drugs."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises, \"discussing these options with his medical team\" and that the oncologist can develop the best plan, which constitutes a recommendation to discuss treatment options and side effects with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that neuropathy from chemotherapy can be managed by dose reduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly mentions \"Dose modifications\" if chemotherapy is causing neuropathy."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that neuropathy from chemotherapy can be managed by schedule modification.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly mentions \"Timing adjustments between treatments,\" which aligns with schedule modification."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that neuropathy from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states \"drug changes if chemo is causing the neuropathy,\" indicating switching regimens."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that neuropathy from chemotherapy can be managed using supportive medications, including gabapentin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Gabapentin is listed under medications for neuropathy."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Although duloxetine (an SNRI) is mentioned, the response does not specify oxaliplatin-associated neuropathy."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Pregabalin is listed, but oxaliplatin-specific management is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should include physical therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Physical therapy is explicitly recommended."
      },
      {
        "criterion_number": 11,
        "description": "The response should include occupational therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Occupational therapy is explicitly recommended."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that peripheral neuropathy could arise from chemotherapy (notably platinum agents), direct tumor involvement, or paraneoplastic syndromes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It mentions neuropathy can result from chemotherapy and the cancer itself, but does not note platinum agents or paraneoplastic syndromes."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that peripheral neuropathy significantly impairs quality of life and functional status.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit statement about quality of life or functional status impact."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that management should be individualized, balancing efficacy, side effects, and patient-specific factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states treatment should be tailored to the specific situation and coordinated by the oncologist/pain specialist, indicating individualized management."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that Duloxetine is the only agent with moderate evidence-based recommendation for the treatment of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Duloxetine is listed but there is no mention of its unique evidence-based recommendation for CIPN."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that the typical starting dose of duloxetine is 30 mg daily, titrated to 60 mg daily as tolerated, with slow tapering recommended to avoid withdrawal symptoms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No dosing or tapering guidance for duloxetine is provided."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that other pharmacologic options include tricyclic antidepressants (nortriptyline, amitriptyline), gabapentin, and pregabalin, which are supported by guidelines for cancer-related neuropathic pain but have inconclusive evidence.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While amitriptyline, gabapentin, and pregabalin are listed, the response does not state guideline support or that evidence is inconclusive."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical agents such as lidocaine and capsaicin patches may be considered for localized neuropathic pain, though evidence is limited.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Topical lidocaine and capsaicin are mentioned, but there is no comment on limited evidence or emphasis on localized pain."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that opioids are not preferred for chronic neuropathic pain due to risk of tolerance, dependence, and adverse effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It generically mentions pain medications but does not caution against opioids for chronic neuropathic pain."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that interventional approaches, notably neurolytic celiac plexus block, are effective for refractory pain in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No interventional pain approaches (e.g., celiac plexus block) are mentioned."
      }
    ],
    "question_number": 141,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:10:05.739547",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define curative treatment as interventions with the intent to eradicate the disease and achieve long-term survival.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states curative treatment \"aims to completely remove or eliminate the cancer,\" which clearly conveys intent to eradicate the disease; curative intent inherently implies pursuit of long-term survival."
      },
      {
        "criterion_number": 2,
        "description": "Curative treatment can include surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions surgery, including the Whipple procedure, as part of curative treatment."
      },
      {
        "criterion_number": 3,
        "description": "In curative treatment, surgery is often followed by adjuvant chemotherapy to reduce recurrence risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes surgery is often combined with chemotherapy and/or radiation, it does not specify adjuvant (postoperative) chemotherapy to reduce recurrence risk."
      },
      {
        "criterion_number": 4,
        "description": "Define palliative treatment as focusing on improving quality of life when cure is not possible.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response states palliative care focuses on managing symptoms and maintaining quality of life and \"doesn't aim to cure,\" satisfying the definition."
      },
      {
        "criterion_number": 5,
        "description": "Mention that palliative treatment is the case for the majority of patients with locally advanced unresectable or metastatic disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes only 15\u201320% are candidates for curative treatment, but it does not explicitly state that the majority with locally advanced unresectable or metastatic disease receive palliative treatment."
      },
      {
        "criterion_number": 6,
        "description": "Include that the primary goal of palliative treatment is to prolong survival, control symptoms, and maintain quality of life.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states palliative care can significantly extend life (prolong survival), reduce discomfort (symptom control), and maintain quality of life."
      },
      {
        "criterion_number": 7,
        "description": "Palliative treatment can include chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly includes chemotherapy as a palliative option to slow cancer growth."
      },
      {
        "criterion_number": 8,
        "description": "Palliative treatment can include radiation for local control or pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly mentions radiation for pain relief."
      },
      {
        "criterion_number": 9,
        "description": "Palliative treatment can include pain management.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions pain relief and comprehensive symptom management, which includes pain management."
      },
      {
        "criterion_number": 10,
        "description": "Mention that palliative approaches include endoscopic or surgical procedures to relieve biliary or gastric outlet obstruction, and comprehensive supportive care for pain, nutrition, and psychosocial needs.",
        "score_given": 0,
        "max_points": 4,
        "justification": "While it references \"procedures to address blockages\" and comprehensive symptom management, it does not specify biliary or gastric outlet obstruction, endoscopic/surgical approaches, or supportive care for nutrition and psychosocial needs."
      },
      {
        "criterion_number": 11,
        "description": "Mention that ASCO emphasizes early integration of palliative care for all patients with advanced disease to address symptom burden and support patient and family well-being.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Early palliative care is implied (can begin at diagnosis), but there is no mention of ASCO or its specific guidance."
      },
      {
        "criterion_number": 12,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises engaging the mother's oncology team and asking them specific questions, which constitutes a recommendation to discuss with an oncologist."
      }
    ],
    "question_number": 142,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:11:10.363288",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define curative treatment as interventions with the intent to eradicate the disease and achieve long-term survival.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that curative treatment aims to eliminate the cancer completely and includes a goal of long-term survival, which matches the criterion."
      },
      {
        "criterion_number": 2,
        "description": "Include that curative treatment can include surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists surgery to remove the tumor as part of curative treatment."
      },
      {
        "criterion_number": 3,
        "description": "Mention that in curative treatment, surgery is often followed by adjuvant chemotherapy to reduce recurrence risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While chemotherapy is mentioned, the response does not specify adjuvant chemotherapy after surgery to reduce recurrence risk."
      },
      {
        "criterion_number": 4,
        "description": "Define palliative treatment as focusing on improving quality of life when cure is not possible.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It clearly states palliative care focuses on managing symptoms, improving quality of life, and providing comfort rather than cure."
      },
      {
        "criterion_number": 5,
        "description": "Mention that palliative treatment is the case for the majority of patients with locally advanced unresectable or metastatic disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that most patients with locally advanced unresectable or metastatic pancreatic cancer receive palliative treatment."
      },
      {
        "criterion_number": 6,
        "description": "Include that the primary goal of palliative treatment is to prolong survival, control symptoms, and maintain quality of life.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions symptom control and quality of life but does not include prolonging survival as a goal."
      },
      {
        "criterion_number": 7,
        "description": "Include that palliative treatment can include chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Chemotherapy is not mentioned in the palliative context."
      },
      {
        "criterion_number": 8,
        "description": "Include that palliative treatment can include radiation for local control or pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Radiation is not mentioned as a palliative option for local control or pain."
      },
      {
        "criterion_number": 9,
        "description": "Include that palliative treatment can include pain management.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Pain management is explicitly listed under palliative treatment."
      },
      {
        "criterion_number": 10,
        "description": "Mention that palliative approaches include endoscopic or surgical procedures to relieve biliary or gastric outlet obstruction, and comprehensive supportive care for pain, nutrition, and psychosocial needs.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Although it mentions relieving 'blockages' and supportive measures (pain, nutrition, emotional/spiritual care), it does not specifically mention endoscopic or surgical procedures or name biliary/gastric outlet obstruction."
      },
      {
        "criterion_number": 11,
        "description": "Mention that ASCO emphasizes early integration of palliative care for all patients with advanced disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ASCO or early integration guidance is included."
      },
      {
        "criterion_number": 12,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests discussing with her medical team and consulting a palliative care specialist but does not specifically recommend speaking with an oncologist."
      }
    ],
    "question_number": 142,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:11:44.653833",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the costs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises researching total costs, including treatment, travel, accommodation, and follow-up care."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment decisions with your oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a section 'Questions for Your Current Oncologist' and mentions coordinating care and seeking second opinions from major cancer centers."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the stage of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of assessing or incorporating the cancer stage into decision-making."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the type of cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not advise confirming tumor subtype (e.g., PDAC vs neuroendocrine)."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding the reputation of the clinic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends verifying hospital/clinic accreditation, patient outcomes, and testimonials."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the qualifications of the providers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically calls for reviewing oncologists\u2019 qualifications and experience with pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the details of the experimental treatments, including types of drugs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises researching the specific treatment\u2019s phase, scientific rationale, and published research, covering key treatment details."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the evidence supporting the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes published research, preliminary results, success rates, and realistic expectations."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the potential side effects of the experimental treatments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention adverse effects, toxicities, or side-effect profiles."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend understanding the safety of the drugs.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit guidance on drug safety profiles, monitoring requirements, or known risks."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding the legal protections of the country.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions legal recourse if complications arise, addressing legal protections."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the availability of medical records.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes medical record translation and transfer processes."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the logistics of traveling abroad for treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Covers travel logistics including visa, length of stay, emergency care availability, and proximity to medical facilities."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention considering your loved one\u2019s health and travel suitability, as long travel can be taxing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address fitness to travel or the physical burden of long-distance travel."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention considering if the other country has specialized high-quality pancreatic cancer care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises checking oncologists\u2019 pancreatic cancer experience, accreditation, and proximity to quality facilities."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention considering visa barriers when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly mentions visa requirements and length of stay."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention considering local accommodations when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes accommodation costs in practical considerations."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention considering cultural barriers when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses language services and communication protocols, key cultural/communication barriers."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention considering challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Notes the need for a continuity of care plan when returning home."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention considering social support challenges when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Mentions local support services for international patients, addressing social support considerations."
      }
    ],
    "question_number": 143,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:12:46.056084",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the costs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises researching total costs including treatment, travel, accommodation, and follow-up care."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment decisions with your oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends getting a second opinion from pancreatic cancer specialists at home and consulting with the current oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the stage of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of determining or considering the cancer stage."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the type of cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not address identifying the histologic type (e.g., adenocarcinoma vs neuroendocrine)."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding the reputation of the clinic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises verifying that treatment is conducted at accredited medical facilities, which reflects clinic reputation."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the qualifications of the providers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends researching the medical team's credentials and experience with pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the details of the experimental treatments, including types of drugs.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Suggests understanding the treatment protocol and risks but does not explicitly call out learning the specific drug types or modalities used."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the evidence supporting the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly advises looking for published research or clinical trial data on the treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the potential side effects of the experimental treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends understanding potential benefits and risks, which encompasses side effects."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend understanding the safety of the drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses safety via regulatory approval status, medical licensing and oversight, emergency care availability, and understanding treatment risks."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding the legal protections of the country.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions legal protections and recourse options in that country."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the availability of medical records.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Calls out medical records transfer and continuity of care."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the logistics of traveling abroad for treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Discusses travel logistics including visas, language services, duration of stay, and follow-up visit requirements."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention considering your loved one\u2019s health and travel suitability, as long travel can be taxing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address the patient\u2019s fitness for travel or the strain of long-distance travel."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention considering if the other country has specialized high-quality pancreatic cancer care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises verifying accredited medical facilities and researching providers\u2019 experience with pancreatic cancer, implying specialized high-quality care."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention considering visa barriers when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly includes visa/travel requirements and restrictions."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention considering local accommodations when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes accommodations as part of total costs, indicating the need to consider lodging arrangements."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention considering cultural barriers when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes language barriers and translation services, a key cultural/communication barrier relevant to care."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention considering challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Addresses follow-up visit requirements, continuity of care, and records transfer, directly relating to follow-up challenges."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention considering social support challenges when traveling abroad for treatment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions connecting with organizations and other patients but does not discuss potential social support gaps or caregiver challenges due to traveling abroad."
      }
    ],
    "question_number": 143,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:13:32.589343",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe why treatments for pancreatic cancer can increase the risk of infections, including immunosuppression due to chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response lists prevention strategies but does not explain why infection risk is elevated during pancreatic cancer treatment (e.g., chemotherapy-induced neutropenia/immunosuppression, biliary stents, surgery). No causal explanation is provided."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend hand hygiene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends frequent handwashing and using hand sanitizer when soap isn't available."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding sick contacts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States to avoid crowds and people who are sick."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend being up to date on age-appropriate vaccinations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises staying current with recommended vaccinations and to check with the oncologist first."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing the infections with the oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages keeping follow-up appointments, reporting fever immediately, and includes specific questions to ask the healthcare team, indicating engagement with the oncology team."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend food safety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple food safety measures: avoid raw/undercooked foods, wash produce, separate cutting boards, refrigerate leftovers."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend adherence with prophylactic medications if prescribed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to take prescribed antibiotics exactly as directed and raises the question of prophylactic antibiotics with the care team, implying adherence if prescribed."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention avoiding exposure to fungal spores, especially for patients with neutropenia, by avoiding environments with high concentrations of airborne fungal spores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of avoiding fungal spore exposures (e.g., soil, mulch, construction sites) or neutropenia-specific environmental precautions."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not provide the nuance that most solid tumor patients without prolonged neutropenia generally do not need routine antimicrobial prophylaxis."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of avoiding low-value interventions such as protected environments, neutropenic diet, footwear exchange, or nutritional supplements due to lack of evidence."
      }
    ],
    "question_number": 144,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:13:58.770716",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe why treatments for pancreatic cancer can increase the risk of infections, including immunosuppression due to chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response acknowledges that treatment-related infections are a concern but does not explain why (e.g., chemotherapy-induced neutropenia/immunosuppression, central lines, biliary stents). No mechanism or mention of immunosuppression is provided."
      },
      {
        "criterion_number": 2,
        "description": "Recommend hand hygiene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit recommendation: 'Maintain excellent hand hygiene for everyone in the household.'"
      },
      {
        "criterion_number": 3,
        "description": "Recommend avoiding sick contacts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit recommendation: 'Avoid crowds and people who are sick.'"
      },
      {
        "criterion_number": 4,
        "description": "Recommend being up to date on age-appropriate vaccinations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Vaccinations are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "Recommend discussing the infections with the oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Multiple recommendations to engage the oncology team: 'Stay in close contact with the oncology team,' and 'Report any signs of infection immediately to the medical team.'"
      },
      {
        "criterion_number": 6,
        "description": "Recommend food safety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit recommendation: 'Practice safe food handling (well-cooked foods, proper storage).' "
      },
      {
        "criterion_number": 7,
        "description": "Recommend adherence with prophylactic medications if prescribed.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response says, 'Ask about prophylactic medications if appropriate,' but does not advise adherence/taking them as prescribed. The rubric requires an explicit recommendation to adhere if prescribed."
      },
      {
        "criterion_number": 8,
        "description": "Mention avoiding exposure to fungal spores, especially for patients with neutropenia, by avoiding environments with high concentrations of airborne fungal spores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of avoiding high spore environments (e.g., construction sites, gardening, mulch, compost). Ventilation/air purifiers are mentioned but do not address fungal spore avoidance."
      },
      {
        "criterion_number": 9,
        "description": "Mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 6,
        "justification": "No statement about not needing antimicrobial prophylaxis for most solid tumors with brief neutropenia."
      },
      {
        "criterion_number": 10,
        "description": "Mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention that these interventions are not recommended due to lack of benefit."
      }
    ],
    "question_number": 144,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:14:29.275708",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes the combination of immune checkpoint blockade with chemotherapy as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions PD-1/PD-L1 inhibitors combined with chemotherapy (FOLFIRINOX or gemcitabine-based)."
      },
      {
        "criterion_number": 2,
        "description": "The response describes the combination of immune checkpoint blockade with radiation as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PD-1/PD-L1 inhibitors combined with radiation therapy."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the combination of immune checkpoint blockade with other novel agents (e.g., targeted therapies, immune modulators, or agents targeting the tumor microenvironment) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes combinations with CTLA-4 inhibitors, targeted therapies, CD40 agonists, and agents targeting the stroma/TME."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly defines immunotherapy as a treatment that uses the body\u2019s immune system to attack cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit definition of immunotherapy as harnessing the immune system is provided."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with MSI-high tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "MSI-H status is mentioned, but there is no explicit statement about pembrolizumab approval in MSI-H pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with dMMR (deficient mismatch repair) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "dMMR-specific pembrolizumab approval is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with TMB-high (tumor mutational burden-high) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of pembrolizumab approval for TMB-high tumors."
      },
      {
        "criterion_number": 8,
        "description": "The response specifically mentions clinicaltrials.gov as a resource for finding immunotherapy clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Clinicaltrials.gov is not referenced."
      },
      {
        "criterion_number": 9,
        "description": "The response specifically mentions the PanCan clinical trial finder as a resource for finding immunotherapy clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The PanCan clinical trial finder is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response describes immune checkpoint blockade as a current strategy for studying immunotherapy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights PD-1/PD-L1 inhibitors and their combinations, which are immune checkpoint blockade strategies."
      },
      {
        "criterion_number": 11,
        "description": "The response describes adoptive cellular therapy (e.g., CAR-T cell therapy or modified T-cells) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions trials using CAR-T cell therapy."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that current research on immunotherapy combinations for patients with pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment (TME) and enhancing antitumor immune responses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It discusses overcoming the 'cold' tumor environment, targeting stroma, CD40 agonists, and increasing T-cell infiltration, directly addressing TME and enhancing immune responses."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery, with early results suggesting potential improvements in disease-free and overall survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes research on timing immunotherapy with surgery but does not specify neoadjuvant priming or mention early improvements in disease-free or overall survival."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cancer vaccines are under investigation as an immunotherapy approach for pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It specifically mentions GVAX and personalized neoantigen vaccines under investigation."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends discussing clinical trial options with the oncology team and seeking a second opinion at a major cancer center."
      }
    ],
    "question_number": 145,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:14:57.621231",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes the combination of immune checkpoint blockade with chemotherapy as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states 'PD-1/PD-L1 inhibitors combined with chemotherapy' under 'Checkpoint Inhibitors + Other Treatments.'"
      },
      {
        "criterion_number": 2,
        "description": "The response describes the combination of immune checkpoint blockade with radiation as a current research strategy in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'combining radiation, immunotherapy' but does not specifically describe checkpoint inhibitor\u2013radiation combinations."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the combination of immune checkpoint blockade with other novel agents (e.g., targeted therapies, immune modulators, or agents targeting the tumor microenvironment) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes checkpoint inhibitor combinations with CTLA-4 inhibitors, targeted therapies (e.g., PARP inhibitors), and mentions targeting the tumor microenvironment."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly defines immunotherapy as a treatment that uses the body\u2019s immune system to attack cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit definition of immunotherapy provided."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with MSI-high tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Pembrolizumab and MSI-high approval are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with dMMR (deficient mismatch repair) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of dMMR or pembrolizumab approval."
      },
      {
        "criterion_number": 7,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with TMB-high (tumor mutational burden-high) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of TMB-high or pembrolizumab approval."
      },
      {
        "criterion_number": 8,
        "description": "The response specifically mentions clinicaltrials.gov as a resource for finding immunotherapy clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Clinicaltrials.gov is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response specifically mentions the PanCan clinical trial finder as a resource for finding immunotherapy clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "PanCAN is mentioned generally as a resource, but the PanCAN clinical trial finder is not specifically referenced."
      },
      {
        "criterion_number": 10,
        "description": "The response describes immune checkpoint blockade as a current strategy for studying immunotherapy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly discusses checkpoint inhibitors (PD-1/PD-L1, CTLA-4) as part of current research strategies."
      },
      {
        "criterion_number": 11,
        "description": "The response describes adoptive cellular therapy (e.g., CAR-T cell therapy or modified T-cells) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section on 'CAR-T Cell Therapy' describing modified immune cells targeting pancreatic cancer markers."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that current research on immunotherapy combinations for patients with pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment (TME) and enhancing antitumor immune responses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions 'overcoming the challenging tumor environment,' 'Combinations targeting the tumor microenvironment,' and making 'cold' tumors more responsive."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery, with early results suggesting potential improvements in disease-free and overall survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neoadjuvant use or pre-surgical priming and outcomes."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cancer vaccines are under investigation as an immunotherapy approach for pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Has a 'Vaccine Combinations' section, including personalized vaccines and combinations with checkpoint inhibitors."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages working closely with the medical team and states 'Your oncologist can help determine which approaches...'"
      }
    ],
    "question_number": 145,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:15:29.842710",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend understanding the goal of the study",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response asks, 'What phase is this trial, and what is its main purpose?', directly prompting clarification of the study's goal."
      },
      {
        "criterion_number": 2,
        "description": "Recommend understanding the phase of the trial",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly includes the question, 'What phase is this trial?'"
      },
      {
        "criterion_number": 3,
        "description": "Recommend understanding the eligibility requirements of the trial",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes, 'What are the specific eligibility criteria?' which directly addresses eligibility."
      },
      {
        "criterion_number": 4,
        "description": "Recommend understanding the potential side effects of the treatments",
        "score_given": 5,
        "max_points": 5,
        "justification": "It asks, 'What are the known and potential risks/side effects?' meeting this criterion."
      },
      {
        "criterion_number": 5,
        "description": "Recommend understanding if there are additional tests required to participate in the trial",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not mention additional trial-specific tests or procedures (e.g., extra imaging, biopsies, or labs) required for participation."
      },
      {
        "criterion_number": 6,
        "description": "Recommend understanding if there are travel costs associated with the trial",
        "score_given": 3,
        "max_points": 3,
        "justification": "It asks about 'travel assistance' and what costs are covered, which encompasses potential travel-related expenses."
      },
      {
        "criterion_number": 7,
        "description": "Recommend understanding the evidence supporting the trial",
        "score_given": 5,
        "max_points": 5,
        "justification": "It asks whether the treatment has been tested before and what the results were, and who is sponsoring/conducting the study, which addresses supporting evidence."
      },
      {
        "criterion_number": 8,
        "description": "Recommend understanding the kind of treatment",
        "score_given": 5,
        "max_points": 5,
        "justification": "It asks, 'What treatment(s) will be tested, and how do they work?' clearly identifying the type of treatment."
      },
      {
        "criterion_number": 9,
        "description": "Recommend understanding the visit schedule of the trial",
        "score_given": 4,
        "max_points": 4,
        "justification": "It asks, 'Where will treatments take place, and how often?' and 'How long will the study last?', covering visit frequency and duration."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly states that research studies determine if a new strategy, treatment, or device is safe and/or effective for humans",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly state the overarching purpose of research studies as establishing safety and/or efficacy in humans."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly states that clinical trials are essential for advancing current/future cancer therapies",
        "score_given": 0,
        "max_points": 6,
        "justification": "There is no explicit statement about the essential role of clinical trials in improving or advancing cancer therapies."
      },
      {
        "criterion_number": 12,
        "description": "Includes the question: 'How will participation impact current treatment and care?'",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it asks about comparison to standard treatment and future eligibility, it does not include this specific question or an equivalent about the impact on current care."
      },
      {
        "criterion_number": 13,
        "description": "Includes the question: 'What are the implications for family members, especially if genetic testing is involved?'",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of genetic testing or implications for family members appears in the response."
      },
      {
        "criterion_number": 14,
        "description": "Recommend discussing the case with an oncologist or relevant healthcare professional to review details and pros/cons",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response suggests bringing a family member and asking for clarification but does not recommend discussing with an oncologist or care team."
      }
    ],
    "question_number": 146,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:16:08.263834",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the goal of the study.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes the question, \"What is the purpose and goals of this research?\" which directly addresses understanding the study\u2019s goal."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the phase of the trial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly asks, \"What phase is the trial (Phase I, II, or III)?\""
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the eligibility requirements of the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks, \"What are the inclusion/exclusion criteria?\" which covers eligibility."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the potential side effects of the treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes \"What are the potential side effects and risks?\" and also addresses monitoring and management of side effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding if there are additional tests required to participate in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks, \"What tests/procedures are required?\" which encompasses any additional tests for participation."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding if there are travel costs associated with the trial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Addresses general costs (insurance vs. out-of-pocket) and location but does not mention travel costs, lodging, or reimbursement."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the evidence supporting the trial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not ask about prior evidence, supporting data, or rationale for the trial; only asks how it compares to standard treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the kind of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks, \"What treatment(s) will be tested?\" which clarifies the treatment type."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the visit schedule of the trial.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes \"What's the treatment schedule and location?\" and \"How often are appointments required?\" clearly addressing visit schedule."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly states that research studies are designed to determine if a new medical strategy, treatment, or device is safe and/or effective for humans.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit statement about the purpose of research studies in terms of determining safety/efficacy."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that clinical trials are essential for improving, optimizing, or advancing current and/or future cancer therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not explicitly state the importance of clinical trials in advancing cancer therapy."
      },
      {
        "criterion_number": 12,
        "description": "The response includes the question: \u201cHow will participation impact current treatment and care?\u201d",
        "score_given": 0,
        "max_points": 6,
        "justification": "Related items (e.g., continuing with current oncologist) are present, but the specific question about impact on current treatment and care is not included."
      },
      {
        "criterion_number": 13,
        "description": "The response includes the question: \u201cWhat are the implications for family members, especially if genetic testing is involved?\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of implications for family members or genetic testing."
      },
      {
        "criterion_number": 14,
        "description": "The response recommends discussing the case with an oncologist or relevant healthcare professional to review trial details and discuss pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends getting a second opinion from another oncologist to review the study and standard treatment options."
      }
    ],
    "question_number": 146,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:16:49.464640",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe non-opioid medications for pain control, including acetaminophen.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly lists acetaminophen among non-opioid options."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe non-opioid medications for pain control, including NSAIDs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly lists NSAIDs among non-opioid options."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe non-opioid medications for neuropathic pain, including gabapentin.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions \"anti-seizure drugs\" for nerve pain but does not name gabapentin."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe non-opioid medications for neuropathic pain, including anti-depressants.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Notes that certain antidepressants can help with nerve pain."
      },
      {
        "criterion_number": 5,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including nerve blocks.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Specifically mentions nerve blocks and celiac plexus blocks for pancreatic cancer pain."
      },
      {
        "criterion_number": 6,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including radiation therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly lists radiation therapy to shrink tumors pressing on nerves."
      },
      {
        "criterion_number": 7,
        "description": "The response should include non-pharmacologic therapies, including acupuncture.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly includes acupuncture as a complementary therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response should include non-pharmacologic therapies, including psychological support.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes counseling for pain-related anxiety, fulfilling psychological support."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing symptom management with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises working with palliative care and pain management specialists but does not mention the oncology team."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe non-opioid medications for neuropathic pain, including pregabalin, duloxetine, nortriptyline, and amitriptyline.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not name pregabalin, duloxetine, nortriptyline, or amitriptyline."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical agents, including lidocaine and capsaicin patches, can be considered for localized neuropathic pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of topical lidocaine or capsaicin patches."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that corticosteroids are reserved for specific indications such as spinal cord compression or inflammatory pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Corticosteroids and their specific indications are not discussed."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that antioxidant supplementation may reduce painful attacks in select cases, though evidence is limited and should be considered adjunctive.",
        "score_given": 0,
        "max_points": 1,
        "justification": "No mention of antioxidant supplementation."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that interventional and procedural approaches are particularly relevant in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights celiac plexus blocks specifically for pancreatic cancer pain, indicating the relevance of interventional approaches."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that neurolytic celiac plexus block is supported by randomized trials for opioid-sparing pain relief.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions celiac plexus blocks but does not note neurolysis, randomized trial evidence, or opioid-sparing benefits."
      },
      {
        "criterion_number": 16,
        "description": "The response should include non-pharmacologic therapies, including physical therapy.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not mention physical therapy; mentions yoga/tai chi, massage, TENS, and heat/cold instead."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend discussing symptom management with a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends working with a palliative care team experienced in cancer pain management."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that cognitive-behavioral therapy and stress management are effective adjuncts.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions meditation, breathing, and counseling but does not specifically mention cognitive-behavioral therapy or state effectiveness of CBT and stress management as adjuncts."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that areas that need further research include the long-term comparative effectiveness of nonopioid and integrative modalities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No statement about research needs or long-term comparative effectiveness."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that effective pain management in pancreatic cancer requires regular assessment and individualized planning.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages keeping a pain diary (regular assessment) and notes creating a personalized plan with specialists."
      }
    ],
    "question_number": 147,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:17:38.182643",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe non-opioid medications for pain control, including acetaminophen.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions acetaminophen under non-opioid medications."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe non-opioid medications for pain control, including NSAIDs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions NSAIDs under non-opioid medications."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe non-opioid medications for neuropathic pain, including gabapentin.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions anticonvulsants broadly but does not name gabapentin."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe non-opioid medications for neuropathic pain, including anti-depressants.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Specifically references antidepressants for nerve pain."
      },
      {
        "criterion_number": 5,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including nerve blocks.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists nerve blocks and other interventional procedures."
      },
      {
        "criterion_number": 6,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including radiation therapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Radiation therapy is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should include non-pharmacologic therapies, including acupuncture.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Acupuncture is explicitly listed."
      },
      {
        "criterion_number": 8,
        "description": "The response should include non-pharmacologic therapies, including psychological support.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention psychological support such as counseling, support groups, or psychotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing symptom management with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises working closely with the oncology team and discussing options with the oncologist."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe non-opioid medications for neuropathic pain, including pregabalin, duloxetine, nortriptyline, and amitriptyline.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specify pregabalin, duloxetine, nortriptyline, or amitriptyline by name."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical agents, including lidocaine and capsaicin patches, can be considered for localized neuropathic pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions topical pain relievers generally but does not specify lidocaine or capsaicin patches or localized neuropathic pain."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that corticosteroids are reserved for specific indications such as spinal cord compression or inflammatory pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Corticosteroids and their specific indications are not discussed."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that antioxidant supplementation may reduce painful attacks in select cases, though evidence is limited and should be considered adjunctive.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Antioxidant supplementation is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that interventional and procedural approaches are particularly relevant in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Interventional approaches are listed but not noted as particularly relevant to pancreatic cancer."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that neurolytic celiac plexus block is supported by randomized trials for opioid-sparing pain relief.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neurolytic celiac plexus block and supporting evidence are not mentioned."
      },
      {
        "criterion_number": 16,
        "description": "The response should include non-pharmacologic therapies, including physical therapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Physical therapy/gentle movement is explicitly listed."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend discussing symptom management with a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends referral to palliative care specialists and notes their expertise."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that cognitive-behavioral therapy and stress management are effective adjuncts.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Meditation/relaxation are mentioned, but CBT and stress management are not specified."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that areas that need further research include the long-term comparative effectiveness of nonopioid and integrative modalities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of research gaps or comparative effectiveness."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that effective pain management in pancreatic cancer requires regular assessment and individualized planning.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions a comprehensive, personalized plan but does not state the need for regular/ongoing assessment."
      }
    ],
    "question_number": 147,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:18:17.362007",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing psychological concerns about the children with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions hospital social workers and child life specialists but does not explicitly advise discussing the teens' psychological concerns with the oncology team or the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends professional counseling and mentions mental health professionals (e.g., therapist, counselor, psychologist, psychiatrist).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends professional support and specifically mentions 'family therapists' and 'hospital social workers,' clearly endorsing counseling by mental health professionals."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly recommends 'Teen support groups at cancer centers or through organizations like CancerCare,' satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends involving school counselors for support.",
        "score_given": 0,
        "max_points": 5,
        "justification": "School counselors are not mentioned; the response notes a 'trusted adult outside the immediate family' but does not specify school counselors."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions cancersupportcommunity.org as a resource.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although 'Cancer Support Community' is mentioned, the response does not specifically cite cancersupportcommunity.org as required."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions PanCAN (Pancreatic Cancer Action Network) patient services as a resource.",
        "score_given": 5,
        "max_points": 5,
        "justification": "PanCAN is explicitly mentioned as offering family support resources, fulfilling the requirement to reference PanCAN as a resource alongside recommending support groups."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that informal support from family, friends, and teachers is highly valued by adolescents.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it notes having a 'trusted adult outside the immediate family,' it does not explicitly identify informal support from family, friends, and teachers as highly valued."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that technology-based resources, such as online support communities and apps, can supplement in-person support and are increasingly used by adolescents for connection and information.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It cites 'Online communities like \"Teens Living with Cancer\"' as resources for teens, which qualifies as technology-based support."
      }
    ],
    "question_number": 148,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:18:52.146188",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing psychological concerns about the children with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly advise discussing the children's psychological concerns with the oncology team or oncologist; it mentions hospital social workers and patient navigators but not the oncology team specifically."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends professional counseling and mentions mental health professionals (e.g., therapist, counselor, psychologist, psychiatrist).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends professional counseling, citing family counselors and individual therapy, which meets the requirement to mention mental health professionals."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends teen support groups (in-person and online) and teen-specific cancer organizations, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends involving school counselors for support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions school counselors as a source of ongoing support."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions cancersupportcommunity.org as a resource.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of cancersupportcommunity.org is included."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions PanCAN (Pancreatic Cancer Action Network) patient services as a resource.",
        "score_given": 0,
        "max_points": 5,
        "justification": "PanCAN patient services are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that informal support from family, friends, and teachers is highly valued by adolescents.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it encourages maintaining friendships and family communication, it does not explicitly state that informal support from family, friends, and teachers is highly valued by adolescents, nor does it mention teachers in this context."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that technology-based resources, such as online support communities and apps, can supplement in-person support and are increasingly used by adolescents for connection and information.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes online support groups and resources but does not explicitly state that technology-based resources supplement in-person support or that they are increasingly used by adolescents; apps are not mentioned."
      }
    ],
    "question_number": 148,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:19:14.936774",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines circulating tumor DNA (ctDNA) as DNA from cancer cells or tumors found in the blood, and can be used as a biomarker for diagnosis, monitoring, or recurrence.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states ctDNA are DNA fragments cancer cells release into the bloodstream and notes uses for monitoring and detecting recurrence."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that ctDNA can be used for mutation testing in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says ctDNA can identify specific mutations that might guide targeted therapy options."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly states that ctDNA can provide prognostic information about recurrence risk or detect minimal residual disease after treatment.",
        "score_given": 0,
        "max_points": 1,
        "justification": "It mentions detecting recurrence but does not discuss prognostic recurrence risk or minimal residual disease after treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly states that ctDNA can be used to monitor response to treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It explicitly lists monitoring treatment response by tracking changes in ctDNA levels."
      },
      {
        "criterion_number": 5,
        "description": "The response states that, per NCCN guidelines, ctDNA is only recommended for mutation testing in pancreatic cancer if a biopsy sample is not available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not reference NCCN guidelines or the recommendation restriction; it only notes ctDNA may help when tissue biopsy isn't feasible."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that ctDNA testing is noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes a simple blood draw and rapid results but does not state that it expedites testing specifically due to not needing archival blocks or a new biopsy."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of limitations regarding copy-number alterations or fusion detection in cfDNA."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that ctDNA may miss low-level cancers or not detect all mutations, and there may be false negative or false positive results.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes potential nondetection when ctDNA levels are very low but does not mention false negatives/false positives or incomplete mutation detection."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions that not all hospitals offer ctDNA testing and that not all insurances cover them.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions insurance coverage may be limited but does not state that not all hospitals offer ctDNA testing."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions that ctDNA testing is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not note that ctDNA is under active research or that it is not standard of care for all patients."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly encourages discussing with the oncologist how the test may guide the treatment plan."
      }
    ],
    "question_number": 149,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:19:40.991351",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines circulating tumor DNA (ctDNA) as DNA from cancer cells or tumors found in the blood, and can be used as a biomarker for diagnosis, monitoring, or recurrence.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ctDNA as tumor DNA fragments in the bloodstream and describes uses including monitoring and detecting recurrence."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that ctDNA can be used for mutation testing in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the test analyzes fragments to detect genetic mutations and may guide targeted therapy."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly states that ctDNA can provide prognostic information about recurrence risk or detect minimal residual disease after treatment.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Mentions early recurrence detection and microscopic disease, but does not explicitly state prognostic information about recurrence risk or MRD after treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly states that ctDNA can be used to monitor response to treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Lists 'Monitoring treatment response' as a potential use."
      },
      {
        "criterion_number": 5,
        "description": "The response states that, per NCCN guidelines, ctDNA is only recommended for mutation testing in pancreatic cancer if a biopsy sample is not available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of NCCN guidance or the contingency of use when tissue is unavailable."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that ctDNA testing is noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes ctDNA is less invasive and does not require tissue, but does not explicitly state that this expedites testing due to avoiding archival blocks or new biopsy."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of limitations regarding copy-number alterations or fusion detection in cfDNA."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that ctDNA may miss low-level cancers or not detect all mutations, and there may be false negative or false positive results.",
        "score_given": 0,
        "max_points": 10,
        "justification": "States not all cancers shed detectable DNA and that the test has limitations, but does not explicitly mention false negatives/positives or inability to detect all mutations."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions that not all hospitals offer ctDNA testing and that not all insurances cover them.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of availability across hospitals or insurance coverage issues."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions that ctDNA testing is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Describes ctDNA as an advancing area but does not explicitly state it is under active research or not standard of care for all."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages specific questions to ask the oncologist, effectively recommending discussion."
      }
    ],
    "question_number": 149,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:20:04.174217",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends designating a single point person (e.g., care coordinator, family member, or friend) to coordinate care and serve as the primary contact for health-related matters.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It advises designating a primary oncologist as the main point of contact and suggests appointing one family member as the primary medical liaison."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the oncology team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends designating a primary oncologist as the main point of contact, which is a direct instruction to coordinate through the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends keeping an organized, centralized medical record of all relevant documents (e.g., test results, treatment plans, medication lists, doctor notes).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends requesting copies of all records and creating a binder or digital folder organizing all medical information chronologically."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends discussing or arranging the transfer of medical records with each hospital involved.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states to request that hospitals send records directly to each other."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends carrying or maintaining an up-to-date medication list.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises bringing updated medication lists to every appointment."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly mentions nurse navigators or patient navigators as resources for care coordination.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It suggests asking if any hospital has a patient navigator or care coordinator."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that effective coordination of care between multiple hospitals for a patient with pancreatic cancer requires addressing several systemic and logistical challenges.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While it notes that managing care can be challenging, it does not explicitly reference systemic or logistical challenges."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the lack of shared electronic health records is a significant barrier.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It mentions using patient portals and sending records but does not state that lack of shared EHRs is a significant barrier."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the lack of shared electronic health records impedes seamless information exchange, and the risk of inconsistent recommendations when care is split between high-volume centers and community hospitals.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It does not address EHR-related impediments or the risk of inconsistent recommendations between different care settings."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention to facilitate doctor-to-doctor communication.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It suggests record transfer and mentions tumor boards, but does not explicitly recommend facilitating direct doctor-to-doctor communication."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention to ask for a summary note after every visit and share it with all the providers.",
        "score_given": 0,
        "max_points": 8,
        "justification": "It does not advise asking for or sharing summary notes after visits."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to use PanCAN or NCI for personalized advice on coordinating care, finding specialists, and accessing clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of PanCAN or NCI resources is made."
      }
    ],
    "question_number": 150,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:20:27.740270",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends designating a single point person (e.g., care coordinator, family member, or friend) to coordinate care and serve as the primary contact for health-related matters.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response states, \"Designate one person as the primary care coordinator,\" which directly recommends a single point person."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the oncology team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says, \"Request that your primary oncologist serve as the lead coordinator,\" and suggests \"regular case conferences between teams,\" clearly involving the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends keeping an organized, centralized medical record of all relevant documents (e.g., test results, treatment plans, medication lists, doctor notes).",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response recommends creating \"a shared medical binder with test results, treatment plans, and contact information\" and maintaining lists, fulfilling the centralized record requirement."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends discussing or arranging the transfer of medical records with each hospital involved.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to \"Request complete medical records from each facility\" and to \"Ask each hospital to copy the others on all reports and communications,\" which addresses record transfer."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends carrying or maintaining an up-to-date medication list.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \"Maintain a current list of all medications and dosages\" and \"Ensure all providers have current medication lists,\" which directly fulfills this criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly mentions nurse navigators or patient navigators as resources for care coordination.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response says, \"Don't hesitate to ask for nurse navigators or patient advocates at each facility,\" explicitly referencing nurse navigators."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that effective coordination of care between multiple hospitals for a patient with pancreatic cancer requires addressing several systemic and logistical challenges.",
        "score_given": 2,
        "max_points": 2,
        "justification": "The response frames coordination as requiring \"strong organization and advocacy\" and addresses logistics such as scheduling, telemedicine, and insurance coordination, indicating systemic/logistical challenges."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the lack of shared electronic health records is a significant barrier.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Although it mentions using a patient portal \"if hospitals share one,\" it does not explicitly identify the lack of shared electronic health records as a significant barrier."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the lack of shared electronic health records impedes seamless information exchange, and the risk of inconsistent recommendations when care is split between high-volume centers and community hospitals.",
        "score_given": 0,
        "max_points": 6,
        "justification": "There is no discussion of how lack of shared EHR impedes information exchange, nor mention of risks of inconsistent recommendations between high-volume centers and community hospitals."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention to facilitate doctor-to-doctor communication.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It recommends \"Schedule regular case conferences between teams\" and to \"Ask each hospital to copy the others,\" which facilitates doctor-to-doctor communication."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention to ask for a summary note after every visit and share it with all the providers.",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response does not instruct to request a summary note after each visit nor to share such notes with all providers."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to use PanCAN or NCI for personalized advice on coordinating care, finding specialists, and accessing clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of PanCAN or NCI as resources for personalized assistance, specialists, or clinical trials."
      }
    ],
    "question_number": 150,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:20:53.022641",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that weight loss can occur due to impaired absorption due to pancreatic enzyme deficiency.",
        "score_given": 0,
        "max_points": 4,
        "justification": "The response recommends PERT and notes the pancreas may not produce enough enzymes, but it does not explicitly link weight loss to impaired absorption due to enzyme deficiency."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic exocrine insufficiency leads to deficiencies in fat-soluble vitamins or micronutrients and explicitly recommends pancreatic enzyme replacement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While PERT is explicitly recommended, there is no mention of fat-soluble vitamin or micronutrient deficiencies resulting from pancreatic exocrine insufficiency."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that appetite stimulants can sometimes be helpful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Appetite stimulants are suggested with examples (megestrol acetate, dronabinol), indicating they can be helpful."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that appetite stimulants may be considered for refractory cases or due to potential side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention is made of limiting appetite stimulants to refractory cases or discussing potential side effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises ensuring the medical team is aware of the weight loss and that treatment plans may need adjustment."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there can be many causes of losing weight in patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Multiple contributing factors are acknowledged (nausea, pain, other symptoms), implying many potential causes."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that losing weight can be due to the cancer itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it states weight loss is common with pancreatic cancer, it does not explicitly attribute weight loss to the cancer itself."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that weight loss can occur as a side effect of chemotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Chemotherapy-related weight loss is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should state the patient should try and get sufficient protein intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It recommends high-protein foods and supplements."
      },
      {
        "criterion_number": 10,
        "description": "The response should state the patient should try and get sufficient calorie intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It recommends high-calorie foods and small frequent meals to increase intake."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that nutrition/protein supplements can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends nutritional drinks and high-calorie, high-protein supplements."
      },
      {
        "criterion_number": 12,
        "description": "The response does not explicitly state the patient should discuss changes to their diet with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response does not specifically instruct discussing dietary changes with the oncology team; it advises informing the medical team of weight loss and suggests referral to a dietitian."
      },
      {
        "criterion_number": 13,
        "description": "The response should discuss concerns with a palliative care specialist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Palliative care is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "States that patients with pancreatic cancer are at high risk of malnutrition, cachexia, and weight loss, and explicitly mentions the need for early and ongoing nutritional assessment/intervention.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While weight loss is noted as common, there is no explicit mention of high risk of malnutrition/cachexia or the need for early and ongoing assessment/intervention."
      },
      {
        "criterion_number": 15,
        "description": "Explicitly recommends prompt referral to a registered dietitian or nutritionist for individualized evaluation/counseling, or states that nutritional support is a cornerstone of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends working with an oncology dietitian and a referral to a registered dietitian for personalized planning."
      },
      {
        "criterion_number": 16,
        "description": "Clearly states that early and aggressive nutritional intervention is essential to reduce further weight/muscle loss, improve tolerance to oncologic therapies, and optimize survival or quality of life.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No statement about early/aggressive nutritional intervention or its impact on treatment tolerance, survival, or quality of life."
      },
      {
        "criterion_number": 17,
        "description": "Explicitly states that enteral nutrition (tube feeding) should be prioritized over parenteral nutrition (IV feeding) when oral intake is inadequate, and mentions at least one benefit of enteral nutrition.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Enteral versus parenteral nutrition is not addressed."
      },
      {
        "criterion_number": 18,
        "description": "Recommends oral nutritional supplements and specifically mentions omega-3 fatty acids as beneficial for supporting body weight or lean body mass.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Oral nutritional supplements are recommended, but omega-3 fatty acids are not mentioned."
      },
      {
        "criterion_number": 19,
        "description": "Recommends discussing the case with an oncologist or dietitian/nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises informing the medical team and specifically recommends referral to a registered dietitian."
      }
    ],
    "question_number": 151,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:21:29.527424",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that weight loss can occur due to impaired absorption due to pancreatic enzyme deficiency.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response specifically mentions pancreatic enzyme deficiency as a possible cause of the weight loss and recommends pancreatic enzymes to improve fat and protein digestion, implying malabsorption."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic exocrine insufficiency leads to deficiencies in fat-soluble vitamins or micronutrients and explicitly recommends pancreatic enzyme replacement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While pancreatic enzyme replacement therapy is recommended, the response does not state that EPI leads to fat-soluble vitamin or micronutrient deficiencies."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that appetite stimulants can sometimes be helpful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Appetite stimulants (megestrol acetate, mirtazapine) are suggested as potential interventions."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that appetite stimulants may be considered for refractory cases or due to potential side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention is made of restricting appetite stimulants to refractory cases or discussing potential side effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises bringing the concern to the next appointment and states the oncology team should evaluate the causes."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there can be many causes of losing weight in patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists multiple potential causes: enzyme deficiency, mechanical obstruction, and cancer-related metabolic changes."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that losing weight can be due to the cancer itself.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references 'cancer-related metabolic changes' as a cause of weight loss."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that weight loss can occur as a side effect of chemotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Chemotherapy-related weight loss is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should state the patient should try and get sufficient protein intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It recommends protein-rich snacks and smoothies and protein shakes, indicating emphasis on adequate protein intake."
      },
      {
        "criterion_number": 10,
        "description": "The response should state the patient should try and get sufficient calorie intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It advises small, frequent, high-calorie meals and calorie-dense foods."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that nutrition/protein supplements can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends liquid nutrition supplements between meals and protein shakes."
      },
      {
        "criterion_number": 12,
        "description": "The response does not explicitly state the patient should discuss changes to their diet with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises discussing weight loss with the oncology team and referral to a dietitian but does not explicitly instruct discussing dietary changes with the oncology team."
      },
      {
        "criterion_number": 13,
        "description": "The response should discuss concerns with a palliative care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests a palliative care consultation for symptom management."
      },
      {
        "criterion_number": 14,
        "description": "States that patients with pancreatic cancer are at high risk of malnutrition, cachexia, and weight loss, and explicitly mentions the need for early and ongoing nutritional assessment/intervention.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not explicitly state high risk of malnutrition/cachexia or the need for early and ongoing nutritional assessment."
      },
      {
        "criterion_number": 15,
        "description": "Explicitly recommends prompt referral to a registered dietitian or nutritionist for individualized evaluation/counseling, or states that nutritional support is a cornerstone of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends requesting a referral to an oncology dietitian and considering working with one."
      },
      {
        "criterion_number": 16,
        "description": "Clearly states that early and aggressive nutritional intervention is essential to reduce further weight/muscle loss, improve tolerance to oncologic therapies, and optimize survival or quality of life.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no explicit statement about early/aggressive nutritional intervention or its impact on treatment tolerance or survival/quality of life."
      },
      {
        "criterion_number": 17,
        "description": "Explicitly states that enteral nutrition (tube feeding) should be prioritized over parenteral nutrition (IV feeding) when oral intake is inadequate, and mentions at least one benefit of enteral nutrition.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of enteral vs. parenteral nutrition is included."
      },
      {
        "criterion_number": 18,
        "description": "Recommends oral nutritional supplements and specifically mentions omega-3 fatty acids as beneficial for supporting body weight or lean body mass.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While oral nutrition supplements are recommended, omega-3 fatty acids are not mentioned."
      },
      {
        "criterion_number": 19,
        "description": "Recommends discussing the case with an oncologist or dietitian/nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises bringing the concern to the oncology team and requesting a referral to an oncology dietitian."
      }
    ],
    "question_number": 151,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:22:01.332772",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing massage therapy with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states 'Consult her oncology team first' and reiterates that her oncologist can provide specific guidance."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using a massage therapist who has experience with oncology patients.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Recommends 'a massage therapist trained in oncology massage' and one who communicates with the medical team."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding massage if the person has a fever.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of fever as a contraindication."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend avoiding massage if the person has an infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of infection as a contraindication."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend avoiding massage if the person has excessive pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise avoiding massage in the presence of excessive pain."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend avoiding massage if the person has a clot or deep vein thrombosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states 'Avoid massage if she has blood clots or is at high risk,' which covers DVT/clots."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend avoiding massage over the tumor.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Advises avoiding deep pressure near tumor sites but does not explicitly state to avoid massage over the tumor."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend avoiding massage over sensitive areas.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes 'Some areas may need to be avoided based on treatment sites,' which implies avoiding sensitive treatment areas."
      },
      {
        "criterion_number": 9,
        "description": "States that massage therapy is generally considered safe for patients undergoing treatment for pancreatic cancer when performed by trained professionals, and explicitly mentions that serious adverse events are extremely rare.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not explicitly state general safety or that serious adverse events are extremely rare."
      },
      {
        "criterion_number": 10,
        "description": "States that evidence from randomized controlled trials or meta-analyses shows massage therapy can reduce pain, anxiety, and fatigue, and may improve quality of life in cancer patients, and explicitly mentions that the certainty of evidence is low and benefits are typically moderate.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No discussion of evidence from RCTs/meta-analyses, effect sizes, or certainty of evidence."
      },
      {
        "criterion_number": 11,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions bleeding risk (e.g., low platelets) as a specific safety concern.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Advises consulting the oncology team and explicitly mentions low platelet counts/bleeding risk."
      },
      {
        "criterion_number": 12,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions unstable bone lesions as a specific safety concern.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of unstable bone lesions."
      }
    ],
    "question_number": 152,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:22:21.064105",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing massage therapy with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states: \"Medical clearance is essential - Always get approval from her oncology team first\" and reiterates discussing with the oncologist before starting."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using a massage therapist who has experience with oncology patients.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises to \"Find a massage therapist trained in oncology massage\" and to ensure coordination with the medical team."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding massage if the person has a fever.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Fever is not mentioned explicitly as a contraindication."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend avoiding massage if the person has an infection.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists \"Active infections\" under \"Red flags to avoid massage.\""
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend avoiding massage if the person has excessive pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state to avoid massage in the setting of excessive or uncontrolled pain."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend avoiding massage if the person has a clot or deep vein thrombosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions to be \"cautious with blood clot risk\" but does not explicitly recommend avoiding massage when a clot/DVT is present."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend avoiding massage over the tumor.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Clearly advises to \"Avoid massage directly over tumor sites.\""
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend avoiding massage over sensitive areas.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises avoiding massage over \"areas receiving radiation\" and lists \"recent surgery sites\" as red flags, both of which are sensitive areas."
      },
      {
        "criterion_number": 9,
        "description": "States that massage therapy is generally considered safe for patients undergoing treatment for pancreatic cancer when performed by trained professionals, and explicitly mentions that serious adverse events are extremely rare.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not explicitly state general safety or that serious adverse events are extremely rare."
      },
      {
        "criterion_number": 10,
        "description": "States that evidence from randomized controlled trials or meta-analyses shows massage therapy can reduce pain, anxiety, and fatigue, and may improve quality of life in cancer patients, and explicitly mentions that the certainty of evidence is low and benefits are typically moderate.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions potential benefits but provides no reference to RCTs/meta-analyses, does not mention fatigue specifically, nor the certainty/magnitude of evidence."
      },
      {
        "criterion_number": 11,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions bleeding risk (e.g., low platelets) as a specific safety concern.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends approval from oncology team and lists \"Low platelet counts\" as a red flag, which addresses bleeding risk."
      },
      {
        "criterion_number": 12,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions unstable bone lesions as a specific safety concern.",
        "score_given": 0,
        "max_points": 4,
        "justification": "While it advises consulting the oncology team, it does not mention unstable bone lesions."
      }
    ],
    "question_number": 152,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:22:49.466287",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe personalized medicine approaches in pancreatic cancer, including tumor genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains personalized medicine and includes tumor (somatic) genetic testing with examples (KRAS, BRCA1/2, ATM, PALB2, NTRK) and how results guide targeted therapy."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that precision medicine, or personalized oncology, tailors cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it describes testing to identify targeted therapies, it does not explicitly state the concept of tailoring to improve effectiveness and reduce toxicity."
      },
      {
        "criterion_number": 3,
        "description": "The response should include somatic testing for patients with locally advanced pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Somatic testing is discussed generally, but there is no explicit mention of locally advanced disease candidates for systemic therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should include somatic testing for patients with metastatic pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Somatic testing is discussed generally, but metastatic disease candidates for systemic therapy are not specifically addressed."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It recommends germline testing for all patients but does not state that somatic testing is recommended for all or that actionable findings can be present without family history."
      },
      {
        "criterion_number": 6,
        "description": "The response should include germline testing for inherited pancreatic cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly notes germline testing can identify hereditary cancer syndromes."
      },
      {
        "criterion_number": 7,
        "description": "The response should include germline testing is recommended for all patients with confirmed pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that germline testing is recommended for all pancreatic cancer patients."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that mutations found by somatic testing can sometimes be targeted with medications.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that tumor testing helps identify targeted therapy options and provides examples."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that based on genetic testing and molecular profiles, targeted therapies can be given.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects specific molecular findings (BRCA, NTRK, MSI-H/dMMR) to targeted therapies or immunotherapy."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that patients with certain germline mutations are candidates for targeted therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions BRCA mutations and PARP inhibitors but does not specify germline mutations as the indication."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that FDA-approved targeted therapies include PARP inhibitors (e.g., olaparib) for patients with germline BRCA1/2 mutations, typically as maintenance therapy following platinum-based chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions olaparib after platinum but does not specify germline BRCA1/2 or the maintenance therapy context."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that larotrectinib or entrectinib can be used for NTRK fusions, adequately conveying the tumor-agnostic indication."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that immune checkpoint inhibitors (pembrolizumab, dostarlimab) are approved for dMMR/MSI-H PDAC, a rare but important subset.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes pembrolizumab for MSI-H/dMMR tumors and acknowledges rarity, meeting the core requirement of ICI use in this subset."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that sotorasib is an emerging agent for KRAS G12C-mutated pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "KRAS testing is mentioned but sotorasib and KRAS G12C are not discussed."
      },
      {
        "criterion_number": 15,
        "description": "The response should include that clinical trials may be testing drugs targeting certain mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing clinical trials that match the molecular profile."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages second opinions and testing discussions but does not explicitly recommend discussing the case with an oncologist."
      }
    ],
    "question_number": 153,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:23:21.142310",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe personalized medicine approaches in pancreatic cancer, including tumor genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes personalized medicine approaches and includes tumor genetic profiling, germline testing, and biomarker testing."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that precision medicine, or personalized oncology, tailors cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it implies tailoring based on test results, it does not explicitly state the concept of tailoring to improve effectiveness and reduce toxicity."
      },
      {
        "criterion_number": 3,
        "description": "The response should include somatic testing for patients with locally advanced pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Somatic testing is mentioned generally but not specifically for locally advanced patients who are candidates for systemic therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should include somatic testing for patients with metastatic pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Somatic testing is mentioned generally but not specifically for metastatic patients who are candidates for systemic therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state that both germline and somatic testing are recommended for all patients regardless of family history."
      },
      {
        "criterion_number": 6,
        "description": "The response should include germline testing for inherited pancreatic cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions germline testing to check for inherited cancer susceptibility genes."
      },
      {
        "criterion_number": 7,
        "description": "The response should include germline testing is recommended for all patients with confirmed pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Suggests discussing whether germline testing is recommended but does not state it is recommended for all patients."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that mutations found by somatic testing can sometimes be targeted with medications.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that targeted drugs can be used for mutations (e.g., NTRK fusions) and provides examples of targeted therapies based on results."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that based on genetic testing and molecular profiles, targeted therapies can be given.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly connects genetic/molecular testing with the use of targeted therapies."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that patients with certain germline mutations are candidates for targeted therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions PARP inhibitors for BRCA-mutated tumors but does not specify germline mutations as the indication."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that FDA-approved targeted therapies include PARP inhibitors (e.g., olaparib) for patients with germline BRCA1/2 mutations, typically as maintenance therapy following platinum-based chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions olaparib for BRCA-mutated tumors but does not specify germline status nor maintenance following platinum-based chemotherapy."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 0,
        "max_points": 3,
        "justification": "References NTRK fusions but does not name larotrectinib or entrectinib or indicate the tumor-agnostic approval."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that immune checkpoint inhibitors (pembrolizumab, dostarlimab) are approved for dMMR/MSI-H PDAC, a rare but important subset.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions immunotherapy and MSI testing but does not specify checkpoint inhibitor names, dMMR/MSI-H status, or approval details."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that sotorasib is an emerging agent for KRAS G12C-mutated pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention sotorasib or KRAS G12C-specific therapy."
      },
      {
        "criterion_number": 15,
        "description": "The response should include that clinical trials may be testing drugs targeting certain mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes clinical trials testing new personalized approaches and suggests trials based on tumor profile."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the oncology team and suggests second opinions at major cancer centers."
      }
    ],
    "question_number": 153,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:23:47.696107",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that diarrhea is a common side effect from certain chemotherapy drugs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes 'treatment-related diarrhea' is common but does not specifically attribute diarrhea to certain chemotherapy drugs."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that diarrhea can be managed with anti-motility agents such as loperamide.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends anti-diarrheal medications like loperamide (Imodium)."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that dietary modifications include the elimination of lactose-containing products and high-osmolar supplements.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It advises limiting dairy if it worsens symptoms but does not explicitly recommend eliminating lactose-containing products or high-osmolar supplements."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that loperamide is given starting at 4 mg followed by 2 mg every 4 hours or after each unformed stool, not exceeding 16 mg per day.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No dosing details for loperamide are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that diarrhea from chemotherapy can be managed by dose reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests asking about adjusting cancer treatment dosing but does not specifically state chemotherapy dose reduction for chemotherapy-induced diarrhea."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that diarrhea from chemotherapy can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of modifying the chemotherapy schedule is made."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that diarrhea from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No suggestion to switch to an alternate chemotherapy regimen is included."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that diarrhea can be associated with pancreatic enzyme deficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes pancreatic enzyme insufficiency can contribute to symptoms, implying association with diarrhea."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that diarrhea associated with pancreatic enzyme deficiency can be improved with pancreatic enzyme supplementation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends pancreatic enzyme supplements if insufficiency is contributing, indicating symptom improvement."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in patients with exocrine pancreatic insufficiency, pancreatic enzyme replacement therapy (PERT) should be initiated and titrated to symptom control, as this can significantly reduce steatorrhea and improve nutritional status.",
        "score_given": 0,
        "max_points": 5,
        "justification": "PERT initiation, titration to symptom control, reduction of steatorrhea, and nutritional benefits are not discussed."
      },
      {
        "criterion_number": 11,
        "description": "The response should discuss symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises discussing with the oncologist/healthcare team and seeking personalized recommendations."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that if diarrhea progresses to grade 3 or 4 or persists after 24\u201348 hours of loperamide, aggressive management is recommended.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not reference CTCAE grading or persistence after 24\u201348 hours of loperamide as a threshold for escalation."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that aggressive management includes intravenous fluids for dehydration, octreotide, and empiric antibiotics if infection is suspected.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Octreotide is mentioned, but intravenous fluids and empiric antibiotics are not; therefore the full set of aggressive measures is not described."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that octreotide is initially given as 100\u2013150 \u03bcg subcutaneously three times daily, with escalation up to 500 \u03bcg if needed.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No dosing details for octreotide are provided."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that stool studies and laboratory evaluation for infectious etiologies should be performed in severe cases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of obtaining stool studies or labs to evaluate for infection in severe cases."
      }
    ],
    "question_number": 154,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:24:08.221671",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that diarrhea is a common side effect from certain chemotherapy drugs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response calls diarrhea a common treatment-related side effect but does not specifically attribute it to chemotherapy drugs."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that diarrhea can be managed with anti-motility agents such as loperamide.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly mentions anti-diarrheal medications like loperamide (Imodium)."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that dietary modifications include the elimination of lactose-containing products and high-osmolar supplements.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It advises avoiding dairy (lactose) but does not mention high-osmolar supplements."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that loperamide is given starting at 4 mg followed by 2 mg every 4 hours or after each unformed stool, not exceeding 16 mg per day.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No dosing regimen for loperamide is provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that diarrhea from chemotherapy can be managed by dose reduction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes the oncology team may need to adjust treatment doses, which includes dose reduction."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that diarrhea from chemotherapy can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of modifying the treatment schedule."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that diarrhea from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention switching to an alternate regimen."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that diarrhea can be associated with pancreatic enzyme deficiency.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of pancreatic enzyme deficiency or exocrine pancreatic insufficiency."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that diarrhea associated with pancreatic enzyme deficiency can be improved with pancreatic enzyme supplementation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Pancreatic enzyme supplementation is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in patients with exocrine pancreatic insufficiency, pancreatic enzyme replacement therapy (PERT) should be initiated and titrated to symptom control, as this can significantly reduce steatorrhea and improve nutritional status.",
        "score_given": 0,
        "max_points": 5,
        "justification": "PERT initiation and titration are not addressed."
      },
      {
        "criterion_number": 11,
        "description": "The response should discuss symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises involving the oncology team, checking medications with them, and contacting them urgently for concerning symptoms."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that if diarrhea progresses to grade 3 or 4 or persists after 24\u201348 hours of loperamide, aggressive management is recommended.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of CTCAE grading or the 24\u201348 hour loperamide timeframe and escalation."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that aggressive management includes intravenous fluids for dehydration, octreotide, and empiric antibiotics if infection is suspected.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Aggressive measures such as IV fluids, octreotide, or empiric antibiotics are not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that octreotide is initially given as 100\u2013150 \u03bcg subcutaneously three times daily, with escalation up to 500 \u03bcg if needed.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Octreotide and its dosing are not discussed."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that stool studies and laboratory evaluation for infectious etiologies should be performed in severe cases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it says to rule out infections, it does not specify stool studies or laboratory evaluation."
      }
    ],
    "question_number": 154,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:24:25.331085",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the treatment plan with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises engaging the healthcare team with specific questions (treatment timeline, effect of work on treatment, return-to-work timing) and mentions doctor's recommendations about working during treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the prognosis.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No mention of prognosis, expected survival, stage-related outlook, or how prognosis should inform the decision."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the goals of treatment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not address treatment goals (e.g., curative vs. palliative intent) or aligning decisions with those goals."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering the impact of stopping work on health insurance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically calls out health insurance coverage, particularly if through the employer, as a factor."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend considering the impact of stopping work on income.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses income-related issues including disability benefits, savings/expenses, and reducing hours versus taking leave."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the expected physical effects of treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Mentions expected side effects, recovery time, and matching these to the physical demands of the job."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the expected mental effects of treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Highlights mental health, sense of purpose, and stress management as considerations."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend considering employer-sponsored medical leave.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses FMLA protections and job protection, as well as disability benefits and flexible/remote arrangements."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly mentions at least two common symptoms of pancreatic cancer, such as pain, fatigue, dietary issues, or weight loss, and states that these symptoms can impair daily functioning and/or the ability to work.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly name pancreatic cancer symptoms (e.g., pain, fatigue, weight loss) nor link them to work impairment."
      },
      {
        "criterion_number": 10,
        "description": "The response states that multiple factors should be systematically evaluated to support informed, patient-centered decision-making when considering stopping work for pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Organizes multiple domains (medical, financial, work options, quality of life) as key factors to consider, promoting a comprehensive decision process."
      },
      {
        "criterion_number": 11,
        "description": "The response states that discussions should elicit or consider the patient\u2019s personal values, goals, and/or preferences, including the importance of quality of life versus life extension.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Emphasizes quality of life, time with family, purpose, and notes the decision is highly personal and circumstance-dependent."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions that financial and practical considerations are critical in the decision to stop working.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Financial and practical factors are highlighted as key factors to consider, indicating their central importance in the decision."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends referral to, or consultation with, financial counselors or social workers to help navigate financial challenges, access resources, or manage cancer care costs.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends consulting a social worker to navigate benefits and resources."
      },
      {
        "criterion_number": 14,
        "description": "The response states that patients should be informed about disability benefits, workplace accommodations, and/or community support programs that may help with financial or practical challenges.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions disability benefits, FMLA/job protection, and workplace accommodations (remote work, flexible scheduling, reduced hours), and suggests social work support for resources."
      }
    ],
    "question_number": 155,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:24:50.673447",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the treatment plan with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises seeking \"Input from the medical team about work capacity\" and considering treatment schedule and side effects, which implies discussing the plan with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the prognosis.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Prognosis or life expectancy is not mentioned."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the goals of treatment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Treatment goals (curative vs palliative, priorities of care) are not addressed."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering the impact of stopping work on health insurance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says to review health insurance options (COBRA, marketplace, spouse's coverage) and to consider maintaining benefits while on leave."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend considering the impact of stopping work on income.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends understanding disability benefits and calculating treatment costs/resources, directly addressing income implications."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the expected physical effects of treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It notes \"Treatment schedule intensity and side effects\" and \"Energy levels and ability to work during treatment,\" addressing physical effects."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the expected mental effects of treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It highlights mental health and stress considerations (e.g., stress reduction, mental health benefits of reduced stress) as part of the decision."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend considering employer-sponsored medical leave.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It references FMLA, leave of absence rather than resignation, maintaining benefits while on leave, and speaking with HR."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly mentions at least two common symptoms of pancreatic cancer, such as pain, fatigue, dietary issues, or weight loss, and states that these symptoms can impair daily functioning and/or the ability to work.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly list common pancreatic cancer symptoms (e.g., pain, fatigue, dietary issues, weight loss) or link them to work impairment."
      },
      {
        "criterion_number": 10,
        "description": "The response states that multiple factors should be systematically evaluated to support informed, patient-centered decision-making when considering stopping work for pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It organizes multiple domains (financial, treatment, workplace, personal well-being, practical steps) as key factors to consider, supporting informed decision-making."
      },
      {
        "criterion_number": 11,
        "description": "The response states that discussions should elicit or consider the patient\u2019s personal values, goals, and/or preferences, including the importance of quality of life versus life extension.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It emphasizes personal well-being, normalcy, purpose, time for family and meaningful activities, reflecting values and preferences."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions that financial and practical considerations are critical in the decision to stop working.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It dedicates sections to financial considerations and practical steps, underscoring their importance in the decision."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends referral to, or consultation with, financial counselors or social workers to help navigate financial challenges, access resources, or manage cancer care costs.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly advises to \"Consult with a financial advisor or social worker.\""
      },
      {
        "criterion_number": 14,
        "description": "The response states that patients should be informed about disability benefits, workplace accommodations, and/or community support programs that may help with financial or practical challenges.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes disability benefits, workplace accommodations (remote work, reduced hours, modified duties, leave), and community support (pancreatic cancer support organizations)."
      }
    ],
    "question_number": 155,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:25:12.588848",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor profiling as involving comprehensive molecular analysis of tumor tissue and often blood to identify genetic, transcriptomic, and proteomic alterations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions analysis of tumor tissue and evaluation of genetic makeup and proteins but does not mention blood-based testing (e.g., ctDNA) or transcriptomic (RNA) analysis."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a tumor biopsy can be used for tumor profiling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states a sample of tumor tissue from biopsy or surgery is analyzed."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that circulating tumor DNA can be used for tumor profiling.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of blood-based testing or circulating tumor DNA."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that tumor biopsies can be tested for mutations in the DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that tests look for DNA mutations in the context of analyzing tumor tissue."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that tumor biopsies can be tested for mutations in the RNA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention RNA or transcriptomic testing."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that tumor biopsies can be tested for the presence of certain proteins.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that tests look for proteins and protein levels as part of tumor profiling."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that circulating tumor DNA can be tested for mutations in DNA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of circulating tumor DNA or blood-based DNA mutation testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that tumor profiling helps identify alterations that may be actionable for therapy selection or clinical trial enrollment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States profiling may identify targeted therapy options and reveal clinical trials the patient might qualify for."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that routine molecular tumor profiling is now feasible and recommended for all patients with pancreatic cancer, regardless of stage or surgical eligibility, and reference key elements of the NCCN Guidelines Version 2.2025 workup pathway.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not reference recommendations for universal profiling, NCCN guidelines, or the specified diagnostic workup details."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 20\u201328% of patients have actionable findings, and those who receive matched therapies based on tumor profiling have significantly improved progression-free and overall survival.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No statistics or survival benefit data provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that actionable alterations include BRCA1/2 mutations, NTRK, BRAF, FGFR2, RET, NRG1, and ALK fusions, and mismatch repair deficiency (dMMR/MSI-H).",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not list specific actionable alterations."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the oncology team about specific tests and how results influence the treatment plan."
      }
    ],
    "question_number": 156,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:25:30.687011",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor profiling as involving comprehensive molecular analysis of tumor tissue and often blood to identify genetic, transcriptomic, and proteomic alterations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes analysis of tumor tissue DNA, and sometimes RNA or proteins (genetic, transcriptomic, proteomic), but does not mention blood-based testing or liquid biopsy. Since 'often blood' is not included, full criterion is not met."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a tumor biopsy can be used for tumor profiling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states, 'A sample of the tumor tissue (usually from a biopsy) is sent to a specialized lab.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should state that circulating tumor DNA can be used for tumor profiling.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of circulating tumor DNA, liquid biopsy, or blood-based profiling."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that tumor biopsies can be tested for mutations in the DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that scientists examine the cancer cells' DNA and look for specific genetic mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that tumor biopsies can be tested for mutations in the RNA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions examining RNA but does not explicitly state testing for RNA mutations or alterations such as fusions; thus the specific requirement is not met."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that tumor biopsies can be tested for the presence of certain proteins.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States scientists examine 'sometimes RNA or proteins,' which indicates protein testing from tumor tissue."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that circulating tumor DNA can be tested for mutations in DNA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention circulating tumor DNA or DNA mutation testing from blood."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that tumor profiling helps identify alterations that may be actionable for therapy selection or clinical trial enrollment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that profiling may identify targeted therapy options and could reveal clinical trial opportunities, directly addressing actionability for therapy and trials."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that routine molecular tumor profiling is now feasible and recommended for all patients with pancreatic cancer, regardless of stage or surgical eligibility. Based on the NCCN Guidelines Version 2.2025, Clinical Presentation and Workup pathway for pancreatic adenocarcinoma, stating that patients with clinical suspicion of pancreatic cancer or evidence of dilated pancreatic/bile duct should undergo pancreatic protocol CT or MRI (abdomen) for evaluation. A multidisciplinary consultation is recommended after imaging. Workup includes chest and pelvis CT, endoscopic ultrasonography (EUS), MRI for indeterminate liver lesions, PET/CT or PET/MRI for high-risk features, and ERCP with stent placement if biliary obstruction is present. Laboratory evaluation should include liver function tests and baseline CA 19-9 after biliary drainage. If diagnosis is confirmed, perform genetic testing for inherited mutations. For metastatic disease, confirm with biopsy from a metastatic site, and perform molecular profiling of tumor tissue and complete staging with chest and pelvis CT. Depending on findings, categorize as resectable (PANC-2), borderline resectable (PANC-4), locally advanced (PANC-5), or metastatic disease (PANC-10). If no mass or diagnosis is confirmed, refer to a high-volume center for evaluation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention NCCN recommendations, routine feasibility for all patients, or the detailed workup pathway and staging considerations."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 20\u201328% of patients have actionable findings, and those who receive matched therapies based on tumor profiling have significantly improved progression-free and overall survival compared to those who do not.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No actionable findings rate or survival benefit statistics are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that actionable alterations include BRCA1/2 mutations, NTRK, BRAF, FGFR2, RET, NRG1, and ALK fusions, and mismatch repair deficiency (dMMR/MSI-H).",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions BRCA1/2 and mismatch repair genes but does not include the specified fusions (NTRK, BRAF, FGFR2, RET, NRG1, ALK). The full required list is not addressed."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages asking his oncologist about the tests, timeline, and treatment implications."
      }
    ],
    "question_number": 156,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:25:54.168080",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe the connection between chronic inflammation of the pancreas and the risk of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, within the pancreatic cancer context, that 'Chronic inflammation can contribute to cancer development and progression,' which conveys the link between chronic inflammation and pancreatic cancer risk/progression."
      },
      {
        "criterion_number": 2,
        "description": "State that inflammation plays a central or significant role in pancreatic cancer pathogenesis, progression, or clinical outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly says, 'Inflammation plays a significant role in pancreatic cancer,' meeting the requirement."
      },
      {
        "criterion_number": 3,
        "description": "Include that there is no treatment for targeting inflammation in pancreatic cancer per NCCN guidelines (version 2.2025).",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not reference NCCN guidelines or state that there is no targeted anti-inflammation treatment in pancreatic cancer per NCCN v2.2025; it instead lists NSAIDs and corticosteroids as options."
      },
      {
        "criterion_number": 4,
        "description": "Include that inflammation is implicated in many cancers and include symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although symptoms related to tumor inflammation (pain, fatigue, weight loss) are listed, the response does not state that inflammation is implicated in many cancers; it focuses on pancreatic cancer only."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly mention that strategies to manage inflammation in pancreatic cancer are being researched or investigated in clinical or translational research.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No mention is made of ongoing clinical or translational research on inflammation-management strategies in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "Explicitly mention that strategies involving cytokine signaling are being researched, investigated, or studied for managing inflammation in pancreatic cancer.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Cytokine signaling or related research is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "Explicitly recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it suggests questions for the 'healthcare team,' it does not explicitly recommend discussing the case with an oncologist."
      }
    ],
    "question_number": 157,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:26:06.864822",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the connection between chronic inflammation of the pancreas and the risk of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that chronic inflammation can contribute to pancreatic cancer development and progression and describes how it creates an environment that promotes tumor growth, which conveys the risk connection."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that inflammation plays a central or significant role in pancreatic cancer pathogenesis, progression, or clinical outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that chronic inflammation contributes to development and progression, can make treatments less effective, and contributes to symptoms, indicating a significant role in pathogenesis and clinical outcomes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that there is no treatment for targeting inflammation in pancreatic cancer per NCCN guidelines (version 2.2025).",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not mention NCCN guidelines or state that there is no targeted anti-inflammatory treatment per NCCN v2.2025; it instead suggests anti-inflammatory medications may be used with oncology approval."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that inflammation is implicated in many cancers and include symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions symptoms (pain and fatigue), it does not state that inflammation is implicated in many cancers; the broader cancer link is missing."
      },
      {
        "criterion_number": 5,
        "description": "The response should explicitly mention that strategies to manage inflammation in pancreatic cancer are being researched or investigated in clinical or translational research.",
        "score_given": 0,
        "max_points": 6,
        "justification": "There is no mention of ongoing clinical or translational research into inflammation-targeting strategies in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should explicitly mention that strategies involving cytokine signaling are being researched, investigated, or studied for managing inflammation in pancreatic cancer.",
        "score_given": 0,
        "max_points": 6,
        "justification": "The response does not reference cytokine signaling or related research in the context of pancreatic cancer inflammation management."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly recommend that the user discuss this case with an oncologist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It clearly recommends discussing the case with the oncologist or oncology nurse and outlines what they can help with."
      }
    ],
    "question_number": 157,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:26:19.347293",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes at least three specific benefits of art therapy for cancer patients, such as emotional expression, stress reduction, coping skills, mood improvement, self-esteem, social connection, or mindfulness/relaxation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response lists multiple concrete benefits: emotional expression/support (non-verbal outlet, processing anxiety/fear, reduced isolation), stress and symptom management (lower stress, relaxation, possible impact on pain/nausea, distraction), sense of control (choice and self-expression), and quality-of-life/social connection (joy, accomplishment, strengthening connections, identity maintenance). This exceeds three specific benefits."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that art therapy is not an anti-cancer therapy, does not treat cancer itself, or is not a substitute for medical cancer treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly state that art therapy does not treat cancer or that it is not a substitute for medical treatment. It focuses on supportive benefits but lacks the required explicit disclaimer."
      },
      {
        "criterion_number": 3,
        "description": "The response provides the name \u201cAmerican Art Therapy Association\u201d and states or implies that this organization can be used to find a qualified art therapist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention the American Art Therapy Association (AATA) or its role in finding qualified art therapists."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly recommends that the user discuss the use of art therapy with an oncologist or healthcare provider involved in the cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends asking the oncology team for referrals to certified art therapists, which constitutes a clear suggestion to involve the cancer care team in the decision."
      }
    ],
    "question_number": 158,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:26:32.268259",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes at least three specific benefits of art therapy for cancer patients, such as emotional expression, stress reduction, coping skills, mood improvement, self-esteem, social connection, or mindfulness/relaxation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response lists multiple specific benefits: emotional expression, reduction of anxiety/depression/stress, sense of control/accomplishment, meaningful activity/distraction, improved family/provider communication, social connection via groups, adaptability to energy levels/physical limitations, relaxation/pain management. This exceeds the threshold of three benefits."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that art therapy is not an anti-cancer therapy, does not treat cancer itself, or is not a substitute for medical cancer treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly state that art therapy does not treat cancer or that it is not a substitute for medical treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response provides the name \u201cAmerican Art Therapy Association\u201d and states or implies that this organization can be used to find a qualified art therapist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention the American Art Therapy Association or using it to find a qualified art therapist."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly recommends that the user discuss the use of art therapy with an oncologist or healthcare provider involved in the cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises asking the loved one's care team about available programs and recommendations, which constitutes a clear recommendation to discuss with healthcare providers."
      }
    ],
    "question_number": 158,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:26:41.406712",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The person should contact the insurance company to understand the reason for the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises to 'Request written denial explanation \u2013 Get the specific reason for denial in writing,' which directly addresses obtaining the reason for denial and implies contacting the insurer."
      },
      {
        "criterion_number": 2,
        "description": "The person should file an appeal as an option to remedy the denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states 'File an appeal immediately' and notes deadlines."
      },
      {
        "criterion_number": 3,
        "description": "The person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends contacting the doctor's office for help with appeals and prior authorizations and having the oncologist write a letter of medical necessity."
      },
      {
        "criterion_number": 4,
        "description": "The person should work with their oncology team to understand the denial.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests contacting the doctor's office for appeals and prior authorizations, it does not explicitly advise working with the oncology team to understand the reason for the denial."
      },
      {
        "criterion_number": 5,
        "description": "Patient assistance programs should be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists 'Drug manufacturer patient assistance programs' and 'Foundation grants for medication costs' as options."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly defines prior authorization as a process in which insurers require approval before a medication is covered.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Prior authorization is mentioned but not defined."
      },
      {
        "criterion_number": 7,
        "description": "The response states that prior authorization denials or delays are common in oncology care and mentions at least one impact.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not discuss the prevalence of prior authorization denials/delays or their impacts."
      },
      {
        "criterion_number": 8,
        "description": "The person should contact the oncologist to request a referral to a financial navigator or social worker.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions a 'patient advocate at your treatment center' but does not instruct contacting the oncologist to request a referral to a financial navigator or social worker."
      },
      {
        "criterion_number": 9,
        "description": "The appeal process involves submitting a formal appeal with supporting evidence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends a letter of medical necessity, clinical evidence, and documentation of failed treatments as part of the appeal."
      },
      {
        "criterion_number": 10,
        "description": "If appeals are unsuccessful, alternative access strategies should be pursued, such as patient assistance programs or manufacturer co-pay cards.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It provides alternative access strategies (manufacturer patient assistance programs, clinical trials, foundation grants)."
      },
      {
        "criterion_number": 11,
        "description": "The response names at least one patient advocacy organization that can help connect the user with resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names the Pancreatic Cancer Action Network (PanCAN) with a phone number and CancerCare."
      }
    ],
    "question_number": 159,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:27:06.308105",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The person should contact the insurance company to understand the reason for the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises: 'Request the specific reason for denial in writing from your insurance company,' which meets the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The person should file an appeal as an option to remedy the denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states: 'File a formal appeal (usually free) - your insurance must provide appeal instructions.'"
      },
      {
        "criterion_number": 3,
        "description": "The person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises: 'Ask your doctor's office to submit a prior authorization,' 'Have your oncologist write a detailed letter,' and 'ask your medical team to advocate strongly,' all indicating collaboration with the oncology team."
      },
      {
        "criterion_number": 4,
        "description": "The person should work with their oncology team to understand the denial.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests contacting the insurer for the reason and having the oncologist support an appeal, it does not explicitly advise working with the oncology team to understand the denial itself."
      },
      {
        "criterion_number": 5,
        "description": "Patient assistance programs should be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states: 'Contact the drug manufacturer's patient assistance program - many offer free/discounted medications.'"
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly defines prior authorization as a process in which insurers require approval before a medication is covered.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although 'prior authorization' is mentioned, it is not defined as insurer-required pre-approval before coverage."
      },
      {
        "criterion_number": 7,
        "description": "The response states that prior authorization denials or delays are common in oncology care and mentions at least one impact.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention frequency/prevalence in oncology or specific impacts (e.g., treatment delays)."
      },
      {
        "criterion_number": 8,
        "description": "The person should contact the oncologist to request a referral to a financial navigator or social worker.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests: 'Ask your hospital's financial counselor or social worker for help,' but does not instruct contacting the oncologist to request a referral."
      },
      {
        "criterion_number": 9,
        "description": "The appeal process involves submitting a formal appeal with supporting evidence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends a 'formal appeal' and submitting 'supporting medical records and research' plus an oncologist's letter of medical necessity."
      },
      {
        "criterion_number": 10,
        "description": "If appeals are unsuccessful, alternative access strategies should be pursued, such as patient assistance programs or manufacturer co-pay cards.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response includes alternative access strategies (e.g., manufacturer patient assistance programs), satisfying the criterion."
      },
      {
        "criterion_number": 11,
        "description": "The response names at least one patient advocacy organization that can help connect the user with resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists Pancreatic Cancer Action Network, Patient Advocate Foundation, and CancerCare.org."
      }
    ],
    "question_number": 159,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:27:26.127591",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a 'When to Contact the Healthcare Team' section and states the oncology team can adjust medications."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe common chemotherapy-related side effects, including dry skin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists dry/itchy skin, rash, hand-foot syndrome, and sun sensitivity as treatment-related side effects."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe management of dry skin, including using thick emollient creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It recommends regular moisturizing but does not specify thick emollient creams for dry skin."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe management of dry skin, including avoiding hot water.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises using lukewarm water and avoiding hot water (mentioned under hand-foot syndrome and general tips)."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe management of dry skin, including avoiding scrubbing the skin.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It suggests patting dry and avoiding harsh soaps but does not explicitly state avoiding scrubbing."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe common chemotherapy-related side effects, including hand-foot syndrome associated with certain chemotherapy drugs like capecitabine.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hand-foot syndrome is mentioned, but no association with specific agents like capecitabine is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should include management of hand-foot syndrome, including the use of urea-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Urea-based creams are not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response should include management of hand-foot syndrome, including the use of lanolin-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Lanolin-based creams are not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should include management of hand-foot syndrome, including the use of supportive footwear.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends cushioned shoes, which meet supportive footwear guidance."
      },
      {
        "criterion_number": 10,
        "description": "The response should include management of hand-foot syndrome, including the use of gloves at night.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gloves are suggested but not specifically at night."
      },
      {
        "criterion_number": 11,
        "description": "The response should include management of hand-foot syndrome, including avoiding friction on affected areas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly advises avoiding friction."
      },
      {
        "criterion_number": 12,
        "description": "The response should include management of hand-foot syndrome, including dose reduction of chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Dose reduction for hand-foot syndrome is not stated; only general treatment adjustments are mentioned elsewhere."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe radiation dermatitis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Radiation dermatitis is not discussed."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe management of radiation dermatitis, including the use of creams approved by the radiation team.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No radiation-specific management is provided."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe management of radiation dermatitis, including avoiding sun exposure.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Sun protection is discussed in general, but not in the context of radiation dermatitis."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly names at least one chemotherapy agent as a cause of skin changes, such as gemcitabine, FOLFIRINOX, or nab-paclitaxel.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It names erlotinib (an EGFR inhibitor), but does not name chemotherapy agents like gemcitabine, FOLFIRINOX, or nab-paclitaxel."
      },
      {
        "criterion_number": 17,
        "description": "The response lists at least four distinct manifestations of chemotherapy-related skin changes, with at least two from the specified list.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It lists rash, dry/itchy skin, hand-foot syndrome, and sun sensitivity, meeting the count requirement."
      },
      {
        "criterion_number": 18,
        "description": "The response states that skin changes may also be due to other causes such as infection, other medications, or unrelated skin disorders/systemic diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that alternative causes (infection, other medications, unrelated conditions) may explain skin changes."
      },
      {
        "criterion_number": 19,
        "description": "The response states that prevention of skin problems is important and should begin at or before therapy initiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although preventive moisturizing is mentioned for EGFR rash, it does not explicitly emphasize starting prevention at or before therapy initiation."
      },
      {
        "criterion_number": 20,
        "description": "The response recommends using gentle, pH-balanced cleansers, regular moisturization, and broad-spectrum sun protection.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It recommends gentle, fragrance-free cleansers, moisturization, and SPF 30+ sunscreen, but does not specify pH-balanced cleansers or broad-spectrum protection."
      },
      {
        "criterion_number": 21,
        "description": "The response mentions prophylactic cooling measures during taxane infusions for hand-foot syndrome, supported by guidelines or evidence.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of prophylactic cooling during taxane infusions."
      },
      {
        "criterion_number": 22,
        "description": "The response states that correct identification of skin changes is important to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly address the importance of correct identification to avoid unnecessary therapy discontinuation."
      },
      {
        "criterion_number": 23,
        "description": "The response recommends hydration with emollients, topical corticosteroids, antihistamines, and oatmeal baths for dry skin and itch.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Moisturizers and antihistamines are included, but topical corticosteroids for dry skin and oatmeal baths are not mentioned."
      },
      {
        "criterion_number": 24,
        "description": "The response states that for acne-like rash, oral tetracyclines and topical steroids are effective treatments.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends topical corticosteroids and oral doxycycline for EGFR-inhibitor rash, aligning with tetracycline-class guidance."
      },
      {
        "criterion_number": 25,
        "description": "The response states that for hand-foot syndrome, urea creams, topical steroids, and cooling procedures are beneficial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It omits urea creams, topical steroids, and cooling procedures for hand-foot syndrome."
      },
      {
        "criterion_number": 26,
        "description": "The response states that mild immune-related rashes can be managed with topical corticosteroids, urea-containing creams, and antihistamines for pruritus.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Immune-related rash management is not discussed."
      },
      {
        "criterion_number": 27,
        "description": "The response states that severe immune-related rashes can be managed with systemic corticosteroids and, if refractory, immunomodulators, and that therapy interruption may be necessary for severe reactions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Severe immune-related rash management with systemic steroids/immunomodulators and therapy interruption is not addressed."
      }
    ],
    "question_number": 160,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:28:09.651280",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly includes 'When to contact the medical team' and states 'The oncology team may prescribe topical treatments, adjust medication dosing, or recommend specific products.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should describe common chemotherapy-related side effects, including dry skin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions 'Rash and dryness' and 'Hand-foot syndrome' as treatment-related skin problems, which are common chemotherapy-related side effects."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe management of dry skin, including using thick emollient creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advises 'gentle, fragrance-free moisturizers' but does not specify 'thick emollient creams.'"
      },
      {
        "criterion_number": 4,
        "description": "The response should describe management of dry skin, including avoiding hot water.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically advises 'Avoid hot water; use lukewarm temperatures' and 'Use lukewarm water for bathing.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should describe management of dry skin, including avoiding scrubbing the skin.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Suggests 'Pat skin dry instead of rubbing' but does not explicitly state avoiding scrubbing/exfoliation."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe common chemotherapy-related side effects, including hand-foot syndrome associated with certain chemotherapy drugs like capecitabine.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions hand-foot syndrome but does not associate it with specific agents such as capecitabine."
      },
      {
        "criterion_number": 7,
        "description": "The response should include management of hand-foot syndrome, including the use of urea-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of urea-based creams."
      },
      {
        "criterion_number": 8,
        "description": "The response should include management of hand-foot syndrome, including the use of lanolin-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of lanolin-based creams."
      },
      {
        "criterion_number": 9,
        "description": "The response should include management of hand-foot syndrome, including the use of supportive footwear.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises 'Wear comfortable, well-fitting shoes' and 'Use thick socks,' which constitute supportive footwear."
      },
      {
        "criterion_number": 10,
        "description": "The response should include management of hand-foot syndrome, including the use of gloves at night.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to use gloves at night."
      },
      {
        "criterion_number": 11,
        "description": "The response should include management of hand-foot syndrome, including avoiding friction on affected areas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends 'Wear loose, soft clothing to reduce friction' and 'avoid activities that cause friction.'"
      },
      {
        "criterion_number": 12,
        "description": "The response should include management of hand-foot syndrome, including dose reduction of chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions 'adjust medication dosing' generally but does not specifically tie dose reduction of chemotherapy to hand-foot syndrome."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe radiation dermatitis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Radiation dermatitis is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe management of radiation dermatitis, including the use of creams approved by the radiation team.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of radiation dermatitis management or team-approved creams."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe management of radiation dermatitis, including avoiding sun exposure.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Sun protection is advised generally, but radiation dermatitis is not discussed."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly names at least one chemotherapy agent as a cause of skin changes, such as gemcitabine, FOLFIRINOX, or nab-paclitaxel.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No chemotherapy agents are named."
      },
      {
        "criterion_number": 17,
        "description": "The response lists at least four distinct manifestations of chemotherapy-related skin changes, with at least two from the specified list.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists rash, dryness, hand-foot syndrome, and painful cracking/bleeding, meeting the four-manifestation threshold."
      },
      {
        "criterion_number": 18,
        "description": "The response states that skin changes may also be due to other causes such as infection, other medications, or unrelated skin disorders/systemic diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state alternate causes; only lists signs of infection as red flags."
      },
      {
        "criterion_number": 19,
        "description": "The response states that prevention of skin problems is important and should begin at or before therapy initiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit statement about initiating preventive measures at or before therapy start."
      },
      {
        "criterion_number": 20,
        "description": "The response recommends using gentle, pH-balanced cleansers, regular moisturization, and broad-spectrum sun protection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises 'avoid harsh soaps; use mild, pH-balanced cleansers,' 'use ... moisturizers 2-3 times daily,' and 'Apply sunscreen (SPF 30+).' These meet the cleanser, moisturization, and sun protection elements."
      },
      {
        "criterion_number": 21,
        "description": "The response mentions prophylactic cooling measures during taxane infusions for hand-foot syndrome, supported by guidelines or evidence.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of cooling measures during taxane infusions."
      },
      {
        "criterion_number": 22,
        "description": "The response states that correct identification of skin changes is important to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address diagnostic accuracy or avoiding unnecessary treatment discontinuation."
      },
      {
        "criterion_number": 23,
        "description": "The response recommends hydration with emollients, topical corticosteroids, antihistamines, and oatmeal baths for dry skin and itch.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions moisturizers but not topical corticosteroids, antihistamines, or oatmeal baths."
      },
      {
        "criterion_number": 24,
        "description": "The response states that for acne-like rash, oral tetracyclines and topical steroids are effective treatments.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of acneiform rash or its treatments."
      },
      {
        "criterion_number": 25,
        "description": "The response states that for hand-foot syndrome, urea creams, topical steroids, and cooling procedures are beneficial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not include urea creams, topical steroids, or cooling procedures for hand-foot syndrome."
      },
      {
        "criterion_number": 26,
        "description": "The response states that mild immune-related rashes can be managed with topical corticosteroids, urea-containing creams, and antihistamines for pruritus.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Immune-related rash management is not discussed."
      },
      {
        "criterion_number": 27,
        "description": "The response states that severe immune-related rashes can be managed with systemic corticosteroids and, if refractory, immunomodulators, and that therapy interruption may be necessary for severe reactions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of severe immune-related rash management or therapy interruption."
      }
    ],
    "question_number": 160,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:29:00.075224",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the tumor microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that the pancreatic tumor microenvironment forms a protective barrier, includes physical components (dense stroma, poor vasculature, high pressure) and immune components that suppress anti-tumor activity."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the tumor microenvironment in pancreatic cancer critically influences both treatment options and outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly links the TME to treatment implications, noting reduced effectiveness of immunotherapy and the need for combination or higher-dose chemotherapy, indicating impact on options and outcomes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that the pancreatic cancer tumor microenvironment has a dense desmoplastic stroma which can act as a physical barrier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states \"Dense fibrous tissue (desmoplasia) surrounds the tumor\" and impedes chemotherapy penetration."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of stromal cells, including fibroblasts.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No stromal cell types (e.g., cancer-associated fibroblasts) are mentioned or described."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of stromal cells, including pancreatic stellate cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Pancreatic stellate cells are not referenced or described."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of immune cells within the tumor microenvironment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While immune suppression is mentioned, no specific immune cell populations (e.g., Tregs, MDSCs, TAMs) are described."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer can be immunosuppressive.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It clearly states the TME contains cells that suppress the immune system and that immunotherapy is less effective."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the tumor microenvironment architecture creates physical and biochemical barriers that limit drug delivery, promote immune evasion, and drive resistance to chemotherapy, targeted therapy, and immunotherapy.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It addresses physical barriers and immune evasion, and reduced immunotherapy efficacy, but does not mention biochemical barriers, targeted therapy, or explicitly link TME to therapy resistance across modalities."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in drug resistance.",
        "score_given": 0,
        "max_points": 6,
        "justification": "The response implies reduced effectiveness but does not explicitly state that the TME contributes to drug resistance."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in metastasis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Metastasis and the TME\u2019s role in it are not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in relapse.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Relapse and TME involvement are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that drugs targeting the tumor microenvironment in pancreatic cancer have not yet shown benefit to patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions ongoing trials to break down the fibrous barrier but does not state the lack of proven patient benefit to date."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that many studies are underway evaluating the role of tumor microenvironment-targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references clinical trials targeting the TME and drugs in testing."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that current and emerging treatment strategies increasingly focus on remodeling the tumor microenvironment to improve therapeutic efficacy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It notes reprogramming the TME to be less protective and combination therapies targeting both cancer cells and the TME."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that locoregional therapies such as radiation and ablation may also alter the tumor microenvironment, increasing antigen presentation and immune response.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of radiation, ablation, or their effects on TME and antigen presentation."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussion with the oncology team and asks about the father's oncologist\u2019s recommendations."
      }
    ],
    "question_number": 161,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:29:24.623572",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the tumor microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines the tumor microenvironment and lists its components (blood vessels, immune cells, fibroblasts, extracellular matrix)."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the tumor microenvironment in pancreatic cancer critically influences both treatment options and outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the microenvironment influences disease progression and response to therapy and discusses impact on treatment approaches."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that the pancreatic cancer tumor microenvironment has a dense desmoplastic stroma which can act as a physical barrier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions 'dense scar tissue (desmoplasia)' blocking chemotherapy drug delivery."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of stromal cells, including fibroblasts.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists fibroblasts as supportive tissue cells within the tumor microenvironment."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of stromal cells, including pancreatic stellate cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Pancreatic stellate cells are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of immune cells within the tumor microenvironment of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions immune cells as part of the microenvironment and notes their response can be suppressed."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer can be immunosuppressive.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States that the environment can suppress immune system responses, indicating immunosuppression."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the tumor microenvironment architecture creates physical and biochemical barriers that limit drug delivery, promote immune evasion, and drive resistance to chemotherapy, targeted therapy, and immunotherapy.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it mentions physical barriers to drug delivery and immunosuppression, it does not explicitly connect the architecture to resistance across chemotherapy, targeted therapy, and immunotherapy or specify biochemical barriers."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States the microenvironment 'creates resistance to standard treatments,' indicating drug resistance."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in metastasis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Says the microenvironment 'facilitates spread to other organs,' which denotes metastasis."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in relapse.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Relapse or recurrence is not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that drugs targeting the tumor microenvironment in pancreatic cancer have not yet shown benefit to patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references trials of microenvironment-modifying drugs but does not state that such approaches have not yet shown patient benefit."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that many studies are underway evaluating the role of tumor microenvironment-targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'Clinical trials testing microenvironment-modifying drugs,' indicating ongoing studies."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that current and emerging treatment strategies increasingly focus on remodeling the tumor microenvironment to improve therapeutic efficacy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "References 'microenvironment-modifying drugs' and immunotherapies as current strategies, implying a focus on remodeling the TME."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that locoregional therapies such as radiation and ablation may also alter the tumor microenvironment, increasing antigen presentation and immune response.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of radiation, ablation, or their effects on antigen presentation and immune response."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages discussing these concepts with the father's oncologist and mentions clinical trials."
      }
    ],
    "question_number": 161,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:29:52.964562",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Pet therapy can offer emotional benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists emotional benefits such as reduced anxiety and stress, improved mood and emotional well-being, and decreased feelings of isolation."
      },
      {
        "criterion_number": 2,
        "description": "Pet therapy can offer psychological benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Psychological benefits are explicitly described, including reduced anxiety and stress, improved mood, distraction from pain, and increased motivation and social interaction."
      },
      {
        "criterion_number": 3,
        "description": "Treatment of cancer can cause immune suppression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that during chemotherapy or when white blood cell counts are low, infection risk increases, acknowledging treatment-related immunosuppression."
      },
      {
        "criterion_number": 4,
        "description": "Pets can carry diseases that can harm immunosuppressed people.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While infection risk is mentioned and certification of therapy animals is noted, the response does not explicitly state that pets can carry diseases harmful to immunosuppressed individuals."
      },
      {
        "criterion_number": 5,
        "description": "Patients should avoid exposing open wounds to pets or animals.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no guidance about avoiding pet contact with open wounds."
      },
      {
        "criterion_number": 6,
        "description": "Patients should avoid exposing port sites to animals.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not address protection of port sites or keeping animals away from them."
      },
      {
        "criterion_number": 7,
        "description": "Patients should discuss the safety of pet therapy with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response advises to discuss timing with the oncologist and to get clearance from the medical team."
      },
      {
        "criterion_number": 8,
        "description": "Pet therapy visits are beneficial and generally safe for patients undergoing treatment for pancreatic cancer when conducted with certified therapy animals under appropriate infection control protocols.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes meaningful benefits, references certified therapy animals, and mentions facility protocols for immunocompromised patients, implying safety under proper controls."
      },
      {
        "criterion_number": 9,
        "description": "To reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on pets.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendations are provided about protecting pets from chemotherapy or radiation residues."
      },
      {
        "criterion_number": 10,
        "description": "Immunocompromised patients with pancreatic cancer receiving chemotherapy or radiation therapy should practice good hand hygiene after handling pets, avoid contact with pet waste, and prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not mention hand hygiene, avoiding pet waste, or preventing pets from licking wounds."
      },
      {
        "criterion_number": 11,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no advice to avoid young animals, reptiles, or exotic pets for severely immunosuppressed patients."
      }
    ],
    "question_number": 162,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:30:16.907119",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Pet therapy can offer emotional benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly mentions emotional comfort, emotional support, stress reduction, and improved overall mood as benefits."
      },
      {
        "criterion_number": 2,
        "description": "Pet therapy can offer psychological benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Psychological benefits such as reduced anxiety, stress reduction, and improved mood are clearly stated."
      },
      {
        "criterion_number": 3,
        "description": "Treatment of cancer can cause immune suppression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes infection risk when the immune system is compromised by treatment and references periods of very low white blood cell counts."
      },
      {
        "criterion_number": 4,
        "description": "Pets can carry diseases that can harm immunosuppressed people.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It highlights infection risk in immunocompromised patients and stresses using vaccinated, health-screened therapy animals and strict hygiene protocols, implying pets can transmit infections."
      },
      {
        "criterion_number": 5,
        "description": "Patients should avoid exposing open wounds to pets or animals.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention open wounds or advising against pet contact with wounds."
      },
      {
        "criterion_number": 6,
        "description": "Patients should avoid exposing port sites to animals.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No guidance is provided about protecting central line/port sites from animal contact."
      },
      {
        "criterion_number": 7,
        "description": "Patients should discuss the safety of pet therapy with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly advises getting medical clearance and discussing with the oncologist or nurse navigator."
      },
      {
        "criterion_number": 8,
        "description": "Pet therapy visits are beneficial and generally safe for patients undergoing treatment for pancreatic cancer when conducted with certified therapy animals under appropriate infection control protocols.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response affirms benefits and recommends certified, vaccinated, health-screened animals and strict hygiene protocols, indicating general safety under proper controls."
      },
      {
        "criterion_number": 9,
        "description": "To reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on pets.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of protecting pets from chemotherapy or radiation residues or related precautions."
      },
      {
        "criterion_number": 10,
        "description": "Immunocompromised patients with pancreatic cancer receiving chemotherapy or radiation therapy should practice good hand hygiene after handling pets, avoid contact with pet waste, and prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not include specific instructions on hand hygiene, avoiding pet waste, or preventing pets from licking wounds."
      },
      {
        "criterion_number": 11,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No advice is provided regarding avoiding young animals, reptiles, or exotic pets in the setting of severe immunosuppression."
      }
    ],
    "question_number": 162,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:30:39.877367",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing financial concerns with a social worker associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Under Financial Help, it says \"Contact your treatment center's social worker or patient navigator,\" which directs the user to a social worker within their care team for assistance related to finances."
      },
      {
        "criterion_number": 2,
        "description": "The response should include information for the American Cancer Society Road to Recovery program.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions the American Cancer Society Road to Recovery program and that it offers local transportation."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including the Pancreatic Cancer Action Network.",
        "score_given": 0,
        "max_points": 3,
        "justification": "PanCAN Patient Central is listed, but the response does not state that PanCAN offers travel grants or travel-specific financial assistance."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises contacting the treatment center's social worker or patient navigator for financial help, which constitutes discussing financial concerns with the oncology care team."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing financial concerns with a financial counselor associated with their oncology team.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No mention of a financial counselor; only references a social worker or patient navigator."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing lodging assistance programs with their oncology team.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Provides lodging resources (Hope Lodge, Ronald McDonald House, Joe's House, Healthcare Hospitality Network) but does not suggest discussing lodging assistance with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including Cancer Care.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States that CancerCare may provide limited financial assistance for travel, satisfying the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that resources include hospital-based transportation programs.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention hospital-based transportation programs; only national and volunteer transportation resources are listed."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that resources include philanthropic or grant-funded travel assistance.",
        "score_given": 4,
        "max_points": 4,
        "justification": "References CancerCare's travel assistance and Patient Advocate Foundation financial assistance, which are philanthropic/grant-funded resources."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that telemedicine is increasingly used to reduce the need for travel, allowing for virtual visits, remote symptom monitoring, and tele-rehabilitation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests asking about telemedicine to reduce travel but does not mention increasing use or specific modalities such as virtual visits, remote monitoring, and tele-rehabilitation."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that telehealth appointments are generally as effective as in-person visits for many aspects of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement comparing effectiveness of telehealth to in-person visits."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that telehealth offers benefits, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Only mentions reducing travel frequency; does not address lower costs, decreased infection risk, or access to expertise."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that telehealth may be less suitable for initial diagnosis, physical examinations, or sensitive discussions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not discuss scenarios where telehealth may be less appropriate."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention limitations of telehealth, including challenges with physical examination, technology barriers, and occasional concerns about reduced personal connection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of telehealth limitations or barriers."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the CDC recommends developing a personal travel health plan, ensuring adequate medication supply, and considering supplemental medical or evacuation insurance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No CDC travel health planning guidance is mentioned."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly advise discussing the situation with an oncologist."
      }
    ],
    "question_number": 163,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:31:10.635640",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing financial concerns with a social worker associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly directs the user to hospital social workers and states the social work team at the treatment center is the best starting point, implying discussion of financial/travel concerns with oncology-associated social workers."
      },
      {
        "criterion_number": 2,
        "description": "The response should include information for the American Cancer Society Road to Recovery program.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response lists 'American Cancer Society Road to Recovery (local volunteer drivers)'."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including the Pancreatic Cancer Action Network.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It cites the Pancreatic Cancer Action Network (PanCAN) and notes it offers travel grants and case management."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly advise discussing financial concerns with the oncology team or oncologist; it focuses on social workers and financial counselors."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing financial concerns with a financial counselor associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It advises contacting 'Your treatment center's financial counselors,' which implies discussing financial concerns with oncology-associated financial counselors."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing lodging assistance programs with their oncology team.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Although lodging resources (Hope Lodge, Joe's House, Ronald McDonald House) are listed, the response does not recommend discussing these lodging programs with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including Cancer Care.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It lists 'CancerCare (travel grants and co-pay assistance)' and other national advocacy organizations."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that resources include hospital-based transportation programs.",
        "score_given": 0,
        "max_points": 4,
        "justification": "There is no mention of hospital-based transportation programs; only volunteer driver programs (ACS Road to Recovery) and flight charities are cited."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that resources include philanthropic or grant-funded travel assistance.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response identifies multiple philanthropic/grant-funded options (CancerCare travel grants, PanCAN travel grants, Patient Advocate Foundation aid, Lustgarten Foundation assistance)."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that telemedicine is increasingly used to reduce the need for travel, allowing for virtual visits, remote symptom monitoring, and tele-rehabilitation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It only suggests asking about telemedicine for some appointments and does not mention increasing use or specific modalities like remote symptom monitoring or tele-rehabilitation."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that telehealth appointments are generally as effective as in-person visits for many aspects of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statements about comparative effectiveness of telehealth are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that telehealth offers benefits, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Benefits of telehealth are not enumerated; only a generic suggestion to ask about telemedicine is made."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that telehealth may be less suitable for initial diagnosis, physical examinations, or sensitive discussions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No limitations regarding initial diagnosis, physical exams, or sensitive discussions are mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention limitations of telehealth, including challenges with physical examination, technology barriers, and occasional concerns about reduced personal connection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No telehealth limitations (exam challenges, technology barriers, or reduced personal connection) are discussed."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the CDC recommends developing a personal travel health plan, ensuring adequate medication supply, and considering supplemental medical or evacuation insurance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No CDC travel planning recommendations are mentioned."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no explicit recommendation to discuss the case with an oncologist or oncology team; the guidance points to social workers and financial counselors instead."
      }
    ],
    "question_number": 163,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:31:45.018558",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapies together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Using two or more immunotherapy drugs together' and mentions combining checkpoint inhibitors."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes 'Sometimes paired with chemotherapy'."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly includes 'targeted therapy' as a possible combination partner."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with other new agents.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention 'new agents' beyond chemotherapy, radiation, or targeted therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the definition of immunotherapy per the NCI definition of cancer terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No definition provided (e.g., treatment that uses the body's immune system to fight cancer)."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are MSI high.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of pembrolizumab or MSI-H approval."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are mismatch repair deficient.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of pembrolizumab or dMMR approval."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors have a high tumor mutational burden.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of pembrolizumab or TMB-H approval."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that other immunotherapies are investigational.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While trials are mentioned, it does not explicitly state that other immunotherapies are investigational."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information for clinicaltrial.gov for current trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists ClinicalTrials.gov as a resource for current trials."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding what type of combination immunotherapy is being tested.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Recommends asking 'Which specific combinations are being tested?'"
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the evidence behind the combination immunotherapy in the trial.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not advise reviewing the scientific or clinical evidence supporting the combination."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the potential side effects of the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises asking about side effects and notes potential immune-related side effects."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe eligibility criteria for clinical trials, including the stage of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions eligibility criteria generally but does not specify stage of disease."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe eligibility criteria for clinical trials, including the site of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not address disease site as part of eligibility."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe eligibility criteria for clinical trials, including prior treatments.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention prior treatments as eligibility criteria."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe eligibility criteria for clinical trials, including required testing.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention required testing (e.g., biomarker testing) for eligibility."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that research trials explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not describe the purpose of trials in terms of assessing safety and efficacy."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not state the broader importance of clinical trials for advancing cancer therapy."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that trials are divided into phases (phase I - phase IV).",
        "score_given": 0,
        "max_points": 8,
        "justification": "Asks 'What phase is the trial in?' but does not mention the phase structure (I\u2013IV)."
      },
      {
        "criterion_number": 21,
        "description": "The response should explain the different phases of clinical trials.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Provides no explanation of what each phase entails."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that current research on immunotherapy combinations for pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment and enhancing antitumor immune responses.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not reference the immunosuppressive tumor microenvironment or enhancing antitumor immunity."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention promising strategies include combining immunotherapy with chemotherapy, TME-modifying agents, and other immune stimulants.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions chemotherapy combinations but not TME-modifying agents or immune stimulants."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neoadjuvant strategies before surgery."
      },
      {
        "criterion_number": 25,
        "description": "The response should mention that cancer vaccines are under investigation as an approach for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention cancer vaccines."
      },
      {
        "criterion_number": 26,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides 'Key questions to ask the oncologist,' implying active discussion with the treating oncologist."
      }
    ],
    "question_number": 164,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:32:18.933184",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapies together.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response lists combinations with chemotherapy, targeted therapy, or radiation but does not mention combining two or more immunotherapies together."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states: 'Common combinations include immunotherapy with chemotherapy.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly includes 'targeted therapy' as a common combination partner."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with other new agents.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions other treatments like radiation, it does not reference 'new agents' or novel investigational agents beyond chemo/targeted/radiation."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the definition of immunotherapy per the NCI definition of cancer terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No definition of immunotherapy is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are MSI high.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Pembrolizumab and MSI-H are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are mismatch repair deficient.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mismatch repair deficiency and pembrolizumab are not discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors have a high tumor mutational burden.",
        "score_given": 0,
        "max_points": 4,
        "justification": "High tumor mutational burden and pembrolizumab approval are not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that other immunotherapies are investigational.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It states these are 'experimental treatments being studied for safety and effectiveness,' conveying investigational status of immunotherapy combinations."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information for clinicaltrial.gov for current trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to ClinicalTrials.gov or where to find current trials is provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding what type of combination immunotherapy is being tested.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It asks, 'What specific combination is being studied?' directly prompting understanding of the regimen type."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the evidence behind the combination immunotherapy in the trial.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it suggests asking about benefits and risks, it does not explicitly recommend reviewing the evidence, rationale, or supporting data."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the potential side effects of the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It prompts asking about potential benefits and risks and notes the patient's ability to handle potential side effects."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe eligibility criteria for clinical trials, including the stage of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It asks how the case fits trial criteria but does not describe specific eligibility aspects such as stage."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe eligibility criteria for clinical trials, including the site of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of site-of-disease eligibility criteria."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe eligibility criteria for clinical trials, including prior treatments.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It does not discuss prior treatment requirements as eligibility criteria."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe eligibility criteria for clinical trials, including required testing.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of required testing (e.g., biomarker testing) for eligibility."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that research trials explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It states trials are studying treatments for 'safety and effectiveness,' matching this criterion."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 4,
        "justification": "It does not explicitly state the essential role of trials in optimizing therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that trials are divided into phases (phase I - phase IV).",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of trial phases."
      },
      {
        "criterion_number": 21,
        "description": "The response should explain the different phases of clinical trials.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No explanation of trial phases is provided."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that current research on immunotherapy combinations for pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment and enhancing antitumor immune responses.",
        "score_given": 0,
        "max_points": 6,
        "justification": "There is no discussion of tumor microenvironment or strategies to enhance antitumor immunity."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention promising strategies include combining immunotherapy with chemotherapy, TME-modifying agents, and other immune stimulants.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While chemotherapy is mentioned, TME-modifying agents and immune stimulants are not discussed."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neoadjuvant strategies before surgery are not mentioned."
      },
      {
        "criterion_number": 25,
        "description": "The response should mention that cancer vaccines are under investigation as an approach for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer vaccines are not mentioned."
      },
      {
        "criterion_number": 26,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages discussion with the oncology team and suggests getting a second opinion."
      }
    ],
    "question_number": 164,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:32:46.700531",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the current treatment plan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests preparing questions and organizing information, it does not explicitly recommend understanding or reviewing the current treatment plan."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing the treatment schedule with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking for a patient navigator or social worker at the treatment center to coordinate appointments and to request specific appointment times, which constitutes discussing scheduling with the care team."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend open communication with the care team about work, family, and personal goals.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit recommendation to tell the oncology/care team about work or family obligations or personal goals."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend open communication with work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends discussing flexible work arrangements, remote options, and protections such as FMLA with employers."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding side effects of treatments.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises planning for treatment side effects and preparing accordingly, which reflects awareness and understanding of side effects."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the timing of side effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of when side effects are likely to occur or timing across treatment cycles."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend utilizing a support system, including talking with a social worker.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It specifically suggests asking for a social worker and building a care team."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend utilizing a support system, including talking with a patient navigator.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly recommends asking for a patient navigator to coordinate appointments."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that early referral to palliative care is recommended for symptom management, emotional support, and caregiver assistance, and is not synonymous with hospice.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of palliative care or clarification that it is distinct from hospice."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that practical strategies for managing treatment schedules include leveraging telehealth, app-based, and telephone support to increase flexibility and reduce travel burden.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it suggests helper coordination apps, it does not recommend telehealth or telephone support for medical appointments to reduce travel burden."
      }
    ],
    "question_number": 165,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:33:06.284698",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the current treatment plan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests obtaining detailed schedules but does not advise understanding the overall treatment plan (regimen, goals, duration) or discussing it with the team."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing the treatment schedule with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking for detailed treatment schedules, bundling appointments, and selecting appointment times, which implies coordinating scheduling with the care team."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend open communication with the care team about work, family, and personal goals.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to inform the oncology/care team about work, family obligations, or personal goals."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend open communication with work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends discussing flexible arrangements with the employer, considering remote work, and building colleague support."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding side effects of treatments.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Side effects are not mentioned or addressed."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the timing of side effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of when side effects are likely to occur or timing patterns to inform scheduling."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend utilizing a support system, including talking with a social worker.",
        "score_given": 0,
        "max_points": 4,
        "justification": "While it suggests family/friend support and meal trains, it does not mention engaging a social worker."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend utilizing a support system, including talking with a patient navigator.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of a patient navigator or similar role."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that early referral to palliative care is recommended for symptom management, emotional support, and caregiver assistance, and is not synonymous with hospice.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Palliative care and its distinction from hospice are not addressed."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that practical strategies for managing treatment schedules include leveraging telehealth, app-based, and telephone support to increase flexibility and reduce travel burden.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Telehealth, app-based clinical support, or telephone visits are not mentioned."
      }
    ],
    "question_number": 165,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:33:22.480361",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention that treatment-related mouth problems, particularly oral mucositis, are common in patients with pancreatic cancer receiving chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes mouth problems are common during pancreatic cancer treatment, but does not specifically mention oral mucositis or link it to chemotherapy."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their mouth problems with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing preventive medications with the oncologist and includes a section on when to contact the healthcare team."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend maintaining good oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides explicit oral hygiene recommendations including gentle brushing, flossing, alcohol-free mouthwash, and lip care."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that meeting with an oral medicine provider can be helpful.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions seeing a dentist and oncologist but does not mention an oral medicine specialist."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend staying hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends sipping water frequently and using ice chips, which support hydration."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend getting regular dental care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises seeing a dentist for needed dental work before treatment and mentions fluoride treatments."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that oral cryotherapy (holding ice chips in the mouth during and after administration of agents such as 5-fluorouracil) is effective for prevention of mucositis for select chemotherapy regimens.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions ice chips for dry mouth but does not describe oral cryotherapy during chemotherapy administration for mucositis prevention."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that benzydamine mouthwash is supported for prevention, especially in patients receiving radiotherapy or chemoradiotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of benzydamine mouthwash."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not address chlorhexidine or its lack of recommendation for prevention."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that bland mouth rinses (e.g., sodium bicarbonate or saline) are preferred for routine care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends salt water (saline) rinses as part of routine care, aligning with bland rinse preference."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical anesthetics and mixed medication mouthwashes may be used for pain control.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions prescription mouth rinses with lidocaine and 'magic mouthwash' for pain control."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that gabapentin may be considered for mucositis-related pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention gabapentin."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that topical and systemic antifungals are indicated for secondary candidiasis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Identifies possible thrush (white patches) but does not recommend topical or systemic antifungal treatment."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of antibiotics or their restricted use for confirmed bacterial infections."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention OTC analgesics like acetaminophen or ibuprofen."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it references the healthcare team, it does not explicitly emphasize the essential role of multidisciplinary supportive care."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, and nutritional support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends soft, bland foods for mouth sores, which addresses dietary adjustments."
      }
    ],
    "question_number": 166,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:33:45.371428",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Mentions that treatment-related mouth problems, particularly oral mucositis, are common in pancreatic cancer patients receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States mouth problems are common during pancreatic cancer treatment and specifically references mouth sores/mucositis."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing mouth problems with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to consult the medical team, report persistent problems, and notes the oncology team may provide referrals."
      },
      {
        "criterion_number": 3,
        "description": "Recommends maintaining good oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends gentle oral hygiene with a soft-bristled toothbrush and alcohol-free mouthwash."
      },
      {
        "criterion_number": 4,
        "description": "Includes that meeting with an oral medicine provider can be helpful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions possible referral to a dental oncologist."
      },
      {
        "criterion_number": 5,
        "description": "Recommends staying hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Says 'Stay hydrated' and advises frequent sips of water."
      },
      {
        "criterion_number": 6,
        "description": "Recommends getting regular dental care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises pre-treatment dental care and regular dental checkups during treatment."
      },
      {
        "criterion_number": 7,
        "description": "Mentions oral cryotherapy (ice chips during/after agents like 5-FU) is effective for prevention for select regimens.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Suggests ice chips for comfort but does not mention cryotherapy timing during chemotherapy or prevention efficacy for specific regimens."
      },
      {
        "criterion_number": 8,
        "description": "Mentions benzydamine mouthwash is supported for prevention, especially with radiotherapy or chemoradiotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention benzydamine."
      },
      {
        "criterion_number": 9,
        "description": "Mentions chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not address chlorhexidine\u2019s lack of benefit for prevention."
      },
      {
        "criterion_number": 10,
        "description": "Mentions that bland mouth rinses (e.g., sodium bicarbonate or saline) are preferred for routine care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends saline rinses (salt water), which are bland rinses used for routine care and symptom relief."
      },
      {
        "criterion_number": 11,
        "description": "Mentions that topical anesthetics and mixed medication mouthwashes may be used for pain control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References 'prescribed mouth rinses' but does not specify topical anesthetics or mixed medication mouthwashes for pain control."
      },
      {
        "criterion_number": 12,
        "description": "Mentions that gabapentin may be considered for mucositis-related pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention gabapentin."
      },
      {
        "criterion_number": 13,
        "description": "Mentions that topical and systemic antifungals are indicated for secondary candidiasis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of antifungal therapy for candidiasis."
      },
      {
        "criterion_number": 14,
        "description": "Mentions that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address antibiotic use or indications."
      },
      {
        "criterion_number": 15,
        "description": "Mentions that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of OTC analgesics like acetaminophen or ibuprofen."
      },
      {
        "criterion_number": 16,
        "description": "Mentions that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes consulting the medical team, referrals to dental oncology, and the importance of professional guidance\u2014reflecting multidisciplinary supportive care."
      },
      {
        "criterion_number": 17,
        "description": "Mentions dietary adjustments such as soft or liquid diets, small frequent meals, and nutritional support.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advises avoiding irritating foods and trying cold foods but does not mention soft/liquid diets, small frequent meals, or nutritional support."
      }
    ],
    "question_number": 166,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:34:05.674733",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define minimal residual disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines MRD as very small amounts of cancer cells remaining after treatment, detectable when standard tests show no evidence of disease."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that minimal residual disease testing in pancreatic cancer is investigational.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states MRD in pancreatic cancer is an emerging area, not yet standard practice, and is being studied in clinical trials\u2014indicating investigational status."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing minimal residual disease testing with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It encourages discussion with the oncology team by providing key questions and notes results should be interpreted by oncologists."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that NCCN guidelines do not recommend minimal residual disease testing in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of NCCN guidelines or their current stance on MRD testing in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that insurance may not cover minimal residual disease testing.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Insurance coverage considerations are not addressed."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that postoperative ctDNA positivity is associated with a higher risk of early recurrence and worse survival in resected pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While postoperative use is mentioned, there is no statement about ctDNA positivity correlating with early recurrence or worse survival."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that serial minimal residual disease testing can provide dynamic risk stratification.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Serial testing and dynamic risk stratification are not discussed."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that minimal residual disease testing may identify patients who could benefit from intensified surveillance or additional therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes MRD testing can help guide decisions about additional chemotherapy, which aligns with identifying patients who may benefit from additional therapy."
      }
    ],
    "question_number": 167,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:34:28.200045",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define minimal residual disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines MRD as very small amounts of cancer cells remaining after treatment detectable by sensitive molecular/cellular methods."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that minimal residual disease testing in pancreatic cancer is investigational.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that MRD testing is still being studied for pancreatic cancer, indicating it is investigational."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing minimal residual disease testing with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly recommends discussing MRD testing with the oncology team."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that NCCN guidelines do not recommend minimal residual disease testing in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of NCCN guidelines or their stance on MRD testing in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that insurance may not cover minimal residual disease testing.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address potential insurance coverage or lack thereof for MRD testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that postoperative ctDNA positivity is associated with a higher risk of early recurrence and worse survival in resected pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss prognostic implications of postoperative ctDNA positivity in resected pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that serial minimal residual disease testing can provide dynamic risk stratification.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of serial testing or dynamic risk stratification over time."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that minimal residual disease testing may identify patients who could benefit from intensified surveillance or additional therapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "States MRD could guide treatment decisions and follow-up planning, but does not specifically mention intensified surveillance or additional therapy identification."
      }
    ],
    "question_number": 167,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:34:41.108151",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking the oncology team for spiritual care professionals.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly says, 'Ask your oncology team about chaplains or spiritual care services at the hospital or cancer center,' meeting the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend reaching out to local places of worship.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises, 'Contact your place of worship if you have one,' fulfilling this requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend reaching out to community support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends 'cancer support groups with spiritual components,' clearly meeting this criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national cancer support organizations, including the American Cancer Society.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions CancerCare and the Pancreatic Cancer Action Network, it does not mention the American Cancer Society."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend national cancer support organizations, including Cancer Care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly references 'CancerCare' as a resource."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that spiritual counseling and support can be accessed through hospital-based chaplaincy services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It notes 'chaplains or spiritual care services at the hospital or cancer center' and 'interfaith chaplains,' which are hospital-based chaplaincy services."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that spiritual counseling and support can be accessed through interdisciplinary palliative care teams.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, 'Palliative care teams often include spiritual care specialists,' satisfying this criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that interventions such as prayer, mindfulness/meditation, and facilitated sessions with trained providers, including both individual and group formats, have demonstrated benefits for spiritual well-being, hope, and meaning in cancer care.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it mentions 'meditation, prayer' and 'support groups,' it does not state evidence of demonstrated benefits for spiritual well-being, hope, and meaning, nor does it clearly describe facilitated sessions with trained providers in both individual and group formats."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information and support services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions the Pancreatic Cancer Action Network but does not mention cancer.net."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends engaging the 'oncology team' to access spiritual care services, which constitutes discussing this aspect with the oncologist/oncology team."
      }
    ],
    "question_number": 168,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:34:56.376747",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking the oncology team for spiritual care professionals.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises asking the medical team at the hospital/cancer center about chaplains or spiritual care coordinators, which fulfills recommending the oncology/cancer care team for spiritual care."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend reaching out to local places of worship.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly suggests contacting local churches, synagogues, mosques, temples, and other faith centers."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend reaching out to community support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions cancer support centers, online communities, and group support as a format, it does not explicitly recommend reaching out to community support groups."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national cancer support organizations, including the American Cancer Society.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly references the American Cancer Society as a resource for local spiritual support."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend national cancer support organizations, including Cancer Care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "CancerCare is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that spiritual counseling and support can be accessed through hospital-based chaplaincy services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It advises asking about hospital chaplains/spiritual care coordinators and notes interfaith spiritual care teams at facilities, indicating hospital-based chaplaincy access."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that spiritual counseling and support can be accessed through interdisciplinary palliative care teams.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that palliative care teams often include spiritual counselors, satisfying the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that interventions such as prayer, mindfulness/meditation, and facilitated sessions with trained providers, including both individual and group formats, have demonstrated benefits for spiritual well-being, hope, and meaning in cancer care.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not mention prayer, mindfulness/meditation, or evidence of demonstrated benefits; it only references preference for individual, family, or group support without discussing outcomes."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information and support services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neither Cancer.Net nor the Pancreatic Cancer Action Network is mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no explicit recommendation to discuss spiritual care needs with the oncologist."
      }
    ],
    "question_number": 168,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:35:21.027632",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend learning about pancreatic cancer, including diagnosis.",
        "score_given": 0,
        "max_points": 2,
        "justification": "The response does not advise learning about the disease or understanding the diagnostic process."
      },
      {
        "criterion_number": 2,
        "description": "Recommend learning about pancreatic cancer, including staging.",
        "score_given": 0,
        "max_points": 2,
        "justification": "There is no mention of staging or guidance to learn about stage and its implications."
      },
      {
        "criterion_number": 3,
        "description": "Recommend learning about pancreatic cancer, including treatment options.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Treatment options are not discussed or suggested for review."
      },
      {
        "criterion_number": 4,
        "description": "Recommend national patient support resources, including information for the Pancreatic Cancer Action Network.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly recommends connecting with support groups and specifically names PanCAN as a resource."
      },
      {
        "criterion_number": 5,
        "description": "Recommend open communication within the couple and with the care team.",
        "score_given": 0,
        "max_points": 8,
        "justification": "It encourages open communication within the couple but does not recommend communication with the medical care team."
      },
      {
        "criterion_number": 6,
        "description": "Recommend building a support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends building a support network, including friends/family, support groups, respite care, and a patient navigator or social worker."
      },
      {
        "criterion_number": 7,
        "description": "Explicitly state that significant lifestyle changes are common for both patients and spouses/partners after diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it acknowledges adjustments, it does not explicitly state that significant lifestyle changes are common for both patients and partners."
      },
      {
        "criterion_number": 8,
        "description": "Explicitly mention at least two of: uncertainty about the future, role changes, emotional upheaval, altered daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions role changes, emotional challenges (feelings/fears), and maintaining/altering routines, satisfying the requirement."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly recommend early integration of supportive and/or palliative care.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No explicit recommendation for early supportive or palliative care is provided."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that palliative/supportive care should be offered to all patients regardless of stage or prognosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Palliative/supportive care availability for all patients is not stated."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly state that both dietary and exercise interventions are important for maintaining quality of life and optimizing outcomes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it recommends nutrition and gentle movement, it does not explicitly link both to maintaining quality of life and optimizing outcomes."
      },
      {
        "criterion_number": 12,
        "description": "Explicitly state that regular exercise and healthy lifestyle changes are associated with improved physical and psychological outcomes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit statement connects regular exercise and healthy lifestyle changes to improved physical and psychological outcomes."
      },
      {
        "criterion_number": 13,
        "description": "Explicitly recommend discussing the case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no recommendation to discuss the situation with an oncologist."
      }
    ],
    "question_number": 169,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:35:38.918323",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend learning about pancreatic cancer, including diagnosis.",
        "score_given": 0,
        "max_points": 2,
        "justification": "The response does not advise learning about the diagnosis or understanding diagnostic information; it focuses on treatment plans and practical adjustments."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend learning about pancreatic cancer, including staging.",
        "score_given": 0,
        "max_points": 2,
        "justification": "There is no mention of learning about staging or discussing stage-related implications."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend learning about pancreatic cancer, including treatment options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises working with the medical team to understand treatment plans and side effects, which implies learning about treatment options."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national patient support resources, including information for the Pancreatic Cancer Action Network.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions the Pancreatic Cancer Action Network and CancerCare as resources and suggests joining support groups via PanCAN."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend open communication within the couple and with the care team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It encourages open communication about fears and needs within the couple and recommends working with the medical team, as well as connecting with a social worker."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend building a support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends joining support groups, accepting help from friends and family, and connecting with a social worker\u2014clear steps to build a support system."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly state that significant lifestyle changes are common for both patients and spouses/partners after a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It acknowledges both partners and states that adapting to pancreatic cancer involves many adjustments, implying significant lifestyle changes affecting both patient and spouse."
      },
      {
        "criterion_number": 8,
        "description": "The response should explicitly mention at least two of the following: uncertainty about the future, role changes, emotional upheaval, or altered daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It addresses emotional needs (emotional upheaval) and recommends creating flexible routines and rest periods (altered daily routines)."
      },
      {
        "criterion_number": 9,
        "description": "The response should explicitly recommend early integration of supportive and/or palliative care for symptom management, psychosocial support, or advance care planning.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it mentions pain management and counseling, it does not explicitly recommend early integration of supportive or palliative care services."
      },
      {
        "criterion_number": 10,
        "description": "The response should explicitly state that palliative and/or supportive care should be offered to all patients with pancreatic cancer, regardless of stage or prognosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit statement is made regarding offering palliative/supportive care to all patients regardless of stage."
      },
      {
        "criterion_number": 11,
        "description": "The response should explicitly state that both dietary and exercise interventions are important for maintaining quality of life and optimizing outcomes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Dietary considerations are mentioned (nutritional counseling, easy-to-digest meals), but exercise is not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should explicitly state that regular exercise and healthy lifestyle changes are associated with improved physical and psychological outcomes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit recommendation regarding exercise or its benefits for physical and psychological outcomes."
      },
      {
        "criterion_number": 13,
        "description": "The response should explicitly recommend discussing the case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests working with the medical team generally but does not specifically recommend discussing the case with an oncologist."
      }
    ],
    "question_number": 169,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:36:04.686183",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe tumor heterogeneity, including diverse genetic, epigenetic, transcriptomic, and microenvironmental features both between patients (inter-tumoral) and within a single tumor (intra-tumoral).",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response defines tumor heterogeneity and mentions genetic variation, different cell types, growth rates, and varying responses within a tumor, but it does not address epigenetic, transcriptomic, or microenvironmental features, nor does it discuss inter-patient or inter-tumoral heterogeneity."
      },
      {
        "criterion_number": 2,
        "description": "Include that tumor heterogeneity can include differences in genetic mutations within a tumor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response explicitly states \u201cGenetic variations between cancer cells,\u201d which reflects differences in mutations within a single tumor."
      },
      {
        "criterion_number": 3,
        "description": "Include that tumor heterogeneity can include differences in genetic mutations between tumor sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no explicit mention of mutation differences between tumor sites such as primary versus metastatic lesions."
      },
      {
        "criterion_number": 4,
        "description": "Include that tumor heterogeneity can include differences in cellular growth between cancer sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although the response mentions \u201cDifferent growth rates and behaviors,\u201d it does not tie this specifically to differences between distinct cancer sites or lesions."
      },
      {
        "criterion_number": 5,
        "description": "Include that tumor heterogeneity can include differences in microenvironment between tumor sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The tumor microenvironment (e.g., stroma, immune components) and its variation between sites is not discussed."
      },
      {
        "criterion_number": 6,
        "description": "Mention that tumor heterogeneity is a major driver of variable treatment response, therapy resistance, and clinical outcomes in pancreatic ductal adenocarcinoma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response notes treatment resistance and uneven responses but does not frame heterogeneity as a major driver of clinical outcomes nor specify pancreatic ductal adenocarcinoma."
      },
      {
        "criterion_number": 7,
        "description": "Include that tumor heterogeneity is thought to contribute to drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It states that some cells respond to chemotherapy while others do not, leading to regrowth\u2014clearly attributing resistance to heterogeneity."
      },
      {
        "criterion_number": 8,
        "description": "Include that tumor heterogeneity is thought to contribute to the use of multiple chemotherapy agents.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response recommends \u201cMultiple treatment approaches\u201d and notes \u201cCombination treatments are often recommended,\u201d aligning with the rationale for multi-agent chemotherapy."
      },
      {
        "criterion_number": 9,
        "description": "Mention that phenotypic plasticity allows tumor cells to shift between subtypes, especially under therapeutic or microenvironmental stress, contributing to acquired resistance and disease progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Phenotypic plasticity or subtype switching under therapy or microenvironmental pressures is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "Mention that tumor heterogeneity limits the effectiveness of one-size-fits-all approaches and underlies the need for molecular profiling and personalized treatment strategies.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it references personalized medicine challenges and evolving treatment plans, it does not explicitly state the limitation of one-size-fits-all nor emphasize the need for molecular profiling."
      },
      {
        "criterion_number": 11,
        "description": "Recommend discussing genetic testing with the oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Genetic testing is mentioned as potentially missing variations, but there is no explicit recommendation to discuss genetic testing with the oncology team."
      },
      {
        "criterion_number": 12,
        "description": "Mention that research efforts focus on integrating genomic, transcriptomic, and single-cell analyses to better classify tumors and guide therapy selection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of integrative research approaches such as genomic, transcriptomic, or single-cell analyses."
      },
      {
        "criterion_number": 13,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response invites discussion on how to talk with the oncology team about addressing tumor heterogeneity, effectively recommending consultation with the oncologist."
      }
    ],
    "question_number": 170,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:36:30.408072",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor heterogeneity, including diverse genetic, epigenetic, transcriptomic, and microenvironmental features both between patients (inter-tumoral) and within a single tumor (intra-tumoral).",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response mentions genetic and functional differences within the same tumor and within the same patient, but does not address epigenetic, transcriptomic, or microenvironmental features, nor does it explicitly address inter-patient (inter-tumoral) heterogeneity."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that tumor heterogeneity can include differences in genetic mutations within a tumor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response states that cells within the same tumor can be 'genetically... different,' which implies differences in genetic mutations within a tumor."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that tumor heterogeneity can include differences in genetic mutations between tumor sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions differences 'within the same patient,' it does not explicitly discuss differences in genetic mutations between distinct tumor sites."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that tumor heterogeneity can include differences in cellular growth between cancer sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions that some cells may become more aggressive, but does not specify differences in cellular growth patterns between separate cancer sites."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that tumor heterogeneity can include differences in microenvironment between tumor sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention is made of tumor microenvironment or its variation between sites."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that tumor heterogeneity is a major driver of variable treatment response, therapy resistance, and clinical outcomes in pancreatic ductal adenocarcinoma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response directly links heterogeneity to variable treatment response ('Different cell populations may respond differently'), therapy resistance ('allowing resistant cells to survive and grow'), and disease progression (a clinical outcome), in the context of pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that tumor heterogeneity is thought to contribute to drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states that different cell populations may respond differently, allowing resistant cells to survive and grow, indicating heterogeneity-driven drug resistance."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that tumor heterogeneity is thought to contribute to the use of multiple chemotherapy agents.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States that 'Combination therapies are often used to target different cell populations,' which reflects the rationale for using multiple agents due to heterogeneity."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that phenotypic plasticity allows tumor cells to shift between subtypes, especially under therapeutic or microenvironmental stress, contributing to acquired resistance and disease progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes that some cells may adapt and become more aggressive, it does not discuss phenotypic plasticity, subtype switching, or stress-induced transitions."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that tumor heterogeneity limits the effectiveness of one-size-fits-all approaches and underlies the need for molecular profiling and personalized treatment strategies.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes personalized medicine approaches and limitations of standard tests, but does not explicitly mention molecular profiling nor explicitly state that one-size-fits-all approaches are limited by heterogeneity."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend discussing genetic testing with the oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation is made to discuss genetic testing; suggested topics are heterogeneity in the treatment plan, monitoring, and clinical trials."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that research efforts focus on integrating genomic, transcriptomic, and single-cell analyses to better classify tumors and guide therapy selection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Research is mentioned generally, but there is no reference to integrating genomic, transcriptomic, or single-cell analyses."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly encourages discussion with the oncology team and suggests specific questions to ask them."
      }
    ],
    "question_number": 170,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:37:02.630065",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the definitions of different types of research studies, including randomized clinical trials and observational studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not define randomized clinical trials or observational studies. It lists types of interventional topics (e.g., drug therapies, supportive care) but provides no definitions of study designs."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain that not all research studies are clinical trials, and some explore ancillary aspects of cancer care such as symptom control or mental health.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it mentions supportive care research (pain, nutrition, quality of life), it does not explicitly state that not all research studies are clinical trials. The required explicit distinction is missing."
      },
      {
        "criterion_number": 3,
        "description": "The response should include links and references to informational websites about clinical trials being held across the United States, such as the National Cancer Institute (NCI).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It references ClinicalTrials.gov, PanCAN Patient Central, and the NCI Cancer Information Service, which are authoritative U.S. resources for clinical trial information."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient ask their oncologist about locations where clinical trials are being held and consider a referral to institutions where trial participation is possible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises discussing with the oncologist how trials fit the treatment plan but does not recommend asking about trial locations or seeking referral to institutions conducting trials."
      },
      {
        "criterion_number": 8,
        "description": "The response should include definitions of phases 1, 2, and 3 clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states Phase 1 focuses on safety and Phase 2\u20133 on effectiveness, which adequately defines the phases at a high level."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that clinical trials are most commonly done at academic medicine institutions.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions trials may be at local hospitals or require travel but does not state that trials are most commonly conducted at academic medical centers."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that clinical trials may include an experimental treatment or placebo, and the efficacy may not be known as compared to standard of care treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of placebo use or that efficacy versus standard of care may be unknown."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention clinical trials as a research opportunity.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clinical trials are explicitly and repeatedly mentioned as research opportunities."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention patient registries or biorepositories as opportunities for further studies.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of patient registries or biorepositories."
      }
    ],
    "question_number": 171,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:37:23.912159",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the definitions of different types of research studies, including randomized clinical trials and observational studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response lists clinical trials and observational studies with examples but does not define them, and it does not mention or define randomized clinical trials."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain that not all research studies are clinical trials, and some explore ancillary aspects of cancer care such as symptom control or mental health.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It distinguishes clinical trials from observational studies and includes ancillary topics like quality of life and treatment outcome tracking, demonstrating that not all studies are interventional clinical trials."
      },
      {
        "criterion_number": 3,
        "description": "The response should include links and references to informational websites about clinical trials being held across the United States, such as the National Cancer Institute (NCI).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It references ClinicalTrials.gov, the NCI\u2019s Cancer Information Service, PanCAN, and CenterWatch.com\u2014appropriate national resources for identifying trials."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient ask their oncologist about locations where clinical trials are being held and consider a referral to institutions where trial participation is possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises consulting the oncologist about eligibility and timing, suggests a second opinion at a major cancer center, and points to NCI-designated and academic centers\u2014meeting both asking and referral elements."
      },
      {
        "criterion_number": 8,
        "description": "The response should include definitions of phases 1, 2, and 3 clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While phases I\u2013III are mentioned, there are no definitions explaining the purpose or differences among the phases."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that clinical trials are most commonly done at academic medicine institutions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes that NCI-designated cancer centers have the most trials and lists academic medical centers, indicating that trials are commonly conducted at such institutions."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that clinical trials may include an experimental treatment or placebo, and the efficacy may not be known as compared to standard of care treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of experimental treatments, placebo use, or uncertainty of efficacy relative to standard of care."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention clinical trials as a research opportunity.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clinical trials are explicitly mentioned multiple times as a key research opportunity."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention patient registries or biorepositories as opportunities for further studies.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Patient registries and biorepositories are not mentioned."
      }
    ],
    "question_number": 171,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:37:46.500838",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how cells that acquire mutations that can go on to form a cancer in our bodies can evade the immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains tumor immune evasion in pancreatic cancer: tumors 'hide,' create a protective microenvironment, release immunosuppressive signals, and limit T\u2011cell infiltration."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the immune system\u2019s role in protecting the body from mutated cells that have oncogenic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that T cells and other immune cells can recognize and attack cancer cells, indicating immune surveillance against malignant cells."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a definition of immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Introduces immunotherapy as strategies that aim to boost the immune response and then lists examples, effectively defining it as treatment leveraging the immune system."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the mechanism of action of immunotherapies in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides mechanism-level explanations: checkpoint inhibitors help T cells recognize and attack, vaccines train the immune system to target cancer, and CAR T engineers immune cells."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe features of pancreatic cancer that make this malignancy difficult to treat with immunotherapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Identifies barriers specific to pancreatic cancer: dense stromal tissue, immunosuppressive signaling, and low T\u2011cell infiltration within tumors."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that there is research being done on the role of the immune system in pancreatic cancer treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly notes that research is very active and that combination treatments show promise."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient speak with his/her oncologist about clinical trials that might utilize immunotherapy for pancreatic cancer, or consider a referral to a center that does clinical trials.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not advise discussing clinical trials with an oncologist or seeking referral to a clinical trials center."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that a limited number of pancreatic cancer cases have features that do make it respond to immunotherapy, such as MSI-H or mismatch repair deficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of MSI\u2011H, mismatch repair deficiency, or other biomarkers indicating potential immunotherapy responsiveness."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that they should ask the oncologist if her mother\u2019s tumor has MSI-H or mismatch repair deficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not advise asking the oncologist about MSI\u2011H or mismatch repair deficiency testing."
      }
    ],
    "question_number": 172,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:38:09.784045",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how cells that acquire mutations that can go on to form a cancer in our bodies can evade the immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that pancreatic tumors create a protective barrier and can suppress normal immune responses, both of which are mechanisms of immune evasion."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the immune system\u2019s role in protecting the body from mutated cells that have oncogenic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references the immune system\u2019s \"normal cancer-fighting responses\" and explains that immunotherapy helps immune cells recognize and attack cancer, implying immune surveillance against oncogenic cells."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a definition of immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines immunotherapy functionally as drugs that remove the \u201cbrakes\u201d on immune cells so they can better recognize and attack cancer, which serves as a clear definition."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the mechanism of action of immunotherapies in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanisms are described: checkpoint inhibition (removing brakes), CAR-T (modifying a patient\u2019s immune cells to target cancer), and vaccines (training the immune system to recognize cancer)."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe features of pancreatic cancer that make this malignancy difficult to treat with immunotherapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It notes a protective barrier (desmoplastic stroma), immune suppression in the tumor microenvironment, and access challenges for immune cells\u2014key features limiting immunotherapy efficacy in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that there is research being done on the role of the immune system in pancreatic cancer treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Mentions CAR-T and cancer vaccines as being in clinical trials/experimental and encourages discussion of clinical trial opportunities, clearly indicating ongoing research."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient speak with his/her oncologist about clinical trials that might utilize immunotherapy for pancreatic cancer, or consider a referral to a center that does clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages discussing clinical trial opportunities with the oncology team."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that a limited number of pancreatic cancer cases have features that do make it respond to immunotherapy, such as MSI-H or mismatch repair deficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of MSI-H, mismatch repair deficiency, or that a small subset of pancreatic cancers may respond to immunotherapy based on these biomarkers."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that they should ask the oncologist if her mother\u2019s tumor has MSI-H or mismatch repair deficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not advise asking about MSI-H or mismatch repair deficiency status."
      }
    ],
    "question_number": 172,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:38:29.468152",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define caregiver burnout as physical, emotional, and mental exhaustion, and normalize it as common.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response acknowledges burnout as real but does not define it as physical, emotional, and mental exhaustion or clearly normalize it as common among caregivers."
      },
      {
        "criterion_number": 2,
        "description": "Link to no-cost support services for caregivers, such as support groups or online groups.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It cites PanCAN\u2019s free helpline and mentions in-person and online caregiver support groups (PanCAN, Cancer Support Community), meeting the requirement."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly mention insurance-covered caregiver assistance and advise inquiring with the insurance carrier about coverage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes that insurance may cover home health aide visits but does not advise contacting the insurance carrier to verify coverage."
      },
      {
        "criterion_number": 5,
        "description": "Provide mental wellbeing resources, specifically mentioning therapists via Psychology Today\u2019s website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Counseling is suggested, but there is no mention of Psychology Today or a similar therapist directory."
      },
      {
        "criterion_number": 6,
        "description": "Describe using family and friends to help with caretaking responsibilities.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises creating a care calendar, delegating tasks, and designating a point person, clearly describing use of family/friends."
      },
      {
        "criterion_number": 7,
        "description": "Recommend reaching out to the oncology team to inquire about social work resources to determine insurance-covered in-home/respite support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests asking about social workers or patient navigators at the treatment center, but does not specify the oncology team or the role of social work in determining insurance coverage for in-home/respite services."
      },
      {
        "criterion_number": 8,
        "description": "Mention that Hospice services offer varying degrees of in-home support and caregiver support, if appropriate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is mentioned in the context of respite care, but there is no explicit statement about varying degrees of in-home hospice support."
      },
      {
        "criterion_number": 9,
        "description": "State that there are options for professional caregiver support to give family/loved ones a break.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Respite care and insurance-covered home health aide visits are noted as options that provide breaks to caregivers."
      },
      {
        "criterion_number": 10,
        "description": "State that palliative care involvement can optimize symptom management and reduce caregiver burden.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Palliative care is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "State they should make sure to take time for self-care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A dedicated 'Self-Care Strategies' section advises taking breaks, setting boundaries, accepting help, and considering counseling, meeting the intent of promoting self-care."
      }
    ],
    "question_number": 173,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:38:47.059947",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must define caregiver burnout as physical, emotional, and mental exhaustion, and normalize it as a common experience among caregivers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It normalizes burnout as common but does not define it specifically as physical, emotional, and mental exhaustion."
      },
      {
        "criterion_number": 2,
        "description": "The response must link to no-cost support services for caregivers, such as support groups or online groups of people with similar experiences.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It references free support resources (e.g., CancerCare\u2019s free counseling and support groups) and provides a URL for PanCAN (pancan.org)."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention insurance-covered caregiver assistance and advise inquiring with the insurance carrier about coverage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions case managers through insurance but does not advise contacting the insurance carrier or explicitly discuss insurance-covered caregiver assistance."
      },
      {
        "criterion_number": 5,
        "description": "The response must provide resources for mental wellbeing, specifically mentioning therapists through Psychology Today\u2019s website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions mental health counselors and counseling but does not reference Psychology Today."
      },
      {
        "criterion_number": 6,
        "description": "The response must describe the use of family members and friends to help with caretaking responsibilities.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises asking family/friends for specific help (meals, errands, sitting with the loved one)."
      },
      {
        "criterion_number": 7,
        "description": "The response must recommend reaching out to the oncology team to inquire if social work resources are available to assist in determining if any in-home support or respite services are financially covered by the patient\u2019s insurance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions social workers at the treatment center but does not instruct to ask about insurance coverage for in-home or respite services."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that Hospice services offer varying degrees of in-home support and caregiver support, if/when appropriate for their loved one.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes hospice provides caregiver support but does not state that hospice offers varying degrees of in-home support."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that there are options for professional caregiver support to give a break to family members/loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly lists respite care options (home health aides, adult day programs, short-term residential care) to provide caregiver breaks."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that palliative care involvement can help with optimizing symptom management which may help reduce caregiver burden.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions palliative care teams offering caregiver support but does not connect palliative care to optimizing symptom management to reduce burden."
      },
      {
        "criterion_number": 11,
        "description": "The response should state they should make sure to take time for self-care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides explicit self-care recommendations including taking breaks and maintaining personal medical appointments."
      }
    ],
    "question_number": 173,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:39:03.889278",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should explain what liquid biopsies are and how they are different from traditional biopsies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines liquid biopsy as a blood test detecting ctDNA/CTCs and contrasts it with surgical biopsy by stating it is non-invasive."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that \u201cliquid biopsy\u201d involves taking a sample of blood to analyze either circulating tumor DNA or circulating tumor cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states it's a blood test analyzing circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs)."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain the different uses of liquid biopsies in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions monitoring treatment response, early detection of recurrence, real-time monitoring, and guiding personalized/targeted therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention if liquid biopsy is FDA approved for any uses in pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address FDA approval status for pancreatic adenocarcinoma."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe that liquid biopsies are used as an adjunct to traditional cancer monitoring techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is used alongside imaging and other tests, indicating adjunctive use."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is not sufficient to establish whether or not the cancer is responding to treatment and that it has to be used in addition to imaging tests.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes use alongside imaging, it does not explicitly state that liquid biopsy alone is insufficient to establish treatment response."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe advantages of liquid biopsy over traditional biopsy, but should state that liquid biopsy cannot be used to diagnose cancer at this time.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Lists advantages (non-invasive, real-time) but does not state that liquid biopsy cannot be used to diagnose cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe that liquid biopsies can provide information about the genetic mutations in a cancer which can impact treatment options.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes it may identify specific mutations for targeted therapies and guide personalized care."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the role of liquid biopsy in cancer care is being heavily studied.",
        "score_given": 0,
        "max_points": 11,
        "justification": "Does not mention ongoing research or that the field is under active study."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that liquid biopsy meaningfulness is different across cancer types and sometimes among patients with the same cancers, as some tumors do not shed material as much as others.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of variability in shedding or differences across cancers/patients."
      },
      {
        "criterion_number": 14,
        "description": "The response should also state that the approach is not established as standard of care and would likely be offered in the context of a research study.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not indicate that liquid biopsy monitoring is not established as standard of care or that it is often offered within research studies."
      }
    ],
    "question_number": 174,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:39:26.698982",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explain what liquid biopsies are and how they are different from traditional biopsies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines liquid biopsy as a blood-based monitoring approach and contrasts it with tissue biopsies, emphasizing that it is less invasive than traditional biopsies."
      },
      {
        "criterion_number": 2,
        "description": "State that liquid biopsy involves taking a sample of blood to analyze either circulating tumor DNA or circulating tumor cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions a simple blood draw and analysis of circulating tumor cells (CTCs) or cell-free DNA (cfDNA)."
      },
      {
        "criterion_number": 3,
        "description": "Explain the different uses of liquid biopsies in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists treatment monitoring, detecting resistance, early detection of progression, and guiding treatment decisions."
      },
      {
        "criterion_number": 4,
        "description": "Mention if liquid biopsy is FDA approved for any uses in pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of FDA approval status or specific approvals in pancreatic adenocarcinoma."
      },
      {
        "criterion_number": 5,
        "description": "Describe that liquid biopsies are used as an adjunct to traditional cancer monitoring techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is used alongside, not instead of, traditional monitoring like CT scans."
      },
      {
        "criterion_number": 6,
        "description": "State that this is not sufficient to establish whether the cancer is responding to treatment and that it must be used with imaging tests.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Indicates it is used alongside CT scans and results are interpreted with other tests, implying it is not sufficient on its own."
      },
      {
        "criterion_number": 7,
        "description": "Describe advantages of liquid biopsy over traditional biopsy, but state that liquid biopsy cannot be used to diagnose cancer at this time.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advantages are listed (less invasive, more frequent, real-time information), but it does not state that liquid biopsy cannot be used to diagnose cancer."
      },
      {
        "criterion_number": 9,
        "description": "Describe that liquid biopsies can provide information about the genetic mutations in a cancer which can impact treatment options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions detecting resistance and guiding treatment, it does not explicitly state that genetic mutations or genomic profiling information is obtained."
      },
      {
        "criterion_number": 11,
        "description": "Mention that the role of liquid biopsy in cancer care is being heavily studied.",
        "score_given": 0,
        "max_points": 11,
        "justification": "Notes the technology is evolving and availability may vary, but does not explicitly state that the role is being heavily studied or under active research."
      },
      {
        "criterion_number": 12,
        "description": "State that liquid biopsy meaningfulness varies across cancer types and among patients due to differences in tumor shedding.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of variability in tumor shedding or differences in usefulness across cancers/patients."
      },
      {
        "criterion_number": 14,
        "description": "State that the approach is not established as standard of care and would likely be offered in a research study context.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state it is not standard of care or that it is typically offered in a research or clinical trial context."
      }
    ],
    "question_number": 174,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:39:44.239294",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should emphasize the importance of managing treatment and disease-related side effects to preserve independence and quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a dedicated section on 'Treatment Side Effect Management' with recommendations (e.g., working with the care team to stay ahead of pain and nausea, keeping anti-nausea medications available, focusing on nutrition and hydration), framed within the goal of maintaining independence."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the expected side effects of pancreatic cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not describe expected treatment side effects (e.g., fatigue, neuropathy, diarrhea, mouth sores, infection risk). Only references pain and nausea without detailing typical treatment-specific effects."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe common symptoms that patients experience from pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not list common disease symptoms (e.g., abdominal/back pain, jaundice, weight loss, steatorrhea, pruritus, new/worsening diabetes). Pain is mentioned under treatment side effects, not as a disease symptom set."
      },
      {
        "criterion_number": 4,
        "description": "The response should suggest ways to use technology to help with everyday tasks in the home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends a medical alert system and using delivery services for groceries and medications\u2014both technology-enabled supports for daily living."
      },
      {
        "criterion_number": 5,
        "description": "The response should suggest ways to make modifications in the home to allow the patient to traverse and use their home independently.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple home modification strategies: install grab bars and stair railings, use shower chairs and raised toilet seats, and arrange items at accessible heights."
      },
      {
        "criterion_number": 6,
        "description": "The response should emphasize the importance of maintaining autonomy and some control for the patient regarding their everyday tasks and life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages participation in treatment decisions, respecting choices about accepting help, and maintaining normal routines\u2014clear emphasis on autonomy and control."
      },
      {
        "criterion_number": 7,
        "description": "The response should make recommendations for how to assist an individual suffering from pancreatic cancer treatment or disease-related side effects on their activities of daily living.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Offers practical ADL assistance: breaking tasks into steps, scheduling during peak energy times, adaptive tools (jar openers, reachers), meal prep/freezing, transportation planning, and symptom management tactics supporting daily function."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining good mental health by the patient and caregivers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses emotional support for the patient (counseling, support groups), but does not explicitly mention caregiver mental health or strategies for caregivers."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention resources for in-home assistance such as paid caregivers or Hospice services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of paid in-home caregivers, home health aides, palliative/home health services, or Hospice resources."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest asking the oncology team if there is social work support available, and/or if anyone can assist in determining if the patient\u2019s insurance will cover the cost of an in-home paid caregiver.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise consulting oncology social work or financial counselors about insurance coverage for in-home care."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that physical independence can be promoted by maintaining strength with rehab and exercises.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendations for physical therapy, occupational therapy, exercise, or strength/conditioning to promote physical independence."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that assistance devices and equipment such as shower chairs and grabbing bars can be used to help maintain independence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly recommends shower chairs and grab bars among assistive equipment."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that emotional support including participating in patient groups is another good way of maintaining independence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests counseling and support groups and frames emotional support as part of maintaining independence."
      }
    ],
    "question_number": 175,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:40:11.744689",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Emphasize the importance of managing treatment and disease-related side effects to preserve independence and quality of life.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response focuses on autonomy, energy pacing, and practical support but does not explicitly discuss the importance of managing treatment- or disease-related side effects to maintain independence."
      },
      {
        "criterion_number": 2,
        "description": "Describe the expected side effects of pancreatic cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No treatment side effects (e.g., fatigue, nausea, neuropathy, cytopenias) are described."
      },
      {
        "criterion_number": 3,
        "description": "Describe common symptoms that patients experience from pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Common disease symptoms (e.g., pain, jaundice, weight loss, anorexia, malabsorption) are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "Suggest ways to use technology to help with everyday tasks in the home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response suggests using medical alert systems and technology for virtual visits, which are concrete technology-based supports for safety and social tasks at home."
      },
      {
        "criterion_number": 5,
        "description": "Suggest ways to make modifications in the home to allow the patient to traverse and use their home independently.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides specific home modifications (rearranging to minimize stairs, keeping essentials accessible) and environmental aids (shower chair, lightweight cookware, jar openers) that facilitate independent use of the home."
      },
      {
        "criterion_number": 6,
        "description": "Emphasize the importance of maintaining autonomy and some control for the patient regarding their everyday tasks and life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Strong emphasis on autonomy: include the patient in decisions, ask preferences, and respect their wish to do tasks independently."
      },
      {
        "criterion_number": 7,
        "description": "Make recommendations for assisting an individual suffering from pancreatic cancer treatment or disease-related side effects on their activities of daily living.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Offers multiple practical ADL supports: pre-chopping food, medication organizers, assistive tools, energy pacing, breaking tasks into segments, backup plans, transportation assistance."
      },
      {
        "criterion_number": 8,
        "description": "Emphasize the importance of maintaining good mental health by the patient and caregivers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses the patient\u2019s emotional support but does not explicitly address caregiver mental health."
      },
      {
        "criterion_number": 9,
        "description": "Mention resources for in-home assistance such as paid caregivers or Hospice services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of paid caregivers, home health, or Hospice resources."
      },
      {
        "criterion_number": 10,
        "description": "Suggest asking the oncology team if there is social work support available, and/or assistance determining insurance coverage for an in-home paid caregiver.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not suggest involving social work or checking insurance coverage for in-home care."
      },
      {
        "criterion_number": 12,
        "description": "State that physical independence can be promoted by maintaining strength with rehab and exercises.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of physical therapy, rehabilitation, or exercise to maintain strength."
      },
      {
        "criterion_number": 13,
        "description": "State that assistance devices and equipment such as shower chairs and grabbing bars can be used to help maintain independence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions assistive devices including a shower chair; this meets the criterion of recommending such equipment."
      },
      {
        "criterion_number": 14,
        "description": "State that emotional support including participating in patient groups is another good way of maintaining independence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages connecting with others who have navigated similar challenges, which aligns with participation in patient/peer support groups."
      }
    ],
    "question_number": 175,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:40:40.750998",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include a definition of genetic testing for heritable cancer syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses the importance of genetic testing and identifies mutations but does not define genetic testing for heritable cancer syndromes (e.g., germline testing for inherited pathogenic variants in blood/saliva)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that genetic testing for inherited mutations is recommended for all patients with pancreatic adenocarcinoma at diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises that the father should be tested and can be tested anytime after diagnosis but does not explicitly state the guideline-based universal recommendation for all patients with pancreatic adenocarcinoma at diagnosis."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss genetic testing for inherited cancer syndromes and molecular testing of tumor tissue with their oncologist and oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response recommends meeting with a genetic counselor but does not advise discussing germline and tumor molecular testing with the oncologist/oncology team, nor does it mention tumor tissue molecular testing."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why family members at risk of inheriting a genetic mutation should be aware if they have it.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that testing identifies at-risk family members, allows for enhanced screening, may influence treatment, and informs risks of other cancers, explaining why knowing status matters."
      },
      {
        "criterion_number": 7,
        "description": "The response should list cancer syndromes and mutated genes that are associated with an increased risk of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists multiple relevant genes associated with increased pancreatic cancer risk (BRCA1/BRCA2, PALB2, ATM, MLH1, MSH2, MSH6, PMS2, CDKN2A, STK11, PRSS1). Although syndromes are not named explicitly, the gene list sufficiently fulfills the requirement."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention that BRCA1 and BRCA2 testing can be considered, particularly if there are other first-degree relatives with malignancies such as breast or prostate cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "BRCA1/2 are listed among key genes, but the response does not explicitly connect BRCA testing to family history of breast or prostate cancer in first-degree relatives."
      },
      {
        "criterion_number": 11,
        "description": "If a patient\u2019s genetic testing for inherited mutations returns positive for a pathogenic mutation or they have a strong family history for cancer (regardless of mutation status), they should be referred to a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends meeting with a genetic counselor for assessment and interpretation, which encompasses referral in the event of a positive mutation or strong family history."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that some family members of a patient with a positive pathogenic mutation may be at increased risk for certain cancers and should consider genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that if a mutation is found, first-degree relatives should consider testing and notes increased risks for certain cancers, satisfying the criterion."
      }
    ],
    "question_number": 176,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:41:07.713096",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include a definition of genetic testing for heritable cancer syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes that ~10% of pancreatic cancers are hereditary but does not define genetic testing (e.g., analysis of blood/saliva to identify inherited pathogenic variants in specific genes)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that genetic testing for inherited mutations is recommended for all patients with pancreatic adenocarcinoma at diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests testing the affected person first, it does not explicitly state the guideline-based recommendation that all patients with pancreatic adenocarcinoma should receive germline testing at diagnosis."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss genetic testing for inherited cancer syndromes and molecular testing of tumor tissue with their oncologist and oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It recommends meeting with a genetic counselor and discussing implications with the healthcare team, but it does not specifically mention molecular testing of tumor tissue or discussing with the oncologist/oncology team."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why family members at risk of inheriting a genetic mutation should be aware if they have it.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that results can affect screening recommendations and family planning, which addresses why at-risk relatives should know their status."
      },
      {
        "criterion_number": 7,
        "description": "The response should list cancer syndromes and mutated genes that are associated with an increased risk of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It lists several genes (BRCA1/2, PALB2, ATM, CDKN2A, mismatch repair genes) but does not name associated cancer syndromes (e.g., Lynch syndrome, Peutz-Jeghers), as requested."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention that BRCA1 and BRCA2 testing can be considered, particularly if there are other first-degree relatives with malignancies such as breast or prostate cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although BRCA1/2 are listed among key genes and breast cancer family history is mentioned, it does not explicitly tie BRCA1/2 testing to family history, nor does it mention prostate cancer."
      },
      {
        "criterion_number": 11,
        "description": "If a patient\u2019s genetic testing for inherited mutations returns positive for a pathogenic mutation or they have a strong family history for cancer (regardless of mutation status), they should be referred to a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends meeting with a genetic counselor to assess family history and guide testing, which covers referral in the context of positive results or strong family history."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that some family members of a patient with a positive pathogenic mutation may be at increased risk for certain cancers and should consider genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises that first-degree relatives should consider testing if a mutation is found, implying increased risk and the need for cascade testing."
      }
    ],
    "question_number": 176,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:41:31.277542",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the phenomenon known as \u201cchemo-brain,\u201d or cognitive issues experienced by individuals undergoing chemotherapy treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions 'Chemo brain' and describes it as cognitive effects from chemotherapy that often improve after treatment ends."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment-related cognitive changes are a known side effect of treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States cognitive changes during pancreatic cancer treatment are common and identifies treatment-related causes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about impaired cognition related to chemotherapy treatment and how long it is expected to last once treatment is completed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that chemo-related cognitive changes often improve after treatment and gives a timeframe of weeks to months."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the cognitive changes can be from the chemotherapy drugs or from the cancer itself.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions chemotherapy and several other reversible factors but does not state that the cancer itself can cause cognitive changes."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that some medications, such as opioids, used for symptom management can cause depressed cognition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists medication side effects including 'pain medications,' which reasonably encompasses opioids used for symptom management."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that other etiologies of impaired cognition may also be present, such as organ dysfunction, age-related cognitive decline, poor nutritional status, or medication side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies multiple other etiologies including dehydration/electrolyte issues, nutritional deficiencies, sleep disruption, and medication side effects."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that depression is related to cognitive impairment, especially in the elderly population.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes depression/anxiety as potential contributors to cognitive changes, satisfying the depression-cognition link."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some causes of cognitive impairment are reversible, while others are not.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Uses the phrase 'potentially reversible causes' and notes many improve, but does not state that some causes may not be reversible."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient or family member discuss cognitive impairment with the patient\u2019s oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly advises discussing symptoms with the oncology team and suggests evaluation and supportive referrals."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that symptoms can be managed with \u201ccognitive rehabilitation,\u201d which can include exercises such as puzzles and word games.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'gentle cognitive exercises' and possible neuropsychological/OT referral but does not mention cognitive rehabilitation by name or give examples like puzzles/word games."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that optimizing lifestyle changes, such as good sleep and exercise, can help manage symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends rest/sleep, hydration, and nutrition as lifestyle optimizations to help manage symptoms."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that in some cases, the treatment team may consider prescribing a stimulant such as methylphenidate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of stimulants or methylphenidate."
      }
    ],
    "question_number": 177,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:41:53.805999",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the phenomenon known as \u201cchemo-brain,\u201d or cognitive issues experienced by individuals undergoing chemotherapy treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly names and describes 'chemo brain/chemo fog' as treatment-related cognitive changes affecting many cancer patients."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment-related cognitive changes are a known side effect of treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'treatment-related cognitive changes' and frames them as a real concern associated with treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about impaired cognition related to chemotherapy treatment and how long it is expected to last once treatment is completed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes improvement after treatment ends and that recovery can be gradual over months to years."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the cognitive changes can be from the chemotherapy drugs or from the cancer itself.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state that changes may come from the cancer itself in addition to chemotherapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that some medications, such as opioids, used for symptom management can cause depressed cognition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions medications for specific symptoms but does not specify opioids or that symptom-management medications can depress cognition."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that other etiologies of impaired cognition may also be present, such as organ dysfunction, age-related cognitive decline, poor nutritional status, or medication side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Acknowledges other etiologies via 'individual factors like age and overall health' and 'presence of other health conditions,' meeting the requirement to note other causes."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that depression is related to cognitive impairment, especially in the elderly population.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Depression is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some causes of cognitive impairment are reversible, while others are not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States some changes may be permanent but many are reversible."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient or family member discuss cognitive impairment with the patient\u2019s oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing concerns with the oncology team and suggests neuropsychology referral."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that symptoms can be managed with \u201ccognitive rehabilitation,\u201d which can include exercises such as puzzles and word games.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends cognitive rehabilitation/therapy and mental exercises/brain training, which aligns with the criterion."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that optimizing lifestyle changes, such as good sleep and exercise, can help manage symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends physical exercise, good sleep hygiene, stress management, and nutritional support."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that in some cases, the treatment team may consider prescribing a stimulant such as methylphenidate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention stimulants (e.g., methylphenidate) as a potential option."
      }
    ],
    "question_number": 177,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:42:15.847787",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what cancer stem cells are.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines CSCs as a small subset of tumor cells with self-renewal and differentiation capacity and notes increased treatment resistance."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role that cancer stem cells play in tumorigenesis and metastasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response discusses recurrence and tumor regeneration, it does not address metastasis or explicitly discuss tumor initiation/tumorigenesis roles."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe what is known about cancer stem cells in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically links CSCs to pancreatic cancer by stating they contribute to treatment resistance, recurrence, and poor prognosis in pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference research on pancreatic cancer stem cells and include real citations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or references to specific studies are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should clearly state what is known about how pancreatic cancer stem cells affect treatment efficacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states CSCs often survive chemotherapy and radiation, can regenerate tumors after standard treatments, and contribute to recurrence, directly addressing treatment efficacy."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that cancer stem cells are a subpopulation of cancer cells within a tumor that possess the ability to self-renew and differentiate into various cell types, and the concept of persistence must be clearly mentioned.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes CSCs as a small subset within tumors with self-renewal and ability to create different cancer cell types; persistence is conveyed by noting they survive therapy, may be left behind, and can regenerate tumors."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that cancer stem cells are more resistant to conventional therapies like chemotherapy and radiation, and mention at least two mechanisms such as quiescence, efflux pumps, DNA repair, or microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States CSCs survive chemotherapy and radiation and details two mechanisms: enhanced DNA repair and drug efflux (pumping out chemotherapy drugs)."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that there are currently no standard of care treatments that directly target cancer stem cells, but it is an active area of research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions emerging approaches and clinical trials but does not explicitly state that no standard-of-care treatments directly target CSCs."
      }
    ],
    "question_number": 178,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:42:36.833669",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what cancer stem cells are.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines CSCs as a small population of cells within tumors and notes their self-renewal capacity and ability to generate new tumor cells, which constitutes an accurate description."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role that cancer stem cells play in tumorigenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that CSCs can self-renew and create new tumor cells (tumorigenesis) and may contribute to recurrence and metastasis, directly addressing both aspects."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe what is known about cancer stem cells in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions that in pancreatic cancer, CSCs are thought to play a significant role in the disease's aggressive nature, satisfying pancreatic-specific content."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference research on pancreatic cancer stem cells and include real citations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No studies or citations are provided; the discussion remains general without referencing specific research."
      },
      {
        "criterion_number": 6,
        "description": "The response should clearly state what is known about how pancreatic cancer stem cells affect treatment efficacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that traditional treatments may kill most cancer cells but leave CSCs behind and that this contributes to difficulty treating pancreatic cancer, clearly linking CSCs to treatment efficacy."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that cancer stem cells are a subpopulation of cancer cells within a tumor that possess the ability to self-renew and differentiate into various cell types, and the concept of persistence must be clearly mentioned.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it identifies CSCs as a small population and mentions self-renewal, it does not explicitly state differentiation into various cell types nor explicitly mention persistence."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that cancer stem cells are more resistant to conventional therapies like chemotherapy and radiation, and mention at least two mechanisms such as quiescence, efflux pumps, DNA repair, or microenvironment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It states CSCs are more resistant to chemotherapy and radiation but does not mention any specific mechanisms (e.g., quiescence, efflux pumps, enhanced DNA repair, microenvironment)."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that there are currently no standard of care treatments that directly target cancer stem cells, but it is an active area of research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions ongoing research and clinical trials but does not explicitly state that no standard-of-care treatments directly target CSCs."
      }
    ],
    "question_number": 178,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:42:54.654040",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe different types of support groups such as in-person, virtual, and telephone.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It clearly describes in-person and online/virtual groups, and mentions one-on-one options, but does not mention telephone-based support groups or helplines as a group format."
      },
      {
        "criterion_number": 2,
        "description": "The response should list resources with website links that provide free or insurance-covered pancreatic cancer support group information such as PanCAN, NCI, and NCCN.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions PanCAN and Cancer Support Community, providing only one URL (cancersupportcommunity.org). It does not include NCI or NCCN, PanCAN\u2019s website link, or note free/insurance-covered aspects."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient and/or family inquire with the oncology team about support group resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises contacting the oncology team and hospital social worker for recommendations."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the importance of maintaining mental health support for patients and caregivers affected by pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists professional counseling under one-on-one support and notes groups are valuable, it does not describe the importance of maintaining ongoing mental health support for patients and caregivers."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention websites for people to find support groups local to their home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It provides cancersupportcommunity.org, a site that helps locate local support resources."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention ways in which support groups for people affected by cancer can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes support groups can be valuable, highlights benefits such as 24/7 accessibility and preference for anonymity vs face-to-face connections\u2014specific ways support groups can help."
      },
      {
        "criterion_number": 7,
        "description": "The response should normalize the use of support groups for people affected by cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It normalizes participation by stating many people try different formats and find them helpful."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that people can use support groups for different stages of cancer, and that mental health challenges can be faced even during the survivorship period.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It mentions stage-specific groups but does not address mental health challenges during survivorship."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize that support groups can help people affected by cancer feel less isolated or alone.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly discuss reduced isolation or feeling less alone."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that faith-based support groups exist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly lists faith-based support groups."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that support groups are not a substitute for seeking mental health services if you are suffering from depression, and should describe what depression is.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not caution that support groups are not a substitute for professional care for depression nor define depression."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention other avenues for support including palliative medicine and Hospice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention palliative care or hospice as additional support avenues."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that virtual options include Facebook groups and PanCAN virtual support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references social media communities and virtual meetings but does not specifically mention Facebook groups or PanCAN virtual support groups."
      }
    ],
    "question_number": 179,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:43:22.315418",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe different types of support groups such as in-person, virtual, and telephone.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists in-person, online/video-conference (virtual), and telephone support groups."
      },
      {
        "criterion_number": 2,
        "description": "The response should list resources with website links that provide free or insurance-covered pancreatic cancer support group information such as PanCAN, NCI, and NCCN.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions PanCAN, American Cancer Society, and CancerCare but provides no website links and does not mention NCI or NCCN."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient and/or family inquire with the oncology team about support group resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises to ask the oncology team for local recommendations."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the importance of maintaining mental health support for patients and caregivers affected by pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly address mental health support or its importance for patients and caregivers."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention websites for people to find support groups local to their home.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No websites are provided; only organizations are named."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention ways in which support groups for people affected by cancer can be helpful.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States support groups can be valuable but does not describe specific benefits (e.g., coping strategies, information sharing, emotional support)."
      },
      {
        "criterion_number": 7,
        "description": "The response should normalize the use of support groups for people affected by cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Normalizes participation by noting many people find them helpful and that couples may attend together or separately."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that people can use support groups for different stages of cancer, and that mental health challenges can be faced even during the survivorship period.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention different cancer stages or survivorship mental health challenges."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize that support groups can help people affected by cancer feel less isolated or alone.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of reducing isolation or loneliness."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that faith-based support groups exist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "References in-person meetings at churches, implying faith-based support group options."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that support groups are not a substitute for seeking mental health services if you are suffering from depression, and should describe what depression is.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No discussion of depression or guidance that support groups are not a substitute for professional mental health care."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention other avenues for support including palliative medicine and Hospice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention palliative care or hospice."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that virtual options include Facebook groups and PanCAN virtual support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions online/video conference groups but not Facebook groups or PanCAN virtual support groups specifically."
      }
    ],
    "question_number": 179,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:43:46.392036",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe how malignant cells evade the body\u2019s immune system.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes that cancer cells may 'hide from or suppress immune responses' and that the immune system may become less effective, but it does not explicitly describe concrete immune evasion mechanisms (e.g., PD-L1 upregulation, MHC downregulation, antigen loss, induction of Tregs or MDSCs)."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly describe the mechanisms of action for chemotherapy, immunotherapy, and radiation in killing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses resistance mechanisms to chemotherapy and immunotherapy but does not explain how these modalities kill cancer cells. Radiation therapy is not mentioned at all."
      },
      {
        "criterion_number": 4,
        "description": "The response must thoroughly cover multiple mechanisms of treatment resistance, including genetic mutations, tumor heterogeneity, drug efflux, alterations in drug targets, epigenetic changes, adaptive responses, and the tumor microenvironment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions new mutations, alternative pathways, dormancy, drug efflux, target alteration, and microenvironmental barriers, it does not explicitly address tumor heterogeneity or epigenetic changes, and coverage is not thorough across the full set specified."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention cancer stem cells and connect them to specific resistance mechanisms such as drug efflux pumps, enhanced DNA repair, or immune evasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer stem cells are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that surviving resistant cells can repopulate the tumor after most cells are killed by treatment.",
        "score_given": 0,
        "max_points": 4,
        "justification": "The concept that resistant subpopulations survive and repopulate the tumor is not stated."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly describe that with every treatment, a selective pressure is applied to cancer cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Selective pressure is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that this topic is being widely researched and cite at least one source from the literature.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes that researchers are working on new approaches but provides no literature citations."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly defines treatment resistance as the phenomenon where cancer cells over time no longer respond to therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No explicit definition of treatment resistance is provided; it only states that treatments may stop working without defining the phenomenon."
      }
    ],
    "question_number": 180,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:43:59.458391",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe how malignant cells evade the body\u2019s immune system.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes that the immune system\u2019s response to immunotherapy can diminish and that the tumor environment can protect cancer cells, but it does not explicitly describe immune evasion mechanisms (e.g., PD-L1 upregulation, MHC downregulation, recruitment of Tregs/MDSCs, secretion of immunosuppressive cytokines)."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly describe the mechanisms of action for chemotherapy, immunotherapy, and radiation in killing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanisms of action are provided. The response does not explain how chemotherapy damages DNA or disrupts mitosis, how immunotherapy activates T cells or blocks checkpoints, or how radiation causes DNA double-strand breaks and induces cell death."
      },
      {
        "criterion_number": 4,
        "description": "The response must thoroughly cover multiple mechanisms of treatment resistance, including genetic mutations, tumor heterogeneity, drug efflux, alterations in drug targets, epigenetic changes, adaptive responses, and the tumor microenvironment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions genetic instability/mutations, stromal barriers, poor perfusion, dormancy, and adaptive pathway activation, it does not address tumor heterogeneity, drug efflux pumps, alterations in drug targets, or epigenetic changes. The coverage is not thorough across the specified mechanisms."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention cancer stem cells and connect them to specific resistance mechanisms such as drug efflux pumps, enhanced DNA repair, or immune evasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer stem cells are mentioned as surviving initial treatment and causing recurrence, but there is no explicit connection to specific mechanisms like ABC transporter-mediated drug efflux, enhanced DNA repair capacity, or immune evasion."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that surviving resistant cells can repopulate the tumor after most cells are killed by treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response states, \u201cCancer stem cells may survive initial treatment and later cause the cancer to return,\u201d which conveys that surviving resistant cells repopulate the tumor."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly describe that with every treatment, a selective pressure is applied to cancer cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it mentions cells \u201clearn\u201d to work around treatments and mutate, it does not explicitly state that therapy imposes selective pressure that favors resistant clones."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that this topic is being widely researched and cite at least one source from the literature.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes that this is an active area of research but provides no literature citations."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly defines treatment resistance as the phenomenon where cancer cells over time no longer respond to therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "The response does not explicitly define treatment resistance as a loss of therapeutic response over time; it only discusses contributing factors."
      }
    ],
    "question_number": 180,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:44:20.121903",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe specific biomarkers for pancreatic cancer, explicitly mentioning both CA 19-9 and CEA.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response lists several genetic/molecular markers (BRCA1/2, MSI/MMR, NTRK, KRAS, PALB2, ATM) but does not mention CA 19-9 or CEA."
      },
      {
        "criterion_number": 2,
        "description": "The response must explain what circulating tumor DNA (ctDNA) is and how it is considered a cancer biomarker in some malignancies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ctDNA is not defined or discussed; only a brief mention of 'liquid biopsy' is provided without explanation of ctDNA."
      },
      {
        "criterion_number": 3,
        "description": "The response must summarize how ctDNA enters the bloodstream and is detected through blood tests.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explanation of tumor DNA shedding into the bloodstream or detection methods is included."
      },
      {
        "criterion_number": 4,
        "description": "The response must include ways that ctDNA detection can enhance existing modalities for cancer monitoring, including detection of new and potentially targetable mutations in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not describe how ctDNA augments monitoring or its role in detecting emerging targetable mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response must include at least one link to existing scientific literature regarding ctDNA use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or links to scientific literature are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must suggest that the patient discuss pancreatic cancer biomarker testing with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly encourages discussion with the father's oncology team and lists specific questions to ask."
      },
      {
        "criterion_number": 7,
        "description": "The response must define biomarkers for cancer in general terms, including at least one example of a measurable indicator (e.g., proteins, genes, or mutations).",
        "score_given": 0,
        "max_points": 10,
        "justification": "While examples of genetic markers are listed, the response does not provide a general definition of biomarkers as measurable indicators."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how biomarkers are used in pancreatic cancer care and explicitly state that they are an adjunct to traditional imaging and biopsy interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes that testing is done on tumor tissue and sometimes via blood tests, but does not state that biomarkers are an adjunct to traditional imaging/biopsy for care decisions."
      },
      {
        "criterion_number": 9,
        "description": "The response must discuss that biomarker reliability varies between individuals with cancer and are not always interpretable, including a specific example of variability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of variability in biomarker reliability or interpretability is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that biomarkers can have false positives and false negatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The possibility of false positives or false negatives is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that BRCA and HRD genes are key biomarkers as they can predict response to platinum chemotherapy and PARP inhibitors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although BRCA and PARP inhibitor sensitivity are mentioned, there is no mention of HRD as a category or prediction of response to platinum chemotherapy."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that MSI/MMR is an important biomarker as it can identify the small percentage of patients that may respond to immunotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It correctly notes MSI-high/dMMR is rare (1\u20132%) and may benefit from immunotherapy."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that testing can be done on a blood sample or from tumor tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states testing is typically done on tumor tissue and that some markers can also be detected in blood (liquid biopsy)."
      }
    ],
    "question_number": 181,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:44:39.368497",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe specific biomarkers for pancreatic cancer, explicitly mentioning both CA 19-9 and CEA.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response lists multiple specific biomarkers and explicitly mentions both CA 19-9 and CEA with their roles."
      },
      {
        "criterion_number": 2,
        "description": "The response must explain what circulating tumor DNA (ctDNA) is and how it is considered a cancer biomarker in some malignancies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ctDNA is not mentioned or explained."
      },
      {
        "criterion_number": 3,
        "description": "The response must summarize how ctDNA enters the bloodstream and is detected through blood tests.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of ctDNA origin or detection methods is provided."
      },
      {
        "criterion_number": 4,
        "description": "The response must include ways that ctDNA detection can enhance existing modalities for cancer monitoring, including detection of new and potentially targetable mutations in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ctDNA utility for monitoring, minimal residual disease, or detecting targetable mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response must include at least one link to existing scientific literature regarding ctDNA use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or links are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must suggest that the patient discuss pancreatic cancer biomarker testing with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly encourages discussing specific tests and implications with the oncology team and provides suggested questions."
      },
      {
        "criterion_number": 7,
        "description": "The response must define biomarkers for cancer in general terms, including at least one example of a measurable indicator (e.g., proteins, genes, or mutations).",
        "score_given": 0,
        "max_points": 10,
        "justification": "While examples of biomarkers (proteins, genes) are listed, there is no general definition of biomarkers as measurable indicators."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how biomarkers are used in pancreatic cancer care and explicitly state that they are an adjunct to traditional imaging and biopsy interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions monitoring and therapy selection but does not explicitly state biomarkers are adjuncts that complement imaging and biopsy."
      },
      {
        "criterion_number": 9,
        "description": "The response must discuss that biomarker reliability varies between individuals with cancer and are not always interpretable, including a specific example of variability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of variability or interpretability (e.g., CA 19-9 non-producers) is included."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that biomarkers can have false positives and false negatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of false positives or false negatives."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that BRCA and HRD genes are key biomarkers as they can predict response to platinum chemotherapy and PARP inhibitors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states BRCA and HRD may predict benefit from platinum chemotherapy and PARP inhibitors."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that MSI/MMR is an important biomarker as it can identify the small percentage of patients that may respond to immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "MSI/MMR is linked to immunotherapy response, but the response does not mention that it identifies only a small percentage of patients."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that testing can be done on a blood sample or from tumor tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states testing can be done on tumor tissue (biopsy) or blood samples."
      }
    ],
    "question_number": 181,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:45:02.179513",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe at least two management strategies for osteopenia and osteoporosis, such as bisphosphonates, denosumab, calcium, or vitamin D.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explicitly recommends bisphosphonates (zoledronic acid), denosumab, and calcium and vitamin D supplements, covering more than two relevant management strategies."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe at least two types of bone and bone density problems that can arise during cancer treatment, such as osteopenia, osteoporosis, or bone metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists bone metastases, osteoporosis, bone pain, and increased fracture risk, which are at least two bone-related problems during cancer treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention bone metastases and at least two treatment options, such as systemic therapy, observation, radiation, or surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While bone metastases are mentioned, the response does not explicitly outline specific bone metastasis treatments such as systemic therapy, radiation, surgery, or observation. It focuses on bone-strengthening agents and pain control without linking them specifically as treatment options for metastases."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that bone metastases can be painful and/or asymptomatic.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Bone pain is mentioned, but the response does not explicitly state that bone metastases can be painful or asymptomatic."
      },
      {
        "criterion_number": 5,
        "description": "The response must mention the frequency or rarity of pancreatic cancer metastasizing to the bone.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement is made about how common or rare bone metastases are in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response must define or describe osteopenia and osteoporosis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Osteoporosis is mentioned but not defined; osteopenia is not mentioned or defined."
      },
      {
        "criterion_number": 7,
        "description": "The response must identify at least one risk factor for osteopenia and osteoporosis and explain how these conditions are tested, such as with a DEXA scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies cancer treatments/chemotherapies as affecting bone health (a risk factor) and recommends regular bone density scans (DEXA), satisfying both components."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention granulocyte colony stimulating factor and its potential side effect of temporary bone pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Granulocyte colony stimulating factor (G-CSF) and its association with transient bone pain are not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response must emphasize that pain related to cancer or cancer-treatment is taken seriously and should be discussed with the patient\u2019s oncology team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It advises to report new or worsening bone pain immediately and suggests working closely with the oncology team, emphasizing communication about pain."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention that palliative medicine is a specialty for managing symptoms related to medical diagnoses and treatments, and that the patient can request a referral to this specialty if available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Palliative medicine or referral to palliative care is not mentioned."
      }
    ],
    "question_number": 182,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:45:20.913153",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "At least two management strategies for osteopenia and osteoporosis (e.g., bisphosphonates, denosumab, calcium, vitamin D).",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response names bisphosphonates, denosumab, and calcium and vitamin D supplements explicitly as management options."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly describe at least two types of bone and bone density problems during cancer treatment (e.g., osteopenia, osteoporosis, bone metastases).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists osteoporosis/bone thinning, bone metastases, increased fracture risk, and bone pain\u2014covering at least two distinct problems."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly mention bone metastases and at least two treatment options (e.g., systemic therapy, observation, radiation, surgery).",
        "score_given": 0,
        "max_points": 5,
        "justification": "While bone metastases are mentioned, no specific treatment options for bone metastases such as systemic therapy, radiation, surgery, or observation are provided."
      },
      {
        "criterion_number": 4,
        "description": "State that bone metastases can be painful and/or asymptomatic.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Bone pain is listed as a general issue, but the response does not explicitly state that bone metastases can be painful or asymptomatic."
      },
      {
        "criterion_number": 5,
        "description": "Mention the frequency or rarity of pancreatic cancer metastasizing to bone.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that bone metastases are less common in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "Define or describe osteopenia and osteoporosis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Osteoporosis is described as bone thinning, but osteopenia is not defined or described; the criterion requires describing both."
      },
      {
        "criterion_number": 7,
        "description": "Identify at least one risk factor for osteopenia/osteoporosis and explain how these are tested (e.g., DEXA scan).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Steroids/treatment are cited as risk factors, and \"regular bone density scans\" are mentioned for testing (which reasonably refers to DEXA)."
      },
      {
        "criterion_number": 8,
        "description": "Mention granulocyte colony stimulating factor (G-CSF) and its potential side effect of temporary bone pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "G-CSF and its association with temporary bone pain are not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize that cancer- or treatment-related pain is taken seriously and should be discussed with the oncology team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response clearly advises discussing symptoms with the oncology team and specifically mentions reporting bone pain or mobility concerns."
      },
      {
        "criterion_number": 10,
        "description": "Mention that palliative medicine is a specialty for symptom management and that the patient can request a referral if available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Palliative care consultation is suggested for symptom management, but it does not explicitly state that palliative medicine is a specialty nor that the patient can request a referral."
      }
    ],
    "question_number": 182,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:45:47.029249",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define epigenetics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines epigenetic changes as modifications that affect gene activity without altering DNA sequence and uses an accessible 'on/off switches' analogy."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how epigenetic changes can happen in normal cells, including gene silencing, activation, and DNA methylation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions gene silencing, activation, and DNA methylation, but does not state that these changes occur in normal cells; the discussion is framed specifically around pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how epigenetic changes impact the cell\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that epigenetic changes turn genes on/off, alter gene accessibility (histone modifications), and affect treatment response\u2014demonstrating impact on cellular function."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of epigenetic changes in cancer cells.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states roles in pancreatic cancer: silencing tumor-protective genes, activating tumor-promoting genes, and influencing treatment response. Note: some gene examples (e.g., VHL, BRCA1) are not typical for PDAC, but the overall role is correctly described."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that epigenetic changes can lead to inactivation of silencing tumor-suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that epigenetic changes can 'silence protective genes that normally prevent cancer growth' and cites promoter methylation as a mechanism."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that epigenetic changes can lead to activation of oncogenes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that epigenetic changes can 'activate genes that promote tumor development,' which covers oncogene activation."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that epigenetic changes can contribute to changes in the behavior of the tumor, such as increased propensity to spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention metastasis, invasion, or changes in propensity to spread or other behavioral changes beyond treatment response."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that epigenetic changes can impact treatment response.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that epigenetic changes affect how cancer cells respond to treatment and discusses epigenetic-targeting drugs."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that targeting epigenetic changes in pancreatic cancer is an experimental topic that is being actively researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that researchers are developing epigenetic therapies and that clinical trials are ongoing with DNMT and HDAC inhibitors, indicating active, experimental research."
      }
    ],
    "question_number": 183,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:46:10.144394",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define epigenetics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines epigenetics as modifications that affect gene activity without altering DNA sequence and uses the on/off switch analogy."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how epigenetic changes can happen in normal cells, including gene silencing, activation, and DNA methylation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions gene silencing/activation conceptually but does not explicitly describe mechanisms in normal cells nor explicitly mention DNA methylation. Reference to DNA methyltransferase inhibitors is not an explanation of DNA methylation in normal cells."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how epigenetic changes impact the cell\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains functional impacts such as impaired DNA repair, disrupted cell cycle control, and uncontrolled growth."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of epigenetic changes in cancer cells.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Directly ties epigenetic alterations to cancer behaviors by discussing silencing of tumor suppressors and other pathways in the cancer context."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that epigenetic changes can lead to inactivation of silencing tumor-suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that epigenetic changes can silence tumor suppressor genes and provides examples (e.g., CDKN2A)."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that epigenetic changes can lead to activation of oncogenes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention activation of oncogenes due to epigenetic changes."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that epigenetic changes can contribute to changes in the behavior of the tumor, such as increased propensity to spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of metastasis, invasiveness, EMT, or other behavior changes related to epigenetic alterations."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that epigenetic changes can impact treatment response.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions potential reversibility and existence of epigenetic-targeted therapies but does not explicitly state that epigenetic states alter or predict response to treatments."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that targeting epigenetic changes in pancreatic cancer is an experimental topic that is being actively researched.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not characterize epigenetic-targeted approaches as experimental or under active research; it implies established treatments without this context."
      }
    ],
    "question_number": 183,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:46:26.723047",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that patients consider care agencies that are accredited and have a good reputation.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response advises looking for 'Medicare/insurance certification' and 'Positive reviews from other cancer patients' under Quality Indicators, which addresses certification/accreditation and reputation."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that patients consider care agencies that provide a broad range of services, as the patient may have evolving needs as their treatment progresses.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It lists multiple service domains (pain/symptom management, 24/7 on-call, coordination with oncology, physical therapy, nutritional support, emotional support) and suggests considering 'skilled nursing vs. personal care assistance' and hospice, indicating a broad range of services for evolving needs."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient inquire with his oncology team if there is social work support available to assist in seeking home health care that is covered by the patient\u2019s insurance carrier.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it mentions coordination with the oncology team and offers help navigating insurance, it does not specifically recommend asking the oncology team about social work support for insurance-covered home health care."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there is a broad range of types of in-home care and that the patient and family should consider what tasks they need assistance with.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions choosing between 'skilled nursing vs. personal care assistance' but does not explicitly state that families should consider the specific tasks they need help with."
      },
      {
        "criterion_number": 5,
        "description": "The response should summarize common types of assistance that cancer patients benefit from such as cooking, cleaning, general home upkeep, shopping.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not list practical household supports like cooking, cleaning, home upkeep, or shopping."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide links to websites where patients can learn more about the types of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No external links or website resources are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention Hospice as a service that provides care in the home for patients with a prognosis of 6 months or less.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is mentioned, but the response does not specify the typical eligibility criterion of a 6-month prognosis nor explicitly note that hospice provides care in the home."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that home health services include skilled nursing care and in-home therapies, such as physical and occupational therapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It references physical therapy and choosing between skilled nursing vs. personal care, but it does not mention occupational therapy explicitly or clearly tie these to 'home health services' as a category."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that they should seek agencies with experience in caring for cancer patients, specifically mentioning oncology-trained staff.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It asks if providers have experience with pancreatic cancer patients, but does not explicitly mention oncology-trained staff."
      }
    ],
    "question_number": 184,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:46:44.930269",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that patients consider care agencies that are accredited and have a good reputation.",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response advises checking state licensing and Medicare ratings, but does not mention accreditation nor explicitly advise selecting agencies with a good reputation."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that patients consider care agencies that provide a broad range of services, as the patient may have evolving needs as their treatment progresses.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It lists a broad array of services (skilled nursing, pain/symptom management, personal care, PT/OT, medical social work, coordination with oncology) and asks about hospice coordination and 24/7 availability, indicating consideration for evolving needs."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient inquire with his oncology team if there is social work support available to assist in seeking home health care that is covered by the patient\u2019s insurance carrier.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it mentions medical social worker support and to ask the oncologist for referrals and check insurance coverage, it does not instruct asking the oncology team about social work support to help find in-network/covered home health services."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there is a broad range of types of in-home care and that the patient and family should consider what tasks they need assistance with.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists some clinical and personal care services but does not explicitly state that there are different types of in-home care nor advise the family to identify specific tasks they need help with."
      },
      {
        "criterion_number": 5,
        "description": "The response should summarize common types of assistance that cancer patients benefit from such as cooking, cleaning, general home upkeep, shopping.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions personal care (bathing, dressing, mobility) but does not include instrumental activities like cooking, cleaning, shopping, or home upkeep."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide links to websites where patients can learn more about the types of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references the Pancreatic Cancer Action Network and Medicare ratings but provides no actual links/URLs."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention Hospice as a service that provides care in the home for patients with a prognosis of 6 months or less.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is mentioned only in the context of potential coordination; it does not state that hospice provides in-home care for those with a prognosis of six months or less."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that home health services include skilled nursing care and in-home therapies, such as physical and occupational therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly lists skilled nursing care and physical/occupational therapy as services to look for."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that they should seek agencies with experience in caring for cancer patients, specifically mentioning oncology-trained staff.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It advises asking if providers are experienced with pancreatic cancer care but does not specifically mention oncology-trained staff."
      }
    ],
    "question_number": 184,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:47:14.978211",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define angiogenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly and correctly defines angiogenesis as the process by which new blood vessels form."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the role of angiogenesis in solid tumors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains that tumors need blood vessels for oxygen/nutrient delivery, waste removal, and routes for spread, which accurately describes angiogenesis in solid tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of angiogenesis in pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions pancreatic tumors, it inaccurately states they are 'particularly dependent' on creating their own blood supply. Pancreatic ductal adenocarcinoma is typically hypovascular with dense stroma, and angiogenesis plays a less targetable role compared to other tumors. The criterion is not met with accurate, pancreas-specific detail."
      },
      {
        "criterion_number": 4,
        "description": "The response should discuss how angiogenesis is a target for cancer treatment in some cancers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It correctly notes that anti-angiogenic drugs (e.g., bevacizumab, ramucirumab) block VEGF and are used to inhibit new blood vessel formation, demonstrating angiogenesis as a therapeutic target."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that anti-angiogenesis drugs are not used routinely in pancreatic cancer as they have not been shown to significantly improve outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that anti-angiogenic therapy has not improved outcomes in pancreatic cancer and is not routinely used. Instead, it suggests they may be used, without clarifying the lack of demonstrated benefit."
      },
      {
        "criterion_number": 6,
        "description": "The response should link to randomized control trials studying the effect of anti-angiogenic therapies in pancreatic cancer, with summaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No randomized controlled trials are cited or summarized; there are no links or specific study results provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss treatment options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises that the oncologist will determine appropriateness and offers specific questions to bring to the healthcare team."
      }
    ],
    "question_number": 185,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:47:30.954160",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define angiogenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines angiogenesis as the formation of new blood vessels and explains its relevance to tumor blood supply."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the role of angiogenesis in solid tumors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that tumors induce new vessel growth to support growth and metastasis and mentions effects on drug delivery, which addresses angiogenesis in solid tumors generally."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of angiogenesis in pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "States that pancreatic tumors are particularly good at promoting angiogenesis; this is inaccurate for pancreatic ductal adenocarcinoma, which is typically hypovascular with dense stroma and abnormal vasculature. The description does not accurately convey the role of angiogenesis specifically in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should discuss how angiogenesis is a target for cancer treatment in some cancers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes anti-angiogenic therapies, their targets, rationale ('starving' the tumor), and combination with chemotherapy, demonstrating understanding that angiogenesis is a treatment target in oncology."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that anti-angiogenesis drugs are not used routinely in pancreatic cancer as they have not been shown to significantly improve outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Says results are 'mixed' but does not explicitly state that anti-angiogenic drugs are not used routinely in pancreatic cancer nor that they have not significantly improved outcomes."
      },
      {
        "criterion_number": 6,
        "description": "The response should link to randomized control trials studying the effect of anti-angiogenic therapies in pancreatic cancer, with summaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No randomized controlled trials are cited or summarized; no links provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss treatment options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages discussing specifics with the oncology team and invites further questions for them."
      }
    ],
    "question_number": 185,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:47:49.979487",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that liver function is routinely monitored during treatment using labs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions regular liver function tests (ALT, AST, bilirubin, alkaline phosphatase) as part of monitoring."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe ways in which pancreatic cancer and pancreatic cancer treatment can affect the liver.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that treatment can cause liver problems (implied chemotherapy hepatotoxicity via dose adjustments) and that bile duct blockage (a cancer-related complication) may require stenting, indicating cholestasis/jaundice."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes in liver function labs will often be investigated further with imaging studies.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Imaging is listed as a monitoring method, but there is no explicit linkage that abnormal labs prompt further investigation with imaging."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe ways in which liver injury can be treated, such as dose reduction in systemic treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly recommends chemotherapy dose reduction, changing drugs, and treatment breaks for hepatotoxicity management."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which liver injury can be treated, such as local therapy to tumors in the liver.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of liver-directed local therapies (e.g., ablation, embolization, SBRT) for hepatic tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways in which liver injury can be treated, such as biliary stenting.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly mentions biliary stents for blocked bile ducts to restore flow."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe ways in which liver injury can be treated, such as elimination of offending medications or supplements.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise discontinuing offending medications/supplements; instead mentions supportive medications and supplements without caution about stopping potential culprits."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways in which liver injury can be treated, such as treatment of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of evaluating for or treating infectious causes of liver injury (e.g., cholangitis, viral hepatitis)."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that in rare cases, biopsy of liver tissue is needed to understand the cause of liver injury.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention liver biopsy as a diagnostic step in unclear cases."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that many different medications and supplements can cause liver toxicity, and the patient should discuss all medications and supplements they take while undergoing cancer treatment to ensure no interactions.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No caution provided about medication/supplement-induced hepatotoxicity or the need to review all agents with the clinical team."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe red flag symptoms for liver injury.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists jaundice, severe abdominal pain/swelling, dark urine, pale stools, persistent nausea/confusion, and unusual bleeding/bruising."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the patient discuss any new or worrisome symptoms with a member of their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a 'When to Contact the Medical Team' section and advises engaging the oncology team about monitoring and warning signs."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of exercise, nutrition, and sleep in mitigating treatment-related toxicities and side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions nutritional support but does not emphasize exercise or sleep; requirement not fully met under binary scoring."
      }
    ],
    "question_number": 186,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:48:11.734073",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that liver function is routinely monitored during treatment using labs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states regular blood tests for liver enzymes (ALT, AST, bilirubin, ALP) and notes typical frequency during treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe ways in which pancreatic cancer and pancreatic cancer treatment can affect the liver.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not describe mechanisms such as biliary obstruction from pancreatic tumor, liver metastases, or specific hepatotoxic effects of therapies; only refers generally to 'treatment-related liver problems.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes in liver function labs will often be investigated further with imaging studies.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions imaging (CT, MRI, ultrasound) as part of monitoring to assess liver structure, implying further evaluation beyond labs."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe ways in which liver injury can be treated, such as dose reduction in systemic treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly mentions dose reductions, treatment delays, and treatment breaks to allow liver recovery."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which liver injury can be treated, such as local therapy to tumors in the liver.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of local liver-directed therapies (e.g., ablation, embolization, SBRT) for hepatic metastases."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways in which liver injury can be treated, such as biliary stenting.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention biliary obstruction management or biliary stenting."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe ways in which liver injury can be treated, such as elimination of offending medications or supplements.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise stopping or avoiding hepatotoxic medications/supplements or reviewing all agents for potential harm."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways in which liver injury can be treated, such as treatment of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of evaluating or treating infectious causes of liver injury (e.g., hepatitis, cholangitis)."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that in rare cases, biopsy of liver tissue is needed to understand the cause of liver injury.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention liver biopsy."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that many different medications and supplements can cause liver toxicity, and the patient should discuss all medications and supplements they take while undergoing cancer treatment to ensure no interactions.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not advise disclosure/review of all medications and supplements for hepatotoxicity or interactions."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe red flag symptoms for liver injury.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists jaundice, fatigue, and abdominal pain as symptoms monitored, which are red flags for liver dysfunction."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the patient discuss any new or worrisome symptoms with a member of their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages asking for clarification and requesting a meeting to discuss concerns with the care team."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of exercise, nutrition, and sleep in mitigating treatment-related toxicities and side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions dietary/nutritional support but does not address exercise or sleep."
      }
    ],
    "question_number": 186,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:48:28.413058",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should discuss what tumor dormancy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor dormancy as a state where cancer cells stop dividing or divide very slowly, can persist for months to decades, and are alive but inactive."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the implications of tumor cells that can enter dormancy, such as disease recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that dormancy explains why cancer can recur years after treatment and notes clinical relevance."
      },
      {
        "criterion_number": 3,
        "description": "The response should outline that there is ongoing study on the subject of tumor dormancy, though it is not fully understood at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions it is an important area of research and that the topic is complex and not fully understood, with ongoing studies."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that dormancy can occur due to microenvironmental factors such as changes in the tumor microenvironment, lack of nutrients, or the presence of certain immune cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Cites immune system surveillance, lack of blood supply, and the surrounding tissue environment as factors contributing to dormancy."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that dormant cells are often less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States dormant cells may be resistant to chemotherapy and explains that chemotherapy typically targets rapidly dividing cells."
      },
      {
        "criterion_number": 6,
        "description": "The response should reference evidence from the scientific literature that discusses tumor dormancy in pancreatic cancer, and only references with a PubMed identification number (PMID) should be included.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No scientific literature or PMIDs are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should indicate whether or not it is possible to detect dormant cancer cells in the body in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address detectability of dormant cells in pancreatic cancer (e.g., via imaging, biopsies, or circulating biomarkers)."
      }
    ],
    "question_number": 187,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:48:36.931386",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should discuss what tumor dormancy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines dormancy as cancer cells stopping division while remaining alive and metabolically quiet, and notes it can involve single cells or small clusters."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the implications of tumor cells that can enter dormancy, such as disease recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions that dormant cells may explain cancer recurrence years after treatment and implies clinical impact."
      },
      {
        "criterion_number": 3,
        "description": "The response should outline that there is ongoing study on the subject of tumor dormancy, though it is not fully understood at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that dormancy research is ongoing and still evolving, indicating incomplete current understanding."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that dormancy can occur due to microenvironmental factors such as changes in the tumor microenvironment, lack of nutrients, or the presence of certain immune cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses angiogenic dormancy (limited blood supply) and immune-mediated dormancy (immune system containment), both microenvironmental factors."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that dormant cells are often less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes dormant cells can be resistant to chemotherapy, which often targets dividing cells."
      },
      {
        "criterion_number": 6,
        "description": "The response should reference evidence from the scientific literature that discusses tumor dormancy in pancreatic cancer, and only references with a PubMed identification number (PMID) should be included.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should indicate whether or not it is possible to detect dormant cancer cells in the body in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address detectability of dormant pancreatic cancer cells."
      }
    ],
    "question_number": 187,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:48:48.998285",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what an advance directive is and why people create them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains components of advance directives (living will, healthcare power of attorney, POLST) and states why they are created\u2014peace of mind and ensuring wishes are respected."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that the patient and family ask their oncology team if there are resources available to assist in the creation of advance directives, such as social work.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises consulting with the oncologist and meeting with a palliative care specialist, directing the family to use the oncology team and associated resources to assist with planning, which fulfills the intent of the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should direct the patient to consider what medical treatments they would accept in the event of an emergency or if they became too sick to make decisions on their own, including wishes surrounding CPR, invasive medical procedures such as dialysis, artificial nutrition, and noninvasive medical treatments such as intravenous fluids or antibiotics. This is also referred to as a living will.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists resuscitation (DNR/CPR), mechanical ventilation, artificial nutrition/hydration, and dialysis, and frames this under a living will. While it does not name IV fluids/antibiotics specifically, it comprehensively covers the key treatment categories and context of a living will."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient elect a specific person to be their durable power of attorney for healthcare, or a person who would make medical decisions for them if they were too sick to make their own decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes Healthcare Power of Attorney with explanation that this designates someone to make medical decisions."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should also complete a POLST, or a physician order for life-sustaining treatment, with their oncologist or other health practitioner, and should have this in their home in an easy-to-see location.",
        "score_given": 0,
        "max_points": 5,
        "justification": "POLST/MOLST is mentioned, but the response does not instruct completing it with the oncologist or other clinician, nor does it advise keeping it in an easy-to-see location at home."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the advance directives should include a DNR order if desired.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists resuscitation preferences (DNR/CPR) as a key decision to address."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to complete advance directives as soon as possible, even if their cancer is in remission or cured.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not encourage completing directives promptly or note the importance even if cancer is in remission or cured."
      },
      {
        "criterion_number": 8,
        "description": "The response should explain the logistics of completing an advance directive and recommend that the patient turn in a completed copy of the form to their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides practical steps (discuss with family/healthcare team, ensure legal validity in the state) and advises providing copies to healthcare providers, which includes the oncology team."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize to patients with pancreatic cancer the importance of future planning, as this disease is difficult to cure and can be aggressive.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes planning is important, it does not specifically emphasize the aggressive nature or poor curability of pancreatic cancer as a reason for early planning."
      }
    ],
    "question_number": 188,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:49:11.636830",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what an advance directive is and why people create them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines advance directives as important documents to ensure a loved one's wishes are honored and outlines their purpose, including specifying preferences and appointing decision-makers."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that the patient and family ask their oncology team if there are resources available to assist in the creation of advance directives, such as social work.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises consulting the oncologist and meeting with a social worker or chaplain, and notes that many hospitals have advance directive specialists, which aligns with recommending oncology team resources."
      },
      {
        "criterion_number": 3,
        "description": "The response should direct the patient to consider what medical treatments they would accept in the event of an emergency or if they became too sick to make decisions on their own, including wishes surrounding CPR, invasive medical procedures such as dialysis, artificial nutrition, and noninvasive medical treatments such as intravenous fluids or antibiotics. This is also referred to as a living will.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it covers CPR, dialysis, ventilators, and feeding tubes and labels this as a living will, it does not explicitly mention noninvasive treatments such as IV fluids or antibiotics as required."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient elect a specific person to be their durable power of attorney for healthcare, or a person who would make medical decisions for them if they were too sick to make their own decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly includes a Healthcare Power of Attorney that designates someone to make medical decisions if needed."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should also complete a POLST, or a physician order for life-sustaining treatment, with their oncologist or other health practitioner, and should have this in their home in an easy-to-see location.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although POLST/MOLST is mentioned, the response does not instruct completing it with a clinician nor placing it in an easy-to-see location at home."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the advance directives should include a DNR order if desired.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directly references resuscitation wishes including DNR orders, indicating inclusion if desired."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to complete advance directives as soon as possible, even if their cancer is in remission or cured.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit encouragement to complete advance directives promptly or regardless of remission/cure status."
      },
      {
        "criterion_number": 8,
        "description": "The response should explain the logistics of completing an advance directive and recommend that the patient turn in a completed copy of the form to their oncology team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not cover logistics such as witnessing/notarization or state-specific forms, and it does not advise submitting a copy to the oncology team; it only suggests keeping copies accessible."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize to patients with pancreatic cancer the importance of future planning, as this disease is difficult to cure and can be aggressive.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response is empathetic but does not specifically emphasize pancreatic cancer\u2019s aggressiveness or link it to the need for proactive planning."
      }
    ],
    "question_number": 188,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:49:29.972419",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what targeted therapy is in oncologic treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that targeted therapy uses drugs that specifically target cancer cells' unique features, contrasting with traditional chemotherapy that affects all rapidly dividing cells."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain what combination targeted therapy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that combination targeted therapy involves using multiple drugs that target cancer cell features and discusses combining agents."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe what kinds of targeted therapy options exist in pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists PARP inhibitors for BRCA mutations, EGFR inhibitors, checkpoint inhibitors, and other drugs targeting specific genetic alterations, which are relevant targeted approaches in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should illustrate why more than one targeted medication might be used at the same time to treat cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes that combinations attack cancer via multiple pathways, may reduce resistance, and can be more effective than single agents."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain why the patient\u2019s tumor tissue needs to undergo molecular testing to understand what targeted therapies are indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It outlines a process including genetic/molecular testing to identify targetable mutations and select matched drugs."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain that some targeted therapies may not work on the patient\u2019s tumor due to lack of targetable mutations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it implies mutation-specific use, it does not explicitly state that targeted therapies may not work if the tumor lacks targetable mutations."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain that targeted therapies do not always work in pancreatic cancer due to tumor heterogeneity.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of tumor heterogeneity or its impact on targeted therapy effectiveness."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe that targeted therapies are sometimes used at the same time as traditional chemotherapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists combinations such as FOLFIRINOX or gemcitabine/nab-paclitaxel with targeted agents."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient discuss this further with their oncologist as targeted therapies are individualized to each patient\u2019s cancer, and not all targeted therapies are treatment options for all patients with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes that the oncology team will tailor the combination to tumor characteristics and encourages discussing specific drugs and rationale."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention KRAS inhibitors as a current area of research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "KRAS inhibitors or KRAS-focused research are not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention PARP inhibitors are used in pancreatic cancer patients with BRCA1/2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that PARP inhibitors are for BRCA mutations, which encompasses BRCA1/2."
      }
    ],
    "question_number": 189,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:49:52.581960",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what targeted therapy is in oncologic treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that targeted therapy involves drugs that target specific molecular pathways involved in cancer growth and spread, which constitutes a clear definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain what combination targeted therapy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that combination targeted therapy uses multiple drugs targeting different pathways and also mentions pairing targeted drugs with chemotherapy or multiple targeted agents, meeting the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe what kinds of targeted therapy options exist in pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists several targeted therapy categories relevant to pancreatic cancer: PARP inhibitors (for BRCA mutations), EGFR inhibitors, immunotherapy drugs, and antiangiogenic drugs, thus describing kinds of options."
      },
      {
        "criterion_number": 4,
        "description": "The response should illustrate why more than one targeted medication might be used at the same time to treat cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains that each drug targets different aspects of cancer cell survival, combinations can be more effective, and may overcome resistance\u2014clearly illustrating the rationale for combination therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain why the patient\u2019s tumor tissue needs to undergo molecular testing to understand what targeted therapies are indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that treatment plans are highly personalized based on genetic testing of the tumor and advises asking about genetic testing results that inform treatment choice, directly addressing the need for molecular testing."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain that some targeted therapies may not work on the patient\u2019s tumor due to lack of targetable mutations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it emphasizes personalization based on genetics, it does not explicitly state that certain targeted therapies will not work if the tumor lacks the corresponding targetable mutation."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain that targeted therapies do not always work in pancreatic cancer due to tumor heterogeneity.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions overcoming resistance but does not address tumor heterogeneity as a reason for variable efficacy in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe that targeted therapies are sometimes used at the same time as traditional chemotherapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists 'Targeted drugs paired with chemotherapy' under common combinations, satisfying this criterion."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient discuss this further with their oncologist as targeted therapies are individualized to each patient\u2019s cancer, and not all targeted therapies are treatment options for all patients with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises discussing specific drugs, genetic testing results, benefits, and side effects with the oncologist and states that plans are highly personalized, fulfilling the requirement."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention KRAS inhibitors as a current area of research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "KRAS is mentioned only as an example of a mutation; the response does not specifically mention KRAS inhibitors or note their status as an active research area."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention PARP inhibitors are used in pancreatic cancer patients with BRCA1/2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states 'PARP inhibitors (for BRCA mutations),' which aligns with their use in patients with BRCA1/2 mutations."
      }
    ],
    "question_number": 189,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:50:25.237477",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metastasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response lists metastatic sites but does not define metastasis (e.g., spread of cancer cells from the primary site to distant locations)."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer metastasizes, such as hematologic spread and lymphatic spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanisms of spread (hematogenous, lymphatic, peritoneal seeding) are described."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how pancreatic cancer metastasizes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response identifies organs involved but does not describe pancreatic-specific routes (e.g., portal venous spread to liver, peritoneal seeding, lymphatic spread, perineural invasion)."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that pancreatic cancer typically spreads locally first, involving surrounding lymph nodes, organs, and blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no explicit statement that local spread typically precedes distant metastases; regional lymph nodes are mentioned only as a less common site, which does not satisfy the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that metastatic spread of the pancreatic cancer can be influenced by the location of the primary tumor, for example whether it is located at the pancreatic head or the tail.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that the pattern of spread depends on the location of the primary tumor in the pancreas."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that the liver is usually the first location for metastases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It states the liver is the most common site, but does not explicitly say it is usually the first location for metastases."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly state that pancreatic cancer can metastasize to the peritoneum or lining of the abdominal cavity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists the peritoneum (lining of the abdominal cavity) as a metastatic site."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that pancreatic cancer can spread to the lungs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists the lungs as a metastatic site."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer can spread to at least one of the following less common sites: bones, brain, or adrenal gland.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists bones, adrenal glands, and brain as possible metastatic sites."
      },
      {
        "criterion_number": 11,
        "description": "The response should explain what proportion of pancreatic cancers are metastatic at diagnosis and why.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No proportion or explanation of metastatic presentation rates at diagnosis is provided."
      },
      {
        "criterion_number": 12,
        "description": "The response should discuss that pancreatic cancer commonly has already metastasized at the time of diagnosis because it often is asymptomatic at an early stage and only becomes symptomatic once it has spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss the typical late presentation due to early asymptomatic disease."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that treatment options exist for all stages of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It states treatment options exist even for metastatic disease, but does not explicitly state that options exist for all stages."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that options for treatment modalities, for example surgery or chemotherapy, depend on the stage of the cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention that treatment modality selection (e.g., surgery vs. chemotherapy) depends on cancer stage."
      }
    ],
    "question_number": 190,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:50:55.833873",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metastasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses sites of spread but does not define metastasis (the process of cancer cells spreading from the primary site to distant locations)."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer metastasizes, such as hematologic spread and lymphatic spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explanation of mechanisms (e.g., hematogenous/portal venous spread, lymphatic spread) is provided; only regional invasion is listed."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how pancreatic cancer metastasizes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response outlines local invasion to nearby organs, spread to regional lymph nodes, involvement of blood vessels, and distant sites, which constitutes a description of how pancreatic cancer spreads."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that pancreatic cancer typically spreads locally first, involving surrounding lymph nodes, organs, and blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While local/regional spread is listed, the response does not explicitly state that local spread typically occurs first."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that metastatic spread of the pancreatic cancer can be influenced by the location of the primary tumor, for example whether it is located at the pancreatic head or the tail.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that the location of the original tumor in the pancreas influences spread, which satisfies the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that the liver is usually the first location for metastases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It states the liver is the most frequent site (70\u201380%) but does not explicitly state it is usually the first site of metastasis."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly state that pancreatic cancer can metastasize to the peritoneum or lining of the abdominal cavity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists the peritoneum and identifies it as the lining of the abdominal cavity."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that pancreatic cancer can spread to the lungs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lungs are explicitly listed as a site of spread."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer can spread to at least one of the following less common sites: bones, brain, or adrenal gland.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Bones are explicitly listed as a less common site."
      },
      {
        "criterion_number": 11,
        "description": "The response should explain what proportion of pancreatic cancers are metastatic at diagnosis and why.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No proportion or explanation regarding metastatic disease at diagnosis is provided."
      },
      {
        "criterion_number": 12,
        "description": "The response should discuss that pancreatic cancer commonly has already metastasized at the time of diagnosis because it often is asymptomatic at an early stage and only becomes symptomatic, prompting diagnostic investigation, once it has spread beyond its original site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of asymptomatic early stages leading to late/metastatic diagnosis."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that treatment options exist for all stages of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Treatment options are mentioned generally, but it is not stated that options exist for all stages."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that options for treatment modalities, for example surgery or chemotherapy, depend on the stage of the cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although staging is mentioned, the response does not explicitly state that treatment modalities depend on cancer stage or give examples such as surgery vs. chemotherapy."
      }
    ],
    "question_number": 190,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:51:19.887718",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how pancreatic cancer chemotherapy treatment can cause injury to the kidneys.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States that chemotherapy drugs can affect kidney function, indicating chemo-related renal injury."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that platinum drugs (e.g., cisplatin, oxaliplatin) can directly injure the kidney.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly mentions cisplatin as a chemotherapy drug that can affect kidney function."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how other pancreatic cancer treatments, such as surgery or radiation, can cause injury to the kidneys.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss kidney injury related to surgery or radiation."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that urinary tract infection should be ruled out, as some cancer treatments can put patients at increased risk for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of urinary tract infection or the need to rule it out."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe that patients undergoing systemic treatment for pancreatic cancer should have their kidney function monitored frequently to evaluate for toxicity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends regular monitoring with blood tests for kidney function during treatment."
      },
      {
        "criterion_number": 7,
        "description": "The response must clearly state that the first step is to identify the offending agent and reduce or hold the drug.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions dose modifications or switching drugs but does not clearly state that the first step is to identify the offending agent and reduce/hold the drug."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is monitored and managed, such as serial lab tests of renal function to understand if it is improving over time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifies regular blood tests (creatinine, BUN) to monitor kidney function."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as dose reduction of systemic treatment, particularly the offending drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes dose modifications or switching to kidney-safer alternatives."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as administration of intravenous fluids or other medications to support the kidneys.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends IV hydration before/after chemotherapy and pre-hydration before contrast studies."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention that IV fluids can be used to provide hydration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states 'Hydration: IV fluids before/after chemotherapy' and 'Pre-hydration before contrast studies.'"
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as thorough evaluation of other medications or supplements a patient is taking to ensure there are no harmful interactions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention reviewing other medications or supplements for interactions."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that alleviating obstruction (e.g., via stenting or nephrostomy) can help recover renal function.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions relieving bile duct blockages but does not explicitly discuss stenting/nephrostomy or link obstruction relief to renal recovery."
      },
      {
        "criterion_number": 14,
        "description": "The response must explicitly state that dehydration and obstruction (e.g., biliary or urinary) can lead to kidney injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists dehydration and bile duct obstruction as causes affecting kidney function."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consult with their oncology team and oncology pharmacist prior to starting new medications or supplements while undergoing pancreatic cancer treatment to avoid harmful interactions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages discussing concerns with the oncology team but does not specifically advise consulting an oncology pharmacist or before starting new medications/supplements."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that sometimes dialysis may be indicated if there is a severe kidney injury related to cancer treatment.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of dialysis for severe kidney injury."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend staying well hydrated and with adequate nutrition intake while undergoing pancreatic cancer treatment to preserve energy and organ functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions hydration but does not recommend adequate nutrition intake."
      }
    ],
    "question_number": 191,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:51:46.711557",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how pancreatic cancer chemotherapy treatment can cause injury to the kidneys.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly lists chemotherapy drugs as a common cause of kidney problems, indicating chemo can injure kidneys."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that platinum drugs (e.g., cisplatin, oxaliplatin) can directly injure the kidney.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Cisplatin is specifically named as a chemotherapy drug associated with kidney problems, satisfying explicit mention of a platinum agent."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how other pancreatic cancer treatments, such as surgery or radiation, can cause injury to the kidneys.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of surgery or radiation causing kidney injury."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that urinary tract infection should be ruled out, as some cancer treatments can put patients at increased risk for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Urinary tract infection is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe that patients undergoing systemic treatment for pancreatic cancer should have their kidney function monitored frequently to evaluate for toxicity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends regular blood tests (creatinine, BUN) and close monitoring by the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response must clearly state that the first step is to identify the offending agent and reduce or hold the drug.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While dose reduction or switching drugs is mentioned, it does not clearly state the first step is to identify the offending agent nor to hold the drug."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is monitored and managed, such as serial lab tests of renal function to understand if it is improving over time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Serial monitoring with regular kidney function blood tests is described."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as dose reduction of systemic treatment, particularly the offending drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Management includes medication adjustments with dose reduction or switching."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as administration of intravenous fluids or other medications to support the kidneys.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically recommends IV fluids before/after chemotherapy."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention that IV fluids can be used to provide hydration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states 'Hydration: IV fluids before/after chemotherapy.'"
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as thorough evaluation of other medications or supplements a patient is taking to ensure there are no harmful interactions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to review medications/supplements for interactions or to consult pharmacy."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that alleviating obstruction (e.g., via stenting or nephrostomy) can help recover renal function.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of urinary obstruction or interventions like stenting/nephrostomy."
      },
      {
        "criterion_number": 14,
        "description": "The response must explicitly state that dehydration and obstruction (e.g., biliary or urinary) can lead to kidney injury.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Dehydration is mentioned, but obstruction is not discussed."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consult with their oncology team and oncology pharmacist prior to starting new medications or supplements while undergoing pancreatic cancer treatment to avoid harmful interactions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit recommendation to consult an oncology pharmacist or verify new meds/supplements before starting them."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that sometimes dialysis may be indicated if there is a severe kidney injury related to cancer treatment.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Dialysis is not mentioned."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend staying well hydrated and with adequate nutrition intake while undergoing pancreatic cancer treatment to preserve energy and organ functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Staying well-hydrated is advised, but adequate nutrition intake is not mentioned."
      }
    ],
    "question_number": 191,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:52:11.157742",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the role of genetic mutations in cancer.",
        "score_given": 9,
        "max_points": 9,
        "justification": "The response explicitly states that cancer begins when normal pancreatic cells acquire mutations and that cancer cells continue to mutate and diversify, clearly describing the role of genetic mutations in cancer initiation and progression."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer treatment applies selective pressure on cancer cells, allowing those that harbor certain characteristics that confer resistance to therapy a survival advantage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions that cancer cells can develop resistance and treatments may become less effective, it does not explain the concept of treatment-induced selective pressure or that resistant clones gain a survival advantage under therapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that after certain treatments, tumor cells susceptible to that treatment will have died while those resistant to the treatment survive, making the residual cancer fundamentally different from the original cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not state that treatment kills susceptible cells while resistant ones survive, nor that the post-treatment tumor is fundamentally different from the pretreatment tumor."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how genetic mutations can cause cancer cells to resist certain treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Resistance is mentioned but not linked to specific genetic mutations or mechanisms by which mutations confer treatment resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the heterogeneous cellular make-up of pancreatic cancer at baseline.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response describes intratumoral heterogeneity by noting diversification into different subpopulations with varying capabilities, indicating a heterogeneous tumor cell population."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the mesenchymal-epithelial transition, including triggers for this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of epithelial\u2013mesenchymal transition (EMT) or mesenchymal\u2013epithelial transition (MET), nor any triggers or relevance to tumor evolution."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe methods for evaluating tumor evolution over time, including circulating tumor DNA and/or traditional biopsy of the primary tumor or metastatic lesion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response only mentions 'regular monitoring' without specifying methods such as circulating tumor DNA (ctDNA) or tissue biopsies."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that tumor evolution is when the cancer changes and adapts over time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly conveys that pancreatic cancer evolves and changes over time and notes that diversity makes the cancer more adaptable."
      }
    ],
    "question_number": 192,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:52:32.480086",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the role of genetic mutations in cancer.",
        "score_given": 9,
        "max_points": 9,
        "justification": "The response clearly states that cancer cells continuously acquire new mutations, that some mutations help cells survive/grow/spread, and that this leads to genetic diversity within the tumor, directly addressing the role of genetic mutations."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer treatment applies selective pressure on cancer cells, allowing those that harbor certain characteristics that confer resistance to therapy a survival advantage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that initially most cells respond to treatment, some cells have or develop resistance, and resistant cells can multiply over time. This describes treatment as a selective pressure giving resistant cells a survival advantage."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that after certain treatments, tumor cells susceptible to that treatment will have died while those resistant to the treatment survive, making the residual cancer fundamentally different from the original cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response notes that most cells may respond to treatment (implying susceptible cells die/shrink) while resistant cells survive and multiply, leading to treatment resistance over time. This conveys that the post-treatment tumor composition differs from the original."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how genetic mutations can cause cancer cells to resist certain treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although the response discusses mutations and, separately, treatment resistance, it does not explicitly connect genetic mutations as the cause of treatment resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the heterogeneous cellular make-up of pancreatic cancer at baseline.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions intratumoral heterogeneity in general, it does not specifically describe the baseline heterogeneous cellular composition of pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the mesenchymal-epithelial transition, including triggers for this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention epithelial\u2013mesenchymal or mesenchymal\u2013epithelial transitions or their triggers."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe methods for evaluating tumor evolution over time, including circulating tumor DNA and/or traditional biopsy of the primary tumor or metastatic lesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references regular scans, blood tests that detect genetic changes, and genetic testing of tumors to guide treatment\u2014capturing imaging, liquid-biopsy-like monitoring, and tissue-based testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that tumor evolution is when the cancer changes and adapts over time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The section title 'How Cancer Changes Over Time' and statements about adaptation in metastases explicitly convey that tumor evolution involves cancer changing and adapting over time."
      }
    ],
    "question_number": 192,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:53:02.957619",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define complementary therapies, including supportive and integrative therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions 'integrative care' and 'supportive options' but does not define complementary therapies or explain what supportive or integrative therapy means."
      },
      {
        "criterion_number": 2,
        "description": "The response should define aromatherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Aromatherapy is referenced as a gentle complementary therapy, but there is no definition (e.g., the use of essential oils from plants via inhalation or topical application)."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that any substances that are ingested or applied to the body can cause a reaction, such as an allergic reaction, and may be difficult to tell if the patient\u2019s reaction is from the complementary therapy or the cancer treatment itself. For this reason, these complementary therapies should be used with caution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response notes skin sensitivity, potential interactions, and to avoid ingestion, it does not explicitly mention allergic reactions or the difficulty of distinguishing whether a reaction is from complementary therapy versus cancer treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response should inform patients that complementary therapies do not treat cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that complementary therapies do not treat cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should inform patients that some complementary therapies may help with symptoms related to their cancer diagnosis, such as stress or insomnia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response clearly states potential symptom benefits (e.g., nausea relief, relaxation, anxiety reduction) and mentions other supportive options like massage, meditation, and acupuncture."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the patient inquire with their oncology team if there are practitioners of complementary therapies that they trust, or can place a referral to.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it advises consulting the oncology team and working with a certified aromatherapist, it does not explicitly recommend asking the oncology team for trusted practitioners or referrals."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide website links to informational pages from cancer societies such as NCI or PanCAN.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No links to NCI, PanCAN, or other cancer societies are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response should strongly recommend that the patient discuss any complementary therapies they are considering with their oncology team to ensure there are no harmful interactions with their cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states 'Consult your oncology team first' and warns about potential interactions with chemotherapy drugs, which constitutes a strong recommendation to discuss with the oncology team to avoid harmful interactions."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that aromatherapy is safest when used through inhalation and that oils must be appropriately prepared.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions diffused oils and proper dilution/avoid ingestion, but does not explicitly state that inhalation is the safest route."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that essential oils on the skin should be used with caution due to the risk of worsening skin irritation from chemotherapy or radiation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response notes that 'Skin may be more sensitive during treatment' but does not explicitly warn that topical essential oils should be used with caution due to risk of worsening skin irritation from chemotherapy or radiation."
      }
    ],
    "question_number": 193,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:53:36.197014",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define complementary therapies, including supportive and integrative therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes that complementary therapies are used alongside conventional treatment, but it does not define supportive therapy or integrative therapy. The rubric requires definitions that include supportive and integrative therapy, which are absent."
      },
      {
        "criterion_number": 2,
        "description": "The response should define aromatherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response lists considerations for aromatherapy, it does not define aromatherapy (e.g., the therapeutic use of essential oils from plants via inhalation or topical application)."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that any substances that are ingested or applied to the body can cause a reaction, such as an allergic reaction, and may be difficult to tell if the patient\u2019s reaction is from the complementary therapy or the cancer treatment itself. For this reason, these complementary therapies should be used with caution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response advises against undiluted oils and mentions possible interactions, but it does not explicitly state the risk of allergic reactions or the difficulty distinguishing adverse effects from cancer treatment versus the complementary therapy, nor does it explicitly tie this to using such therapies with caution."
      },
      {
        "criterion_number": 4,
        "description": "The response should inform patients that complementary therapies do not treat cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response emphasizes comfort and quality of life but never explicitly states that complementary therapies do not treat cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should inform patients that some complementary therapies may help with symptoms related to their cancer diagnosis, such as stress or insomnia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response notes aromatherapy may help with nausea, anxiety, and sleep issues, and mentions meditation, massage, and other supportive therapies for comfort, directly addressing symptom relief."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the patient inquire with their oncology team if there are practitioners of complementary therapies that they trust, or can place a referral to.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises discussing with the oncology team and notes the team can connect patients with qualified practitioners, satisfying the referral recommendation."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide website links to informational pages from cancer societies such as NCI or PanCAN.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No links to NCI, PanCAN, or other reputable cancer society resources are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response should strongly recommend that the patient discuss any complementary therapies they are considering with their oncology team to ensure there are no harmful interactions with their cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states to always discuss complementary therapies with the oncology team first and highlights potential interference with chemotherapy, fulfilling the strong recommendation."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that aromatherapy is safest when used through inhalation and that oils must be appropriately prepared.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although diffusion is mentioned, the response does not explicitly state that inhalation is the safest method. It mentions topical dilution but does not clearly assert safest-by-inhalation nor detail appropriate preparation beyond dilution."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that essential oils on the skin should be used with caution due to the risk of worsening skin irritation from chemotherapy or radiation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response advises against undiluted skin application but does not connect this caution to increased risk of skin irritation specifically from chemotherapy or radiation."
      }
    ],
    "question_number": 193,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:54:03.502373",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metabolism in humans.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response discusses altered metabolism in cancer cells but does not define human metabolism (e.g., the biochemical processes that convert nutrients into energy and building blocks to sustain life)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the Warburg Effect.",
        "score_given": 9,
        "max_points": 9,
        "justification": "It explicitly states that cancer cells use more glucose even when oxygen is available and names this the Warburg effect, which is an accurate description."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about glucose, amino acid, and lipid metabolism in cancer cells, specifically in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Glucose metabolism (increased glucose consumption/Warburg effect) and amino acid metabolism (glutamine dependence) are mentioned, but lipid/fatty acid metabolism is not addressed, nor are pancreatic cancer\u2013specific metabolic features described."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes in metabolism can alter sensitivity to cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that some treatments may work better when combined with metabolic interventions and mentions targeted therapies against metabolic differences, indicating that metabolic changes can impact treatment effectiveness."
      },
      {
        "criterion_number": 5,
        "description": "The response should not recommend specific diets for the management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "No specific diets are recommended; it only notes that nutrition strategies may be discussed and that evidence is evolving."
      },
      {
        "criterion_number": 6,
        "description": "The response should not indicate that restrictive diets, such as the ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response does not mention or advocate any restrictive diets."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises discussing with the oncology team, it does not explicitly recommend requesting a referral to a nutritionist/dietitian."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that there is not any current evidence for dietary interventions to alter the metabolism of the cancer and improve treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It says evidence is still evolving but does not clearly state that there is currently no evidence that dietary interventions alter tumor metabolism to improve treatment outcomes."
      }
    ],
    "question_number": 194,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:54:23.378705",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metabolism in humans.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response discusses cancer metabolism generally but does not define human metabolism (e.g., the sum of chemical processes that convert nutrients into energy and building blocks, and manage waste)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the Warburg Effect.",
        "score_given": 9,
        "max_points": 9,
        "justification": "It explicitly mentions that cancer cells consume glucose more rapidly than normal cells and names this the Warburg effect, which is a correct, concise description."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about glucose, amino acid, and lipid metabolism in cancer cells, specifically in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions altered glucose use but does not address amino acid (e.g., glutamine) or lipid metabolism, nor does it provide pancreatic cancer\u2013specific metabolic features."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes in metabolism can alter sensitivity to cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that combination metabolic approaches can make cancer cells more sensitive to standard treatments and that metabolic changes can affect how well treatments work."
      },
      {
        "criterion_number": 5,
        "description": "The response should not recommend specific diets for the management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "No specific diets are recommended; it only generally emphasizes maintaining adequate nutrition and consulting the care team."
      },
      {
        "criterion_number": 6,
        "description": "The response should not indicate that restrictive diets, such as the ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It does not mention or endorse restrictive diets such as ketogenic diets or intermittent fasting."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages discussing questions with the oncology team and specifically suggests consultation with an oncology nutritionist."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that there is not any current evidence for dietary interventions to alter the metabolism of the cancer and improve treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not state the lack of evidence for dietary interventions to alter tumor metabolism or improve treatment outcomes."
      }
    ],
    "question_number": 194,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:54:35.859808",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "List causes of eye problems related to cancer and/or cancer treatment, including chemotherapy-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, dry eye, metastatic disease to the brain or eye, and infections.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions dry eyes and infections but does not mention chemotherapy-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, or metastatic disease. It lists symptoms rather than the specific causes requested."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly state that chemotherapy can lead to eye dryness and irritations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While dry eyes are listed as a possible issue, the response does not explicitly attribute dryness or irritation to chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly state that the use of steroids can lead to an increase in cataracts or glaucoma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of steroids, cataracts, or glaucoma."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly state that immunosuppressed patients are more likely to have infections in their eyes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response states \"Eye infections (due to lowered immunity),\" which explicitly links immunosuppression to increased eye infection risk."
      },
      {
        "criterion_number": 5,
        "description": "Mention that the patient\u2019s eye symptoms may not be related to cancer or cancer treatment, and they should seek out an eye exam by a qualified practitioner.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it suggests the oncology team may refer to an ophthalmologist, it does not explicitly state that symptoms may be unrelated to cancer/treatment, nor does it directly recommend seeking an eye exam independently."
      },
      {
        "criterion_number": 6,
        "description": "Recommend documenting characteristics of symptoms, such as severity and date of onset.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises documenting when symptoms occur, their severity, and patterns, which satisfies this criterion."
      },
      {
        "criterion_number": 7,
        "description": "List red flag eye symptoms that should prompt immediate presentation to medical care, such as vision loss or severe pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists sudden vision changes or loss, severe eye pain, signs of infection, and worsening jaundice as reasons to contact the oncology team immediately."
      },
      {
        "criterion_number": 8,
        "description": "Explicitly state that any eye symptoms should be discussed with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly instructs that the oncology team should evaluate any eye symptoms and indicates when to contact them immediately."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient possibly request a referral to an ophthalmologist, based on reported symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes they might be referred to an ophthalmologist familiar with cancer-related eye issues, effectively recommending specialist involvement."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly state that eye drops can be used to mitigate symptoms of dry eyes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The recommendation to use preservative-free artificial tears explicitly endorses eye drops for dry eye symptom relief."
      }
    ],
    "question_number": 195,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:54:51.724314",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should list causes of eye problems related to cancer and/or cancer treatment, including chemotherapy-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, dry eye, metastatic disease to the brain or eye, and infections.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions dry eyes and generic changes in vision/eye pressure but does not explicitly list chemotherapy-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, metastatic disease to the brain or eye, or infections."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly state that chemotherapy can lead to eye dryness and irritations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states 'Dry eyes or irritation from chemotherapy,' which directly meets the requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly state that the use of steroids can lead to an increase in cataracts or glaucoma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of steroids or the risks of cataracts or glaucoma from steroid use."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that immunosuppressed patients are more likely to have infections in their eyes.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention immunosuppression or increased risk of ocular infections."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the patient\u2019s eye symptoms may not be related to cancer or cancer treatment, and they should seek out an eye exam by a qualified practitioner.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Recommends seeing an ophthalmologist if symptoms persist, but does not state that symptoms may be unrelated to cancer/treatment; the combined requirement is not fully met."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the patient document characteristics of their symptoms, such as severity and date of onset.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to 'Document what symptoms you're noticing and when they occur,' which addresses documentation of onset/timing; although severity is not mentioned, the recommendation to document is present."
      },
      {
        "criterion_number": 7,
        "description": "The response should list \u201cred flag\u201d eye symptoms that should prompt immediate presentation to medical care, such as vision loss or severe pain.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not list specific red flag symptoms; only suggests asking the medical team about warning signs."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly state that any eye symptoms should be discussed with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states to 'Contact the oncologist immediately to report any eye symptoms.'"
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient possibly request a referral to an ophthalmologist, based on reported symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises 'Ask about seeing an ophthalmologist if symptoms persist,' which meets the criterion."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that eye drops can be used to mitigate symptoms of dry eyes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of artificial tears or lubricating eye drops."
      }
    ],
    "question_number": 195,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:55:06.668289",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define neoantigens in cancer as proteins expressed on the surface of cancer cells, used by the immune system to differentiate cancer from healthy tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains neoantigens as new proteins that appear on cancer cells but not on healthy cells and states they help the immune system recognize cancer cells as foreign, satisfying the intent of the definition."
      },
      {
        "criterion_number": 2,
        "description": "Mention ongoing research involving neoantigens in cancer, including cancer vaccines, immunotherapy, and CAR-T trials.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions personalized vaccines and immunotherapy relevance but does not mention CAR-T trials; thus it does not include all required elements."
      },
      {
        "criterion_number": 3,
        "description": "State that there are no FDA-approved treatments targeting neoantigens at this time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses clinical trials and advanced options but does not explicitly state that no FDA-approved neoantigen-targeted therapies currently exist."
      },
      {
        "criterion_number": 4,
        "description": "Recommend that the patient discuss the role of neoantigens in their cancer care with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response directly recommends asking the medical team specific questions about neoantigen testing, trials, and integration into the treatment plan."
      },
      {
        "criterion_number": 5,
        "description": "Recommend considering referral to be considered for clinical trials for pancreatic cancer treatment in their area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response suggests discussing relevant clinical trials with the care team, which implies consideration of referral to trials."
      }
    ],
    "question_number": 196,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:55:18.954773",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define neoantigens in cancer as proteins expressed on the surface of cancer cells, used by the immune system to differentiate cancer from healthy tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that neoantigens are new proteins on cancer cells due to mutations and describes them as 'foreign flags' that help the immune system recognize and target cancer cells, effectively conveying surface expression and immune discrimination."
      },
      {
        "criterion_number": 2,
        "description": "Mention ongoing research involving neoantigens in cancer, including cancer vaccines, immunotherapy, and CAR-T trials.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While the response mentions immunotherapy and neoantigen-based vaccines and notes ongoing clinical trials, it does not mention CAR-T trials. Because all elements are required, full credit cannot be awarded."
      },
      {
        "criterion_number": 3,
        "description": "State that there are no FDA-approved treatments targeting neoantigens at this time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response characterizes vaccines as experimental but does not explicitly state that there are no FDA-approved neoantigen-targeted treatments."
      },
      {
        "criterion_number": 4,
        "description": "Recommend that the patient discuss the role of neoantigens in their cancer care with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly encourages asking the oncology team how neoantigen information might influence the treatment plan."
      },
      {
        "criterion_number": 5,
        "description": "Recommend considering referral to be considered for clinical trials for pancreatic cancer treatment in their area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response recommends discussing whether clinical trials could be appropriate with the oncology team, effectively encouraging consideration of clinical trials."
      }
    ],
    "question_number": 196,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:55:30.598110",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define autophagy, including degradation and recycling of cellular components, maintaining homeostasis by removing damaged organelles and protein aggregates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines autophagy as the cell's recycling system that breaks down damaged parts and reuses materials, and notes its role in maintaining normal cell function. While it does not explicitly mention 'organelles' or 'protein aggregates,' it clearly covers degradation/recycling and homeostatic maintenance by removing damaged components."
      },
      {
        "criterion_number": 2,
        "description": "Describe the dual role of autophagy in cancer (tumor suppression and promotion) with context on changes during progression.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response clearly explains that autophagy suppresses tumors in early stages and supports survival and treatment resistance in established cancers, indicating a shift during progression."
      },
      {
        "criterion_number": 3,
        "description": "State that autophagy can be protective against cancer by removing damaged or dysregulated proteins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although the response notes removal of damaged cellular components, it does not specifically state removal of damaged or dysregulated proteins."
      },
      {
        "criterion_number": 4,
        "description": "Describe the role of autophagy in pancreatic adenocarcinoma, addressing upregulation and contribution to survival and treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that pancreatic cancers often have high autophagy levels and that autophagy helps cancer cells survive harsh conditions and resist some treatments, satisfying upregulation and functional contribution."
      },
      {
        "criterion_number": 5,
        "description": "State that cancerous cells can utilize autophagy to promote survival, growth, and therapy resistance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions survival and therapy resistance but does not mention growth; the criterion requires all three elements."
      },
      {
        "criterion_number": 6,
        "description": "Explain whether autophagy can be targeted with treatment, providing at least one reference with a PMID.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response mentions exploration of autophagy inhibitors (e.g., hydroxychloroquine) and clinical trials but provides no references or PMIDs."
      },
      {
        "criterion_number": 7,
        "description": "State that blocking autophagy has been explored but there are no current standard-of-care treatments targeting autophagy in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response discusses ongoing research but does not explicitly state that no autophagy-targeting therapies are standard of care in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "Mention specific drugs targeting autophagy, reference existing evidence, and clearly state FDA approval status.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Hydroxychloroquine is mentioned, but there are no literature references or a statement regarding FDA approval status for this indication."
      },
      {
        "criterion_number": 10,
        "description": "Reference at least one scientific literature source with a PMID.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No scientific literature citations or PMIDs are provided."
      }
    ],
    "question_number": 197,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:55:47.444774",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must define autophagy, including its normal role in cellular turnover, specifically mentioning degradation and recycling of cellular components, and maintaining cellular homeostasis by removing damaged organelles and protein aggregates.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes autophagy as a recycling process that breaks down damaged components, but it does not explicitly mention removal of damaged organelles and protein aggregates or maintenance of cellular homeostasis."
      },
      {
        "criterion_number": 2,
        "description": "The response must describe the dual role of autophagy in cancer, including both tumor suppression and promotion, with context on how these roles change during cancer progression.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response clearly presents a dual role: tumor-suppressive effects (removing damage, potential cell death, prevention of initial development) and tumor-promoting effects (survival under stress, energy supply, treatment resistance), implying early prevention versus later support of established tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that autophagy can be protective against cancer by removing damaged or dysregulated proteins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes removal of damaged cellular components, it does not explicitly state removal of damaged or dysregulated proteins."
      },
      {
        "criterion_number": 4,
        "description": "The response must describe the role of autophagy in pancreatic adenocarcinoma, specifically addressing its upregulation and contribution to cancer cell survival and treatment resistance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions that autophagy helps pancreatic cancer cells survive and grow, but does not state that autophagy is upregulated in pancreatic adenocarcinoma, nor does it specifically tie treatment resistance to pancreatic cancer in this section."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cancerous cells can utilize autophagy to promote survival, growth, and therapy resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly notes that autophagy can help cancer cells survive in stressful conditions, provide energy for growth, and resist some treatments."
      },
      {
        "criterion_number": 6,
        "description": "The response must explain if the autophagy process can be targeted with cancer treatment, providing at least one reference with a PMID if available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it mentions experimental treatments aiming to block autophagy, it provides no scientific references or PMIDs."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that blocking autophagy has been explored as an area of research but there are no current standard of care treatments targeting autophagy in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes clinical trials and experimental approaches but does not explicitly state that there are no standard-of-care autophagy-targeting treatments in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention specific drugs targeting autophagy, reference existing evidence in the scientific literature, and clearly state if any treatment strategy is FDA approved.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No specific autophagy-targeting drugs, FDA approval status, or literature references are mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response must reference at least one scientific literature source with a PubMed identification number (PMID).",
        "score_given": 0,
        "max_points": 3,
        "justification": "No scientific references or PMIDs are provided."
      }
    ],
    "question_number": 197,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:56:10.481072",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the different types of support groups that exist for cancer patients and family members of cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions groups for pancreatic cancer patients and caregivers but does not describe different types (e.g., patient-only vs caregiver-only, bereavement, peer-led vs professionally facilitated, psychoeducational vs therapeutic), so it lacks a broader description of types."
      },
      {
        "criterion_number": 3,
        "description": "The response should address whether there is evidence that a telehealth support group is inferior to an in-person support group.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It directly states that research suggests telehealth groups can be just as effective as in-person groups for many people, addressing the question of inferiority."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide references and sources for evidence regarding the effectiveness of telehealth versus in-person support groups.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No citations or sources are provided for the claims about effectiveness."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that in-person and telehealth groups each have their advantages and disadvantages and either may be as effective based on an individual\u2019s needs and preferences.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists benefits and limitations of telehealth, acknowledges comparable effectiveness for many, and recommends trying both formats to see what works best, reflecting individual preference."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that telehealth groups can be more accessible and convenient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly mentions increased accessibility (travel difficulties, comfort of home) and convenience (more scheduling options)."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some may feel that in-person groups will lead to better emotional connection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes telehealth may feel less personal and that non-verbal cues are harder to read, which conveys that some may perceive in-person as enabling a better emotional connection."
      },
      {
        "criterion_number": 9,
        "description": "The response should include a way for the patient or family member to input their location to generate a list of local support group resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanism to input location or generate local resources is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should list organizations to contact that might be able to provide support resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN and CancerCare as organizations to check for virtual groups."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ask their oncology team for assistance in finding support groups.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not advise contacting the oncology team or clinic social worker for help finding groups."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe that increased stress is normal when dealing with a cancer diagnosis and treatment, or as a family member of a cancer patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While empathetic, it does not explicitly normalize stress or state that increased stress is common/normal."
      }
    ],
    "question_number": 198,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:56:31.151467",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the different types of support groups that exist for cancer patients and family members of cancer patients.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response mentions distinct group types such as patient vs. caregiver support and notes professional facilitation versus peer connection, indicating different formats and audiences. While brief, it identifies different types relevant to patients and family members."
      },
      {
        "criterion_number": 3,
        "description": "The response should address whether there is evidence that a telehealth support group is inferior to an in-person support group.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly states that research shows virtual groups provide similar emotional and psychological benefits to in-person ones, directly addressing non-inferiority."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide references and sources for evidence regarding the effectiveness of telehealth versus in-person support groups.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No citations, studies, or source links are provided to support the claims about effectiveness."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that in-person and telehealth groups each have their advantages and disadvantages and either may be as effective based on an individual\u2019s needs and preferences.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It describes advantages of virtual groups and suggests trying both, but does not explicitly discuss advantages and disadvantages of both formats nor clearly state equivalence based on individual preferences."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that telehealth groups can be more accessible and convenient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly states greater accessibility, comfort from home, scheduling flexibility, and convenience of virtual groups."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some may feel that in-person groups will lead to better emotional connection.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no statement acknowledging that some people may feel in-person offers better emotional connection."
      },
      {
        "criterion_number": 9,
        "description": "The response should include a way for the patient or family member to input their location to generate a list of local support group resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanism or prompt for entering a location is provided to generate local resources."
      },
      {
        "criterion_number": 10,
        "description": "The response should list organizations to contact that might be able to provide support resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists Pancreatic Cancer Action Network, Cancer Support Community, and hospital-based programs, which are appropriate organizations to contact."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ask their oncology team for assistance in finding support groups.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not advise contacting the oncology team for help finding groups."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe that increased stress is normal when dealing with a cancer diagnosis and treatment, or as a family member of a cancer patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not address or normalize increased stress related to a cancer diagnosis or caregiving."
      }
    ],
    "question_number": 198,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:57:01.765564",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the effect of caffeine on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises to avoid caffeine after noon, acknowledging caffeine\u2019s impact on sleep."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention the effect of alcohol on sleep.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Alcohol and its effects on sleep are not mentioned."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the effect of illegal drugs on sleep.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of illegal drugs or their impact on sleep."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe strategies to improve sleep that are evidence-based.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes multiple evidence-based strategies: sleep hygiene (consistent schedule, limiting naps, reducing caffeine, bedtime routine), optimizing environment (cool and dark), managing pain, addressing nausea (antiemetics), anxiety management (relaxation, counseling), and medication review."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references for evidence-based sleep improvement interventions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No references or citations are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should include insights into things in everyday life that may be interfering with a patient\u2019s ability to sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It addresses everyday factors such as caffeine intake, daytime naps, bedroom environment, and bedtime routines."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide insights into how cancer-related symptoms can interfere with sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes pain, nausea, night sweats, reflux/breathing issues, and anxiety as contributors to sleep disturbance, which are cancer- or treatment-related."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of appropriate management of cancer-related or cancer-treatment related symptoms to prevent interference in everyday life, including sleep.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It emphasizes discussing sleep issues with the oncology team, adjusting medications, managing pain, and using anti-nausea medicines, highlighting the importance of symptom management."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe common symptoms that people with pancreatic cancer might experience.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not explicitly describe hallmark pancreatic cancer symptoms (e.g., jaundice, weight loss, abdominal/back pain, steatorrhea, new-onset diabetes)."
      },
      {
        "criterion_number": 10,
        "description": "The response should direct the patient to discuss any symptoms of cancer or cancer treatment with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises talking to the oncology team about sleep issues and keeping the healthcare team informed."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize the importance of mental health and the impact of stress on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It addresses anxiety and suggests relaxation techniques, meditation apps, and counseling, indicating the importance of mental health for sleep."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that sleep hygiene is an important first step.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it lists a Sleep Hygiene section, it does not explicitly state that sleep hygiene is an important first step."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention a consistent relaxing bedtime routine starting 30 to 60 minutes before bedtime.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends a calming bedtime routine but does not specify starting 30 to 60 minutes before bedtime."
      },
      {
        "criterion_number": 14,
        "description": "The response must clearly state that stimulant use, such as nicotine, should be avoided in the afternoon and evenings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions avoiding caffeine after noon but does not clearly state avoiding stimulants such as nicotine in the afternoon/evenings."
      },
      {
        "criterion_number": 15,
        "description": "The response must explicitly recommend optimizing the sleep environment by keeping the room dark, cool, and quiet.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends keeping the bedroom cool and dark but does not mention keeping it quiet."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that supportive therapies, such as melatonin or other sleep aids, can be considered if deemed safe by the medical team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises discussing sleep issues with the oncology team who may adjust medications or prescribe sleep aids, aligning with considering supportive therapies under medical guidance."
      }
    ],
    "question_number": 199,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:57:31.965563",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the effect of caffeine on sleep.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention caffeine or its impact on sleep latency, quality, or nighttime awakenings."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention the effect of alcohol on sleep.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Alcohol is not discussed; there is no mention of its initial sedative effect followed by sleep fragmentation."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the effect of illegal drugs on sleep.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of illicit/illegal drugs or their effects on sleep."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe strategies to improve sleep that are evidence-based.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes multiple evidence-based strategies: consistent sleep/wake times, optimizing sleep environment (dark, cool, quiet), limiting screens before bed, relaxation techniques (breathing/meditation), white noise, and management of pain/nausea timing with clinicians."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references for evidence-based sleep improvement interventions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to guidelines, trials, or authoritative sources are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should include insights into things in everyday life that may be interfering with a patient\u2019s ability to sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Everyday factors such as screen use before bed, noise, light, and room temperature are addressed."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide insights into how cancer-related symptoms can interfere with sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses nausea, pain, and anxiety during treatment as sleep disruptors and suggests mitigation strategies."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of appropriate management of cancer-related or cancer-treatment related symptoms to prevent interference in everyday life, including sleep.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It emphasizes working with the medical team on pain medication timing, contacting the team for severe insomnia or worsening symptoms, and adjusting medication timing to reduce sleep disruption."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe common symptoms that people with pancreatic cancer might experience.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not list pancreatic cancer\u2013specific symptoms (e.g., abdominal/back pain, jaundice, weight loss, steatorrhea, pruritus, early satiety, new-onset diabetes)."
      },
      {
        "criterion_number": 10,
        "description": "The response should direct the patient to discuss any symptoms of cancer or cancer treatment with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises contacting the medical team for severe insomnia, pain preventing sleep, new/worsening nighttime symptoms, and if sleep medications aren't helping; also recommends discussing timing of medications."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize the importance of mental health and the impact of stress on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Anxiety is identified as a contributor to poor sleep, with suggested relaxation strategies (breathing, meditation). The closing expresses concern for caregiver well-being, reinforcing mental health importance."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that sleep hygiene is an important first step.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While sleep hygiene practices are given and 'sleep hygiene counselors' are mentioned, it does not explicitly state that sleep hygiene is an important first step."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention a consistent relaxing bedtime routine starting 30 to 60 minutes before bedtime.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends a calming pre-sleep ritual but does not specify starting 30\u201360 minutes before bedtime."
      },
      {
        "criterion_number": 14,
        "description": "The response must clearly state that stimulant use, such as nicotine, should be avoided in the afternoon and evenings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of avoiding stimulants (e.g., nicotine) in the afternoon/evening."
      },
      {
        "criterion_number": 15,
        "description": "The response must explicitly recommend optimizing the sleep environment by keeping the room dark, cool, and quiet.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises keeping the bedroom cool, dark, and quiet."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that supportive therapies, such as melatonin or other sleep aids, can be considered if deemed safe by the medical team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes contacting the team if sleep medications aren't helping but does not recommend considering melatonin or other sleep aids with clinician approval."
      }
    ],
    "question_number": 199,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:57:53.057669",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer-related cachexia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains cachexia as loss of both muscle and fat, not fully reversible by increased calories, with significant muscle wasting and complex metabolic changes triggered by cancer\u2014an adequate functional definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cachexia occurs in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The mechanisms described (inflammation, tumor-released substances altering metabolism) are generic to cancer and do not specifically address pancreatic cancer\u2013related factors (e.g., pancreatic exocrine insufficiency, biliary obstruction, treatment effects)."
      },
      {
        "criterion_number": 3,
        "description": "The response should delineate cancer cachexia from regular weight loss.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides a clear side-by-side contrast: regular weight loss involves primarily fat loss, is reversible with calories, and preserves muscle, whereas cachexia involves loss of muscle and fat, is not fully reversible by eating, and includes metabolic changes."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that cachexia can occur independently of dietary changes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly notes that cachexia \"cannot be fully reversed by eating more\" and that weight maintenance is hard \"even with adequate nutrition,\" indicating independence from dietary intake alone."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cachexia involves muscle loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly emphasizes muscle loss and significant muscle wasting."
      },
      {
        "criterion_number": 6,
        "description": "The response should include information about prognosis in patients experiencing cancer cachexia.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No statements are made about prognosis, survival, treatment tolerance, or clinical outcomes associated with cachexia."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide evidence-based recommendations to patients experiencing cancer cachexia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends early intervention and mentions nutritional support and appetite-stimulating medications\u2014recognized evidence-based categories for cachexia management\u2014though specifics are not detailed."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss their concerns about cancer cachexia with their oncology team and/or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing signs with the oncology team to obtain support and interventions."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that cachexia is difficult to manage.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it notes cachexia is not fully reversible by eating, it does not explicitly state that cachexia is difficult to manage."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that cachexia can be mitigated by nutritional support, medications, and physical therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions nutritional support and medications but does not mention physical therapy or exercise."
      }
    ],
    "question_number": 200,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:58:10.078251",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer-related cachexia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes cachexia as involving loss of fat and muscle, metabolic/inflammatory disruption, not easily reversible by eating more, and includes diagnostic features like \u22655% unintentional weight loss and functional impact\u2014amounting to a clear definitional description."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cachexia occurs in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It attributes cachexia to the body's inflammatory response disrupting metabolism and mentions symptoms (appetite loss, nausea) and high prevalence in pancreatic cancer, thereby addressing mechanism and context in pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should delineate cancer cachexia from regular weight loss.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides a side-by-side contrast: regular weight loss is primarily fat and reversible; cachexia includes muscle loss, metabolic changes, fatigue, and is not reversible with increased intake."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that cachexia can occur independently of dietary changes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly notes cachexia cannot be easily reversed by eating more and is driven by inflammatory/metabolic changes, conveying that it is not solely due to reduced dietary intake."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cachexia involves muscle loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states loss of both fat and muscle (lean body mass) and lists loss of muscle mass and strength among key characteristics."
      },
      {
        "criterion_number": 6,
        "description": "The response should include information about prognosis in patients experiencing cancer cachexia.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it notes reduced quality of life and fatigue, it does not address prognostic implications such as poorer survival or treatment tolerance."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide evidence-based recommendations to patients experiencing cancer cachexia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends nutritional support/counseling, appetite stimulants, anti-inflammatory medications, and physical therapy, which are evidence-based approaches for cancer cachexia management."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss their concerns about cancer cachexia with their oncology team and/or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises working closely with the oncology team and asks about nutritional counseling, clearly encouraging discussion with clinicians and a nutrition professional."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that cachexia is difficult to manage.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states cachexia cannot be easily reversed by eating more and emphasizes early intervention, implying it is difficult to manage."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that cachexia can be mitigated by nutritional support, medications, and physical therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions nutritional support/counseling, appetite stimulants/anti-inflammatory medications, and physical therapy as helpful interventions."
      }
    ],
    "question_number": 200,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:58:32.642987",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe epithelial-mesenchymal transition (EMT) as a transformation where epithelial cells acquire mesenchymal characteristics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that epithelial cells transform to become more like mesenchymal cells, emphasizing reduced adhesion, increased mobility, and invasiveness."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention that EMT is a key feature of cancer progression, contributing to tumor progression, invasion, metastasis, and therapy resistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States EMT can make cancer more aggressive, help spread (metastasize), and make tumors more resistant to treatments, directly addressing progression, invasion, metastasis, and resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response must define epithelial cells as those forming the lining of glands, organs, and body surfaces, including the pancreas, and describe their tight connections and specific functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions epithelial cells in the pancreas and tight adhesion, but does not explicitly state that they form the lining of glands/organs/body surfaces or describe specific epithelial functions."
      },
      {
        "criterion_number": 4,
        "description": "The response must define mesenchymal cells as those that can move, change shape, and are found in connective tissue, supporting organs and glands.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes increased mobility and invasiveness but does not state that mesenchymal cells are connective tissue cells supporting organs/glands or that they change shape."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that EMT enables cancer cells to migrate to distant sites, leading to metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions that EMT may help cancer cells spread (metastasize) to other parts of the body."
      },
      {
        "criterion_number": 6,
        "description": "The response must mention that EMT is an area of current research and explicitly state that there are no treatments aimed at this process yet.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that new therapies targeting EMT are being researched but does not explicitly state that there are currently no treatments targeting EMT."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that plasticity is a key factor in treatment resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention plasticity or its role in treatment resistance."
      }
    ],
    "question_number": 201,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:58:49.700624",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe epithelial-mesenchymal transition (EMT) as a transformation where epithelial cells acquire mesenchymal characteristics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that normal epithelial cells can transform into mesenchymal cells and describes mesenchymal traits as more mobile and flexible."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention that EMT is a key feature of cancer progression, contributing to tumor progression, invasion, metastasis, and therapy resistance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions metastasis and treatment resistance, it does not explicitly address invasion or characterize EMT as a key feature of cancer progression. The criterion requires inclusion of all listed aspects."
      },
      {
        "criterion_number": 3,
        "description": "The response must define epithelial cells as those forming the lining of glands, organs, and body surfaces, including the pancreas, and describe their tight connections and specific functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes that epithelial cells line organs and form barriers but does not mention glands, body surfaces, the pancreas, or tight junctions/specific functions."
      },
      {
        "criterion_number": 4,
        "description": "The response must define mesenchymal cells as those that can move, change shape, and are found in connective tissue, supporting organs and glands.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response describes mesenchymal cells as more mobile and flexible but does not mention their presence in connective tissue or their role in supporting organs and glands."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that EMT enables cancer cells to migrate to distant sites, leading to metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states EMT can make cancer cells more likely to spread (metastasize) to other parts of the body, meeting the requirement."
      },
      {
        "criterion_number": 6,
        "description": "The response must mention that EMT is an area of current research and explicitly state that there are no treatments aimed at this process yet.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests the opposite by stating that some newer therapies specifically target this process and does not explicitly say there are no treatments yet."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that plasticity is a key factor in treatment resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The term 'plasticity' and its role in treatment resistance are not mentioned."
      }
    ],
    "question_number": 201,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:59:07.424823",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define the microbiome as the microorganisms that live in the body and play roles in digestion, immune function, metabolism, and inflammation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly define the microbiome as microorganisms living in the body, nor does it clearly list roles including digestion and metabolism; it only references immune function, inflammation, and nutrient absorption without a formal definition."
      },
      {
        "criterion_number": 2,
        "description": "Mention that the microbiome is associated with cancer, specifically pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It directly connects bacteria/microbiome to pancreatic tumors (migration to pancreas, influence on tumor growth, tumor microbiome differs from healthy tissue)."
      },
      {
        "criterion_number": 3,
        "description": "Describe how the microbiome is thought to affect pancreatic cancer treatment, including its influence on the efficacy of immunotherapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response states the gut microbiome may influence immunotherapy efficacy and notes impacts on treatment response, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "Describe how the microbiome can influence how the body metabolizes chemotherapy drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes that some bacteria can metabolize chemotherapy drugs, potentially reducing effectiveness."
      },
      {
        "criterion_number": 5,
        "description": "Mention that modulating the microbiome to improve cancer outcomes is an active area of research with limited evidence and no standard of care options to date.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it calls the field an active and rapidly evolving area, it does not state that evidence is limited or that there are no standard-of-care microbiome-modulating interventions."
      },
      {
        "criterion_number": 6,
        "description": "Mention the various roles the microbiome is postulated to play in the human body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references roles such as immune function, inflammation, and nutrient absorption, which count as various bodily roles of the microbiome."
      },
      {
        "criterion_number": 7,
        "description": "Summarize the scientific research with references (PMID if available).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 8,
        "description": "Describe standard of care treatments for pancreatic cancer, including chemotherapy and immunotherapy, and mention that appropriate treatment selection depends on the stage of cancer and fitness of the patient.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not discuss standard-of-care treatments or how selection depends on stage and patient fitness."
      },
      {
        "criterion_number": 9,
        "description": "Suggest that the patient discuss whether there are ways to support a healthy microbiome with a nutritionist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it suggests discussing dietary approaches with the oncology team, it does not recommend consulting a nutritionist specifically."
      }
    ],
    "question_number": 202,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T19:59:25.177459",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define the microbiome as the microorganisms that live in the body and play roles in digestion, immune function, metabolism, and inflammation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not define the microbiome nor explicitly mention its roles in digestion and metabolism; it only alludes to immune responses and inflammation without a formal definition."
      },
      {
        "criterion_number": 2,
        "description": "Mention that the microbiome is associated with cancer, specifically pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explicitly discusses the relationship between the microbiome and pancreatic cancer, including effects on tumor development and progression."
      },
      {
        "criterion_number": 3,
        "description": "Describe how the microbiome is thought to affect pancreatic cancer treatment, including its influence on the efficacy of immunotherapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states that the gut microbiome can affect how well immunotherapy works and may influence chemotherapy effectiveness and side effects."
      },
      {
        "criterion_number": 4,
        "description": "Describe how the microbiome can influence how the body metabolizes chemotherapy drugs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes that bacteria may influence chemotherapy effectiveness, it does not describe effects on drug metabolism specifically."
      },
      {
        "criterion_number": 5,
        "description": "Mention that modulating the microbiome to improve cancer outcomes is an active area of research with limited evidence and no standard of care options to date.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response calls this an active research area and emphasizes that most microbiome-based treatments are still experimental, implying no current standard-of-care."
      },
      {
        "criterion_number": 6,
        "description": "Mention the various roles the microbiome is postulated to play in the human body.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not describe broader human-body roles (e.g., digestion, metabolism) beyond immune response/inflammation in a cancer context."
      },
      {
        "criterion_number": 7,
        "description": "Summarize the scientific research with references (PMID if available).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 8,
        "description": "Describe standard of care treatments for pancreatic cancer, including chemotherapy and immunotherapy, and mention that appropriate treatment selection depends on the stage of cancer and fitness of the patient.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not outline standard-of-care treatments or discuss stage and patient fitness considerations."
      },
      {
        "criterion_number": 9,
        "description": "Suggest that the patient discuss whether there are ways to support a healthy microbiome with a nutritionist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It advises discussing probiotics with the oncology team but does not suggest consulting a nutritionist."
      }
    ],
    "question_number": 202,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T19:59:49.238895",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that mood changes are very common with the diagnosis of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states 'mood changes are very common with pancreatic cancer, affecting up to 75% of patients.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment-related mood changes with the oncology team to ensure they are provided with available local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises 'The oncology team should have resources to help - don't hesitate to ask for support,' and includes a 'When to contact the medical team' section."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend a referral to a mental health provider familiar with cancer patients and cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends 'Counseling: Individual or family therapy with someone experienced in cancer care,' which implies referral to a cancer-informed mental health provider."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe counseling as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists counseling as a management strategy and specifies individual or family therapy as helpful."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe medications, such as antidepressants, as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Antidepressants or anti-anxiety medications can help' under medical support."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe support group participation as an intervention that may help alleviate mood issues.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Includes 'Support groups: Connecting with others facing similar challenges.'"
      },
      {
        "criterion_number": 7,
        "description": "The response should provide supportive language about mood changes during cancer treatment and attempt to normalize this phenomenon.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses empathetic language and normalizes mood changes ('not a sign of weakness')."
      },
      {
        "criterion_number": 8,
        "description": "The response should reference studies that quantify patients with cancer that suffer from mood changes after diagnosis and/or during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides a statistic ('up to 75%') but does not cite or reference any specific studies."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe different interventions that may help alleviate mood issues, such as psychiatric evaluation, exercise, nutrition, and cancer-related symptom control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Offers multiple interventions: medications, counseling, pain management (symptom control), nutrition support, sleep hygiene, light exercise, and support groups."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that patients with suicidal thoughts consider presentation to medical care urgently or emergently.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions 'Thoughts of self-harm' as a reason to contact the medical team but does not specify urgent/emergent presentation."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the role of palliative medicine in cancer care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of palliative care or its role."
      },
      {
        "criterion_number": 12,
        "description": "The response should list common side effects of both pancreatic cancer and pancreatic cancer treatment, and suggest that feeling poorly can impact one\u2019s mood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists pain, fatigue, nausea, 'chemo brain', and treatment side effects (chemotherapy, steroids, pain meds) as contributors to mood changes."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that some patients benefit from a mental health standpoint by having their affairs in order, as this can provide some peace of mind in the face of a serious illness.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not discuss advance care planning or getting affairs in order."
      },
      {
        "criterion_number": 14,
        "description": "The response should list online resources for support for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific online resources (e.g., patient organizations or websites) are provided."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that mindfulness and relaxation techniques can be considered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention mindfulness, relaxation, or similar techniques."
      }
    ],
    "question_number": 203,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:00:13.207606",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that mood changes are very common with the diagnosis of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, \"mood changes are very common with pancreatic cancer and its treatment.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment-related mood changes with the oncology team to ensure they are provided with available local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises bringing concerns to the oncology team and notes many cancer centers have integrated mental health services, implying access to local resources."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend a referral to a mental health provider familiar with cancer patients and cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends therapy with oncology social workers or psychologists and encourages professional mental health support."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe counseling as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Counseling is listed as a management approach, including individual or family therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe medications, such as antidepressants, as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions antidepressants, anti-anxiety medications, and mood stabilizers as helpful options."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe support group participation as an intervention that may help alleviate mood issues.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Support groups are explicitly recommended as a management approach."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide supportive language about mood changes during cancer treatment and attempt to normalize this phenomenon.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response uses supportive, normalizing language (e.g., \"You're not alone\" and \"very common\")."
      },
      {
        "criterion_number": 8,
        "description": "The response should reference studies that quantify patients with cancer that suffer from mood changes after diagnosis and/or during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No studies, statistics, or quantitative data are cited."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe different interventions that may help alleviate mood issues, such as psychiatric evaluation, exercise, nutrition, and cancer-related symptom control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple interventions are described: medications, counseling, support groups, gentle exercise, meditation, and communicating with the care team for supportive care. This demonstrates a range of approaches consistent with the examples."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that patients with suicidal thoughts consider presentation to medical care urgently or emergently.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not address suicidality or emergency/urgent care recommendations."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the role of palliative medicine in cancer care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Palliative care is not mentioned or described; only general supportive care is referenced."
      },
      {
        "criterion_number": 12,
        "description": "The response should list common side effects of both pancreatic cancer and pancreatic cancer treatment, and suggest that feeling poorly can impact one\u2019s mood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions pain, fatigue, sleep disturbances, cognitive changes (chemo brain), and steroid-induced mood swings, and links these symptoms to mood changes."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that some patients benefit from a mental health standpoint by having their affairs in order, as this can provide some peace of mind in the face of a serious illness.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of advance care planning or having affairs in order."
      },
      {
        "criterion_number": 14,
        "description": "The response should list online resources for support for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources are provided."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that mindfulness and relaxation techniques can be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends meditation as part of lifestyle approaches, which aligns with mindfulness/relaxation techniques."
      }
    ],
    "question_number": 203,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:00:46.430688",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor suppressor genes and their function in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor suppressor genes as the 'brakes' of the cell and lists core functions: controlling cell division, repairing DNA damage, and inducing apoptosis."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how defects in tumor suppressor genes can lead to cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that inactivation through mutations disables the brakes, leading to uncontrolled growth and tumor formation; provides an apt analogy."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how tumor suppressor genes gain defects or mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that tumor suppressor genes become inactivated 'through mutations,' which addresses how defects arise, albeit briefly."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that there are genetic syndromes inherited in families that affect tumor suppressor genes, leaving affected individuals at higher risk of developing cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention inherited cancer syndromes or familial risk related to tumor suppressor genes."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention tumor suppressor genes that are thought to play a role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions p53 and CDKN2A/p16 as key tumor suppressors in pancreatic cancer with prevalence estimates."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is an active area of research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly notes ongoing research into restoring tumor suppressor function or compensating for their loss."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss whether there are clinical trials available in their area with their oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not recommend discussing clinical trials with the oncology team or exploring trial availability."
      }
    ],
    "question_number": 204,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:01:03.318015",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor suppressor genes and their function in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor suppressor genes as the body's 'emergency brakes' and lists core functions: controlling cell division, repairing DNA, inducing cell death, and preventing malignant transformation."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how defects in tumor suppressor genes can lead to cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that when tumor suppressor genes are damaged or turned off, cells grow uncontrollably, ignore stop signals, resist apoptosis, and accumulate more damage, with an apt 'car losing brakes' analogy."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how tumor suppressor genes gain defects or mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that some changes are inherited and others develop over time, covering germline and acquired (somatic) origins of defects."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that there are genetic syndromes inherited in families that affect tumor suppressor genes, leaving affected individuals at higher risk of developing cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes 'some changes are inherited' and lists BRCA1/2, it does not explicitly state that there are inherited familial syndromes that confer higher cancer risk."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention tumor suppressor genes that are thought to play a role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists p53, CDKN2A/p16, SMAD4, and BRCA1/BRCA2, all relevant tumor suppressor genes in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is an active area of research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States the field is 'rapidly advancing with new targeted therapies,' indicating active research."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss whether there are clinical trials available in their area with their oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages discussion of genetic testing and personalized treatment with the oncology team but does not mention clinical trials."
      }
    ],
    "question_number": 204,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:01:16.145549",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must recommend discussing mental health counseling with the oncology team to connect with local resources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions the cancer treatment center as a resource but does not explicitly advise discussing counseling with the oncology team to connect with local resources."
      },
      {
        "criterion_number": 3,
        "description": "The response must introduce palliative medicine as a specialty for managing symptoms or end-of-life care for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Palliative care is referenced only as including counseling support; it does not describe palliative medicine\u2019s role in symptom management or end-of-life care."
      },
      {
        "criterion_number": 4,
        "description": "The response must list at least three types of mental health care providers, including their credentials and any limitations in practice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Three provider types are listed (oncology social workers, psycho-oncologists, licensed counselors) but credentials (e.g., LCSW, PhD/PsyD, MD, LPC) and practice limitations (e.g., prescribing authority) are not specified."
      },
      {
        "criterion_number": 5,
        "description": "The response must mention at least one modality for delivery of mental health counseling, such as in-person or telehealth.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly notes that many offer telehealth if travel is difficult."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that choosing the best provider is individualized and cannot be recommended online.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement about the individualized nature of choosing a provider or the inability to recommend one online."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention providers affiliated with religious denominations or faith-based counseling options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Faith-based or clergy-affiliated counseling options are not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention mental health resources available for family members and caregivers of cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests family/caregiver counseling and support groups."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend seeking counseling proactively, not waiting for a crisis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no explicit recommendation to seek counseling proactively before a crisis."
      },
      {
        "criterion_number": 10,
        "description": "The response must recommend at least one additional way to improve overall wellbeing, such as nutrition, exercise, sleep, or symptom control.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No additional wellbeing strategies (nutrition, exercise, sleep, symptom control) are discussed."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that a licensed clinical social worker would be a good resource to utilize for advice and to be connected to further resources such as financial or caregiver support.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While oncology social workers are mentioned, it does not specify licensed clinical social workers or their role in connecting to financial or caregiver resources."
      }
    ],
    "question_number": 205,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:01:42.571922",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must recommend discussing mental health counseling with the oncology team to connect with local resources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions the cancer center's social work department, it does not explicitly advise discussing counseling with the oncology team to connect with resources."
      },
      {
        "criterion_number": 3,
        "description": "The response must introduce palliative medicine as a specialty for managing symptoms or end-of-life care for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of palliative medicine, palliative care, or hospice as a specialty for symptom management or end-of-life care."
      },
      {
        "criterion_number": 4,
        "description": "The response must list at least three types of mental health care providers, including their credentials and any limitations in practice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Three provider types are listed (oncology social workers, LCSW/LPC, psychologists), and some credentials are given (LCSW, LPC), but no practice limitations are described (e.g., prescribing limits, scope differences)."
      },
      {
        "criterion_number": 5,
        "description": "The response must mention at least one modality for delivery of mental health counseling, such as in-person or telehealth.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No modality (in-person, telehealth, virtual) is mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that choosing the best provider is individualized and cannot be recommended online.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that provider selection is individualized or that a definitive recommendation cannot be made online."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention providers affiliated with religious denominations or faith-based counseling options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of faith-based or religiously affiliated counseling options."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention mental health resources available for family members and caregivers of cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes the importance of providers who can work with both patients and families and mentions support groups, indicating resources for family members."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend seeking counseling proactively, not waiting for a crisis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It affirms that seeking counseling is wise but does not explicitly advise doing so proactively or before a crisis."
      },
      {
        "criterion_number": 10,
        "description": "The response must recommend at least one additional way to improve overall wellbeing, such as nutrition, exercise, sleep, or symptom control.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No suggestions regarding nutrition, exercise, sleep, symptom control, or other wellbeing strategies."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that a licensed clinical social worker would be a good resource to utilize for advice and to be connected to further resources such as financial or caregiver support.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although LCSWs and oncology social workers are mentioned, it does not explicitly state that an LCSW can connect patients/families to financial or caregiver support resources."
      }
    ],
    "question_number": 205,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:02:07.381361",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what DNA damage repair pathways are in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines DDR as cellular mechanisms that detect and repair DNA damage and notes their role in cancer development and as therapeutic targets."
      },
      {
        "criterion_number": 2,
        "description": "The response should list examples of genes implicated in DNA repair pathways in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly lists BRCA1/2, PALB2, and ATM as DDR genes relevant to pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain treatments in pancreatic cancer that are indicated for mutations in certain DNA repair pathway mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links PARP inhibitors to BRCA1/2 mutations and explains platinum-based chemotherapy efficacy in DDR-defective tumors; also mentions regimen choices potentially more effective in DDR-deficient tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response should list DNA pathway repair targeted therapies in pancreatic cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies PARP inhibitors and specifically names olaparib as a targeted therapy against DNA repair pathways."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how mutations in DNA damage repair pathways affect chemotherapy effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that platinum-based chemotherapy is particularly effective in tumors with DDR defects and that certain combination regimens may be more effective in DDR-deficient tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how mutations in these pathways are detected in tumors, which is through genetic testing of tumor tissue from a biopsy or through a blood test.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that genetic testing can be done on tumor tissue or blood to identify DDR mutations."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide references to scientific literature with PMID for any of the FDA-approved treatments listed in rubric 4.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No scientific literature references or PMIDs are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss tumor genetic testing with their oncologist to understand if they are a candidate for any DNA damage repair pathway mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although genetic testing is described, there is no explicit recommendation to discuss tumor genetic testing with the oncologist."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the patient inquire about clinical trials in their local area that might be evaluating new drugs that target DNA damage repair pathways, or inquire about a referral to a local institution that might have general clinical trials for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions that results can identify clinical trial options but does not explicitly advise the patient to inquire about local trials or seek referral."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that around 5-10 percent of pancreatic cancers have these mutations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States BRCA1/2 mutations are found in 5\u20137% of pancreatic cancers, which aligns with the 'around 5\u201310%' prevalence range."
      }
    ],
    "question_number": 206,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:02:35.488143",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what DNA damage repair pathways are in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines DDR as cellular mechanisms that detect and repair damaged DNA and notes consequences when defective."
      },
      {
        "criterion_number": 2,
        "description": "The response should list examples of genes implicated in DNA repair pathways in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple relevant genes: BRCA1/2, PALB2, ATM, CHEK2, and mismatch repair genes (MLH1, MSH2, MSH6, PMS2)."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain treatments in pancreatic cancer that are indicated for mutations in certain DNA repair pathway mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains PARP inhibitors for BRCA-mutated tumors, platinum sensitivity in DDR-deficient tumors, and immunotherapy for mismatch repair deficient tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response should list DNA pathway repair targeted therapies in pancreatic cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists PARP inhibitors as DDR-targeted therapy and gives examples (olaparib, rucaparib)."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how mutations in DNA damage repair pathways affect chemotherapy effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that DDR-deficient tumors are often more responsive to platinum-based chemotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how mutations in these pathways are detected in tumors, which is through genetic testing of tumor tissue from a biopsy or through a blood test.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends germline and somatic genetic testing and tumor biomarker testing, which covers blood/germline and tumor tissue testing."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide references to scientific literature with PMID for any of the FDA-approved treatments listed in rubric 4.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No references or PMIDs are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss tumor genetic testing with their oncologist to understand if they are a candidate for any DNA damage repair pathway mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises asking about germline and somatic genetic testing and tumor biomarker testing, effectively recommending discussion with the care team."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the patient inquire about clinical trials in their local area that might be evaluating new drugs that target DNA damage repair pathways, or inquire about a referral to a local institution that might have general clinical trials for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of clinical trials or referral for trials."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that around 5-10 percent of pancreatic cancers have these mutations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "States 25\u201330% rather than the required 5\u201310% figure."
      }
    ],
    "question_number": 206,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:02:55.270384",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define inflammation using terms such as \u201cimmune response,\u201d \u201ctissue injury,\u201d or \u201cprotective mechanism.\u201d",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses inflammation\u2019s role but does not define inflammation as an immune response to tissue injury or a protective mechanism."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly distinguish between acute and chronic inflammation (e.g., short-term vs. long-term).",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions chronic inflammation but does not contrast it with acute inflammation or discuss short-term vs. long-term characteristics."
      },
      {
        "criterion_number": 3,
        "description": "Describe at least two medical strategies for managing inflammation (e.g., targeted therapies, immunotherapies, steroids, pain management).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists NSAIDs, corticosteroids, targeted therapies to inflammatory pathways, and standard cancer treatments; this exceeds the minimum of two strategies."
      },
      {
        "criterion_number": 4,
        "description": "State that there is no formal, evidence-based strategy to quantify and target inflammation in cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not address the absence of a formal evidence-based framework to quantify and target inflammation."
      },
      {
        "criterion_number": 5,
        "description": "State that treating the cancer itself (e.g., surgery or radiation) is postulated to improve cancer-related inflammation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that standard cancer treatments, including chemotherapy and radiation, can reduce inflammation, implying that treating the cancer improves inflammation."
      },
      {
        "criterion_number": 6,
        "description": "Mention chronic pancreatitis or chronic pancreatic injury as a factor in cancer formation and provide at least one scientific reference with a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention chronic pancreatitis or provide any scientific reference/PMID."
      },
      {
        "criterion_number": 7,
        "description": "Recommend at least two lifestyle interventions to decrease inflammation (e.g., plant-based diet, exercise, hydration, good sleep).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends nutritional support with anti-inflammatory foods, exercise, stress reduction, and hydration\u2014meeting the requirement of at least two interventions."
      },
      {
        "criterion_number": 8,
        "description": "Recommend against nicotine and alcohol use and reference their role in promoting inflammation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of avoiding nicotine or alcohol or their pro-inflammatory effects."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient report any symptoms to their oncology team for symptom management.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Advises keeping detailed notes about symptoms to share with the oncology team and encourages discussing symptoms with them, aligning with symptom reporting for management."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that chronic inflammation promotes tumor growth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly says \u201cChronic inflammation can promote tumor growth and spread.\u201d"
      },
      {
        "criterion_number": 11,
        "description": "Explicitly state that inflammatory signaling pathways are overactivated in cancer (e.g., overactivated, upregulated, enhanced).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions cancer-triggered inflammatory responses but does not state that signaling pathways are overactivated/upregulated/enhanced."
      },
      {
        "criterion_number": 12,
        "description": "Explicitly state that the immune system can be activated to recognize and attack cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss leveraging or stimulating the immune system to attack cancer."
      },
      {
        "criterion_number": 13,
        "description": "Explicitly state that anti-inflammatory drugs are not used as a primary treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions NSAIDs and corticosteroids but does not clarify that these are not primary/first-line treatments for pancreatic cancer."
      },
      {
        "criterion_number": 14,
        "description": "Explicitly state that NSAIDs and steroids are prescribed to manage symptoms associated with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists NSAIDs and corticosteroids and mentions pain management, but does not explicitly state these drugs are used for symptom management/control."
      }
    ],
    "question_number": 207,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:03:21.461399",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must clearly define inflammation using terms such as \u201cimmune response,\u201d \u201ctissue injury,\u201d or \u201cprotective mechanism.\u201d",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses effects of inflammation but does not define inflammation as an immune response to tissue injury or a protective mechanism."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly distinguish between acute and chronic inflammation, mentioning characteristics like \u201cshort-term\u201d vs. \u201clong-term\u201d or \u201crapid onset\u201d vs. \u201cpersistent.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions 'chronic inflammation' and 'steroids for acute inflammation,' it does not explicitly describe characteristics such as short-term vs. long-term or rapid vs. persistent."
      },
      {
        "criterion_number": 3,
        "description": "The response must describe at least two medical strategies for managing inflammation, such as \u201ctargeted therapies,\u201d \u201cimmunotherapies,\u201d \u201csteroids,\u201d or \u201cpain management.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions steroids, COX-2 inhibitors, targeted therapies addressing inflammatory pathways, and pain management\u2014meeting the requirement of at least two strategies."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is no formal, evidence-based strategy to quantify and target inflammation in cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state the absence of a formal, evidence-based strategy; it instead mentions monitoring inflammatory markers."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that treating the cancer itself, such as through \u201csurgery\u201d or \u201cradiation,\u201d is postulated to improve cancer-related inflammation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention that definitive cancer treatments like surgery or radiation can reduce cancer-related inflammation."
      },
      {
        "criterion_number": 6,
        "description": "The response must mention chronic pancreatitis or chronic pancreatic injury as a factor in cancer formation and provide at least one scientific reference with a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chronic pancreatitis or pancreatic injury is not mentioned, and no scientific references or PMIDs are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response must recommend at least two lifestyle interventions to decrease inflammation, such as \u201cplant-based diet,\u201d \u201cexercise,\u201d \u201chydration,\u201d or \u201cgood quality sleep.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends dietary adjustments, exercise, stress management, and adequate sleep\u2014meeting the requirement."
      },
      {
        "criterion_number": 8,
        "description": "The response must recommend against nicotine and alcohol use and reference their role in promoting inflammation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of avoiding nicotine or alcohol or their pro-inflammatory effects."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend that the patient report any symptoms to their oncology team for symptom management.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it suggests discussing supplements/diet with the oncology team, it does not instruct reporting symptoms for symptom management."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that chronic inflammation promotes tumor growth. Synonyms for \u201cpromotes\u201d include \u201csupports,\u201d \u201caids,\u201d or \u201cfacilitates.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that chronic inflammation can 'promote cancer cell growth and spread.'"
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that inflammatory signaling pathways are overactivated in cancer, using terms like \u201coveractivated,\u201d \u201cupregulated,\u201d or \u201cenhanced.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although inflammatory pathways are mentioned, there is no explicit statement that they are overactivated/upregulated/enhanced in cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that the immune system can be activated to recognize and attack cancer, using terms like \u201cempower,\u201d \u201cstimulate,\u201d or \u201cleverage.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that the immune system can be activated to recognize and attack cancer."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that anti-inflammatory drugs are not used as a primary treatment for pancreatic cancer. Synonyms for \u201cprimary\u201d include \u201cmain\u201d or \u201cfirst-line.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement clarifies that anti-inflammatory drugs are not first-line therapy for pancreatic cancer."
      },
      {
        "criterion_number": 14,
        "description": "The response must explicitly state that NSAIDs and steroids are prescribed to manage symptoms associated with cancer, using terms like \u201csymptom management,\u201d \u201csymptom control,\u201d or \u201calleviate symptoms.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "While steroids and COX-2 inhibitors are mentioned, the response does not explicitly link NSAIDs/steroids to symptom management or use the specified terminology."
      }
    ],
    "question_number": 207,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:03:45.485731",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention using a pill organizer with compartments for different times of the day and days of the week.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends \"Weekly pill organizers with AM/PM compartments,\" which addresses both days (weekly) and times of day (AM/PM)."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention using a medication management application, with examples such as Medisafe, MyTherapy, or CareZone.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists medication reminder apps and includes \"Medisafe\" by name, fulfilling the example requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention setting alarms or reminders on digital devices to alert when it\u2019s time to take medication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends \"Smartphone alarms with specific labels\" and \"Digital calendars with recurring reminders.\""
      },
      {
        "criterion_number": 4,
        "description": "The response should mention creating a physical chart or digital document listing all medications, dosages, and times.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions a \"Medication chart posted in a visible location,\" \"Medication tracking spreadsheets,\" and an \"updated medication list,\" but does not explicitly state including dosages and times; thus it does not meet the full criterion as written."
      },
      {
        "criterion_number": 5,
        "description": "The response should direct the patient to discuss options for medication management with their oncology team and/or pharmacy team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to \"Ask about oncology pharmacy consultations\" and to request simplified dosing, directing engagement with oncology/pharmacy teams."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend exploring medication delivery services and bubble packs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends \"Set up pharmacy auto-refills and delivery\" (delivery services) and \"Pre-filled medication boxes from pharmacies,\" which corresponds to pharmacy-prepared bubble/blister packs."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient have a loved one help with their medication management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Suggests \"Assign a primary medication manager\" and using a \"buddy system,\" clearly encouraging caregiver involvement."
      },
      {
        "criterion_number": 8,
        "description": "The response should empathize about the medication burden in patients undergoing cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with empathy: \"I'm sorry to hear about your loved one's diagnosis\" and acknowledges the challenge of managing medications during cancer treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention meeting with a pharmacist or provider to complete a medication reconciliation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions \"oncology pharmacy consultations\" but does not specifically recommend meeting to perform a formal medication reconciliation."
      }
    ],
    "question_number": 208,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:04:04.371965",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention using a pill organizer with compartments for different times of the day and days of the week.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends 'Pill organizers with multiple compartments for different times/days.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should mention using a medication management application, with examples such as Medisafe, MyTherapy, or CareZone.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists medication apps and gives examples including MyTherapy and Medisafe."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention setting alarms or reminders on digital devices to alert when it\u2019s time to take medication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that medication apps 'send reminders and track doses,' which satisfies setting digital reminders."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention creating a physical chart or digital document listing all medications, dosages, and times.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends 'Wall charts or whiteboards,' 'Medication binders,' and tracking 'Medication names, dosages, and timing.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should direct the patient to discuss options for medication management with their oncology team and/or pharmacy team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises requesting a medication reconciliation sheet from the oncologist and consulting a clinical pharmacist; also mentions palliative care team coordination."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend exploring medication delivery services and bubble packs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions PillPack in the context of apps but does not explicitly recommend medication delivery services or bubble/strip packs."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient have a loved one help with their medication management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Suggests shared calendars for caregiver coordination and designating one person as the primary medication coordinator."
      },
      {
        "criterion_number": 8,
        "description": "The response should empathize about the medication burden in patients undergoing cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with empathy and acknowledges the complexity and burden of managing pancreatic cancer medications."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention meeting with a pharmacist or provider to complete a medication reconciliation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically references obtaining a medication reconciliation sheet from the oncologist and seeking clinical pharmacist consultations."
      }
    ],
    "question_number": 208,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:04:27.399673",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define oncogenes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines oncogenes as genes that, when altered or overactive, can contribute to cancer development, and distinguishes proto-oncogenes from oncogenes."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that oncogenes can undergo mutation, which might put the individual at risk for developing cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that mutations or overexpression convert proto-oncogenes into oncogenes that drive excessive cell growth, implying increased risk of cancer development."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how oncogenes mutate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mechanisms of alteration are described (e.g., point mutations, gene amplification, chromosomal translocation). The response only states that genes can be mutated or overexpressed without explaining how these changes occur."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference which mutated oncogenes are implicated in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists KRAS (mutated in ~90% of pancreatic cancers) and mentions HER2 and MYC, satisfying the requirement to reference oncogenes implicated in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state whether there are FDA-approved treatments available for pancreatic cancers with mutated oncogenes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response vaguely notes that some treatments target specific oncogenes but does not state whether FDA-approved treatments exist for pancreatic cancers with mutated oncogenes."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that patients with pancreatic cancer undergo tumor genetic testing either with biopsy of primary tumor or blood test.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions genetic testing, it does not recommend that patients undergo tumor genomic testing specifically, nor does it specify biopsy-based or blood-based testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that patients inquire with their oncology team if there are clinical trial opportunities available to them, or a local institution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of clinical trials or advising the patient to ask their oncology team about trial opportunities."
      }
    ],
    "question_number": 209,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:04:47.006025",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define oncogenes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines oncogenes as genes that, when altered or overactive, promote cancer, using the 'gas pedal' analogy and noting their normal role in controlled growth."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that oncogenes can undergo mutation, which might put the individual at risk for developing cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that mutations can make oncogenes overactive and drive uncontrolled growth, linking mutation to cancer development."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how oncogenes mutate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not describe mechanisms of oncogene activation/mutation (e.g., point mutations, gene amplification, chromosomal translocations, promoter activation); only states that mutations can make them overactive and may increase protein levels."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference which mutated oncogenes are implicated in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names KRAS (~90% of pancreatic cancers) and MYC, satisfying the requirement to reference oncogenes implicated in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state whether there are FDA-approved treatments available for pancreatic cancers with mutated oncogenes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions targeted therapies in general but does not state whether FDA-approved treatments exist for oncogene-mutated pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that patients with pancreatic cancer undergo tumor genetic testing either with biopsy of primary tumor or blood test.",
        "score_given": 0,
        "max_points": 7,
        "justification": "References genetic testing in a general sense but does not explicitly recommend tumor genomic testing or specify biopsy versus liquid biopsy."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that patients inquire with their oncology team if there are clinical trial opportunities available to them, or a local institution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of clinical trial opportunities or advising the patient to ask their oncology team about trials."
      }
    ],
    "question_number": 209,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:05:02.715432",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe that treatment sequencing in pancreatic cancer is determined by the stage of the cancer and the intent of the treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response clearly references stage (e.g., resectable, borderline resectable, advanced) but does not explicitly address treatment intent (curative vs palliative) as a determinant of sequencing."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that sometimes pancreatic cancer management requires different modalities of treatments, such as chemotherapy and surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response discusses surgery, chemotherapy (neoadjuvant and adjuvant), and also mentions radiation for advanced disease, clearly indicating multimodality treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe that in pancreatic tumors thought to be surgically resectable, patients often undergo chemotherapy prior to surgery to shrink the tumor and kill any micrometastases for the best possible surgical outcome.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions neoadjuvant chemotherapy to shrink the tumor, it lists the most common resectable sequence as 'Surgery \u2192 chemotherapy' and does not state the micrometastatic rationale or that neoadjuvant is often used in resectable cases."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that surgery rarely plays a role in advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "For advanced disease, it states 'Systemic chemotherapy first, with radiation considered later' but does not explicitly state that surgery rarely has a role."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe what treatment sequencing in pancreatic cancer is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains sequencing as the order/timing of therapies (e.g., operate first vs neoadjuvant chemo vs adjuvant chemo) and provides stage-based example sequences, effectively describing the concept."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain the goal of treatment sequencing in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states goals such as shrinking the tumor preoperatively, eliminating residual cells postoperatively, preserving strength for subsequent therapies, and optimizing response to later treatments."
      },
      {
        "criterion_number": 7,
        "description": "The response should state risks involved if cancer treatment is not appropriately sequenced.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes benefits of proper sequencing (tolerance, response), it does not explicitly state risks of improper sequencing (e.g., missing surgical window, disease progression, reduced ability to tolerate subsequent therapy)."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient request a multidisciplinary conference to discuss their pancreatic cancer management recommendations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to request a multidisciplinary conference or tumor board is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe what a tumor board (or multidisciplinary conference) is for discussions on management of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no description of a tumor board or multidisciplinary conference."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain that the oncology care team needs to gather information to make informed recommendations on pancreatic cancer treatment, such as imaging studies, tumor biomarkers, and possibly tumor genetic testing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions considering 'specific genetic markers' but does not indicate the need to gather comprehensive information such as imaging studies or tumor biomarkers, nor does it frame this as necessary for making recommendations."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize that treatment sequencing is individualized to the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The statement 'Every patient's situation is unique' and consideration of overall health, tumor location, and genetic markers emphasize individualized sequencing."
      },
      {
        "criterion_number": 12,
        "description": "The response should define the following terms: neoadjuvant, adjuvant, perioperative.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Neoadjuvant and adjuvant are implicitly defined (chemo before surgery to shrink tumor; chemo after surgery to eliminate residual cells), but 'perioperative' is not mentioned or defined; the criterion requires definitions of all three."
      }
    ],
    "question_number": 210,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:05:38.273746",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe that treatment sequencing in pancreatic cancer is determined by the stage of the cancer and the intent of the treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response clearly ties sequencing to disease stage and resectability, but it does not explicitly address treatment intent (curative vs palliative), which is required."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that sometimes pancreatic cancer management requires different modalities of treatments, such as chemotherapy and surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly references surgery, neoadjuvant/adjuvant therapy, and systemic chemotherapy as modalities used in different sequences."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe that in pancreatic tumors thought to be surgically resectable, patients often undergo chemotherapy prior to surgery to shrink the tumor and kill any micrometastases for the best possible surgical outcome.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes neoadjuvant therapy is increasingly used for resectable tumors and that chemotherapy first can shrink tumors in borderline resectable cases, but it does not state that resectable cases often receive preoperative chemo nor mention eradicating micrometastases."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that surgery rarely plays a role in advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It says metastatic disease is typically treated with systemic therapy, but does not explicitly state that surgery rarely has a role in advanced disease."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe what treatment sequencing in pancreatic cancer is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "By outlining surgery-first vs chemotherapy-first approaches and adjuvant/neoadjuvant timing, it effectively describes sequencing as the order in which treatments are given."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain the goal of treatment sequencing in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains goals: improving outcomes, reducing recurrence (adjuvant), and in advanced disease managing side effects and maintaining quality of life."
      },
      {
        "criterion_number": 7,
        "description": "The response should state risks involved if cancer treatment is not appropriately sequenced.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit risks (e.g., loss of resectability window, increased toxicity, worse survival) are described."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient request a multidisciplinary conference to discuss their pancreatic cancer management recommendations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends a specialist/center of excellence and a second opinion but does not suggest requesting a multidisciplinary conference or tumor board review."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe what a tumor board (or multidisciplinary conference) is for discussions on management of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention or description of a tumor board or multidisciplinary conference."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain that the oncology care team needs to gather information to make informed recommendations on pancreatic cancer treatment, such as imaging studies, tumor biomarkers, and possibly tumor genetic testing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it mentions genetic markers (e.g., BRCA), it does not state the need to gather comprehensive diagnostic information like imaging, biomarkers, and genetic testing to guide sequencing."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize that treatment sequencing is individualized to the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes the optimal order depends on multiple patient-specific factors, including performance status and patient preferences."
      },
      {
        "criterion_number": 12,
        "description": "The response should define the following terms: neoadjuvant, adjuvant, perioperative.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It defines neoadjuvant (before surgery) and adjuvant (after surgery) but does not define perioperative."
      }
    ],
    "question_number": 210,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:06:02.981466",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define hypoxia as a low oxygen state often seen in tumors because the tumor outgrows its blood supply.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines hypoxia as low oxygen and explains it occurs because tumors outgrow their blood supply, compress vessels, and form abnormal vasculature."
      },
      {
        "criterion_number": 2,
        "description": "Describe why cancer cells that exist in a hypoxic environment are difficult to treat.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states hypoxia makes radiation less effective and reduces chemotherapy delivery due to poor blood flow, clearly explaining treatment difficulty."
      },
      {
        "criterion_number": 3,
        "description": "Describe how hypoxic environments affect cancer\u2019s response to treatment.",
        "score_given": 9,
        "max_points": 9,
        "justification": "It directly addresses treatment response: hypoxia leads to radiation resistance and impairs chemotherapy penetration."
      },
      {
        "criterion_number": 4,
        "description": "State that radiation therapy becomes less effective in hypoxic conditions because oxygen plays a role in radiation-induced DNA damage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes oxygen is needed to create DNA damage from radiation and that hypoxic areas are 2\u20133 times more resistant."
      },
      {
        "criterion_number": 5,
        "description": "Describe the mechanism of action of VEGF inhibitors and their postulated role in the treatment of hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of VEGF inhibitors, anti-angiogenesis, or vascular normalization and their role in hypoxia."
      },
      {
        "criterion_number": 6,
        "description": "Explain whether there is evidence-based information about hyperbaric oxygen therapy in hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hyperbaric oxygen therapy is not discussed."
      },
      {
        "criterion_number": 7,
        "description": "Describe how hypoxic environments affect the immune system\u2019s ability to access cancer cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of immune infiltration, immunosuppression, or effects of hypoxia on immune access."
      },
      {
        "criterion_number": 8,
        "description": "Recommend discussing whether there are clinical trials focusing on tumor cell hypoxic environments available in their area.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response encourages asking the care team questions but does not mention clinical trials targeting hypoxia."
      },
      {
        "criterion_number": 9,
        "description": "State that hypoxia can make the tumor more aggressive and promote metastasis (spread).",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states hypoxia can make tumors more aggressive and more likely to spread."
      }
    ],
    "question_number": 211,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:06:23.038701",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define hypoxia as a low oxygen state often seen in tumors because the tumor outgrows its blood supply.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines hypoxia as low oxygen in tumors and explains it occurs when cancer growth outpaces blood supply."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe why cancer cells that exist in a hypoxic environment are difficult to treat.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States hypoxic areas make tumors more aggressive and harder to treat and that hypoxic cells are more resistant to radiation and some chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how hypoxic environments affect cancer\u2019s response to treatment.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Notes reduced effectiveness of radiation in hypoxia and variable chemotherapy efficacy; mentions imaging to identify hypoxia and combination approaches to overcome resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that radiation therapy becomes less effective in hypoxic conditions because oxygen plays a role in radiation-induced DNA damage.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions radiation may be less effective in hypoxic areas but does not explain that oxygen is required to fix radiation-induced DNA damage."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the mechanism of action of VEGF inhibitors and their postulated role in the treatment of hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of VEGF inhibitors, anti-angiogenesis, or vascular normalization in hypoxic tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain whether there is evidence-based information about hyperbaric oxygen therapy in hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address hyperbaric oxygen therapy or evidence for/against its use in tumor hypoxia."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how hypoxic environments affect the immune system\u2019s ability to access cancer cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of immune exclusion, impaired immune cell infiltration, or hypoxia-driven immunosuppression."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend the patient discuss whether there are clinical trials focusing on tumor cell hypoxic environments available in their area.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages asking about clinical trials addressing hypoxia and hypoxia-targeting therapies."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that hypoxia can make the tumor more aggressive and promote metastasis (spread).",
        "score_given": 0,
        "max_points": 3,
        "justification": "States tumors can be more aggressive but does not mention metastasis or spread."
      }
    ],
    "question_number": 211,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:06:42.529966",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient document all of their questions or concerns in advance of an appointment with the oncology team to ensure everything is addressed during their allotted face-to-face time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: 'Write down all questions and concerns' before appointments."
      },
      {
        "criterion_number": 2,
        "description": "The response should encourage the patient and/or family members to ask for clarification on any aspects of care that are unclear, and to encourage question-asking during appointments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States: 'Ask doctors to explain things in plain language' and 'Don't hesitate to ask for clarification.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient request a language interpreter if they feel more comfortable communicating in an alternate language than what their medical team speaks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of requesting a language interpreter."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient bring a loved one or family member to all appointments and consider taking notes or recording the conversation.",
        "score_given": 110,
        "max_points": 110,
        "justification": "Advises bringing a second person to take notes and suggests recording conversations (with permission)."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the patient utilize online patient portals to send messages if needed.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically mentions asking about patient portals for test results and messages."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the patient inquire about communication contacts and channels that would be best to contact their oncology team as soon as possible in their treatment journey to establish a \u201cpoint person.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends asking for the best way to reach the team, clarifying who to contact for different concerns, and designating a primary family contact."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide a list of online resources that patients and family members can reference to provide some answers to questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions PanCAN as a resource and suggests support groups; provides at least one named online resource."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend additional points of contact with the oncology team, such as patient advocates, social workers, nurses, and/or palliative medicine specialists.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends requesting a nurse navigator or patient advocate and mentions communication coaches."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of feeling supported in their cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Shows empathy and directs to support groups and organizations, emphasizing support during a challenging time."
      },
      {
        "criterion_number": 10,
        "description": "The response should inform patients that they can ask for a written summary of their medical appointments after the visit.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises to 'Request written summaries of treatment plans,' which conveys obtaining written summaries of visits."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that, if available, patient navigators can be a useful resource to assist with care coordination and communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests requesting a nurse navigator, indicating navigators as helpful for coordination and communication."
      }
    ],
    "question_number": 212,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:07:09.381063",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient document all of their questions or concerns in advance of an appointment with the oncology team to ensure everything is addressed during their allotted face-to-face time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to 'Write down questions in advance' and 'Prioritize your most important concerns' before appointments."
      },
      {
        "criterion_number": 2,
        "description": "The response should encourage the patient and/or family members to ask for clarification on any aspects of care that are unclear, and to encourage question-asking during appointments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly encourages asking for clarification, requesting repetition, and asking what information means for them during appointments."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient request a language interpreter if they feel more comfortable communicating in an alternate language than what their medical team speaks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of interpreters or language assistance."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient bring a loved one or family member to all appointments and consider taking notes or recording the conversation.",
        "score_given": 110,
        "max_points": 110,
        "justification": "Advises bringing a consistent family member to appointments and suggests bringing a notebook or recording conversations."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the patient utilize online patient portals to send messages if needed.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions email and phone preferences but does not specifically recommend using an online patient portal."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the patient inquire about communication contacts and channels that would be best to contact their oncology team as soon as possible in their treatment journey to establish a \u201cpoint person.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Suggests asking 'Who do we contact with urgent concerns?' and to express preferred communication style, which supports establishing appropriate contacts/channels."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide a list of online resources that patients and family members can reference to provide some answers to questions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resource list is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend additional points of contact with the oncology team, such as patient advocates, social workers, nurses, and/or palliative medicine specialists.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends asking about patient navigators and social workers and inquires about palliative care services."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of feeling supported in their cancer journey.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While empathetic, it does not explicitly emphasize the importance of feeling supported in the cancer journey."
      },
      {
        "criterion_number": 10,
        "description": "The response should inform patients that they can ask for a written summary of their medical appointments after the visit.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises to 'Ask for written summaries of key decisions,' which aligns with requesting written summaries of visits."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that, if available, patient navigators can be a useful resource to assist with care coordination and communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically suggests asking about patient navigators who can help, implying their usefulness for coordination and communication."
      }
    ],
    "question_number": 212,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:07:31.010697",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell plasticity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines plasticity as the ability of cancer cells to change characteristics and shift between states, using an accessible analogy."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cancer cell plasticity makes cancer cells more difficult to treat.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains treatment resistance, shifts between proliferative and dormant states, and acquisition of stem-like properties that reduce sensitivity to therapies."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the epithelial-mesenchymal transition in pancreatic cancer.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention EMT or its relevance to pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role plasticity plays in the metastatic potential of cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of metastasis or how plasticity facilitates invasion or dissemination."
      },
      {
        "criterion_number": 5,
        "description": "The response should define and describe cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies dormancy as a state where cells are not actively dividing and may survive treatment, which is a basic definition."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how cancer cell plasticity can contribute to cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that plasticity enables switching between active and dormant states."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how cancer cell plasticity allows cancer cells to evade the immune system, making immunotherapy relatively ineffective.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of immune evasion or immunotherapy response in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention ways that cancer-directed therapy can be used to attempt to overcome cancer cell plasticity, such as treatment sequencing and medication combinations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Discusses combination therapies, sequencing, monitoring, and adapting plans in response to resistance."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that therapeutic strategies to target plasticity is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that newer approaches targeting plasticity are being studied in clinical trials."
      }
    ],
    "question_number": 213,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:07:49.181325",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell plasticity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines plasticity as the ability of cancer cells to change characteristics and behavior, including switching states, altering metabolism, and changing responses\u2014meets definition requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cancer cell plasticity makes cancer cells more difficult to treat.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains treatment resistance and changing molecular targets that reduce efficacy, and notes rationale for combination therapies\u2014adequately links plasticity to treatment difficulty."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the epithelial-mesenchymal transition in pancreatic cancer.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of epithelial\u2013mesenchymal transition (EMT) or its role in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role plasticity plays in the metastatic potential of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that plastic cancer cells may be better at spreading and adapting to new environments, directly linking plasticity to metastasis."
      },
      {
        "criterion_number": 5,
        "description": "The response should define and describe cancer cell dormancy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Dormancy is not mentioned or defined."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how cancer cell plasticity can contribute to cancer cell dormancy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion connecting plasticity to dormancy."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how cancer cell plasticity allows cancer cells to evade the immune system, making immunotherapy relatively ineffective.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explanation of immune evasion or why immunotherapy may be less effective in pancreatic cancer due to plasticity."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention ways that cancer-directed therapy can be used to attempt to overcome cancer cell plasticity, such as treatment sequencing and medication combinations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions combination therapies, monitoring tumor changes, and adjusting treatment plans\u2014meets the criterion for strategies to address plasticity."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that therapeutic strategies to target plasticity is an active area of research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that targeting plasticity is an active area of research."
      }
    ],
    "question_number": 213,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:08:06.783619",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mechanical forces in relation to cancer cells, explicitly mentioning \u201cphysical forces\u201d or \u201cpressure.\u201d",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly mentions mechanical forces and explicitly references \u201cpressure,\u201d \u201chigh pressure inside tumors,\u201d and \u201cmechanical stress,\u201d clearly defining mechanical forces in this context."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the effect of different mechanical forces on cancer growth and proliferation, including the activation of pathways or signaling pathways.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It explains that high pressure promotes aggressive behavior, impedes drug penetration, and that mechanical stress can \u201ctrigger signals\u201d aiding survival and spread; it also mentions \u201cmechanical signaling pathways,\u201d satisfying the signaling requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response should define desmoplastic stroma, which is often seen in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes a \u201cdense, fibrous shell (called desmoplasia) that makes the tumor very stiff,\u201d effectively capturing the concept of desmoplastic stroma characteristic of pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the pancreatic cancer tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response discusses key TME features, including dense fibrotic stroma, stiffness, compression of vessels/ducts/nerves, and consequences like impaired drug penetration and altered blood flow."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention future research directions as it pertains to desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It cites ongoing research to reduce tumor stiffness, target mechanical signaling pathways, and understand how mechanical forces drive treatment resistance, directly addressing desmoplastic stroma research directions."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain if there are FDA approved therapies that act on the desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not address whether any FDA-approved therapies specifically target the desmoplastic stroma in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that in pancreatic cancer, the stroma is very dense and stiff, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it states the stroma is dense and stiff and mentions high pressure, it does not explicitly mention \u201cinterstitial\u201d pressure nor reduced oxygen and nutrient delivery."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that the dense stroma can impede treatment delivery and induce hypoxia, explicitly mentioning \u201chypoxia\u201d and \u201ctreatment resistance.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes impaired drug penetration and mentions \u201ctreatment resistance,\u201d but it does not explicitly mention \u201chypoxia,\u201d which is required."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that the dense stroma can impede immune cells from reaching the tumor, explicitly mentioning \u201cimmune evasion\u201d or \u201creduced efficacy of immunotherapy.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of immune cell exclusion, immune evasion, or reduced efficacy of immunotherapy."
      }
    ],
    "question_number": 214,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:08:36.930930",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mechanical forces in relation to cancer cells, explicitly mentioning \u201cphysical forces\u201d or \u201cpressure.\u201d",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly references \u201cPhysical pressure\u201d and \u201cPhysical forces,\u201d and links them to tumor compression of tissues and vessels, satisfying the requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the effect of different mechanical forces on cancer growth and proliferation, including the activation of pathways or signaling pathways.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it describes effects of stiffness, pressure, migration, and angiogenesis, it does not mention activation of specific signaling pathways (e.g., integrins/FAK, YAP/TAZ, TGF-\u03b2), which the criterion requires."
      },
      {
        "criterion_number": 3,
        "description": "The response should define desmoplastic stroma, which is often seen in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines the concept succinctly by stating pancreatic tumors create a very stiff, fibrous environment (desmoplasia), which effectively describes desmoplastic stroma."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the pancreatic cancer tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes a dense, fibrous matrix, vessel compression, impaired perfusion, drug penetration barriers, and altered angiogenesis, all core features of the pancreatic tumor microenvironment."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention future research directions as it pertains to desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions ongoing research and clinical trials targeting mechanical aspects, including drugs that break down fibrous tissue or reduce tumor pressure."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain if there are FDA approved therapies that act on the desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not address whether any FDA-approved stromal-targeting therapies exist; no specific approval status is discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that in pancreatic cancer, the stroma is very dense and stiff, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it notes a very stiff, dense stroma and increased tissue pressure with reduced oxygen supply, it does not explicitly mention high interstitial pressure or reduced nutrient delivery as required."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that the dense stroma can impede treatment delivery and induce hypoxia, explicitly mentioning \u201chypoxia\u201d and \u201ctreatment resistance.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "It states drug delivery is impeded and mentions treatment resistance, but does not explicitly use the term \u201chypoxia,\u201d which the criterion requires."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that the dense stroma can impede immune cells from reaching the tumor, explicitly mentioning \u201cimmune evasion\u201d or \u201creduced efficacy of immunotherapy.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not mention immune cell infiltration, immune evasion, or the efficacy of immunotherapy."
      }
    ],
    "question_number": 214,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:09:09.841575",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient discuss the primary medical team responsible for keeping track of their referrals and oncologic care; this is usually the medical oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends identifying a primary oncologist as the main point of contact to oversee the treatment plan and coordinate between specialists."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly state that a clinician is designated as the main provider responsible for care coordination and continuity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that the primary oncologist should serve as the main point of contact and coordinate care among specialists."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the potential medical teams involved in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple relevant specialists (medical, surgical, radiation oncologists; gastroenterologist; pain management; palliative care; dietitian)."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient keep a comprehensive log of their test results and progress notes, in order to provide these to providers in the event that they did not receive everything.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises keeping a binder with all medical records, test results, and appointment notes, which constitutes a comprehensive log."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly recommend creating a centralized document listing all providers, their roles, and test results, which can be taken to appointments.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not explicitly recommend a centralized document that lists all providers and their roles; suggests a binder for records but not a provider/role list to bring to visits."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the patient have a loved one accompany them to all appointments, preferably the same person, and take notes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests bringing a trusted person for support and taking notes, but does not specify attending all appointments, having the same person, or that the companion should take notes."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient use online patient portals to ask questions and contact their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages use of patient portals for accessing test results and messaging providers, which aligns with contacting the oncology team."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe different professionals that can possibly help with care coordination, such as nurse case managers and social workers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions a nurse navigator but does not include other coordination professionals such as nurse case managers or social workers."
      }
    ],
    "question_number": 215,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:09:37.886126",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing the primary medical team responsible for referrals and oncologic care; usually the medical oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response notes that the medical oncologist leads treatment planning and suggests contacting the oncologist\u2019s office, but it does not explicitly recommend discussing and confirming who is the primary team responsible for tracking referrals and overall oncologic care, nor state that this is usually the medical oncologist."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly state that a clinician is designated as the main provider responsible for care coordination and continuity.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests asking for a nurse navigator or care coordinator, but does not explicitly state that a clinician (e.g., medical oncologist) is the main provider responsible for coordination and continuity; it also suggests designating a family member as primary contact if unavailable, which does not meet the criterion."
      },
      {
        "criterion_number": 3,
        "description": "Describe the potential medical teams involved in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists key team members including a medical oncologist, surgeon, gastroenterologist, pain management specialist, palliative care team, and nutritionist, which satisfies the criterion."
      },
      {
        "criterion_number": 4,
        "description": "Recommend keeping a comprehensive log of test results and progress notes to provide to providers if they did not receive everything.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it recommends a binder/digital folder with test results, medication lists, and appointment notes, it does not mention clinician progress notes or explicitly state the purpose of sharing with providers who may not have received all records."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly recommend a centralized document listing all providers, their roles, and test results, to bring to appointments.",
        "score_given": 0,
        "max_points": 6,
        "justification": "The response does not explicitly recommend creating a document that includes all providers and their roles, nor does it state that the document should be brought to appointments."
      },
      {
        "criterion_number": 6,
        "description": "Recommend having a loved one accompany the patient to all appointments, preferably the same person, and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises bringing the same support person to appointments for consistency and taking notes, fully meeting the criterion."
      },
      {
        "criterion_number": 7,
        "description": "Recommend using online patient portals to ask questions and contact the oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of using online patient portals or secure messaging to communicate with the oncology team."
      },
      {
        "criterion_number": 8,
        "description": "Describe professionals who can help with care coordination (e.g., nurse case managers, social workers).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly mentions nurse navigators/care coordinators and social workers as resources for care coordination, satisfying the requirement."
      }
    ],
    "question_number": 215,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:10:04.698464",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define senescence in cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines senescence as permanent cessation of cell division with continued metabolic activity, using an accurate and accessible analogy."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how senescence can lead to secretion of inflammatory molecules (senescence-associated secretory phenotype) which can alter the microenvironment to make it more amenable to tumor progression.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions that senescent cells release inflammatory substances affecting surrounding tissue but does not link this to pro-tumor microenvironmental changes or tumor progression."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe senescence-associated secretory phenotype factors.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not name or describe specific SASP factors (e.g., IL-6, IL-8, MMPs, TGF-\u03b2)."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of senescence in normal cells.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not address physiological roles of senescence in normal contexts such as development, wound healing, aging, or as a tumor-suppressive barrier."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which cancer cells evade senescence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that senescent cells may 'wake up' but provides no mechanisms by which cancer cells evade senescence (e.g., p53/p16INK4a/RB pathway inactivation, telomerase activation)."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain how some cancer therapies induce senescence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that chemotherapy and radiation aim to push cancer cells into senescence, accurately linking standard therapies to therapy-induced senescence."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain what senolytics are, and describe if there are any FDA approved in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Alludes to therapies that remove senescent cells but does not define senolytics explicitly nor address FDA approval status in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that this is an active area of research in the scientific community.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states researchers are studying senescence strategies in pancreatic cancer and mentions potential combinations with immunotherapy and clinical trials."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that senescence is caused by cellular stressors such as DNA damage or activation of tumor suppressor genes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention triggers such as DNA damage, telomere attrition, oncogene activation, or activation of tumor suppressor pathways (p53/p16)."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that senescence can be a positive factor as it stops tumor growth.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that inducing senescence can stop tumor growth, acknowledging the beneficial anti-proliferative effect."
      }
    ],
    "question_number": 216,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:10:30.640027",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define senescence in cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines senescence as a permanent growth arrest where cells remain alive but stop dividing."
      },
      {
        "criterion_number": 2,
        "description": "Describe how senescence can lead to secretion of inflammatory molecules (SASP) which can alter the microenvironment to make it more amenable to tumor progression.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions that senescent cells produce inflammatory signals but does not discuss microenvironmental remodeling or promotion of tumor progression."
      },
      {
        "criterion_number": 3,
        "description": "Describe senescence-associated secretory phenotype factors.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not list or describe specific SASP factors such as cytokines (e.g., IL-6, IL-8), chemokines, MMPs, or growth factors."
      },
      {
        "criterion_number": 4,
        "description": "Describe the role of senescence in normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States senescence is a protective mechanism preventing damaged cells from becoming cancerous, which captures its role in normal physiology."
      },
      {
        "criterion_number": 5,
        "description": "Describe ways in which cancer cells evade senescence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that some cells may escape senescence but provides no mechanisms (e.g., p53 or p16 pathway inactivation, telomerase activation), so does not meet the criterion."
      },
      {
        "criterion_number": 6,
        "description": "Explain how some cancer therapies induce senescence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that chemotherapy and radiation can damage cancer cells and force them into senescence."
      },
      {
        "criterion_number": 7,
        "description": "Explain what senolytics are, and describe if there are any FDA approved in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Defines senolytics as drugs targeting senescent cells but does not address FDA approval status in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "State that this is an active area of research in the scientific community.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes current research directions and that scientists are exploring related approaches, indicating active research."
      },
      {
        "criterion_number": 10,
        "description": "State that senescence is caused by cellular stressors such as DNA damage or activation of tumor suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links treatment-induced DNA damage (from chemotherapy and radiation) to induction of senescence, satisfying the requirement regarding DNA damage."
      },
      {
        "criterion_number": 11,
        "description": "State that senescence can be a positive factor as it stops tumor growth.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly lists as a benefit that senescence stops cancer cell division and tumor progression."
      }
    ],
    "question_number": 216,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:10:52.092435",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define exosomes as vesicles that cells can release into their surroundings.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines exosomes as tiny vesicles that cells release to communicate, correctly identifying them as cell-released vesicles."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe what exosomes contain, such as proteins, lipids, and RNA.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions exosomes carry 'molecules' but does not specify key cargo types (proteins, lipids, RNA)."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of exosomes in cancer cells, including cell-cell communication.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states exosomes are released to communicate and describes their role in spreading cancer signals."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of exosomes in tumor promotion.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Notes exosomes make nearby healthy cells support tumor growth, indicating tumor-promoting effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the role of exosomes in immune evasion.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States cancer exosomes can suppress or interfere with immune cells that would attack the tumor."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the role of exosomes in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explains exosomes may help cancer cells share resistance mechanisms, indicating a role in drug resistance."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the emerging or experimental role of exosomes as tumor biomarkers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States researchers are studying exosomes as potential biomarkers for earlier detection."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how exosomes travel in the body.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not describe routes of transport (e.g., circulation, lymph, bodily fluids); only discusses functional effects."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain how exosomes are thought to facilitate metastases in cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes pre-metastatic niche formation by 'preparing the soil' for distant organs, which facilitates metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe if there are any FDA approved treatments that are associated with cancer exosomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions trials and investigational approaches but does not explicitly address the status of FDA-approved exosome-related treatments."
      }
    ],
    "question_number": 217,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:11:05.755623",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define exosomes as vesicles that cells can release into their surroundings.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly defines exosomes as tiny vesicles that cells release to communicate with other cells."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe what exosomes contain, such as proteins, lipids, and RNA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states exosomes carry proteins and genetic material, which encompasses RNA; contents are described sufficiently."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of exosomes in cancer cells, including cell-cell communication.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explains that exosomes enable communication between cells and details multiple roles in cancer biology."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of exosomes in tumor promotion.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It notes exosomes promote cancer spread and can make normal cells adopt pro-tumor behaviors."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the role of exosomes in immune evasion.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly states exosomes help cancer cells evade the immune system."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the role of exosomes in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It mentions transfer of drug-resistance factors and aiding cancer cell survival during chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the emerging or experimental role of exosomes as tumor biomarkers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It highlights exosomes in blood as potential tools for early detection and monitoring treatment response."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how exosomes travel in the body.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It indicates exosomes circulate in blood (detectable in blood samples) and are released to act at distant sites."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain how exosomes are thought to facilitate metastases in cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It states that exosomes can prepare distant sites for metastasis, reflecting the pre-metastatic niche concept."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe if there are any FDA approved treatments that are associated with cancer exosomes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It correctly notes that most exosome-based treatments are still in clinical trials, implying none are FDA-approved for pancreatic cancer."
      }
    ],
    "question_number": 217,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:11:22.220514",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define advance directive and living will, and recommend that a patient have these documents completed and/or updated as they reach end of life.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advance directives and living wills are mentioned, but neither is defined, and there is no explicit recommendation to complete or update these documents."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend a palliative medicine consultation to consider transitioning treatment focus from disease-targeted to comfort-focused care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Palliative care is not mentioned; only general comfort care goals are referenced without recommending a palliative medicine consultation."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe Hospice, and ensure to include that patients with a prognosis of less than 6 months are eligible to enroll.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Hospice is mentioned as an option, but there is no description or the 6-month prognosis eligibility criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the different categories of tasks that need to be addressed when a patient is approaching end of life due to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly organizes considerations into medical decisions, legal/financial matters, and personal wishes, along with timing and resources."
      },
      {
        "criterion_number": 5,
        "description": "The response should define what a medical durable power of attorney is.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Power of attorney is listed but not defined; no explanation of a medical durable power of attorney."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the steps one needs to take in order to elect a medical durable power of attorney.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No steps are provided for appointing a medical durable power of attorney."
      },
      {
        "criterion_number": 7,
        "description": "The response should define a POLST and recommend that a patient have this filled out and displayed in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "POLST is not mentioned or defined, and no recommendation is made to complete or display it."
      },
      {
        "criterion_number": 8,
        "description": "The response should ensure the patient\u2019s healthcare provider teams have a copy of the patient\u2019s POLST.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of sharing POLST forms with healthcare teams."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that Hospice benefits vary across insurance plans, so it is important to understand what their specific benefits are.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of variability in hospice benefits across insurance plans."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information about Hospice, namely that services are provided for the patient but also for the family and caregivers of the patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While hospice organizations are mentioned, there is no statement that hospice provides services to family/caregivers as well as the patient."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient elects a financial durable power of attorney as someone to make financial decisions for the patient if they are unable to make decisions for themselves from illness.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Power of attorney and financial items are listed generally, but there is no explicit recommendation to appoint a financial durable power of attorney."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient consider what funeral arrangements they would prefer after their death, and communicate this to their loved ones and family.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Funeral/memorial preferences are listed, but there is no explicit recommendation to communicate these preferences to loved ones and family."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient plan for their death with regard to any religious or spiritual rituals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes spiritual or religious preferences and suggests consulting spiritual advisors, which meets the criterion."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe the importance of open communication between the patient and their decision makers to ensure their wishes can be respected as they approach death.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes discussing wishes as soon as possible and reviewing/updated over time to ensure wishes are honored, satisfying the communication focus."
      },
      {
        "criterion_number": 16,
        "description": "The response should state that end of life planning is highly individualized and should follow the wishes of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response centers on honoring the loved one\u2019s wishes and personal preferences, conveying that planning should follow the patient\u2019s wishes."
      }
    ],
    "question_number": 218,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:11:50.773845",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define advance directive and living will, and recommend that a patient have these documents completed and/or updated as they reach end of life.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advance directives and living wills are mentioned, but neither is defined and there is no explicit recommendation to complete or update these documents."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend a palliative medicine consultation to consider transitioning treatment focus from disease-targeted to comfort-focused care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Palliative care teams are listed as a resource, but the response does not explicitly recommend a palliative medicine consultation nor discuss transitioning from disease-directed to comfort-focused care."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe Hospice, and ensure to include that patients with a prognosis of less than 6 months are eligible to enroll.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Hospice is mentioned as a topic for discussion and a resource, but there is no description of hospice or the eligibility criterion of a prognosis of less than six months."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the different categories of tasks that need to be addressed when a patient is approaching end of life due to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly organizes tasks into medical decisions, legal and financial matters, personal wishes, timing considerations, and support resources."
      },
      {
        "criterion_number": 5,
        "description": "The response should define what a medical durable power of attorney is.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Healthcare power of attorney is mentioned but not defined."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the steps one needs to take in order to elect a medical durable power of attorney.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No steps or process for appointing a medical durable power of attorney are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should define a POLST and recommend that a patient have this filled out and displayed in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "POLST is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response should ensure the patient\u2019s healthcare provider teams have a copy of the patient\u2019s POLST.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of sharing POLST with healthcare teams."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that Hospice benefits vary across insurance plans, so it is important to understand what their specific benefits are.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of variability of hospice benefits by insurance."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information about Hospice, namely that services are provided for the patient but also for the family and caregivers of the patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that hospice provides services for both the patient and their family/caregivers."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient elects a financial durable power of attorney as someone to make financial decisions for the patient if they are unable to make decisions for themselves from illness.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Financial power of attorney is listed but without an explicit recommendation to elect one or an explanation that this person makes financial decisions if the patient is incapacitated."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient consider what funeral arrangements they would prefer after their death, and communicate this to their loved ones and family.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Funeral/memorial preferences are mentioned, but there is no recommendation to communicate these preferences to loved ones."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient plan for their death with regard to any religious or spiritual rituals.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of religious or spiritual rituals or planning related to them."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe the importance of open communication between the patient and their decision makers to ensure their wishes can be respected as they approach death.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes having conversations early so the loved one's wishes are honored, highlighting the importance of communication."
      },
      {
        "criterion_number": 16,
        "description": "The response should state that end of life planning is highly individualized and should follow the wishes of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes that each family's situation is unique and stresses honoring the loved one's wishes."
      }
    ],
    "question_number": 218,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:12:28.120401",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell dormancy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines dormancy as cancer cells stopping division while remaining alive/inactive."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how long a cancer cell can remain dormant in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States dormancy can last months, years, or even decades."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain why it is advantageous for cancer cells to be able to enter a dormant state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes survival while undetected and resistance to treatments targeting rapidly dividing cells, both advantages for cancer cells."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe scenarios in which a cancer cell may be prompted to enter dormancy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists triggers for reactivation, not scenarios that prompt entry into dormancy."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what is known about cancer cell dormancy in pancreatic cancer, preferably with references to the scientific literature with PMID.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that dormancy can occur in pancreatic cancer, particularly after treatment; while PMIDs are not provided, references were noted as preferable, not required."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that dormancy can occur because of microenvironmental or genetic factors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions immune changes, inflammation, and hormonal changes, which are microenvironmental/systemic factors influencing dormancy."
      },
      {
        "criterion_number": 8,
        "description": "The dormant cells will often be less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states dormant cells may be resistant to treatments targeting rapidly dividing cells."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that these dormant cells can lead to disease recurrence after treatments as they can reactivate after a long period of time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses reactivation after long periods and ties dormancy to the need for ongoing monitoring post-treatment, implying recurrence risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that dormancy is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that research is ongoing and that unknown factors remain."
      }
    ],
    "question_number": 219,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:12:46.623957",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell dormancy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines dormancy as a state of temporary growth arrest where cancer cells are present but not actively dividing or spreading, with a helpful 'sleeping' analogy."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how long a cancer cell can remain dormant in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that dormant cells can remain inactive for months, years, or even decades, directly addressing duration."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain why it is advantageous for cancer cells to be able to enter a dormant state.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explain advantages to cancer cells (e.g., evasion of therapy or immune surveillance); only provides general characteristics and factors."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe scenarios in which a cancer cell may be prompted to enter dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists triggers/influences such as immune activity, treatment effects, microenvironmental conditions, and stressors like surgery or illness."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what is known about cancer cell dormancy in pancreatic cancer, preferably with references to the scientific literature with PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides only a generic statement that pancreatic cancer is aggressive and research is ongoing; no specific details about dormancy in pancreatic cancer or literature references/PMIDs."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that dormancy can occur because of microenvironmental or genetic factors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions 'microenvironment conditions' as influencing dormancy; satisfies the criterion that microenvironmental or genetic factors can drive dormancy."
      },
      {
        "criterion_number": 8,
        "description": "The dormant cells will often be less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention chemotherapy susceptibility or resistance of dormant cells."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that these dormant cells can lead to disease recurrence after treatments as they can reactivate after a long period of time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement that dormant cells can later reactivate and cause recurrence."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that dormancy is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that scientists are still researching dormancy and that research is ongoing, including for pancreatic cancer."
      }
    ],
    "question_number": 219,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:13:03.481412",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define mechanical stress as physical forces and pressures exerted on and within a tumor mass, arising from tumor growth, interactions with surrounding tissues, and the tumor\u2019s microenvironment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes stiffness, high pressure, and vessel compression (physical forces), but does not explicitly define mechanical stress nor state its origins from tumor growth, interactions with surrounding tissues, and the broader tumor microenvironment."
      },
      {
        "criterion_number": 2,
        "description": "Describe how mechanical stress on tumor cells impacts their ability to grow and metastasize.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states that physical pressure can stimulate more aggressive behavior, promote metastasis, and activate growth-promoting pathways, directly addressing growth and spread."
      },
      {
        "criterion_number": 3,
        "description": "Describe the relationship between mechanical stress in tumors and hypoxia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains that compressed blood vessels reduce oxygen delivery and create low-oxygen areas (hypoxia)."
      },
      {
        "criterion_number": 4,
        "description": "Explain that mechanical stress on tumor tissue is implicated in treatment resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes impaired drug delivery due to vessel compression and that hypoxia can make cancer cells more resistant to treatment."
      },
      {
        "criterion_number": 5,
        "description": "Define the tumor microenvironment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response does not define the tumor microenvironment or enumerate its components (e.g., stroma, extracellular matrix, fibroblasts, immune cells, vasculature)."
      },
      {
        "criterion_number": 6,
        "description": "Describe sources of mechanical stress in tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies fibrosis (dense scar tissue) leading to stiffness and high intratumoral pressure as sources of mechanical stress."
      },
      {
        "criterion_number": 7,
        "description": "Inform that effects of mechanical stress on tumor tissue are not fully elucidated and are an area of active scientific research.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states this is an active area of research and mentions ongoing therapeutic investigations."
      },
      {
        "criterion_number": 8,
        "description": "Mention the effect of mechanical stress on the tumor in angiogenesis, invasion, metastasis, and promotion of tumor cell survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While metastasis is mentioned, the response does not address angiogenesis, invasion, or explicitly the promotion of tumor cell survival."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that pancreatic cancer is characterized by a very dense and stiff stroma, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states pancreatic tumors are very stiff and dense due to fibrosis, that this creates high pressure inside the tumor, and that vessel compression reduces oxygen and nutrient delivery."
      },
      {
        "criterion_number": 11,
        "description": "State that the dense stroma can impede immune cells from reaching the tumor, aiding immune evasion and reducing the efficacy of immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention immune cell infiltration barriers or immunotherapy efficacy."
      }
    ],
    "question_number": 220,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:13:24.985522",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mechanical stress as physical forces and pressures exerted on and within a tumor mass, arising from tumor growth, interactions with surrounding tissues, and the tumor\u2019s microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains a high-pressure, stiff environment in pancreatic tumors due to fibrosis and poor vasculature, describing mechanical pressure on and around cancer cells. This conveys mechanical stress as physical forces/pressures from the tumor microenvironment."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how mechanical stress on tumor cells impacts their ability to grow and metastasize.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states that mechanical stress can make cancer cells more aggressive and likely to spread, directly linking stress to metastasis and growth behavior."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the relationship between mechanical stress in tumors and hypoxia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains that compressed blood vessels deliver less oxygen and nutrients, which captures the concept of hypoxia resulting from mechanical compression."
      },
      {
        "criterion_number": 4,
        "description": "The response should explain that mechanical stress on tumor tissue is implicated in treatment resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states that high pressure can prevent chemotherapy drugs from reaching cancer cells and notes immune access interference, indicating treatment resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response should define the tumor microenvironment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it references surrounding tissue, fibrosis, vessels, and immune access, it does not provide a definition of the tumor microenvironment as the ensemble of cancer cells, stromal cells, ECM, vasculature, and immune components."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe sources of mechanical stress in tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies dense scar tissue (fibrosis) and poor blood vessel formation as contributors to a high-pressure, stiff environment, which are valid sources of mechanical stress."
      },
      {
        "criterion_number": 7,
        "description": "The response should inform the patient that effects of mechanical stress on tumor tissue are not fully elucidated and are an area of active scientific research.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly frames mechanical stress as an active research area and notes ongoing scientific exploration, implying current understanding is still evolving."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention the effect of mechanical stress on the tumor in angiogenesis, invasion, metastasis, and promotion of tumor cell survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions increased aggressiveness and likelihood to spread (metastasis) but does not explicitly address angiogenesis, invasion, or promotion of tumor cell survival."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer is characterized by a very dense and stiff stroma, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states pancreatic tumors have dense scar tissue (fibrosis) creating a stiff, high-pressure environment and that compressed vessels deliver less oxygen and nutrients, fulfilling the requirement."
      },
      {
        "criterion_number": 11,
        "description": "The response must state that the dense stroma can impede immune cells from reaching the tumor, aiding immune evasion and reducing the efficacy of immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes the mechanical environment can prevent immune cells from accessing the tumor but does not attribute this specifically to dense stroma nor mention reduced efficacy of immunotherapy."
      }
    ],
    "question_number": 220,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:13:48.032257",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor organoids as a miniature 3D model of the patient\u2019s tumor grown in a lab from the patient\u2019s own cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines organoids as tiny, 3D clusters of cells grown in the lab from a patient's own cancer cells and describes them as miniature versions of the tumor."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how tumor organoids are used for testing cancer medications to determine the most effective one.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states doctors can test different chemotherapies or combinations on the organoids to see which work best before giving them to the patient."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that the use of tumor organoids is experimental and not available at all cancer centers, and that there are no large randomized clinical trials for tumor organoids.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions the technology is still evolving and not widely available, but does not state that there are no large randomized clinical trials."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how tumor organoids are grown.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes they can be grown from biopsy samples within weeks, but provides no description of the growth process (e.g., 3D matrices, growth factors, culture conditions)."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain how tumor organoids are different than cultured cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not compare organoids to conventional 2D cultured cell lines or explain differences in architecture or tumor heterogeneity."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how tumor organoids are used to tailor treatments to the patient from which they are derived.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States organoids can be used to identify which treatments work best for the individual patient before administering them, which directly addresses tailoring."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe advantages of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Highlights research applications such as understanding cancer development and spread, testing new treatments more efficiently, and preserving tumor characteristics\u2014clear advantages for research."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe limitations of using patient-derived organoids for research.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions availability and insurance issues (clinical implementation), but does not discuss research-specific limitations (e.g., lack of microenvironment/immune components, culture bias, variable success rates)."
      }
    ],
    "question_number": 221,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:14:23.974953",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor organoids as a miniature 3D model of the patient\u2019s tumor grown in a lab from the patient\u2019s own cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines organoids as three-dimensional cultures grown from a patient's tumor tissue ('mini-tumors') that retain characteristics of the original cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how tumor organoids are used for testing cancer medications to determine the most effective one.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states organoids are used for drug testing to see which drugs work best and mentions personalized medicine applications."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that the use of tumor organoids is experimental and not available at all cancer centers, and that there are no large randomized clinical trials for tumor organoids.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes organoids are largely a research tool, but does not state they are not available at all centers nor mention the absence of large randomized clinical trials."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how tumor organoids are grown.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes the creation process: obtaining tumor tissue via biopsy/surgery, isolating cells, growing them under special conditions to form 3D structures."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain how tumor organoids are different than cultured cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "States organoids are 3D and mimic tumors but does not explicitly contrast them with traditional 2D cultured cell lines or explain specific differences."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how tumor organoids are used to tailor treatments to the patient from which they are derived.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions that results may help doctors choose the most effective treatment for the specific patient, reflecting patient-tailored application."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe advantages of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists advantages such as retaining genetic mutations and behavior of the original tumor, enabling drug testing and study of resistance."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe limitations of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that organoid results may not perfectly predict patient response and that establishing organoids takes weeks to months, indicating practical and predictive limitations."
      }
    ],
    "question_number": 221,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:14:47.409750",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend choosing a medical decision maker/medical durable power of attorney.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises, 'Consider appointing a healthcare proxy or power of attorney if not already done,' which directly fulfills the criterion."
      },
      {
        "criterion_number": 2,
        "description": "Recommend requesting assistance from social work from the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, 'Consider involving a patient advocate or social worker from the hospital,' which meets the intent of engaging oncology/hospital social work support."
      },
      {
        "criterion_number": 3,
        "description": "Inform about the role of palliative medicine in cancer care (goals of care, documentation).",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes, 'Many hospitals have palliative care teams who excel at facilitating these conversations. They focus on quality of life and can help navigate both medical and family complexities,' which accurately conveys the role of palliative care in aligning care with patient goals."
      },
      {
        "criterion_number": 4,
        "description": "Recommend designating a primary family member to attend appointments and relay information.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends, 'Designate one person as the main medical contact to avoid confusion,' which satisfies the criterion of having a primary point person to communicate and relay information."
      },
      {
        "criterion_number": 5,
        "description": "Recommend establishing a meeting schedule for regular updates.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response says, 'Hold regular family meetings with clear agendas,' directly meeting this requirement."
      },
      {
        "criterion_number": 7,
        "description": "State that the priority is the patient\u2019s wishes and she should be as involved in decision-making as possible.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it advises to 'Focus discussions on your mother's values and wishes,' it does not explicitly state that she should be as involved in the decision-making process as possible."
      },
      {
        "criterion_number": 8,
        "description": "Recommend holding family meetings with the healthcare team so family hears information directly from the physician.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response clearly states, 'Ask for family meetings with the medical team so everyone hears information together,' which fulfills this criterion."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize the importance of clear communication between family members.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple suggestions emphasize communication, including 'Hold regular family meetings with clear agendas,' 'Designate one person as the main medical contact,' and 'How will you share updates and make decisions?' indicating a strong emphasis on clear, structured communication."
      }
    ],
    "question_number": 222,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:15:27.701976",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend choosing a medical decision maker/medical durable power of attorney",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to clarify legal authority via healthcare proxy/power of attorney."
      },
      {
        "criterion_number": 2,
        "description": "Recommend requesting assistance from social work from the oncology team",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically suggests involving the medical team's social worker or patient advocate."
      },
      {
        "criterion_number": 3,
        "description": "Inform about the role of palliative medicine in cancer care and goals-of-care documentation",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of palliative care/palliative medicine or their role in goals-of-care discussions/documentation."
      },
      {
        "criterion_number": 4,
        "description": "Recommend designating a primary family member to attend appointments and relay information",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises designating one family spokesperson for medical team communication, which fulfills the intent of having a primary contact to relay information."
      },
      {
        "criterion_number": 5,
        "description": "Recommend establishing a meeting schedule for regular updates to the greater family",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests creating structured family meetings but does not specify establishing a schedule or providing regular updates."
      },
      {
        "criterion_number": 7,
        "description": "State that the priority is the patient\u2019s wishes and she should be as involved as possible",
        "score_given": 0,
        "max_points": 7,
        "justification": "Emphasizes focusing on the mother's stated preferences and documenting wishes, but does not explicitly state that she should be as involved in decision-making as possible."
      },
      {
        "criterion_number": 8,
        "description": "Recommend holding family meetings with the healthcare team so family can hear information directly from the physician",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises asking about family meetings with healthcare providers to align everyone, meeting the criterion."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize the importance of clear communication between family members",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple suggestions support clear communication: designate a spokesperson, document conversations, create structured meetings with agendas, and focus discussions on the mother's preferences."
      }
    ],
    "question_number": 222,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:16:05.910252",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define circadian rhythms as the body\u2019s natural 24-hour internal clock regulated by the brain and influenced by external cues, including hormone regulation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions 24-hour cycles and hormone levels but does not define circadian rhythms as an internal clock regulated by the brain (SCN) or note the influence of external cues like light/dark."
      },
      {
        "criterion_number": 2,
        "description": "Describe chronotherapy as timing cancer treatments to align with circadian rhythms for better efficacy and fewer side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains that administering chemotherapy at specific times may increase effectiveness and reduce side effects, explicitly under 'Chronotherapy in Cancer Treatment.'"
      },
      {
        "criterion_number": 3,
        "description": "Explain how disruptions in the circadian rhythm are thought to promote pancreatic cancer growth, including references to scientific literature or reputable sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes cancer cells may have disrupted rhythms but does not explain mechanisms relating to pancreatic cancer growth nor cite any sources."
      },
      {
        "criterion_number": 4,
        "description": "Recommend ways to promote normal circadian rhythms in pancreatic cancer patients, including consistent sleep, regular meal times, exposure to natural light, and avoiding screens/blue light at night.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It generally mentions 'good sleep hygiene' and consistent treatment scheduling but does not provide specific recommendations such as regular meal times, natural light exposure, or avoiding blue light."
      },
      {
        "criterion_number": 5,
        "description": "Explain the effect of poor or interrupted sleep on circadian rhythms, stating that disruptions can affect overall health and potentially promote cancer progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not discuss the negative effects of poor or interrupted sleep on circadian rhythms or potential links to cancer progression."
      },
      {
        "criterion_number": 6,
        "description": "Explain the effect of poor or inadequate diet on circadian rhythms, mentioning that irregular eating can disrupt circadian rhythms and that maintaining regular meal times is important.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of diet, irregular eating, or the importance of regular meal times for circadian regulation."
      },
      {
        "criterion_number": 7,
        "description": "Provide general recommendations for sleep hygiene, including consistent sleep duration, avoiding screens/blue light at night, and exposure to natural light during the day.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response references 'good sleep hygiene' but does not specify consistent sleep duration, avoiding blue light/screens at night, or daytime light exposure."
      },
      {
        "criterion_number": 8,
        "description": "Recommend that the patient consult a nutritionist familiar with nutritional challenges associated with pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to consult a nutritionist is provided."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient inquire with their oncology team about clinical trials pertaining to circadian rhythms in pancreatic cancer, mentioning resources like ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it suggests asking about ongoing clinical trials exploring chronotherapy, it does not mention ClinicalTrials.gov or specify pancreatic cancer trials."
      },
      {
        "criterion_number": 11,
        "description": "Clearly state that there is no current high-quality data supporting timed treatment in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state the lack of high-quality evidence for timed treatment in pancreatic cancer and instead implies potential benefit of timed chemotherapy."
      }
    ],
    "question_number": 223,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:16:33.715617",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define circadian rhythms as the body\u2019s natural 24-hour internal clock regulated by the brain and influenced by external cues, including hormone regulation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions 'natural 24-hour cycles' but does not specify regulation by the brain, influence of external cues (e.g., light), or hormone regulation."
      },
      {
        "criterion_number": 2,
        "description": "Describe chronotherapy as timing cancer treatments to align with circadian rhythms for better efficacy and fewer side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response names chronotherapy and states that some chemotherapy may be more effective or cause fewer side effects when given at specific times and that timing may influence radiation therapy effectiveness."
      },
      {
        "criterion_number": 3,
        "description": "Explain how circadian rhythm disruptions are thought to promote pancreatic cancer growth, including references to scientific literature or reputable sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes that cancer cells may disrupt circadian patterns but provides no mechanism relating to pancreatic cancer growth and includes no references or sources."
      },
      {
        "criterion_number": 4,
        "description": "Recommend ways to promote normal circadian rhythms (consistent sleep, regular meal times, exposure to natural light, avoiding screens/blue light at night).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only general advice to maintain regular sleep schedules is provided; there is no mention of regular meal times, exposure to natural light, or avoiding screens/blue light at night."
      },
      {
        "criterion_number": 5,
        "description": "Explain the effect of poor or interrupted sleep on circadian rhythms and potential promotion of cancer progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response says sleep-wake cycles affect immune function and recovery but does not state that poor or interrupted sleep disrupts circadian rhythms or may promote cancer progression."
      },
      {
        "criterion_number": 6,
        "description": "Explain the effect of poor or inadequate diet on circadian rhythms, noting irregular eating can disrupt rhythms and importance of regular meal times.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Diet and meal timing are not discussed."
      },
      {
        "criterion_number": 7,
        "description": "Provide general sleep hygiene recommendations: consistent sleep duration, avoiding screens/blue light at night, and daylight exposure.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Only maintaining regular sleep schedules is mentioned; there is no guidance on blue light avoidance or daytime light exposure."
      },
      {
        "criterion_number": 8,
        "description": "Recommend consulting a nutritionist familiar with pancreatic cancer nutritional challenges.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to consult a nutritionist is provided."
      },
      {
        "criterion_number": 9,
        "description": "Recommend inquiring with the oncology team about clinical trials on circadian rhythms in pancreatic cancer, mentioning resources like ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While the response suggests discussing with the oncology team and notes some centers may have studies, it does not mention clinical trials resources such as ClinicalTrials.gov."
      },
      {
        "criterion_number": 11,
        "description": "Clearly state that there is no current high-quality data supporting timed treatment in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response says research is developing and that protocols don\u2019t routinely factor in timing but does not explicitly state that there is no current high-quality data in pancreatic cancer."
      }
    ],
    "question_number": 223,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:17:08.875628",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mitochondria.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response references mitochondria but does not define them as organelles responsible for energy production (ATP) via oxidative phosphorylation or other core functions."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the roles of mitochondria in normal cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explanation of normal mitochondrial functions (e.g., ATP generation, biosynthesis, apoptosis regulation, ROS handling) is provided."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain what is known about how the role of mitochondria in cancer cells differs from that of normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response notes increased reliance on glycolysis despite oxygen (Warburg effect), that pancreatic cancer cells still require functioning mitochondria, and that they adapt metabolism, which addresses differences from normal cells."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the increased metabolic demands on cancer cells and why this happens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly state that cancer cells have increased anabolic and energy demands due to rapid proliferation or the need for biomass synthesis."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain the Warburg effect.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The Warburg effect is correctly described as reliance on glycolysis for energy even in the presence of oxygen."
      },
      {
        "criterion_number": 6,
        "description": "The response should define apoptosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Apoptosis is not mentioned or defined."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain the role of mitochondria in apoptosis in normal cells, and explain how this can be altered in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of mitochondrial outer membrane permeabilization, cytochrome c release, or how cancer alters apoptotic pathways."
      },
      {
        "criterion_number": 8,
        "description": "The response should define reactive oxygen species and how they are created with regard to the role that mitochondria play.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Reactive oxygen species and mitochondrial electron transport chain leakage are not discussed."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how ROS can damage surrounding cells, and the subsequent cellular signaling pathways that are stimulated as a result.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of ROS-mediated DNA/protein/lipid damage or activation of signaling pathways (e.g., HIF-1, NF-\u03baB, MAPK)."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe that as a facilitator of cellular energy, mitochondria are a potential treatment target.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly states that therapies can target cancer metabolism and mentions agents affecting mitochondrial function, indicating mitochondria as a treatment target."
      },
      {
        "criterion_number": 11,
        "description": "The response should define glutamine and how this substance is used in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Glutamine metabolism, anaplerosis, or its role as a carbon/nitrogen source in cancer is not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that cancer treatment targeting mitochondrial functions are experimental and not part of FDA-approved treatment regimens at this time.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it notes ongoing research and clinical trials, it does not explicitly state that mitochondrial-targeted treatments are experimental and not part of FDA-approved standard regimens."
      }
    ],
    "question_number": 224,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:17:36.714281",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mitochondria.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response functionally defines mitochondria by stating that healthy cells use mitochondria to produce energy through oxygen-dependent processes, conveying their core identity as energy-producing structures."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the roles of mitochondria in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that in normal cells mitochondria efficiently produce energy via oxygen-dependent processes, capturing their principal role in cellular energy metabolism."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain what is known about how the role of mitochondria in cancer cells differs from that of normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response contrasts normal and cancer cell metabolism, stating cancer cells rely more on glycolysis despite oxygen availability (Warburg effect) and that this shift aids survival and rapid growth, thereby explaining altered mitochondrial roles."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the increased metabolic demands on cancer cells and why this happens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions rapid growth and harsh conditions, it does not explicitly describe increased metabolic demands or the reasons (e.g., biosynthetic needs for nucleotides, lipids, proteins) driving those demands."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain the Warburg effect.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It correctly defines the Warburg effect as increased reliance on glycolysis even when oxygen is available."
      },
      {
        "criterion_number": 6,
        "description": "The response should define apoptosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Apoptosis is not defined anywhere in the response."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain the role of mitochondria in apoptosis in normal cells, and explain how this can be altered in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not discuss mitochondrial regulation of apoptosis or how these pathways are altered in cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should define reactive oxygen species and how they are created with regard to the role that mitochondria play.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Reactive oxygen species (ROS) are not defined and their mitochondrial generation is not addressed."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how ROS can damage surrounding cells, and the subsequent cellular signaling pathways that are stimulated as a result.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of ROS-mediated damage or downstream signaling pathways."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe that as a facilitator of cellular energy, mitochondria are a potential treatment target.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that some chemotherapy drugs target mitochondrial function and that therapies aim to exploit metabolic weaknesses, identifying mitochondria/metabolism as treatment targets."
      },
      {
        "criterion_number": 11,
        "description": "The response should define glutamine and how this substance is used in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Glutamine and its role in cancer metabolism are not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that cancer treatment targeting mitochondrial functions are experimental and not part of FDA-approved treatment regimens at this time.",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response does not explicitly state that mitochondrial-targeting treatments are experimental/not FDA-approved; it references research and clinical trials but also implies existing therapies without clarifying regulatory status."
      }
    ],
    "question_number": 224,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:18:01.605381",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend that the patient/family discuss insurance coverage issues with the oncology team administering the experimental treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises involving the oncologist in coverage matters by stating 'Get your oncologist to write a letter of medical necessity' and 'Ask your oncologist about trials,' which implies discussing coverage issues with the treating oncology team."
      },
      {
        "criterion_number": 2,
        "description": "Mention that financial assistance programs are available for some experimental drugs and explicitly state that this varies from drug to drug, requiring inquiry.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it lists financial assistance resources, it does not explicitly state that assistance varies by drug and that the patient must inquire."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly mention that travel to and from the trial center is often not covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states 'Travel costs may be covered by some trials,' but does not explicitly mention that travel is often not covered."
      },
      {
        "criterion_number": 5,
        "description": "Describe what 'compassionate use' is and recommend asking the oncology team about this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions 'Drug manufacturers' compassionate use programs' but does not describe what compassionate use is or recommend discussing it with the oncology team."
      },
      {
        "criterion_number": 6,
        "description": "Recommend that the patient discuss their concerns with their cancer center\u2019s financial team and/or patient advocacy office.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends engaging 'Hospital financial counselors and social workers,' which corresponds to the cancer center\u2019s financial team."
      },
      {
        "criterion_number": 7,
        "description": "Recommend that the patient and/or family become familiar with their insurance policy to understand what is or is not covered.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit recommendation to review or become familiar with the details of the insurance policy."
      },
      {
        "criterion_number": 8,
        "description": "Inform the patient that they have the right to appeal any decision made by the insurance company.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The section 'Insurance Appeals Process' advises requesting formal review and external review, effectively informing the patient about the right to appeal."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient seek out patient advocacy groups online to learn how other patients navigated the same issues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises 'Contact patient advocacy organizations' but does not specify seeking them out online or learning how others navigated similar issues."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that insurance usually only covers standard of care treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly state that insurance typically only covers standard of care treatments."
      },
      {
        "criterion_number": 11,
        "description": "Clearly indicate that clinical trials typically cover the cost of the experimental treatment itself, while insurance covers the standard of care components, such as imaging.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes trials 'often cover the experimental treatment costs' but does not state that insurance covers standard-of-care components such as imaging."
      }
    ],
    "question_number": 225,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:18:37.776580",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend that the patient/family discuss insurance coverage issues with the oncology team administering the experimental treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises, 'Ask your oncologist to submit a \"letter of medical necessity\"' which directly involves the oncology team in addressing insurance coverage."
      },
      {
        "criterion_number": 2,
        "description": "Mention that financial assistance programs are available for some experimental drugs and explicitly state that this varies from drug to drug, requiring inquiry.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes manufacturer patient assistance programs, it does not explicitly state that availability varies by drug and that the patient must inquire to confirm."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly mention that travel to and from the trial center is often not covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of travel costs or coverage for transportation to trial centers."
      },
      {
        "criterion_number": 5,
        "description": "Describe what 'compassionate use' is and recommend asking the oncology team about this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references 'compassionate use/expanded access' but does not describe what it is and suggests asking pharmaceutical companies rather than the oncology team."
      },
      {
        "criterion_number": 6,
        "description": "Recommend discussing concerns with the cancer center\u2019s financial team and/or patient advocacy office.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises, 'Ask your care team's financial counselor for guidance' and mentions patient advocate services, meeting the criterion."
      },
      {
        "criterion_number": 7,
        "description": "Recommend that the patient/family become familiar with their insurance policy to understand what is or is not covered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs to 'Look into your plan's ... provisions' and to 'Check if treatments are covered under clinical trial provisions,' which effectively recommends reviewing the policy."
      },
      {
        "criterion_number": 8,
        "description": "Inform the patient that they have the right to appeal any decision made by the insurance company.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly suggests filing a formal appeal if coverage is denied."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient seek out patient advocacy groups online to learn how other patients navigated the same issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends PanCAN, CancerCare.org, and patient advocate services, which are online advocacy resources helpful for navigating similar issues."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that insurance usually only covers standard of care treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not make this explicit statement."
      },
      {
        "criterion_number": 11,
        "description": "Clearly indicate that clinical trials typically cover the cost of the experimental treatment itself, while insurance covers the standard of care components, such as imaging.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes that treatment in trials is 'often provided at no cost' but does not clarify that insurance covers standard-of-care components like imaging; the full distinction is missing."
      }
    ],
    "question_number": 225,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:19:12.497788",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ferroptosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ferroptosis as a form of programmed cell death characterized by iron-dependent oxidative damage to cell membranes and failure of defenses like GPX4."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role of iron in ferroptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that excess iron drives a chain reaction damaging lipids in cell membranes, leading to ferroptosis."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of ferroptosis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains relevance to pancreatic cancer: potential vulnerability of cancer cells, overcoming treatment resistance, and use in combinations, providing a clear connection to PDAC treatment strategies."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there are currently drugs under investigation with the aim to induce ferroptosis in pancreatic cancer cells but there are no current available established treatments that target ferroptosis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions ongoing research and clinical trials but does not explicitly state that no established/approved ferroptosis-targeting treatments currently exist."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references in the scientific literature about ferroptosis and link PMID if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why ferroptosis occurs.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States ferroptosis occurs due to iron-driven lipid peroxidation and failure of antioxidant defenses (e.g., GPX4), which explains the mechanistic 'why.'"
      },
      {
        "criterion_number": 7,
        "description": "The response should define apoptosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions apoptosis only as a contrast but does not define it."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe the difference between apoptosis and ferroptosis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "States ferroptosis is different from apoptosis but does not describe specific distinguishing features."
      }
    ],
    "question_number": 226,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:19:34.196799",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ferroptosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ferroptosis as a distinct, programmed form of cell death characterized by iron dependence, lipid peroxidation, and loss of GPX4 antioxidant defense."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role of iron in ferroptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states iron dependency and that iron is required for ferroptosis to occur."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of ferroptosis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that pancreatic cancer cells may be vulnerable to ferroptosis and discusses its exploration as a therapeutic target and in overcoming treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there are currently drugs under investigation with the aim to induce ferroptosis in pancreatic cancer cells but there are no current available established treatments that target ferroptosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that ferroptosis-based treatments are experimental and in laboratory/early clinical phases (no established therapies) and mentions ferroptosis inducers and investigation in the context of pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references in the scientific literature about ferroptosis and link PMID if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No references or PMIDs are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why ferroptosis occurs.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explains that ferroptosis occurs due to lipid peroxidation and loss of antioxidant defenses (GPX4), which is the mechanistic basis for initiation."
      },
      {
        "criterion_number": 7,
        "description": "The response should define apoptosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions apoptosis only as a contrasting term without defining it."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe the difference between apoptosis and ferroptosis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "States ferroptosis is distinct from apoptosis but does not describe specific differences."
      }
    ],
    "question_number": 226,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:19:54.716406",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly links stiffness and pressure to how cancer cells move (e.g., following stiff collagen fibers, breaking through barriers), relating mechanics to spread."
      },
      {
        "criterion_number": 2,
        "description": "The response includes descriptions of the mechanical properties of tissue: elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions stiffness/elasticity and compression/pressure, but does not discuss viscosity or density."
      },
      {
        "criterion_number": 3,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that internal tumor pressure compresses blood vessels and pushes cells into surrounding tissues."
      },
      {
        "criterion_number": 4,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Desmoplasia is described as dense, fibrous tissue that stiffens the tumor and influences spread; role is accurately conveyed."
      },
      {
        "criterion_number": 5,
        "description": "The response describes ways by which cancer metastasizes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes invasion through basement membrane and entry into blood and lymphatic vessels, as well as migration along collagen fibers."
      },
      {
        "criterion_number": 6,
        "description": "The response describes epithelial-to-mesenchymal transition and what environmental factors trigger this transition in pancreatic cells and pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention EMT or its triggers (e.g., TGF-\u03b2, hypoxia, stiffness, inflammation)."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that dense collagen can initially trap cells but also provides aligned pathways for cell migration, reflecting cell\u2013stroma interaction."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Focuses on mechanical aspects but does not discuss inflammation, hypoxia, immune cells, or other TME elements that promote migration."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of KRAS or other genomic alterations and their effects on invasion or metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response explains other methods for the spread of pancreatic cancer besides invasion into solid tissue, such as hematologic spread, lymphatic spread, and perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that cancer must breach blood and lymphatic vessel walls, covering hematologic and lymphatic routes (perineural not mentioned but not required for full credit)."
      },
      {
        "criterion_number": 11,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects stiffness/pressure to drug delivery challenges and mentions therapeutic strategies targeting the stiff microenvironment and implications for surgical planning."
      },
      {
        "criterion_number": 12,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific literature are provided."
      }
    ],
    "question_number": 227,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:20:19.082068",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly links stiffness and mechanical cues to invasion/metastasis and describes how pressure and ECM remodeling influence cancer cell movement."
      },
      {
        "criterion_number": 2,
        "description": "The response includes descriptions of the mechanical properties of tissue: elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions stiffness (elasticity proxy) and pressure, but does not describe viscosity or density, and does not explicitly cover compression as a mechanical property; therefore does not address all required properties."
      },
      {
        "criterion_number": 3,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes high internal tumor pressure that impedes blood flow and drug penetration and may push cells into surrounding tissues, effectively describing compressive effects on surrounding tissue and vasculature."
      },
      {
        "criterion_number": 4,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies desmoplasia as an unusually stiff, fibrous environment in pancreatic tumors and links it to promoting invasion/metastasis."
      },
      {
        "criterion_number": 5,
        "description": "The response describes ways by which cancer metastasizes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes ECM remodeling creating paths for cell movement and mechanosensing-driven migration toward stiffer regions that facilitate invasion and spread, addressing mechanisms contributing to metastasis."
      },
      {
        "criterion_number": 6,
        "description": "The response describes epithelial-to-mesenchymal transition and what environmental factors trigger this transition in pancreatic cells and pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention EMT or environmental triggers for EMT."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that cancer cells remodel the surrounding ECM and that pancreatic tumors generate a stiff desmoplastic environment that influences cell behavior, indicating bidirectional interaction."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Focuses on mechanical aspects (stiffness, pressure, ECM remodeling) but does not address inflammation, hypoxia, immune/stromal components, or how these elements encourage cell travel."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of genetic drivers (e.g., KRAS) or their influence on metastatic potential."
      },
      {
        "criterion_number": 10,
        "description": "The response explains other methods for the spread of pancreatic cancer besides invasion into solid tissue, such as hematologic spread, lymphatic spread, and perineural invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention hematogenous, lymphatic, or perineural routes of spread."
      },
      {
        "criterion_number": 11,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that stiffness/pressure impede drug delivery and notes therapeutic strategies that target the tumor\u2019s mechanical environment."
      },
      {
        "criterion_number": 12,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references provided."
      }
    ],
    "question_number": 227,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:20:49.130503",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s healthcare team or oncology team about patient advocacy opportunities within their organization.",
        "score_given": 0,
        "max_points": 6,
        "justification": "The response mentions hospital patient advisory councils but does not explicitly advise contacting the patient's healthcare or oncology team for advocacy opportunities."
      },
      {
        "criterion_number": 2,
        "description": "The response offers examples of patient advocacy groups and provides contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists PanCAN, Lustgarten Foundation, and National Pancreatic Cancer Foundation but provides no websites, phone numbers, or contact details."
      },
      {
        "criterion_number": 3,
        "description": "The response defines patient advocacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No clear definition is provided; it describes advocacy as meaningful and lists activities but does not define what patient advocacy is."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of patient advocacy work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple concrete examples are given: clinical trial advocacy, legislative advocacy, peer support, awareness campaigns, fundraising events, online communities, hospital advisory councils, and speaking engagements."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of patient advocacy opportunities specific to pancreatic cancer and provides contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While pancreatic cancer\u2013specific organizations are named, no contact information or websites are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends joining pancreatic cancer support groups, either online or in-person, to learn about advocacy opportunities.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Support groups and forums are mentioned generally, but there is no explicit recommendation to join pancreatic cancer\u2013specific support groups for the purpose of learning about advocacy opportunities."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions at least three different areas of advocacy for pancreatic cancer patients, such as direct patient support, support groups, funding for cancer research, awareness of clinical trials, or political lobbying.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It covers multiple areas: direct patient support (peer support), support groups/online communities, clinical trial advocacy, legislative advocacy (political lobbying), awareness campaigns, and fundraising."
      }
    ],
    "question_number": 228,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:21:17.726405",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s healthcare team or oncology team about patient advocacy opportunities within their organization.",
        "score_given": 0,
        "max_points": 6,
        "justification": "The response does not mention contacting the healthcare or oncology team for advocacy opportunities; it only suggests contacting advocacy organizations, online communities, and support groups."
      },
      {
        "criterion_number": 2,
        "description": "The response offers examples of patient advocacy groups and provides contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists PanCAN, Lustgarten Foundation, and the Hirshberg Foundation, it does not provide any contact information or website links for these organizations."
      },
      {
        "criterion_number": 3,
        "description": "The response defines patient advocacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states that advocacy is a meaningful way to help others but does not clearly define patient advocacy as actions that support, inform, represent, or empower patients within healthcare, policy, research, or community contexts."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of patient advocacy work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes concrete examples such as policy advocacy, awareness campaigns, patient support/mentoring, research advocacy (including clinical trial awareness), and fundraising activities."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of patient advocacy opportunities specific to pancreatic cancer and provides contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although pancreatic cancer\u2013specific organizations are listed, no contact information or website URLs are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends joining pancreatic cancer support groups, either online or in-person, to learn about advocacy opportunities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises joining online communities/forums and attending local support group meetings as part of getting started, which reasonably directs the reader to support groups to discover opportunities."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions at least three different areas of advocacy for pancreatic cancer patients, such as direct patient support, support groups, funding for cancer research, awareness of clinical trials, or political lobbying.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions multiple areas: policy advocacy/lobbying, awareness campaigns, patient support/mentoring, research advocacy including clinical trial awareness, and fundraising for research."
      }
    ],
    "question_number": 228,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:21:38.589524",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains normal cellular metabolism in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly explains that normal cells use oxygen via oxidative phosphorylation to efficiently make energy and even provides an approximate ATP yield per glucose in simple language."
      },
      {
        "criterion_number": 2,
        "description": "The response outlines the differences between normal cellular metabolism and cancer cell metabolism.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It contrasts normal oxidative phosphorylation with cancer cells\u2019 preference for glycolysis even with oxygen present, notes ATP yield differences, and mentions increased glucose consumption."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the Warburg effect.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly names the Warburg effect and describes glycolysis despite oxygen availability."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of how cancer cell metabolism affects its clinical behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that acid production may aid spread (metastasis) and that glycolysis supports survival in low-oxygen conditions; also mentions PET scan detectability via high glucose uptake."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of targeting the differences in cancer cell metabolism as a means of treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It only states that some treatments target metabolic differences without giving any concrete examples."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should define glycolysis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Glycolysis is mentioned but not defined (e.g., breakdown of glucose to pyruvate/lactate to produce ATP)."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how cancer cells use glutamine, and how this is different than normal cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states cancer cells have increased glutamine consumption for energy and building materials, indicating both use and a difference from normal cells."
      },
      {
        "criterion_number": 9,
        "description": "The response should define lactic acid and describe how excess lactic acid can be produced by cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions creation of an acidic environment but does not define lactic acid or explain its production via aerobic glycolysis."
      },
      {
        "criterion_number": 10,
        "description": "The response should not recommend specific diets for management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "No dietary recommendations are made."
      },
      {
        "criterion_number": 11,
        "description": "The response should not reference specific diets unless it provides PMID to studies that examine the effect of diet on pancreatic cancer, and the response should provide a summary of the findings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "No specific diets are referenced."
      },
      {
        "criterion_number": 12,
        "description": "The response should not indicate that restrictive diets, such as ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "No restrictive diet recommendations are suggested."
      },
      {
        "criterion_number": 13,
        "description": "The response should clearly state if treatments are experimental or if they are evidence-based and/or FDA approved.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes that metabolic therapies are an active area of research but does not clearly state whether any treatments mentioned are experimental or FDA-approved."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No recommendation to discuss diet with the oncology team or to seek a nutritionist referral is provided."
      }
    ],
    "question_number": 229,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:22:13.269117",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains normal cellular metabolism in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that normal cells primarily use oxygen to efficiently convert glucose into energy (cellular respiration), which is a clear lay explanation of aerobic metabolism."
      },
      {
        "criterion_number": 2,
        "description": "The response outlines the differences between normal cellular metabolism and cancer cell metabolism.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It contrasts normal oxidative metabolism with cancer cells\u2019 reliance on glucose fermentation despite oxygen being available, and provides reasons (rapid growth, biosynthesis, survival in low oxygen)."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the Warburg effect.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly names and briefly describes the Warburg effect."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of how cancer cell metabolism affects its clinical behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes rapid growth, survival in hypoxic/harsh environments, and highlights high glucose uptake enabling PET imaging, all reflecting clinical behavior implications."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of targeting the differences in cancer cell metabolism as a means of treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It only mentions general 'targeted therapies that exploit metabolic weaknesses' and 'dietary approaches' without concrete examples (e.g., specific metabolic inhibitors or pathways)."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific articles are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should define glycolysis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Glycolysis is not defined; only glucose fermentation is mentioned without explaining glycolysis."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how cancer cells use glutamine, and how this is different than normal cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Glutamine is not mentioned; only a generic statement about using amino acids is included."
      },
      {
        "criterion_number": 9,
        "description": "The response should define lactic acid and describe how excess lactic acid can be produced by cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lactic acid is not defined or discussed; no explanation of lactate overproduction from aerobic glycolysis is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should not recommend specific diets for management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "No specific diet is recommended."
      },
      {
        "criterion_number": 11,
        "description": "The response should not reference specific diets unless it provides PMID to studies that examine the effect of diet on pancreatic cancer, and the response should provide a summary of the findings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "No specific diets are referenced, so the criterion is met."
      },
      {
        "criterion_number": 12,
        "description": "The response should not indicate that restrictive diets, such as ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It does not suggest starting any restrictive diet."
      },
      {
        "criterion_number": 13,
        "description": "The response should clearly state if treatments are experimental or if they are evidence-based and/or FDA approved.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions areas 'being researched' or 'studied,' it does not clearly distinguish experimental treatments from established, evidence-based or FDA-approved options (e.g., PET is established but presented under research)."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests discussing nutritional support with the oncology team but does not recommend requesting a referral to a nutritionist/dietitian."
      }
    ],
    "question_number": 229,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:22:45.815400",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises to work with the oncology team, keep them informed about symptoms, and discuss medication adjustments and pain management."
      },
      {
        "criterion_number": 2,
        "description": "The response states peripheral neuropathy is a common side effect of certain chemotherapy agents used to treat pancreatic cancer, including oxaliplatin.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it notes neuropathy is a common side effect of pancreatic cancer treatments, it does not mention specific agents or oxaliplatin."
      },
      {
        "criterion_number": 3,
        "description": "The response should define chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No definition of chemotherapy-induced peripheral neuropathy is provided (e.g., nerve damage from chemotherapy causing sensory and/or motor symptoms)."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of symptoms of peripheral neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response focuses on rehabilitation techniques and mentions pain and hypersensitivity in the context of treatment, but it does not explicitly list neuropathy symptoms such as numbness, tingling, burning pain, weakness, or balance problems."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of how peripheral neuropathy symptoms may affect a patient\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It addresses functional impacts by referencing balance problems leading to falls, gait issues necessitating assistive devices, and fine motor/ADL challenges that may require adaptive equipment."
      },
      {
        "criterion_number": 6,
        "description": "The response states some patients may see an improvement in symptoms when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions medication adjustments but does not state that symptoms may improve when the causative agent is stopped."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe that some patients have diminishment of chemotherapy-induced peripheral neuropathy over time, but sometimes it is permanent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No comment on the time course or potential permanence of symptoms is included."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends physical therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Physical therapy is explicitly recommended with examples such as balance, strength, gait, proprioception, and manual techniques."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends occupational therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Occupational therapy is explicitly recommended, including adaptive equipment, fine motor exercises, home safety modifications, and energy conservation."
      },
      {
        "criterion_number": 10,
        "description": "The response states medication may help with some symptoms of peripheral neuropathy and provides examples like gabapentin, pregabalin, and duloxetine.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions pain management options generally, it does not provide medication examples such as gabapentin, pregabalin, or duloxetine."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the grading system oncologists use to quantify the severity of chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of a CIPN grading system (e.g., CTCAE grades) is included."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that patients with peripheral neuropathy can adapt to their environment to prevent adverse events.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends safety modifications for the home and the use of assistive devices and adaptive equipment, which are environmental adaptations to prevent falls and other adverse events."
      },
      {
        "criterion_number": 13,
        "description": "The response should inform patients of the importance of protecting body parts that are experiencing neuropathy, such as appropriately sized and firm shoes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific guidance on protecting insensate areas (e.g., proper footwear, skin checks) is provided."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage patients to participate in activities that promote general wellness such as exercise, balanced nutrition with an emphasis on plant-based foods, good sleep hygiene, and adequate hydration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It encourages exercise explicitly (gentle yoga/tai chi, aquatic therapy), which fits within general wellness activities. Although nutrition, sleep, and hydration are not addressed, the criterion is met by encouraging wellness-promoting activity."
      }
    ],
    "question_number": 230,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:23:26.658161",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing with the oncology team and states they should be the first contact."
      },
      {
        "criterion_number": 2,
        "description": "The response states peripheral neuropathy is a common side effect of certain chemotherapy agents used to treat pancreatic cancer, including oxaliplatin.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention chemotherapy agents or oxaliplatin specifically."
      },
      {
        "criterion_number": 3,
        "description": "The response should define chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No definition of chemotherapy-induced peripheral neuropathy is provided."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of symptoms of peripheral neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No symptom examples (e.g., numbness, tingling, burning pain) are listed."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of how peripheral neuropathy symptoms may affect a patient\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions fall risk and need for assistive devices for gripping, writing, and cooking, which reflect functional impacts."
      },
      {
        "criterion_number": 6,
        "description": "The response states some patients may see an improvement in symptoms when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes treatment adjustments by oncology but does not state that symptoms may improve when the causative medication is stopped."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe that some patients have diminishment of chemotherapy-induced peripheral neuropathy over time, but sometimes it is permanent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of symptom trajectory over time or potential permanence."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends physical therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a dedicated Physical Therapy section with specific interventions."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends occupational therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides an Occupational Therapy section with specific strategies and tools."
      },
      {
        "criterion_number": 10,
        "description": "The response states medication may help with some symptoms of peripheral neuropathy and provides examples like gabapentin, pregabalin, and duloxetine.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists medications including gabapentin, pregabalin, and duloxetine explicitly."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the grading system oncologists use to quantify the severity of chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of a grading system (e.g., CTCAE) for neuropathy severity."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that patients with peripheral neuropathy can adapt to their environment to prevent adverse events.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends home safety modifications such as better lighting, grab bars, and non-slip surfaces."
      },
      {
        "criterion_number": 13,
        "description": "The response should inform patients of the importance of protecting body parts that are experiencing neuropathy, such as appropriately sized and firm shoes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions protective footwear, addressing protection of insensate areas like the feet."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage patients to participate in activities that promote general wellness such as exercise, balanced nutrition with an emphasis on plant-based foods, good sleep hygiene, and adequate hydration.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not encourage general wellness activities such as nutrition, sleep hygiene, or hydration; only mentions meditation as a complementary therapy."
      }
    ],
    "question_number": 230,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:23:52.890378",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what liquid-liquid phase separation is in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines LLPS clearly using an oil-and-water analogy, explains droplet-like, membrane-less compartments with distinct boundaries in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how liquid-liquid phase separation relates to cancer cell biology.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly links LLPS to cancer biology via dysregulated gene regulation, stress granules aiding survival and treatment resistance, DNA repair organization and genomic instability, and abnormal condensates formed by oncogenic proteins."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the role of liquid-liquid phase separation in normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies normal cellular functions of LLPS (gene regulation, stress granule formation during stress response, organization of DNA repair machinery) even though framed within cancer context."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of liquid-liquid phase separation in pancreatic cancer and specific ways it can be affected.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions pancreatic cancer and notes that mutant KRAS, common in pancreatic cancer, may affect phase separation, tying LLPS to a pancreas-specific driver."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the link between common mutations seen in pancreatic cancer and dysregulated liquid-liquid phase separation, including references to the scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions KRAS mutation may affect LLPS but provides no supporting citations or literature references."
      },
      {
        "criterion_number": 6,
        "description": "The response explains that this is an active area of scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States LLPS is an emerging area in cancer research and references ongoing development of therapeutic approaches."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that there are no FDA-approved treatments that target liquid-liquid phase separation at this time.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state the current lack of FDA-approved LLPS-targeting therapies."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends that the patient consider inquiring about liquid-liquid phase separation in pancreatic cancer with their oncology team and ask about local clinical trial availability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Offers to explain more but does not advise discussing LLPS with the oncology team or asking about clinical trials."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references are provided."
      }
    ],
    "question_number": 231,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:24:17.978145",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what liquid-liquid phase separation is in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines LLPS as separation into droplet-like compartments akin to oil and water and explains that these condensates organize cellular activities without membranes, in clear lay language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how liquid-liquid phase separation relates to cancer cell biology.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Connects LLPS to cancer biology via tumor suppressors (p53), oncogenes, and DNA repair, and notes that abnormal phase separation can promote uncontrolled growth and impaired repair."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the role of liquid-liquid phase separation in normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that LLPS creates biomolecular condensates that organize cellular processes and facilitate DNA repair in normal physiology."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of liquid-liquid phase separation in pancreatic cancer and specific ways it can be affected.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions pancreatic cancer only in a general way without specific PDAC mechanisms or examples of how LLPS is altered in this disease."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the link between common mutations seen in pancreatic cancer and dysregulated liquid-liquid phase separation, including references to the scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not link LLPS to common PDAC mutations (e.g., KRAS, TP53, CDKN2A, SMAD4) and provides no literature citations."
      },
      {
        "criterion_number": 6,
        "description": "The response explains that this is an active area of scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that this is still active research."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that there are no FDA-approved treatments that target liquid-liquid phase separation at this time.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that there are currently no FDA-approved therapies targeting LLPS."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends that the patient consider inquiring about liquid-liquid phase separation in pancreatic cancer with their oncology team and ask about local clinical trial availability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages discussing treatment with the medical team but does not specifically suggest asking about LLPS or clinical trials."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No references or citations are provided."
      }
    ],
    "question_number": 231,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:24:38.285815",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response refers to a dense, fibrous tumor environment but does not explicitly mention tissue stiffness."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links desmoplasia and dense tissue to reduced drug penetration and treatment resistance, clearly tying mechanics to effectiveness."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions compressed blood vessels and reduced blood flow, it does not mention hypoxia."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to published scientific articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines mechanical properties of tissues, including at least two of the following: interstitial fluid pressure, solid stress, or fibrotic structure.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions \"high internal pressure\" and fibrous tissue but does not define interstitial fluid pressure, solid stress, or fibrotic structure explicitly, nor provide definitions."
      },
      {
        "criterion_number": 6,
        "description": "The response describes compression of surrounding tissue by the tumor, specifically mentioning blood vessels or lymphatics.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states that high internal pressure can compress blood vessels, reducing blood flow."
      },
      {
        "criterion_number": 7,
        "description": "The response defines desmoplastic stroma and describes its role in pancreatic cancer, including its composition.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Desmoplasia is mentioned but not defined, and the composition of the desmoplastic stroma is not described."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer remodels the extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of ECM remodeling or how it promotes a pro-tumor microenvironment."
      },
      {
        "criterion_number": 9,
        "description": "The response states that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not state that this is an active or ongoing area of research."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly prompts asking the medical team about clinical trials addressing drug delivery barriers."
      }
    ],
    "question_number": 232,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:25:15.205484",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states the tumor environment is 'stiff' and that this blocks drug penetration."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects dense fibrous tissue, high internal pressure, and poor blood flow to reduced drug penetration, lower intratumoral drug concentration, and treatment difficulty."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions poor blood flow and vessel compression but does not mention hypoxia."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to published scientific articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines mechanical properties of tissues, including at least two of the following: interstitial fluid pressure, solid stress, or fibrotic structure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies a fibrotic structure ('dense, fibrous tissue/desmoplasia') and high internal pressure, meeting two required properties."
      },
      {
        "criterion_number": 6,
        "description": "The response describes compression of surrounding tissue by the tumor, specifically mentioning blood vessels or lymphatics.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically states that high internal pressure compresses blood vessels."
      },
      {
        "criterion_number": 7,
        "description": "The response defines desmoplastic stroma and describes its role in pancreatic cancer, including its composition.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions desmoplasia as dense fibrous tissue and its barrier role but does not describe composition (e.g., collagen, hyaluronan, CAFs)."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer remodels the extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss ECM remodeling or how it creates a pro-tumor microenvironment."
      },
      {
        "criterion_number": 9,
        "description": "The response states that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that mechanical disruption and pressure-enhanced delivery are being researched and under investigation."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials with their oncology team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages discussion with the oncology team but does not specifically mention experimental treatments or clinical trials."
      }
    ],
    "question_number": 232,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:25:52.419129",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends having a plan for emergencies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly recommend creating an emergency plan (e.g., when to call 911, who to contact, medication/allergy list, advance directives, emergency contacts)."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker or patient care navigator.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions a care manager/patient advocate, it does not recommend speaking with a hospital/clinic social worker or patient navigator."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends utilizing telemedicine when available and appropriate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises participating in doctor appointments via phone/video, which is a clear telemedicine recommendation."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends engaging family and friends for assistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It suggests setting up a group chat/app for family and care team updates and designating a local point person, directly engaging family/friends."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s healthcare team may have resources to help patients at home and lighten caregivers\u2019 load.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it suggests connecting with hospice/palliative care, it does not explicitly state that the patient\u2019s healthcare team may have at-home support resources to reduce caregiver burden."
      },
      {
        "criterion_number": 6,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No data or citations regarding caregiver burnout are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions self-care but does not list specific signs/symptoms of caregiver burnout (e.g., sleep disturbance, irritability, exhaustion)."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions assisted living, home health aides, and respite homes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references respite care options but does not mention assisted living or home health aides, nor respite homes specifically."
      },
      {
        "criterion_number": 9,
        "description": "The response offers resources for cancer patients and their caregivers and provides contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It mentions PanCAN but does not provide contact information or website links for any resources."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of regular and comprehensive communication with the patient to ensure they feel well supported.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes regular video calls, shared updates, and coordinated communication, underscoring ongoing supportive communication."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend shared apps or other technological tools to share information between the patient and distant caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends a shared digital calendar, group chat/app, patient portal access, shared documents, and remote monitoring devices."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend ways that caregivers can provide support from afar.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It offers multiple remote-support strategies: coordinating meals/groceries, arranging transportation, joining appointments remotely, monitoring, organizing schedules, and maintaining shared records."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient look into their insurance to understand if they have a benefit for paid caregiving.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no recommendation to review insurance benefits for paid caregiving or home care coverage."
      },
      {
        "criterion_number": 14,
        "description": "The response should provide online resources for patients with pancreatic cancer to learn more about local caregiving opportunities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests contacting PanCAN for resources, which is an online resource that can guide users to local caregiving options, even though a link is not provided."
      }
    ],
    "question_number": 233,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:26:39.780675",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends having a plan for emergencies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises preparing emergency contact lists for local friends/family, which constitutes emergency planning."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker or patient care navigator.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of a social worker, oncology social worker, or patient care navigator."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends utilizing telemedicine when available and appropriate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends attending important appointments via video call when possible, which aligns with telemedicine use."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends engaging family and friends for assistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises connecting with neighbors, friends, and family nearby to check in regularly and creating a communication plan with local helpers."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s healthcare team may have resources to help patients at home and lighten caregivers\u2019 load.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it suggests adding the caregiver as an authorized contact and obtaining records, it does not state that the healthcare team can provide home-support resources or referrals."
      },
      {
        "criterion_number": 6,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No data or citations regarding caregiver burnout are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No signs or symptoms of caregiver burnout are listed."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions assisted living, home health aides, and respite homes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Respite care is mentioned, but there is no mention of assisted living or home health aides."
      },
      {
        "criterion_number": 9,
        "description": "The response offers resources for cancer patients and their caregivers and provides contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Area Agency on Aging is referenced but without any contact information or website; no other specific resources are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of regular and comprehensive communication with the patient to ensure they feel well supported.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends scheduled regular check-ins, consistent communication times, and a communication plan, emphasizing ongoing support."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend shared apps or other technological tools to share information between the patient and distant caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests medication reminder apps, smart devices, shared calendars, and a shared medical information document."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend ways that caregivers can provide support from afar.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Multiple actionable strategies are offered for remote support, including coordinating services, virtual appointment attendance, technology use, and arranging deliveries."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient look into their insurance to understand if they have a benefit for paid caregiving.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of reviewing insurance benefits for paid caregiving or related coverage."
      },
      {
        "criterion_number": 14,
        "description": "The response should provide online resources for patients with pancreatic cancer to learn more about local caregiving opportunities.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No pancreatic cancer\u2013specific online resources or links are provided."
      }
    ],
    "question_number": 233,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:27:18.032714",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cell competition for oxygen and nutrients within a tumor in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response clearly states that cancer cells compete for nutrients, oxygen, and growth factors and explains in simple language that more aggressive cells outcompete others."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses how cell competition may lead to clonal evolution of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes selective pressures where aggressive cells outcompete others and notes that treatment can eliminate sensitive cells, leaving resistant ones to proliferate\u2014both conveying clonal evolution."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses how clonal evolution in cancer can lead to drug resistance and progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly mentions treatment eliminating sensitive cells and resistant cells proliferating, which describes drug resistance and implied disease progression."
      },
      {
        "criterion_number": 4,
        "description": "The response describes cancer cell competition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The answer directly defines cancer cell competition within a tumor for resources and space and provides examples."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the origin of cancer, from a single mutated cell that proliferates over time.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not address cancer\u2019s origin from a single mutated cell or its stepwise proliferation."
      },
      {
        "criterion_number": 6,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells oppose each other, and how.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes competition for limited resources where more aggressive clones outcompete others, demonstrating opposing interests among subpopulations."
      },
      {
        "criterion_number": 7,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells are aligned and their effect benefits all of the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly describes cooperation, with some cells creating favorable conditions that help other cancer cells grow."
      },
      {
        "criterion_number": 8,
        "description": "The response explains ways pancreatic cancer cells differ and how they compete with each other.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions relevance to pancreatic cancer, it remains generic and does not provide pancreas-specific differences or competition mechanisms among pancreatic cancer subclones."
      }
    ],
    "question_number": 234,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:27:33.724188",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cell competition for oxygen and nutrients within a tumor in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions competition for nutrients and space but does not explain competition for oxygen specifically or describe resource/oxygen gradients within a tumor in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses how cell competition may lead to clonal evolution of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly describes subpopulations arising from mutations and states this creates 'clonal evolution' where the most successful cancer cells dominate."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses how clonal evolution in cancer can lead to drug resistance and progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It connects competition/clonal evolution to treatment resistance and recurrence after initial therapy, aligning with disease progression concepts."
      },
      {
        "criterion_number": 4,
        "description": "The response describes cancer cell competition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly describes that cancer cells compete within the tumor and against normal cells for resources and space, meeting the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the origin of cancer, from a single mutated cell that proliferates over time.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions accumulating mutations and subpopulations, it does not state that cancer originates from a single mutated cell expanding over time."
      },
      {
        "criterion_number": 6,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells oppose each other, and how.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that more aggressive subclones outcompete others for nutrients and space, reflecting opposing interests among subpopulations."
      },
      {
        "criterion_number": 7,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells are aligned and their effect benefits all of the cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No cooperative or aligned inter-clonal interactions are described; the response focuses on competition and interaction with normal cells."
      },
      {
        "criterion_number": 8,
        "description": "The response explains ways pancreatic cancer cells differ and how they compete with each other.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It only mentions that the dense tissue environment creates competitive pressures; it does not specify how pancreatic cancer cell subtypes differ or compete with each other."
      }
    ],
    "question_number": 234,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:28:18.425555",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states pancreatic tumors are 'very stiff and dense.'"
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It connects stiffness/density and mechanical pressure to reduced drug penetration, activated survival pathways, and increased resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions compression of blood vessels reducing drug delivery, it does not mention blood flow explicitly nor hypoxia."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of invasion or metastasis in relation to tissue mechanics."
      },
      {
        "criterion_number": 6,
        "description": "The response includes descriptions of the mechanical properties of tissue: stiffness, elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions stiffness, density, and compression, but not elasticity or viscosity; per binary grading, full criteria are not met."
      },
      {
        "criterion_number": 7,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states tumors 'compress blood vessels,' indicating compression of surrounding tissues."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Desmoplasia is described as a 'barrier of dense tissue around cancer cells' that can impede treatment, effectively defining its role."
      },
      {
        "criterion_number": 9,
        "description": "The response explains what the tumor microenvironment is.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it references the tumor microenvironment and surrounding tissue, it does not define or explain what it is."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how pancreatic cancer is able to remodel its surrounding extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ECM remodeling or mechanisms by which cancer alters the matrix."
      },
      {
        "criterion_number": 11,
        "description": "The response explains that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly states 'This is an active area of research' and mentions ongoing development of approaches."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials in their area with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It suggests asking the medical team about clinical trials and mentions trials targeting mechanical barriers."
      }
    ],
    "question_number": 235,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:29:01.297801",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions attempts to 'reduce tumor stiffness (like PEGPH20)' and discusses a dense, fibrous tumor matrix."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links desmoplasia and compression to reduced drug delivery, hypoxia-driven resistance, slower proliferation reducing chemo sensitivity, and increased efflux pumps/survival pathways."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that compressed vessels reduce blood flow, hindering drug delivery, and that low oxygen areas make cells more resistant."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published studies are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of metastasis or how mechanical properties influence cancer spread."
      },
      {
        "criterion_number": 6,
        "description": "The response includes descriptions of the mechanical properties of tissue: stiffness, elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions stiffness, density (dense tissue), and compression, but does not address elasticity or viscosity."
      },
      {
        "criterion_number": 7,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes that desmoplasia 'physically compresses blood vessels' and references a 'compressed environment.'"
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines desmoplasia as 'dense, fibrous tissue' and explains its role in compressing vessels and limiting drug delivery."
      },
      {
        "criterion_number": 9,
        "description": "The response explains what the tumor microenvironment is.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under 'The tumor microenvironment,' describes components/effects such as fibrous stroma, vessel compression, reduced perfusion, and hypoxia."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how pancreatic cancer is able to remodel its surrounding extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that pancreatic tumors 'create dense, fibrous tissue (desmoplasia)' which promotes a hostile-to-therapy environment by compressing vessels and fostering resistance."
      },
      {
        "criterion_number": 11,
        "description": "The response explains that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "References 'newer approaches' (e.g., PEGPH20) with mixed results and suggests considering clinical trials, indicating ongoing research activity."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials in their area with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly includes 'What clinical trials might address these resistance mechanisms?' as a question for the oncology team."
      }
    ],
    "question_number": 235,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:29:42.496452",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains proteostasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines proteostasis as the cell\u2019s quality control for making, folding, and disposing of proteins, using accessible language and a helpful analogy."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how proteostasis may be altered in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that cancer cells experience increased protein stress (rapid growth, hypoxia/acidic environment, mutations) and thus become unusually dependent on proteostasis machinery compared to normal cells."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of cancer treatments that target proteostasis in cancer cells and explains their mechanism of action in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Gives three relevant categories\u2014proteasome inhibitors (blocking disposal), heat shock protein inhibitors (blocking refolding), and ER stress inducers (overwhelming folding capacity)\u2014with simple mechanism explanations."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises the reader to speak with the father's medical team about which proteostasis-related treatments might be appropriate, which reasonably encompasses discussing with the oncologist."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the role of proteostasis in normal cells, including protein synthesis, protein folding, protein trafficking, and protein degradation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions synthesis, folding, and disposal (degradation) but does not address protein trafficking; therefore it does not cover all listed components."
      },
      {
        "criterion_number": 6,
        "description": "The response explains different steps and phases of proteostasis, which could be potential targets for cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies multiple proteostasis steps as therapeutic targets\u2014refolding (chaperones), degradation (proteasome), and ER stress/UPR\u2014sufficiently covering distinct phases relevant to targeting."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions whether there are any FDA-approved therapies for pancreatic cancer that target proteostasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state whether any FDA-approved proteostasis-targeting therapies exist specifically for pancreatic cancer."
      }
    ],
    "question_number": 236,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:30:06.157646",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains proteostasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines proteostasis as the cell\u2019s system for making, folding, and disposing of proteins, using accessible language and examples."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how proteostasis may be altered in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that cancer cells produce abnormal proteins and become dependent on heightened quality-control systems, creating both vulnerability and survival advantage."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of cancer treatments that target proteostasis in cancer cells and explains their mechanism of action in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions proteasome inhibitors (e.g., bortezomib) and heat shock protein inhibitors, describing mechanisms in simple terms (blocking disposal leading to toxic buildup; disrupting folding assistance)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises discussing with the oncology team, including suitability, clinical trials, and integration into the treatment plan."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the role of proteostasis in normal cells, including protein synthesis, protein folding, protein trafficking, and protein degradation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Covers synthesis, folding, and degradation but does not address protein trafficking, which is explicitly required."
      },
      {
        "criterion_number": 6,
        "description": "The response explains different steps and phases of proteostasis, which could be potential targets for cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies distinct steps (protein folding via chaperones and protein degradation via proteasome) and links them to therapeutic targets, satisfying the requirement to explain different targetable steps."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions whether there are any FDA-approved therapies for pancreatic cancer that target proteostasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state whether FDA-approved proteostasis-targeting therapies exist for pancreatic cancer; only mentions that such drugs are under study in clinical trials."
      }
    ],
    "question_number": 236,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:30:27.055499",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises engaging doctors: 'Ask doctors to prioritize decisions' and 'Request written summaries of options,' clearly directing the user to involve the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a Palliative Care team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically states: 'A palliative care team can help clarify goals and values,' directly recommending palliative care involvement."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups and online resources for cancer patients and their families.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions support groups but does not mention online resources; the rubric requires both."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends breaking up decisions into smaller portions and creating pros and cons lists to organize thoughts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends 'Focus on one decision at a time' (breaking up) and refers to 'written summaries of options with clear pros/cons,' which serves the function of organizing via pros/cons."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing goals of care with the patient to help with decision making.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages clarifying goals and values via palliative care and centers 'quality of life and preferences,' effectively prompting goals-of-care discussion."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a patient care navigator or social worker.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly includes: 'Social workers can assist with logistics and resources.'"
      },
      {
        "criterion_number": 7,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No data or citations regarding caregiver burnout are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list symptoms (e.g., exhaustion, sleep issues, irritability, withdrawal)."
      },
      {
        "criterion_number": 9,
        "description": "The response should attempt to normalize treatment decision fatigue for patients undergoing cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly normalizes: 'Treatment decision fatigue is incredibly common with pancreatic cancer.'"
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining mental health while undergoing cancer treatments, for both the patient and their loved ones.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While supportive and suggesting breaks/structure, it does not explicitly emphasize mental health for patient and caregivers."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients lean on their support network for assistance in making medical decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages leveraging support network: 'Designate a point person,' 'Rotate family members,' and 'bring a friend who can take notes.'"
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that the patient request more frequent appointments with their oncology team for ongoing conversations and to answer questions that arise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not suggest scheduling more frequent appointments with the oncology team; only suggests scheduling times to discuss options generally."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that documentation of thoughts can be helpful to reflect upon when it comes time to make a medical decision.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests requesting written summaries and having a friend take notes, but does not explicitly recommend documenting the patient/family\u2019s own thoughts for reflection."
      }
    ],
    "question_number": 237,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:30:56.125918",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises engaging the medical team and doctor (e.g., ask your medical team to prioritize decisions, request written summaries, ask your doctor what they would recommend)."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a Palliative Care team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of palliative care or palliative care specialists."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups and online resources for cancer patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends pancreatic cancer support groups and cites PanCAN, an organization with robust online resources."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends breaking up decisions into smaller portions and creating pros and cons lists to organize thoughts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises focusing on one decision at a time and creating a simple pros/cons list."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing goals of care with the patient to help with decision making.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit mention of discussing goals of care, patient values, or what matters most to the patient."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a patient care navigator or social worker.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It specifically suggests consulting with a patient navigator or social worker at the treatment center."
      },
      {
        "criterion_number": 7,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No data or citations from published literature are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not list any specific signs or symptoms of caregiver burnout."
      },
      {
        "criterion_number": 9,
        "description": "The response should attempt to normalize treatment decision fatigue for patients undergoing cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly normalizes decision fatigue as common and understandable."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining mental health while undergoing cancer treatments, for both the patient and their loved ones.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests counseling and breaks, it does not explicitly emphasize mental health for both the patient and loved ones; the focus is largely on the caregiver."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients lean on their support network for assistance in making medical decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises bringing a trusted friend/family member to appointments and delegating research tasks to family or friends."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that the patient request more frequent appointments with their oncology team for ongoing conversations and to answer questions that arise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation is made about scheduling more frequent appointments."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that documentation of thoughts can be helpful to reflect upon when it comes time to make a medical decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends creating a simple pros/cons list, which is a form of documenting thoughts for later reflection."
      }
    ],
    "question_number": 237,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:31:26.932155",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines metastasis and breaks it into simple, understandable steps (local invasion, entering circulation, travel/survival, exit/colonization) using non-technical language."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides direct invasion (local invasion) and spread via blood and lymphatic vessels as examples."
      },
      {
        "criterion_number": 3,
        "description": "The response describes lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions entry into lymph vessels (lymphatic spread)."
      },
      {
        "criterion_number": 4,
        "description": "The response describes hematologic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions entry into blood vessels (hematogenous spread)."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of epithelial-to-mesenchymal transition (EMT)."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not discuss specific modalities (e.g., surgery vs. systemic therapy) or their role/limitations in metastatic disease."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages consultation with the oncology team for individualized information."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions enzymes breaking down barriers, immune evasion and survival in circulation, extravasation, and adaptation/colonization at distant sites."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not connect metastasis to cellular stress responses."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of imaging modalities such as CT, MRI, or PET/CT."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe perineural invasion and describe how cancer can spread this way.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Perineural invasion is not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe how cancer cells lodge in tissues distant from their original site.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes extravasation (\u201cexit\u201d) and colonization/adaptation at distant sites, which corresponds to lodging and growth."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe that pancreatic cancer is often diagnosed at advanced stages, when it has already spread outside of the original site.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that pancreatic cancer is frequently diagnosed at advanced stages."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain the most common sites that cancer cells spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists liver (most common), lungs, peritoneum, and bones."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe patterns of spread in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides a list of metastatic sites but does not describe characteristic patterns for pancreatic cancer (e.g., portal venous spread to liver, peritoneal seeding, regional lymph nodes, perineural spread)."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe characteristics of cancers that have higher predilection for spreading.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss tumor characteristics (e.g., grade, molecular features, EMT, angiogenesis) associated with higher metastatic potential."
      }
    ],
    "question_number": 238,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:32:00.933444",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly outlines metastasis in simple steps (local invasion, circulation, colonization) using accessible language and analogies (e.g., 'highways')."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that cancer cells break away, penetrate nearby tissues and blood vessel walls, and spread\u2014explicitly covering direct invasion and entry into vessels."
      },
      {
        "criterion_number": 3,
        "description": "The response describes lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions cancer cells entering the lymphatic system and traveling through it."
      },
      {
        "criterion_number": 4,
        "description": "The response describes hematologic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions cancer cells entering the bloodstream and traveling through the body."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of epithelial-to-mesenchymal transition (EMT) or equivalent concepts."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Discusses that understanding spread helps choose treatments but does not specify how modalities (e.g., surgery vs systemic therapy) change or are limited in metastatic disease."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises consulting the oncology team for case-specific information."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that cancer cells use enzymes to dissolve barriers, penetrate vessel walls, exit circulation, and adapt to new tissue environments\u2014covering mechanistic aspects at a high level."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of stress-related triggers for metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No reference to imaging modalities (CT, MRI, PET/CT) for detecting metastases."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe perineural invasion and describe how cancer can spread this way.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Perineural invasion is not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe how cancer cells lodge in tissues distant from their original site.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that surviving cells exit circulation at distant sites and establish new tumors, describing extravasation and colonization (i.e., lodging)."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe that pancreatic cancer is often diagnosed at advanced stages, when it has already spread outside of the original site.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention the typical late-stage diagnosis of pancreatic cancer."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain the most common sites that cancer cells spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists common metastatic sites (liver most common, lungs, peritoneum, bones, nearby organs)."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe patterns of spread in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides sites but not specific patterns/mechanisms of spread in pancreatic cancer (e.g., portal venous spread to liver, peritoneal seeding, nodal/perineural pathways)."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe characteristics of cancers that have higher predilection for spreading.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of tumor characteristics associated with higher metastatic potential (e.g., grade, EMT features, vascular invasion)."
      }
    ],
    "question_number": 238,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:32:26.930496",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines cancer stem cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that cancer stem cells are a small population within tumors that self-renew, resist treatment, and regenerate tumors\u2014an accurate functional definition."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the role of cancer stem cells in cancer biology using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains in plain language that CSCs resist conventional treatments and can regenerate tumors, making cancer hard to treat."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the role cancer stem cells may play in cancer recurrence.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly connects CSCs to recurrence, noting they can remain after treatment and lead to tumor regrowth months or years later."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly references tissue stiffness and a stiff, dense tumor environment."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss metastasis or how tissue properties influence cancer spread."
      },
      {
        "criterion_number": 6,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links stiffness to barriers to drug delivery, activation of survival signals, and reduced treatment vulnerability."
      },
      {
        "criterion_number": 7,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to scientific literature are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response defines tumor microenvironment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it mentions the tumor environment, it does not define the tumor microenvironment or describe its components."
      },
      {
        "criterion_number": 9,
        "description": "The response describes mechanical cues as they pertain to solid tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies mechanical cues (tissue stiffness, pressure, physical forces) and applies them to pancreatic tumors."
      },
      {
        "criterion_number": 10,
        "description": "The response delineates between other types of environmental inputs that cells experience and mechanical forces, such as chemical or hormonal cues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not contrast mechanical cues with chemical, hormonal, or other environmental signals."
      },
      {
        "criterion_number": 11,
        "description": "The response describes that pancreatic cancer promotes desmoplasia in its microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that pancreatic tumors are stiff and dense due to excessive scar-like tissue (desmoplasia), indicating desmoplastic remodeling."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how mechanical forces in the tumor microenvironment influence the behavior of cancer stem cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains that stiffness activates survival signaling, maintains stem-like properties, and promotes dormancy in CSCs."
      },
      {
        "criterion_number": 13,
        "description": "The response links scientific literature with PMID on the subject, if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs or literature references are included."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how mechanical forces in the tumor microenvironment affect disease recurrence and metastatic potential.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it addresses recurrence, it does not mention metastatic potential or how mechanics influence spread."
      },
      {
        "criterion_number": 15,
        "description": "The response mentions how mechanical cues affect tumor cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that stiffness can promote a dormant state that reduces treatment vulnerability."
      },
      {
        "criterion_number": 16,
        "description": "The response mentions that the desmoplastic tumor microenvironment in pancreatic cancer is actively being researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes researchers are exploring strategies to soften the tumor environment and target mechanical signaling, implying active research in the desmoplastic TME of pancreatic cancer."
      }
    ],
    "question_number": 239,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:32:48.676880",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines cancer stem cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It discusses properties (treatment resistance, tumor-initiating ability) but never explicitly defines cancer stem cells as a distinct subpopulation with self-renewal and tumor-initiating capacity."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the role of cancer stem cells in cancer biology using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains in accessible language that these cells resist treatment, can remain dormant, and can form new tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the role cancer stem cells may play in cancer recurrence.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states CSCs \"may be responsible for cancer recurrence months or years later.\""
      },
      {
        "criterion_number": 4,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions \"Stiffer tissue (common in pancreatic cancer due to dense fibrous tissue)\" and its effects."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not link stiffness or other mechanical properties to metastasis or spread; focuses on recurrence and treatment resistance."
      },
      {
        "criterion_number": 6,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States stiffness can promote resistance and that a rigid environment protects CSCs and hinders drug delivery."
      },
      {
        "criterion_number": 7,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response defines tumor microenvironment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions the \"tumor environment\" but does not define the tumor microenvironment as the surrounding cells, matrix, and signals."
      },
      {
        "criterion_number": 9,
        "description": "The response describes mechanical cues as they pertain to solid tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses tissue stiffness, dense fibrous tissue, and mechanical forces activating cellular pathways in pancreatic (solid) tumors."
      },
      {
        "criterion_number": 10,
        "description": "The response delineates between other types of environmental inputs that cells experience and mechanical forces, such as chemical or hormonal cues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not distinguish mechanical cues from chemical, hormonal, or other signals."
      },
      {
        "criterion_number": 11,
        "description": "The response describes that pancreatic cancer promotes desmoplasia in its microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References \"dense, fibrous tissue\" but does not state that pancreatic cancer promotes a desmoplastic reaction or use the term desmoplasia."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how mechanical forces in the tumor microenvironment influence the behavior of cancer stem cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that mechanical forces activate pathways aiding CSC survival and dormancy, linking mechanics to CSC behavior."
      },
      {
        "criterion_number": 13,
        "description": "The response links scientific literature with PMID on the subject, if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs or literature citations are included."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how mechanical forces in the tumor microenvironment affect disease recurrence and metastatic potential.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Connects mechanical cues to recurrence via CSCs but does not address metastatic potential."
      },
      {
        "criterion_number": 15,
        "description": "The response mentions how mechanical cues affect tumor cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that mechanical forces activate pathways and that cells can remain dormant."
      },
      {
        "criterion_number": 16,
        "description": "The response mentions that the desmoplastic tumor microenvironment in pancreatic cancer is actively being researched.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Notes research into softening the tumor environment and targeting CSCs, but does not specifically mention the desmoplastic microenvironment in pancreatic cancer."
      }
    ],
    "question_number": 239,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:33:12.852187",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit recommendation to speak with the oncology/healthcare team or doctors."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends connecting with a counselor who specializes in cancer/grief."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly advises joining a support group for families facing pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages sharing feelings with trusted friends/family, accepting help, and joining support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of stress relief strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides practical strategies such as journaling, focusing on the present, taking breaks, and creating meaningful moments."
      },
      {
        "criterion_number": 6,
        "description": "The response offers examples of organizations that offer support for cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions PanCAN but does not provide contact information or a website."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends prioritizing self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly frames self-care as essential and gives examples (sleep, nutrition, taking breaks)."
      },
      {
        "criterion_number": 8,
        "description": "The response should normalize the range of emotions felt after a loved one receives a serious cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is normal to struggle and explicitly validates emotions like fear, anger, and sadness."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of maintaining mental health during times of strife.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends counseling, support groups, journaling, and open communication, underscoring mental health maintenance."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining healthy lifestyle habits to support wellbeing during times of stress, such as a cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises maintaining routines for eating and sleeping."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend organization of thoughts and questions to discuss with the oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not suggest preparing questions or organizing thoughts for discussion with the oncology team."
      },
      {
        "criterion_number": 12,
        "description": "The response should emphasize the importance of understanding the diagnosis to the patient and suggest ways to educate themselves.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No guidance on learning about the diagnosis or educational resources."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention the importance of getting one\u2019s affairs in order upon receiving a cancer diagnosis, as this can provide some peace of mind about the future.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address advance care planning or getting affairs in order."
      },
      {
        "criterion_number": 14,
        "description": "The response should emphasize the importance of avoiding isolation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages engagement with counselors, support groups, friends, and family, which discourages isolation."
      }
    ],
    "question_number": 240,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:33:31.506614",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: \"Ask the medical team what to realistically expect at each stage,\" which encourages engagement with the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends counseling: \"Consider counseling, either individually or as a family - many cancer centers offer specialized support,\" which meets the criterion for counselor referral."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions support groups twice: \"Build a support network of friends, family, or support groups\" and \"Consider joining a caregiver support group,\" which qualifies as recommending cancer-related support groups."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes building and using a support network and accepting help: \"Build a support network...\" and \"Accept help from others.\""
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of stress relief strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple coping/stress reduction strategies: taking one day at a time, creating meaningful experiences, finding moments of normalcy and joy, taking breaks, focusing on what can be controlled, and maintaining physical health."
      },
      {
        "criterion_number": 6,
        "description": "The response offers examples of organizations that offer support for cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations (e.g., ACS, PanCAN, CancerCare) or contact information/websites are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends prioritizing self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Contains a 'Self-care reminders' section and advises maintaining physical health, taking breaks, and accepting help."
      },
      {
        "criterion_number": 8,
        "description": "The response should normalize the range of emotions felt after a loved one receives a serious cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Normalizes emotions directly: \"Allow yourself to feel whatever emotions arise - grief, fear, anger are all normal.\""
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of maintaining mental health during times of strife.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages counseling, support groups, and emotional processing, underscoring mental health maintenance."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining healthy lifestyle habits to support wellbeing during times of stress, such as a cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises: \"Maintain your own physical health - you need strength for this journey,\" highlighting healthy habits to support wellbeing."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend organization of thoughts and questions to discuss with the oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests asking the medical team what to expect, it does not advise organizing thoughts or preparing a list of questions."
      },
      {
        "criterion_number": 12,
        "description": "The response should emphasize the importance of understanding the diagnosis to the patient and suggest ways to educate themselves.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit emphasis on understanding the diagnosis or guidance on educational resources beyond asking the team; lacks suggestions like reputable websites or printed materials."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention the importance of getting one\u2019s affairs in order upon receiving a cancer diagnosis, as this can provide some peace of mind about the future.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention advance care planning, legal/financial preparation, or getting affairs in order; only references discussing wishes and preferences broadly."
      },
      {
        "criterion_number": 14,
        "description": "The response should emphasize the importance of avoiding isolation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages building a support network, accepting help, and joining support groups, reinforcing staying connected and avoiding isolation."
      }
    ],
    "question_number": 240,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:34:14.977885",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what phase separation is using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses a clear oil-and-water analogy and explains membrane-less droplet formation in simple language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how phase separation relates to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Connects phase separation to gene regulation, stress responses, DNA repair, and oncogenic signaling in cancer cells."
      },
      {
        "criterion_number": 3,
        "description": "The response defines biomolecular condensates.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly defines biomolecular condensates as membrane-less compartments formed by clustered molecules."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how phase separation affects drug resistance in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that stress granules and phase separation help cancer cells survive harsh conditions like chemotherapy, implying treatment resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response describes how phase separation affects gene manipulation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that abnormal condensates alter which genes are turned on or off, describing manipulation of gene expression programs."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the role that phase separation plays in the tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of tumor microenvironment components (e.g., stroma, immune cells, ECM) or how condensates influence them."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect that phase separation has on cellular metabolism and survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions survival under stress but does not address cellular metabolism; binary scoring requires both aspects."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that phase separation is the topic of ongoing research at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes increasing research attention and exploration of drugs targeting condensates."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the role of phase separation in the facilitation of invasion and metastasis of cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address invasion or metastasis or how condensates may facilitate these processes."
      },
      {
        "criterion_number": 10,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references provided."
      }
    ],
    "question_number": 241,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:34:34.695720",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what phase separation is using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes phase separation as proteins and molecules clustering into droplet-like compartments (like oil in water) that organize cell activities without membranes, using accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how phase separation relates to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links altered phase separation to cancer-relevant processes (DNA repair, stress response, signaling, metabolism) and notes functional consequences for cancer cell behavior."
      },
      {
        "criterion_number": 3,
        "description": "The response defines biomolecular condensates.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While the concept of droplet-like compartments is mentioned, the term 'biomolecular condensates' is not explicitly defined or named."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how phase separation affects drug resistance in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that altered phase separation can enhance stress responses making cancer cells 'more resistant to treatments.'"
      },
      {
        "criterion_number": 5,
        "description": "The response describes how phase separation affects gene manipulation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address gene manipulation or gene editing (e.g., CRISPR efficiency, chromatin accessibility) in the context of phase separation."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the role that phase separation plays in the tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of tumor microenvironment components (stroma, immune cells, ECM) or how phase separation influences them."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect that phase separation has on cellular metabolism and survival.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that metabolism may change and that stress-response alterations can increase resistance to treatments, implying enhanced survival under stress."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that phase separation is the topic of ongoing research at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states phase separation is an 'emerging area' and 'still an active area of research.'"
      },
      {
        "criterion_number": 9,
        "description": "The response describes the role of phase separation in the facilitation of invasion and metastasis of cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention invasion, epithelial\u2013mesenchymal transition, metastasis, or related mechanisms in the context of phase separation."
      },
      {
        "criterion_number": 10,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to scientific literature are provided."
      }
    ],
    "question_number": 241,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:34:55.361571",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes surface force sensors (integrins, stretch-activated ion channels, membrane proteins) and types of forces detected in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that force-induced protein shape changes trigger signaling cascades to the nucleus, altering gene expression and cell behaviors (growth, movement)."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how these processes may be altered in pancreatic cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes tumor stiffness/fibrosis creates abnormal forces and that cancer cells exploit mechanotransduction to drive growth, spread, and treatment response changes."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published scientific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "Define mechanotransduction as the process by which cells convert mechanical stimuli into biochemical signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly defines mechanotransduction as converting mechanical forces into biochemical signals."
      },
      {
        "criterion_number": 6,
        "description": "Include the relevance of mechanotransduction in normal physiology and disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions disease relevance (pancreatic cancer) but does not discuss normal physiological roles (e.g., development, vascular tone, hearing)."
      },
      {
        "criterion_number": 7,
        "description": "Describe at least two types of mechanical forces acting on tissues, such as stretch, pressure, stiffness, compression, tension, shear stress, or hydrostatic pressure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple forces: pushing/pulling (tension), changes in tissue stiffness, fluid flow and pressure, and cell\u2013cell contact forces."
      },
      {
        "criterion_number": 8,
        "description": "Explain how mechanical forces in tumors and/or the surrounding tissues differ from normal tissue, specifically mentioning the creation of a stiff and dense extracellular matrix (ECM).",
        "score_given": 0,
        "max_points": 7,
        "justification": "States tumors become stiff/fibrotic but does not explicitly mention the dense extracellular matrix (ECM), which the criterion requires."
      },
      {
        "criterion_number": 9,
        "description": "Describe at least two ways cells detect mechanical forces, including structures like ion channels, integrins, cell surface receptors, or the cytoskeleton.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies integrins, stretch-activated ion channels, and membrane proteins changing shape\u2014covering at least two detection mechanisms."
      },
      {
        "criterion_number": 10,
        "description": "Describe how pancreatic cancer cells respond to mechanical forces in their environment, particularly focusing on stiffness or desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links stiffness in pancreatic tumors to enhanced mechanotransduction that promotes growth, spread, and treatment response changes."
      },
      {
        "criterion_number": 11,
        "description": "Define desmoplastic stroma as a key feature of pancreatic cancer characterized by excessive fibrous tissue formation around the tumor.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention or define desmoplastic stroma."
      }
    ],
    "question_number": 242,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:35:35.462831",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly describes sensing components (mechanosensitive ion channels, integrins, focal adhesions, cadherins) and their roles in simple language."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It outlines a three-step response (detection \u2192 signal conversion \u2192 cellular response) and gives understandable outcomes like changes in gene expression, protein activity, and behavior."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how these processes may be altered in pancreatic cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links mechanotransduction to pancreatic cancer by describing tumor stiffening, enhanced cell migration in response to mechanical cues, and therapy resistance in stiff environments."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No scientific articles or citations are provided."
      },
      {
        "criterion_number": 5,
        "description": "Define mechanotransduction as the process by which cells convert mechanical stimuli into biochemical signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly defines mechanotransduction as converting physical forces into biochemical signals."
      },
      {
        "criterion_number": 6,
        "description": "Include the relevance of mechanotransduction in normal physiology and disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While disease relevance (cancer progression and treatment resistance) is mentioned, there is no explicit discussion of normal physiological roles."
      },
      {
        "criterion_number": 7,
        "description": "Describe at least two types of mechanical forces acting on tissues, such as stretch, pressure, stiffness, compression, tension, shear stress, or hydrostatic pressure.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Only stiffness is referenced; no second specific force type (e.g., shear, compression, tension) is described."
      },
      {
        "criterion_number": 8,
        "description": "Explain how mechanical forces in tumors and/or the surrounding tissues differ from normal tissue, specifically mentioning the creation of a stiff and dense extracellular matrix (ECM).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states tumors create dense, rigid scar tissue, capturing the stiff, dense ECM characteristic."
      },
      {
        "criterion_number": 9,
        "description": "Describe at least two ways cells detect mechanical forces, including structures like ion channels, integrins, cell surface receptors, or the cytoskeleton.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists multiple detection mechanisms: mechanosensitive ion channels, integrins, focal adhesions, and cadherins."
      },
      {
        "criterion_number": 10,
        "description": "Describe how pancreatic cancer cells respond to mechanical forces in their environment, particularly focusing on stiffness or desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly connects pancreatic tumor stiffness to altered responses like migration and therapy resistance."
      },
      {
        "criterion_number": 11,
        "description": "Define desmoplastic stroma as a key feature of pancreatic cancer characterized by excessive fibrous tissue formation around the tumor.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although dense, rigid scar tissue is mentioned, the term 'desmoplastic stroma' is not used or defined."
      }
    ],
    "question_number": 242,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:36:18.893196",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends meeting with a Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \"Look into palliative care services for symptom management,\" which constitutes a recommendation to involve palliative care."
      },
      {
        "criterion_number": 2,
        "description": "The response explains Advanced Care Planning and how it impacts a patient\u2019s clinical course.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While medical directives are mentioned, there is no explanation of advanced care planning or how these decisions affect treatment choices, hospitalization, or interventions."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions code status.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of code status (e.g., DNR/DNI)."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions an advanced directive or living will.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly says, \"Ensure medical directives (living will, healthcare proxy) are current.\""
      },
      {
        "criterion_number": 5,
        "description": "The response mentions financial planning and recommends discussing this with a professional with experience in this.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Financial matters are noted (review/update documents and beneficiaries), but there is no recommendation to consult a financial professional, estate attorney, or planner."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a social worker or counselor.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states, \"Consider involving a social worker or counselor for support.\""
      },
      {
        "criterion_number": 7,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages connecting with pancreatic cancer support organizations and focusing on meaningful time with loved ones, underscoring the value of social support."
      },
      {
        "criterion_number": 8,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or websites.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should instruct patients to create a POLST with their healthcare provider, and post this in a visible place in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "POLST is not mentioned and no instruction about posting it visibly is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the patient elect a healthcare durable power of attorney.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises ensuring a \"healthcare proxy\" is current, which corresponds to a healthcare durable power of attorney."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ensure their financial affairs are in order.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends reviewing/updating financial documents and beneficiaries and organizing accounts/passwords, which aligns with ensuring financial affairs are in order."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient elect a financial durable power of attorney.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of a financial durable power of attorney."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient complete a will and designate beneficiaries on life insurance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions updating beneficiaries generally but does not specifically recommend completing a will or designating life insurance beneficiaries."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient consider reaching out to friends and loved ones in order to connect and spend time together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes \"Quality time\" with meaningful conversations and activities and creating new memories with loved ones."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consider how to reconcile their affairs in the financial, legal, and social realms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It addresses legal (medical directives), financial (documents/beneficiaries), and social/personal legacy projects and funeral preferences, effectively covering these realms."
      },
      {
        "criterion_number": 16,
        "description": "The response should provide online references and links to resources regarding legacy planning.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No online references or links are included."
      },
      {
        "criterion_number": 17,
        "description": "The response should suggest the patient inquire about assistance with some of these aspects of legacy planning with their oncology team, to understand if there are resources available.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no suggestion to ask the oncology team about available resources."
      }
    ],
    "question_number": 243,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:37:22.381914",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends meeting with a Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of palliative care or referral to a palliative care specialist."
      },
      {
        "criterion_number": 2,
        "description": "The response explains Advanced Care Planning and how it impacts a patient\u2019s clinical course.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While healthcare directives are listed, there is no explanation of advance care planning or its impact on treatment decisions and trajectory."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions code status.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of code status (e.g., DNR/DNI)."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions an advanced directive or living will.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly mentions 'Healthcare directives,' which qualifies as an advance directive."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions financial planning and recommends discussing this with a professional with experience in this.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends coordinating with an estate planning attorney and working with financial advisors familiar with serious illness."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a social worker or counselor.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of a social worker, counselor, or similar supportive professional."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it suggests involving family in conversations, it does not explicitly emphasize the importance of a support system during treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or websites.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations, contact information, or websites are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should instruct patients to create a POLST with their healthcare provider, and post this in a visible place in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "POLST is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the patient elect a healthcare durable power of attorney.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically lists 'Healthcare directives and power of attorney,' which encompasses a healthcare durable power of attorney."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ensure their financial affairs are in order.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a detailed 'Financial Organization' section advising organization of accounts, beneficiaries, taxes, and records."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient elect a financial durable power of attorney.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly lists 'Financial power of attorney.'"
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient complete a will and designate beneficiaries on life insurance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends will/estate planning updates and reviewing beneficiaries on insurance policies and retirement accounts."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient consider reaching out to friends and loved ones in order to connect and spend time together.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions letters and involving family in conversations, but does not explicitly recommend reaching out to spend time together."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consider how to reconcile their affairs in the financial, legal, and social realms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers legal (will, directives), financial (accounts, beneficiaries, taxes), and social/personal legacy planning, advising organization in each area."
      },
      {
        "criterion_number": 16,
        "description": "The response should provide online references and links to resources regarding legacy planning.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No links or references are provided."
      },
      {
        "criterion_number": 17,
        "description": "The response should suggest the patient inquire about assistance with some of these aspects of legacy planning with their oncology team, to understand if there are resources available.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not suggest asking the oncology team about available support or resources."
      }
    ],
    "question_number": 243,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:37:58.752077",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that cells use adhesion molecules to stick to each other and tissues, in accessible language with simple concepts (sticking, communication, stability)."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cell adhesion processes are changed in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details decreased adhesion (E-cadherin), increased motility, ECM degradation, shape change, and anoikis resistance, capturing key alterations in cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions integrins and cadherins as adhesion molecules."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Provides only general statements about pancreatic cancer (dense tissue, spreading) without specific adhesion changes or molecules in pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'surrounding matrix' and 'dense tissue' but does not describe what the extracellular matrix is or its components."
      },
      {
        "criterion_number": 7,
        "description": "The response explains epithelial-mesenchymal transition (EMT).",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or explained."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how EMT facilitates cancer cell spread.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of EMT\u2019s role in invasion, intravasation, or metastasis."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the components of cell adhesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies adhesion molecules (integrins, cadherins) and their roles in cell-cell and cell-matrix adhesion."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the components of cell detachment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Outlines key elements: loss of adhesion proteins, ECM degradation, anoikis resistance, and entry into vessels."
      },
      {
        "criterion_number": 11,
        "description": "The response includes different enzymes implicated in cell adhesion and detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only mentions MMPs; does not include additional enzyme classes (e.g., serine proteases, cathepsins, LOX)."
      },
      {
        "criterion_number": 12,
        "description": "The response describes factors in the tumor microenvironment that promote or facilitate tumor cell detachment and migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss microenvironmental factors such as stromal cells (CAFs), cytokines, hypoxia, stiffness, or inflammation."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions if there are any FDA-approved treatments that target cancer cell detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of FDA-approved therapies targeting adhesion/detachment."
      }
    ],
    "question_number": 244,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:38:25.836290",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that healthy cells use adhesion molecules to stay attached and in place, in understandable language."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cell adhesion processes are changed in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes loss of adhesion proteins (E-cadherin), enzyme-mediated tissue breakdown, increased mobility, and altered surface proteins that enable detachment and reattachment."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions E-cadherin (a cadherin) but does not mention integrins."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Notes the pancreas has a dense fibrous environment and typical spread patterns but does not detail pancreatic cancer\u2013specific adhesion changes (e.g., integrin switching, EMT patterns, desmoplastic interactions)."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to scientific literature are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not describe the extracellular matrix (ECM) or its components; only mentions a 'dense, fibrous environment' without defining ECM."
      },
      {
        "criterion_number": 7,
        "description": "The response explains epithelial-mesenchymal transition (EMT).",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or explained."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how EMT facilitates cancer cell spread.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of EMT, so no explanation of how it aids invasion or metastasis."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the components of cell adhesion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only broadly refers to 'adhesion molecules' and mentions E-cadherin; does not describe multiple adhesion components such as integrins, selectins, CAMs, or focal adhesion complexes."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the components of cell detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides general processes (loss of adhesion proteins, enzymes) but does not identify components such as specific proteases, integrin switching, or cytoskeletal changes."
      },
      {
        "criterion_number": 11,
        "description": "The response includes different enzymes implicated in cell adhesion and detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions enzymes in general but does not specify any (e.g., MMPs, uPA, cathepsins)."
      },
      {
        "criterion_number": 12,
        "description": "The response describes factors in the tumor microenvironment that promote or facilitate tumor cell detachment and migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References a dense fibrous environment but does not describe microenvironmental factors (CAF activity, stiffness, hypoxia, cytokines, hyaluronan) that promote detachment/migration."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions if there are any FDA-approved treatments that target cancer cell detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that some treatments target movement but does not specify any FDA-approved therapies or explicitly state whether such treatments exist."
      }
    ],
    "question_number": 244,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:39:04.016901",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response suggests having honest conversations with the medical team, but it does not specifically mention the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it encourages family members to process at their own pace and to set short-term goals, it does not explicitly recommend open communication between the patient and caregivers."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends palliative care early and suggests counseling to process complex emotions."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it mentions setting meaningful short-term goals, it does not explicitly address establishing the patient's goals of care regarding values and treatment preferences."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly recommends joining a pancreatic cancer support group."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations, websites, or contact information are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes emotional support, counseling, and permission to feel complex emotions, highlighting mental health importance."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that balancing hope and realism is one of the most challenging aspects for families, implying this conflict is common/expected."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions palliative care is about quality of life but does not explain QoL or describe specific treatment-related factors that impact it."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or links are provided."
      }
    ],
    "question_number": 245,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:39:35.053560",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention the oncologist or suggest discussing these concerns with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly encourages honest conversations about preferences and wishes and poses reflective questions to guide communication."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends counselors experienced with serious illness and specifically mentions palliative care teams."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises making practical plans, having honest conversations about preferences and wishes, and redefining hopes from cure to comfort\u2014core elements of goals-of-care discussions."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It directly recommends support groups and their benefits."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations or websites (e.g., PanCAN, ACS) are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes emotional well-being by encouraging counseling, support groups, and normalizing fluctuating emotions."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It validates the experience as difficult and normalizes uncertainty and mixed emotions."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions quality time and symptom management, it does not explain quality of life or detail treatment-related factors (e.g., side effects, fatigue, hospital visits) that impact it."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or links are provided."
      }
    ],
    "question_number": 245,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:39:59.701300",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what condensates are using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes condensates as tiny droplets like oil in water and as specialized work zones without membranes, using accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response defines biomolecular condensates as membrane-less organelles containing proteins, RNA, and other molecules.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It identifies condensates as membraneless organelles made of proteins and RNA but does not mention other molecules, so the definition is incomplete per the rubric."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how condensates relate to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides multiple links to cancer biology, including altered formation, transcription hubs, stress response, and DNA repair impacts in cancer cells."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how biomolecular condensates become deregulated in cancer cells, including at least one mechanism of deregulation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states that cancer-causing mutations can increase or decrease inappropriate condensate formation, satisfying mechanism of deregulation."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No scientific articles or citations are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response references at least one scientific literature source regarding biomolecular condensates, including a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No references or PMIDs are included."
      },
      {
        "criterion_number": 7,
        "description": "The response defines liquid-liquid phase separation (LLPS) as the process by which condensates form.",
        "score_given": 0,
        "max_points": 5,
        "justification": "LLPS is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the role of biomolecular condensates in normal cells, including at least one function such as gene regulation or stress response.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes condensates as work zones, it does not explicitly discuss specific functions in normal cells (e.g., gene regulation or stress response) outside the cancer context."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the protein YAP/TAZ and its role in biomolecular condensates in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "YAP/TAZ is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response lists at least two ways that biomolecular condensates encourage cancer cell growth, proliferation, or migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies multiple pro-cancer roles: overactive transcription of oncogenic programs, stress-related survival under harsh conditions including chemotherapy, and altered DNA repair influencing treatment response."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the study of biomolecular condensates and their role in cancer is an area of active scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states it is an important and relatively new area of cancer research with ongoing therapeutic exploration."
      },
      {
        "criterion_number": 12,
        "description": "The response states whether there are FDA-approved therapies that target biomolecular condensates in cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes emerging drug development but does not explicitly state whether FDA-approved therapies exist."
      }
    ],
    "question_number": 246,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:40:26.943859",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what condensates are using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (e.g., 'like droplets,' 'oil droplets in water') and plain language to explain what condensates are."
      },
      {
        "criterion_number": 2,
        "description": "The response defines biomolecular condensates as membrane-less organelles containing proteins, RNA, and other molecules.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes condensates as droplet-like compartments that form from 'proteins and genetic material' and explicitly notes they function 'without... membrane barriers,' satisfying the membrane-less and molecular content aspects."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how condensates relate to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links condensates to cancer features such as abnormal formation, survival under stress, tumor growth/spread, and treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how biomolecular condensates become deregulated in cancer cells, including at least one mechanism of deregulation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions 'abnormal formation' but provides no concrete mechanisms (e.g., oncogenic signaling, mutations, altered PTMs, concentration changes) for deregulation."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response references at least one scientific literature source regarding biomolecular condensates, including a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No literature references or PMIDs are included."
      },
      {
        "criterion_number": 7,
        "description": "The response defines liquid-liquid phase separation (LLPS) as the process by which condensates form.",
        "score_given": 0,
        "max_points": 5,
        "justification": "LLPS is not mentioned or defined."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the role of biomolecular condensates in normal cells, including at least one function such as gene regulation or stress response.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists normal functions: organizing protein production, managing stress responses, and coordinating DNA repair."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the protein YAP/TAZ and its role in biomolecular condensates in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of YAP/TAZ."
      },
      {
        "criterion_number": 10,
        "description": "The response lists at least two ways that biomolecular condensates encourage cancer cell growth, proliferation, or migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple ways: promoting tumor growth and spread, helping survival under stress/chemotherapy, and contributing to treatment resistance."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the study of biomolecular condensates and their role in cancer is an area of active scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states this is an active area of cancer research."
      },
      {
        "criterion_number": 12,
        "description": "The response states whether there are FDA-approved therapies that target biomolecular condensates in cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address the status of FDA-approved therapies targeting condensates."
      }
    ],
    "question_number": 246,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:40:49.931337",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly discusses tissue stiffness and quantifies it as up to 10x higher than normal tissue."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that stiff tissue activates pathways that make cancer cells more mobile and invasive, linking stiffness to spread."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that stiffness creates a physical barrier, reduces blood flow, and limits drug delivery, directly relating stiffness to treatment challenges."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions 'excessive fibrous tissue (called desmoplasia)' but does not define 'desmoplastic stroma' or describe its components (e.g., fibroblasts/stellate cells, ECM)."
      },
      {
        "criterion_number": 6,
        "description": "The response explains how and why pancreatic cancer promotes the formation of desmoplastic stroma around itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanistic explanation (e.g., role of pancreatic stellate cells, TGF-\u03b2, inflammatory signaling) is provided for how or why desmoplasia forms."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the process of cell adhesion in normal tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Normal cell adhesion mechanisms are not discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how increased stiffness in tumors and the tumor microenvironment influences cell adhesion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While invasiveness is mentioned, there is no description of how stiffness alters adhesion (e.g., integrins, focal adhesions, traction forces)."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the effect of tissue stiffness on angiogenesis and drug resistance.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Drug delivery and protection from therapy are discussed, but angiogenesis is not addressed."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how the development of desmoplastic stroma around pancreatic cancer tumors is a protective factor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states that the stiff, fibrous barrier protects tumor cells from chemotherapy and immune cells."
      },
      {
        "criterion_number": 11,
        "description": "The response explains whether there are FDA-approved treatments that target tissue stiffness in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions research and clinical trials to 'soften' tumors but does not address the status of FDA-approved treatments."
      },
      {
        "criterion_number": 12,
        "description": "The response defines mechanotransduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mechanotransduction is not defined or mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests that the patient discuss the role of clinical trials in their cancer care with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes active clinical trials targeting stiffness and advises discussing with the oncology team whether these approaches might be relevant."
      }
    ],
    "question_number": 247,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:41:24.327876",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly discusses tissue stiffness multiple times and frames the explanation around this concept."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that stiffness sends mechanical signals that make cancer cells more aggressive and enhance invasion of surrounding tissue."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that the dense, stiff tissue compresses blood vessels, reduces blood flow, limits chemotherapy penetration, and hinders immune cell access."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published scientific articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines desmoplastic stroma as an unusually stiff, fibrous environment around tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response explains how and why pancreatic cancer promotes the formation of desmoplastic stroma around itself.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that cancer cells trigger excessive production of collagen and other structural proteins, leading to a dense, rigid matrix."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the process of cell adhesion in normal tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no description of normal cell adhesion mechanisms."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how increased stiffness in tumors and the tumor microenvironment influences cell adhesion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions mechanical signals and aggressiveness, it does not specifically describe effects on cell adhesion."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the effect of tissue stiffness on angiogenesis and drug resistance.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It discusses vessel compression and poor drug penetration but does not mention angiogenesis or drug resistance explicitly."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how the development of desmoplastic stroma around pancreatic cancer tumors is a protective factor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states the stiff matrix can shield cancer cells from treatments and may help them resist immune responses."
      },
      {
        "criterion_number": 11,
        "description": "The response explains whether there are FDA-approved treatments that target tissue stiffness in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes investigational approaches but does not state whether any FDA-approved treatments exist."
      },
      {
        "criterion_number": 12,
        "description": "The response defines mechanotransduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mechanotransduction is not mentioned or defined."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests that the patient discuss the role of clinical trials in their cancer care with their oncology team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It recommends discussing with the medical team but does not mention clinical trials."
      }
    ],
    "question_number": 247,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:41:56.214435",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly emphasizes clear communication, such as recommending regular family meetings or using communication tools.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends shared calendars/apps, a communication chain, and regular family meetings to coordinate care and updates."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the patient\u2019s healthcare team or medical providers.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of engaging the oncology team, physicians, nurses, or other medical providers for care coordination."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests family counseling but does not reference a social worker, spiritual care/chaplaincy, or palliative care specialists."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of a strong support system, such as building a caregiver network or ensuring emotional support.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It highlights rotating caregiving tasks, emotional support roles, and regular meetings, underscoring a robust support network."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions apps (CaringBridge, Lotsa Helping Hands) but provides no cancer-specific organizations or contact information/websites."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends participating in a support group for cancer patients and their families.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No recommendation to join support groups is included."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests age-appropriate communication, it does not advise educating family members about the diagnosis or treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that one family member is designated as a communication person, and perhaps accompany the patient to their medical appointments and take notes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly recommends designating a primary point person for medical updates. Although accompaniment/note-taking is not mentioned, the designation criterion is met."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the communication person to develop a strategy to deliver information to the multi-generational family members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It proposes a communication chain, use of shared tools, and tailoring communication to comfort with technology and privacy, which are strategy elements."
      },
      {
        "criterion_number": 10,
        "description": "The response should reinforce the importance of boundaries for the pancreatic cancer patient while they undergo treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes privacy preferences generally but does not explicitly emphasize setting and honoring the patient\u2019s boundaries during treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient inquire with their oncology team if there are resources available for group support or for cultural mediation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No suggestion to ask the oncology team about group support resources or cultural mediation is included."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient or loved ones identify care needs, such as cleaning or food prep, and assign roles to family members according to their strengths.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It gives age-appropriate task assignments (transportation, groceries, chores) and suggests rotating demanding tasks, satisfying role assignment by strengths."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage the patient to focus on their own wellbeing and mental health.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit encouragement for the patient\u2019s self-care or mental health is provided."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend online resources for pancreatic cancer information as well as support services that the patient and family members can access to answer questions, etc.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not reference online pancreatic cancer information resources or support service websites."
      }
    ],
    "question_number": 248,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:42:22.330842",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly emphasizes clear communication, such as recommending regular family meetings or using communication tools.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends regular family meetings and using shared calendars, group texts, or care apps, and to establish clear communication channels."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the patient\u2019s healthcare team or medical providers.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of involving the oncology team or other medical providers in care coordination."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No reference to social work, spiritual care, or palliative care resources."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of a strong support system, such as building a caregiver network or ensuring emotional support.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It highlights emotional support roles, rotating duties, ensuring breaks, and monitoring for caregiver overwhelm, emphasizing a robust support system."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations, websites, or contact information are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends participating in a support group for cancer patients and their families.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit recommendation to educate the family about the diagnosis or treatment plan."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that one family member is designated as a communication person, and perhaps accompany the patient to their medical appointments and take notes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends designating a primary care coordinator and establishing communication channels. While it does not mention accompanying to appointments, the core recommendation to designate a point person is present."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the communication person to develop a strategy to deliver information to the multi-generational family members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides concrete strategies for information dissemination (family meetings, shared calendars, group texts, care apps) to reach all family members."
      },
      {
        "criterion_number": 10,
        "description": "The response should reinforce the importance of boundaries for the pancreatic cancer patient while they undergo treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to respect the patient's need for space and preferences for specific family members, reinforcing boundaries."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient inquire with their oncology team if there are resources available for group support or for cultural mediation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No suggestion to ask the oncology team about support groups or cultural mediation resources."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient or loved ones identify care needs, such as cleaning or food prep, and assign roles to family members according to their strengths.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends matching tasks to capabilities and lists concrete caregiving roles (transportation, household help, technology support), aligning with assigning tasks by strengths."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage the patient to focus on their own wellbeing and mental health.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Focus on caregiver burnout is included, but there is no explicit encouragement for the patient\u2019s own wellbeing or mental health."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend online resources for pancreatic cancer information as well as support services that the patient and family members can access to answer questions, etc.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or support service links are provided."
      }
    ],
    "question_number": 248,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:42:59.392108",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains epithelial-mesenchymal transition and how this affects a cell\u2019s ability to migrate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention epithelial-mesenchymal transition (EMT) or explain how epithelial cells adopt mesenchymal traits to enhance migration."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While local invasion is discussed, there is no explicit mention of lymphatic or hematogenous (blood) spread."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes protease production, loss of adhesion, cytoskeletal changes enabling movement, angiogenesis, and manipulation of the local environment\u2014core cellular mechanisms of invasion and spread."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of metastasis being triggered or promoted by cellular stress conditions."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No imaging modalities (CT, MRI, PET/CT) are mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states surgery is for local disease, chemotherapy for cells that may have spread, and radiation for local control, addressing modality roles when disease has spread."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicit recommendation to discuss specifics with the oncology team is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses plain language to explain how cancer cells move, invade, and spread, including changing shape and mimicking immune cell movement."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how a cancer cell develops, including DNA mutations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No discussion of DNA mutations or the genetic changes that drive cancer development."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe tumor suppressor genes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Tumor suppressor genes are not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe oncogenes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Oncogenes are not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe cell adhesion, and how this process can be altered in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that cancer cells break down proteins that keep cells attached to neighbors, indicating altered cell adhesion."
      },
      {
        "criterion_number": 13,
        "description": "The response should explain the phenomenon of loss of cell-cell adhesion in cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Loss of cell-cell adhesion is explicitly described via breakdown of attachment proteins."
      },
      {
        "criterion_number": 14,
        "description": "The response should define tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it references the 'local environment,' it does not define the tumor microenvironment or its components."
      },
      {
        "criterion_number": 15,
        "description": "The response should explain how cancer cells can use enzymes to change the tumor microenvironment to their advantage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Protease production that cuts through surrounding tissue/ECM is described, reflecting enzymatic remodeling of the microenvironment."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe other ways cancer cells can interact with the tumor microenvironment to promote migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions recruiting normal cells, inducing inflammation, forming new blood vessels, and altering the surrounding tissue\u2014key microenvironment interactions."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe any unique ways pancreatic cancer cells are thought to metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address pancreatic-specific features (e.g., perineural invasion, desmoplastic stroma, early liver spread via portal circulation)."
      },
      {
        "criterion_number": 18,
        "description": "The response should recommend websites that help explain different aspects of pancreatic cancer and provide resources for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No external resources or websites are recommended."
      }
    ],
    "question_number": 249,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:43:42.618745",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains epithelial-mesenchymal transition and how this affects a cell\u2019s ability to migrate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or explained; no discussion of epithelial-to-mesenchymal phenotype change."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Routes of spread (direct invasion, lymphatic, hematogenous) are not explicitly described."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides mechanisms: loss of adhesion, increased motility, ECM degradation by enzymes, angiogenesis, and immune evasion."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of metastasis being triggered by cell stress."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Imaging modalities (CT, MRI, PET/CT) are not referenced."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of treatment options or their role after metastasis."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly encourages discussion with the oncology team and mentions support resources."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Explains invasion and spread vaguely ('highways for spread') but does not clearly explain metastasis as travel to distant sites and new tumor formation in simple terms."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how a cancer cell develops, including DNA mutations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of DNA mutations or how cancer cells arise."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe tumor suppressor genes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Tumor suppressor genes are not discussed."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe oncogenes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Oncogenes are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe cell adhesion, and how this process can be altered in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes normal cell adhesion and loss of adhesive properties in cancer."
      },
      {
        "criterion_number": 13,
        "description": "The response should explain the phenomenon of loss of cell-cell adhesion in cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly states that cancer cells lose adhesive properties and break away."
      },
      {
        "criterion_number": 14,
        "description": "The response should define tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No definition of the tumor microenvironment; only ECM is mentioned without broader context."
      },
      {
        "criterion_number": 15,
        "description": "The response should explain how cancer cells can use enzymes to change the tumor microenvironment to their advantage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains enzyme-mediated ECM breakdown creating pathways for movement."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe other ways cancer cells can interact with the tumor microenvironment to promote migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes angiogenesis stimulated by cancer cells, which modifies the microenvironment and facilitates spread."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe any unique ways pancreatic cancer cells are thought to metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No pancreatic cancer\u2013specific metastatic patterns or mechanisms are described."
      },
      {
        "criterion_number": 18,
        "description": "The response should recommend websites that help explain different aspects of pancreatic cancer and provide resources for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific websites or external resources are recommended."
      }
    ],
    "question_number": 249,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:44:33.133443",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response discusses the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system and blood vessels using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It briefly mentions that lymphatics normally remove excess fluid but does not explain normal fluid movement from blood to tissue to lymph and back in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how fluids move in normal tissue to perform tasks such as nutrient and oxygen delivery, and to manage waste products.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No description of normal tissue fluid dynamics for nutrient/oxygen delivery or waste removal is provided."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses changes to fluid flow that may occur in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes leaky/abnormal vessels, dense stroma, high pressure, and poor lymphatic drainage in pancreatic tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response describes abnormalities seen in tumors with fluid management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies leaky vessels, disorganized vasculature, poor lymphatics, and high interstitial pressure affecting fluid handling."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, including reduced drug delivery or immune cell penetration into the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains high pressure hindering drug penetration, uneven drug distribution, and limited perfusion; adequately covers reduced drug delivery."
      },
      {
        "criterion_number": 6,
        "description": "The response describes how fluid flow affects cancer behavior.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that abnormal fluid environment can increase aggressiveness, promote spread, and induce hypoxia leading to treatment resistance."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While hypoxia and aggressiveness are mentioned, it does not explicitly link low flow to stimulation of growth/development mechanisms."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions how altered cellular biology and extracellular structures can impact cancer behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects extracellular changes (dense stroma, stiffness) and the abnormal fluid environment to more aggressive cancer cell behavior."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence of its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific literature are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response describes different fluids that exist in a tumor and its environment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not enumerate or describe the different fluids (e.g., blood, interstitial fluid, lymph, ascites) in the tumor environment."
      },
      {
        "criterion_number": 11,
        "description": "The response describes the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions stroma, abnormal vasculature, lymphatics, stiffness, and hypoxia\u2014core features of the tumor microenvironment."
      },
      {
        "criterion_number": 12,
        "description": "The response describes attributes of tumors and the surrounding tissue that disrupt the normal function of fluids.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies desmoplastic stiffness, leaky/disorganized vessels, limited perfusion, and poor lymphatic drainage disrupting fluid function."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages the development of this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'dense tissue (stroma)' but does not define desmoplastic stroma or explain how pancreatic cancer promotes it."
      },
      {
        "criterion_number": 14,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Refers to 'high pressure inside tumors' but does not define interstitial fluid pressure explicitly."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains outward pressure impeding drug penetration and uneven intratumoral distribution, satisfying the criterion."
      },
      {
        "criterion_number": 16,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly states this is an active area of research and lists related strategies under investigation."
      }
    ],
    "question_number": 250,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:45:05.949927",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response discusses the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system and blood vessels using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response focuses on abnormal fluid dynamics in tumors and does not describe normal physiology of fluid movement from blood to tissue to lymphatics in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how fluids move in normal tissue to perform tasks such as nutrient and oxygen delivery, and to manage waste products.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no discussion of normal tissue fluid functions like nutrient/oxygen delivery or waste removal; only tumor-related abnormalities are addressed."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses changes to fluid flow that may occur in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that pancreatic tumors create dense, fibrous tissue that compresses blood vessels leading to poor blood flow, abnormal drainage, and high internal pressure\u2014all changes to fluid flow in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response describes abnormalities seen in tumors with fluid management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Abnormalities such as compressed blood vessels, abnormal fluid drainage, and high internal (interstitial) pressure are described."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, including reduced drug delivery or immune cell penetration into the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that compressed vessels and high pressure limit chemotherapy delivery and penetration, making standard chemotherapy less effective. While immune cell penetration is not mentioned, reduced drug delivery is clearly addressed."
      },
      {
        "criterion_number": 6,
        "description": "The response describes how fluid flow affects cancer behavior.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It focuses on treatment delivery challenges rather than how fluid dynamics influence tumor behavior such as growth, invasion, metastasis, or hypoxia-driven changes."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no discussion of low perfusion/hypoxia promoting growth, angiogenesis, or aggressive phenotypes."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions how altered cellular biology and extracellular structures can impact cancer behavior.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although desmoplasia is mentioned, its impact is framed in terms of drug delivery barriers; effects on cancer cell behavior are not discussed."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence of its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response describes different fluids that exist in a tumor and its environment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not enumerate or describe different fluid compartments (e.g., blood, interstitial fluid, lymph) present in tumors and their environment."
      },
      {
        "criterion_number": 11,
        "description": "The response describes the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes key features of the tumor microenvironment, including desmoplastic stroma, compressed vasculature, and references to targeting surrounding tissue and vascular normalization."
      },
      {
        "criterion_number": 12,
        "description": "The response describes attributes of tumors and the surrounding tissue that disrupt the normal function of fluids.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Attributes like dense fibrous stroma, vessel compression, abnormal drainage, and high pressure are clearly stated as disrupting normal fluid function."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages the development of this.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines desmoplasia as dense, fibrous tissue and states that pancreatic tumors create this tissue, indicating pancreatic cancer fosters desmoplastic stroma."
      },
      {
        "criterion_number": 14,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While 'high internal pressure' is mentioned, there is no definition of interstitial fluid pressure or clarification of what it means."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that high internal pressure prevents drugs from penetrating deeply into the tumor, which addresses how elevated pressure impairs delivery and implies uneven intratumoral distribution."
      },
      {
        "criterion_number": 16,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states, 'This research is leading to better treatment strategies,' indicating the topic is an ongoing area of study."
      }
    ],
    "question_number": 250,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:46:03.546207",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not mention the oncologist or recommend discussing dignity-preserving approaches with them."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with a Palliative Care specialist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it suggests exploring palliative care early for symptom management, it does not explicitly recommend discussing dignity-preserving approaches with a palliative care specialist."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions Advance Care Planning and includes either Advance Directives or Living Wills.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advance Care Planning, Advance Directives, or Living Wills are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care, including understanding and documenting the patient\u2019s preferences and involving them in decision-making.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It encourages including him in decisions, but does not mention establishing goals of care or documenting preferences."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize feelings of loss of control for cancer patients at the time of diagnosis and/or during cancer treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response is empathetic but does not explicitly normalize feelings of loss of control."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe components of personal dignity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details components such as privacy, control over personal space, autonomy in decisions, maintaining roles and identity, respectful communication, and managing personal care preferences."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient, family, and friends of the patient, and oncology care team to respect the patient\u2019s bodily autonomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It encourages inclusion in decisions, respecting preferences for personal care, and ensuring healthcare providers address him respectfully, which supports respecting bodily autonomy across caregivers and providers."
      },
      {
        "criterion_number": 10,
        "description": "The response should encourage the patient to prioritize management of side effects and symptoms of cancer or cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends exploring palliative care early for symptom management, which encourages prioritizing symptom control."
      },
      {
        "criterion_number": 11,
        "description": "The response should encourage the patient to communicate any side effects or symptoms of cancer or cancer treatment to their oncology care team to ensure they are being offered management solutions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit recommendation to report side effects or symptoms to the oncology care team."
      },
      {
        "criterion_number": 12,
        "description": "The response should encourage the patient and family to have open and ongoing communication about the patient\u2019s wishes for medical care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not explicitly encourage ongoing communication between the patient and family about medical care wishes."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient and loved ones promote independence and normalcy in the patient\u2019s life as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends creating routines that preserve normalcy and suggests adaptive clothing to support independence, as well as maintaining roles and identity."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage the patient to always remember that anything that happens to their body with regard to cancer treatment is their choice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it emphasizes autonomy in decisions, it does not explicitly state that any treatment that happens to his body is his choice."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient disclose any feelings of overwhelm or loss of autonomy with their oncology team and inquire about resources for support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not advise sharing feelings of overwhelm or loss of autonomy with the oncology team or asking for resources."
      },
      {
        "criterion_number": 16,
        "description": "The response should emphasize the importance of prevention of caregiver burnout.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Caregiver burnout prevention is not addressed."
      }
    ],
    "question_number": 251,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:46:41.393895",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not mention the oncologist or recommend discussing dignity-preserving approaches with them."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with a Palliative Care specialist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it suggests considering hospice/palliative care specialists, it does not explicitly recommend discussing dignity-preserving approaches with them."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions Advance Care Planning and includes either Advance Directives or Living Wills.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of Advance Care Planning, Advance Directives, or Living Wills."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care, including understanding and documenting the patient\u2019s preferences and involving them in decision-making.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It emphasizes involving the patient in decisions and honoring preferences, but does not mention establishing goals of care or documenting preferences."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No support groups are mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize feelings of loss of control for cancer patients at the time of diagnosis and/or during cancer treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response is empathetic but does not explicitly normalize feelings of loss of control."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe components of personal dignity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It addresses autonomy, privacy, grooming, personal environment, identity, meaningful relationships, independence, and respect for preferences\u2014clear components of personal dignity."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient, family, and friends of the patient, and oncology care team to respect the patient\u2019s bodily autonomy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "It encourages family involvement and respect for choices but does not explicitly call on the oncology care team to respect bodily autonomy."
      },
      {
        "criterion_number": 10,
        "description": "The response should encourage the patient to prioritize management of side effects and symptoms of cancer or cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends advocating for pain management, which is a key symptom/side-effect management priority."
      },
      {
        "criterion_number": 11,
        "description": "The response should encourage the patient to communicate any side effects or symptoms of cancer or cancer treatment to their oncology care team to ensure they are being offered management solutions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit recommendation to report symptoms or side effects to the oncology care team."
      },
      {
        "criterion_number": 12,
        "description": "The response should encourage the patient and family to have open and ongoing communication about the patient\u2019s wishes for medical care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages including the patient in all treatment decisions, asking about preferences, and supporting care choices, which promotes open communication about medical wishes."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient and loved ones promote independence and normalcy in the patient\u2019s life as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends respecting independence, maintaining grooming routines, and encouraging enjoyable activities\u2014promoting normalcy."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage the patient to always remember that anything that happens to their body with regard to cancer treatment is their choice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although autonomy is emphasized, it does not explicitly state that all treatments and interventions are the patient\u2019s choice."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient disclose any feelings of overwhelm or loss of autonomy with their oncology team and inquire about resources for support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No recommendation is made to share feelings of overwhelm or loss of autonomy with the oncology team or to ask about resources."
      },
      {
        "criterion_number": 16,
        "description": "The response should emphasize the importance of prevention of caregiver burnout.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Caregiver burnout or its prevention is not addressed."
      }
    ],
    "question_number": 251,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:47:30.145758",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explains how cells respond to mechanical stress, including ECM remodeling, increased contractility, and effects on proliferation, invasion, metastasis, and drug resistance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response covers increased contractility, ECM remodeling, invasion, and entry into blood vessels, but it does not explicitly address effects on proliferation or drug resistance. Because not all required aspects are present, full credit cannot be awarded."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly relates tissue properties, such as stiffness and fibrous stroma, to their potential effect on cancer spread, including invasiveness and metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response links stiffness/desmoplasia to aggressive behavior and explains how enhanced contractility enables invasion and intravasation, satisfying the criterion."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including drug penetration and resistance mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that pancreatic tumors' stiffness and fibrosis hinder drug delivery and suggests strategies to improve drug penetration, fulfilling the requirement."
      },
      {
        "criterion_number": 4,
        "description": "Explains how cells sense mechanical stress, including mechanosensing mechanisms like mechanoreceptors, integrins, or mechanotransduction pathways.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While 'mechanosensing' is mentioned, no specific mechanisms (e.g., integrins, FAK, YAP/TAZ, Piezo channels) or pathways are described."
      },
      {
        "criterion_number": 5,
        "description": "Provides specific citations from published scientific journal articles as evidence.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No references or citations are provided."
      },
      {
        "criterion_number": 6,
        "description": "Explains normal cell contractility, including the role of the actomyosin complex in generating mechanical forces for movement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses increased contractility in cancer cells but does not explain normal actomyosin-based contractility."
      },
      {
        "criterion_number": 7,
        "description": "Defines actin, including its role in cellular structure and function.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Actin is not defined or described."
      },
      {
        "criterion_number": 8,
        "description": "Defines myosin, including its function in cell contractility.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Myosin is not defined or described."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly describes the tumor microenvironment, including its components and characteristics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response mentions dense fibrous tissue and barriers to immune cells but does not explicitly describe TME components (e.g., CAFs, immune cells, ECM, vasculature, nerves) in a comprehensive way."
      },
      {
        "criterion_number": 10,
        "description": "Defines the extracellular matrix, including its composition and function.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although collagen remodeling is mentioned, there is no explicit definition of the ECM, its broader composition, or its functions."
      },
      {
        "criterion_number": 11,
        "description": "Defines mechanobiology, including its relevance to cancer progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mechanobiology is not defined."
      },
      {
        "criterion_number": 12,
        "description": "Explains epithelial-mesenchymal transition (EMT), including its occurrence in pancreatic cancer cells and its impact on cancer spread.",
        "score_given": 0,
        "max_points": 7,
        "justification": "EMT is not discussed."
      }
    ],
    "question_number": 252,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:47:53.638876",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cells respond to mechanical stress, including processes like ECM remodeling, increased contractility, and effects on proliferation, invasion, metastasis, and drug resistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that cancer cells generate contractile forces to invade and metastasize, notes stiffening/remodeling of surrounding tissue, and connects mechanics to growth (proliferation), invasion/metastasis, and treatment resistance. While it does not use the term 'ECM remodeling' explicitly, it clearly describes stiffening of the surrounding tissue driven by cellular forces, which is consistent with ECM remodeling."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly relates tissue properties, such as stiffness and fibrous stroma, to their potential effect on cancer spread, including invasiveness and metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly links tissue stiffening and a stiff, fibrotic stroma (desmoplasia) to increased growth and invasion, and describes how contractility aids metastatic behavior."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including drug penetration and resistance mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that pancreatic tumor stiffness compresses blood vessels, making drug delivery challenging, and that the mechanical barrier may contribute to treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how cells sense mechanical stress, including mechanosensing mechanisms like mechanoreceptors, integrins, or mechanotransduction pathways.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of mechanosensing mechanisms (e.g., integrins, focal adhesions, YAP/TAZ, RhoA/ROCK) or how cells detect and transduce mechanical stress."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific citations from published scientific journal articles as evidence for its statements.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must explain normal cell contractility, including the role of the actomyosin complex in generating mechanical forces for movement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not describe the actomyosin complex or how normal cell contractility generates force for movement."
      },
      {
        "criterion_number": 7,
        "description": "The response must define actin, including its role in cellular structure and function.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Actin is not defined or discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response must define myosin, including its function in cell contractility.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Myosin is not defined or discussed."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly describe the tumor microenvironment, including its components and characteristics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions a stiff, fibrotic microenvironment and effects on vasculature, it does not explicitly describe the components of the tumor microenvironment (e.g., ECM, fibroblasts, immune cells, vasculature) or provide a definition."
      },
      {
        "criterion_number": 10,
        "description": "The response must define the extracellular matrix, including its composition and function.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The extracellular matrix is not defined; no description of its composition (e.g., collagen, proteoglycans) or its functions."
      },
      {
        "criterion_number": 11,
        "description": "The response must define mechanobiology, including its relevance to cancer progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mechanobiology is not defined or explicitly discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response must explain epithelial-mesenchymal transition (EMT), including its occurrence in pancreatic cancer cells and its impact on cancer spread.",
        "score_given": 0,
        "max_points": 7,
        "justification": "EMT is not mentioned or explained."
      }
    ],
    "question_number": 252,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:48:25.568667",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines the extracellular matrix and explains its role in normal cellular biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines ECM as a supportive mesh/scaffolding around cells and explains its organizing/supportive role in healthy tissue."
      },
      {
        "criterion_number": 2,
        "description": "The response contrasts the role of the extracellular matrix in cancer cell biology with normal cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Contrasts normal supportive scaffolding with the pathologic, dense barrier in pancreatic cancer that impedes therapies and immune cells."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the potential consequences of an altered extracellular matrix for cancer treatment effectiveness and resistance, including examples like decreased drug and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states the ECM barrier makes it harder for chemotherapy drugs to reach cancer cells, blocks immune cell access, and increases tumor pressure."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential consequences of an altered extracellular matrix on cancer cell biology, including examples like angiogenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that altered ECM provides 'highways' for tumor cell spread (metastasis) and pro-survival/growth signaling; although angiogenesis is not named, metastasis and growth effects are covered."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to scientific literature are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the different components of the extracellular matrix in normal tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not describe ECM components such as collagen, laminin, fibronectin, proteoglycans, or hyaluronan."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how the extracellular matrix changes in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes pancreatic tumors forming an unusually dense, thick ECM with high pressure and abnormal scaffolding production."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how the changes in the extracellular matrix in pancreatic cancer promote cancer growth and facilitate movement of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States altered ECM sends survival/growth signals and creates migration 'highways' that facilitate spread."
      },
      {
        "criterion_number": 9,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not defined."
      },
      {
        "criterion_number": 10,
        "description": "The response defines tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions the term 'tumor microenvironment' but does not define it."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how desmoplastic stroma causes hypoxia in the tumor microenvironment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention hypoxia or mechanisms (e.g., vessel compression, poor perfusion) by which stroma leads to hypoxia."
      },
      {
        "criterion_number": 12,
        "description": "The response describes how hypoxia in the tumor microenvironment causes inflammation, and how this promotes cancer growth.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of hypoxia-driven inflammation or its pro-tumor effects."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment contributes to treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that the dense ECM barrier reduces drug delivery and blocks immune attack, describing stromal-mediated treatment resistance in pancreatic cancer."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment can cause symptoms and complications due to mechanical forces on the surrounding structures, specifically mentioning the effect on blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of mechanical compression of surrounding structures or specific effects on blood vessels."
      }
    ],
    "question_number": 253,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:49:03.160072",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines the extracellular matrix and explains its role in normal cellular biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines the ECM as scaffolding made of proteins and other molecules that surrounds and supports cells and provides structure. This conveys a basic role in normal biology (structural support)."
      },
      {
        "criterion_number": 2,
        "description": "The response contrasts the role of the extracellular matrix in cancer cell biology with normal cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It contrasts normal structural support with the cancer context by stating pancreatic tumors create an unusually thick, dense ECM that forms a protective 'fortress' around cancer cells, indicating a different role in cancer versus normal tissues."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the potential consequences of an altered extracellular matrix for cancer treatment effectiveness and resistance, including examples like decreased drug and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states the dense ECM prevents chemotherapy drugs from reaching cancer cells and blocks immune cells, linking this to treatment challenges."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential consequences of an altered extracellular matrix on cancer cell biology, including examples like angiogenesis and metastasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not address angiogenesis, invasion, metastasis, or other direct effects on cancer cell biology beyond drug/immune exclusion."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the different components of the extracellular matrix in normal tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions ECM is made of proteins and other molecules but does not specify components such as collagens, hyaluronan, proteoglycans, fibronectin, or laminins."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how the extracellular matrix changes in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states pancreatic cancer creates an unusually thick, dense ECM, forming a fibrous, firm tissue (desmoplasia), which is an accurate description of ECM changes in PDAC."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how the changes in the extracellular matrix in pancreatic cancer promote cancer growth and facilitate movement of cancer cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not explain mechanisms such as ECM-driven signaling, migration along ECM tracks, EMT, or metastasis facilitation."
      },
      {
        "criterion_number": 9,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions desmoplasia as making the tumor firm and fibrous, it does not actually define 'desmoplastic stroma' as the fibrotic, ECM-rich stromal reaction (including fibroblasts and matrix) surrounding the tumor."
      },
      {
        "criterion_number": 10,
        "description": "The response defines tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The term 'tumor microenvironment' is not defined or described."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how desmoplastic stroma causes hypoxia in the tumor microenvironment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Hypoxia and its relation to stromal density or vascular compression are not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response describes how hypoxia in the tumor microenvironment causes inflammation, and how this promotes cancer growth.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Hypoxia-driven inflammation and pro-tumor effects are not discussed."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment contributes to treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states the dense ECM forms a barrier to chemotherapy and immune cell infiltration, contributing to difficulty in treatment, which aligns with stromal-mediated treatment resistance."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment can cause symptoms and complications due to mechanical forces on the surrounding structures, specifically mentioning the effect on blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no discussion of mechanical compression of surrounding structures, including blood vessels, or related symptoms/complications."
      }
    ],
    "question_number": 253,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:49:36.038130",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing relationship challenges or support strategies with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of discussing relationship challenges with the oncologist or medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing relationship challenges with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No suggestion to speak with a social worker, chaplain, or palliative care specialist."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends joining a support group for cancer patients or their families.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The section 'Preserving energy' encourages limiting draining interactions and using phone/video when in-person is too much, which emphasizes self-care."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly emphasizes the importance of having a support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages prioritizing supportive relationships, designating a point person, and guiding others on how to help."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only 'CaringBridge' is named without contact information or a website, and no cancer-support organizations are listed."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that loved ones of a patient with pancreatic cancer seek education about the disease and common symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to seek education about pancreatic cancer or its symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage open communication between the patients and their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises being honest about needs and setting communication boundaries, which promotes open communication."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient to seek support from their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It suggests guiding people on how to help (e.g., groceries, company) and designating a point person, directly encouraging seeking support."
      },
      {
        "criterion_number": 10,
        "description": "The response should attempt to normalize the stress that patients feel after receiving a pancreatic cancer diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While empathetic, it does not explicitly state that stress/anxiety after diagnosis is common or normal."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend against behaviors that might isolate the patient after a serious medical diagnosis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It offers alternatives to in-person visits but does not explicitly caution against isolation or withdrawing from others."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient prioritize symptom control to feel as normal as possible.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Symptom control or medical symptom management is not discussed."
      },
      {
        "criterion_number": 13,
        "description": "The response should indicate that some people may not feel comfortable discussing a serious cancer diagnosis with a friend or loved one, and that this can be a normal response.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that some people may pull away out of discomfort or not knowing what to say, normalizing this reaction."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient observe which people in their social circle want to be supportive, and to lean on these people.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Although it suggests prioritizing supportive relationships, this criterion carries no available points."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient continue to reach out to friends and loved ones, and try to participate in the same activities they previously did, to maintain relationships.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends simple shared activities (movies, meals) and using calls/video to maintain connections."
      },
      {
        "criterion_number": 16,
        "description": "The response should suggest that the patient consider creating boundaries with people, including how to handle unsolicited advice.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises setting boundaries around visits and discussion topics and acknowledges managing overwhelming advice."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend that the patient consider activities where they can be fully present with the people they are with, for the best quality interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes quality over quantity and suggests simple, present-focused activities without pressure to make every moment profound."
      }
    ],
    "question_number": 254,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:50:15.767370",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing relationship challenges or support strategies with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of consulting the oncologist or oncology team about relationship challenges or support strategies."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing relationship challenges with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions counseling, it does not explicitly reference a social worker, spiritual counselor, or palliative care specialist."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends joining a support group for cancer patients or their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests considering support groups."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated section ('Take care of yourself') emphasizes self-care, breaks, and seeking support."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly emphasizes the importance of having a support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages accepting help, letting others assist with tasks, and nurturing close relationships."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific support organizations (e.g., ACS, PanCAN) or contact info/URLs are provided; CaringBridge is mentioned only as a communication tool without a URL."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that loved ones of a patient with pancreatic cancer seek education about the disease and common symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No suggestion to learn about pancreatic cancer or common symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage open communication between the patients and their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages being open about needs and sharing updates through manageable channels."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient to seek support from their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Promotes asking friends/family for specific help and accepting assistance (meals, errands, tasks)."
      },
      {
        "criterion_number": 10,
        "description": "The response should attempt to normalize the stress that patients feel after receiving a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Validates that the situation can feel overwhelming and acknowledges the emotional difficulty."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend against behaviors that might isolate the patient after a serious medical diagnosis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly caution against isolating behaviors; emphasizes boundaries and taking space without balancing with anti-isolation guidance."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient prioritize symptom control to feel as normal as possible.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of symptom management or prioritizing symptom control."
      },
      {
        "criterion_number": 13,
        "description": "The response should indicate that some people may not feel comfortable discussing a serious cancer diagnosis with a friend or loved one, and that this can be a normal response.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes that relationships may shift, but does not explicitly state that discomfort discussing the diagnosis is common and normal."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient observe which people in their social circle want to be supportive, and to lean on these people.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Although it advises prioritizing comforting connections, this criterion has zero available points."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient continue to reach out to friends and loved ones, and try to participate in the same activities they previously did, to maintain relationships.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Encourages communication and accepting help but does not suggest participating in previous activities."
      },
      {
        "criterion_number": 16,
        "description": "The response should suggest that the patient consider creating boundaries with people, including how to handle unsolicited advice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides guidance on setting boundaries and limiting visitors but does not address handling unsolicited advice."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend that the patient consider activities where they can be fully present with the people they are with, for the best quality interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes quality time over quantity and the value of simple presence, aligning with being fully present for high-quality interactions."
      }
    ],
    "question_number": 254,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:51:01.178139",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cancer cells detect mechanical characteristics of their environment.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response correctly notes surface mechanoreceptors (integrins) and nuclear mechanosensing that detect stiffness/constraint, but this criterion has zero available points."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how cancer cells respond to mechanical characteristics of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains cytoskeletal reorganization, shape change, migration, and gene-expression changes in response to forces and stiffness; also links stiff desmoplastic environments to survival, invasion, and treatment resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how mechanosensing processes may be altered in pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It describes the stiff stromal context and its effects but does not detail altered mechanosensing in pancreatic cancer cells (e.g., changes in integrin/focal adhesion signaling, mechanotransduction pathway alterations, or stromal-cancer crosstalk specific to PDAC)."
      },
      {
        "criterion_number": 4,
        "description": "The response defines mechanosensing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition: cells detect and respond to physical forces and mechanical properties in their surroundings."
      },
      {
        "criterion_number": 5,
        "description": "The response describes mechanosensing in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "General mechanisms (surface sensors, cytoskeletal changes, nuclear sensing) are described in a way that applies to normal cells, not only cancer cells."
      },
      {
        "criterion_number": 6,
        "description": "The response defines desmoplastic stroma and describes its development in pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It identifies desmoplasia as dense, stiff tissue but does not describe how it develops in pancreatic cancer (e.g., activation of pancreatic stellate cells/CAFs, ECM deposition and crosslinking, fibrosis)."
      },
      {
        "criterion_number": 7,
        "description": "The response describes integrins, cytoskeleton, ion channels, and membrane sensors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Integrins and cytoskeleton are mentioned, and surface sensors are noted, but ion channels and other membrane mechanosensors (e.g., Piezo/TRP) are not described."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the YAP/TAZ pathway and its role in the development of desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "YAP/TAZ is not mentioned and no link to stromal development in PDAC is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions if there are FDA-approved therapies that target the cancer cells\u2019 ability to mechanosense.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes investigational approaches (targeting stiff tissue and mechanosensing pathways) but does not state whether FDA-approved therapies exist."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how cancer cells migrate in response to cues from mechanical forces in their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states that external forces drive cytoskeletal reorganization enabling shape change and movement through tissues, indicating mechanosensitive migration."
      },
      {
        "criterion_number": 11,
        "description": "The response defines epithelial-mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or defined."
      },
      {
        "criterion_number": 12,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific literature are provided."
      }
    ],
    "question_number": 255,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:51:26.156513",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cancer cells detect mechanical characteristics of their environment.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response lists detection mechanisms (integrins, ion channels, adhesion molecules, cytoskeleton, nuclear sensors), but this criterion carries 0 possible points."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how cancer cells respond to mechanical characteristics of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly states responses such as increased migration, enhanced invasion, altered growth, and changes in drug sensitivity in relation to mechanical cues."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how mechanosensing processes may be altered in pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes PDAC has a stiff, fibrous environment and its consequences but does not describe alterations in mechanosensing pathways in pancreatic cancer cells (e.g., specific receptor/signaling changes)."
      },
      {
        "criterion_number": 4,
        "description": "The response defines mechanosensing.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While mechanisms are listed, the response does not explicitly define mechanosensing as the process by which cells convert mechanical stimuli into biochemical signals."
      },
      {
        "criterion_number": 5,
        "description": "The response describes mechanosensing in normal cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It contrasts cancer cells with healthy cells but does not describe how normal cells mechanosense."
      },
      {
        "criterion_number": 6,
        "description": "The response defines desmoplastic stroma and describes its development in pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It mentions a stiff, fibrous environment in pancreatic cancer but does not define desmoplastic stroma or explain its development (e.g., pancreatic stellate cell activation, ECM deposition)."
      },
      {
        "criterion_number": 7,
        "description": "The response describes integrins, cytoskeleton, ion channels, and membrane sensors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Integrins, ion channels, cell adhesion molecules (membrane sensors), and cytoskeleton are listed with brief functional descriptions."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the YAP/TAZ pathway and its role in the development of desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "YAP/TAZ is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions if there are FDA-approved therapies that target the cancer cells\u2019 ability to mechanosense.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It refers to research and potential therapies but does not state whether FDA-approved mechanosensing-targeted therapies exist."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how cancer cells migrate in response to cues from mechanical forces in their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly notes increased migration toward softer or stiffer regions, indicating guidance by mechanical gradients (e.g., durotaxis)."
      },
      {
        "criterion_number": 11,
        "description": "The response defines epithelial-mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or defined."
      },
      {
        "criterion_number": 12,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to scientific literature are provided."
      }
    ],
    "question_number": 255,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:51:51.167681",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system, including nutrient and oxygen delivery and waste management.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not describe normal physiology of fluid exchange (capillary filtration into interstitium and lymphatic return) or tie it to nutrient/oxygen delivery and waste clearance."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how fluid flow becomes compromised in tumors, including increased intratumoral pressure due to abnormal blood vessels, poor lymphatic drainage, and dense stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly cites leaky blood vessels, poor lymphatic drainage, compressed vessels, and dense collagen-rich tissue as causes of elevated pressure, capturing how tumor fluid flow is compromised."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, specifically mentioning reduced drug delivery and immune cell penetration.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Reduced drug delivery is discussed, but there is no mention of impaired immune cell penetration into the tumor."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that high intratumoral pressure opposes drug flow from vessels, creates a barrier to penetration, and causes uneven drug distribution with underdosed regions."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the impact of altered fluid flow on radiation therapy due to hypoxia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links elevated pressure to hypoxia and notes hypoxic cells are 2\u20133\u00d7 more radioresistant, implying the need for adjusted radiation planning."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions the impact of altered cellular biology and extracellular structures on cancer behavior, including tumor growth, metastasis, and resistance to therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While radiation resistance is mentioned in the context of hypoxia, there is no discussion of altered cellular biology, tumor growth, or metastasis driven by extracellular structures."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explanation is provided about how low perfusion or flow can further stimulate tumor growth or evolution."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although 'dense tissue with excessive collagen' is mentioned, the term 'desmoplastic stroma' is not defined and its specific promotion in pancreatic cancer is not explained."
      },
      {
        "criterion_number": 9,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Interstitial fluid pressure is named but not defined (e.g., as the pressure within the interstitial space opposed to capillary filtration)."
      },
      {
        "criterion_number": 10,
        "description": "The response describes ways that increased pressure from interrupted fluid dynamics and desmoplastic stroma can cause compression on surrounding structures, leading to blockages and symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Compression of intratumoral blood vessels is noted, but there is no discussion of compression of surrounding structures (e.g., bile duct, duodenum) or resulting clinical blockages/symptoms."
      },
      {
        "criterion_number": 11,
        "description": "The response provides specific published scientific journal articles as evidence of its claims, with proper citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations to scientific literature are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not mention the current research status of tumor fluid dynamics."
      }
    ],
    "question_number": 256,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:52:20.319461",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system, including nutrient and oxygen delivery and waste management.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not describe normal physiologic fluid flow, nutrient/oxygen delivery, or waste clearance via lymphatics."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how fluid flow becomes compromised in tumors, including increased intratumoral pressure due to abnormal blood vessels, poor lymphatic drainage, and dense stroma.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions high pressure and compressed vessels, it does not explain the specific mechanisms (abnormal vasculature, poor lymphatic drainage, dense stroma) that drive elevated pressure and impaired flow."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, specifically mentioning reduced drug delivery and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states high pressure limits chemotherapy penetration and restricts immune cell infiltration, impacting immunotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that high pressure compresses vessels limiting drug delivery and that tumor centers have the highest pressure with poorest penetration, indicating uneven distribution."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the impact of altered fluid flow on radiation therapy due to hypoxia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links elevated pressure to reduced oxygen levels and explains that oxygenation influences radiation effectiveness."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions the impact of altered cellular biology and extracellular structures on cancer behavior, including tumor growth, metastasis, and resistance to therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not address tumor growth, metastatic potential, or resistance mechanisms related to extracellular changes."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of low perfusion or flow directly promoting cancer cell growth or development."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not defined, nor is its specific prominence in pancreatic cancer discussed."
      },
      {
        "criterion_number": 9,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Interstitial fluid pressure is referenced indirectly as 'high pressure' but not defined."
      },
      {
        "criterion_number": 10,
        "description": "The response describes ways that increased pressure from interrupted fluid dynamics and desmoplastic stroma can cause compression on surrounding structures, leading to blockages and symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of mass effect on surrounding organs, ductal blockage, or related symptoms."
      },
      {
        "criterion_number": 11,
        "description": "The response provides specific published scientific journal articles as evidence of its claims, with proper citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific literature are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that strategies are being researched and that clinical trials may target tumor pressure, indicating active research in this area."
      }
    ],
    "question_number": 256,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:52:49.920909",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends clear communication with the family regarding how everyone is dealing with the patient\u2019s cancer diagnosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends regular family meetings to share updates and feelings, creating a communication system (group text/email/CaringBridge), and acknowledging everyone's grief and fear\u2014clear guidance on open communication."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No recommendation to involve or consult the oncology/healthcare team regarding family coping or communication."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions family counseling but does not specifically suggest a social worker, spiritual care, or palliative care specialist."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of self-care and healthy boundaries.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly emphasizes self-care (\u201cYou can\u2019t pour from an empty cup\u201d) and setting boundaries with well-meaning but overwhelming relatives."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system for patients with cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages coordinated support (designate a point person, specific help tasks, clear visiting preferences) and maintaining quality time, highlighting a strong, organized support system."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations that support cancer patients and their families and includes contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not provide organizations with contact information or websites. Mention of CaringBridge as a communication tool lacks contact details and is not framed as a support organization."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly suggests joining a pancreatic cancer support group for families."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises designating a medical information point person and sharing updates but does not specifically recommend education about the diagnosis and treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage that family members provide emotional support to each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages sharing feelings, acknowledging grief and fear, and allowing different coping styles\u2014promoting mutual emotional support."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend pursuit of professional mental health counseling for family members of a patient with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends family counseling specialized in serious illness, which constitutes professional mental health support."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend resources that patients and families of patients with pancreatic cancer can access for information about the disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No informational resources (e.g., reputable websites or hotlines) about pancreatic cancer are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response should list sources and/or websites for support groups for patients with pancreatic cancer and their family members.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions support groups but does not list specific sources or websites where these can be accessed."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage family members to provide assistance and support to their loved ones affected by pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages concrete assistance (specific ways to help, coordinating updates, setting visiting expectations) and focusing on quality time\u2014clear support and assistance guidance."
      }
    ],
    "question_number": 257,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:53:12.516793",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends clear communication with the family regarding how everyone is dealing with the patient\u2019s cancer diagnosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises creating clear communication channels, designating one person for updates, using group texts/apps (e.g., CaringBridge), and being honest while respecting privacy."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of speaking with the oncology care team, nurses, or clinicians for guidance."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests professional counseling, it does not specifically recommend a social worker, chaplain/spiritual counselor, or palliative care specialist."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of self-care and healthy boundaries.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly emphasizes self-care (\u201cYou can\u2019t support others if you\u2019re depleted,\u201d accept help, join a support group). Boundaries are implied via designating one communicator and respecting the mother\u2019s privacy/wishes."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system for patients with cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages organizing practical support (visits, meals, transportation, childcare) and giving people specific tasks, highlighting the value of a strong support network."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations that support cancer patients and their families and includes contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations (e.g., ACS, PanCAN, CancerCare) or contact info/websites are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly suggests joining a support group for families facing similar situations."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not recommend learning about pancreatic cancer or treatment/side effects; only mentions being honest about prognosis and sharing updates."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage that family members provide emotional support to each other.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses different grief responses but does not explicitly encourage family members to emotionally support one another."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend pursuit of professional mental health counseling for family members of a patient with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends professional counseling for those struggling and counseling resources specifically for children."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend resources that patients and families of patients with pancreatic cancer can access for information about the disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No disease-information resources (e.g., reputable websites about pancreatic cancer) are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response should list sources and/or websites for support groups for patients with pancreatic cancer and their family members.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Recommends joining a support group but provides no specific sources or websites."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage family members to provide assistance and support to their loved ones affected by pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly encourages practical assistance via schedules for visits, meals, transportation, childcare, and assigning specific tasks."
      }
    ],
    "question_number": 257,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:53:51.146003",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that metastasis is cancer spread and uses plain language to describe how cells move and form tumors elsewhere."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Describes direct invasion and spread through blood (intravasation/extravasation), but does not mention lymphatic spread."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions cytoskeletal dynamics, membrane fluidity, protease-mediated matrix breakdown, and loss of cell-cell connections, all mechanisms facilitating spread."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention epithelial-to-mesenchymal transition (EMT)."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes survival under mechanical stress in circulation, but does not frame metastasis as a response to cell stress."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines deformability as the ability to change shape and squeeze through tight spaces and links it directly to metastatic steps."
      },
      {
        "criterion_number": 7,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions the cytoskeleton becoming more dynamic but does not define it; does not mention or define the extracellular matrix."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "References loss of cell-to-cell connections but does not explain adhesion mechanisms or processes (e.g., cadherins/integrins)."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly contrasts normal cells as relatively rigid with cancer cells as more flexible/deformable."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains how deformability enables intravasation, migration through tissues, survival in circulation, and extravasation to seed new tumors."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that deformable cells survive mechanical stress in circulation, implying resilience to stresses that normal cells cannot withstand."
      },
      {
        "criterion_number": 12,
        "description": "The response describes desmoplastic stroma in the pancreatic cancer tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions \u2018dense tissue around the pancreas\u2019 but does not describe or name the desmoplastic stroma characteristic of pancreatic cancer."
      },
      {
        "criterion_number": 13,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes that dense tissue requires cells to be deformable, but does not connect this specifically to desmoplastic stroma or its unique barriers."
      }
    ],
    "question_number": 258,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:54:42.205336",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes how cancer cells detach, move through tissues and vessels, and seed new sites using simple, accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions squeezing through tissue (direct invasion) and traveling through blood vessels and lymphatic channels."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses cellular-level behaviors such as detachment, shape change, compression through gaps, and transit through vessels as mechanisms enabling spread."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of metastasis being driven by cellular stress (e.g., hypoxia, mechanical, oxidative, or metabolic stress)."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear explanation with analogies (rigid block vs soft clay) and describes how flexibility enables squeezing through tight spaces."
      },
      {
        "criterion_number": 7,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neither extracellular matrix nor cytoskeleton is defined or mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While detachment is mentioned, there is no explanation of adhesion processes or molecules (e.g., cadherins, integrins)."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly contrasts healthy cells maintaining shape with cancer cells being more flexible and deformable."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Connects increased deformability to detachment, invasion through tissue gaps, intravasation/extravasation, and colonization of distant sites."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address survival under mechanical or shear stress, immune attack, or other stresses; only mentions movement."
      },
      {
        "criterion_number": 12,
        "description": "The response describes desmoplastic stroma in the pancreatic cancer tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma and tumor microenvironment features of pancreatic cancer are not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of desmoplastic stroma or how deformability specifically facilitates movement through that dense ECM."
      }
    ],
    "question_number": 258,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:55:04.673210",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal physiological flow of fluid from blood vessels to the extracellular space and lymphatic system in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not describe normal microvascular fluid exchange (e.g., capillary filtration, interstitial fluid flow) or lymphatic drainage. There is no explanation of how fluid normally moves from blood vessels to tissues and then into lymphatics."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses changes to fluid flow in pancreatic cancer, such as increased intratumoral pressure, and how these changes differ from normal tissue.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it mentions abnormal tumor vessels and desmoplasia affecting flow patterns, it does not discuss increased interstitial/intratumoral pressure or explicitly contrast these changes with normal tissue physiology."
      },
      {
        "criterion_number": 3,
        "description": "The response addresses how altered fluid flow impacts cancer treatment, including drug delivery and immune cell penetration into tumors.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It briefly notes attempts to normalize blood flow to improve drug delivery, but does not address immune cell penetration into tumors. Given the rubric\u2019s requirement including both aspects, full credit cannot be awarded."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential impacts of altered fluid flow on cancer behavior, including metastasis, proliferation, migration, and invasion.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response touches on metastasis and invasion (adhesion to vessel walls, invasion) but does not address proliferation or migration. The discussion is incomplete relative to the specified domains."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article as evidence for its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response defines shear stress.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Shear stress is clearly defined as the forces that fluids (like blood) exert on cells as they flow past them, which is an accurate lay definition."
      },
      {
        "criterion_number": 7,
        "description": "The response describes what sources of shear stress exist in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies blood flow in the bloodstream and abnormal tumor vasculature as sources of shear stress for cancer cells."
      },
      {
        "criterion_number": 8,
        "description": "The response defines mechanobiology.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mechanobiology is not defined or mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response explains that cancer cells can encounter shear stress forces in the tumor, in the bloodstream, and in lymph channels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions shear stress in the bloodstream and within tumors (tumor blood vessels) but does not mention lymphatic channels."
      },
      {
        "criterion_number": 10,
        "description": "The response describes desmoplastic stroma and how this forms in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplasia is named as \u2018dense tissue,\u2019 but there is no description of what it consists of (e.g., fibroblasts, extracellular matrix) or how it forms in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response explains the effect that the desmoplastic stroma has on fluid flow in and around a pancreatic cancer tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that desmoplasia affects blood flow patterns and creates unique mechanical environments, which addresses effects on fluid flow."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased shear stress encourages cancer cells to proliferate and metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While metastasis is implied (cells surviving circulation and traveling), there is no link made between shear stress and increased proliferation; thus the criterion is not fully met."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how shear stresses on cancer cells impact drug resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that shear stress can affect cells\u2019 ability to resist certain treatments, directly addressing drug resistance."
      }
    ],
    "question_number": 259,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:55:56.763267",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal physiological flow of fluid from blood vessels to the extracellular space and lymphatic system in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not describe normal fluid movement from capillaries into the interstitial space and its return via lymphatics; it only lists locations where shear stress occurs."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses changes to fluid flow in pancreatic cancer, such as increased intratumoral pressure, and how these changes differ from normal tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that the dense, fibrous tissue around pancreatic tumors creates unique flow patterns and poor blood flow, indicating altered flow compared to normal tissue."
      },
      {
        "criterion_number": 3,
        "description": "The response addresses how altered fluid flow impacts cancer treatment, including drug delivery and immune cell penetration into tumors.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions drug delivery limitations (poor blood flow limiting chemotherapy), it does not address immune cell penetration into tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential impacts of altered fluid flow on cancer behavior, including metastasis, proliferation, migration, and invasion.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Metastasis is mentioned, but there is no discussion of proliferation, migration, or invasion."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article as evidence for its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response defines shear stress.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Shear stress is clearly defined as the friction-like force from flowing fluids."
      },
      {
        "criterion_number": 7,
        "description": "The response describes what sources of shear stress exist in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists multiple sources: blood vessels, lymphatic vessels, around tumors where blood flow changes, and areas with fluid accumulation due to poor drainage."
      },
      {
        "criterion_number": 8,
        "description": "The response defines mechanobiology.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mechanobiology is not defined."
      },
      {
        "criterion_number": 9,
        "description": "The response explains that cancer cells can encounter shear stress forces in the tumor, in the bloodstream, and in lymph channels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions shear exposure in the bloodstream, lymphatic vessels, and around the tumor."
      },
      {
        "criterion_number": 10,
        "description": "The response describes desmoplastic stroma and how this forms in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions dense, fibrous tissue, it does not identify or explain desmoplastic stroma or how it forms."
      },
      {
        "criterion_number": 11,
        "description": "The response explains the effect that the desmoplastic stroma has on fluid flow in and around a pancreatic cancer tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that the dense fibrous tissue creates unique flow patterns and poor blood flow, affecting fluid movement and drug delivery."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased shear stress encourages cancer cells to proliferate and metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Metastatic effects are only generally noted (influencing where cells settle), and proliferation is not addressed."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how shear stresses on cancer cells impact drug resistance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions cells becoming more resistant to shear but does not link shear stress to drug resistance specifically."
      }
    ],
    "question_number": 259,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:56:48.051897",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises having honest conversations with the medical team about prognosis and treatment goals. The oncologist is a central member of the medical team for pancreatic cancer, so this effectively recommends discussing with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While the response suggests counseling for both patient and family and leaning on family/friends, it does not explicitly recommend open communication between the patient and caregivers about hopes, fears, or goals."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends counseling for both the patient and family members and mentions spiritual communities, which satisfies the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises honest conversations about prognosis and treatment goals and mentions advance directives and practical planning, which align with establishing goals of care."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends joining support groups for people facing similar challenges, which reasonably encompasses cancer support groups in this context."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations, websites, or contact information are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes counseling, support groups, and notes that understanding the situation can reduce anxiety\u2014all reinforcing the importance of mental health."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although empathetic, it does not explicitly state that it is normal to feel conflicted or to struggle with balancing hope and realism."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Quality of life is not defined or discussed in terms of treatment impacts (e.g., side effects, fatigue, hospital visits, symptom burden)."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or support group websites are provided."
      }
    ],
    "question_number": 260,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:57:21.770123",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not advise speaking with the oncologist or medical team. While it mentions staying grounded in current treatment options, it does not recommend discussing prognosis or goals with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly encourages communication strategies: following the loved one\u2019s lead, asking what kind of hope feels most important, and sharing feelings when appropriate."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends counseling (\u201cConsider counseling or support groups\u201d), which satisfies the criterion by encouraging involvement of a counselor/mental health professional."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it suggests planning for different scenarios and discussing what kind of hope is important, it does not explicitly recommend establishing or documenting goals of care with the patient and care team."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly suggests support groups for families facing similar situations."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations (e.g., PanCAN, ACS) or websites/contact information are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes emotional well-being, normalizes shifting emotions, and recommends counseling and support groups, underscoring mental health maintenance."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly states the tension is natural and validates the feelings (\u201ccompletely natural\u201d)."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it references focusing on meaningful time and manageable symptoms, it does not explain quality of life in detail or describe specific treatment-related factors (e.g., side effects, symptom burden) that impact it."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or links for pancreatic cancer information or support communities are provided."
      }
    ],
    "question_number": 260,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:57:55.108675",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes that cells can 'sense the stiffness of nearby structures' but does not explain the underlying sensing biology (e.g., adhesion receptors, focal contacts) even in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes responses such as generating stronger pulling forces, moving through tissue, breaking barriers, and remodeling the surroundings, all in accessible language."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects stiff, dense tissues and desmoplasia to invasion/metastasis and the creation of paths that facilitate spread."
      },
      {
        "criterion_number": 4,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiffer, fibrous tissues hinder drug penetration and can shield cells from chemotherapy; also mentions barriers to immune cells."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No journal citations or sources are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response defines traction forces that exist in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines cell traction forces generally as the mechanical forces cells exert to grip, pull, move, sense, and communicate\u2014applicable to normal cells."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the extracellular matrix.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not define the extracellular matrix; only refers to the 'surrounding environment' or tissue without explaining what ECM is."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how traction forces are changed in cancer cells, as opposed to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states that cancer cells often generate stronger traction forces than normal cells."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how increased traction forces from pancreatic cancer cells on their environment promote cancer cell proliferation and migration.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Addresses migration/invasion but does not describe effects on proliferation."
      },
      {
        "criterion_number": 10,
        "description": "The response describes changes in the pancreatic cancer environment that are prompted by traction forces from the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that cancer cells use forces to reorganize surrounding tissue and create paths; links this to the dense, scar-like environment typical of pancreatic tumors."
      },
      {
        "criterion_number": 11,
        "description": "The response defines mechanotransduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The term mechanotransduction is not defined or mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response defines desmoplastic stroma in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes desmoplasia as a dense, scar-like, fibrous environment created by cancer and surrounding support cells in pancreatic tumors."
      },
      {
        "criterion_number": 13,
        "description": "The response describes the effect of desmoplastic stroma on cancer cell\u2019s ability to metastasize.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that tissue remodeling and the scar-like environment create paths that facilitate invasion and spread."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how traction forces in cancer cells contribute to drug resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses stiff tissue limiting drug penetration but does not explicitly link cancer cell traction forces to drug resistance in pancreatic cancer."
      }
    ],
    "question_number": 261,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T20:58:32.971210",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explanation of how cells detect mechanical cues (e.g., via integrins, stretch-sensitive structures, or other mechanosensors); focuses on forces exerted rather than sensing."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not describe cellular adaptations or signaling responses to mechanical stress (e.g., cytoskeletal remodeling, changes in gene expression); instead lists downstream effects of exerted forces."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly links tissue stiffness and remodeling to facilitation of invasion and metastasis (e.g., stiffening creates pathways for spread; migration to distant sites)."
      },
      {
        "criterion_number": 4,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that stiff tumor environments may impede drug delivery and that the mechanical environment can promote survival and drug resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific literature are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response defines traction forces that exist in normal cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Defines traction forces in the context of cancer cells only; does not state that normal cells also generate traction forces or provide a general definition tied to normal physiology."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the extracellular matrix.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No definition or description of the extracellular matrix is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how traction forces are changed in cancer cells, as opposed to normal cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit comparison between cancer and normal cell traction forces (e.g., increased magnitude, altered adhesion dynamics) is made."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how increased traction forces from pancreatic cancer cells on their environment promote cancer cell proliferation and migration.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Migration is mentioned generally, but not specifically tied to increased traction forces from pancreatic cancer cells; proliferation effects are not discussed."
      },
      {
        "criterion_number": 10,
        "description": "The response describes changes in the pancreatic cancer environment that are prompted by traction forces from the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that cancer-cell forces can stiffen tissue and help recruit blood vessels; also notes pancreatic tumors develop very stiff, fibrous tissue, implying force-driven microenvironmental changes."
      },
      {
        "criterion_number": 11,
        "description": "The response defines mechanotransduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The term mechanotransduction is not defined or described."
      },
      {
        "criterion_number": 12,
        "description": "The response defines desmoplastic stroma in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned or defined."
      },
      {
        "criterion_number": 13,
        "description": "The response describes the effect of desmoplastic stroma on cancer cell\u2019s ability to metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of desmoplastic stroma or its impact on metastasis."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how traction forces in cancer cells contribute to drug resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes that mechanical environment influences drug resistance in pancreatic cancer but does not specifically attribute this to traction forces generated by cancer cells."
      }
    ],
    "question_number": 261,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T20:59:20.806452",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links a dense, high-pressure tissue environment (desmoplasia) to promoting cancer cell spread, explicitly stating that high pressure can promote spread."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that dense tissue makes chemotherapy penetration harder, may require higher doses or special delivery, and that radiation can be less effective due to reduced oxygen levels\u2014directly tying tissue properties to treatment effectiveness."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions reduced blood flow and hypoxia as potential consequences of tissue thickness which may have effects on treatment effectiveness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes blood vessel compression with reduced oxygen and nutrient flow and explicitly connects reduced oxygen to decreased radiation effectiveness, satisfying the reduced blood flow and hypoxia concepts."
      },
      {
        "criterion_number": 4,
        "description": "Define viscosity and explain its role in normal cells, including the term \u201cviscosity\u201d and its function in cellular environments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although the term \u201cviscosity\u201d is mentioned, there is no definition of viscosity nor explanation of its role in normal cellular environments."
      },
      {
        "criterion_number": 5,
        "description": "Describe changes in viscosity within the pancreatic cancer microenvironment, mentioning \u201cviscosity\u201d and specific alterations in cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not describe specific viscosity changes within the pancreatic cancer microenvironment; it focuses on tissue density/fibrosis without detailing viscosity alterations."
      },
      {
        "criterion_number": 6,
        "description": "Define the tumor microenvironment, using the term \u201ctumor microenvironment\u201d and describing its components.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The term \u201ctumor microenvironment\u201d is not used, nor are its components (e.g., cancer-associated fibroblasts, ECM, immune cells, vasculature) defined."
      },
      {
        "criterion_number": 7,
        "description": "Define desmoplastic stroma and explain its formation in pancreatic cancer, using the term \u201cdesmoplastic stroma\u201d and describing its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions \u201cdesmoplasia\u201d but does not use the term \u201cdesmoplastic stroma\u201d or explain its formation/development in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "Describe the influence of desmoplasia on cancer cells, mentioning \u201cdesmoplasia\u201d and its effects on proliferation, migration, or invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Within a section labeled \u201cDesmoplasia,\u201d it states that high pressure can promote cancer cell spread, addressing effects on migration/invasion."
      },
      {
        "criterion_number": 9,
        "description": "Describe how desmoplasia limits oxygen delivery to tumor tissue, attributing reduced oxygen delivery specifically to \u201cdesmoplasia.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under the desmoplasia heading, it explains that compressed blood vessels reduce oxygen flow, attributing reduced oxygen delivery to the dense/desmoplastic tissue."
      },
      {
        "criterion_number": 10,
        "description": "Explain how hypoxia affects cancer cell behavior, describing hypoxia\u2019s role in selecting aggressive, therapy-resistant cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While reduced oxygen is mentioned, there is no explanation of hypoxia selecting for aggressive or therapy\u2011resistant phenotypes."
      },
      {
        "criterion_number": 11,
        "description": "Describe how desmoplasia limits tumor access by the immune system, mentioning \u201cdesmoplasia\u201d and its impact on immune cell infiltration.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention is made of the immune system or immune cell infiltration in relation to desmoplasia."
      },
      {
        "criterion_number": 12,
        "description": "Explain how desmoplasia causes drug resistance in pancreatic cancer, connecting \u201cdesmoplasia\u201d to reduced treatment efficacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly links the dense desmoplastic barrier to poor chemotherapy penetration and reduced efficacy, and notes radiation may be less effective due to low oxygen."
      },
      {
        "criterion_number": 13,
        "description": "Explain how desmoplastic stroma selects for aggressive tumor cell behavior, linking \u201cdesmoplastic stroma\u201d to increased migratory behavior.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although increased spread is mentioned, the term \u201cdesmoplastic stroma\u201d is not used, nor is selection for aggressive behavior explicitly discussed."
      },
      {
        "criterion_number": 14,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published scientific journal articles are provided."
      }
    ],
    "question_number": 262,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:00:00.516700",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that the dense matrix affects how cancer cells interact and spread, directly linking tissue properties (density/viscosity) to spread."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly notes that the thick, viscous environment makes it harder for chemotherapy drugs to penetrate and that low oxygen can increase treatment resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions reduced blood flow and hypoxia as potential consequences of tissue thickness which may have effects on treatment effectiveness.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions areas of low oxygen (hypoxia) and nutrient gradients, it does not mention reduced blood flow explicitly."
      },
      {
        "criterion_number": 4,
        "description": "Define viscosity and explain its role in normal cells, including the term \u201cviscosity\u201d and its function in cellular environments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response uses the word 'viscous' but does not define viscosity or explain its role in normal cellular environments."
      },
      {
        "criterion_number": 5,
        "description": "Describe changes in viscosity within the pancreatic cancer microenvironment, mentioning \u201cviscosity\u201d and specific alterations in cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions a 'thick, viscous barrier' and increased density (5\u201310\u00d7 normal), describing altered viscosity characteristics around cancer cells."
      },
      {
        "criterion_number": 6,
        "description": "Define the tumor microenvironment, using the term \u201ctumor microenvironment\u201d and describing its components.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It refers to the 'tumor environment' but does not use the term 'tumor microenvironment' or define its components."
      },
      {
        "criterion_number": 7,
        "description": "Define desmoplastic stroma and explain its formation in pancreatic cancer, using the term \u201cdesmoplastic stroma\u201d and describing its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions 'desmoplasia' but does not use the term 'desmoplastic stroma' or explain its formation (e.g., PSCs/CAFs, ECM deposition)."
      },
      {
        "criterion_number": 8,
        "description": "Describe the influence of desmoplasia on cancer cells, mentioning \u201cdesmoplasia\u201d and its effects on proliferation, migration, or invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes the dense matrix affects how cells spread, it does not explicitly link these effects to 'desmoplasia' nor discuss proliferation/migration/invasion using that term."
      },
      {
        "criterion_number": 9,
        "description": "Describe how desmoplasia limits oxygen delivery to tumor tissue, attributing reduced oxygen delivery specifically to \u201cdesmoplasia.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Low oxygen areas are mentioned, but the cause is not attributed specifically to 'desmoplasia.'"
      },
      {
        "criterion_number": 10,
        "description": "Explain how hypoxia affects cancer cell behavior, describing hypoxia\u2019s role in selecting aggressive, therapy-resistant cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that areas of low oxygen can make cancer cells more aggressive and treatment-resistant, capturing the effect of hypoxia on behavior."
      },
      {
        "criterion_number": 11,
        "description": "Describe how desmoplasia limits tumor access by the immune system, mentioning \u201cdesmoplasia\u201d and its impact on immune cell infiltration.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It references immunotherapies being studied but does not mention desmoplasia limiting immune cell infiltration."
      },
      {
        "criterion_number": 12,
        "description": "Explain how desmoplasia causes drug resistance in pancreatic cancer, connecting \u201cdesmoplasia\u201d to reduced treatment efficacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Drug delivery barriers are described, but they are not explicitly attributed to 'desmoplasia' causing reduced efficacy."
      },
      {
        "criterion_number": 13,
        "description": "Explain how desmoplastic stroma selects for aggressive tumor cell behavior, linking \u201cdesmoplastic stroma\u201d to increased migratory behavior.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit mention of 'desmoplastic stroma' selecting for increased migratory behavior."
      },
      {
        "criterion_number": 14,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published scientific journal articles are provided."
      }
    ],
    "question_number": 262,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:00:45.127438",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It suggests involving religious or community leaders, which fulfills the intent of engaging a spiritual counselor. Social worker and palliative care were not mentioned, but inclusion of a spiritual advisor meets the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends respectful and open communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes sensitivity, clear communication, and explicitly encourages open dialogue and family meetings with providers."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions cultural mediators.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends asking for cultural liaisons or interpreters who understand both medical and cultural contexts."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends that the patient and family members communicate their important cultural beliefs to their oncology team for better understanding.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises a family meeting with healthcare providers, identifying decision-makers based on cultural values, discussing integration of traditional practices, and creating a care plan that honors cultural beliefs\u2014implicitly guiding communication of these beliefs to the care team."
      },
      {
        "criterion_number": 5,
        "description": "The response strongly recommends that a medical interpreter is present for all medical appointments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While interpreters are mentioned, there is no explicit, strong recommendation to have an interpreter present for all medical appointments."
      },
      {
        "criterion_number": 6,
        "description": "The response suggests that the patient request more time for their appointments, especially if a medical interpreter is needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No suggestion to request longer appointment times is included."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests the patient and/or family inquire about services a patient advocacy office could provide.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of a patient advocacy office or similar services."
      },
      {
        "criterion_number": 8,
        "description": "The response encourages the patient to communicate their preferences around medical decision-making with their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It encourages clarifying decision-making models, but does not explicitly advise communicating these preferences to the oncology team."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends online resources for both patients and medical teams to learn about particular cultural norms around medical care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources are provided or recommended."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends medical teams to complete thorough documentation on patient preferences surrounding communication and medical decision-making.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It advises documenting the loved one\u2019s wishes but does not recommend that the medical team document preferences in the medical record."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends organizations that support cancer patients and their families and includes contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No supporting organizations or contact information/websites are cited."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends setting boundaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit guidance on setting boundaries with family or the care team."
      }
    ],
    "question_number": 263,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:01:24.013653",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly mentions involving social workers and patient advocates, and also references community or religious leaders. While palliative care is not named, the inclusion of social workers satisfies the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends respectful and open communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response emphasizes patience, respect, open communication, and specific strategies such as listening without judgment and asking open-ended questions."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions cultural mediators.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends asking the medical team about cultural liaisons or interpreters who understand both language and cultural nuances."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends that the patient and family members communicate their important cultural beliefs to their oncology team for better understanding.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises, \"Inform the medical team about cultural considerations,\" which directs communication of cultural beliefs to the healthcare/oncology team."
      },
      {
        "criterion_number": 5,
        "description": "The response strongly recommends that a medical interpreter is present for all medical appointments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions interpreters, it does not strongly recommend having a medical interpreter present for all appointments."
      },
      {
        "criterion_number": 6,
        "description": "The response suggests that the patient request more time for their appointments, especially if a medical interpreter is needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not advise requesting longer appointment times; it only suggests requesting time for family consultation."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests the patient and/or family inquire about services a patient advocacy office could provide.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends utilizing patient advocates/social workers to help navigate these situations, implying reaching out to those services."
      },
      {
        "criterion_number": 8,
        "description": "The response encourages the patient to communicate their preferences around medical decision-making with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that the loved one's wishes should guide decisions and advises informing the medical team about considerations, effectively encouraging communication of decision-making preferences."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends online resources for both patients and medical teams to learn about particular cultural norms around medical care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or websites are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends medical teams to complete thorough documentation on patient preferences surrounding communication and medical decision-making.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of documentation of preferences by the medical team."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends organizations that support cancer patients and their families and includes contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends setting boundaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit recommendation to set boundaries."
      }
    ],
    "question_number": 263,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:01:59.453095",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly contrasts normal vs cancer cell stiffness and notes tumor masses become stiffer due to fibrosis."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States softer, more deformable cells can squeeze through tight spaces, enter vessels, and thus spread more easily."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that a stiff, fibrotic tumor microenvironment can protect cancer cells from treatment and mentions therapies targeting stiffness/normalizing the environment."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or specific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes that cancer cells are softer/more deformable and explains functional consequences (squeezing through spaces, adapting)."
      },
      {
        "criterion_number": 6,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neither the extracellular matrix nor the cytoskeleton is defined."
      },
      {
        "criterion_number": 7,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of adhesion molecules or adhesion dynamics is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly contrasts normal cells (firm) with cancer cells (50\u201370% softer) and notes this change occurs early."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Connects deformability to invasion, intravasation, and increased risk of metastasis, including survival in the circulation."
      },
      {
        "criterion_number": 10,
        "description": "The response explains ways that cancer cells migrate from the primary tumor, including hematologic and lymphatic spread, perineural invasion, and direct invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions entry into blood vessels (hematogenous spread) but does not address lymphatic spread, perineural invasion, or explicitly direct invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that softer cells better survive the stress of traveling through blood vessels and adapt to new environments."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Links softer cells to movement through dense tissue and notes the stiff, fibrotic (desmoplastic) tumor environment typical of pancreatic cancer, implying deformability is needed."
      }
    ],
    "question_number": 264,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:02:25.788647",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that cancer cells become softer and that pancreatic tumors have a very stiff surrounding environment (stroma)."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly links cell softness/deformability to invasion and metastasis by describing how softer cells squeeze through tight spaces, traverse vessel walls, and invade surrounding tissue."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that the stiff tumor stroma can hinder treatment delivery, mentions therapies aiming to modify the tumor\u2019s physical environment, and suggests stiffness as a potential biomarker."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that cancer cells are softer/less stiff and that this deformability enables them to squeeze and navigate through tissues and vessel walls."
      },
      {
        "criterion_number": 6,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neither the extracellular matrix nor the cytoskeleton is defined or described."
      },
      {
        "criterion_number": 7,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Cell adhesion mechanisms (e.g., attachment/detachment, integrins, focal adhesions) are not discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states that cancer cells typically become softer (less stiff) than healthy cells."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly connects increased deformability with the ability to invade tissues and cross blood vessel walls to spread."
      },
      {
        "criterion_number": 10,
        "description": "The response explains ways that cancer cells migrate from the primary tumor, including hematologic and lymphatic spread, perineural invasion, and direct invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions invasion of surrounding tissue and movement through blood vessels but does not address lymphatic spread or perineural invasion as required."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explain survival under mechanical or environmental stresses (e.g., shear stress, confinement) attributable to increased deformability."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes that pancreatic stroma is stiff, but does not explicitly explain that increased deformability is necessary to traverse the desmoplastic stroma."
      }
    ],
    "question_number": 264,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:02:47.365217",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how physical space restriction affects cancer cells, mentioning at least two effects such as \u201cenhanced migration,\u201d \u201cnuclear deformation,\u201d or \u201cadaptation.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions migration changes, nuclear deformation with DNA damage, increased invasiveness, and metabolic adaptation\u2014well over two effects."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how confinement enhances migration and invasion, using terms like \u201camoeboid migration,\u201d \u201cincreased speed,\u201d or \u201cmetastasis.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states a switch to an \u201camoeba-like\u201d squeezing motion in tight spaces and notes increased invasiveness via pathways that break down surrounding tissues."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how confinement can promote genetic mutations, mentioning \u201cnuclear deformation,\u201d \u201cDNA damage,\u201d or \u201cgenomic instability.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states severe confinement deforms the nucleus and can cause DNA damage."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how confinement enhances cancer cells\u2019 ability to survive and adapt to stress, using terms like \u201cupregulate survival signals,\u201d \u201cresistant to therapies,\u201d or \u201cmechanical stress.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions triggering survival mechanisms and metabolic adaptations to survive in cramped, low-oxygen environments."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not describe how cells sense mechanical stress (e.g., sensors or signals); no clear lay analogy about sensing is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains behavior changes (amoeba-like squeezing), nuclear deformation, increased invasiveness, and metabolic adaptation in clear, non-jargon terms with an analogy."
      },
      {
        "criterion_number": 7,
        "description": "The response provides at least one specific citation from a published scientific journal article as evidence for its statements.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly relates tissue properties to their potential effect on cancer spread, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes dense tissue creating barriers and links confinement to invasion via pathways that break down surrounding tissues."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including at least one specific example or mechanism.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it says this knowledge guides treatment strategies, it does not provide a specific mechanism connecting tissue properties to treatment effectiveness or resistance."
      },
      {
        "criterion_number": 10,
        "description": "The response defines confinement in the context of cancer cells, using terms like \u201cphysical restriction,\u201d \u201ctumor microenvironment,\u201d or \u201cnarrow spaces.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It refers to physical confinement, tight spaces, and cramped environments, effectively defining confinement."
      },
      {
        "criterion_number": 11,
        "description": "The response defines desmoplastic stroma in pancreatic cancer, using terms like \u201cdense,\u201d \u201cfibrous,\u201d \u201cscar-like tissue,\u201d or \u201cstiff extracellular matrix,\u201d and describes its formation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Desmoplastic stroma is not mentioned or defined."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly connects desmoplastic stroma to the confinement of cancer cells, explaining how it creates physical restriction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No connection to desmoplastic stroma is made."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions the role of hypoxia in pancreatic cancer and describes why pancreatic tumors are in a hypoxic environment, using terms like \u201clow-oxygen\u201d or \u201cdense stroma.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "Low-oxygen is mentioned generally, but not specifically tied to pancreatic tumors or explained (e.g., dense stroma/poor perfusion)."
      },
      {
        "criterion_number": 14,
        "description": "The response states that understanding confinement is an area of active scientific research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states researchers are working on therapies that exploit mechanical properties and that this opens new avenues for treatment development."
      }
    ],
    "question_number": 265,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:03:40.072331",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how physical space restriction affects cancer cells, mentioning at least two effects such as \u201cenhanced migration,\u201d \u201cnuclear deformation,\u201d or \u201cadaptation.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response mentions multiple effects: enhanced migration/invasion (\"squeeze through tight spaces\") and adaptation/survival (\"activate specific pathways that help them survive in cramped conditions\")."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how confinement enhances migration and invasion, using terms like \u201camoeboid migration,\u201d \u201cincreased speed,\u201d or \u201cmetastasis.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly explains that confined cells develop enhanced ability to traverse tight spaces and can switch movement strategies (\"changing from crawling to flowing\"), and notes this can affect how cancer spreads, addressing invasion and dissemination."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how confinement can promote genetic mutations, mentioning \u201cnuclear deformation,\u201d \u201cDNA damage,\u201d or \u201cgenomic instability.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of nuclear deformation, DNA damage, or genomic instability; genetic consequences of confinement are not addressed."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how confinement enhances cancer cells\u2019 ability to survive and adapt to stress, using terms like \u201cupregulate survival signals,\u201d \u201cresistant to therapies,\u201d or \u201cmechanical stress.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that cells \"activate specific pathways that help them survive in cramped conditions\" and notes physical barriers may protect cells from treatment, covering survival/adaptation and therapy resistance conceptually."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not describe mechanosensing or how cells detect mechanical stress; no analogy explaining sensing is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses accessible descriptions and examples of responses: switching movement strategies (\"crawling to flowing\"), squeezing through tight spaces, and producing enzymes to break down tissue\u2014lay explanations of cellular responses to mechanical constraints."
      },
      {
        "criterion_number": 7,
        "description": "The response provides at least one specific citation from a published scientific journal article as evidence for its statements.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations to peer-reviewed literature are included."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly relates tissue properties to their potential effect on cancer spread, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects physical confinement/tissue density to spread by describing squeezing through tight spaces and enzyme-mediated matrix degradation facilitating invasion."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that \"dense tissue around tumors can limit drug penetration\" and that physical barriers may protect cells from treatment\u2014clear mechanism tying tissue properties to therapy effectiveness."
      },
      {
        "criterion_number": 10,
        "description": "The response defines confinement in the context of cancer cells, using terms like \u201cphysical restriction,\u201d \u201ctumor microenvironment,\u201d or \u201cnarrow spaces.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Effectively defines confinement via phrases such as \"cramped conditions,\" \"tight spaces,\" and references to dense tissue restricting space."
      },
      {
        "criterion_number": 11,
        "description": "The response defines desmoplastic stroma in pancreatic cancer, using terms like \u201cdense,\u201d \u201cfibrous,\u201d \u201cscar-like tissue,\u201d or \u201cstiff extracellular matrix,\u201d and describes its formation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Desmoplastic stroma is not mentioned or defined; no description of its composition or formation is provided."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly connects desmoplastic stroma to the confinement of cancer cells, explaining how it creates physical restriction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit discussion of desmoplastic stroma; thus no link to confinement is made."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions the role of hypoxia in pancreatic cancer and describes why pancreatic tumors are in a hypoxic environment, using terms like \u201clow-oxygen\u201d or \u201cdense stroma.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "Hypoxia and low-oxygen conditions are not discussed."
      },
      {
        "criterion_number": 14,
        "description": "The response states that understanding confinement is an area of active scientific research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The \"Current Research Focus\" section explicitly notes ongoing research aimed at modifying the tumor environment and improving treatment access."
      }
    ],
    "question_number": 265,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:04:13.518194",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends flexibility in plans and modifications to allow the father to participate in family traditions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly advises adapting traditions to energy levels, shortening activities, bringing traditions to him, scheduling around best times, and having backup plans."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of social workers, counselors, chaplains/spiritual care, or Palliative Care services."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not reference building or leaning on a support system (family/friends/community resources)."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations, hotlines, or websites are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages including him in planning, asking his preferences, and respecting his need for rest\u2014core elements of open communication."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient prioritize management of cancer or cancer-treatment related side effects to feel as \u201cnormal\u201d as possible to be present for himself and his family.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No advice to coordinate with the care team for symptom/side-effect management (e.g., fatigue, pain, nausea) to optimize participation."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the family members consider documentation of the family traditional events with their father, as a way to reminisce and honor his presence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly suggests recording stories, taking photos, creating memory books, and letters/videos."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the family members to be thoughtful about ways their father can feel included in family events.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides multiple inclusion strategies: bringing traditions to him, virtual participation, quieter versions, guiding from a chair."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the family seek their father\u2019s input on what meaningful events and activities he desires to participate in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly advises letting him choose which traditions matter most and asking how he'd like to participate."
      }
    ],
    "question_number": 266,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:04:39.731327",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends flexibility in plans and modifications to allow the father to participate in family traditions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises adapting rather than abandoning traditions, modifying activities to energy levels and treatment schedule, and creating travel-sized versions."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of social work, spiritual care, counseling, or palliative care consultation."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages sharing responsibilities and accepting help from extended family and friends, emphasizing support network involvement."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations, websites, or contact information are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Promotes asking for his stories, including his preferences, and ends with a prompt inviting discussion about important traditions."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient prioritize management of cancer or cancer-treatment related side effects to feel as \u201cnormal\u201d as possible to be present for himself and his family.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it suggests scheduling around energy, it does not advise symptom or side-effect management to optimize well-being."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the family members consider documentation of the family traditional events with their father, as a way to reminisce and honor his presence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly suggests documenting traditions through photos, videos, or recordings."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the family members to be thoughtful about ways their father can feel included in family events.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends inclusion through leadership roles, adapting activities, and focusing on meaningful participation."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the family seek their father\u2019s input on what meaningful events and activities he desires to participate in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages letting him guide or direct, including his preferences, and invites discussion about which traditions are most important."
      }
    ],
    "question_number": 266,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:05:03.758458",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, using accessible language and avoiding jargon, including the concept of cancer cells moving from the primary tumor to other parts of the body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response uses accessible language and conveys that cancer can spread to distant organs via fluids, effectively explaining metastasis in lay terms, even though it does not explicitly say 'primary tumor'."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, explicitly mentioning direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions direct invasion ('invade surrounding tissues including blood vessels'), spread through the lymphatic system, and spread through the bloodstream."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads in the body, such as amoeboid, mesenchymal, or collective migration, enzyme production, or environmental signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists amoeboid movement, mesenchymal movement, and collective migration, satisfying the requirement for at least two mechanisms."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response clarifies that cancer cells do not swim, explicitly stating they lack the cellular machinery (e.g., flagella or cilia) to do so.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not state that cancer cells lack flagella/cilia or that they do not swim; the wording even frames mechanisms under 'Swimming and Movement Methods' without clarifying this point."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways cancer cells migrate, including in solid tissues and through a fluid-filled environment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It discusses movement through tissues (amoeboid/mesenchymal) and through fluid-filled environments (passive transport in blood/lymph; peritoneal cavity as a route)."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain hematologic spread and lymphatic metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that cells can be carried by blood flow and lymphatic fluid and that pancreatic cancer often spreads through the lymphatic system and bloodstream."
      },
      {
        "criterion_number": 8,
        "description": "The response should explain amoeboid motility that some cancer cells can perform to actively travel through fluid.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid movement is described as squeezing through tissues, not specifically as active travel through fluid."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain membrane fluctuations and how some cancer cells can do this to actively travel through fluid.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Membrane fluctuations are not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain chemical gradients and provide examples, and should define chemotaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotaxis, chemical gradients, or examples thereof are not discussed."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe passive movements of cancer cells in fluid-filled environments.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states that cells can be carried by blood flow or lymphatic fluid, which is passive transport."
      },
      {
        "criterion_number": 12,
        "description": "The response should provide links to the scientific literature that discusses ways cancer cells can move through fluid substances, with PMIDs if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 13,
        "description": "The response should define desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned or defined."
      },
      {
        "criterion_number": 14,
        "description": "The response should summarize ways pancreatic cancer cells migrate in their solid tissue environment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Aside from a brief note about invading surrounding tissues, it does not summarize specific modes of migration within the solid tumor microenvironment."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the most common way that pancreatic cancer cells are thought to spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not identify the most common route of spread; it only states that spread often occurs through lymphatics and bloodstream without specifying which is most common."
      }
    ],
    "question_number": 267,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:05:42.280131",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, using accessible language and avoiding jargon, including the concept of cancer cells moving from the primary tumor to other parts of the body.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explain metastasis or explicitly state that cancer cells leave the primary tumor to establish growths elsewhere; it focuses on movement mechanisms only."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, explicitly mentioning direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not explicitly mention direct invasion, lymphatic spread, or hematogenous (blood) spread."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads in the body, such as amoeboid, mesenchymal, or collective migration, enzyme production, or environmental signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It mentions amoeboid motion, collective migration, matrix-degrading enzymes, and chemical guidance (chemotaxis), satisfying the requirement."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response clarifies that cancer cells do not swim, explicitly stating they lack the cellular machinery (e.g., flagella or cilia) to do so.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response incorrectly states that some cancer cells use flagella or cilia to propel themselves and does not clarify that typical human cancer cells lack such swimming machinery."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways cancer cells migrate, including in solid tissues and through a fluid-filled environment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes movement through fluid environments and mechanisms relevant to solid tissues (squeezing through tight spaces, matrix breakdown)."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain hematologic spread and lymphatic metastasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no explanation of spread via blood or lymphatic systems."
      },
      {
        "criterion_number": 8,
        "description": "The response should explain amoeboid motility that some cancer cells can perform to actively travel through fluid.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Amoeboid motion is described and presented within the context of movement through fluid environments."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain membrane fluctuations and how some cancer cells can do this to actively travel through fluid.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Membrane fluctuations or blebbing are not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain chemical gradients and provide examples, and should define chemotaxis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines chemotaxis as following chemical signals and gives examples (movement toward blood vessels or other tissues), effectively conveying the concept of chemical gradients."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe passive movements of cancer cells in fluid-filled environments.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Passive transport (e.g., being carried by blood/lymph flow, shear forces, or emboli) is not described."
      },
      {
        "criterion_number": 12,
        "description": "The response should provide links to the scientific literature that discusses ways cancer cells can move through fluid substances, with PMIDs if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 13,
        "description": "The response should define desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should summarize ways pancreatic cancer cells migrate in their solid tissue environment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No pancreas-specific discussion of tumor microenvironment or migration is provided."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the most common way that pancreatic cancer cells are thought to spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention common spread patterns for pancreatic cancer (e.g., early lymphatic/hematogenous spread to liver or peritoneal seeding)."
      }
    ],
    "question_number": 267,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:06:55.980243",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines surface tension.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Surface tension is referenced and used by analogy (water droplets deforming), but no explicit definition of surface tension as an interfacial energy/force per unit length or area is provided."
      },
      {
        "criterion_number": 2,
        "description": "The response defines interfacial forces.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Interfacial forces are mentioned as important but are not defined or described conceptually."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the influence of surface tension on pancreatic cancer cells, specifically mentioning cell detachment, migration, or tumor spheroid formation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that cancer cells change surface properties to detach and invade (squeeze through gaps by changing surface tension) and links this to pancreatic cancer by noting its aggressive spread and potential to target these surface properties."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of interfacial forces during cancer cell metastasis, specifically mentioning cell detachment, migration, or invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly discusses detachment from the primary tumor, invasion through tight spaces, and travel through the bloodstream, attributing behaviors to changes in surface properties/interfacial effects."
      },
      {
        "criterion_number": 5,
        "description": "The response states interfacial tissue planes typically serve as barriers for cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of tissue planes acting as barriers to tumor spread."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Metastasis is described in accessible language (reduced stickiness, breaking away, traveling through blood, squeezing through gaps, forming clusters) suitable for lay readers."
      },
      {
        "criterion_number": 7,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Direct invasion and spread through the blood are mentioned, but spread through the lymphatic system is not discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It mentions altering surface proteins to reduce adhesion, changing surface properties to invade, clustering, and blocking signals that coordinate these changes\u2014covering cellular mechanisms of spread."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response describes cell-to-cell adhesion, specifically in the context of tumor spheroid formation and the balance with surface tension.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cell-to-cell adhesion and clustering are mentioned, but tumor spheroid formation and the adhesion\u2013surface tension balance in spheroids are not described."
      },
      {
        "criterion_number": 11,
        "description": "The response describes at least two mechanical cues in the tumor microenvironment, such as stiffness or surface tension, and how cancer cells sense these signals.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only surface tension/surface properties are referenced; other mechanical cues (e.g., stiffness, shear stress) and mechanosensing mechanisms are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions desmoplastic stroma and its relevance to pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response defines the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The extracellular matrix is not defined or described."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how normal cells and cancer cells interact with the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of cell\u2013ECM interactions is provided."
      }
    ],
    "question_number": 268,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:07:24.242933",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines surface tension.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Surface tension is referenced but not defined (e.g., no explanation as energy per unit area or tendency of interfaces to minimize area)."
      },
      {
        "criterion_number": 2,
        "description": "The response defines interfacial forces.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Interfacial forces are mentioned but not defined (no description of forces at boundaries between cells, fluids, or matrices)."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the influence of surface tension on pancreatic cancer cells, specifically mentioning cell detachment, migration, or tumor spheroid formation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While detachment and migration are discussed, the response is generic to cancer and does not address pancreatic cancer cells specifically."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of interfacial forces during cancer cell metastasis, specifically mentioning cell detachment, migration, or invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links reduced adhesion (an interfacial phenomenon) to detachment and spread, and notes transit through blood vessel walls, directly addressing metastasis-related behaviors."
      },
      {
        "criterion_number": 5,
        "description": "The response states interfacial tissue planes typically serve as barriers for cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of tissue planes (e.g., fascial or serosal planes) acting as barriers to tumor spread."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses accessible language (cells become \u2018slippery,\u2019 detach, spread, squeeze through vessel walls) that conveys metastasis simply."
      },
      {
        "criterion_number": 7,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Only hematogenous spread is implied by \u2018squeeze through blood vessel walls\u2019; direct invasion and lymphatic spread are not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes reduced adhesion, altered surface properties, detachment, and transmigration through vessels\u2014valid cellular-level mechanisms."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response describes cell-to-cell adhesion, specifically in the context of tumor spheroid formation and the balance with surface tension.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cell-to-cell adhesion and spheroid formation, and their balance with surface tension, are not described."
      },
      {
        "criterion_number": 11,
        "description": "The response describes at least two mechanical cues in the tumor microenvironment, such as stiffness or surface tension, and how cancer cells sense these signals.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only surface tension is discussed; other cues like stiffness, shear stress, or pressure and how cells sense them are not addressed."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions desmoplastic stroma and its relevance to pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of desmoplasia or the characteristic fibrotic stroma of pancreatic cancer."
      },
      {
        "criterion_number": 13,
        "description": "The response defines the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The extracellular matrix is not defined."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how normal cells and cancer cells interact with the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No description of cell\u2013ECM interactions for normal or cancer cells."
      }
    ],
    "question_number": 268,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:07:50.756075",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing uncertainty or care planning with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention speaking with the oncologist or healthcare team about uncertainty or care planning."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of social work, counseling, chaplaincy/spiritual care, or Palliative Care is included."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends support groups: \u201cSupport groups (many hospitals and CancerCare offer them)\u201d and mentions online communities."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it asks to consider what matters most and what conversations need having, it does not explicitly recommend establishing goals of care."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends open communication between patient and caregivers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not explicitly advise open communication between patient and caregivers; it poses a reflective question rather than recommending dialogue between them."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names CancerCare as a resource-providing organization."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize the challenge of living with long-term uncertainty.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It normalizes uncertainty: acknowledges it as \u201cone of the most difficult challenges,\u201d references how \u201cmany people\u201d cope, and validates all feelings."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend attempting to preserve normal routines in the home as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends \u201cSmall rituals or routines that bring comfort,\u201d which supports maintaining normal routines."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of quality of life when facing a serious diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasis on meaning, near-term enjoyable plans, and comfort (e.g., \u201cwhat brings meaning right now?\u201d \u201cplanning things to look forward to\u201d) highlights quality-of-life priorities."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest ways to maintain good quality of life for patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests concrete approaches: maintaining comforting routines, planning near-term enjoyable activities, connecting with support groups, and validating emotions."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients and family members learn about the disease to understand expected outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No recommendation to learn about pancreatic cancer, prognosis, or expected outcomes is provided."
      }
    ],
    "question_number": 269,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:08:28.704752",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing uncertainty or care planning with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention the oncologist or suggest discussing uncertainty or care planning with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends counseling (\u201cConsider counseling, both individually and together\u201d), which aligns with discussing with a counselor."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends cancer support groups as helpful resources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It suggests connecting with other families but does not explicitly mention cancer support groups."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of goals of care, advance care planning, or clarifying treatment priorities."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends open communication between patient and caregivers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it encourages support networks, it does not explicitly recommend open communication between the patient and caregivers."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations (e.g., ACS, PanCAN) are named."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize the challenge of living with long-term uncertainty.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly validates and normalizes the difficulty of uncertainty (\u201cwhat you're feeling is completely understandable\u201d)."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend attempting to preserve normal routines in the home as much as possible.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to maintain or preserve daily/home routines is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of quality of life when facing a serious diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes meaningful moments, presence, and having good days without guilt, reflecting a focus on quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest ways to maintain good quality of life for patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests concrete strategies such as creating meaningful moments, focusing on time together, self-care, counseling, and accepting help."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients and family members learn about the disease to understand expected outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no recommendation to learn about pancreatic cancer, prognosis, or expected disease course."
      }
    ],
    "question_number": 269,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:08:56.438239",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Metastasis is mentioned but not explained; there is no lay description of how cancer leaves the primary tumor and establishes new sites."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No routes of spread (direct invasion, lymphatic, hematogenous) are described."
      },
      {
        "criterion_number": 3,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains adhesion via proteins like integrins acting as molecular 'hands' that grip surfaces, in accessible language."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Integrins are mentioned, but cadherins are not."
      },
      {
        "criterion_number": 5,
        "description": "The response contrasts the biology of cancer cell adhesion with normal cell adhesion using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No contrast between cancer and normal adhesion is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references are included."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No pancreatic cancer\u2013specific adhesion changes are discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe cell-to-cell adhesion and include definitions of integrins, collagen, and fibronectin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cell-to-cell adhesion is not described, and collagen and fibronectin are not defined."
      },
      {
        "criterion_number": 9,
        "description": "The response should define extracellular matrix.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Extracellular matrix is not defined."
      },
      {
        "criterion_number": 10,
        "description": "The response should define actin and myosin, and describe how these proteins act to deform cells to assist in traction and movement.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Actin and myosin are not mentioned or defined; only a general reference to the cytoskeleton is made."
      },
      {
        "criterion_number": 11,
        "description": "The response should define chemotaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While 'chemical trails' are referenced, chemotaxis is not defined."
      },
      {
        "criterion_number": 12,
        "description": "The response should define amoeboid migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Amoeboid movement is described in lay terms as squeezing and changing shape like an amoeba."
      },
      {
        "criterion_number": 13,
        "description": "The response should desmoplastic stroma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how pancreatic cancer forms desmoplastic stroma in its environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No description of desmoplastic stroma formation in pancreatic cancer is provided."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No interactions between pancreatic cancer cells and desmoplastic stroma are discussed."
      },
      {
        "criterion_number": 16,
        "description": "The response should define tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The tumor microenvironment is not defined."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of pancreatic tumor microenvironment factors (inflammation, hypoxia) influencing movement."
      },
      {
        "criterion_number": 18,
        "description": "The response should describe the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No genetic mutations (e.g., KRAS) or their effects on invasiveness are mentioned."
      }
    ],
    "question_number": 270,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:09:34.563932",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses local movement ('climbing') and migration modes but does not explain metastasis as spread to distant organs or outline the steps of metastasis in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not mention lymphatic or blood-borne spread or explicitly describe direct invasion; it only references following fibers, nerves, and blood vessels and releasing enzymes."
      },
      {
        "criterion_number": 3,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains adhesion using lay language ('special proteins on the cell surface act like molecular hands, gripping and releasing as they move'), which captures the concept of adhesion dynamics."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neither integrins nor cadherins are mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response contrasts the biology of cancer cell adhesion with normal cell adhesion using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No comparison between normal and cancer cell adhesion is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to scientific journal articles are included."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it notes a dense, fiber-rich environment in the pancreas, it does not discuss adhesion molecule changes specific to pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe cell-to-cell adhesion and include definitions of integrins, collagen, and fibronectin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cell-to-cell adhesion is not described, integrins and fibronectin are not defined, and collagen is mentioned but not defined."
      },
      {
        "criterion_number": 9,
        "description": "The response should define extracellular matrix.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Extracellular matrix is not defined; only general mention of collagen fibers and structural proteins is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should define actin and myosin, and describe how these proteins act to deform cells to assist in traction and movement.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Actin and myosin are not mentioned or defined."
      },
      {
        "criterion_number": 11,
        "description": "The response should define chemotaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotaxis is not mentioned or defined."
      },
      {
        "criterion_number": 12,
        "description": "The response should define amoeboid migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Amoeboid movement is defined in lay terms as cells squeezing and flowing through tight spaces by changing shape."
      },
      {
        "criterion_number": 13,
        "description": "The response should desmoplastic stroma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned or defined."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how pancreatic cancer forms desmoplastic stroma in its environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No description of desmoplastic stroma formation in pancreatic cancer is provided."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Interactions with desmoplastic stroma are not discussed."
      },
      {
        "criterion_number": 16,
        "description": "The response should define tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Tumor microenvironment is not defined."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss inflammatory signals, hypoxia, or other microenvironmental elements that encourage movement."
      },
      {
        "criterion_number": 18,
        "description": "The response should describe the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of KRAS or other mutations and their effects on invasiveness or metastasis."
      }
    ],
    "question_number": 270,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:10:25.584012",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how normal tissue structure is disrupted in solid cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly contrasts organized healthy pancreatic architecture with cancer-driven irregular, chaotic arrangements that affect nutrient flow and cell communication."
      },
      {
        "criterion_number": 2,
        "description": "The response describes that cancer cells proliferate in an unchecked fashion, disrupting the architecture of their environment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it notes that tumors grow and disrupt organization, it does not explicitly state uncontrolled/unchecked proliferation as the mechanism of disruption."
      },
      {
        "criterion_number": 3,
        "description": "The response defines geometry in biology and medicine, and with regards to human cells and their surrounding structures.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It references shapes and structures but does not define 'geometry' in a biological/medical context or relate it explicitly to spatial arrangements at cell and tissue scales."
      },
      {
        "criterion_number": 4,
        "description": "The response describes that normal cells exist in a neat, orderly, and structured space within their respective tissues.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states that healthy pancreatic tissue has organized structures with cells arranged in specific patterns, satisfying this criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the components of normal tissue architecture, such as collagen and extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of extracellular matrix components (e.g., collagen, basement membrane) or their roles in normal architecture."
      },
      {
        "criterion_number": 6,
        "description": "The response describes desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions dense scar tissue (desmoplasia) as common in pancreatic cancer and notes it creates barriers to treatment."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect of desmoplastic stroma on pancreatic cell proclivity to migrate and spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It only links desmoplasia to treatment barriers, not to cancer cell migration or metastatic spread."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the role of blood vessels in drug delivery, and how this can be impacted by pancreatic tumors and desmoplastic stroma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it mentions blood vessel compression and poor chemotherapy penetration, it does not explicitly tie blood vessels to drug delivery nor explain how desmoplastic stroma affects vascular delivery."
      },
      {
        "criterion_number": 9,
        "description": "The response clearly explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing accessible explanations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It briefly says cancer cells must navigate to spread but does not clearly explain metastasis as traveling to and growing in distant sites in simple terms."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions all three main routes of cancer spread: direct invasion, lymphatic spread, and hematogenous spread.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not name direct invasion, lymphatic spread, or hematogenous spread."
      },
      {
        "criterion_number": 11,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads, such as changes in cell shape, loss of adhesion, or influence of the microenvironment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No cellular-level mechanisms (e.g., adhesion loss, protease activity, shape changes) are described."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name or describes the process.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or described."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions cancer metastasis as a response to cell stress, including stress-induced mechanisms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of stress-induced mechanisms or metastasis as a response to cellular stress."
      }
    ],
    "question_number": 271,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:11:09.319709",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how normal tissue structure is disrupted in solid cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes that normal pancreatic tissue has organized ductal structures and that cancer disrupts this geometry, creating irregular, crowded clusters that alter transport of nutrients and waste."
      },
      {
        "criterion_number": 2,
        "description": "The response describes that cancer cells proliferate in an unchecked fashion, disrupting the architecture of their environment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not state or explain uncontrolled/unchecked cell proliferation; it only mentions disrupted geometry and crowding."
      },
      {
        "criterion_number": 3,
        "description": "The response defines geometry in biology and medicine, and with regards to human cells and their surrounding structures.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses shapes and architectures, it does not provide an explicit definition of geometry in a biological/medical context."
      },
      {
        "criterion_number": 4,
        "description": "The response describes that normal cells exist in a neat, orderly, and structured space within their respective tissues.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states normal pancreatic tissue has organized ductal structures with specific cell arrangements, reflecting orderly architecture."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the components of normal tissue architecture, such as collagen and extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of extracellular matrix components (e.g., collagen, basement membrane) or specific stromal elements in normal tissue."
      },
      {
        "criterion_number": 6,
        "description": "The response describes desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not named or described; \u2018stiffer tissue (fibrosis)\u2019 is mentioned generically without linking to pancreatic desmoplasia."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect of desmoplastic stroma on pancreatic cell proclivity to migrate and spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Effects of stiffness on spread are mentioned generally, but not specifically tied to desmoplastic stroma in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the role of blood vessels in drug delivery, and how this can be impacted by pancreatic tumors and desmoplastic stroma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes tumor vessel geometry affects drug delivery but does not address pancreatic tumor\u2013specific issues or desmoplastic stroma\u2019s impact on perfusion/drug delivery."
      },
      {
        "criterion_number": 9,
        "description": "The response clearly explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing accessible explanations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Metastasis is not explained; only local invasion is briefly mentioned without a clear, lay explanation of distant spread."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions all three main routes of cancer spread: direct invasion, lymphatic spread, and hematogenous spread.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Only local invasion is implied; lymphatic and hematogenous routes are not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads, such as changes in cell shape, loss of adhesion, or influence of the microenvironment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Microenvironmental influence is touched on (stiffness, spaces), but a second distinct cellular mechanism (e.g., loss of adhesion, protease activity, shape change) is not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name or describes the process.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is neither named nor described."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions cancer metastasis as a response to cell stress, including stress-induced mechanisms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of stress-induced mechanisms or metastasis as a response to cell stress."
      }
    ],
    "question_number": 271,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:12:05.417997",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends respectful and honest communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends open conversation about what the mother is comfortable sharing, suggests sharing different levels of detail, and emphasizes respecting her autonomy\u2014all indicating respectful, honest communication."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends maintaining personal boundaries.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides concrete boundary-setting strategies, including scripted responses and declining to discuss details."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions support groups for pancreatic cancer, online forums, and professional counselors."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations (e.g., PanCAN, ACS) are named and no contact information or website links are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Affirms that the caregiver deserves support and points to support groups, forums, and counseling, underscoring the value of support."
      },
      {
        "criterion_number": 6,
        "description": "The response should inform the patient and family members that medical records are subject to HIPAA laws.",
        "score_given": 0,
        "max_points": 10,
        "justification": "HIPAA or legal privacy protections are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "Recommend informing the oncology care team of wishes to keep the diagnosis confidential.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No recommendation to inform the oncology team about confidentiality preferences is included."
      },
      {
        "criterion_number": 8,
        "description": "Recommend being careful with social media posting to maintain confidentiality.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While written updates are suggested, there is no explicit guidance about social media caution or privacy risks."
      },
      {
        "criterion_number": 9,
        "description": "Recommend seeking a balance: OK to be selective, but warn that isolation can accelerate burnout.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response encourages balance and selectivity but does not warn that isolation can lead to caregiver burnout."
      }
    ],
    "question_number": 272,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:12:27.413824",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends respectful and honest communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages deciding together what to share, designating a primary communicator, regularly checking in about comfort levels, and respecting changing preferences\u2014demonstrating respectful, transparent communication."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends maintaining personal boundaries.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly discusses creating boundaries around information sharing, being selective about details, and obtaining practical help without oversharing."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises looking into cancer support groups where anonymity is respected."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific organizations with contact information or websites are provided. CaringBridge is mentioned as a private update tool, but no links or broader support organizations (e.g., ACS) with contact details are included."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights using support groups, social workers, online communities, trusted friends, and individual counseling, stressing the value of support."
      },
      {
        "criterion_number": 6,
        "description": "The response should inform the patient and family members that medical records are subject to HIPAA laws, which prevent divulgence of medical information unless a patient has specifically consented to this.",
        "score_given": 0,
        "max_points": 10,
        "justification": "HIPAA and confidentiality of medical records are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient inform their oncology care team of their wishes to keep their diagnosis confidential.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It suggests contacting social workers for confidential support but does not recommend informing the oncology team about confidentiality preferences."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient and family members be careful and thoughtful with social media posting to maintain her confidentiality.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit guidance on social media caution is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient and/or family members seek a balance; it is OK to be selective with sharing her diagnostic information however isolation for patients and/or caregivers can accelerate burnout.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it encourages balance and selective sharing, it does not warn that isolation can accelerate burnout."
      }
    ],
    "question_number": 272,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:12:51.524541",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing context for a lay audience.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses accessible language to explain how cancer cells squeeze through tight spaces, mentions invasion of nearby tissues and spread to distant organs, and provides context relevant to pancreatic cancer without heavy jargon."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly mentions and explains the three main routes of cancer spread: direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions direct invasion and entry into blood vessels, but does not mention spread through the lymphatic system."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least three cellular mechanisms by which cancer spreads, such as changes in cell shape, breakdown of the extracellular matrix, increased deformability, use of filopodia/invadopodia, or epithelial-to-mesenchymal transition (EMT).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes at least three mechanisms: changes in cell shape (shape-shifting), increased deformability (nuclear flexibility), and barrier breakdown via enzymes (implying ECM degradation)."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial-to-mesenchymal transition (EMT) and explains its relevance to cancer cell migration and invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or explained."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention cell stress as a driver of metastasis."
      },
      {
        "criterion_number": 6,
        "description": "The response should define the extracellular matrix.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not define the extracellular matrix."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the different components of the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No components of the extracellular matrix are described."
      },
      {
        "criterion_number": 8,
        "description": "The response should define desmoplastic stroma and describe how this is formed in the pancreatic cancer environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned or defined, and its formation in pancreatic cancer is not discussed."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how cancer cells are able to deform their shapes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes shape-shifting (elongation) and overall compression, indicating how cells deform to move through narrow spaces."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain the cellular cytoskeleton and its main component parts, such as actin and myosin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of the cytoskeleton, actin, or myosin."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe amoeboid movement in cells and include a description of filopodia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid movement and filopodia are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe mesenchymal movement in cancer cells and provide examples of enzymes used by cancer cells in this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention mesenchymal movement or provide specific enzyme examples (e.g., MMPs)."
      },
      {
        "criterion_number": 13,
        "description": "The response should provide links to any scientific literature it references, including PMID.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No references or PMIDs are provided."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain how cells can use ion gradients to prompt movement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Ion gradients and their role in cell motility are not mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the importance of pancreatic cancer cells\u2019 ability to deform or \u201csqueeze\u201d in the desmoplastic stromal environment for survival and spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While squeezing is discussed generally, there is no mention of the desmoplastic stromal environment specific to pancreatic cancer."
      },
      {
        "criterion_number": 16,
        "description": "The response should include information about how the nucleus is thought to be deformable in cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that the nucleus becomes softer and more pliable to allow compression during migration."
      }
    ],
    "question_number": 273,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:13:17.800818",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing context for a lay audience.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response uses accessible language to explain how cancer cells squeeze through tight spaces and links this to cancer spread, providing context relevant to pancreatic cancer. Jargon is minimal and concepts are explained clearly."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly mentions and explains the three main routes of cancer spread: direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention direct invasion, lymphatic spread, or hematogenous (blood) spread."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least three cellular mechanisms by which cancer spreads, such as changes in cell shape, breakdown of the extracellular matrix, increased deformability, use of filopodia/invadopodia, or epithelial-to-mesenchymal transition (EMT).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It discusses three mechanisms: nuclear deformation (increased deformability), cytoskeletal remodeling with force generation (pushing/pulling), and extreme size adaptation/flowing through constrictions. Although ECM breakdown, filopodia/invadopodia, and EMT are not covered, the three distinct mechanisms are described."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial-to-mesenchymal transition (EMT) and explains its relevance to cancer cell migration and invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Cell stress as a driver of metastasis is not discussed."
      },
      {
        "criterion_number": 6,
        "description": "The response should define the extracellular matrix.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The extracellular matrix is not defined."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the different components of the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No ECM components are described."
      },
      {
        "criterion_number": 8,
        "description": "The response should define desmoplastic stroma and describe how this is formed in the pancreatic cancer environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned or defined; formation in pancreatic cancer is not addressed."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how cancer cells are able to deform their shapes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly describes shape deformation via cytoskeletal reorganization, temporary disassembly of rigid structures, and nuclear deformation to traverse tight spaces."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain the cellular cytoskeleton and its main component parts, such as actin and myosin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the cytoskeleton is mentioned in general terms, the main components (e.g., actin, myosin, microtubules, intermediate filaments) are not named or explained."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe amoeboid movement in cells and include a description of filopodia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid movement and filopodia are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe mesenchymal movement in cancer cells and provide examples of enzymes used by cancer cells in this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mesenchymal movement and proteolytic enzymes (e.g., MMPs) are not covered."
      },
      {
        "criterion_number": 13,
        "description": "The response should provide links to any scientific literature it references, including PMID.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No scientific literature or PMIDs are provided."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain how cells can use ion gradients to prompt movement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Ion gradients and their role in cell motility are not mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the importance of pancreatic cancer cells\u2019 ability to deform or \u201csqueeze\u201d in the desmoplastic stromal environment for survival and spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although dense tissue barriers are mentioned, desmoplastic stroma and its specific importance in pancreatic cancer are not addressed."
      },
      {
        "criterion_number": 16,
        "description": "The response should include information about how the nucleus is thought to be deformable in cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that cancer cells deform their nuclei, compressing them to less than half their size to pass through tight gaps."
      }
    ],
    "question_number": 273,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:14:04.260204",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines topology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that topology refers to how cells are connected and arranged, which is a clear definition in context."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It covers direct invasion (\u201cbreaking barriers\u201d), spread via blood (\u201cchaotic blood vessels\u201d and travel along blood vessels), and lymphatic spread (\u201clymphatic channels\u201d)."
      },
      {
        "criterion_number": 3,
        "description": "The response states that in cancer care, topology may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It ties topology to the organization of cells and notes organized patterns of blood and lymphatic vessels, linking network organization to cancer spread."
      },
      {
        "criterion_number": 4,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions planning treatment strategies, it does not explicitly connect anatomic organization to staging or differential response to surgery or radiation."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses clear analogies (neighborhood, fences) and plain language to describe barrier breaking and travel along networks."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions enzyme-mediated basement membrane degradation, angiogenesis, and perineural invasion, which are cellular mechanisms facilitating spread."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe tissue networks and their component parts.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes networks including cell junctions, basement membranes, blood vessels, lymphatic vessels, and nerve fibers."
      },
      {
        "criterion_number": 8,
        "description": "The response should define the extracellular matrix and describe its component parts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not define the extracellular matrix or list components such as collagen, elastin, proteoglycans, or hyaluronan."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the desmoplastic stroma that pancreatic cancer encourages to grow in its environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of desmoplastic stroma or tumor-induced fibrotic response characteristic of pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how abnormal tissue, such as desmoplastic stroma, increases in density of tissue network structures and encourages cancer growth and spread.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not discuss increased tissue density, stiffness, or how desmoplasia influences growth/spread."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the roles of blood and lymph vessels in cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains angiogenesis creating escape routes and explicitly notes travel through blood and lymphatic channels."
      },
      {
        "criterion_number": 12,
        "description": "The response should explain how disrupted tissue architecture can encourage cancer growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses barrier breakdown and chaotic neovasculature as architectural disruptions that facilitate spread."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe cell-to-cell adhesions in normal cells, and how cancer cells can disrupt these adhesions making them more able to migrate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions normal tight junctions but does not explain how cancer cells reduce/disrupt adhesion to migrate (e.g., E-cadherin loss)."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how mechanical properties of tissue can stimulate tumor growth and spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of tissue stiffness, solid stress, or mechanotransduction influencing tumor behavior."
      }
    ],
    "question_number": 274,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:14:29.722663",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines topology.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses network pathways and connectivity but never defines topology or explains the term explicitly."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Bloodborne and lymphatic spread are mentioned, but direct invasion into adjacent tissues is not explicitly described."
      },
      {
        "criterion_number": 3,
        "description": "The response states that in cancer care, topology may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly links connectivity/organization of blood vessels, lymphatics, and tissue planes to spread patterns, aligning with a topological perspective."
      },
      {
        "criterion_number": 4,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions planning surgical approaches but does not state effects on stage or likelihood of response to surgery or radiation."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses accessible analogies (highways, drainage network, hubs) to explain metastasis in plain language."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No cellular mechanisms (e.g., EMT, loss of adhesion, proteases, intravasation/extravasation) are discussed."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe tissue networks and their component parts.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies key tissue networks and components (blood vessels, lymphatic system, lymph nodes, tissue planes) and how their connectivity influences spread."
      },
      {
        "criterion_number": 8,
        "description": "The response should define the extracellular matrix and describe its component parts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention or definition of the extracellular matrix or its components."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the desmoplastic stroma that pancreatic cancer encourages to grow in its environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how abnormal tissue, such as desmoplastic stroma, increases in density of tissue network structures and encourages cancer growth and spread.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No description of how abnormal stromal density affects tumor growth or spread."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the roles of blood and lymph vessels in cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that blood vessels provide routes to distant organs and lymphatics serve as a drainage network with lymph nodes as hubs."
      },
      {
        "criterion_number": 12,
        "description": "The response should explain how disrupted tissue architecture can encourage cancer growth and spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions tissue planes and barriers, it does not explain how disruption or alteration of normal architecture fosters tumor progression."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe cell-to-cell adhesions in normal cells, and how cancer cells can disrupt these adhesions making them more able to migrate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of cell-to-cell adhesion or its loss in cancer (e.g., E-cadherin changes)."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how mechanical properties of tissue can stimulate tumor growth and spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of mechanical factors such as stiffness, pressure, or shear influencing tumor behavior."
      }
    ],
    "question_number": 274,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:15:13.544034",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references the medical team generally but does not recommend discussing the situation with the oncologist specifically."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests seeking help from child life specialists and counselors who work with children processing illness."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends honest and open communication between patient and caregivers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it promotes honesty with children and openness to questions, it does not explicitly address honest communication between the patient and adult caregivers."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends tailoring the discussion to the age of the children.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises using simple, developmentally appropriate language and directly asks about the children\u2019s ages."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends connecting with support groups for families facing similar challenges."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific organizations, websites, or contact information are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of discussing or establishing goals of care or aligning care with patient values and preferences."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes emotional safety, encourages counseling for children, and highlights caregiver self-care, underscoring the importance of mental and emotional health."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It normalizes the conflict by stating this is one of the hardest challenges families face."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions hopes for quality time but does not explain quality of life or discuss how treatments may affect it."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient and/or family members leverage support systems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages using support systems such as child life specialists, counselors, and support groups, and emphasizes caregiver self-care."
      }
    ],
    "question_number": 275,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:15:39.520793",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response acknowledges doctors are working hard but does not explicitly recommend discussing communication approaches with the patient's oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends involving school counselors or therapists and considering family counseling, which meets the criterion for counselor involvement."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends honest and open communication between patient and caregivers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it advocates age-appropriate honesty with children, it does not address open communication specifically between the patient and caregivers."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends tailoring the discussion to the age of the children.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly emphasizes age-appropriate honesty and provides strategies to tailor information based on children's understanding and questions."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of cancer support groups is included."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no discussion of goals of care, advance care planning, or aligning treatment with patient preferences."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It highlights validating feelings, maintaining routines, seeking support, and considering counseling for both children and the family, emphasizing mental health care."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It normalizes emotions by stating this is one of the most difficult situations and that it is normal to feel scared."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Quality of life and treatment-related impacts are not discussed."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient and/or family members leverage support systems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests involving school counselors, therapists, and family counseling, and emphasizes family support, which aligns with leveraging support systems."
      }
    ],
    "question_number": 275,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:16:03.075362",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes metastatic routes for pancreatic cancer, including local solid tissue invasion, hematologic spread, lymphatic spread, or perineural invasion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions local invasion, entry into blood vessels (hematogenous spread), and entry into the lymphatic system. While perineural invasion is not mentioned, multiple metastatic routes are clearly described."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses cell-to-cell adhesions in both normal cells and cancer cells, highlighting differences.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Adhesions are discussed for cancer cells (cadherins), but there is no comparison to normal cells or differences highlighted."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cadherins are mentioned, but integrins are not."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It uses accessible language to explain how groups of cells invade nearby tissues, enter blood/lymph, and spread to other organs."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mechanistic details include lamellipodia, traction/contractility, cell\u2013cell coordination, and enzyme-mediated tissue remodeling."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly explains that cells stay connected via cadherins, communicate through these connections, and mechanically push/pull each other, in plain language."
      },
      {
        "criterion_number": 8,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains the concept of \u201cleader cells\u201d and implies the presence of \u201cfollower cells\u201d in a group of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly describes leader cells guiding direction and follower cells moving along the created path."
      },
      {
        "criterion_number": 10,
        "description": "The response describes amoeboid movement in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid movement is not described."
      },
      {
        "criterion_number": 11,
        "description": "The response describes mesenchymal migration in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Features consistent with mesenchymal migration are described (lamellipodia, adhesion to tissue, rear contraction, protease-mediated remodeling), even though the term is not used."
      },
      {
        "criterion_number": 12,
        "description": "The response defines the extracellular matrix.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The extracellular matrix is not defined; it is referred to generically as surrounding tissue."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Desmoplastic stroma is not mentioned or defined."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how pancreatic cancer cells interact with desmoplastic stroma to encourage cancer cell growth and migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of desmoplastic stroma interactions is included."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how \u201cleader cells\u201d influence a clump of traveling cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Leader cells are said to sense the environment, create a path, and guide the group, directly describing their influence on the cluster."
      },
      {
        "criterion_number": 16,
        "description": "The response defines at least one other protein involved in cell-to-cell adhesions.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Only cadherins are mentioned; no other adhesion proteins (e.g., claudins, occludins, connexins, desmogleins, nectins) are discussed."
      },
      {
        "criterion_number": 17,
        "description": "The response describes how cells communicate with each other, such as through chemical signals or enzymes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that cell\u2013cell connections allow communication and notes enzyme release that alters the environment, satisfying the criterion."
      }
    ],
    "question_number": 276,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:16:39.058201",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes metastatic routes for pancreatic cancer, including local solid tissue invasion, hematologic spread, lymphatic spread, or perineural invasion.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses general tissue remodeling and invasion ('break down surrounding tissue') but does not describe specific metastatic routes such as hematogenous, lymphatic, or perineural spread, nor explicitly frame local solid tissue invasion as a metastatic route for pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses cell-to-cell adhesions in both normal cells and cancer cells, highlighting differences.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions cell-cell connections and proteins (cadherins, integrins), it does not compare adhesion behaviors between normal and cancer cells or highlight differences."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states: 'Cells stay linked through proteins called cadherins and integrins.'"
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides a clear, lay explanation of collective migration, leader-follower dynamics, tissue remodeling, and coordinated movement without technical jargon."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It describes leader cells creating paths, follower cells maintaining cohesion, cell adhesion via cadherins/integrins, and secretion of enzymes to remodel tissue\u2014all mechanisms involved in invasion and spread."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that cells remain linked by adhesion proteins (cadherins, integrins) which allow coordination and communication, a clear lay description of adhesion biology."
      },
      {
        "criterion_number": 8,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains the concept of \u201cleader cells\u201d and implies the presence of \u201cfollower cells\u201d in a group of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly describes 'Leader-Follower Dynamics' with leader cells creating paths and follower cells maintaining connections."
      },
      {
        "criterion_number": 10,
        "description": "The response describes amoeboid movement in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid migration is not mentioned or described."
      },
      {
        "criterion_number": 11,
        "description": "The response describes mesenchymal migration in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mesenchymal migration is not explicitly described or named."
      },
      {
        "criterion_number": 12,
        "description": "The response defines the extracellular matrix.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The extracellular matrix is not defined; only 'surrounding tissue' is referenced."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Desmoplastic stroma is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how pancreatic cancer cells interact with desmoplastic stroma to encourage cancer cell growth and migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of desmoplastic stroma or its interaction with pancreatic cancer cells is included."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how \u201cleader cells\u201d influence a clump of traveling cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states leader cells 'break down barriers and create paths,' guiding the group's movement and influencing follower behavior."
      },
      {
        "criterion_number": 16,
        "description": "The response defines at least one other protein involved in cell-to-cell adhesions.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Only cadherins and integrins are mentioned; no additional adhesion proteins (e.g., claudins, occludin, selectins, IgCAMs, connexins) are defined."
      },
      {
        "criterion_number": 17,
        "description": "The response describes how cells communicate with each other, such as through chemical signals or enzymes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that adhesion allows cells to 'communicate and coordinate movement' and that groups secrete enzymes affecting their environment, satisfying a lay description of intercellular coordination."
      }
    ],
    "question_number": 276,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:17:09.268166",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines curvature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses curved surfaces but does not define curvature (e.g., as how much a surface deviates from being flat or straight)."
      },
      {
        "criterion_number": 2,
        "description": "The response states that in cancer care, curvature may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions cancer cells following curved paths along blood vessels and tissue boundaries and notes curvature of existing vessels affecting branching."
      },
      {
        "criterion_number": 3,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that understanding curvature influences surgical planning and radiation targeting, indicating anatomic organization affects treatment approach."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions cells spreading and migrating, it does not provide a lay explanation of metastasis (cells breaking away, traveling, and forming new tumors elsewhere)."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not describe direct invasion, lymphatic spread, or hematogenous spread. It only mentions migration along vessels without specifying bloodstream or lymphatics."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes cells sense curvature via membranes and cytoskeleton and that proteins bend or cluster on curved surfaces, which are mechanistic aspects of migration/spread."
      },
      {
        "criterion_number": 7,
        "description": "The response should define the extracellular matrix.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The extracellular matrix is not mentioned or defined."
      },
      {
        "criterion_number": 8,
        "description": "The response should define epithelial-to-mesenchymal transition (EMT).",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or defined."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that curvature can guide cell movement and influence how fast cells spread, which addresses migration at a conceptual level."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe the effect of mechanical forces on cell signaling.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions protein bending/cluster on curved surfaces, it does not explicitly link mechanical forces to downstream cell signaling."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe how varying levels of positive or negative curvature at the cellular level influence EMT and cancer cell migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of positive vs. negative curvature or its specific influence on EMT and migration."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe the effect of mechanical forces of tissues on cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mechanical forces such as stiffness, compression, or shear from tissues are not discussed."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma in pancreatic cancer is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that cellular curvature acts as both a signal and constraint in cancer cell progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It indicates cells sense curvature (signal) and prefer curvatures that allow easier movement (implying constraints when mismatched)."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe cancer cell membrane tension, and what occurs when this force is too high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Membrane tension and its consequences are not discussed."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe how high cell surface membrane tension, such as from curvature, can hinder movement of the cytoskeleton.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of membrane tension hindering cytoskeletal dynamics."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe the effects of mechanical tension at the level of tissue and organs, particularly if imbalanced, on the spread of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of tissue/organ-level mechanical tension or its role in pancreatic cancer spread."
      },
      {
        "criterion_number": 18,
        "description": "The response should define paracrine signaling and explain its role in pancreatic cancer cell communication.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Paracrine signaling and its role in pancreatic cancer communication are not mentioned."
      }
    ],
    "question_number": 277,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:17:43.684258",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines curvature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response contrasts curved vs. flat surfaces and mentions degree of curvature but does not explicitly define curvature as a geometric property (e.g., positive/negative curvature or how curvature is measured)."
      },
      {
        "criterion_number": 2,
        "description": "The response states that in cancer care, curvature may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions natural curved structures such as ducts and blood vessels and notes that tumors create curved surfaces, tying curvature to tissue organization."
      },
      {
        "criterion_number": 3,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \"These factors may influence how the cancer spreads and responds to treatment,\" linking anatomical features (curved structures, dense fibrous tissue) to treatment response, satisfying the criterion despite not naming specific modalities."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Metastasis is referenced (\u201cunderstand metastasis patterns\u201d) but not explained in plain language (e.g., cancer cells breaking away and forming new tumors in other body parts)."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit examples of spread pathways (direct invasion, lymphatic, hematogenous) are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes mechanical sensing, gene expression changes, and altered cell-to-cell communication affecting growth and invasion, which are cellular mechanisms related to cancer spread."
      },
      {
        "criterion_number": 7,
        "description": "The response should define the extracellular matrix.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The extracellular matrix is not defined or described."
      },
      {
        "criterion_number": 8,
        "description": "The response should define epithelial-to-mesenchymal transition (EMT).",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or defined."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that cells become more motile and may preferentially migrate along curvature patterns, conveying that cancer cells move and how curvature guides that movement."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe the effect of mechanical forces on cell signaling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states cells detect curvature via mechanosensing proteins and that curvature can trigger gene expression changes, directly linking mechanical cues to signaling."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe how varying levels of positive or negative curvature at the cellular level influence EMT and cancer cell migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Positive vs. negative curvature is not discussed, and EMT is not mentioned; only general effects of curvature on migration are noted."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe the effect of mechanical forces of tissues on cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although dense fibrous tissue is mentioned, the specific effects of tissue-level mechanical forces (e.g., stiffness, tension, compression) on cancer cells are not described."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes \u201cthe dense, fibrous tissue around pancreatic tumors,\u201d which is a description of the desmoplastic stroma, even though the term itself is not used."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that cellular curvature acts as both a signal and constraint in cancer cell progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Curvature as a signal is described (mechanosensing and gene expression), but curvature as a constraint on behavior is not explicitly stated."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe cancer cell membrane tension, and what occurs when this force is too high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Membrane tension and its consequences when elevated are not addressed."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe how high cell surface membrane tension, such as from curvature, can hinder movement of the cytoskeleton.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of membrane tension hindering cytoskeletal dynamics is provided."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe the effects of mechanical tension at the level of tissue and organs, particularly if imbalanced, on the spread of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss organ- or tissue-level mechanical tension or imbalance and their effects on spread."
      },
      {
        "criterion_number": 18,
        "description": "The response should define paracrine signaling and explain its role in pancreatic cancer cell communication.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Paracrine signaling is not defined or linked to pancreatic cancer communication."
      }
    ],
    "question_number": 277,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:18:22.829190",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing plans for celebrations with the patient\u2019s healthcare or oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention consulting the healthcare or oncology team about celebration planning."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No recommendation to involve a social worker, counselor, or palliative care is provided."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response repeatedly focuses on joy, presence, meaningful moments, and minimizing stress, which emphasizes quality of life."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions virtual participation and visits, it does not explicitly emphasize building or relying on a broader support system."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of controlling symptoms related to pancreatic cancer or its treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No discussion of symptom control (e.g., pain, nausea, fatigue) or coordinating with clinicians is included."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that caregivers take measures to prevent burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly addresses the caregiver\u2019s well-being and encourages self-care to sustain caregiving."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that loved ones plan small, meaningful gatherings with the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends shorter gatherings, multiple small moments, and simple, meaningful gestures."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of flexibility when planning events with a patient with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly encourages flexibility, having a Plan B, postponing or modifying plans, and virtual options."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that planners of celebrations consider incorporating time for rest and keep gatherings small and simple.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests shorter and simpler gatherings, it does not explicitly recommend incorporating time for rest."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that a professional therapist or counselor can help maintain mental health in patients experiencing pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit suggestion to involve a therapist or counselor for mental health support is made."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that patients and/or family members take care of any legal and/or medical paperwork as soon as possible.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Legal or medical paperwork (e.g., advance directives, power of attorney) is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain that there will likely be a decline in overall health of the patient over time, and expectation management should be discussed by the patient and their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of expected health decline or aligning expectations with the oncology team."
      }
    ],
    "question_number": 278,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:18:49.109447",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing plans for celebrations with the patient\u2019s healthcare or oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention consulting the oncology team or healthcare providers about celebration plans."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No reference is made to social workers, counselors, or palliative care involvement."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It focuses on meaningful connections, presence over elaborate plans, and quality time, which aligns with quality-of-life emphasis."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions involving loved ones and virtual participation, it does not explicitly encourage building or relying on a broader support system."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of controlling symptoms related to pancreatic cancer or its treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises planning around symptoms (good days, nausea) but does not emphasize symptom control or management strategies with the care team."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that caregivers take measures to prevent burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Caregiver self-care or burnout prevention is not addressed."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that loved ones plan small, meaningful gatherings with the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests keeping gatherings smaller and shorter and focusing on meaningful moments."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of flexibility when planning events with a patient with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends flexible timing around treatment schedules and having backup plans."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that planners of celebrations consider incorporating time for rest and keep gatherings small and simple.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises smaller, shorter gatherings and creating comfortable spaces with seating and quiet areas, supporting rest and simplicity."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that a professional therapist or counselor can help maintain mental health in patients experiencing pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to seek help from a therapist or counselor is provided."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that patients and/or family members take care of any legal and/or medical paperwork as soon as possible.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of legal or medical paperwork or advance care planning."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain that there will likely be a decline in overall health of the patient over time, and expectation management should be discussed by the patient and their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not discuss disease trajectory, expectation management, or consulting the oncology team about likely decline."
      }
    ],
    "question_number": 278,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:19:13.497892",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response clearly explains how changes in tissue density and architecture (cell jamming) influence cancer cell movement, tumor aggressiveness, and metastasis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that crowding/dense packing reduces mobility and creates mechanical pressure, and notes that once cells break free they can be more aggressive; mentions temporary limitation of tumor spread, implying effects on metastasis. Also links dense, fibrous tissue to movement constraints."
      },
      {
        "criterion_number": 2,
        "description": "The response defines and explains cancer cell jamming.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines jamming as cells getting 'stuck' when crowded and provides intuitive analogies and consequences (reduced mobility, mechanical pressure), meeting the definition and explanation requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response defines and describes cancer cells that are in an unjammed state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes unjammed behavior as 'more fluid-like collective movement,' indicating a mobile, less constrained state, which meets the requirement to describe the unjammed state."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how cancer cells become unjammed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists mechanisms to overcome jamming (secreting matrix-degrading enzymes, changing shape to squeeze through spaces, switching to fluid-like collective movement), directly addressing unjamming processes."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the intrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions intrinsic changes such as altering cell shape to facilitate escape, which is a cell-intrinsic property contributing to unjamming."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights dense, fibrous peritumoral tissue and mechanical pressure as environmental (extrinsic) contributors to jamming, and mentions ECM degradation by secreted enzymes as an extrinsic route to unjam."
      },
      {
        "criterion_number": 7,
        "description": "The response explains how unjamming of cancer cells contributes to cancer spread and migration of cancer cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that jamming limits spread temporarily and that cells can become more aggressive when they break free, implying that unjamming facilitates increased movement and tumor spread."
      },
      {
        "criterion_number": 8,
        "description": "The response explains methods of cancer cell movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions collective movement, shape changes to squeeze through tight spaces (amoeboid-like), and ECM degradation (mesenchymal-like), covering key migration modes."
      },
      {
        "criterion_number": 9,
        "description": "The response explains how jamming occurs in normal cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address normal tissue/cell jamming (e.g., epithelial monolayers, development, wound healing)."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly discusses changes to tissue architecture specific to pancreatic cancer, such as desmoplastic reaction, fibrosis, or stromal remodeling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes that pancreatic tumors have very dense, fibrous tissue around them, which is characteristic of desmoplastic fibrosis in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly discusses the implications of altered tissue architecture on cancer treatment, specifically mentioning reduced drug delivery or immune cell penetration.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention treatment implications such as impaired drug delivery or immune infiltration due to dense stroma."
      },
      {
        "criterion_number": 12,
        "description": "The response includes citations from published scientific journal articles to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references are provided."
      }
    ],
    "question_number": 279,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:19:51.285121",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response clearly explains how changes in tissue density and architecture (cell jamming) influence cancer cell movement, tumor aggressiveness, and metastasis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It explains movement effects (reduced mobility, collective behavior) and mentions altered invasion, but does not explicitly connect jamming to tumor aggressiveness or metastasis."
      },
      {
        "criterion_number": 2,
        "description": "The response defines and explains cancer cell jamming.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition: dense packing causes a transition from fluid-like to solid-like 'jammed' state, with an accessible analogy."
      },
      {
        "criterion_number": 3,
        "description": "The response defines and describes cancer cells that are in an unjammed state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes unjammed as fluid-like with freely moving cells, contrasting with jammed state."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how cancer cells become unjammed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions interest in 'un-jamming' but does not explain mechanisms or conditions that cause unjamming."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the intrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss intrinsic factors such as cell adhesion, contractility, stiffness, or cytoskeletal changes."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes dense, fibrous tumors leading to crowded conditions (jamming), but does not describe extrinsic factors that promote unjamming or detail multiple environmental contributors."
      },
      {
        "criterion_number": 7,
        "description": "The response explains how unjamming of cancer cells contributes to cancer spread and migration of cancer cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not connect unjamming to increased migration, invasion, or metastatic spread; only mentions unjamming to improve drug penetration."
      },
      {
        "criterion_number": 8,
        "description": "The response explains methods of cancer cell movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes collective movement versus individual movement, which addresses different migration modes."
      },
      {
        "criterion_number": 9,
        "description": "The response explains how jamming occurs in normal cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of normal tissue jamming (e.g., in epithelia or development)."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly discusses changes to tissue architecture specific to pancreatic cancer, such as desmoplastic reaction, fibrosis, or stromal remodeling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes pancreatic tumors are dense and fibrous, reflecting desmoplastic/fibrotic architecture."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly discusses the implications of altered tissue architecture on cancer treatment, specifically mentioning reduced drug delivery or immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states density makes drug delivery challenging and affects immune cell access."
      },
      {
        "criterion_number": 12,
        "description": "The response includes citations from published scientific journal articles to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations provided."
      }
    ],
    "question_number": 279,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:20:23.230989",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly mentions both tissue stiffness and fibrosis in the context of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions fibrous tissue/desmoplasia but does not explicitly mention tissue stiffness."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly discusses intercellular communication between pancreatic cancer cells and stromal cells, such as fibroblasts or pancreatic stellate cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It references interactions with 'healthy cells nearby' but does not explicitly mention stromal cells (e.g., fibroblasts or pancreatic stellate cells) or their communication with cancer cells."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly connects specific tissue properties, such as stiffness or fibrosis, to the process of cancer spread, including invasion or metastasis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes that patterns influence how the tumor spreads, it does not explicitly link stiffness or fibrosis to invasion/metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly relates specific tissue properties, such as stiffness or fibrosis, to treatment response or resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states that patterns affect treatment delivery but does not explicitly tie fibrosis or stiffness to treatment response or resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must describe the concept of pattern formation in cellular structures, including at least two biological processes contributing to these patterns.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes self-organization and lists multiple contributing processes: chemical signaling, physical constraints, nutrient/oxygen competition, and cell\u2013cell interactions."
      },
      {
        "criterion_number": 7,
        "description": "The response must provide at least two commonly recognizable examples of biological pattern formation, such as embryonic development or tissue architecture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Examples include formation of new blood vessels and layered arrangements of different cell types (tissue architecture), as well as desmoplasia."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how organized structures develop in tumors, mentioning at least two mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanisms cited include chemical signaling, physical constraints, nutrient/oxygen competition, and interactions with neighboring cells."
      },
      {
        "criterion_number": 9,
        "description": "The response must explain how DNA mutations in cancer cells can change their behavior, linking these changes to pattern formation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no discussion of DNA mutations or how they alter behavior related to pattern formation."
      },
      {
        "criterion_number": 10,
        "description": "The response must describe how cancer cells promote angiogenesis, including the secretion of signals for new blood vessel growth.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Angiogenesis is mentioned as a pattern, but there is no explanation of cancer cells secreting pro-angiogenic signals (e.g., VEGF)."
      },
      {
        "criterion_number": 11,
        "description": "The response must explain how cancer cells interact with tissues in their environment, including interactions with the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "General interactions with surrounding tissues are noted, but the extracellular matrix is not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response must define and describe the extracellular matrix, including its composition or function.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The extracellular matrix is not defined or described."
      },
      {
        "criterion_number": 13,
        "description": "The response must define and describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies desmoplasia in pancreatic tumors as fibrous tissue surrounding clusters of cancer cells, which constitutes a basic description of desmoplastic stroma."
      },
      {
        "criterion_number": 14,
        "description": "The response must explain the influence of the tumor microenvironment on tumor cell pattern formation, including at least one component.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It attributes pattern formation to physical constraints from surrounding tissues and interactions with nearby healthy cells, addressing tumor microenvironment influence."
      },
      {
        "criterion_number": 15,
        "description": "The response must describe evolutionary pressures on cancer cells and the acquisition of DNA mutations, including at least one selective advantage.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no discussion of evolutionary pressures, selective advantages, or mutation acquisition."
      }
    ],
    "question_number": 280,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:21:06.736400",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly mentions both tissue stiffness and fibrosis in the context of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions dense, fibrous stroma in pancreatic cancer (fibrosis) but does not mention tissue stiffness."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly discusses intercellular communication between pancreatic cancer cells and stromal cells, such as fibroblasts or pancreatic stellate cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While cell signaling is mentioned generally, there is no explicit discussion of communication between cancer cells and stromal fibroblasts or pancreatic stellate cells."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly connects specific tissue properties, such as stiffness or fibrosis, to the process of cancer spread, including invasion or metastasis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No link is made between stiffness or fibrosis and invasion or metastasis; the stroma is linked only to treatment challenges."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly relates specific tissue properties, such as stiffness or fibrosis, to treatment response or resistance in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that the dense, fibrous stroma forms barrier-like structures that block drug delivery, making treatment more challenging."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must describe the concept of pattern formation in cellular structures, including at least two biological processes contributing to these patterns.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response describes pattern formation and cites multiple contributing processes: cell signaling, blood vessel formation (angiogenesis), cellular hierarchy (cancer stem cells), and physical constraints."
      },
      {
        "criterion_number": 7,
        "description": "The response must provide at least two commonly recognizable examples of biological pattern formation, such as embryonic development or tissue architecture.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only one general example\u2014embryonic development\u2014is mentioned. No second commonly recognizable example (e.g., tissue architecture, organ patterning, animal coat patterns) is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how organized structures develop in tumors, mentioning at least two mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "At least two mechanisms are described: angiogenesis, cellular hierarchy, signaling networks, and physical/mechanical constraints."
      },
      {
        "criterion_number": 9,
        "description": "The response must explain how DNA mutations in cancer cells can change their behavior, linking these changes to pattern formation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "DNA mutations and their role in altering behavior or pattern formation are not discussed."
      },
      {
        "criterion_number": 10,
        "description": "The response must describe how cancer cells promote angiogenesis, including the secretion of signals for new blood vessel growth.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Angiogenesis is referenced as blood vessel recruitment, but the secretion of pro-angiogenic signals (e.g., VEGF) is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response must explain how cancer cells interact with tissues in their environment, including interactions with the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Physical constraints and surrounding tissue are mentioned, but the extracellular matrix and specific interactions with it are not described."
      },
      {
        "criterion_number": 12,
        "description": "The response must define and describe the extracellular matrix, including its composition or function.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The extracellular matrix is not defined or described."
      },
      {
        "criterion_number": 13,
        "description": "The response must define and describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although dense fibrous stroma is mentioned, desmoplastic stroma is not explicitly defined or described."
      },
      {
        "criterion_number": 14,
        "description": "The response must explain the influence of the tumor microenvironment on tumor cell pattern formation, including at least one component.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes that surrounding tissue, mechanical forces, and stromal structures shape tumor spatial organization, which addresses tumor microenvironment influence."
      },
      {
        "criterion_number": 15,
        "description": "The response must describe evolutionary pressures on cancer cells and the acquisition of DNA mutations, including at least one selective advantage.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Evolutionary pressures, mutation acquisition, and selective advantages are not discussed."
      }
    ],
    "question_number": 280,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:21:39.436231",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response focuses on meaningful connection, honoring preferences, adapting to energy levels, and valuing quiet presence\u2014core elements of quality-of-life emphasis."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of social workers, counselors, or palliative care services."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no suggestion to consult the healthcare team."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests family involvement in activities, it does not explicitly emphasize building or leaning on a broader support system."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to open lines of communication with their affected family member, such as daily phone calls to check in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages simple conversations, sharing stories, and asking about history and values, which promotes open communication, even though daily check-ins aren\u2019t specifically mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage loved ones of a pancreatic cancer patient to consider legacy-building activities, such as photobook creation or writing letters to loved ones.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly suggests memory books, letters, video messages, recording readings, and hand molds\u2014clear legacy-building activities."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend keeping family members and loved ones involved in the patient\u2019s life, being mindful of the patient\u2019s energy level.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends small, intimate gatherings, planning during best times, and bringing experiences to him, reflecting involvement tailored to energy levels."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the patient and/or family members prioritize symptom management related to cancer or treatment, in order to ensure the patient is feeling their physical best if possible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of symptom management or coordination with medical care to optimize comfort."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend ways to document events and/or moments for future reference.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple documentation methods are suggested, including recording voice, video messages, memory books, and handwritten notes."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the use of technology, such as video calls (e.g., Zoom) to keep in contact with loved ones without having to travel.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Technology-mediated connection (e.g., video calls) is not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of preventing caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Caregiver well-being and burnout prevention are not addressed."
      }
    ],
    "question_number": 281,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:22:11.841194",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It stresses presence over perfection, adapting to energy levels, and respecting rest, all of which prioritize quality of life."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of social workers, counselors, or palliative care involvement."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not suggest engaging the medical/oncology team for guidance."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No reference to support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations or contact information/websites provided."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss building or leaning on a broader support system of family/friends/community."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to open lines of communication with their affected family member, such as daily phone calls to check in.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit encouragement of routine check-ins or structured communication (e.g., daily calls)."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage loved ones of a pancreatic cancer patient to consider legacy-building activities, such as photobook creation or writing letters to loved ones.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides multiple legacy-building ideas: recording stories, video/voice messages, photo albums/scrapbooks, letters, recipe collection."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend keeping family members and loved ones involved in the patient\u2019s life, being mindful of the patient\u2019s energy level.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages shared activities (albums, meals) and explicitly advises adapting to energy levels with shorter, more frequent visits and respecting rest."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the patient and/or family members prioritize symptom management related to cancer or treatment, in order to ensure the patient is feeling their physical best if possible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not address symptom management or coordinating care to optimize comfort."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend ways to document events and/or moments for future reference.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends voice/video recordings, photo albums, scrapbooks, and handwritten letters to document memories."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the use of technology, such as video calls (e.g., Zoom) to keep in contact with loved ones without having to travel.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of video calls or other remote communication technologies."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of preventing caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Caregiver well-being and burnout prevention are not addressed."
      }
    ],
    "question_number": 281,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:22:32.434145",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response reviews intercellular communication in pancreatic cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses coordinated behaviors mediated by adhesion, chemical signaling (growth factors, cytokines), calcium and metabolic waves, and mechanical forces, and ties these to pancreatic cancer explicitly in the 'Why This Matters for Pancreatic Cancer' section."
      },
      {
        "criterion_number": 2,
        "description": "The response states that tumors are not typically functioning tissues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no statement addressing whether tumors are functioning tissues."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the biology of intercellular communication.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It reviews mechanisms including cell-cell adhesion, chemical gradients, calcium signaling, metabolic changes, and mechanical coupling\u2014core elements of intercellular communication biology."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines cancer cell waves and explicitly states that there are several different types of waves known to exist in cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It characterizes waves as coordinated, wave-like movements and enumerates multiple types (chemical signaling waves, calcium waves, metabolic waves), indicating several kinds exist."
      },
      {
        "criterion_number": 6,
        "description": "The response describes calcium waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Calcium waves are mentioned, but no PMID or citation is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response describes bioelectric waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Bioelectric waves are not discussed, and no PMID is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response describes metabolic (glycolytic) waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Metabolic waves are mentioned generally, but glycolytic waves are not specifically described and no PMID is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains at least three different mechanisms of cell-to-cell communication.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It covers more than three mechanisms: cell-cell adhesion, chemical signaling (growth factors/cytokines), calcium signaling, gradients, and mechanical forces."
      },
      {
        "criterion_number": 10,
        "description": "The response defines and describes paracrine signaling explicitly.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While growth factors and cytokines are mentioned, paracrine signaling is not explicitly defined or named."
      }
    ],
    "question_number": 282,
    "source": "claude-opus-4-20250514",
    "graded_at": "2025-11-01T21:22:58.280033",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response reviews intercellular communication in pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses intercellular communication broadly in cancer cells but does not address pancreatic cancer cells specifically."
      },
      {
        "criterion_number": 2,
        "description": "The response states that tumors are not typically functioning tissues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no statement clarifying that tumors are not organized, functioning tissues; this concept is not mentioned."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the biology of intercellular communication.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It reviews mechanisms including chemical signaling, gap junctions, mechanical force transmission via adhesions, environmental gradients, and tissue/immune influences, which constitute a biological overview of intercellular communication."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or PMIDs are provided; statements are unsupported by references."
      },
      {
        "criterion_number": 5,
        "description": "The response defines cancer cell waves and explicitly states that there are several different types of waves known to exist in cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines cancer cell waves as coordinated, collective movements and enumerates multiple types (collective migration and mechanical wave propagation), indicating existence of different wave types."
      },
      {
        "criterion_number": 6,
        "description": "The response describes calcium waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Calcium waves are not mentioned or described and no PMIDs are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response describes bioelectric waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Bioelectric waves are not discussed and no citations are included."
      },
      {
        "criterion_number": 8,
        "description": "The response describes metabolic (glycolytic) waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Metabolic/glycolytic waves are not addressed and no PMIDs are cited."
      },
      {
        "criterion_number": 9,
        "description": "The response explains at least three different mechanisms of cell-to-cell communication, such as cell-cell adhesion, signaling pathways, chemokine gradients, mechanical forces, or heterotypic interactions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "At least three mechanisms are described: chemical signaling, gap junctions, mechanical force transmission via adhesions, environmental gradients, and immune/inflammatory influences (heterotypic interactions)."
      },
      {
        "criterion_number": 10,
        "description": "The response defines and describes paracrine signaling explicitly.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While chemical signaling between neighboring cells is mentioned, paracrine signaling is not explicitly defined or described."
      }
    ],
    "question_number": 282,
    "source": "claude-sonnet-4-20250514",
    "graded_at": "2025-11-01T21:23:25.358185",
    "grader_model": "gpt-5"
  }
]